Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,vasculature development (GO:0001944),-0.7396825505549416,-2.1078977245029233,0.0,0.07921213999512984,0.07,14/16,21.10%,CDH5;ERRFI1;PDGFRB;PDGFRA;NOTCH4;FLT4;BMPR2;SOX18;ACVRL1;APLNR;ACVR2B;STRA6;STK11;FOXF1
prerank,B cell receptor signaling pathway (GO:0050853),-0.6243155860785989,-2.0837201193548403,0.0,0.06245572576539084,0.109,11/32,11.76%,BCL2;TEC;PRKCB;RFTN1;BMX;NFATC2;CD38;VAV3;SYK;PIK3CD;SH2B2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6099776578441106,-2.0678838385009572,0.0,0.05687025435547784,0.15,14/30,9.28%,TJP1;GJB6;OCLN;PECAM1;CDH5;LAMA2;CLDN5;ESAM;JAM2;LSR;F11R;SLC1A1;CLDN1;MFSD2A
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.5976842727063937,-2.060603015527107,0.0,0.047222621920173555,0.163,17/35,7.04%,KSR1;PDE7B;RAPGEF3;IRAG1;PDE4D;APOE;ADGRG6;RAPGEF2;RIMS2;CAP2;GUCY1B1;NUDT4;ADCY1;AHR;AKAP6;HTR2C;PDE2A
prerank,collagen fibril organization (GO:0030199),0.7262352073715318,2.034744706079758,0.0,0.003985212452505273,0.004,30/88,4.96%,COL12A1;PLOD2;COL6A3;COL6A2;COL6A1;ADAMTS3;ADAMTS2;COL8A2;COL8A1;BMP1;COL11A1;DDR2;COL3A1;COL1A2;COL1A1;COL5A3;COL14A1;P4HB;SERPINH1;COL5A2;COL15A1;COL27A1;COL16A1;LOXL1;CYP1B1;TLL1;TGFB2;PLOD1;P3H1;PLOD3
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.714554485879235,-1.9666330013046955,0.0,0.14623779691408587,0.462,5/15,11.88%,PLTP;APOE;ABCG1;ABCA5;SCARB1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6495907933759799,-1.956727814006204,0.0,0.1377749614445207,0.505,6/19,6.32%,TJP1;ROCK2;OCLN;CLDN5;PRKCH;F11R
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5163972688563658,-1.905405981705029,0.0,0.21282822229460707,0.707,18/46,14.80%,ATP1A2;GRM7;GRM5;NRXN1;SHANK3;GRM3;GRM8;GRM1;CACNG7;OPHN1;CACNG8;CDH2;HOMER1;CACNG3;CACNG4;DGKZ;RELN;TPRG1L
prerank,positive regulation of blood coagulation (GO:0030194),0.8280922702092406,1.863688739074014,0.0,0.20374398663433207,0.279,3/17,1.07%,THBS1;ST3GAL4;F3
prerank,bicarbonate transport (GO:0015701),0.7778202546280586,1.858107290759044,0.0,0.1547590835722881,0.313,7/25,7.29%,SLC4A10;SLC26A7;SLC4A4;SLC26A6;SLC4A8;SLC4A11;SLC4A2
prerank,muscle tissue morphogenesis (GO:0060415),-0.6438905982702754,-1.8430458134934273,0.007168458781362007,0.3466800550107365,0.883,8/16,15.96%,TGFBR3;MYLK;NOTCH1;TBX1;PROX1;HEY2;EFEMP2;BMP2
prerank,melanocyte differentiation (GO:0030318),-0.7332584696928719,-1.8413508485684567,0.0032258064516129032,0.3123350477300846,0.886,4/11,4.52%,LRMDA;KIT;ENPP1;MITF
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.661062273637357,1.833284127577635,0.0,0.2057365928605847,0.471,11/79,2.20%,BMPER;THBS1;SLIT2;HTRA3;FGF2;SKIL;NEDD4;CRIM1;SMAD9;EMILIN1;SMAD6
prerank,response to ketone (GO:1901654),0.7646693908752825,1.816851632562576,0.002506265664160401,0.2339319709620595,0.573,5/24,4.20%,THBS1;SLIT3;SLIT2;TGFB3;TGFB2
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6583984783382296,-1.8114825809931212,0.010676156583629894,0.37341415225909286,0.944,12/15,25.05%,IL31RA;NR1H3;LRFN5;CD200;ZC3H12A;CD300A;CD84;HAVCR2;GPER1;MILR1;CD300LF;GRN
prerank,response to glucocorticoid (GO:0051384),0.752362313014383,1.7964572932265215,0.0,0.3035403484658183,0.728,3/26,1.23%,SLIT3;SLIT2;ADAM9
prerank,external encapsulating structure organization (GO:0045229),0.6099943887398953,1.7869961773789724,0.0,0.3129815065378248,0.791,36/205,3.24%,THBS1;COL6A3;COL6A2;SMOC2;COL6A1;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;MFAP5;ELN;COL11A1;ITGA11;DDR2;FGF2;COL3A1;COL1A2;COL1A1;COL5A3;COL14A1;TGFBI;ADAMTSL1;COL5A2;BGN;VIT;COL15A1;COL27A1;COL16A1;LOXL1;DMP1;COMP;SPARC
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.684725013111302,-1.7849962523856222,0.013071895424836602,0.4343742641924078,0.973,3/12,2.53%,ROCK2;APOE;PICALM
prerank,extracellular structure organization (GO:0043062),0.6082913280622716,1.7824522489268664,0.0,0.2964001761550797,0.817,36/204,3.24%,THBS1;COL6A3;COL6A2;SMOC2;COL6A1;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;MFAP5;ELN;COL11A1;ITGA11;DDR2;FGF2;COL3A1;COL1A2;COL1A1;COL5A3;COL14A1;TGFBI;ADAMTSL1;COL5A2;BGN;VIT;COL15A1;COL27A1;COL16A1;LOXL1;DMP1;COMP;SPARC
prerank,carboxylic acid transmembrane transport (GO:1905039),0.70294821546875,1.7815518832102253,0.0,0.2680055374309796,0.822,10/40,7.05%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC5A6;SLC16A1;SLC38A6;ABCC1;SLC7A10;SLC38A3
prerank,extracellular matrix organization (GO:0030198),0.6048047470469715,1.7802347999668933,0.0,0.2485776267250164,0.83,58/276,6.99%,COL12A1;PLOD2;THBS1;COL6A3;COL6A2;SMOC2;COL6A1;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;BMP1;MFAP5;ELN;COL11A1;ITGA11;GAS6;DDR2;FGF2;COL3A1;COL1A2;GSN;COL1A1;COL5A3;COL14A1;P4HB;HTRA1;TGFBI;SERPINH1;TIMP2;ADAMTSL1;COL5A2;BGN;VIT;COL15A1;COL27A1;COL16A1;LOXL1;DMP1;COMP;SPARC;CYP1B1;TLL1;TGFB2;ADAMTS10;PLOD1;P3H1;PLOD3;MMP28;ADAM10;P4HA1;MMP14;LOX;QSOX1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.8189115764912089,1.7767323829174315,0.0013297872340425532,0.2402901962840111,0.843,3/14,7.13%,THBS1;CMKLR1;IRAK3
prerank,positive regulation of macrophage activation (GO:0043032),0.7896651003277484,1.7652986018042633,0.0026246719160104987,0.2713265478080673,0.897,3/17,1.29%,THBS1;LBP;IL33
prerank,establishment of endothelial barrier (GO:0061028),-0.5393444439666585,-1.764330961662261,0.0056179775280898875,0.4759498668083443,0.986,11/29,11.60%,TJP1;RAPGEF3;PDE4D;PECAM1;PPP1R16B;RAPGEF2;F11R;PDE2A;ROBO4;SOX18;RAP2B
prerank,regulation of cell junction assembly (GO:1901888),-0.5432555344827166,-1.7610773863057538,0.005128205128205128,0.45136858470597646,0.986,7/27,6.32%,TJP1;ROCK2;OCLN;CLDN5;RAPGEF2;PRKCH;F11R
prerank,protein hydroxylation (GO:0018126),0.8087503351227695,1.760931876874867,0.004016064257028112,0.27214402728550435,0.91,6/15,7.69%,PLOD2;P3H3;PLOD1;P3H1;PLOD3;P3H2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.7015851967293261,1.7599392582789706,0.0,0.25704620318659005,0.912,11/39,6.39%,SLIT2;LRP6;SIX1;PKD1;VEGFA;FGF2;GLI2;LRP5;PKHD1;SEMA3E;TGFBR2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7576557327313276,1.7597787653123806,0.002638522427440633,0.2402418906785262,0.913,5/20,8.26%,THBS1;SMOC2;FGF2;SULF1;NOG
prerank,embryonic digestive tract development (GO:0048566),0.759314476732054,1.7590160778662591,0.0,0.2290251781299124,0.917,6/18,4.20%,PKDCC;ID2;PCSK5;RARB;GLI2;TGFB2
prerank,regulation of cellular pH (GO:0030641),0.7107628917160261,1.7535031611087988,0.0012106537530266344,0.2370615348585857,0.941,9/29,7.29%,SLC4A10;SLC4A4;SLC26A6;SLC4A8;TM9SF4;SLC9A8;SLC9A4;SLC9A1;SLC4A2
prerank,Rap protein signal transduction (GO:0032486),-0.7022127339782779,-1.7506035583490387,0.013289036544850499,0.45887911868973563,0.992,4/10,11.65%,RAPGEF3;RAPGEF2;RAP2B;PLK2
prerank,negative regulation of heart contraction (GO:0045822),-0.7130208948819086,-1.7502657650434847,0.010714285714285714,0.42916731233258804,0.992,2/11,1.29%,ATP1A2;PDE4D
prerank,cellular response to zinc ion (GO:0071294),-0.6569725355426077,-1.7493720160452488,0.0,0.4051370910167578,0.993,12/15,18.03%,GLRA2;MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;GLRA1;ATP13A2;MT3
prerank,positive regulation of hemostasis (GO:1900048),0.8788449721589355,1.746916254973899,0.0014814814814814814,0.2375396369716959,0.959,2/10,0.30%,THBS1;ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.8788449721589355,1.746916254973899,0.0014814814814814814,0.2375396369716959,0.959,2/10,0.30%,THBS1;ST3GAL4
prerank,lipoprotein catabolic process (GO:0042159),-0.6678424795851982,-1.743845401590346,0.0297029702970297,0.39964495970393565,0.996,4/11,15.58%,APOE;NOTUM;ABHD17C;LYPLA1
prerank,motor neuron axon guidance (GO:0008045),0.792323833454466,1.7419758060858994,0.0,0.24593742347523165,0.97,4/15,2.65%,SLIT2;SLIT1;NTN1;TMEFF1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.7808563932886856,1.7376570840832362,0.004021447721179625,0.25239678865866727,0.973,5/16,6.29%,ESR1;DDX5;DDX17;RBFOX2;SAFB
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.6588857538964167,1.7369305577350675,0.0,0.2444112682519427,0.974,11/51,8.26%,BMPER;HTRA3;CHRDL1;FSTL1;SKIL;CRIM1;SMAD9;SMAD6;SMAD4;SKI;NOG
prerank,Golgi to endosome transport (GO:0006895),0.7844455290140159,1.735855953223655,0.005555555555555556,0.2386795718837397,0.978,6/16,7.31%,VPS13A;VPS13C;DOP1B;AP2A1;GBF1;MON2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.8019184337153706,1.7357039559672967,0.005427408412483039,0.22939879179733477,0.978,2/13,0.94%,CACNA1G;KCNB1
prerank,endoderm formation (GO:0001706),0.6713232078245426,1.735066401795139,0.006082725060827251,0.22317189734029524,0.979,4/35,0.88%,COL12A1;COL6A1;COL8A1;COL11A1
prerank,cAMP-mediated signaling (GO:0019933),-0.5531017816989126,-1.7330061364726257,0.010101010101010102,0.4145661002024316,0.998,12/24,7.04%,KSR1;PDE7B;RAPGEF3;PDE4D;ADGRG6;RAPGEF2;RIMS2;CAP2;ADCY1;AHR;AKAP6;PDE2A
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.7687689694510383,1.7317265281932792,0.0013315579227696406,0.22681223563825684,0.981,3/18,1.72%,IRS1;KCNB1;CCN3
prerank,mesonephros development (GO:0001823),-0.6788224534654934,-1.729512661974828,0.016339869281045753,0.4026349868983219,0.998,4/11,2.44%,OSR1;ZBTB16;BMP7;FGF1
prerank,regulation of acrosome reaction (GO:0060046),-0.7003337645412728,-1.727122420289177,0.010101010101010102,0.3902721205144666,0.998,1/10,0.15%,PLCB1
prerank,ion homeostasis (GO:0050801),0.6974648719528794,1.7251580287986026,0.001177856301531213,0.2439097621394431,0.984,12/30,15.00%,SLC4A10;SLC4A4;FHL1;HCN4;SLC4A8;CAMK2D;SLC4A11;SLC4A2;AP3D1;SLC4A3;WNK1;SLC4A5
prerank,negative regulation of insulin secretion (GO:0046676),0.7631869221325985,1.7178271995591752,0.003968253968253968,0.26295285735726753,0.993,3/17,1.72%,IRS1;KCNB1;CCN3
prerank,regulation of intracellular pH (GO:0051453),0.6769870277009924,1.7150788934554768,0.0023391812865497076,0.2647761411332598,0.995,13/34,15.00%,SLC4A10;SLC4A4;SLC26A6;SLC4A8;TM9SF4;SLC9A8;SLC9A4;SLC9A1;SLC4A2;TMEM165;CHP1;SLC4A3;SLC4A5
prerank,cardiac muscle cell contraction (GO:0086003),0.7629902373606223,1.7107957315659006,0.0025575447570332483,0.27388372579842485,0.997,5/19,3.61%,KCNJ2;CACNA1G;CACNA1C;GSN;CAMK2D
prerank,positive regulation of leukocyte activation (GO:0002696),0.7608877050775739,1.7105625604864154,0.007874015748031496,0.2661736252552312,0.998,3/18,1.29%,THBS1;LBP;IL33
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6787663842797519,1.7084051017182957,0.001199040767386091,0.26657335170586055,0.998,11/35,11.55%,ESR1;PMEPA1;NEDD4;DDX5;DDX17;ZMIZ1;RBFOX2;PLPP1;SAFB;UBR5;RNF14
prerank,regulation of fibrinolysis (GO:0051917),0.8004750292334202,1.7083706722288736,0.0014204545454545455,0.258706708375134,0.998,2/13,3.76%,THBS1;FAP
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.5475705769769995,-1.7079633534056406,0.013574660633484163,0.4337324075801707,1.0,5/22,8.99%,SORBS1;APOE;PPARA;PPARD;ZBTB20
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6971457591948982,-1.6987545074234631,0.015873015873015872,0.44314483913359354,1.0,2/10,2.11%,LYN;KIT
prerank,type I interferon signaling pathway (GO:0060337),-0.49398948777045365,-1.6982321359140262,0.013986013986013986,0.40807792634243173,1.0,23/41,21.26%,IFNAR2;STAT1;SAMHD1;IFITM1;BST2;SP100;IFIT3;IP6K2;IFIT2;RNASEL;IFIT1;EGR1;RSAD2;IFITM3;OAS2;PSMB8;IRF9;IFI27;MYD88;IRF8;ISG15;IRF7;ADAR
prerank,cellular response to type I interferon (GO:0071357),-0.49398948777045365,-1.6982321359140262,0.013986013986013986,0.40807792634243173,1.0,23/41,21.26%,IFNAR2;STAT1;SAMHD1;IFITM1;BST2;SP100;IFIT3;IP6K2;IFIT2;RNASEL;IFIT1;EGR1;RSAD2;IFITM3;OAS2;PSMB8;IRF9;IFI27;MYD88;IRF8;ISG15;IRF7;ADAR
prerank,carbohydrate transport (GO:0008643),0.8213935197001316,1.696948655163664,0.004120879120879121,0.2995942067236317,1.0,3/11,2.98%,SLC23A1;SLC23A2;SLC26A6
prerank,endodermal cell differentiation (GO:0035987),0.680824530827862,1.6958159989812314,0.005050505050505051,0.2959304904017487,1.0,4/31,0.88%,COL12A1;COL6A1;COL8A1;COL11A1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6931281411455578,-1.692839766031045,0.017361111111111112,0.4084909127133464,1.0,7/12,21.69%,IL34;LYN;BST2;CSF1;PTK2;MAPK3;CSF1R
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6565334940265486,-1.6909723654215403,0.013986013986013986,0.3976621288414284,1.0,2/12,0.54%,IGF1R;INSR
prerank,B cell homeostasis (GO:0001782),-0.6942087516504084,-1.6901333984657085,0.013377926421404682,0.3857924596059101,1.0,3/10,3.05%,LYN;DOCK11;DOCK10
prerank,transition metal ion transport (GO:0000041),-0.4914172861062294,-1.6885004894245979,0.006622516556291391,0.37643901145121456,1.0,6/35,6.30%,CP;SLC30A10;TRPC3;TFRC;SLC39A8;TRPC6
prerank,regulation of fibroblast migration (GO:0010762),0.7316547831858128,1.6870313535967796,0.00395778364116095,0.32764534878618007,1.0,4/20,2.21%,THBS1;DDR2;FGF2;PRKCE
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.8167341124884068,1.683562458199736,0.010115606936416185,0.3344616477876216,1.0,2/11,1.72%,SLIT2;CCN3
prerank,digestive tract development (GO:0048565),0.6717336055994588,1.6829545786636317,0.006024096385542169,0.32867515331977704,1.0,12/32,9.70%,PKD1;PKDCC;PCSK5;RARB;GLI2;COBL;CLMP;TGFB2;AGR2;EPHB3;CCDC39;FGFR2
prerank,regulation of mononuclear cell migration (GO:0071675),0.7154058294791699,1.6768128200543853,0.006510416666666667,0.3487571820615512,1.0,3/23,0.51%,THBS1;SLIT2;CMKLR1
prerank,embryonic skeletal system development (GO:0048706),0.6612778134620753,1.6748142878743777,0.001215066828675577,0.3501258215304163,1.0,12/35,8.26%,SIX1;XYLT1;WNT9A;PCSK5;HOXA3;COL1A1;DEAF1;HOXB3;KIAA1217;SULF1;HOXA9;NOG
prerank,regulation of muscle cell differentiation (GO:0051147),0.6789908105273699,1.6717182642923185,0.006265664160401002,0.3567494147270117,1.0,11/31,13.63%,BOC;CDON;ID2;HDAC9;FGFR2;ABL1;MAPK12;SRF;MEF2A;PTBP1;RBM4
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5965688687421662,-1.669039638878158,0.023809523809523808,0.4216593181615201,1.0,6/15,8.00%,GRM7;GRM5;GRM3;GRM8;GRM1;HOMER1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5948162028229662,-1.6668759602062657,0.03345724907063197,0.4135956950685881,1.0,5/15,11.89%,ATP1A2;ADRA2A;PACSIN3;NOS1;SLC30A1
prerank,response to prostaglandin E (GO:0034695),-0.6835654336411089,-1.6666201527506819,0.025236593059936908,0.4010401231680643,1.0,3/10,12.39%,TGFBR3;GNG2;SFRP1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.6778844706986586,-1.6639974493973704,0.0380952380952381,0.3957750792785513,1.0,3/10,7.82%,TGFA;ADRA2A;HBEGF
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7504728777528574,1.6623637422537272,0.005242463958060288,0.3954374499003744,1.0,7/15,12.83%,SIX1;VEGFA;SIX4;SOX9;NOG;BMP4;SMO
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.7274711829194073,1.6600491323248043,0.005312084993359893,0.3990773214066908,1.0,8/18,16.20%,ESR1;EGFR;DDX5;NCOR2;BMP4;TERT;IL6;ZC3H10
prerank,regulation of BMP signaling pathway (GO:0030510),0.6044372777836095,1.658451613399488,0.001081081081081081,0.3983853857351009,1.0,18/73,11.75%,BMPER;HTRA3;FSTL1;ZNF423;FOXD1;SKIL;SFRP4;CRIM1;SMAD9;SMAD6;HES5;SMAD4;SULF1;SKI;NOG;BMP4;BMPR1A;SMAD7
prerank,skeletal system development (GO:0001501),0.577628144100137,1.657766687191642,0.0,0.39320762864718695,1.0,34/148,9.70%,MYOC;GNAS;EXT1;PKD1;XYLT1;CMKLR1;CDH11;PKDCC;GDF10;BMP1;ALPL;PCSK5;COL1A2;COL1A1;NPR3;PAPSS2;GLI2;COMP;DEAF1;TLL1;HES5;TGFB2;P3H1;KIAA1217;SLC10A7;SULF1;MMP14;FGFR1;SOX9;NOG;HAPLN4;SH3PXD2B;EVC;FGFR2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5754693238373663,1.6524990513117286,0.0,0.4130975929708319,1.0,32/104,17.10%,BMPER;HTRA3;HTRA4;PMEPA1;SKIL;CRIM1;CCN3;SMAD9;EMILIN1;SMAD6;LDLRAD4;SPRED2;ACVR1;BCL9L;SMAD4;TGFBR2;SKI;NOG;BMPR1A;PDPK1;SMAD7;CIDEA;TGFB1I1;TGFBR1;LRP2;NBL1;STUB1;CD109;IL17RD;UBC;RPS27A;SLC2A10
prerank,response to hexose (GO:0009746),0.6868120623496181,1.6509852072391866,0.0140485312899106,0.412787457912953,1.0,2/25,1.27%,THBS1;TCF7L2
prerank,peptide cross-linking (GO:0018149),0.6886412295863513,1.6509245140129434,0.011278195488721804,0.4044990639292852,1.0,4/25,2.73%,THBS1;COL3A1;TGM5;TGM6
prerank,positive regulation of wound healing (GO:0090303),0.6489060105088951,1.6487285383269712,0.0035671819262782403,0.40813862019968544,1.0,5/36,2.21%,THBS1;SMOC2;ST3GAL4;PRKCE;PLPP3
prerank,regulation of interleukin-1 production (GO:0032652),0.7541175225352789,1.6486737024447704,0.011049723756906077,0.40019503448057947,1.0,5/15,13.07%,FOXP1;GAS6;HMGB1;ANXA1;F2R
prerank,myoblast differentiation (GO:0045445),0.7598278273699337,1.648071009936602,0.004243281471004243,0.395571406621467,1.0,7/14,11.42%,TCF7L2;DDX5;DDX17;SDC1;MBNL1;JAG1;MAPK12
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6726497892404077,-1.6480551423869332,0.035483870967741936,0.42840411844296905,1.0,4/10,8.24%,SLC1A3;SLC25A13;SLC1A1;SLC1A2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5907389759647569,1.6456535749612873,0.0,0.4001498176469838,1.0,43/80,24.01%,ARFGAP1;ARFGAP3;KDELR3;PLPP3;SCYL1;ARCN1;COPA;COPB1;COPG1;TMEM115;COPE;ARFGAP2;GBF1;KLC2;KDELR1;ARF4;COPZ2;ERGIC1;NSF;SCFD1;KDELR2;ATP9A;TMED9;RER1;ZW10;PICK1;LMAN2;ERGIC2;SEC22B;RINT1;COPB2;KLC1;NAPA;GOLPH3;BNIP1;TMED2;RAB1A;UVRAG;RAB1B;COPZ1;USE1;ARF5;TMED7
prerank,transepithelial transport (GO:0070633),0.7522373063900403,1.6407425420115946,0.00938337801608579,0.41698105010128284,1.0,5/15,3.96%,SLC23A1;SLC23A2;SLC12A2;SLC26A6;ABCC1
prerank,heart trabecula morphogenesis (GO:0061384),-0.565099613362722,-1.6379693373742585,0.028225806451612902,0.4456130907192089,1.0,9/18,7.38%,TGFBR3;ENG;TEK;ADGRG6;BMP7;RBP4;NOTCH1;S1PR1;RBPJ
prerank,negative regulation of cellular protein localization (GO:1903828),-0.4716458894258547,-1.6367818094315045,0.006060606060606061,0.4365952639218749,1.0,6/34,2.53%,ROCK2;MFHAS1;NEDD4L;ACTN2;RIPOR2;PICALM
prerank,apoptotic cell clearance (GO:0043277),0.6606663144359464,1.6364488606110943,0.007220216606498195,0.43322580369109404,1.0,8/30,9.72%,THBS1;RHOBTB1;GAS6;LRP1;HMGB1;RARA;ANXA1;ITGAV
prerank,negative regulation of coagulation (GO:0050819),-0.6092331012248512,-1.635420158477359,0.021505376344086023,0.4283605220178228,1.0,6/14,13.04%,VTN;APOE;TFPI;EDN1;SERPINE1;CD34
prerank,response to zinc ion (GO:0010043),-0.5118725487749635,-1.634775530400784,0.026455026455026454,0.41867705595485466,1.0,14/25,18.03%,PAM;GLRA2;CRIP1;MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;GLRA1;ATP13A2;MT3
prerank,negative regulation of hemostasis (GO:1900047),-0.6328850107160899,-1.6336089909972757,0.037037037037037035,0.41094638215422113,1.0,6/12,13.04%,VTN;APOE;TFPI;EDN1;SERPINE1;CD34
prerank,response to estradiol (GO:0032355),0.6598416220833885,1.6330217414752284,0.009864364981504316,0.4435722605658937,1.0,8/31,9.84%,ESR1;EGFR;CYP19A1;STAT3;NRIP1;SOCS2;ANXA1;FOXA1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.6481292747984889,1.631747153283553,0.009626955475330927,0.44271440476848756,1.0,5/33,1.12%,BMPER;THBS1;RHOJ;VEGFA;FGF2
prerank,cell-cell junction organization (GO:0045216),-0.4059768049709974,-1.6299480611647614,0.0,0.41074697445206376,1.0,25/79,9.52%,TJP1;SDK1;TLN2;CADM1;CDH8;CDH13;OCLN;CDH5;CLDN5;CADM2;LIMS2;PKP4;SMAD3;CDH4;ARVCF;GJC1;CXADR;CDH1;CDH6;CDH2;CLDN1;NECTIN2;CDH7;CDH19;CDH20
prerank,neuron remodeling (GO:0016322),-0.6575611429334911,-1.6292105972430577,0.045454545454545456,0.40228088404577955,1.0,8/10,16.32%,APP;EPHA8;ANKS1A;ADGRB3;CX3CL1;C1QA;SCARF1;C3
prerank,actomyosin structure organization (GO:0031032),-0.39646943354626957,-1.628605286776843,0.0,0.39437638930658453,1.0,19/75,8.20%,TJP1;SORBS1;FRMD5;ROCK2;PHACTR1;FAM171A1;ACTN2;EPB41L3;EPB41;TPM1;PGM5;MYH10;TMOD3;TMOD1;F11R;MYH9;TNFAIP1;FRMD3;LMOD1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.7133055851515435,1.6283675304429146,0.013020833333333334,0.45303825244072005,1.0,10/19,12.12%,SLIT3;SMAD6;TGFB2;ACVR1;SMAD4;TGFBR2;HEYL;MDM4;BMPR1A;HEY1
prerank,negative regulation of protein catabolic process (GO:0042177),0.6278641827094921,1.6274606839059484,0.0047169811320754715,0.45051796117179227,1.0,15/40,16.82%,EGFR;TIMP2;PTPN3;TIMP3;RILP;SNRNP70;RIC1;IRAK3;MDM4;CST3;CDK5RAP3;RGP1;NELL1;SIRT2;AZIN1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.4982662558299529,-1.6274246947703208,0.0111731843575419,0.3876704030958231,1.0,6/29,6.42%,TGFBR3;ENG;NOTCH1;TPM1;PROX1;S1PR1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.660502190265083,-1.6272259325202656,0.03691275167785235,0.3790799222009031,1.0,5/10,10.96%,LRCH1;RIPOR2;APOD;CD200;PADI2
prerank,organic anion transport (GO:0015711),0.5901746425833396,1.626163434794473,0.0010834236186348862,0.449940617783911,1.0,11/76,7.29%,SLC4A10;SLC26A7;SLC4A4;SLC23A1;SLCO3A1;SLCO2A1;SLC26A6;SLC4A8;LRRC8D;SLC4A11;SLC4A2
prerank,spliceosomal complex assembly (GO:0000245),0.6115207799832076,1.6261504500811794,0.006936416184971098,0.4424748175912834,1.0,20/46,17.73%,SRSF6;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;CELF3;LUC7L;LUC7L3;SF3B1;SF3A1;RBM5;CRNKL1;ZRSR2;SRPK1;YTHDC1;NCBP1;SMN1;SRSF10
prerank,nucleotide biosynthetic process (GO:0009165),0.7178834623808505,1.6258008508180857,0.01797175866495507,0.4369197472006908,1.0,2/18,0.29%,PRPS2;ME1
prerank,detection of mechanical stimulus (GO:0050982),0.7074326019767311,1.625466068857758,0.017632241813602016,0.43159208084430084,1.0,5/19,10.80%,PIEZO2;PKD1;LHFPL5;JUP;CSRP3
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.7209798290651397,1.6249765921166837,0.01358695652173913,0.4270977488286108,1.0,4/20,1.33%,THBS1;PDCD4;GSN;SFRP4
prerank,regulation of cilium movement (GO:0003352),0.802104873205126,1.6248303719023272,0.014104372355430184,0.42114043936572326,1.0,5/10,11.52%,CFAP298;CFAP206;ODAD2;CCDC39;CFAP43
prerank,amino sugar biosynthetic process (GO:0046349),0.7676451240727928,1.6238254081377752,0.01818181818181818,0.4197808209106227,1.0,6/12,8.39%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2;NANP
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7162409718932119,1.622176360484809,0.009259259259259259,0.4217230313849993,1.0,4/19,1.98%,SLC26A2;PAPSS2;SULT1C2;SULT1C4
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.5499382751468294,1.6210226242094177,0.0,0.421257774503813,1.0,91/173,24.30%,GAS6;ARFGAP1;ARFGAP3;SEC31A;KDELR3;SEC24D;STX5;ATL2;SEC13;ARCN1;SEC23A;LMAN2L;RAB2A;COPA;COPB1;DYNC1H1;GOPC;COPG1;NRBP2;GOLGB1;TMEM115;ATL3;CNIH2;COPE;ARFGAP2;PROZ;ANK2;GBF1;KDELR1;ARF4;COPZ2;ERGIC1;BET1;DCTN2;NSF;SCFD1;KDELR2;HYOU1;SPAST;TRAPPC12;TRAPPC6A;BCAP31;TMED9;USO1;NRBP1;ZW10;DYNC1LI2;SEC24C;TRIP11;SEC24B;PREB;LMAN2;ERGIC2;SEC16A;SEC22B;BCAP29;MIA3;COPB2;CNIH1;COG6;DCTN5;SEC16B;SPTBN1;YIF1A;SEC24A;IER3IP1;NAPA;TMED2;COG2;TRAPPC3;ACTR10;CTSZ;TRAPPC11;COG8;DYNC1I2;TRAPPC6B;DCTN1;MIA2;CAPZA1;COG5;RAB1A;LMAN1;KLHL12;ACTR1A;VAMP4;RAB1B;COPZ1;USE1;PGAP1;TMED7;BET1L
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.7269661453578277,1.6209072845692103,0.00922266139657444,0.41567817091921727,1.0,6/17,15.33%,CACNA1G;KCNB1;SLC4A8;RAB3D;NLGN1;STX1A
prerank,axon extension (GO:0048675),0.6930353710146768,1.6207333891713995,0.008962868117797696,0.41041912590583285,1.0,5/23,1.37%,SLIT3;SLIT2;SLIT1;MAP1B;ULK2
prerank,cellular response to estradiol stimulus (GO:0071392),0.7069060908642006,1.6199899144694732,0.015957446808510637,0.4085839066931031,1.0,2/18,0.31%,ESR1;EGFR
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7535463265420893,1.6187529806215293,0.009575923392612859,0.4091017036631645,1.0,3/15,1.12%,THBS1;SMOC2;FGF2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.7287163549268301,1.616302197670657,0.023746701846965697,0.41540304800072325,1.0,8/18,15.53%,NUP93;ENY2;NXF1;ZC3H11A;PABPN1;SARNP;DDX19A;THOC2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.6408746750194304,-1.6145640202427145,0.032490974729241874,0.4034002863737993,1.0,5/12,20.77%,GCNT2;BMP7;CD44;THY1;AGER
prerank,anterior/posterior pattern specification (GO:0009952),0.601838079727542,1.6135213663189403,0.0022222222222222222,0.4229101995403455,1.0,17/53,13.91%,HOXA5;PCSK5;HOXA3;HOXB6;LRP5;HOXC6;HOXB3;HES5;BHLHE40;SKI;HEYL;HOXA9;HOXA6;HEY1;TGFBR1;HOXB4;HOXA4
prerank,neutral amino acid transport (GO:0015804),0.6636624659822948,1.6122116942415463,0.009615384615384616,0.4233480417451885,1.0,8/28,9.00%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1;SLC6A7
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.4830100128798555,-1.6117114702446842,0.020942408376963352,0.40181542809495346,1.0,13/30,17.42%,BCL2L1;NOS3;FAS;DDX3X;RFFL;ARHGEF2;FAIM;SERPINE1;FAIM2;GPX1;TNFAIP3;ICAM1;BRCA1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.6502476970133271,1.6099171890603063,0.011138613861386138,0.42912767688576775,1.0,9/27,15.25%,EGFR;DDX5;STAT3;PUM1;BMP4;AGO2;EIF4G1;LIMD1;IL6
prerank,regulation of macrophage chemotaxis (GO:0010758),0.6861897371647558,1.6074763311766453,0.016905071521456438,0.4364463098067699,1.0,2/21,0.51%,THBS1;CMKLR1
prerank,O-glycan processing (GO:0016266),0.603746637260829,1.6073914289685094,0.009009009009009009,0.4311534069557815,1.0,10/54,9.01%,ST3GAL4;GXYLT2;GALNT10;GALNT15;GALNT13;MUC1;B3GNT7;MUC13;ST3GAL2;B4GALT5
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7240322018066605,1.6072990239720217,0.010526315789473684,0.42626445501604476,1.0,4/17,6.57%,SLIT2;FSTL1;SFRP4;SULF1
prerank,cGMP-mediated signaling (GO:0019934),-0.5997431736572922,-1.6072704039392642,0.023076923076923078,0.40506810051021247,1.0,6/13,8.11%,IRAG1;APOE;GUCY1B1;HTR2C;PDE2A;KCNC2
prerank,androgen receptor signaling pathway (GO:0030521),0.7843109720018996,1.6067813821132042,0.010130246020260492,0.4236936631467315,1.0,6/11,11.55%,PMEPA1;DDX5;DDX17;ZMIZ1;PLPP1;RNF14
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.7446941690737175,1.6061727751334007,0.024759284731774415,0.4211995948630651,1.0,2/14,0.51%,THBS1;CMKLR1
prerank,cell differentiation in spinal cord (GO:0021515),-0.6719268531283402,-1.6057141477398948,0.034055727554179564,0.40116000849688505,1.0,3/10,3.71%,SOX13;MDGA2;SOX6
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.7439299664834341,1.6035198778510582,0.018156424581005588,0.4290499406428671,1.0,2/14,1.28%,THBS1;PDCD4
prerank,regulation of protein acetylation (GO:1901983),-0.6122952235941124,-1.602666026177878,0.04,0.40029211771043177,1.0,5/12,14.06%,RAPGEF3;DDX3X;FAM161A;TERF2IP;SIRT1
prerank,negative regulation of macroautophagy (GO:0016242),0.667361684285584,1.60051967032623,0.012515644555694618,0.43898087167382777,1.0,19/26,24.51%,TMEM39A;LZTS1;NRBP2;QSOX1;CLEC16A;SCFD1;SMG1;PHF23;USP36;SEC22B;AKT1;CHMP4A;CHMP4B;LRRK2;RUBCN;TSC2;MTM1;SMCR8;PINK1
prerank,amino acid transmembrane transport (GO:0003333),0.6213687043071223,1.6003956753229314,0.004519774011299435,0.4343521463671786,1.0,8/45,7.05%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SFXN3;LRRC8D;SLC7A10;SLC38A3
prerank,organic cation transport (GO:0015695),0.7018823020417468,1.598320927688776,0.0129366106080207,0.4401169002235511,1.0,1/20,0.01%,SLC47A1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7476932467748011,1.595367419802024,0.029931972789115645,0.4496374555604552,1.0,6/12,12.83%,SIX1;VEGFA;SIX4;SOX9;NOG;SMO
prerank,endothelial cell development (GO:0001885),-0.5062364474683607,-1.595244329140821,0.02617801047120419,0.41141815568899065,1.0,9/25,7.31%,COL22A1;RAPGEF3;PDE4D;PECAM1;COL18A1;PPP1R16B;RAPGEF2;PDE2A;ROBO4
prerank,acidic amino acid transport (GO:0015800),-0.5554412313369439,-1.594170933490566,0.030434782608695653,0.4061754809288734,1.0,6/17,8.24%,SLC6A13;SLC1A3;SLC6A1;SLC25A13;SLC1A1;SLC1A2
prerank,negative regulation of protein processing (GO:0010955),0.7406332472510768,1.5926930426812433,0.01764705882352941,0.45717569480585923,1.0,2/12,3.37%,THBS1;GAS1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5940811511264402,1.5920245034798641,0.005500550055005501,0.4551387462999126,1.0,19/56,14.52%,BMPER;GDF10;PMEPA1;EMILIN1;INHBC;SMAD6;TGFB3;LDLRAD4;TGFB2;ACVR1;SMAD4;NOG;BMP4;BMPR1A;SMAD7;TGFBR1;INHBA;DAB2;BMP5
prerank,engulfment of apoptotic cell (GO:0043652),0.7336483887297888,1.5916850649625405,0.016216216216216217,0.45144984813536293,1.0,2/15,0.83%,THBS1;RHOBTB1
prerank,mRNA splice site selection (GO:0006376),0.6342358375570722,1.5913385862667269,0.016049382716049384,0.4482692344048347,1.0,12/30,9.69%,SRSF6;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;CELF3;LUC7L;LUC7L3;PSIP1;SF3A1
prerank,regulation of cardiac conduction (GO:1903779),-0.41943768019113253,-1.5912367299923542,0.009708737864077669,0.40603688955271305,1.0,16/54,13.08%,ATP1A2;ITPR1;ATP1B3;SLC8A1;RYR2;ITPR3;ABCC9;ATP2B1;SLC8A3;ATP1B2;ATP2A3;NPR1;ITPR2;NOS1;ACE2;FXYD1
prerank,response to glucose (GO:0009749),0.606452933689478,1.5906221359982626,0.012557077625570776,0.44662054554534786,1.0,7/46,5.38%,THBS1;SLC39A14;KCNB1;GAS6;TCF7L2;UNC13B;ADCY8
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7360718672291062,1.589054287470152,0.026462395543175487,0.45006624587249106,1.0,6/14,15.27%,ME1;AK5;AK3;NMNAT3;AK1;NMNAT2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7205897762282476,1.588448998743051,0.020491803278688523,0.44806566636523276,1.0,3/16,1.12%,THBS1;VEGFA;FGF2
prerank,skeletal system morphogenesis (GO:0048705),0.6095762854685779,1.588230071148923,0.01384083044982699,0.4443190496442371,1.0,15/42,14.51%,LRP6;SIX1;HOXA3;SFRP4;LRP5;HOXB3;FGFR1;SKI;HOXA9;FGFR2;IFITM5;TGFBR1;HOXB4;HOXA4;FUZ
prerank,regulation of sensory perception of pain (GO:0051930),0.7773047382806803,1.587489936783461,0.01925925925925926,0.44321709874046006,1.0,7/11,16.94%,MGLL;TMEM100;CCN3;SCN11A;VIP;F2R;ACP3
prerank,retinoic acid metabolic process (GO:0042573),-0.5848254983234461,-1.5874610879032605,0.03169014084507042,0.40783706102522094,1.0,6/14,20.85%,ALDH1A2;CYP26B1;ADH1A;ALDH1A3;CYP2S1;BCO2
prerank,mesonephric tubule development (GO:0072164),0.7197420012874693,1.587215219955866,0.0332409972299169,0.4396213705172856,1.0,3/15,0.46%,SLIT2;SIX1;PKD1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.5971873430436967,-1.5870129034901517,0.034220532319391636,0.4013300126265105,1.0,12/14,40.33%,CSF1;TYROBP;POU4F1;CCR1;ATP6AP1;TRAF6;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.714554108522361,1.5849683917430581,0.02066115702479339,0.44622963494887813,1.0,9/16,15.34%,SRSF6;DDX5;DDX17;SRSF1;CELF4;SFPQ;HNRNPM;RBM17;SCNM1
prerank,positive regulation of macrophage migration (GO:1905523),0.6985526658243134,1.583289463742693,0.02890932982917214,0.44929161935551065,1.0,2/19,0.51%,THBS1;CMKLR1
prerank,dopaminergic neuron differentiation (GO:0071542),0.6979419974202761,1.5820022919905443,0.023316062176165803,0.4509288222726311,1.0,4/19,13.60%,LRP6;VEGFA;FOXA1;MANF
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.6424577432589704,1.5806260287285971,0.014545454545454545,0.452985815434766,1.0,15/29,20.54%,GOLGA5;COPA;COPB1;TRAPPC10;COPG1;COPE;COPZ2;NSF;COPB2;COG6;NAPA;COG2;TRAPPC3;COG8;COG5
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7281541435660022,1.5804343304167365,0.015625,0.4494024452378883,1.0,4/15,1.89%,PGF;VEGFA;F3;NTRK3
prerank,bone development (GO:0060348),0.6218293108692644,1.5795120593873007,0.009080590238365494,0.4492932464709348,1.0,12/39,11.15%,MYOC;GNAS;LRP6;SFRP4;LRP5;P3H1;SLC10A7;SULF1;SKI;SH3PXD2B;FGFR2;IFITM5
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.7339187052409893,1.5793037458786525,0.031988873435326845,0.44608006738593947,1.0,5/13,7.90%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.6775421035538151,1.5778238958915631,0.02056555269922879,0.44900382726418026,1.0,6/23,12.78%,SLC12A7;SLC12A2;SLC9A1;SLC12A4;SLC26A4;SCNN1A
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7281071221007617,1.5771857589916531,0.015759312320916905,0.4476370727601296,1.0,3/14,6.57%,THBS1;FGF2;SULF1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6497036340364433,1.5764395724438571,0.013888888888888888,0.446837201936615,1.0,5/25,6.69%,THBS1;EGFR;GLMN;ILK;FZD7
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.7556027950564095,1.5760263292115848,0.02702702702702703,0.44468015646338904,1.0,5/11,7.90%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2
prerank,positive regulation of chemotaxis (GO:0050921),0.6153711965957348,1.575993028324834,0.009122006841505131,0.44068255829946157,1.0,6/43,1.89%,THBS1;SMOC2;VEGFA;F3;FGF2;NTRK3
prerank,atrioventricular valve development (GO:0003171),0.72710602924477,1.5751559292216881,0.025495750708215296,0.44035675097300747,1.0,7/14,11.27%,SLIT3;TGFB2;ACVR1;TGFBR2;HEYL;MDM4;BMPR1A
prerank,membrane repolarization during action potential (GO:0086011),0.7480708848428076,1.574340876542795,0.028925619834710745,0.44039339718843246,1.0,4/13,6.98%,KCNJ2;ATP1B1;KCNE5;KCNIP2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.7224361238762698,1.5741659524441383,0.017663043478260868,0.4371596914377716,1.0,3/15,2.87%,PIEZO2;COL11A1;LHFPL5
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.6916186013177613,1.5728654730237774,0.024296675191815855,0.4395402112594216,1.0,6/17,14.42%,PLA2G4F;PLA2G4A;LPCAT1;LPCAT4;PLA2G5;PLA2G12A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6327440789973013,1.569118805924675,0.01858736059479554,0.45362926119532676,1.0,9/32,9.69%,THBS1;RHOJ;VEGFA;FGF2;HDAC9;MEOX2;FOXC2;RHOA;ANXA1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.4758169073723197,-1.5688906193087726,0.028735632183908046,0.44266271396138795,1.0,15/32,16.32%,SORBS1;APOE;PPARA;PRKAA2;PRKAG2;ADIPOR1;ZBTB20;MID1IP1;ASXL3;CEACAM1;GPER1;CREBL2;AVIL;STAR;C3
prerank,supramolecular fiber organization (GO:0097435),0.5263381367082609,1.5666780642433236,0.0,0.4612089898021036,1.0,66/333,10.64%,COL12A1;PLOD2;COL6A3;COL6A2;COL6A1;ADAMTS3;ADAMTS2;COL8A2;COL8A1;BMP1;RHOBTB1;COL11A1;MAP7D3;DDR2;FGF13;COL3A1;COL1A2;LTBP2;LTBP3;GSN;COL1A1;COL5A3;COL14A1;P4HB;TGFBI;SERPINH1;EMILIN1;COL5A2;STMND1;COL15A1;RND3;COL27A1;COL16A1;LOXL1;PPP1R9B;CYP1B1;TLL1;ARHGAP17;TGFB2;CORO6;SNCAIP;PLOD1;P3H1;DYNC1H1;PLOD3;CLIP4;TUBGCP3;FAT1;TLE6;MYO1E;CDC42EP2;ADAM10;GGA2;P4HA1;LOX;P3H2;IAPP;ELMO3;CST3;DLG1;RHOA;BACE1;SPAST;RIPK3;CKAP5;COL25A1
prerank,actin filament depolymerization (GO:0030042),0.7409950449641913,1.5645016473053126,0.023088023088023088,0.4677206141078447,1.0,2/11,1.30%,MICAL2;GSN
prerank,cellular response to fatty acid (GO:0071398),0.7388115702545206,1.5644535288334682,0.03927068723702665,0.46387872947161374,1.0,2/12,0.49%,IRS1;PID1
prerank,sprouting angiogenesis (GO:0002040),0.5878162398544645,1.5605022762409964,0.005611672278338945,0.4794107514524555,1.0,9/51,4.72%,BMPER;THBS1;SLIT2;PGF;VEGFA;FGF2;RSPO3;SEMA3E;RAMP2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.6857726836077231,1.559882267528112,0.03342245989304813,0.4785320491046716,1.0,5/17,9.70%,TMEM100;FGF2;SFRP4;SOX9;BMP4
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.7223246727636163,1.5580080238720777,0.025606469002695417,0.48371360466954894,1.0,12/14,26.67%,SEC31A;SEC24D;SEC13;SEC23A;SEC24C;SEC24B;MIA3;SEC24A;SEC23B;RAB1A;TBC1D20;SAR1A
prerank,monosaccharide transmembrane transport (GO:0015749),0.7209803299752411,1.5574221666714456,0.026385224274406333,0.4824618756051867,1.0,3/16,2.03%,SLC23A1;SLC23A2;SLC5A2
prerank,sulfate transport (GO:0008272),0.7194099913986016,1.5567893744082213,0.027662517289073305,0.48136384910698066,1.0,3/14,2.98%,SLC26A7;SLC26A2;SLC26A6
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.6001787772233205,-1.556715141365935,0.059027777777777776,0.4680902007031553,1.0,3/11,2.53%,NEDD4L;ACTN2;PICALM
prerank,regulation of RNA splicing (GO:0043484),0.556064516252784,1.5556111351976736,0.007683863885839737,0.482614168344404,1.0,31/69,20.91%,SLC38A2;CLK1;HNRNPH1;AHNAK;AHNAK2;CLK3;MBNL1;RBM39;FASTK;SNRNP70;FUS;HNRNPL;HNRNPH2;MBNL2;METTL16;KHDRBS1;CLK4;PTBP1;U2AF2;SRPK1;HNRNPK;YTHDC1;SRSF3;SRSF10;RBM22;CLK2;BRDT;LARP7;TRA2B;HNRNPH3;AFF2
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.7514189062552192,1.5551210292163484,0.02635431918008785,0.4809775774901702,1.0,5/11,11.27%,ZFPM2;TGFB2;JAG1;BMP4;BMPR1A
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5457024950839855,-1.5527921166866028,0.05533596837944664,0.47044902375312686,1.0,3/17,3.56%,ATP1A2;BMP7;TFPI
prerank,RNA 3'-end processing (GO:0031123),0.5676715596961838,1.5517102962325044,0.003293084522502744,0.4943202445915433,1.0,31/69,22.01%,SRSF6;SRSF1;SRSF5;SRSF2;CASC3;TENT4B;SRSF11;SYMPK;ZC3H11A;SRRM1;U2AF1;CHTOP;PABPN1;SUPV3L1;U2AF2;CLP1;CPSF4;SARNP;THOC2;SRSF3;PCF11;RPRD1A;TUT7;NCBP1;SRSF7;CPSF7;NCBP2;CSTF2;CSTF2T;TENT2;SRSF4
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5842405989047668,1.5499125441069403,0.013590033975084938,0.499059477948508,1.0,16/49,15.81%,PMEPA1;SMAD6;ANKRD27;LDLRAD4;DACT1;PRRT2;HMGB1;TMC8;PEX5;RAF1;IAPP;IMPACT;LCMT1;HSPA5;TFIP11;HDAC6
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6490239744520857,1.5491211661052924,0.03128911138923655,0.4986218116325548,1.0,2/24,0.24%,BOC;CDON
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.5349698530171675,1.5487936179325912,0.0010214504596527069,0.4961747646720355,1.0,45/136,19.92%,ESR1;PKD1;CMKLR1;ID2;GAS6;TCF7L2;SFRP4;PTGIS;GLIS2;CYP1B1;HDAC4;PKHD1;ANXA4;TAX1BP1;BHLHE40;IRAK3;HEYL;DAP;CDK5RAP3;WWP2;ITCH;CHUK;IRAK1;COMMD7;SMAD7;RNF2;CHP1;TRAF3;USP7;MAP3K10;ID1;ARRB1;OTULIN;SUMO1;MDFI;UFL1;RWDD3;MEN1;ACOD1;SUFU;LRRC14;ERBIN;ZNF431;NFKBIA;EIF2AK4
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6557982618920579,1.5485022150745176,0.022756005056890013,0.4939231520121742,1.0,9/23,12.83%,SIX1;VEGFA;FGF2;SIX4;LBX2;SOX9;NOG;BMP4;SMO
prerank,endoderm development (GO:0007492),-0.5918895361036665,-1.5478249198999758,0.03289473684210526,0.4762705637314015,1.0,9/13,33.62%,SOX17;SOX7;LHX1;DUSP4;TBX20;DUSP5;DUSP2;GATA4;LAMC1
prerank,cellular component maintenance (GO:0043954),-0.5990775738752658,-1.54713573921298,0.06439393939393939,0.46986246170851215,1.0,4/12,9.00%,IGF1R;INSR;ITGA3;CLDN1
prerank,positive regulation of protein acetylation (GO:1901985),-0.5927126477315704,-1.5458770075907664,0.08754208754208755,0.46532398796791397,1.0,6/12,12.75%,RAPGEF3;PRKAA2;DDX3X;PRKAA1;FAM161A;TERF2IP
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.5577650533543146,-1.5442681849436335,0.05303030303030303,0.4616138235229008,1.0,7/15,10.23%,PPARA;LPGAT1;NR1H3;PPARGC1A;PPARD;SLC45A3;MID1IP1
prerank,response to alcohol (GO:0097305),0.6464212542070765,1.5441862591071889,0.01240694789081886,0.511150198742229,1.0,7/27,12.60%,SLIT3;SLIT2;GRIN3A;TGFBR2;CHRNB2;SOD1;TGFBR1
prerank,"phagocytosis, engulfment (GO:0006911)",0.6183474114153482,1.5423531964266215,0.017772511848341232,0.5166951517152234,1.0,3/36,1.30%,THBS1;RHOBTB1;GSN
prerank,peptidyl-lysine modification (GO:0018205),0.5457848082692325,1.5421572909125139,0.0010416666666666667,0.5137705238289394,1.0,48/99,26.59%,PLOD2;NUP93;LOXL1;P3H3;HDAC9;HDAC4;TOPORS;EEF1AKMT3;PLOD1;TRIM28;RAE1;PLOD3;SEH1L;SIRT5;LOX;TRPM4;NUP37;EEF1AKMT2;SENP5;VIPAS39;RANBP2;PIAS4;GCSH;NUP88;STX1A;SIRT2;HDAC6;LIPT1;SUMO1;USPL1;POM121;NUP210;SAE1;NUP62;SENP1;LOXL2;SUMO2;NDC1;SENP7;NUP35;SENP6;KAT2B;SENP3;P3H4;NUP85;NUP160;TPR;ESCO1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5322529014399413,-1.540621202986371,0.03361344537815126,0.4646845841832837,1.0,8/17,7.38%,MAML2;MAML3;STAT1;NOTCH1;PLXND1;NOTCH3;NOTCH4;RBPJ
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5906552571002364,1.5396627180481692,0.013761467889908258,0.522595206987495,1.0,5/51,0.97%,THBS1;PGF;CMKLR1;VEGFA;GAS6
prerank,regulation of interleukin-12 production (GO:0032655),0.5902181438263248,1.5394297175175418,0.009248554913294798,0.5197305762633724,1.0,5/47,7.13%,THBS1;FOXP1;CMKLR1;HMGB1;IRAK3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.6698624823486536,1.5392751126348378,0.03756476683937824,0.5167067656700304,1.0,6/19,8.41%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2;PMM2
prerank,mRNA export from nucleus (GO:0006406),0.5485180438110472,1.5392337550830428,0.004149377593360996,0.5131109734557722,1.0,49/102,27.01%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;ENY2;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;PABPN1;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;DDX19A;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E
prerank,spinal cord development (GO:0021510),0.7308304282423298,1.5390384622354862,0.04195804195804196,0.5103581147047216,1.0,3/12,2.48%,PKD1;VIT;GLI2
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.6725251759060353,1.5368969062264883,0.03820816864295125,0.5171912020853304,1.0,2/19,0.51%,THBS1;CMKLR1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.7352533227557306,1.5362770561149854,0.03536067892503536,0.5163177257353456,1.0,2/12,5.19%,PRPS2;ADA
prerank,purine nucleotide metabolic process (GO:0006163),0.6456655780051668,1.5361715741663369,0.026785714285714284,0.5132043970766981,1.0,3/24,4.54%,PRPS2;FHIT;XDH
prerank,hemidesmosome assembly (GO:0031581),-0.6169946680320472,-1.5360581672154083,0.059375,0.469490812382218,1.0,4/11,11.06%,ITGA6;DST;ITGB4;LAMC2
prerank,fatty acid transport (GO:0015908),-0.5351376069813799,-1.5351028662394588,0.025974025974025976,0.4644404105697356,1.0,5/17,9.28%,APOE;ACSL1;PPARD;SLC27A4;MFSD2A
prerank,sensory perception of chemical stimulus (GO:0007606),0.6953205684280852,1.5348147666058136,0.038157894736842106,0.5165222391454811,1.0,1/15,0.25%,GNAS
prerank,response to acidic pH (GO:0010447),0.7157196201808949,1.5348010349508503,0.04539385847797063,0.5129324248914688,1.0,6/13,15.51%,SLC9A1;IMPACT;RAB11FIP5;CHP1;RAB11B;PKD2L1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5849165381292949,1.5343522060125603,0.01598173515981735,0.5115415877643958,1.0,8/46,6.17%,THBS1;FOXP1;ID2;IGFBP5;ELN;TCF7L2;HES5;PRKDC
prerank,organic acid transport (GO:0015849),0.5467459135497447,1.5335383737661448,0.004223864836325237,0.5118893135737319,1.0,15/94,7.47%,SLC38A2;SLC38A1;SLC26A7;SLC23A1;SLC23A2;SLC5A6;SLC16A1;SLC26A6;SLC1A5;RXRA;LRRC8D;SLC25A32;SLC7A10;SLC38A3;SLC43A1
prerank,response to organic cyclic compound (GO:0014070),0.5783508258159403,1.5335288232548498,0.014508928571428572,0.5083723724160005,1.0,10/52,9.84%,ESR1;ALPL;IGFBP5;CYP19A1;CYP1B1;STAT3;CHRNB2;SOCS2;ANXA1;FOXA1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6984169426469645,1.5334323034195416,0.030470914127423823,0.5051879472996137,1.0,3/14,9.02%,THBS1;MEOX2;RHOA
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.5492785318948066,1.533353973060229,0.0031479538300104933,0.5021230269037591,1.0,46/96,27.01%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E
prerank,response to hydrogen peroxide (GO:0042542),0.586159788146198,1.5332909265717871,0.017462165308498253,0.4990250277856261,1.0,18/45,17.53%,PRKCD;ADAM9;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;ANXA1;RIPK3;ABL1;SOD1;STK25;PRDX3;RHOB;CAT;IL6;HDAC6;HMOX1
prerank,ureteric bud development (GO:0001657),0.6766524553835902,1.5313467624562271,0.04849279161205767,0.5052002316492229,1.0,3/17,1.31%,SLIT2;SIX1;GPC3
prerank,carboxylic acid transport (GO:0046942),0.5729218311894226,1.5313455734132164,0.014476614699331848,0.5017867165705119,1.0,8/55,3.80%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC16A9;SLC16A1;SLC38A6;SLC1A5
prerank,cell junction organization (GO:0034330),-0.3859695591931349,-1.5311735571603753,0.011764705882352941,0.46802124782779536,1.0,22/71,10.24%,TJP1;SDK1;OCLN;GRM5;PPFIA2;SLC6A1;PPFIBP1;APP;LIMS2;SMAD3;PPFIBP2;CXADR;PAK3;OPHN1;RAB8B;SLC8A3;CDC42;CLDN1;FLNC;ELFN1;RAB39B;APBB2
prerank,RNA export from nucleus (GO:0006405),0.5466438687287037,1.531061273433618,0.005235602094240838,0.4997697132972301,1.0,48/100,27.33%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;HNRNPA1;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E;XPO5
prerank,positive regulation of response to wounding (GO:1903036),-0.4777238621027478,-1.528148207606304,0.041666666666666664,0.4693358353952071,1.0,7/24,9.00%,PTN;MYLK;VTN;OCLN;ADRA2A;HBEGF;CLDN1
prerank,negative regulation of vascular permeability (GO:0043116),0.7285396037149384,1.525965750350648,0.04613297150610583,0.5209868239160144,1.0,5/12,8.40%,SLIT2;VEGFA;PDE3A;RAMP2;DDAH1
prerank,nucleotide metabolic process (GO:0009117),0.6410863297092344,1.525899921474861,0.026525198938992044,0.5178598837082473,1.0,7/23,15.27%,ME1;AK5;FHIT;REXO2;NMNAT3;AK1;NMNAT2
prerank,chordate embryonic development (GO:0043009),0.5652641959049527,1.5253053691102352,0.016018306636155607,0.5171337527185133,1.0,19/55,9.70%,PKD1;XYLT1;VEGFA;PCSK5;COL1A1;TGFB3;DEAF1;MBNL1;HES5;SIX4;DACT1;KIAA1217;DVL1;ADAM10;SULF1;FGFR1;NOG;FUT8;FGFR2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6910527391336803,1.52529453613827,0.04144385026737968,0.5138189114009495,1.0,3/15,1.12%,BMPER;VEGFA;FGF2
prerank,protein trimerization (GO:0070206),0.7065911996558947,1.525286929514563,0.03112313937753721,0.5072147010115985,1.0,4/14,11.92%,SCARA5;SLC1A5;DISP1;CLYBL
prerank,protein homotrimerization (GO:0070207),0.7065911996558947,1.525286929514563,0.03112313937753721,0.5072147010115985,1.0,4/14,11.92%,SCARA5;SLC1A5;DISP1;CLYBL
prerank,response to progesterone (GO:0032570),0.6810908090433652,1.525193990083446,0.028645833333333332,0.5043465182281112,1.0,4/18,9.65%,THBS1;TGFB3;TGFB2;CATSPER3
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6284189523350796,-1.5243873033533875,0.05555555555555555,0.47259550656768023,1.0,3/10,9.13%,ATP1A2;ADRA2A;SESTD1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5985748042306713,1.524324084531653,0.03075030750307503,0.5050368360392231,1.0,13/33,20.36%,ESR1;DDX5;CARM1;AXIN1;RNF14;RUNX1;UBA5;HDAC6;DNAAF4;UFL1;SAFB2;CBFB;CALR
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7156082831420628,1.5242102208392803,0.024216524216524215,0.5023574690723696,1.0,2/13,5.57%,SLC4A10;RAB3GAP1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6083163004063784,1.523972821774049,0.023485784919653894,0.5003070802796085,1.0,12/31,14.51%,SIX1;HOXA3;TWIST1;HOXB3;TGFBR2;HOXA9;NOG;FGFR2;TGFBR1;HOXB4;HOXA4;FUZ
prerank,bone morphogenesis (GO:0060349),0.7141131937094995,1.5236802299435641,0.03337783711615487,0.49858121228069485,1.0,6/14,11.15%,LRP6;SFRP4;LRP5;SKI;FGFR2;IFITM5
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.4928819233976854,-1.522267758635582,0.03755868544600939,0.4711045777245753,1.0,8/23,13.95%,EFNB2;AKAP6;PIEZO1;PROX1;NIBAN2;EDN1;MYOCD;IGF1
prerank,regulation of dendrite extension (GO:1903859),-0.5250474352586127,-1.5215953711481287,0.040160642570281124,0.46601350233937244,1.0,5/18,14.66%,NEDD4L;RIMS2;RIMS1;SYT3;SYT2
prerank,regulation of endothelial cell migration (GO:0010594),0.5419214434259262,1.517759692276549,0.008438818565400843,0.5242163311748862,1.0,12/85,5.88%,BMPER;THBS1;SLIT2;SMOC2;FOXP1;RHOJ;VEGFA;FGF2;SPARC;PRKCA;BCAS3;FOXC2
prerank,primary neural tube formation (GO:0014020),0.6096357386495799,1.5174049525515194,0.04197530864197531,0.5226040329692717,1.0,10/30,16.72%,LRP6;PRICKLE1;DEAF1;COBL;TGFB2;SKI;LMO4;LRP2;FUZ;MTHFD1
prerank,neural tube closure (GO:0001843),0.6035051199048789,1.5152816494062105,0.026993865030674847,0.5296665188409462,1.0,11/34,16.72%,LRP6;PRICKLE1;DEAF1;COBL;TGFB2;DVL1;SKI;LMO4;LRP2;FUZ;MTHFD1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.7231100248952187,1.5146106836630648,0.03868194842406877,0.5297416552720424,1.0,6/13,16.91%,TMEM30B;TM9SF4;EDEM2;BCAP31;SEC16A;SEC16B
prerank,regulation of blood coagulation (GO:0030193),0.6257654576262036,1.5145235738508085,0.043316831683168314,0.5269296210307957,1.0,4/27,3.76%,THBS1;ST3GAL4;EPHB2;FAP
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.4898967847436247,-1.5131352210709164,0.039473684210526314,0.48332357214791316,1.0,9/22,19.08%,SLC7A5;RFTN1;SPHK1;PRKCQ;ZBTB7B;NR1H4;NOD2;MYD88;TGFB1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.6902724546759536,1.5117982402932584,0.03819918144611187,0.5371394181467046,1.0,3/16,1.16%,SIX1;FGF2;FOXD1
prerank,protein localization to nucleus (GO:0034504),0.5319081612648057,1.5117877184704127,0.0063025210084033615,0.533970741540467,1.0,53/102,30.28%,SIX1;COL1A1;NUP93;PRICKLE1;SEC13;TOPORS;IPO5;LMNA;SIX4;STAT3;MORC3;RRS1;IPO4;DVL1;HIKESHI;E2F3;BMP4;WRN;INTS13;CNEP1R1;IPO13;TNPO2;YWHAE;ARL2;NUP88;POM121;AKT1;IPO9;TNPO1;APPL2;APPL1;CALR;NUP62;PPP1R10;TBRG1;PAF1;TSC2;IPO8;HNRNPU;NUTF2;NUP85;TPR;XPA;RPAIN;NOP53;TAF3;TOR1AIP1;TOR1AIP2;RPF2;NUP50;ZBTB7A;PIKFYVE;FAM53C
prerank,negative regulation of leukocyte migration (GO:0002686),0.7589996753476621,1.5115003885822265,0.04878048780487805,0.5320614446634941,1.0,2/10,1.76%,SLIT2;EMILIN1
prerank,actin filament-based transport (GO:0099515),-0.4995595056328066,-1.5110830502057757,0.07272727272727272,0.4821640059959963,1.0,7/21,14.71%,MYO1B;SYNE2;MYO6;ACTN4;MYO1D;SUN2;MYO5C
prerank,peroxisomal membrane transport (GO:0015919),0.62367547749197,1.5110620913249964,0.033623910336239106,0.5310236640116345,1.0,14/27,22.68%,ABCD3;PEX7;PXMP2;PEX5;PEX16;PEX13;PEX1;PEX10;ALDH3A2;PEX6;PEX2;ABCD1;ACBD5;PEX14
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7236313760475757,1.5110104739255201,0.04915730337078652,0.5281402802682612,1.0,3/11,7.69%,P4HB;P4HA1;P3H2
prerank,tube closure (GO:0060606),0.605357743693033,1.510230252840943,0.03827160493827161,0.52876894170631,1.0,10/31,16.72%,LRP6;PRICKLE1;DEAF1;COBL;TGFB2;SKI;LMO4;LRP2;FUZ;MTHFD1
prerank,lipid phosphorylation (GO:0046834),-0.6270241128712053,-1.5098717865481524,0.06329113924050633,0.4786627419532358,1.0,7/10,14.58%,DGKB;DGKD;DGKG;DGKH;DGKE;DGKZ;DGKA
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.7182854327230127,1.508902797596089,0.04962406015037594,0.5320953719289744,1.0,1/11,0.08%,THBS1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6292875417490881,1.5073914014166467,0.02977667493796526,0.5359016542888413,1.0,2/27,0.11%,SLC47A1;SLC38A1
prerank,xenobiotic transport (GO:0042908),0.6747859803665344,1.5069605030606505,0.0426098535286285,0.5347456553906895,1.0,2/17,3.96%,SLC47A1;ABCC1
prerank,mRNA transport (GO:0051028),0.5383209390644328,1.5065819153768403,0.0031479538300104933,0.533528856820113,1.0,47/101,27.01%,SRSF6;NUP93;SRSF1;ARC;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5925720304563832,1.506443969058414,0.028604118993135013,0.5311824012511821,1.0,9/38,8.86%,KCNJ2;CACNA1G;CACNA1C;HCN4;CAMK2D;KCNE5;ANK2;JUP;TRPM4
prerank,positive regulation of potassium ion transport (GO:0043268),0.5932599604177863,1.5052526813624378,0.0313588850174216,0.5338439748701308,1.0,8/38,8.78%,KCNJ2;KCNJ15;FHL1;DRD1;KCNN1;KCNE5;ANK2;DLG1
prerank,response to fatty acid (GO:0070542),0.6617286117046812,1.5021825001522737,0.037383177570093455,0.5452744549306336,1.0,3/17,7.68%,IRS1;PID1;SOX9
prerank,cellular response to interleukin-7 (GO:0098761),0.677742488754536,1.5021365719701179,0.04062909567496723,0.5394427855849498,1.0,5/17,8.51%,IRS1;STAT5A;STAT3;BRWD1;SOCS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.677742488754536,1.5021365719701179,0.04062909567496723,0.5394427855849498,1.0,5/17,8.51%,IRS1;STAT5A;STAT3;BRWD1;SOCS2
prerank,embryonic eye morphogenesis (GO:0048048),0.7216622909828695,1.501165962008912,0.06111111111111111,0.5413173522158474,1.0,2/11,0.73%,LRP6;MFAP5
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.46769792540096383,-1.5006469856797788,0.0391304347826087,0.49714926965960493,1.0,14/26,22.14%,LYN;ROCK2;EPHA4;PICALM;GRIN2B;AIM2;PSME3;PSME1;GRIN1;PYCARD;PRELID1;AGER;APH1B;MBP
prerank,positive regulation of dendrite extension (GO:1903861),-0.5330361196630087,-1.4989717643469718,0.05263157894736842,0.4943455206756127,1.0,5/17,14.66%,NEDD4L;RIMS2;RIMS1;SYT3;SYT2
prerank,positive regulation of cell cycle (GO:0045787),0.5526112780257411,1.498624767862643,0.017297297297297298,0.5504300990376444,1.0,12/62,9.84%,SMOC2;EGFR;LRP6;PKD1;TGFB2;PRKCA;USP2;RARA;PKN2;FGFR2;CDC25B;FOXA1
prerank,peptidyl-threonine modification (GO:0018210),0.5467587353710894,1.4976123565710169,0.015086206896551725,0.5522622485924622,1.0,34/66,24.65%,PRKCD;CIT;GALNT13;ACVR1B;CAMK2D;CSNK2A2;CSNK2A1;PRKCA;DYRK4;ACVR1;PRKDC;TGFBR2;STK39;CDK10;MAPK8;MAP3K12;PDPK1;TGFBR1;MAP3K10;WNK1;CDC42BPB;GALNT1;GALNT3;CAD;AKT1;HIPK2;CDK5;LRRK2;HIPK4;GALNT2;TAF1;TBK1;ROCK1;LMTK2
prerank,potassium ion export across plasma membrane (GO:0097623),0.7065828355003727,1.4975474599375775,0.04519774011299435,0.5496019488508019,1.0,3/13,6.98%,KCNK5;KCNE5;KCNIP2
prerank,circulatory system development (GO:0072359),0.5227661978733907,1.4968029196528363,0.00932642487046632,0.5501747353350522,1.0,39/118,16.85%,MICAL2;PKD1;CACNA1C;ID2;ZFPM2;PCSK5;PLCE1;COL3A1;NTRK3;ECE1;GLI2;PDLIM7;NXN;HDAC9;TGFB2;RAMP2;ACVR1;FOXC2;TGFBR2;SOX9;FOXL1;SH3PXD2B;ALPK3;TAB2;POU6F1;ZDHHC16;WDR11;SRF;HEY1;KAT2A;TGFBR1;MEF2A;TCF25;AKAP13;CRB2;DNAAF4;MTHFD1;KDM6B;NF1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6401201380133368,1.49648559836815,0.04584882280049566,0.5456970591382353,1.0,12/23,19.00%,THBS1;SMAD4;GIPC1;TGFB1I1;DAB2;CREBBP;SLC2A10;FLCN;CDKN1C;MEN1;CITED2;HIPK2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6401201380133368,1.49648559836815,0.04584882280049566,0.5456970591382353,1.0,12/23,19.00%,THBS1;SMAD4;GIPC1;TGFB1I1;DAB2;CREBBP;SLC2A10;FLCN;CDKN1C;MEN1;CITED2;HIPK2
prerank,negative chemotaxis (GO:0050919),0.602259897226331,1.4957712044032754,0.03170731707317073,0.5461913848636383,1.0,8/33,9.72%,SLIT3;SLIT2;SLIT1;NTN1;SEMA3E;SEMA4B;RHOA;ITGAV
prerank,regulation of T cell migration (GO:2000404),-0.5251313163756584,-1.4949969048564729,0.06276150627615062,0.49900080082517595,1.0,5/18,3.54%,LRCH1;RIPOR2;APOD;APP;CXCL12
prerank,aortic valve morphogenesis (GO:0003180),0.5978903893942185,1.4943948630058306,0.03864734299516908,0.5497115605287068,1.0,11/30,9.70%,SLIT3;SLIT2;ELN;EMILIN1;SMAD6;TWIST1;JAG1;HEYL;SOX9;NFATC1;BMP4
prerank,aortic valve development (GO:0003176),0.587287899205896,1.4943318076278642,0.03403755868544601,0.5470962579206383,1.0,12/34,9.70%,SLIT3;SLIT2;ELN;EMILIN1;SMAD6;TWIST1;TNFRSF1B;JAG1;HEYL;SOX9;NFATC1;BMP4
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5909068911348897,1.4941723825682915,0.03241296518607443,0.5449778028800961,1.0,7/33,9.43%,THBS1;FGF2;MEOX2;HMGB1;JUP;RHOA;ANGPT4
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5523352528513519,1.492110108179325,0.0242024202420242,0.5517962523105543,1.0,30/59,24.65%,PRKCD;CIT;ACVR1B;CAMK2D;CSNK2A2;CSNK2A1;PRKCA;DYRK4;ACVR1;PRKDC;TGFBR2;STK39;CDK10;MAPK8;MAP3K12;PDPK1;TGFBR1;MAP3K10;WNK1;CDC42BPB;CAD;AKT1;HIPK2;CDK5;LRRK2;HIPK4;TAF1;TBK1;ROCK1;LMTK2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6460435028156297,1.4919661886381679,0.03901170351105332,0.5496702356771521,1.0,2/20,0.46%,EGFR;PKD1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.6554717968341839,1.4892838346414041,0.04432855280312908,0.5593985201051408,1.0,2/20,1.56%,PLOD2;GCLC
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5722472198460625,1.4890686039588514,0.030508474576271188,0.5575005666250837,1.0,8/47,12.19%,THBS1;PID1;PRKCD;XDH;TGFBR2;AKR1C1;SOD1;DHRS4
prerank,positive regulation of embryonic development (GO:0040019),-0.5016974158875707,-1.4886219031529484,0.046610169491525424,0.5100313978113771,1.0,5/19,7.94%,PLCB1;WNT4;OSR1;TENM4;NIBAN2
prerank,water transport (GO:0006833),-0.5516635279347144,-1.486822676893776,0.07849829351535836,0.5080240132379962,1.0,9/12,44.86%,AQP11;CFTR;AQP1;AQP4;AQP9;PDPN;AQP6;AQP7;SLC5A1
prerank,thymus development (GO:0048538),0.7090202521641372,1.4864564658346824,0.04426002766251729,0.567653865062017,1.0,5/13,12.60%,SIX1;EPHB3;RIPK3;SOD1;TGFBR1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.58766775552569,-1.4853728486836861,0.051194539249146756,0.5060951461926603,1.0,5/11,15.34%,ADIPOR1;SH2B3;CAV1;PTPRT;SOCS3
prerank,cation transport (GO:0006812),0.5089876434675213,1.4850770265420277,0.00202020202020202,0.5712812165418727,1.0,22/167,9.65%,SLC47A1;PIEZO2;SLC4A4;KCNJ2;SLC23A1;KCNJ15;KCNK5;SLC5A6;ATP1B1;FGF13;SLC12A2;SLC5A2;HCN4;SLC9B2;KCNN1;SLC4A11;SCN11A;KCNIP2;TRPM7;TRPM4;KCNK6;CATSPER3
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.5367752255876961,-1.4850719233804122,0.06690140845070422,0.5004269909357019,1.0,5/14,14.06%,RAPGEF2;PRKAR2B;PRKAR1B;PKIG;SIRT1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.6164147870262466,1.4849435412426386,0.0422360248447205,0.5690551281139821,1.0,15/27,23.43%,MORF4L2;MRGBP;TRRAP;ATAT1;SGF29;MORF4L1;KAT6B;TAF6;KAT2A;CREBBP;BRD8;KAT7;KAT8;TAF6L;KAT2B
prerank,microtubule polymerization (GO:0046785),0.6079642655554305,1.4837571995087862,0.03822441430332922,0.5720832554151005,1.0,10/28,18.76%,MAP7D3;FGF13;TUBG2;CSNK1D;TUBGCP3;CKAP5;AKAP9;NDEL1;CCDC57;SLAIN2
prerank,regulation of mast cell activation (GO:0033003),-0.6171453228428203,-1.4835770796380274,0.0804953560371517,0.4981417781485356,1.0,5/10,22.28%,LYN;NECTIN2;CD84;MILR1;CD300LF
prerank,peptidyl-serine modification (GO:0018209),0.5097152447115068,1.4835093184345896,0.003051881993896236,0.5704582549983016,1.0,76/166,24.65%,PKD1;PRKCD;GAS6;ULK2;GALNT13;MARK1;PRKCE;CSNK1D;CAMK2D;CSNK2A2;CSNK2A1;MORC3;POGLUT3;PRKCA;DYRK4;PRKDC;POGLUT1;TGFBR2;TLK1;STK39;RPS6KA4;AKT2;DGKQ;PKN2;PAK2;MAPK8;SMG1;CSNK1G1;CHUK;MAP3K12;ATM;MAPK12;PDPK1;UHMK1;CSNK1E;TGFBR1;MAP3K10;DMPK;WNK1;NDNF;LATS2;CAMK4;GALNT1;TLK2;GALNT3;PARP1;MKNK2;VRK2;MAST2;AKT1;HIPK2;CDK2;IKBKE;NTMT1;CDK5;SGK3;MAPK9;PRKACA;VRK3;LRRK2;CSNK1G3;MAST4;CAMK1;STK38;EIF2AK3;PRKCI;TOP1;HIPK4;GALNT2;RPS6KA2;RPS6KB1;TAF1;TBK1;ROCK1;PINK1;LMTK2
prerank,Golgi organization (GO:0007030),0.5174066049814552,1.4834968603016545,0.00625,0.5676845917419451,1.0,61/112,30.16%,STX5;ATL2;CSNK1D;LMAN2L;RAB2A;FBXW8;GOLGA8B;GOLGA5;RAB30;RAB43;BCAS3;GOLGB1;ATL3;GBF1;ATP8B2;HUWE1;TJAP1;ARHGAP21;BET1;PLEKHM2;TRAPPC12;TMED9;ZW10;TRIP11;STK25;PI4K2A;LMAN2;SEC16A;SEC22B;STX16;SEC16B;GOLPH3;TMED2;NPLOC4;COG2;BLZF1;SEC23IP;TRAPPC11;OPTN;LRRK2;RAB1A;LMAN1;ATP8B1;VAMP4;GORASP2;DYNC2H1;TMED7;VPS51;TBC1D20;CUL7;VTI1B;GOLGA2;GCC2;CSNK1A1;SURF4;ARL1;UBXN2A;TMED3;PRMT5;STX17;VTI1A
prerank,regulation of exit from mitosis (GO:0007096),0.5732292928866352,1.4833427517443634,0.040983606557377046,0.5655845078634711,1.0,15/38,18.88%,ANAPC5;PPP1R9B;CDC16;CDC14A;UBE2C;ANAPC4;ZW10;ANAPC2;SIRT2;ANAPC1;UBC;RPS27A;ANAPC10;CDC20;CDC27
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6584091249704032,1.4831198839912743,0.04806408544726302,0.5639811804861311,1.0,2/17,0.46%,EGFR;PKD1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.7274836212911133,1.482038211098028,0.04486251808972504,0.566305526875305,1.0,4/11,15.25%,EGFR;DDX5;BMP4;IL6
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5615105524322679,1.4817579203642934,0.02823529411764706,0.5649038651426224,1.0,18/46,18.31%,PRKCD;GAS6;TCF7L2;NEDD4;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;ANP32B;UBR5;XPO4;KHDRBS1;YWHAE;CPSF6;RBM22;NCBP2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5726900965248157,1.4816596723849023,0.027809965237543453,0.5625775457377012,1.0,6/43,4.11%,THBS1;FOXP1;ID2;IGFBP5;FGF2;HES5
prerank,import into cell (GO:0098657),0.5736165109605625,1.480690278676265,0.03819444444444445,0.5645284465782558,1.0,7/41,5.42%,SLC47A1;SLC38A1;SLC5A6;SLC39A14;SLC12A7;LRRC8D;LRSAM1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.6330581723884422,1.4796818721231553,0.04381443298969072,0.566537227457892,1.0,3/20,1.02%,SLIT2;IGFBP5;LRP1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.6199385054923818,1.4796665351381704,0.05759162303664921,0.5639456980338263,1.0,15/23,27.66%,SEC13;VCP;FAF2;SYVN1;TMED9;TECPR2;PREB;SEC16A;NPLOC4;LMAN1;DERL1;HERPUD1;SELENOS;SEC61B;SURF4
prerank,histone modification (GO:0016570),0.520015444852847,1.4767735812409049,0.0072992700729927005,0.5749570379841208,1.0,38/109,19.38%,PRMT8;PRKCD;EYA2;PRDM5;HDAC9;HDAC4;BAZ2A;UBE2B;MORF4L2;MIDEAS;MRGBP;TRRAP;SGF29;EHMT1;RPS6KA4;HUWE1;NSD1;RCOR3;ENY2;CARM1;MORF4L1;MIER2;MAP3K12;KAT6B;TAF6;KDM4A;KAT2A;HDAC1;USP36;SIRT2;HDAC6;CREBBP;SIN3B;MTA3;UFL1;CDK2;BRD8;NTMT1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.7219411081132897,1.4765402240118228,0.05121293800539083,0.5733748025120471,1.0,6/12,8.70%,NFIB;GLI2;EPHB2;EPHB6;CHRNB2;TSKU
prerank,muscle contraction (GO:0006936),-0.3412364551868961,-1.4763135330576187,0.034482758620689655,0.5124670018595179,1.0,29/126,11.62%,SORBS1;ITGA1;ROCK2;MYLK;SLC8A1;SNTB1;ACTN2;TPM1;UTRN;GJC1;TMOD3;MYOF;SMTN;BDKRB2;MYL6;MYL9;TMOD1;DYSF;LMOD1;KCNJ12;DES;MYH11;TPM3;CHRNB1;VIM;ADRA1A;NOS1;ACTA2;TPM2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6889893614540826,1.476237517469135,0.05364511691884457,0.5720988654548695,1.0,4/14,6.04%,EHHADH;ACOXL;ACOX3;ECI2
prerank,osteoclast differentiation (GO:0030316),0.625160173637783,1.4754348191968705,0.07088607594936709,0.5731502613324895,1.0,5/22,9.20%,FOXP1;GAB2;ANXA2;GLO1;SBNO2
prerank,protein O-linked glycosylation (GO:0006493),0.5243479530747124,1.4750411619372945,0.015889830508474576,0.5722969929166627,1.0,18/96,9.91%,PLOD2;ST3GAL4;GXYLT2;GALNT10;GALNT15;GALNT13;MUC1;PGM3;PLOD1;POGLUT3;PLOD3;B3GNT7;POGLUT1;MUC13;ST3GAL2;B4GALT5;OGT;GALNT18
prerank,nuclear export (GO:0051168),0.5316931456477224,1.4740112647373955,0.012752391073326248,0.5745332505801876,1.0,41/80,27.33%,PKD1;SRSF6;XPO1;SRSF1;SRSF5;STRADA;RAE1;SRSF2;CASC3;XPO6;SRSF11;NXF1;ZC3H11A;SRRM1;U2AF1;CHTOP;XPO4;CHP1;WASHC4;U2AF2;SARNP;THOC2;SRSF3;NCBP1;SRSF7;POM121;NCBP2;CALR;NUP62;RITA1;CCHCR1;HNRNPA1;SRSF4;DESI1;UPF3B;DDX39B;NUTF2;TPR;XPO7;EIF4E;XPO5
prerank,potassium ion import across plasma membrane (GO:1990573),0.5726610392327964,1.4734635272199241,0.03608847497089639,0.5745716953514779,1.0,6/41,2.89%,KCNJ2;KCNJ15;SLC12A7;ATP1B1;SLC12A2;HCN4
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6873038368628478,1.473299403129918,0.05006765899864682,0.572676865928442,1.0,3/15,1.12%,SMOC2;VEGFA;FGF2
prerank,early endosome to Golgi transport (GO:0034498),0.7085428503876893,1.4725063051536105,0.05459770114942529,0.5740168394892916,1.0,5/11,11.71%,STX5;SNX2;TRAPPC10;SNX1;TMED9
prerank,serine family amino acid metabolic process (GO:0009069),0.6737877315474441,1.471533771364334,0.052770448548812667,0.5759268899969835,1.0,9/16,20.13%,GCLC;SRR;GLYAT;MTHFD1;SHMT2;SHMT1;DAO;SARS1;SEPHS2
prerank,response to estrogen (GO:0043627),0.5848998069068945,1.4706207293779405,0.05432098765432099,0.5777154174473241,1.0,9/31,17.75%,ESR1;BCAS3;RARA;SRA1;SFR1;SERPINB9;KMT2D;CYP27B1;CITED2
prerank,ventricular septum development (GO:0003281),0.5712015336586423,1.470502926892327,0.04280618311533888,0.5756873811905779,1.0,15/37,12.60%,SLIT3;SLIT2;ZFPM2;TGFB2;ACVR1;SMAD4;TGFBR2;MATR3;HEYL;MDM4;NOG;BMPR1A;SMAD7;HEY1;TGFBR1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6929189654101735,1.4699105251580713,0.06770098730606489,0.5758991022018993,1.0,2/12,6.47%,FOXP1;HMGB1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6854209006091935,1.4694779673729224,0.07300275482093664,0.5755370553185895,1.0,6/13,15.73%,XPO1;LTV1;RRS1;ABCE1;NUP88;EIF6
prerank,response to UV (GO:0009411),0.5156546949448886,1.468395857913686,0.010438413361169102,0.5784429128049282,1.0,40/95,26.92%,EGFR;PRKCD;NEDD4;SCARA3;UBE2B;ATF4;CCAR2;ERCC8;ERCC5;ERCC4;MAPK8;WRN;SDE2;ERCC3;ERCC2;CAT;N4BP1;CREBBP;PARP1;CDC25A;REV1;MEN1;AKT1;USP1;EIF2AK4;NOC2L;CIRBP;EIF2S1;MAP2K7;USP47;TRIAP1;PRIMPOL;SDF4;TAF1;TP53;UVSSA;POLD1;XPA;YY1;ZRANB3
prerank,negative regulation of endothelial cell migration (GO:0010596),0.578657046362186,1.4681549388392923,0.038777908343125736,0.5770764751781079,1.0,6/36,9.43%,THBS1;SLIT2;FGF2;HMGB1;JUP;ANGPT4
prerank,ventricular septum morphogenesis (GO:0060412),0.6061324464953882,1.4679780879769233,0.04353393085787452,0.575276879413358,1.0,14/27,12.60%,SLIT3;SLIT2;ZFPM2;TGFB2;ACVR1;SMAD4;TGFBR2;HEYL;NOG;BMP4;BMPR1A;SMAD7;HEY1;TGFBR1
prerank,iron ion transmembrane transport (GO:0034755),0.7281944415513608,1.4672179966096577,0.06323529411764706,0.5762143194268803,1.0,2/10,0.72%,SCARA5;SLC39A14
prerank,chloride transport (GO:0006821),0.5352052780638551,1.4652120020392918,0.01829924650161464,0.5831519432146202,1.0,9/74,5.17%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;SLC26A6;CLIC3;SLC4A8;CLIC4;GABRA3
prerank,protein targeting to peroxisome (GO:0006625),0.5985055456068051,1.4647657183549523,0.049079754601226995,0.5827111517890242,1.0,15/29,22.68%,ABCD3;PEX7;PXMP2;PEX5;PEX16;PEX13;PEX1;PEX10;ALDH3A2;HACL1;PEX6;PEX2;ABCD1;ACBD5;PEX14
prerank,establishment of protein localization to extracellular region (GO:0035592),0.580933429240785,1.464660776928635,0.040697674418604654,0.5806801083513443,1.0,17/39,20.71%,LTBP2;NECAB3;ARFGAP3;COPG1;RAB8A;MON1A;RAB3D;ABCA1;PREB;TMEM167A;MIA3;RAB3B;TANGO6;GOLPH3;STEAP3;MIA2;RCN3
prerank,eye development (GO:0001654),0.5514103347924916,1.4642267962422713,0.03532008830022075,0.5802753988879998,1.0,19/54,17.08%,SMOC1;CACNA1C;CHRDL1;PBX3;COL5A2;HES5;TGFB2;RAB3GAP1;PBX1;MEIS3;SKI;TSKU;SH3PXD2B;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3;NIPBL;MAB21L2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.4708719845220655,-1.4627536563016625,0.06224066390041494,0.5444549527427205,1.0,6/22,6.43%,LYN;ROCK2;EPHA4;PICALM;ABCG1;GSAP
prerank,miRNA metabolic process (GO:0010586),0.6365585422238691,1.4623980921366015,0.06501950585175553,0.5864660976038606,1.0,8/20,16.62%,DDX17;TENT4B;PRKRA;DIS3L2;DGCR8;AGO2;SND1;TUT7
prerank,negative regulation of secretion by cell (GO:1903531),-0.41602037678961856,-1.4621953764244453,0.034013605442176874,0.5393014146697818,1.0,13/38,17.93%,GRM7;APOE;STXBP6;IL1RAPL1;NOTCH1;RHBDF1;TNFRSF1A;SLC30A1;RSAD2;RHBDF2;SNCA;SERGEF;SYT11
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.5857715971796135,1.462165273526608,0.05569007263922518,0.5849411028598324,1.0,4/31,5.57%,CACNA1G;KCNB1;SYT8;RAB3GAP1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6545200830258191,1.4613386411853249,0.060240963855421686,0.5863201243692266,1.0,8/17,16.85%,SPRED2;CALM2;DGKQ;SMAD7;PPEF2;EIF4G1;SIRT2;CALM3
prerank,muscle cell differentiation (GO:0042692),-0.44207244151871555,-1.46131360104619,0.041666666666666664,0.5350918316970981,1.0,10/32,10.69%,NEBL;WNT5B;MRTFB;SGCZ;TBX18;TBX1;TMEM204;GATA6;CHRNB1;MYOCD
prerank,response to cholesterol (GO:0070723),0.6504845210250235,1.4611873812445355,0.05668016194331984,0.5846306667825235,1.0,7/17,13.94%,LRP6;GRAMD1A;OSBPL7;TGFBR2;TGFBR1;SMO;GRAMD1C
prerank,mRNA 3'-end processing (GO:0031124),0.5289608248481636,1.4610821878910758,0.011969532100108813,0.5826473481276644,1.0,33/78,22.01%,SRSF6;CPSF4L;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;TENT4B;SRSF11;SYMPK;ZC3H11A;SRRM1;U2AF1;CHTOP;PABPN1;U2AF2;CLP1;CPSF4;SARNP;THOC2;SRSF3;PCF11;RPRD1A;NCBP1;SRSF7;CPSF7;CPSF6;NCBP2;CSTF2;CSTF2T;TENT2;PAF1;SRSF4
prerank,protein localization to cilium (GO:0061512),0.5883171408841672,1.460547639536495,0.04093567251461988,0.5827406335350063,1.0,9/32,11.96%,ZNF423;EHD1;MAPK15;CSNK1D;BBS9;TMEM107;IFT20;TCTN1;INVS
prerank,myelination in peripheral nervous system (GO:0022011),0.6888626020418961,1.459620766293885,0.05675675675675676,0.5845578278154294,1.0,7/13,16.85%,MYOC;LGI4;SKI;SOD1;NCMAP;SIRT2;NF1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6197989252644958,1.4594741135422986,0.04568527918781726,0.5828748388693487,1.0,4/22,6.30%,SLIT2;PRKCD;GSN;PFN2
prerank,positive regulation of locomotion (GO:0040017),0.6116755742573733,1.4593691174623984,0.06724782067247821,0.580977555367727,1.0,3/27,2.99%,THBS1;NTN1;TWIST1
prerank,nucleosome assembly (GO:0006334),0.5852755228411608,1.4591475141246655,0.05076741440377804,0.579517688814413,1.0,16/31,27.85%,CHAF1B;IPO4;NAA60;SOX9;ANP32B;SPTY2D1;CABIN1;KAT6B;BRD2;NAP1L3;NAP1L2;UBN1;H3-3A;DAXX;CHAF1A;HIRA
prerank,smooth muscle cell differentiation (GO:0051145),-0.5608308105809274,-1.4590402464553343,0.0711743772241993,0.5358183828730394,1.0,8/12,14.98%,MRTFB;TBX18;TMEM204;GATA6;EDNRB;MYOCD;HEY2;APLNR
prerank,muscle organ development (GO:0007517),0.5463852023578472,1.456892061796267,0.029312288613303268,0.5877159128692048,1.0,14/54,13.47%,COL6A3;FHL1;ITGA11;SGCD;MKX;MRAS;DMD;MEF2B;EVC;CTF1;POU6F1;MAPK12;MEF2D;MEF2A
prerank,oligosaccharide biosynthetic process (GO:0009312),0.6232212501705268,1.456687887317664,0.06997455470737914,0.5861829316328512,1.0,6/20,11.13%,ST3GAL4;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;FUT4
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5677978104613458,-1.4559655634152464,0.06690140845070422,0.5382721784616266,1.0,7/11,21.60%,MECOM;WNT5A;ETV6;CD34;YJEFN3;WNT2B;WNT10B
prerank,COPII-coated vesicle budding (GO:0090114),0.5321100562540565,1.4554685160339158,0.028199566160520606,0.5895787000304189,1.0,40/68,26.67%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;MIA3;CNIH1;SEC16B;SEC24A;NAPA;TMED2;SEC23B;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2;SAR1A
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5739410730712277,-1.4550772210530354,0.057432432432432436,0.5344930072450153,1.0,4/11,11.60%,TJP1;RAPGEF2;F11R;RAP2B
prerank,positive regulation of protein maturation (GO:1903319),-0.5771401859225332,-1.4548622109276435,0.08709677419354839,0.5289680719156062,1.0,9/11,39.76%,CCBE1;NKD2;SOX4;BAG2;NLRC4;RHBDD1;TFR2;ADAM8;ANGPTL8
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5076257516112648,-1.4543299781887902,0.0743801652892562,0.5245496228640198,1.0,6/16,12.06%,APOE;NOS3;GUCY1B1;KCNC2;NOS1;DDAH2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5401968750735471,1.454261507352223,0.02696629213483146,0.5929874133028279,1.0,9/61,6.47%,SMOC2;EGFR;FGF2;EYA2;GNL3;PARP3;TRIM28;ERCC8;HMGB1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5546943587455837,-1.4542447758869068,0.07357859531772576,0.5188041442175984,1.0,5/12,15.09%,CDH5;MAP2;EML2;SNCA;TUBB4A
prerank,fatty acid beta-oxidation (GO:0006635),0.5454948185386145,1.4532305397763172,0.04044943820224719,0.5953802103713848,1.0,30/51,32.94%,ABCD3;EHHADH;ACOXL;ECHDC2;ACOX3;ECI2;ETFDH;ETFA;ETFB;AUH;ACAT1;BDH2;CRAT;SLC27A2;PEX2;ABCD1;ECHDC1;MCAT;HADHA;GCDH;ACOT8;MTLN;ACAT2;SCP2;ECI1;CPT2;ABCD4;MECR;DECR2;CROT
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5304032853746989,1.452667906233265,0.01991150442477876,0.5956319506316763,1.0,22/65,17.10%,HTRA3;HTRA4;PMEPA1;SKIL;EMILIN1;SMAD6;LDLRAD4;SPRED2;BCL9L;TGFBR2;SKI;PDPK1;SMAD7;CIDEA;TGFB1I1;TGFBR1;STUB1;CD109;IL17RD;UBC;RPS27A;SLC2A10
prerank,potassium ion homeostasis (GO:0055075),0.6109794713821554,1.4524543662006357,0.05283505154639175,0.5942586508184854,1.0,4/23,1.20%,KCNJ2;SLC12A7;ATP1B1;SLC12A2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.648234553652524,1.452437980945025,0.055782312925170066,0.5919160832820431,1.0,14/18,26.50%,EHMT1;ASH1L;EEF1AKMT2;KMT2D;SETD4;KMT2B;SUV39H2;SETD1A;SUV39H1;SETD2;KMT2A;SMYD2;EHMT2;SETD7
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.44508624505701566,-1.4523551581582435,0.078125,0.5183543144011786,1.0,6/28,6.05%,ARHGAP28;ARHGAP18;ESAM;CXCL12;PLEKHG2;PAK3
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5110931867549762,1.452325537845257,0.020942408376963352,0.5900306296556682,1.0,21/92,12.40%,THBS1;SMOC2;FOXP1;VEGFA;FGF2;ADAM9;PRKCE;SPARC;TGFB2;PRKCA;BCAS3;FOXC2;DOCK5;GFUS;SOX9;ANGPT4;BMP4;ABL1;IQSEC1;PIK3CB;NRP1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6000259261272847,1.4517736940818682,0.045454545454545456,0.5901289897797449,1.0,6/30,7.38%,KCNJ2;CACNA1G;CACNA1C;KCNE5;ANK2;SNTA1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5859862721660565,1.4515882316702142,0.05555555555555555,0.5886767644252754,1.0,12/29,19.65%,ESR1;CARM1;FOXA1;AXIN1;KMT2D;RUNX1;UBA5;DNAAF4;UFL1;VPS11;CNOT9;CBFB
prerank,regulation of interleukin-17 production (GO:0032660),-0.4340285330938527,-1.4508099447191938,0.030612244897959183,0.5168207122167453,1.0,24/31,42.06%,SLC7A5;RFTN1;SPHK1;PRKCQ;ZBTB7B;NR1H4;NOD2;MYD88;TGFB1;LY9;NCKAP1L;SLAMF6;IL18;IL15;IL12A;CARD9;IL23A;FOXP3;TLR4;IL23R;CCL1;IL12B;IL2;OSM
prerank,nucleosome organization (GO:0034728),0.5381756954809597,1.4505931950842148,0.0389321468298109,0.5908274358687511,1.0,26/55,26.19%,CHAF1B;NAA60;SOX9;SMARCC2;ANP32B;SPTY2D1;KAT6B;ACTR6;ZNHIT1;BRD2;NFE2;VPS72;HMGA1;NAP1L3;NAP1L2;BRDT;BPTF;PAF1;SETD2;SMARCA4;SRCAP;ANP32E;H3-3A;DAXX;ARID1A;CHAF1A
prerank,protein deacetylation (GO:0006476),0.5600932172043278,1.4503858629480677,0.04689331770222743,0.5894348874634571,1.0,15/41,17.04%,PRDM5;HDAC9;HDAC4;BAZ2A;MORF4L2;MIDEAS;SIRT5;RCOR3;MORF4L1;MIER2;HDAC1;SIRT2;HDAC6;SIN3B;MTA3
prerank,mitochondrion transport along microtubule (GO:0047497),0.6695215025442427,1.4502555453500303,0.0673352435530086,0.5878227438155595,1.0,4/13,9.94%,SYBU;RHOT2;RHOT1;SPAST
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6612009539539481,1.449431809675032,0.07095926412614981,0.5895234491021424,1.0,7/15,6.20%,GPC3;SFRP4;RSPO3;TIAM1;CSNK1D;DACT1;LBX2
prerank,integrated stress response signaling (GO:0140467),0.6561630166315482,1.4486448455686507,0.08513513513513514,0.5908271294129559,1.0,10/14,26.97%,ATF4;NFE2L2;IMPACT;HSPA5;QRICH1;EIF2AK4;EIF2S1;EIF2AK3;HERPUD1;CCL2
prerank,chromatin assembly or disassembly (GO:0006333),0.7014858791742882,1.4478030531017745,0.0631424375917768,0.5923601253531966,1.0,7/11,26.19%,CHAF1B;M1AP;CDAN1;SUV39H2;NOC2L;TP53;CHAF1A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5125442540099668,1.4477105403194117,0.008492569002123142,0.5905038544007523,1.0,33/95,17.75%,THBS1;HTRA3;HTRA4;PMEPA1;SKIL;EMILIN1;SMAD6;DKK3;LDLRAD4;SPRED2;BCL9L;SMAD4;TGFBR2;SKI;GIPC1;PDPK1;SMAD7;CIDEA;TGFB1I1;TGFBR1;DAB2;STUB1;CD109;LATS2;IL17RD;CREBBP;UBC;RPS27A;SLC2A10;FLCN;CDKN1C;MEN1;CITED2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.6703614555077237,1.4471387344140925,0.0698005698005698,0.5909801831611785,1.0,3/14,1.02%,SLIT2;IGFBP5;LRP1
prerank,myotube cell development (GO:0014904),0.7238329540394731,1.4470284547566816,0.06277372262773723,0.5892732102544936,1.0,3/10,8.09%,SIX1;SKI;SELENON
prerank,action potential (GO:0001508),0.5649662099095971,1.446886896090385,0.04691075514874142,0.587746585755408,1.0,6/44,6.62%,KCNJ2;CACNA1G;KCNB1;DMD;KCNE5;SCN11A
prerank,positive regulation of axonogenesis (GO:0050772),0.5480982422572681,1.446082023533173,0.06285714285714286,0.5890954684902447,1.0,5/43,2.40%,SLIT2;PLXNA4;NTN1;TIAM1;TIAM2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7069312315482279,1.4454572705364286,0.07692307692307693,0.5897284177113532,1.0,8/10,26.97%,ATF4;NFE2L2;HSPA5;QRICH1;EIF2S1;EIF2AK3;HERPUD1;CCL2
prerank,COPII vesicle coating (GO:0048208),0.5325818283517083,1.444418022437288,0.027412280701754384,0.5879233179698743,1.0,37/61,26.49%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;CNIH1;SEC16B;SEC24A;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2
prerank,vesicle coating (GO:0006901),0.5325818283517083,1.444418022437288,0.027412280701754384,0.5879233179698743,1.0,37/61,26.49%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;CNIH1;SEC16B;SEC24A;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.5325818283517083,1.444418022437288,0.027412280701754384,0.5879233179698743,1.0,37/61,26.49%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;CNIH1;SEC16B;SEC24A;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2
prerank,regulation of cellular metabolic process (GO:0031323),0.5552322759173953,1.4443481839854222,0.03815028901734104,0.5860344132583314,1.0,13/45,15.73%,PID1;COQ7;NCOR2;CYP1B1;LAMTOR1;PM20D2;RSPO1;ARF4;FOXM1;ARF1;ACACA;STUB1;EIF6
prerank,positive regulation of organelle organization (GO:0010638),0.5753720688643992,1.4442087083359134,0.057387057387057384,0.584511406707272,1.0,12/32,12.94%,SORBS3;ANXA2;C2CD5;RAB3GAP1;ATL3;AKT2;ANXA1;SYNJ1;PLA2G5;KATNBL1;TMED9;LIG4
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5022135580789655,-1.4439276622456247,0.084,0.5297698209010961,1.0,7/16,12.94%,PDGFD;PLAT;PDGFRB;PDGFRA;PDGFC;PIK3C2A;PTPN1
prerank,embryonic limb morphogenesis (GO:0030326),0.5677976455869673,1.44235979923241,0.05889281507656066,0.590892616349099,1.0,9/34,8.26%,LRP6;CACNA1C;AFF3;ECE1;TWIST1;MBNL1;TGFB2;SKI;NOG
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.607612347467302,1.4419251737797083,0.05759803921568627,0.5906128971355831,1.0,7/23,14.42%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,limb morphogenesis (GO:0035108),0.632864395789356,1.4418372277785234,0.061946902654867256,0.5889103747140558,1.0,5/20,7.28%,LRP6;PCSK5;MBNL1;TGFB2;SKI
prerank,positive regulation of calcium ion transport (GO:0051928),-0.42014059479503835,-1.441616673650953,0.04081632653061224,0.5301010940258586,1.0,9/36,6.59%,MYLK;CACNA1D;CACNB2;TRPC3;CXCL12;PDGFRB;ATP2B1;TRPC6;ORAI1
prerank,histone deacetylation (GO:0016575),0.5508534152151857,1.43951249852826,0.04988399071925754,0.5973439324414497,1.0,17/43,17.32%,PRDM5;HDAC9;HDAC4;BAZ2A;MORF4L2;MIDEAS;RCOR3;MORF4L1;MIER2;SFPQ;HDAC1;PER1;SIRT2;HDAC6;SIN3B;MTA3;SMARCAD1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.6547564340782903,1.4393951856494072,0.07407407407407407,0.5957019942235711,1.0,14/16,32.27%,CELF4;THRAP3;CELF3;DAZAP1;NCBP1;RBMXL1;TRA2B;CIRBP;TRA2A;RBM3;SF3B4;PRDX6;SNW1;NCL
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6627594165697857,1.438766966742109,0.08163265306122448,0.5965174686522233,1.0,6/14,20.88%,GAS6;CARD16;PTPN2;TRAIP;CCDC3;GPS2
prerank,mitotic nuclear membrane organization (GO:0101024),0.5422971277521628,1.438480541785391,0.04285714285714286,0.5935125112141268,1.0,25/51,27.35%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;POM121;CC2D1B;IST1;CHMP4A;CHMP4B;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.5422971277521628,1.438480541785391,0.04285714285714286,0.5935125112141268,1.0,25/51,27.35%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;POM121;CC2D1B;IST1;CHMP4A;CHMP4B;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.6470494364225838,1.4382974075830042,0.06349206349206349,0.5921552639635307,1.0,5/16,7.74%,PYGB;STBD1;PHKA1;GAA;PHKB
prerank,cell-cell junction maintenance (GO:0045217),-0.5884381661702186,-1.4371020165904158,0.08239700374531835,0.5371019557907637,1.0,1/11,0.05%,TJP1
prerank,cardiac myofibril assembly (GO:0055003),-0.5335795045987023,-1.436635943826222,0.08029197080291971,0.532506550839055,1.0,4/15,6.34%,NEBL;PDGFRB;PROX1;PDGFRA
prerank,heart development (GO:0007507),0.49336770061928,1.4365703821801168,0.008105369807497468,0.5979461329051953,1.0,46/150,16.93%,MICAL2;PKD1;CACNA1C;ID2;ZFPM2;VEGFA;PCSK5;PLCE1;SGCD;COL3A1;GPC3;NTRK3;ECE1;GLI2;PDLIM7;HDAC9;TGFB2;RAMP2;ACVR1;FOXC2;TGFBR2;SOX9;FOXL1;CRELD1;SH3PXD2B;ALPK3;BMP4;TAB2;POU6F1;CSRP3;FLRT2;ZDHHC16;WDR11;SRF;KAT2A;TGFBR1;MEF2D;MEF2A;TCF25;BMP5;AKAP13;DNAAF4;MTHFD1;KDM6B;NF1;NIPBL
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6836993933614782,1.436414287538048,0.07327586206896551,0.5964937902795348,1.0,6/12,16.20%,ESR1;NCOR2;STAT3;TERT;IL6;ZC3H10
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5770027216506597,1.4362190809916298,0.05392156862745098,0.5952574272475135,1.0,5/32,6.52%,THBS1;MYOC;SEMA3E;BCAS3;JAG1
prerank,cellular response to hexose stimulus (GO:0071331),0.6131661069639671,1.4361365265076589,0.08734177215189873,0.5934892853139169,1.0,6/23,5.38%,SLC39A14;KCNB1;GAS6;UNC13B;SLC26A6;ADCY8
prerank,glucan catabolic process (GO:0009251),0.6581836976856069,1.4359866938781136,0.06174496644295302,0.5920821691473404,1.0,5/15,7.74%,PYGB;STBD1;PHKA1;GAA;PHKB
prerank,regulation of autophagosome assembly (GO:2000785),0.5718091497169803,1.4359642432138837,0.050175029171528586,0.5901306809401272,1.0,21/33,27.18%,NPRL3;TMEM39A;LRSAM1;RAB3GAP1;IFT20;SCFD1;PIP4K2B;PHF23;SEC22B;IFT88;RAB3GAP2;CHMP4A;CHMP4B;LRRK2;RAB1B;MTM1;NPRL2;SMCR8;PINK1;RAB5A;PIP4K2C
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5419951169892704,1.4352973530199702,0.02711864406779661,0.5910384689101043,1.0,14/55,16.42%,THBS1;PID1;COQ7;CYP1B1;XDH;TGFBR2;SIRT5;ARF4;AKR1C1;FOXM1;DHRS4;SIRT2;EIF6;AATF
prerank,antibacterial humoral response (GO:0019731),0.6421556694897061,1.4351672842170273,0.06728232189973615,0.5895710761357954,1.0,5/16,18.50%,RNASE7;RNASE3;RNASE6;DEFB1;DMBT1
prerank,regulation of autophagosome maturation (GO:1901096),0.6748659474936728,1.4346416561219621,0.0708215297450425,0.5898600431226402,1.0,8/13,24.22%,TMEM39A;CLEC16A;TBC1D25;PHF23;CLN3;RUBCN;UVRAG;SMCR8
prerank,regulation of response to stress (GO:0080134),0.7122730397334522,1.4342881516160249,0.06392045454545454,0.589392857287835,1.0,2/10,5.38%,SLC38A2;ADCY8
prerank,regulation of T cell mediated immunity (GO:0002709),0.7109631494489582,1.4333158962462396,0.07600596125186289,0.5916316784162153,1.0,4/10,10.45%,TNFRSF1B;HMGB1;TRPM4;RIPK3
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6769676174116391,1.4320769370754387,0.09116809116809117,0.5948960243757009,1.0,6/12,11.90%,KDELR3;GPAA1;KDELR1;KDELR2;RER1;HSPA5
prerank,regulation of chromosome segregation (GO:0051983),0.6540267179819241,1.4317243723507476,0.07732634338138926,0.5943649932816326,1.0,6/16,8.65%,CSNK2A2;CSNK2A1;HORMAD1;PUM1;RMI2;CDC6
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5365857119156425,1.4293899749307342,0.03192702394526796,0.6030841111559221,1.0,8/53,6.12%,EGFR;PRKCD;EYA2;DDX5;SPRED2;TRIM28;CCAR2;ERCC8
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.7030807254389498,1.4288997953908955,0.07092198581560284,0.6033890481950581,1.0,3/11,6.98%,KCNJ2;ATP1B1;KCNIP2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3956116528294928,-1.4288011841664774,0.029850746268656716,0.5492697576077894,1.0,12/41,10.40%,ITPR1;SLC8A1;SLC24A2;RYR2;CACNA2D1;ITPR3;GRIN2B;HTR2C;TRPV2;SLC8A3;GRIN2A;ITPR2
prerank,ureteric bud morphogenesis (GO:0060675),0.6490489630523816,1.4285336718640462,0.08152173913043478,0.602936211532475,1.0,2/16,1.12%,SIX1;FGF2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5468321011621006,1.4284316574506941,0.04919908466819222,0.6013415406935372,1.0,5/44,4.18%,THBS1;VEGFA;GAS6;CSNK2A1;CARD16
prerank,histone methylation (GO:0016571),0.5971546726640365,1.4273213285359996,0.07115628970775095,0.6043958395558355,1.0,15/26,30.13%,PRMT8;EHMT1;NSD1;CARM1;CREBBP;SUV39H2;NTMT1;SUV39H1;FBL;PRMT1;SMYD2;TRMT112;EHMT2;PRMT5;NSD3
prerank,extracellular matrix assembly (GO:0085029),0.6007433387266614,1.4265991729944882,0.07329192546583851,0.6055275375330591,1.0,6/23,6.99%,GAS6;LTBP3;EMILIN1;NTN4;RAMP2;QSOX1
prerank,tRNA export from nucleus (GO:0006409),0.5728946592599428,1.4258976293548693,0.06971153846153846,0.6046260370877021,1.0,17/32,26.41%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.5728946592599428,1.4258976293548693,0.06971153846153846,0.6046260370877021,1.0,17/32,26.41%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,positive regulation of lipid catabolic process (GO:0050996),0.6262523323902,1.4258579555641167,0.08421052631578947,0.6027932725348163,1.0,4/19,8.56%,IRS1;PRKCD;TWIST1;AKT2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.44486539398940184,-1.4255128620103419,0.07142857142857142,0.552401552017319,1.0,5/25,7.60%,WNT5A;KIT;B2M;SLC7A5;LACC1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6699635454761287,1.425415763788984,0.08356940509915015,0.6027534535100625,1.0,5/12,14.44%,FOXP1;NCOR2;HEYL;HDAC1;DAB2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.5083984027010887,1.4253252892387223,0.029157667386609073,0.6011666592468757,1.0,42/80,30.16%,SGSM2;STX5;RAB7B;SNX2;ERC1;TRAPPC10;RIC1;GBF1;VPS52;TBC1D23;TRIM27;SNX1;RGP1;VPS26A;TMED9;SNX32;TMEM87B;VPS53;CLTC;TBC1D10A;TBC1D17;SPAG9;STX16;GGA1;PHETA2;EVI5;HEATR5A;DCTN1;LMAN1;VPS51;BET1L;SNX3;RNF126;VTI1B;GCC2;SURF4;CLN5;SNX5;ARL1;ARFRP1;PIKFYVE;VTI1A
prerank,intestinal lipid absorption (GO:0098856),0.6852184399588784,1.4252304694819453,0.08192090395480225,0.5996561014549394,1.0,3/11,8.80%,LIMA1;CEL;AKR1C1
prerank,cell junction assembly (GO:0034329),-0.3465351982608439,-1.4244656812989325,0.04,0.5497906969442194,1.0,34/100,12.86%,TJP1;SDK1;TLN2;ADGRL3;CDH8;GPM6A;CDH5;ITGA6;NRXN1;SHANK3;CLDN5;DNM3;SPOCK2;LIMS2;PKP4;PLXND1;ARVCF;GJC1;CDH1;OPHN1;CDH6;CDH2;DNER;CDC42;FLNC;CDH7;CDH19;CDH20;SLITRK1;FN1;CTNND1;SDK2;FBLIM1;PKP2
prerank,histone H3-K4 methylation (GO:0051568),0.5848112390029777,1.4244410722130088,0.06463878326996197,0.601160777446953,1.0,12/26,22.60%,KMT2C;OGT;WDR5;KMT2D;SETD4;KMT2B;MEN1;WDR82;SETD1A;DPY30;TET2;KMT2A
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.5687764649212638,-1.4241674834208644,0.09966777408637874,0.5450373781871579,1.0,6/11,19.08%,EFNB2;FRS2;SOX6;MYOCD;BMP2;TGFB1
prerank,cellular senescence (GO:0090398),0.5789829042564835,1.423833669373874,0.07711138310893513,0.6019924734915937,1.0,3/27,0.88%,ID2;PRKCD;ECRG4
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5882212435522078,1.4234698090643825,0.06218274111675127,0.6017670803282962,1.0,4/27,1.86%,IRS1;PID1;PRKCD;GRB10
prerank,protein O-linked glycosylation via serine (GO:0018242),0.7000307181024483,1.4234455016034435,0.08464849354375897,0.599910776156608,1.0,5/10,16.03%,GALNT13;POGLUT3;POGLUT1;GALNT1;GALNT3
prerank,adherens junction organization (GO:0034332),-0.38682997996304924,-1.422699619950645,0.01694915254237288,0.5436390100281141,1.0,15/48,9.52%,TJP1;CADM1;CDH8;CDH13;CDH5;CADM2;CDH4;PIP5K1C;CDH1;CDH6;CDH2;NECTIN2;CDH7;CDH19;CDH20
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.5573614631520738,1.4208695359018428,0.055424528301886794,0.6093719784418026,1.0,7/39,9.02%,THBS1;MYOC;EFNA5;SEMA3E;JAG1;FZD7;RHOA
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.540101364689358,1.4207814188316223,0.06414662084765177,0.6078255060550416,1.0,19/49,23.43%,THBS1;RAB7B;KMT2C;AGO1;PITHD1;WDR5;HDAC1;KMT2D;RUNX1;SCIN;EIF6;NFE2;KMT2B;SETD1A;CBFB;DPY30;KMT2A;PRMT1;KAT2B
prerank,positive regulation of protein sumoylation (GO:0033235),0.6950544500659473,1.4207148162527523,0.07163323782234957,0.6061958083601933,1.0,6/10,21.21%,GNL3;HDAC4;PIAS4;RWDD3;SAE1;MUL1
prerank,positive regulation of cytokinesis (GO:0032467),0.559149568935561,1.4198685451724262,0.07439024390243902,0.6079499260142569,1.0,11/32,15.11%,CIT;PRKCE;CDC14A;GIPC1;CDC6;RHOA;PKN2;CDC25B;SPAST;OPN1MW;CSPP1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5339507965743049,1.419802691716541,0.04735062006764374,0.6063079233631219,1.0,8/50,9.52%,THBS1;VEGFA;GAS6;NOL3;CSNK2A1;CARD16;RAF1;PAK2
prerank,positive regulation of mRNA processing (GO:0050685),0.6052388538096574,1.4195165239204721,0.09125964010282776,0.6056504343155618,1.0,16/21,32.27%,CELF4;THRAP3;CELF3;DAZAP1;NCBP1;NCBP2;RBMXL1;TRA2B;CIRBP;TRA2A;PAF1;RBM3;SF3B4;PRDX6;SNW1;NCL
prerank,tRNA transport (GO:0051031),0.5669665377167403,1.4190761694669378,0.06205250596658711,0.6056222022469219,1.0,18/35,26.41%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NUP62;NDC1;NUP35;YBX1;NUP85;NUP160;TPR
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5160684662094407,1.4189183937499057,0.03747323340471092,0.6043258397521666,1.0,10/69,8.13%,THBS1;LBP;IL33;EPHB2;TWIST1;SPN;STAT3;MAVS;HMGB1;FZD5
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5132196330016492,1.4180198535329591,0.028846153846153848,0.606370252939576,1.0,10/73,8.13%,THBS1;LBP;IL33;EPHB2;TWIST1;SPN;STAT3;MAVS;HMGB1;FZD5
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6218216142459112,1.418019068711639,0.087248322147651,0.6044574130249402,1.0,6/16,15.25%,ST3GAL4;NFAT5;RHOA;IRAK1;FUT4;IL6
prerank,embryonic appendage morphogenesis (GO:0035113),0.6832768686646354,1.4175138593795016,0.0784313725490196,0.6048687786993497,1.0,4/12,7.28%,LRP6;MBNL1;TGFB2;SKI
prerank,ncRNA export from nucleus (GO:0097064),0.5595933667440816,1.4174050972885985,0.06324582338902147,0.6034130105496678,1.0,18/36,26.41%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NCBP2;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,negative regulation of protein phosphorylation (GO:0001933),0.48712228634081123,1.4172658710296386,0.007135575942915392,0.6021126729706618,1.0,36/150,12.80%,SLIT2;RASSF2;LRP6;PID1;PRKCD;PMEPA1;EMILIN1;UBASH3B;NTRK3;SMAD6;PLPP3;EPHB2;TWIST1;LDLRAD4;SPRED2;WWTR1;XDH;CALM2;DVL1;DMD;PRKDC;TRIM27;NOG;IMPACT;AKT1S1;CDK5RAP3;DGKQ;PAK2;PAQR3;NIBAN1;PDPK1;SMAD7;DEPTOR;CHP1;PPEF2;EIF4G1
prerank,lymphocyte chemotaxis (GO:0048247),0.5640148230410139,1.4160562077812633,0.06524317912218268,0.6054481254752363,1.0,5/34,7.21%,GAS6;SLC12A2;CCL13;CCL15;CXCL16
prerank,vitamin transport (GO:0051180),0.5786458655528852,1.4159449511415028,0.0654320987654321,0.6040505328049647,1.0,3/29,5.92%,SLC23A1;SLC5A6;SLC25A32
prerank,negative regulation of bone mineralization (GO:0030502),-0.5230639430822155,-1.4156349170341191,0.09795918367346938,0.5591303225246483,1.0,5/13,13.26%,ENPP1;SRGN;BCOR;RFLNA;RFLNB
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6661757966845372,1.4153587032191548,0.07567567567567568,0.6047744968462472,1.0,2/14,0.78%,PGF;VEGFA
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.6597394716280892,1.4151409093211438,0.07827260458839407,0.603864236881235,1.0,10/14,25.05%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF7;SRSF10;SAP18;SFSWAP;SRSF4;C1QBP
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5483798528701376,1.414131757948565,0.06960556844547564,0.6065432041752218,1.0,16/40,15.98%,TCF7L2;COL1A1;TIAM1;TGFB3;TWIST1;WWTR1;TGFB2;BCL9L;SMAD4;TGFBR2;JAG1;TGFB1I1;TGFBR1;DAB2;IL6;CRB2
prerank,smooth muscle contraction (GO:0006939),-0.5261836935004636,-1.414089409515028,0.12260536398467432,0.55791989553885,1.0,9/14,12.55%,ROCK2;MYLK;SLC8A1;SMTN;BDKRB2;MYH11;ADRA1A;ACTA2;PIK3C2A
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.6113165442424046,1.414022033983574,0.07365792759051186,0.6051716253222309,1.0,4/20,5.27%,PID1;PKDCC;RHOQ;PPFIA1
prerank,chemical homeostasis (GO:0048878),0.521016500379822,1.4137161492574144,0.04962243797195254,0.6046006029436096,1.0,15/61,15.91%,SLC4A10;SLC4A4;ACOXL;SLC4A8;TLCD2;ACOX3;TENT4B;SLC4A11;SLC4A2;NR1D2;SLC4A3;WNK1;PNPLA3;SLC4A5;THADA
prerank,catecholamine metabolic process (GO:0006584),0.6564855482524758,1.413673955920496,0.08042895442359249,0.602945634010897,1.0,3/14,4.35%,DRD1;LRTOMT;SNCAIP
prerank,histone deubiquitination (GO:0016578),0.6337316435319007,1.4130193331456589,0.09561752988047809,0.6039322983401058,1.0,12/18,27.84%,TRRAP;ENY2;KAT2A;USP7;USP36;BRCC3;USP49;ATXN7;TAF10;USP21;USP16;USP22
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5707620784789893,1.4129573201733907,0.06761565836298933,0.6023920340992572,1.0,8/29,14.42%,PLA2G4F;PLA2G4A;LPCAT1;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,regulation of cholesterol esterification (GO:0010872),-0.5754459149241522,-1.4128917000815937,0.10101010101010101,0.5557864490322965,1.0,4/10,8.10%,APOE;ABCG1;STARD4;AGTR1
prerank,chromatin assembly (GO:0031497),0.5514449340695665,1.4110153196239457,0.05263157894736842,0.6089880204140666,1.0,18/38,26.19%,CHAF1B;M1AP;NAA60;EZH1;SOX9;CDAN1;ANP32B;SPTY2D1;KAT6B;BRD2;NAP1L3;NAP1L2;NOC2L;PAF1;TP53;H3-3A;DAXX;CHAF1A
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.57064597638946,-1.4101611602931907,0.10410094637223975,0.5582053726357984,1.0,3/10,2.42%,ENG;ERRFI1;ENPP1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5082503980868281,1.410101382562241,0.035864978902953586,0.611186946208126,1.0,29/86,17.75%,THBS1;GDF10;ZNF423;FOXD1;NUP93;INHBC;ACVR1B;TGFB3;HES5;TGFB2;ACVR1;SMAD4;SULF1;GIPC1;BMP4;SH2B1;BMPR1A;TGFB1I1;TGFBR1;INHBA;DAB2;BMP5;CRB2;CREBBP;SLC2A10;FLCN;CDKN1C;MEN1;CITED2
prerank,ceramide transport (GO:0035627),-0.560102321845495,-1.4090798119908605,0.0944055944055944,0.5558003463931783,1.0,3/12,9.50%,PLTP;CERT1;GLTP
prerank,protein localization to Golgi apparatus (GO:0034067),0.5721367423674437,1.4074652511964618,0.07954545454545454,0.6208883211570958,1.0,6/27,10.27%,VPS13A;VPS13C;CSNK1D;IFT20;GBF1;PAQR3
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.3999021818028747,-1.4074436173294265,0.04794520547945205,0.5549640083887144,1.0,11/35,9.41%,TJP1;TEK;RAPGEF3;ESAM;F11R;PDGFRA;BAIAP2;ARHGDIA;IQGAP2;CDC42;ABI3
prerank,visual system development (GO:0150063),0.555457467817886,1.4070340307676936,0.06565064478311841,0.6210846221265179,1.0,14/37,20.04%,SMOC1;CHRDL1;PBX3;TGFB2;PBX1;MEIS3;SH3PXD2B;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3;MAB21L2;HIPK2;ATF6
prerank,regulation of tumor necrosis factor production (GO:0032680),0.49267177183278305,1.406222441800103,0.02497398543184183,0.6226805235865179,1.0,15/112,8.13%,THBS1;FOXP1;GAS6;LBP;IL33;EPHB2;TWIST1;SPN;STAT3;MAVS;HMGB1;IRAK3;TRIM27;RARA;FZD5
prerank,regulation of phospholipase activity (GO:0010517),0.6888780213118078,1.4055938979510758,0.10838150289017341,0.6235404546130776,1.0,5/10,11.56%,LRP1;FGFR1;FGFR2;PLA2G5;PDPK1
prerank,protein import (GO:0017038),0.5003618258264411,1.4053542924449864,0.03624733475479744,0.6227663118195017,1.0,44/84,31.44%,ABCD3;NUP93;PRICKLE1;PXMP2;SEC13;IPO5;STAT3;IPO4;HIKESHI;E2F3;PEX5;PEX16;PEX13;IPO13;TNPO2;ALDH3A2;NUP88;POM121;AKT1;IPO9;TNPO1;APPL2;APPL1;CLU;NUP62;PPP1R10;LAMP2;PEX2;ABCD1;ACBD5;PEX14;TSC2;IPO8;NUTF2;NUP85;TPR;RPAIN;FIS1;NUP50;FAM53C;ATAD1;HSP90AA1;NUP188;RANBP6
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5757870911492387,1.4052996515884344,0.07711757269279393,0.6212008863189524,1.0,4/28,1.86%,IRS1;PID1;PRKCD;GRB10
prerank,protein import into peroxisome membrane (GO:0045046),0.5944265312989135,1.40528721850922,0.09475032010243278,0.6194037026936975,1.0,10/22,22.68%,ABCD3;PXMP2;PEX5;PEX16;PEX13;ALDH3A2;PEX2;ABCD1;ACBD5;PEX14
prerank,regulation of vasculature development (GO:1901342),0.5873741598295513,1.4049086927681445,0.08433734939759036,0.6191848029883634,1.0,3/26,1.91%,BMPER;FGF2;PROK2
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.6451156331506618,1.4037284388942723,0.08753315649867374,0.6224849260033072,1.0,5/15,11.75%,ACVR1B;DACT1;ACVR1;SKI;SMAD7
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3639305939002808,-1.4035451943583237,0.011363636363636364,0.5602555264692685,1.0,23/59,13.94%,ROBO1;SDK1;CADM1;CDH13;PECAM1;BSG;ROBO2;CDH4;TENM3;CNTN6;CDH1;DSCAML1;CNTN4;CDH2;ROBO4;NECTIN2;NEXN;PLXNB2;CD84;CEACAM1;SDK2;PTPRT;IGSF21
prerank,monoacylglycerol metabolic process (GO:0046462),0.660340591935844,1.4035322727857018,0.09165526675786594,0.6215970080799068,1.0,2/13,1.79%,MGLL;PLA2G4A
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5393384788476541,1.4033377469475263,0.061855670103092786,0.6205719385043305,1.0,12/48,9.69%,THBS1;RHOJ;VEGFA;FGF2;HDAC9;STAT5A;PRKCA;FOXC2;HMGB1;FGFR1;ANGPT4;ANXA1
prerank,glycogen metabolic process (GO:0005977),0.5783077613553255,1.403117601664938,0.09101941747572816,0.61971791374445,1.0,6/27,7.74%,PYGB;PPP1R3C;STBD1;PHKA1;GAA;PHKB
prerank,contractile actin filament bundle assembly (GO:0030038),-0.5111149478004865,-1.402970584983051,0.09125475285171103,0.55180171763721,1.0,3/15,0.88%,SORBS1;PHACTR1;FAM171A1
prerank,stress fiber assembly (GO:0043149),-0.5111149478004865,-1.402970584983051,0.09125475285171103,0.55180171763721,1.0,3/15,0.88%,SORBS1;PHACTR1;FAM171A1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.48351508365727947,1.4018778818724738,0.01330603889457523,0.6232554613856089,1.0,67/153,24.65%,PKD1;PRKCD;GAS6;ULK2;MARK1;PRKCE;CSNK1D;CAMK2D;CSNK2A2;CSNK2A1;MORC3;PRKCA;DYRK4;PRKDC;TGFBR2;TLK1;STK39;RPS6KA4;AKT2;DGKQ;PKN2;PAK2;MAPK8;SMG1;CSNK1G1;CHUK;MAP3K12;ATM;MAPK12;PDPK1;UHMK1;CSNK1E;TGFBR1;MAP3K10;DMPK;WNK1;LATS2;CAMK4;TLK2;MKNK2;VRK2;MAST2;AKT1;HIPK2;CDK2;IKBKE;CDK5;SGK3;MAPK9;PRKACA;VRK3;LRRK2;CSNK1G3;MAST4;CAMK1;STK38;EIF2AK3;PRKCI;TOP1;HIPK4;RPS6KA2;RPS6KB1;TAF1;TBK1;ROCK1;PINK1;LMTK2
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3998199312735946,-1.4014001514407437,0.03289473684210526,0.5514291270127167,1.0,12/39,14.71%,MYO1B;PPFIA2;DYNC1I1;MYO6;ACTN4;BICDL1;TRAK2;MYO1D;KIF1A;TRAK1;KIF5B;MYO5C
prerank,regulation of calcium ion transport (GO:0051924),-0.3705454690768517,-1.4009168980669269,0.01,0.5478885428053072,1.0,15/54,11.56%,MYLK;BCL2;EPB41;CACNA1D;CACNB2;CACNA2D1;ATP2B1;TRPC6;ORAI1;ADRA2A;PLPP4;HOMER1;PACSIN3;CD84;NOS1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5667147639371274,1.4005250449223217,0.07407407407407407,0.6273196636400966,1.0,7/34,12.40%,MYOC;P4HB;ILK;S100A10;DOCK5;ABL1;NRP1
prerank,intracellular protein transport (GO:0006886),0.47089502086677504,1.4002778318258733,0.002002002002002002,0.6266143631553716,1.0,116/304,23.73%,PKD1;SGSM2;XPO1;LTBP2;NUP93;ARFGAP3;CTTN;SEC31A;KIF13A;PRICKLE1;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;IPO5;STRADA;RAB43;STAT3;C2CD5;COPA;BAG3;RAB24;STX11;AP2A1;IPO4;RAB21;RIC1;TLK1;GGA2;XPO6;HIKESHI;E2F3;GIPC1;ARF4;COPZ2;AKT2;SNX1;NSF;SCFD1;STX2;VPS26A;ARFIP2;RAB38;XPO4;ARF1;SNX9;AP3D1;TMED9;WDR11;USO1;EVI5L;IPO13;CHP1;TECPR2;TBC1D9B;NLGN1;TBC1D25;TNPO2;ERP29;PICK1;VIPAS39;PREB;CLTC;SEC16A;RAB23;HPS4;TBCK;NUP88;TBC1D10A;SIL1;STX4;COPB2;STX1A;SCFD2;TBC1D17;HDAC6;STX16;GGA1;BCS1L;SNX13;NAPA;TMED2;POM121;RAB5B;VPS45;AKT1;IPO9;TNPO1;SNX15;SEC23IP;RAB3GAP2;COX18;EVI5;APPL2;APPL1;CALR;TBC1D22B;VPS26C;NUP62;IFT27;PPP1R10;CCHCR1;LAMP2;RAB1A;LMAN1;RAB18;DESI1;CAMSAP3;TSC2;RAB1B;COPZ1;IPO8;RABGAP1;ARF5
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5552524824898899,1.4002427171768104,0.08303249097472924,0.6249454424083843,1.0,12/33,15.81%,PRKCD;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;ANXA1;RIPK3;ABL1;RHOB;IL6;HDAC6
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.6418898634917318,1.4000086013233841,0.10695187165775401,0.6242624056332686,1.0,4/15,11.75%,TGFB3;TGFB2;IRAK3;SMAD7
prerank,cellular response to organic substance (GO:0071310),0.48969123360020755,1.3998230882191285,0.024922118380062305,0.6233925510437837,1.0,25/116,13.71%,SLIT3;SLIT2;PID1;IGFBP5;GHR;DPYSL3;ACVR1B;SHC1;CYP1B1;NFAT5;STAT3;RAMP2;ACVR1;TGFBR2;SOCS2;RHOA;PTPN18;MAPK8;RAMP1;URI1;BMPR1A;TGFBR1;PTPN2;LRP2;CASP1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5901461507692111,1.3992301078697054,0.08439897698209718,0.6242165427833276,1.0,7/22,17.98%,ESR1;MED13;SRF;PSMC5;PSMC4;MED14;MED12
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.46287038625174015,-1.3985239890498589,0.0625,0.5493256727707132,1.0,11/22,24.95%,PPM1E;DUSP16;DUSP10;PPP2CB;PPM1G;DUSP6;PPP5C;DUSP4;PPP1CA;PPM1D;PPM1A
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.6723749935833534,1.3974728878666336,0.09903713892709766,0.6299324561201144,1.0,6/12,17.86%,SEH1L;CENPC;MAD1L1;MIS12;RMDN1;CDT1
prerank,endomembrane system organization (GO:0010256),0.47973907005619953,1.3970826470211473,0.006091370558375634,0.6297736406443089,1.0,69/178,24.23%,NUP93;SEC31A;MAPK15;ATL2;SEC61A1;CSNK1D;LMAN2L;RAB2A;FBXW8;GOLGA8B;GOLGA5;RAB30;RAB43;TLCD2;DOP1B;DNAJC13;BCAS3;SMPD4;GOLGB1;LAMTOR1;ATL3;USP50;GBF1;ATP8B2;HUWE1;TJAP1;ARHGAP21;LAPTM4B;PLEKHM2;TRAPPC12;AP3D1;TMED9;ZW10;TRIP11;WASHC4;PI4K2A;DMPK;REEP3;LMAN2;SEC16A;SQSTM1;MIA3;SEC16B;SPTBN1;TLCD1;VPS11;TMEM170A;GOLPH3;BNIP1;TMED2;NPLOC4;COG2;BLZF1;PHETA2;SEC23IP;TRAPPC11;REEP5;OPTN;ARFGEF2;ATL1;LRRK2;RAB1A;LMAN1;ATP8B1;EIF2AK3;GORASP2;DYNC2H1;TMED7;VPS51
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.5809371251861433,1.3970759315546906,0.0898876404494382,0.6280227632163059,1.0,10/25,25.10%,LDB1;TCEA2;CCAR2;HMGN1;CCNT2;SETD5;ZMYND11;KAT7;EAF1;DDX39B
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.5192130446235835,-1.3970730894052956,0.11553784860557768,0.5483288288544199,1.0,7/13,15.66%,NOS3;ALDH4A1;GLUL;GLS;PRODH;NOS1;GAD1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5738671922616191,1.3969964614662445,0.08303249097472924,0.6266073024530315,1.0,8/27,8.86%,CACNA1C;FGF13;HCN4;CAMK2D;ANK2;JUP;DLG1;TRPM4
prerank,nucleotide-sugar metabolic process (GO:0009225),0.6604143577537684,1.3965528402722776,0.09673024523160763,0.6266858525734555,1.0,5/12,9.50%,GFPT1;GMDS;GFUS;GFPT2;FUT8
prerank,skin development (GO:0043588),0.5116879622897096,1.3963353410385881,0.04787812840043525,0.6259071977751943,1.0,10/65,6.77%,PKD1;COL3A1;ADAM9;COL1A2;COL1A1;COL5A3;COL5A2;CLIC4;JAG1;BCR
prerank,ERBB2 signaling pathway (GO:0038128),0.5653647795537498,1.3962308675978343,0.06900726392251816,0.6245902139337401,1.0,4/31,4.91%,MYOC;EGFR;SHC1;PRKCA
prerank,glycogen catabolic process (GO:0005980),0.6372374374066021,1.3956473753736105,0.09428950863213811,0.6253314528451641,1.0,5/15,7.74%,PYGB;STBD1;PHKA1;GAA;PHKB
prerank,carboxylic acid metabolic process (GO:0019752),0.5655048821146818,1.395575941521071,0.08323281061519903,0.6238545668445771,1.0,4/33,1.79%,SLC23A1;SLC23A2;PTGIS;PLA2G4A
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.6569245059240182,1.395527290092773,0.07340720221606649,0.6223361858743639,1.0,8/13,20.99%,CPSF4L;CPSF4;NCBP1;CPSF7;CPSF6;NCBP2;CSTF2;CSTF2T
prerank,relaxation of cardiac muscle (GO:0055119),0.6355440407003832,1.3951244861037106,0.08719346049046321,0.6224059671938604,1.0,4/13,3.61%,KCNJ2;ATP1B1;GSN;CAMK2D
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.3868802572197054,-1.3949200622542668,0.03676470588235294,0.5495052694106595,1.0,13/40,9.15%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;OSR1;WNT6;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.5853355563635616,1.3943316280546336,0.08489388264669163,0.6241276353217952,1.0,9/25,12.31%,CACNA1C;FGF13;HCN4;CAMK2D;ANK2;JUP;DLG1;TRPM4;AKAP9
prerank,positive regulation of integrin activation (GO:0033625),-0.5492535863530443,-1.394132867420509,0.1166077738515901,0.5469611512840972,1.0,3/11,11.13%,RASIP1;PIEZO1;PLEK
prerank,cellular response to copper ion (GO:0071280),-0.4809749453856742,-1.3933340078660188,0.08058608058608059,0.5445134252074592,1.0,10/16,18.03%,MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;SNCA;MT3
prerank,icosanoid biosynthetic process (GO:0046456),0.6791552217773236,1.3932860963991862,0.08241758241758242,0.627055114565038,1.0,3/10,10.32%,PLA2G4A;PLA2G5;FADS1
prerank,protein O-linked mannosylation (GO:0035269),-0.47383965114620985,-1.3920665765623819,0.09090909090909091,0.5430015632210528,1.0,3/18,2.16%,TMTC2;TMTC4;CRPPA
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.408216143483637,-1.3919696989790116,0.04487179487179487,0.5386064056187756,1.0,10/29,11.88%,SORBS1;APOE;PPARA;LPGAT1;NR1H3;SLC45A3;ZBTB20;MFSD2A;MID1IP1;SCARB1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.6125882116646347,1.3914828385799989,0.08224543080939947,0.6330509980804626,1.0,6/19,12.40%,MYOC;VEGFA;COL16A1;S100A10;ABL1;NRP1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.6175857096517794,1.3913354053597737,0.09561752988047809,0.6319855526201412,1.0,8/18,19.62%,RDX;DNAJC13;RAB21;EZR;CHMP3;DAB2;VPS11;PTPN23
prerank,sodium ion homeostasis (GO:0055078),-0.45595190678325004,-1.3906272673178057,0.08936170212765958,0.5377840364224409,1.0,4/21,1.29%,ATP1A2;ATP1B3;NEDD4L;SLC8A1
prerank,endothelial cell proliferation (GO:0001935),0.6232017471178866,1.390066317763756,0.1127129750982962,0.6359590086929446,1.0,5/17,9.70%,BMPER;PROK2;DLG1;ANGPT4;BMP4
prerank,cellular response to reactive oxygen species (GO:0034614),0.5022668693109413,1.390047387392528,0.05426356589147287,0.6343202016115322,1.0,16/59,15.81%,EGFR;PRKCD;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;MAPK8;ANXA1;CHUK;RIPK3;ABL1;PRDX3;RHOB;IL6;HDAC6
prerank,establishment of protein localization to organelle (GO:0072594),0.4992456468250738,1.3900115942620377,0.055853920515574654,0.632763177181115,1.0,32/72,27.27%,NUP93;TSPAN10;PRICKLE1;SEC13;IPO5;STAT3;LRSAM1;IPO4;HIKESHI;E2F3;IPO13;TNPO2;NUP88;POM121;AKT1;IPO9;TNPO1;NEURL1B;APPL2;APPL1;NUP62;LAMP1;PPP1R10;LAMP2;TSC2;IPO8;PINK1;NUTF2;NUP85;TPR;RPAIN;RALA
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6775536001842484,1.389433998362418,0.11063829787234042,0.6334629828812959,1.0,6/11,19.62%,RDX;RAB21;EZR;DAB2;VPS11;PTPN23
prerank,cardiac muscle cell action potential (GO:0086001),0.567837305703151,1.3883055593868723,0.06990521327014218,0.6366564874596632,1.0,8/30,6.98%,KCNJ2;CACNA1G;CACNA1C;ATP1B1;HCN4;DMD;ANK2;KCNIP2
prerank,carbohydrate biosynthetic process (GO:0016051),0.590138564255734,1.388301683779989,0.10459183673469388,0.6349691493966483,1.0,6/21,11.13%,ST3GAL4;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;FUT4
prerank,energy reserve metabolic process (GO:0006112),0.5993250573530251,1.388150360975385,0.08949416342412451,0.6338624642621457,1.0,6/19,7.90%,PID1;PPP1R3C;GFPT1;PHKA1;PHKB;GFPT2
prerank,regulation of protein sumoylation (GO:0033233),0.6045166038422842,1.388057466675063,0.10789473684210527,0.632593870769734,1.0,7/17,21.21%,ZMIZ1;GNL3;HDAC4;PIAS4;RWDD3;SAE1;MUL1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6011320340838291,1.3875699828867691,0.08147174770039421,0.6330430276555575,1.0,4/21,8.75%,SLIT2;EPHB2;TGFB2;LZTR1
prerank,relaxation of muscle (GO:0090075),0.6356127131268957,1.3873245577815445,0.10176390773405698,0.6323345077565546,1.0,4/13,3.61%,KCNJ2;ATP1B1;GSN;CAMK2D
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.487271910497155,-1.3865199929607166,0.0851063829787234,0.5444142057571263,1.0,6/17,10.26%,PPARA;PRKAA2;PRKAG2;PPARD;ADIPOR1;CAV1
prerank,positive regulation of catabolic process (GO:0009896),0.5108836252413208,1.3864681106413113,0.05333333333333334,0.6342988875500071,1.0,15/65,11.34%,WWP1;GPC3;NEDD4;STX5;CSNK2A1;ACTN3;RILP;VCP;DACT1;HUWE1;WWP2;NSF;ITCH;VIP;AXIN1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5784119783323038,1.3862545107529995,0.09429280397022333,0.633477457984441,1.0,8/24,16.48%,PLA2G4F;PLA2G4A;LPCAT1;LPCAT4;PGS1;PLA2G5;PLA2G12A;PLA2G15
prerank,protein alkylation (GO:0008213),0.5929060413163784,1.386010332020002,0.10292249047013977,0.6328732933563271,1.0,10/22,23.22%,PRMT8;FAM98A;GSPT1;FAM98B;LCMT1;EEF1AKMT2;ETF1;PCMT1;SNRPB;PRMT1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6851698564832603,1.3858002054645906,0.10850439882697947,0.6321254849253742,1.0,1/10,0.08%,MYOC
prerank,in utero embryonic development (GO:0001701),0.5723143116401112,1.3848283830140509,0.11053984575835475,0.6346921524998801,1.0,9/25,12.94%,PKD1;VEGFA;TGFB3;MBNL1;ADAM10;FUT8;FGFR2;TGFBR1;LIG4
prerank,positive regulation of immune system process (GO:0002684),0.6177623049416714,1.383598513833662,0.12649800266311584,0.6383147125907023,1.0,5/16,14.88%,VEGFA;TGFB2;ANXA1;PIK3CB;MIA3
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.4811705318619165,-1.383573519196691,0.07818930041152264,0.5477370926427383,1.0,5/18,8.74%,OCLN;SLC2A1;PRKCB;PRKAG2;BRAF
prerank,embryonic organ morphogenesis (GO:0048562),0.5242017969315497,1.3822134462420268,0.07737397420867527,0.6426623316114785,1.0,13/42,17.63%,SIX1;ID2;MFAP5;HOXA3;HOXB3;ACVR1;HOXA9;FGFR2;HOXB4;HOXA4;FUZ;NIPBL;DYNC2I1
prerank,reverse cholesterol transport (GO:0043691),-0.5068956234953835,-1.382145805095888,0.1111111111111111,0.5468850762442239,1.0,4/13,11.88%,APOE;ABCG1;ABCA5;SCARB1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5266505182245241,1.3820271109779139,0.07151095732410612,0.6418241734625598,1.0,9/47,12.40%,MYOC;EFNA5;P4HB;ILK;S100A10;DOCK5;ABL1;RCC2;NRP1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.4987585836197685,1.3819546997197631,0.05452562704471101,0.6404676337225924,1.0,36/69,29.10%,UBXN8;VCP;DNAJB14;EDEM2;FAF2;SYVN1;HSPA5;RNF103-CHMP3;UBQLN1;FBXO17;STUB1;USP19;RNF121;YOD1;TRIM13;UBE4A;DNAJC18;NPLOC4;UBXN4;UBE2G2;ECPAS;DERL1;SGTB;HERPUD1;AMFR;TMEM67;SELENOS;DNAJB12;JKAMP;SEC61B;TMUB2;SEL1L2;FAM8A1;STT3B;UBE4B;TMUB1
prerank,regulation of plasminogen activation (GO:0010755),0.6568595741729333,1.381943357704319,0.11239193083573487,0.6388754996480296,1.0,1/12,0.08%,THBS1
prerank,calcium ion import into cytosol (GO:1902656),-0.512665404494139,-1.3806570491888388,0.10074626865671642,0.5465588121114868,1.0,5/15,7.35%,SLC8A1;SLC24A2;CACNA2D1;TRPV2;SLC8A3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6449847835170226,1.3805336242636908,0.1133428981348637,0.6433131775883285,1.0,2/12,2.70%,ESR1;NCOR2
prerank,negative regulation of locomotion (GO:0040013),-0.5397700181800905,-1.3800525484963784,0.11428571428571428,0.5439282752043577,1.0,5/12,12.01%,FRMD5;FBLN1;SPOCK3;DUSP3;SPINT2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3019110069203157,-1.3793127204272118,0.0,0.5412992052774888,1.0,33/138,9.39%,FLT1;IGF1R;PTPRG;MTSS1;INSR;LYN;PTN;TEK;KIT;EPHA4;EPHA7;TIE1;FRS2;IL31RA;KDR;NEDD9;PTPRD;PDGFRB;MPZL1;ROR2;EPHA8;BDKRB2;ERBB4;EPHA6;PDGFRA;MERTK;CSF1;FGFR4;FLT4;LIFR;BMPR2;ANGPTL1;NPR1
prerank,regulation of myotube differentiation (GO:0010830),0.5712753009921929,1.3790789639264618,0.10025706940874037,0.6480617937987971,1.0,8/24,13.86%,CCN3;HDAC9;HDAC4;MMP14;TMEM119;FBXO22;HDAC1;DMPK
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5923631524055196,1.3789452877727482,0.0978120978120978,0.6469823378067847,1.0,17/23,34.49%,GPS1;CUL4A;PARP1;UBC;RPS27A;COPS4;COPS7A;COPS3;XPA;DDB1;RBX1;COPS5;RAD23B;CUL4B;COPS2;CETN2;COPS7B
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5802399226365224,1.378757680693592,0.10532837670384139,0.646166434446592,1.0,13/24,25.82%,FLVCR1;FXN;RSAD1;SUCLA2;NFE2L1;HMBS;ABCB6;FECH;UROS;SLC25A38;ABCG2;ABCB10;COX15
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5848887479139916,1.3785224059629821,0.08974358974358974,0.6455891287670338,1.0,5/22,5.50%,ADAM9;TIMP2;PTPN3;TIMP3;TNFRSF1B
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4379058327377481,-1.3772004733079954,0.0547945205479452,0.5426208906219089,1.0,5/23,5.35%,TGFBR3;ENG;NREP;SMAD3;ITGA3
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6369290276287212,1.377093215097723,0.09029649595687332,0.6502275687415092,1.0,3/15,6.98%,KCNJ2;ATP1B1;KCNIP2
prerank,ion transport (GO:0006811),0.48499128441389705,1.3754710190714685,0.03537981269510926,0.6557905392105401,1.0,15/111,7.64%,PIEZO2;SLC26A7;SLC26A2;SLC12A7;SLC12A2;SLC24A3;HCN4;SLC26A6;KCNN1;SLC9A8;SLC9A4;CHRNB2;SLC9A1;SLC4A2;SLC12A4
prerank,eye photoreceptor cell development (GO:0042462),0.6295975772005279,1.3752514860148315,0.10526315789473684,0.655021251806571,1.0,5/15,19.47%,VEGFA;TOPORS;RPGRIP1L;CRB2;MYO7A
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.5871173404198182,1.3749611976725937,0.11447368421052631,0.6546089796194261,1.0,7/20,16.66%,ZC3H7A;PUM1;PRKRA;AGO1;TERT;AGO2;TSN
prerank,muscle cell migration (GO:0014812),0.678756280844811,1.374857865398267,0.1130690161527166,0.6533584733529636,1.0,2/10,1.72%,SIX1;CCN3
prerank,protein import into peroxisome matrix (GO:0016558),0.6649170840199299,1.3743155015983897,0.10699588477366255,0.6540566814998325,1.0,9/12,22.68%,PEX7;PEX5;PEX16;PEX13;PEX1;PEX10;PEX6;PEX2;PEX14
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5831912106336195,1.3739523174026131,0.10573248407643313,0.653910280947445,1.0,4/22,4.63%,NTRK3;NTRK1;EHD1;KIDINS220
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5893860133996762,1.373757882753309,0.11728395061728394,0.6531004121569951,1.0,5/21,12.73%,IGFBP5;FGF2;P2RY6;BMPR1A;MEF2D
prerank,gastrulation (GO:0007369),0.6334284422168559,1.373461029892354,0.10340136054421768,0.6527578736581011,1.0,2/15,2.62%,GPC3;LRP5
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5758528517070685,1.3733744840363893,0.10606060606060606,0.6514977614064419,1.0,7/25,13.07%,SLIT2;PRKCD;LIMK2;PFN2;CDK10;EVI5L;ARHGAP44
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5479036240578841,-1.3733086026752652,0.12222222222222222,0.5489035067459814,1.0,2/11,1.06%,LYN;MFHAS1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6460001983779741,1.3730038701201688,0.0937062937062937,0.6514657527848187,1.0,7/13,25.74%,PKD1;GOPC;MDFI;SUFU;NFKBIA;YWHAB;GET4
prerank,ncRNA metabolic process (GO:0034660),0.5395366359938921,1.37283608711137,0.09389671361502347,0.6505587384937082,1.0,12/37,23.20%,DDX17;TENT4B;PRKRA;MAEL;DTD1;DGCR8;AGO2;TDRD12;TUT7;TDRKH;ZCCHC8;NIFK
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.42906283658092925,-1.372774596526545,0.07772020725388601,0.546003632043754,1.0,9/26,13.58%,TGFA;ERRFI1;CBLB;APP;ADRA2A;HBEGF;SNX6;SOCS5;GPRC5A
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.43883899927357006,-1.3722688444459208,0.08415841584158416,0.5431329718290595,1.0,10/26,14.89%,NRXN1;SHANK3;APP;RIMS2;RIMS1;SLC8A3;CUX2;RELN;GRIN1;PRKCZ
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.6234025601859781,1.3722574863702326,0.11416781292984869,0.651530447951504,1.0,7/15,16.93%,SIX1;TWIST1;TGFBR2;FGFR2;TGFBR1;MTHFD1;NIPBL
prerank,tRNA methylation (GO:0030488),0.544995470936859,1.3719477487371672,0.08214285714285714,0.651235374900783,1.0,19/34,33.87%,TRMT61B;TARBP1;TRMT1;DALRD3;TYW3;THADA;THUMPD3;TRMT44;ALKBH8;TRMT61A;METTL1;NSUN6;MTO1;TRMT112;TRMT1L;METTL6;PRORP;METTL2A;METTL2B
prerank,nuclear membrane reassembly (GO:0031468),0.5158849037685541,1.3716898518451006,0.06504961411245866,0.6507086302992108,1.0,26/54,28.51%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;POM121;CC2D1B;IST1;CHMP4A;CHMP4B;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1;UBXN2A
prerank,negative regulation of macrophage activation (GO:0043031),-0.4771682168768193,-1.3710144206584804,0.10606060606060606,0.5421891310159744,1.0,7/16,17.93%,IL31RA;NR1H3;LRFN5;CD200;ZC3H12A;CX3CL1;SYT11
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.6164201880909215,1.370999852404902,0.11444141689373297,0.6520057260056706,1.0,8/16,27.04%,HNRNPA2B1;SMG6;ERCC4;ATM;TNKS2;PARP1;SLX4;RTEL1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.6286918613097788,1.3707475255454273,0.11015736766809728,0.6514625819342611,1.0,7/13,21.87%,RHOQ;AK3;RAB23;EFL1;ENTPD7;LRRK2;MFN1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.44366380331751715,-1.3705520728964096,0.05687203791469194,0.53931389384627,1.0,10/23,16.81%,DYNC1I1;CCDC88A;TUBA1B;KIF1A;CCDC88C;TUBA1A;KIF1C;KIF5B;HOOK2;MAP6D1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.5016398869935124,1.3704796676708557,0.046840958605664486,0.6510097879856275,1.0,26/76,19.72%,CMKLR1;PTGIS;CYP1B1;PKHD1;ANXA4;TAX1BP1;IRAK3;DAP;CDK5RAP3;ITCH;CHUK;NFKBIB;IRAK1;COMMD7;CHP1;TRAF3;USP7;G3BP2;ARRB1;OTULIN;UFL1;RWDD3;ACOD1;LRRC14;ERBIN;NFKBIA
prerank,DNA duplex unwinding (GO:0032508),0.523268868809153,1.3702784902955791,0.08123569794050343,0.6502821819223619,1.0,33/50,35.17%,CHD1L;MCMDC2;MCM2;ANXA1;WRN;CUL4A;ERCC3;RAD50;ERCC2;SUPV3L1;PARP1;UBC;RPS27A;MCM4;HMGA1;RAD51;TWNK;RECQL5;GTF2H4;MCM7;XPA;RTEL1;DDB1;RBX1;DDX11;SSBP1;BLM;RAD23B;PURA;CUL4B;CETN2;DHX9;MRE11
prerank,histone lysine demethylation (GO:0070076),0.572338634270629,1.3682327884337222,0.10918114143920596,0.6574703631422371,1.0,9/25,16.74%,JMJD1C;RIOX2;KDM2A;PHF8;KDM5B;KDM4A;HR;KDM5C;KDM6B
prerank,extracellular matrix disassembly (GO:0022617),0.5180944719047507,1.3680413906874682,0.07632743362831858,0.6567426991967761,1.0,10/53,10.35%,BMP1;GSN;HTRA1;TIMP2;TLL1;ADAM10;MMP14;CAPN2;SH3PXD2B;SCUBE3
prerank,protein import into nucleus (GO:0006606),0.5010827546798617,1.3679805749371756,0.059275521405049394,0.6553720475844219,1.0,32/66,27.60%,NUP93;PRICKLE1;SEC13;IPO5;STAT3;IPO4;HIKESHI;E2F3;RGPD1;KPNA2;IPO13;TNPO2;RANBP2;NUP88;KPNA3;POM121;AKT1;IPO9;TNPO1;KPNA4;APPL2;APPL1;NUP62;PPP1R10;TSC2;NUP35;IPO8;NUTF2;NUP85;TPR;RPAIN;KPNA6
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5605817609528502,1.3673020096132238,0.08383961117861483,0.6566215082524539,1.0,11/31,8.86%,GDF10;TWIST2;CRIM1;SMAD6;LRP5;TWIST1;NBR1;SKI;SOX9;NOG;TRPM4
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.48361467659685825,-1.3672965481826742,0.100418410041841,0.5443141904288497,1.0,4/18,1.91%,ROCK2;TEK;CDH5;RIPOR2
prerank,brain morphogenesis (GO:0048854),-0.5357944565115209,-1.3670129883307713,0.14930555555555555,0.5409698953513551,1.0,2/12,4.18%,SHANK3;CTNNA2
prerank,metanephros development (GO:0001656),0.5630277495321566,1.3660469204235353,0.11951219512195121,0.6603425011889446,1.0,4/26,4.17%,SIX1;PKD1;FOXD1;SIX4
prerank,cellular component disassembly (GO:0022411),0.5186403327075745,1.365872821282502,0.06896551724137931,0.6594879969856458,1.0,10/53,10.35%,BMP1;GSN;HTRA1;TIMP2;TLL1;ADAM10;MMP14;CAPN2;SH3PXD2B;SCUBE3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5804482124802285,1.3655817691301146,0.11372064276885044,0.6591847216104345,1.0,12/24,20.36%,SEC31A;SEC24D;SEC13;SEC23A;FCER1G;PDIA3;BCAP31;SEC24C;SEC24B;IDE;SEC24A;CALR
prerank,protein methylation (GO:0006479),0.5343393625919148,1.3655763591014711,0.08930669800235018,0.6576267926709478,1.0,21/40,31.18%,PRMT8;EEF1AKMT3;FAM98A;EHMT1;NSD1;GSPT1;CARM1;FAM98B;LCMT1;EEF1AKMT2;ETF1;PCMT1;NTMT1;SNRPB;PRMT1;TRMT112;EHMT2;PRMT5;PRMT3;NSD3;EEF2KMT
prerank,ERAD pathway (GO:0036503),0.4856962442729683,1.3653191771825424,0.036170212765957444,0.6572057607162199,1.0,43/83,29.90%,UBXN8;VCP;DNAJB14;FAF2;SYVN1;UGGT2;UGGT1;HSPA5;RNF103-CHMP3;UBQLN1;USP13;FBXO17;STUB1;USP19;RNF121;YOD1;TRIM13;UBE4A;DNAJC18;NPLOC4;UBXN4;ERLEC1;UBE2G2;RCN3;ECPAS;DERL1;SGTB;HERPUD1;AMFR;TMEM67;SELENOS;DNAJB12;GET4;JKAMP;SEC61B;TMUB2;SEL1L2;CCDC47;FAM8A1;STT3B;UBE4B;TMUB1;PRKN
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3552857078370065,-1.3645821613011995,0.045871559633027525,0.5432534078770471,1.0,10/57,8.56%,ADCY5;LPAR1;GRM7;GRM8;ADCY1;ADRA2A;PDE2A;HTR4;ADCY4;OPRM1
prerank,cell-substrate junction assembly (GO:0007044),-0.4079960410869042,-1.3645768044716848,0.07772020725388601,0.5392443536002742,1.0,9/33,6.90%,SORBS1;ACTN2;ITGA6;DST;PEAK1;THSD1;ITGB4;WHAMM;PTPRK
prerank,regulation of B cell differentiation (GO:0045577),0.614508941365709,1.3643640447896357,0.11994784876140809,0.659609592496087,1.0,5/17,13.02%,ID2;MMP14;IKZF3;CD27;INHBA
prerank,regulation of Wnt signaling pathway (GO:0030111),0.48194168386749525,1.3643000105001344,0.025933609958506226,0.6583031405957255,1.0,26/108,11.34%,ESR1;TRABD2B;CTNND2;LRP1;GPC3;SFRP4;RSPO3;TIAM1;GRB10;ATP6V1C2;MDFIC;NXN;CSNK2A1;TCF7L1;DACT1;SULF1;FZD7;SKI;RSPO1;DACT3;TSKU;NFATC1;FOXL1;FGFR2;TERT;AXIN1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5791149637218569,1.3640803570485378,0.12244897959183673,0.6576639346088144,1.0,5/21,9.67%,EXT1;XYLT1;HS3ST4;SULF1;HS6ST2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6260849156051582,1.3639474259388413,0.14093959731543623,0.656683873202181,1.0,4/14,11.89%,CARD14;TNFSF15;IRAK1;TNFRSF10B
prerank,regulation of focal adhesion assembly (GO:0051893),0.5134551294533839,1.362323077305083,0.07134767836919592,0.6623512387380506,1.0,13/54,12.40%,THBS1;MYOC;VEGFA;EFNA5;LDB1;COL16A1;BCAS3;S100A10;SLC9A1;RHOA;ABL1;RCC2;NRP1
prerank,regulation of cell differentiation (GO:0045595),0.4664395619557608,1.3616292017111127,0.015274949083503055,0.6637558879057062,1.0,30/148,13.69%,SIX1;SMOC1;ID2;ZFHX3;DDX5;TIAM1;DDX17;PHLDB1;HES5;ATF4;TCFL5;MBOAT2;FGFR1;RAF1;PA2G4;CDK5RAP3;EDN3;FGFR2;ANP32B;RUNX2;FADS1;SMAD7;SRF;NR1D2;HEY1;TGFBR1;PDCD2;NLGN1;PTBP1;RUNX1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6520391984510244,1.3614422828517934,0.11862068965517242,0.662936817238669,1.0,5/13,16.47%,BGN;ARSB;CSPG4;HEXA;VCAN
prerank,RNA transport (GO:0050658),0.5021465045311542,1.3611348044374674,0.048034934497816595,0.6627212314461227,1.0,36/71,27.33%,SRSF6;SRSF1;ARC;SRSF5;SIDT2;RAE1;SRSF2;CASC3;TGFBR2;HNRNPA2B1;SRSF11;NXF1;ZC3H11A;SRRM1;U2AF1;CKAP5;CHTOP;U2AF2;SARNP;THOC2;SRSF3;NCBP1;SRSF7;POM121;NCBP2;RTRAF;NUP62;ATXN2;HNRNPA1;SRSF4;YBX1;UPF3B;DDX39B;TPR;EIF4E;XPO5
prerank,global genome nucleotide-excision repair (GO:0070911),0.5814534293025727,1.3609444599738012,0.09908735332464146,0.6619200446888037,1.0,18/26,34.39%,CHD1L;ERCC4;CUL4A;USP45;ERCC3;ERCC2;PARP1;UBC;RPS27A;GTF2H4;RNF111;XPA;DDB1;RBX1;ERCC1;RAD23B;CUL4B;CETN2
prerank,membrane lipid catabolic process (GO:0046466),0.6761973645695839,1.3608980655345442,0.1341991341991342,0.6605745102364189,1.0,2/10,3.46%,PDXDC1;CYP1B1
prerank,positive regulation of ossification (GO:0045778),-0.383376719284631,-1.359901586992822,0.034482758620689655,0.5476674192743974,1.0,14/39,9.15%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;WNT5A;OSR1;ZBTB16;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,regulation of vacuole organization (GO:0044088),0.5875152310681937,1.359485679516771,0.11660329531051965,0.6650114751559613,1.0,12/20,26.19%,NPRL3;ANXA2;IFT20;LAPTM4B;IFT88;ENO2;RAB1B;MTM1;NPRL2;ENO4;SCARB2;RAB5A
prerank,cell projection assembly (GO:0030031),0.5780751842563402,1.3594816330450163,0.11011523687580026,0.6634823947465013,1.0,6/22,14.91%,RHOJ;GSN;RHOQ;CYFIP1;PARVA;SCIN
prerank,polyol metabolic process (GO:0019751),-0.36569598089093813,-1.3589250105741728,0.048,0.5461382768370939,1.0,11/46,8.83%,PLCB1;INPP4B;ITPKB;INPP5D;ISYNA1;NUDT4;PLCB4;PLCH1;SLC5A3;IP6K2;PLCD1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6555483239416254,1.3588520586370016,0.1325478645066274,0.6647002269741087,1.0,1/11,0.33%,LRP6
prerank,cellular response to alkaloid (GO:0071312),-0.4601716527924341,-1.3588361209187347,0.10984848484848485,0.5424162406875724,1.0,3/17,3.25%,SLC8A1;TGM2;RYR2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5406486524214287,1.358488911157405,0.09625,0.6647412602432019,1.0,8/30,15.81%,FOXP1;DDX5;NCOR2;HEYL;RNF14;HDAC1;DAB2;HDAC6
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3819696995279125,-1.3583296798802442,0.05555555555555555,0.5400043987566903,1.0,9/40,10.26%,TCF4;ZEB1;BRINP3;BRINP1;PROX1;GPRC5B;BRINP2;ARHGEF2;MMD
prerank,mitotic chromosome condensation (GO:0007076),0.5636800389992277,1.357876276880117,0.1103030303030303,0.6657921813077732,1.0,6/26,10.76%,SMC4;CSNK2A2;CSNK2A1;KMT5A;MCPH1;PHF8
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.336533490554431,-1.3574983722679168,0.04225352112676056,0.538453951633561,1.0,44/87,23.32%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;RPL11;RPL18A;RPS12;RPL12;RPS11;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;SRP68;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.6744472315244573,1.3560345723854887,0.12797619047619047,0.6719594975880256,1.0,1/10,0.33%,LRP6
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.48032478145030644,1.3559884777857163,0.0527448869752422,0.6706102543859948,1.0,43/84,25.05%,SRSF6;DDX5;DDX17;RBFOX2;MBNL1;RBM39;CELF4;THRAP3;CELF3;HNRNPL;MBNL2;RBM25;PCBP4;DAZAP1;RBM5;METTL16;KHDRBS1;PTBP1;RBM4;U2AF2;SRPK1;HNRNPK;YTHDC1;SRSF3;ZC3H10;NCBP1;SRSF7;SRSF10;LARP7;RBMXL1;TRA2B;CIRBP;TRA2A;SAP18;SFSWAP;HNRNPA1;FXR2;SRSF4;HNRNPU;SF1;RBM24;RBM3;C1QBP
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.52624784019838,1.3556346692967347,0.0784313725490196,0.6706921048501151,1.0,18/42,25.81%,VARS1;VARS2;WARS2;HARS2;PPA2;YARS1;DARS2;YARS2;NARS2;EPRS1;PPA1;SARS1;SARS2;DARS1;CARS2;TARS2;QARS1;CARS1
prerank,cytosolic transport (GO:0016482),0.47222965075972534,1.3555822245092684,0.040837696335078534,0.6693655641545243,1.0,36/108,20.99%,VPS13A;ANKRD27;VPS13C;STX5;SNX2;DOP1B;ERC1;AP2A1;RILP;RIC1;GBF1;VPS52;MON2;TBC1D23;TRIM27;EEA1;SNX1;RGP1;VPS26A;SNX32;TMEM87B;VPS53;CLTC;TBC1D10A;TBC1D17;SPAG9;STX16;GGA1;CLN3;PHETA2;EVI5;PTPN23;HEATR5A;DCTN1;CORO7;LAMP1
prerank,intracellular protein transmembrane transport (GO:0065002),0.5279808905204745,1.35545833691051,0.08660508083140878,0.6683400997370603,1.0,18/42,22.68%,PEX7;SEC61A1;C2CD5;TOMM40;PEX5;AKT2;PEX16;PEX1;AIFM1;HSPA5;HSPD1;PEX10;TOMM70;GRPEL1;PEX6;ZFAND2B;PEX2;PEX14
prerank,negative regulation of transmembrane transport (GO:0034763),0.6754382049177882,1.354846270991648,0.12389380530973451,0.6694885201178006,1.0,1/10,0.08%,THBS1
prerank,ubiquinone metabolic process (GO:0006743),0.6261695278621264,1.3545750241651673,0.1206896551724138,0.6691271112148592,1.0,8/15,20.19%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,neutrophil activation (GO:0042119),0.6440224929767278,1.3544505539832494,0.13846153846153847,0.6681339413232694,1.0,2/12,8.56%,PRKCD;FCER1G
prerank,response to UV-A (GO:0070141),0.627751518704951,1.354296981837907,0.10699588477366255,0.6673161786018394,1.0,1/14,0.31%,EGFR
prerank,metal ion export (GO:0070839),0.5447889970056469,1.353794264154241,0.11015911872705018,0.6679606513510739,1.0,6/31,6.98%,SLC4A4;KCNK5;ATP1B1;KCNE5;SLC9A1;KCNIP2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.4645960595021409,-1.353377746417473,0.11607142857142858,0.5453163080061161,1.0,10/20,23.25%,WNT4;ASXL3;CEACAM1;GPER1;BMP2;BRCA1;ERLIN2;TRIB3;SIK1;APOC1
prerank,negative regulation of mRNA processing (GO:0050686),0.6271773578003432,1.3533181873442064,0.12297297297297298,0.6686358108445741,1.0,10/15,25.05%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF7;SRSF10;SAP18;SFSWAP;SRSF4;C1QBP
prerank,cellular response to light stimulus (GO:0071482),0.49649369292525763,1.3532184413767265,0.0627062706270627,0.6675856339721389,1.0,28/66,28.71%,PRKCD;NEDD4;ATF4;PDE6A;ERCC4;SDE2;OPN1MW;OPN1MW3;N4BP1;CREBBP;PARP1;CDC25A;SAG;EIF2AK4;NOC2L;EIF2S1;GNB1;USP47;TRIAP1;OPN3;TAF1;TP53;POLD1;YY1;RRH;GPR52;PDE6G;ATR
prerank,DNA packaging (GO:0006323),0.6057842455315559,1.3531771696468815,0.13008130081300814,0.6662838362847938,1.0,8/16,26.19%,CHAF1B;M1AP;CDAN1;AIFM1;NOC2L;TP53;BANF1;CHAF1A
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6733874610928152,1.3526171983048754,0.15028901734104047,0.667253994998454,1.0,4/10,8.07%,RARB;RXRA;RXRB;RARA
prerank,regulation of metal ion transport (GO:0010959),-0.47545828596732553,-1.3524278034391592,0.08,0.5438504140420413,1.0,5/16,6.59%,BCL2;EPB41;SLC30A10;CACNA2D1;ORAI1
prerank,camera-type eye morphogenesis (GO:0048593),0.6710768481082174,1.3524012819843354,0.13352272727272727,0.6666554810791936,1.0,3/10,7.28%,LRP6;VEGFA;SKI
prerank,cellular response to hormone stimulus (GO:0032870),0.49265605613569957,1.3520510306377957,0.06938325991189427,0.6666950472072793,1.0,14/69,10.48%,SLIT3;SLIT2;GHR;RDX;STAT3;RAMP2;BCAS3;RARA;SRA1;SOCS2;AKR1C1;SFR1;RAMP1;URI1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.46813583234365846,1.3520313199237448,0.022426095820591234,0.6653073606893878,1.0,12/150,2.35%,THBS1;MYOC;ESR1;EGFR;IRS1;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;FGF17;GAB2
prerank,response to light stimulus (GO:0009416),0.507580696047056,1.351618430327039,0.07796610169491526,0.665737675348544,1.0,26/55,27.17%,UBE2B;CCAR2;ERCC8;ERCC5;ERCC4;MAPK8;ERCC3;OPN1MW;OPN1MW3;ERCC2;FECH;REV1;MEN1;USP1;CIRBP;MAP2K7;DRD2;CRY2;OPN3;PRIMPOL;UVSSA;POLD1;COPS3;ZRANB3;RRH;GPR52
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.6412128914709434,1.351521882252383,0.13165266106442577,0.6647079246802806,1.0,2/13,1.76%,NEDD4;EMILIN1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5775558297683724,1.3512886898344325,0.11823899371069183,0.6642225574198712,1.0,4/22,5.85%,RASSF2;VEGFA;CALM2;TOM1L1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.44363820305439694,-1.3512870927544671,0.09623430962343096,0.542873732978995,1.0,8/22,15.97%,APOD;ADRA2A;PRKAA1;ASXL3;CEACAM1;BSCL2;GPER1;PPP2R5A
prerank,quinone biosynthetic process (GO:1901663),0.6341705934244121,1.3512019799048025,0.13055181695827725,0.6631503004827358,1.0,8/14,20.19%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,positive regulation of endothelial cell migration (GO:0010595),0.4864475693736204,1.351123942671663,0.05970149253731343,0.6620019060427249,1.0,20/84,12.40%,THBS1;SMOC2;FOXP1;VEGFA;FGF2;PLPP3;SPARC;STAT5A;PRKCA;BCAS3;FOXC2;HMGB1;FGFR1;GFUS;ANGPT4;BMP4;ABL1;PDPK1;PIK3CB;NRP1
prerank,protein localization to cell-cell junction (GO:0150105),-0.48814494340472153,-1.351003995350073,0.11301369863013698,0.5398160651519959,1.0,5/15,6.32%,TJP1;CDH5;CGNL1;LSR;F11R
prerank,sulfur compound biosynthetic process (GO:0044272),0.47506961717976015,1.3503680683055388,0.049214659685863874,0.6637602429647512,1.0,26/104,16.63%,SLC26A2;ST3GAL4;DSE;GCLC;GSTT1;BGN;PAPSS2;CHST11;CHPF2;CSPG4;GSTM5;MPST;B3GNT7;SLC10A7;B4GALT1;LIAS;ST3GAL2;B4GALT5;METTL16;MAT2B;GSTO2;SLC35B3;GSTZ1;B4GAT1;VCAN;AKR1A1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5812885616885585,1.3500046695892085,0.11357702349869452,0.6637858614532554,1.0,4/20,7.85%,ADAM9;HM13;ADAM10;MBTPS1
prerank,inorganic anion transport (GO:0015698),0.5059576709535711,1.3498843526513726,0.08508287292817679,0.662847624126498,1.0,6/53,5.65%,SLC4A10;SLC26A7;SLC26A6;CLIC3;CLIC4;SLC4A11
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.4213341604705705,-1.3497465956489971,0.08064516129032258,0.5394269692683377,1.0,14/26,26.77%,PPARA;SLC30A10;SLC25A33;SLC5A3;TRAP1;ADGRB1;GRIN1;SNCA;ABCD2;ABCB7;SLC18A2;CD36;TLR6;ALOX5
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5487416327737056,1.349012767517737,0.10184049079754601,0.665038825640816,1.0,8/28,10.63%,PRKCD;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;UBR5
prerank,cytoplasmic translational initiation (GO:0002183),0.5967349964888956,1.3483413224783138,0.14285714285714285,0.6663884672818537,1.0,13/17,32.20%,EIF4A2;EIF4A1;EIF4G1;DHX29;RBM4;EIF2S2;EIF3D;EIF3A;EIF4B;EIF4H;EIF3M;EIF3I;EIF2D
prerank,regulation of macrophage activation (GO:0043030),0.5484536975998859,1.3482255858737209,0.09113300492610837,0.6654183415556476,1.0,4/30,4.66%,THBS1;LBP;IL33;SHPK
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6166417093018819,1.3480389191784274,0.1196236559139785,0.6647536643981028,1.0,6/15,15.25%,LRP1;DDR2;FAP;CST3;DDR1;IL6
prerank,negative regulation of double-strand break repair (GO:2000780),0.5394835225353869,1.347330028832104,0.12157330154946365,0.6663550062826921,1.0,18/30,32.74%,HELB;TWIST1;RMI2;OTUB1;OGG1;UBR5;OTUB2;TFIP11;MAD2L2;CGAS;FBH1;SHLD3;SHLD1;HSF1;TRIP12;PARPBP;ERCC6;POLQ
prerank,actin filament bundle organization (GO:0061572),-0.3998124654140385,-1.347250578969679,0.0641025641025641,0.5420967799895016,1.0,12/33,13.26%,MYO1B;PAWR;SHROOM2;EPS8;PLS3;NEDD9;BAIAP2;SHROOM1;AIF1L;LCP1;RFLNA;RFLNB
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5473037400807401,1.3466131221932185,0.11883691529709228,0.6679151792778635,1.0,15/26,29.95%,FOXP1;NCOR2;HEYL;HDAC1;DAB2;PER1;VPS11;CNOT9;CALR;CRY2;SMARCA4;NCOR1;KANK2;VPS18;ZBTB7A
prerank,ether lipid biosynthetic process (GO:0008611),0.6742592243760017,1.3465387890173308,0.11976911976911978,0.6668068593077291,1.0,4/10,17.93%,PLA2G4A;PEX7;FAR1;AGPS
prerank,regulation of actin nucleation (GO:0051125),0.6527540861151285,1.346329004291538,0.12871287128712872,0.6661811700384095,1.0,5/12,14.91%,GSN;ARFIP2;ARF1;PICK1;SCIN
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4783432735340794,1.346122962473185,0.046858359957401494,0.6656454376198951,1.0,18/95,9.67%,ST3GAL4;EXT1;XYLT1;GPC6;GPC3;DSE;BGN;CHST11;SDC1;CHPF2;CSPG4;B3GNT7;SLC10A7;B4GALT1;ST3GAL2;B4GALT5;ABCC5;HS6ST2
prerank,negative regulation of cellular component movement (GO:0051271),-0.49225732418092977,-1.3459922095588914,0.13793103448275862,0.5417734556687661,1.0,5/15,7.72%,TGFBR3;FRMD5;FBLN1;SPOCK3;SP100
prerank,cellular sodium ion homeostasis (GO:0006883),-0.492171995841497,-1.3453430789969418,0.1289198606271777,0.5399106049356198,1.0,4/15,1.29%,ATP1A2;ATP1B3;NEDD4L;SLC8A1
prerank,regulation of cell projection organization (GO:0031344),-0.5060898076976112,-1.3450381871622115,0.10545454545454545,0.5370095087090242,1.0,5/13,12.67%,NTNG1;MACF1;MFSD2A;SEMA4D;ERMN
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6110852233835138,1.3447741002415516,0.14522821576763487,0.6698279661309701,1.0,10/15,26.41%,GAS6;TCF7L2;BAG3;ANP32B;XPO4;YWHAE;RBM22;CAMK1;TP53;TPR
prerank,regulation of smoothened signaling pathway (GO:0008589),0.503163405097577,1.3444640863777397,0.09111361079865017,0.6696895151172184,1.0,18/50,19.32%,GPC3;GLIS2;GAS1;RAB34;ARMC9;VCP;TEDC1;ZIC1;EVC;RORA;FGFR2;WDR11;PDCL;SMO;FUZ;CREBBP;SUFU;UCHL5
prerank,regulation of cell morphogenesis (GO:0022604),0.5439698457900337,1.3441032126215107,0.1120584652862363,0.6698245248330227,1.0,10/30,19.42%,EFNA5;FMNL2;ARC;SPARC;BCL9L;MYO9A;PHIP;SH3D19;ZMYM3;ZRANB1
prerank,protein polymerization (GO:0051258),0.500197370907014,1.3440816958676078,0.06927374301675977,0.6684961699792756,1.0,16/55,20.57%,PSTPIP1;MAP7D3;FGF13;GSN;COBL;CKAP5;UBE2C;TTC17;CHMP3;SPIRE2;MICALL2;WASHC3;TRIM6;CORO7;CHMP4A;CHMP4B
prerank,odontogenesis (GO:0042476),0.5335680959551605,1.3437926491932108,0.1128084606345476,0.6683256047927328,1.0,9/35,13.02%,LRP6;COL1A2;GLI2;TGFB3;TGFB2;BMP4;FGFR2;HDAC1;INHBA
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5068897383874869,1.3429886317687683,0.08465011286681716,0.6702282379182483,1.0,17/52,20.75%,ARFGAP1;SEC31A;KDELR3;SHC1;LMNA;GFPT1;ERN2;SYVN1;HYOU1;ATP6V0D1;HSPA5;ADD1;PREB;SSR1;YIF1A;DCTN1;FKBP14
prerank,positive regulation of DNA replication (GO:0045740),0.6026251537728802,1.3426040762536806,0.14323607427055704,0.6704469732466292,1.0,3/16,9.05%,EGFR;GLI2;BRPF3
prerank,negative regulation of autophagosome assembly (GO:1902902),0.6338239958297244,1.3423077589045371,0.12745098039215685,0.6703278046425099,1.0,10/13,24.51%,TMEM39A;SCFD1;PHF23;SEC22B;CHMP4A;CHMP4B;LRRK2;MTM1;SMCR8;PINK1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5935559831482918,1.3418282251159468,0.13534822601839686,0.6708900472586995,1.0,6/18,9.69%,RHOJ;VEGFA;FGF2;HDAC9;FOXC2;ANXA1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.6423947681620072,1.3414757307918708,0.12606232294617564,0.6709517858387604,1.0,4/11,12.82%,ZMIZ1;ELOF1;SERTAD2;ZMIZ2
prerank,negative regulation of B cell proliferation (GO:0030889),-0.534306038387297,-1.341256281162571,0.16279069767441862,0.5428468886281629,1.0,4/11,15.02%,LYN;TNFRSF21;CD300A;TYROBP
prerank,vesicle transport along actin filament (GO:0030050),-0.4537900086583671,-1.3411793751111138,0.10126582278481013,0.5394132864925614,1.0,4/19,8.29%,MYO1B;MYO6;ACTN4;MYO1D
prerank,modulation by symbiont of entry into host (GO:0052372),-0.47471107101225124,-1.3410930235020266,0.11952191235059761,0.5361050375631927,1.0,7/16,11.22%,TRIM14;FUCA2;NECTIN2;TRIM21;CAV1;EXOC2;TRIM68
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6632554349232548,1.3402842237568866,0.15689149560117302,0.6744888877275351,1.0,3/10,8.56%,IRS1;PRKCE;AKT2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.5141637196216243,-1.3392619373883414,0.12452830188679245,0.5369685699234128,1.0,5/14,7.35%,SLC8A1;SLC24A2;CACNA2D1;TRPV2;SLC8A3
prerank,negative regulation of lipid storage (GO:0010888),-0.4465665726480684,-1.3390905640282358,0.10267857142857142,0.5339895311559802,1.0,6/19,6.84%,OSBPL8;PPARA;ABCG1;NR1H3;ABHD5;PPARD
prerank,regulation of osteoblast differentiation (GO:0045667),0.48323338134472027,1.3387342534342095,0.06638115631691649,0.6797236476674592,1.0,26/82,15.25%,SMOC1;GDF10;DDR2;TWIST2;CRIM1;DDX5;SMAD6;LRP5;TWIST1;WWTR1;ATF4;ACVR1;NBR1;SKI;SOX9;NOG;TRPM4;BMP4;FGFR2;TMEM119;RUNX2;BMPR1A;NELL1;LIMD1;HGF;IL6
prerank,protein secretion (GO:0009306),0.5037557872010939,1.338363884729773,0.07683741648106904,0.6798329182297885,1.0,21/56,20.71%,PCSK5;LTBP2;NECAB3;ARFGAP3;COPG1;RAB8A;NAGPA;MON1A;ANXA1;VIP;RAB3D;ABCA1;PREB;TMEM167A;MIA3;RAB3B;TANGO6;GOLPH3;STEAP3;MIA2;RCN3
prerank,negative regulation of protein modification process (GO:0031400),0.48509220933152997,1.3382916393262,0.07475622968580715,0.678726328270037,1.0,18/79,11.14%,SLIT2;LRP6;PID1;NTRK3;PLPP3;EPHB2;WWTR1;XDH;P3H1;DMD;PRKDC;PPP1R8;SNTA1;BEX4;IMPACT;CDK5RAP3;PAQR3;NIBAN1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.4844714598157997,1.337827923036616,0.06593406593406594,0.6791920023804626,1.0,13/75,8.86%,KCNJ2;KCNJ15;SLC39A14;SLC12A7;ATP1B1;SLC12A2;SLC5A2;HCN4;TRPV3;SLC9A4;SLC9A1;SLC12A4;TRPM4
prerank,protein modification process (GO:0036211),0.4850188743423309,1.3377719772144065,0.059957173447537475,0.6780130871675499,1.0,31/76,24.12%,PLOD2;ST8SIA2;TGM5;GGCX;PRKDC;LOX;NAGPA;AKT2;WWP2;RIPK3;ABL1;LCMT1;FBXO22;ATG3;UBE2L6;PARP1;LIPT1;GNMT;NTAQ1;ARAF;FBXW2;CSNK1G3;LOXL2;CDKL3;STK38;UBA3;MAN2B1;B4GALT7;FBXO11;PHEX;PHKA2
prerank,histone lysine methylation (GO:0034968),0.538074894453921,1.3376233846497425,0.11552346570397112,0.6772211208401371,1.0,15/33,26.40%,PRDM5;WDR5;KMT2D;SETDB1;KMT2B;MEN1;WDR82;SUV39H2;DPY30;SUV39H1;KMT2A;SETDB2;SMYD2;TRMT112;EHMT2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5655088330937336,1.3375022839276478,0.11278195488721804,0.6763299133131324,1.0,7/24,12.40%,MYOC;VEGFA;COL16A1;S100A10;ABL1;IQSEC1;NRP1
prerank,ubiquinone biosynthetic process (GO:0006744),0.6167469237127378,1.337375068871215,0.1475195822454308,0.6754382741820782,1.0,8/15,20.19%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,cellular response to sterol (GO:0036315),0.6255563204004699,1.3367595520470386,0.1434659090909091,0.6766082268876908,1.0,6/13,13.94%,LRP6;GRAMD1A;OSBPL7;RORA;SMO;GRAMD1C
prerank,regulation of macroautophagy (GO:0016241),0.473611139201602,1.336687494316922,0.06210526315789474,0.6755016604183605,1.0,55/105,28.60%,NEDD4;ATP6V1C2;EXOC4;SESN3;LZTS1;NRBP2;LAMTOR1;ATP6V0A1;QSOX1;CLEC16A;MAPK8;SMG1;VPS26A;ATP6V0D1;SESN2;SNX32;TBC1D25;PAFAH1B2;ATP6V1B2;UBQLN1;USP36;ATP6V1E1;HDAC6;TRIM13;PRKAG1;CLN3;RB1CC1;AKT1;ATP6V1C1;CDK5;PRKAB1;RHEB;UCHL1;PRKACA;IL4;RUFY4;CAPNS1;LRRK2;TSC2;RPTOR;ATP6V0E1;SMCR8;TBK1;PINK1;ATP6V0B;LAMTOR2;EXOC7;ATG13;GPSM1;ERN1;CAPN1;LAMTOR3;SNX5;ULK1;LARP1
prerank,protein transport (GO:0015031),0.4475934828282414,1.336664653819952,0.008008008008008008,0.6742105162825363,1.0,133/332,25.71%,SGSM2;LRP1;LTBP2;NECAB3;ARFGAP3;CTTN;SEC31A;ATP6V1C2;KIF13A;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;LMAN2L;RAB34;RAB43;TCIRG1;COPA;RAMP2;RAB24;STX11;AP2A1;RILP;COPG1;LRSAM1;DNM2;SLC10A7;RAB21;ATP6V0A1;RIC1;TLK1;GGA2;RAB8A;HIKESHI;ARF4;GOLGA4;COPZ2;MON1A;SNX1;NSF;SCFD1;STX2;VPS26A;RAMP1;ARFIP2;RAB38;ATP6V0D1;ARF1;RAB3D;SNX9;AP3D1;TMED9;WDR11;USO1;EVI5L;TBC1D9B;LRP2;TBC1D25;ATP6V1B2;RAB11B;ERP29;ABCA1;PICK1;TOM1;VIPAS39;CHMP3;PREB;CLTC;RAB23;ATP6V1E1;TMEM167A;TBCK;MIA3;TBC1D10A;SIL1;STX4;COPB2;STX1A;RAB3B;SCFD2;TBC1D17;HDAC6;STX16;SCAMP2;GGA1;TANGO6;SPTBN1;SNX13;NAPA;GOLPH3;TMED2;BLZF1;RAB5B;VPS45;SNX15;SEC23IP;RAB3GAP2;ATP6V1C1;NEURL1B;EVI5;STEAP3;SCAMP3;MIA2;CLU;TBC1D22B;RCN3;VPS26C;OPTN;IFT27;LAMP2;RAB1A;RAB18;ZG16;NDC1;VAMP4;RAB1B;SNX4;COPZ1;RABGAP1;ARF5;ATP6V0E1;SCAMP1;TMED7;CHMP2A;LMTK2;AP3B1;ATP6V0B;STX1B;VAMP2;FAM91A1;STX19
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6347835766729831,1.336441885880074,0.15321477428180574,0.6738093323210391,1.0,4/12,14.57%,P4HB;SOAT1;LPCAT3;ACSL3
prerank,RNA splicing (GO:0008380),0.47095191194750824,1.3363487840050632,0.05907172995780591,0.6728610024739035,1.0,40/95,25.10%,NOL3;PPP1R9B;MBNL1;SRSF2;SNRNP48;CCAR2;FUS;YJU2;SRSF11;CELF3;LUC7L3;CDK12;SF3B2;SF3B1;SNRNP25;SRRM1;U2AF1;SFPQ;ZRSR2;PTBP1;HNRNPC;SRPK1;SCNM1;NCBP1;WDR83;SRSF7;SRSF10;NCBP2;SYNCRIP;TRA2B;HNRNPH3;DHX8;SNRPB;GEMIN2;SRSF4;DHX16;PPIG;PPP2CA;SNRNP35;DDX39B
prerank,negative regulation of signal transduction (GO:0009968),0.44802469134392836,1.3362277510077762,0.0050150451354062184,0.6719468332888188,1.0,36/249,9.39%,THBS1;EGFR;IRS1;PID1;TRABD2B;IGFBP5;NTN1;PRKCD;LRP1;FGF2;GPC3;SFRP4;NEDD4;EMILIN1;UBASH3B;GRB10;NXN;GLIS2;DKK3;LRPAP1;CSNK2A2;CSNK2A1;CARD16;XDH;VCP;DACT1;ACVR1;SULF1;MMP14;IRAK3;NOG;DACT3;TSKU;NFATC1;WWP2;PTPN18
prerank,regulation of protein polymerization (GO:0032271),-0.3933165162973742,-1.3361464890655288,0.07333333333333333,0.5380594353035605,1.0,7/35,6.69%,ARHGAP28;ARHGAP18;MAP2;ESAM;PLEKHG2;PAK3;CAMSAP1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6349210662447177,1.3357172104134516,0.1370056497175141,0.6726820804573399,1.0,1/11,0.08%,THBS1
prerank,respiratory tube development (GO:0030323),0.5544245809149503,1.3349948368280402,0.1116564417177914,0.6742496413584073,1.0,7/28,9.70%,VEGFA;PCSK5;FGF2;GLI2;CCDC39;BMP4;FGFR2
prerank,regulation of ion transmembrane transport (GO:0034765),0.5378561599474067,1.333642367098568,0.11862396204033215,0.6785788364693253,1.0,8/33,13.92%,KCNJ2;KCNJ15;NEDD4;KCNE5;WWP2;AKAP9;YWHAE;WNK1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5887095872722907,1.3335732816609998,0.15242165242165243,0.6774720844876834,1.0,9/17,26.60%,HM13;VCP;FAF2;SYVN1;NPLOC4;DERL1;HERPUD1;SELENOS;SEC61B
prerank,protein homooligomerization (GO:0051260),0.4672549894276565,1.333505536934473,0.056016597510373446,0.6764197925096386,1.0,33/114,21.38%,SCARA5;KCNJ2;PRMT8;MPP2;EHD1;TRMT61B;ARC;ATL2;SLC1A5;ADCY8;ATL3;CRYZ;DISP1;FUS;C9;TRPM4;SPAST;CBR4;CLYBL;LETM1;ACACA;MICU1;G3BP2;PKD2L1;SHMT2;GNMT;ACOT13;SHMT1;TK1;APPL2;IKZF4;PDCD6IP;ATL1
prerank,protein K11-linked ubiquitination (GO:0070979),0.5533085649534761,1.3329460188382904,0.11685116851168512,0.6772984365799367,1.0,16/27,31.31%,ANAPC5;CDC16;UBE2B;UBE2C;ANAPC4;ANAPC2;ANAPC1;ANAPC10;CDC27;RNF4;UBE2W;PRKN;UBE2H;ANAPC11;UBE2S;UBE2A
prerank,lamellipodium assembly (GO:0030032),-0.41845861280421187,-1.3324588485113438,0.09547738693467336,0.5438087875273805,1.0,11/26,8.77%,ABLIM1;CDH13;KIT;CCDC88A;PARVB;PTPRO;S1PR1;WHAMM;SPATA13;SPEF1;ARHGEF6
prerank,regulation of protein metabolic process (GO:0051246),-0.3786228972448297,-1.3322347660366036,0.047619047619047616,0.540881915258269,1.0,10/44,11.44%,ROCK2;NEDD4L;APOE;APP;FAF1;GSAP;KLF2;ACE;MTPN;SPOP
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6518683674147148,1.3314627822193246,0.14977307110438728,0.681875828442331,1.0,4/10,16.30%,ESR1;HMGB1;PSMC5;PSMC4
prerank,dermatan sulfate metabolic process (GO:0030205),0.6406083932553047,1.3313316819201044,0.1499312242090784,0.681045762779182,1.0,3/13,4.29%,DSE;BGN;CSPG4
prerank,endoplasmic reticulum organization (GO:0007029),0.48453243661634565,1.3305947879401154,0.07577374599786553,0.6828586120000656,1.0,30/72,22.44%,SEC31A;MAPK15;STX5;ATL2;SEC61A1;LMAN2L;DOP1B;TLE6;SMPD4;ATL3;TRAM2;LPCAT3;ALDH3A2;REEP3;LMAN2;SEC16A;MIA3;STX1A;SEC16B;HMOX1;TMEM170A;BNIP1;TMEM33;REEP5;SHTN1;ATL1;LRRK2;LMAN1;RAB18;EIF2AK3
prerank,negative regulation of cell growth (GO:0030308),0.4662140645880389,1.3305393471043534,0.05549845837615622,0.6817446689998955,1.0,28/121,17.28%,SLIT3;SLIT2;FHL1;FGF13;OSGIN2;ULK2;CCN3;ACVR1B;PPP1R9B;PRDM11;PTPRS;TGFB2;CCAR2;SMAD4;DACT3;NDRG3;SERTAD2;DCBLD2;SESN2;INHBA;CGRRF1;RBBP7;SERTAD3;CYP27B1;MINAR1;APBB1;DIP2B;FLCN
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6443260755392611,1.3299986447390426,0.14580265095729014,0.682643566969838,1.0,2/10,1.86%,PID1;GRB10
prerank,triglyceride metabolic process (GO:0006641),-0.3674562270728781,-1.3297970448497534,0.05084745762711865,0.5438732270340719,1.0,19/48,26.80%,APOE;PLAAT3;LPGAT1;GK;MOGAT3;CAV1;LPIN2;LPL;SIRT1;GK5;DGAT2;FABP5;DGAT1;FABP7;FABP3;APOC1;LIPH;LIPC;LPIN1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.5175541427452177,1.3293235996569777,0.10057803468208093,0.6840913106343061,1.0,18/38,29.90%,ABLIM3;CSNK2A2;HUWE1;FZD5;SREBF1;USP36;HPS4;MICALL2;VPS11;NPEPPS;SAE1;LRRK2;LMAN1;PINK1;ATG13;HTRA2;SREBF2;PRKN
prerank,histone H4 deacetylation (GO:0070933),0.6537856952138135,1.3286536934282858,0.15058479532163743,0.685434883067578,1.0,5/10,17.32%,HDAC9;HDAC4;HDAC1;SIRT2;SMARCAD1
prerank,peptidyl-arginine modification (GO:0018195),0.5981321303881206,1.328469725657701,0.1436241610738255,0.6848905945003737,1.0,1/15,0.46%,PRMT8
prerank,import into nucleus (GO:0051170),0.4809148937600392,1.3283516612693418,0.07926167209554831,0.6840032729198309,1.0,32/73,27.22%,NUP93;PRICKLE1;SEC13;IPO5;STAT3;IPO4;HIKESHI;E2F3;IPO13;SNUPN;TNPO2;GEMIN7;NUP88;SMN1;POM121;AKT1;IPO9;TNPO1;APPL2;APPL1;NUP62;PPP1R10;SNRPB;GEMIN2;HNRNPA1;TSC2;IPO8;NUTF2;NUP85;DDX20;TPR;RPAIN
prerank,sodium ion transport (GO:0006814),0.47951284784303616,1.3276551521641982,0.061375661375661375,0.6855367941445379,1.0,14/85,7.04%,SLC4A4;SLC23A1;SLC5A6;ATP1B1;FGF13;SLC12A2;SLC24A3;SLC5A2;HCN4;SLC9B2;SLC4A8;SLC4A11;SCN11A;SLC6A2
prerank,actin filament bundle assembly (GO:0051017),-0.3901303891973587,-1.3274603814014143,0.09195402298850575,0.5465714304211607,1.0,10/33,11.92%,MYO1B;PAWR;SHROOM2;EPS8;PLS3;NEDD9;BAIAP2;SHROOM1;AIF1L;LCP1
prerank,positive regulation of cell division (GO:0051781),0.5127269133574293,1.3268973879131607,0.12559241706161137,0.6871736995494129,1.0,13/38,15.39%,CIT;PRKCE;CDC14A;GIPC1;CDC6;RHOA;PKN2;FGFR2;CDC25B;SPAST;OPN1MW;CSPP1;SIRT2
prerank,regulation of lipid kinase activity (GO:0043550),-0.5365775852085007,-1.3266383103730204,0.13268608414239483,0.5452626050129502,1.0,3/11,4.77%,PIK3R1;WDR91;RB1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5051692055796014,1.3266063767552527,0.1160609613130129,0.6869870661827742,1.0,8/48,6.89%,MYOC;P4HB;CUX1;FBXW8;ILK;S100A10;PRKDC;DOCK5
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4864738922580172,1.326153970697466,0.08940397350993377,0.6875075251926944,1.0,22/63,21.30%,THBS1;TCF7L2;NOL3;ACVR1;FGFR1;TMC8;PAK2;BMP4;ITGAV;LTBR;MADD;PHIP;TNFRSF10B;DEPTOR;TGFBR1;STX4;BIRC6;BID;ZMYND11;BCL2L12;IL4;SH3RF1
prerank,regulation of protein import into nucleus (GO:0042306),0.5175341303951261,1.3260500993642619,0.12135355892648775,0.6865732558465943,1.0,14/36,18.52%,PRKCD;MDFIC;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;BMP4;UBR5;CHP1;RAB23;RBM22;SUFU
prerank,natural killer cell mediated immunity (GO:0002228),0.6050170773692672,1.3256203473301185,0.14380825565912117,0.6869955781574095,1.0,3/15,8.96%,KLRK1;RAET1E;PLEKHM2
prerank,fatty acid oxidation (GO:0019395),0.48737227687952933,1.3255647982252476,0.10714285714285714,0.6858918198900397,1.0,18/57,22.45%,ABCD3;EHHADH;ECHDC2;ECI2;ADIPOR2;PEX13;AUH;ACAT1;ALDH3A2;BDH2;HACL1;PHYH;SLC27A2;PEX2;ABCD1;ECHDC1;MCAT;HADHA
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.6260033353335279,1.3255196959925277,0.1396011396011396,0.6847614466357026,1.0,2/12,1.72%,SLIT2;CCN3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.6134482195787061,1.325516793375504,0.13636363636363635,0.6834465918367274,1.0,8/14,20.99%,CPSF4L;CPSF4;NCBP1;CPSF7;CPSF6;NCBP2;CSTF2;CSTF2T
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.642822885343586,1.3252080906991606,0.15247252747252749,0.6832812159217451,1.0,3/12,4.29%,DSE;BGN;CSPG4
prerank,phagolysosome assembly (GO:0001845),0.6285042152837065,1.3248277513646285,0.15804195804195803,0.6835733561777723,1.0,4/12,18.37%,RAB7B;RAB34;PLA2G5;CLN3
prerank,regulation of RNA metabolic process (GO:0051252),0.48881502495346607,1.3246127771778324,0.09192825112107623,0.6830979858073328,1.0,24/59,20.91%,CLK1;HNRNPH1;AHNAK;AHNAK2;CLK3;MBNL1;FASTK;TNFRSF1B;SNRNP70;FUS;HNRNPL;HNRNPH2;MBNL2;PCBP4;PCBP2;CLK4;PTBP1;USP36;RC3H2;CLK2;BRDT;TRA2B;HNRNPH3;AFF2
prerank,positive regulation of angiogenesis (GO:0045766),0.46739462072709553,1.3244336294019434,0.04890738813735692,0.6825250011928596,1.0,19/108,10.01%,BMPER;THBS1;SMOC2;PGF;VEGFA;F3;FGF2;PTGIS;TWIST1;CYP1B1;RAMP2;PRKCA;FOXC2;ANGPTL4;JUP;PAK4;STIM1;ANGPT4;AGGF1
prerank,cation transmembrane transport (GO:0098655),-0.3633700611793083,-1.324394305716502,0.05426356589147287,0.5477609680822644,1.0,7/44,8.08%,ATP1A2;TRPM3;SLC7A5;ABCC9;SLC6A9;SLC38A5;SLC7A1
prerank,sulfation (GO:0051923),0.652689867063925,1.322628611662932,0.13852813852813853,0.6884187303971369,1.0,2/11,1.98%,SULT1C2;SULT1C4
prerank,regulation of mRNA metabolic process (GO:1903311),0.6332874254455918,1.3224958283221224,0.16302765647743814,0.6876586955570523,1.0,5/11,19.23%,SAFB;SLTM;SRPK1;NCBP1;SAFB2
prerank,electron transport chain (GO:0022900),0.6077564961300413,1.322450934913286,0.15117891816920942,0.686526997274972,1.0,5/15,10.19%,ETFRF1;ENOX2;ETFDH;ETFA;ETFB
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4542315050550162,1.3223160268514296,0.04568527918781726,0.6857355067025823,1.0,44/144,19.02%,PRKCD;KCNB1;GAS6;TMEM30B;TCF7L2;ABLIM3;IPO5;CSNK2A2;C2CD5;TM9SF4;TRIM28;BAG3;MAVS;BCAS3;MIEF2;JUP;HUWE1;FZD5;AKT2;ZIC1;PPP3CC;MAPK8;ANP32B;UBR5;XPO4;TENM1;CHP1;YWHAE;SEC16A;USP36;HPS4;YWHAQ;PCM1;TFDP1;MICALL2;ERBB2;SEC16B;VPS11;E2F1;BID;KIF20B;RBM22;NPEPPS;SAE1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4644440668694882,1.3218389278437408,0.06171548117154812,0.6863316217515617,1.0,40/100,25.08%,RNF144A;XPO1;PRICKLE1;FHIT;CSNK1D;GLMN;COP1;VCP;DVL1;CCAR2;GIPC1;OGT;FBXO22;RNF14;SMAD7;CSNK1E;USP7;DAB2;DDA1;STUB1;SIRT2;TLK2;N4BP1;SUMO1;UFL1;ARAF;HECTD1;RYBP;UCHL5;CLU;USP5;LRRK2;DESI1;SUMO2;DET1;TAF1;HERPUD1;CAMLG;RCHY1;BBS7
prerank,secondary palate development (GO:0062009),-0.49820894812470606,-1.3213804201269246,0.13028169014084506,0.5519085167229524,1.0,4/14,2.06%,TGFBR3;LEF1;CHD7;WNT5A
prerank,regulation of protein kinase activity (GO:0045859),0.4630065397693725,1.3211920635285006,0.05567226890756303,0.6877478499392733,1.0,29/106,20.30%,RASSF2;LRP6;PLCE1;GAS6;DDR2;UBASH3B;CAMKK1;WWTR1;DVL1;TRIM27;AKT1S1;PAK2;TAB2;SNX9;PDPK1;SOD1;DEPTOR;CHP1;MAPRE3;CAMK2N1;IQGAP1;GSKIP;NF1;PRKAG1;AKT1;XRCC6;DUSP19;MAP2K3;RTRAF
prerank,response to interleukin-6 (GO:0070741),0.6362807036863892,1.3206287963815082,0.1574468085106383,0.6888209517754225,1.0,3/10,9.20%,PID1;PTGIS;SBNO2
prerank,amino acid transport (GO:0006865),0.5070184689643424,1.320271082782005,0.10352673492605233,0.689004812275387,1.0,7/49,7.47%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1
prerank,receptor signaling pathway via STAT (GO:0097696),0.5534353808421438,1.320195541392858,0.14856429463171036,0.6880055739467547,1.0,6/25,8.51%,PKD1;GHR;STAT5A;STAT3;SOCS6;SOCS2
prerank,regulation of chromatin organization (GO:1902275),0.6085315055187348,1.3197061173246174,0.14225941422594143,0.6888038200866835,1.0,10/14,28.53%,TLK1;SETD5;TLK2;MLLT3;SSRP1;SETD1A;HNRNPU;PARG;IGF2;CDK9
prerank,regulation of membrane depolarization (GO:0003254),0.5884872850269952,1.3193929576946934,0.12958115183246074,0.6888181284626019,1.0,4/18,3.61%,FHL1;PTPN3;HCN4;CAMK2D
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.4440426335389074,1.3181487277011827,0.015015015015015015,0.6927970339983499,1.0,106/264,25.89%,SRSF6;DDX5;DDX17;HNRNPH1;SRSF1;PABPC1;SRSF5;CELF4;SRSF2;CASC3;SNRNP70;SNRNP48;PRPF40B;FUS;HNRNPA2B1;SRSF11;CHERP;SYMPK;HNRNPL;RAVER2;HNRNPH2;SF3B2;SF3B1;PPIL3;SF3A1;PNN;RBM10;SNRNP25;GTF2F1;SRRM1;U2AF1;RBM6;RBM5;PABPN1;SFPQ;CRNKL1;SNUPN;XAB2;CWF19L1;HNRNPM;PCBP2;LSM2;ZRSR2;PTBP1;RALY;GEMIN7;RBM4;HNRNPC;U2AF2;SRPK1;RBM17;CLP1;CPSF4;HNRNPK;YTHDC1;POLR2F;TFIP11;SCNM1;SRSF3;ISY1;PCF11;IK;NCBP1;WDR83;SNRPA;SRSF7;SMN1;SRSF10;CWC25;CPSF7;AQR;U2SURP;RBM22;NCBP2;SYNCRIP;CSTF2;TRA2B;MTREX;HNRNPH3;TRA2A;ZCCHC8;SNRPB2;CSTF2T;DHX8;HNRNPA3;SNRPB;GEMIN2;HNRNPA1;SRSF4;POLR2B;DHX16;WDR77;RBM19;SF3B6;HNRNPU;YBX1;USP49;SF1;CDK13;SUGP1;UPF3B;SNRNP35;DDX39B;METTL14;POLR2H;DDX20
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5407450672142108,1.3179091097247604,0.12378640776699029,0.6924885014439651,1.0,6/29,8.51%,PKD1;GHR;STAT5A;STAT3;SOCS6;SOCS2
prerank,positive regulation of RNA splicing (GO:0033120),0.537260737074089,1.3176851890097774,0.13861386138613863,0.692119668071591,1.0,12/29,20.67%,SLC38A2;CELF4;THRAP3;CELF3;DAZAP1;U2AF2;NCBP1;RBM22;RBMXL1;TRA2B;CIRBP;TRA2A
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5887569175880198,1.3172186717261365,0.14247669773635152,0.6926797394010729,1.0,3/17,1.12%,SLIT2;VEGFA;FGF2
prerank,fluid transport (GO:0042044),0.6336714228779867,1.3171307668489578,0.162534435261708,0.6917497637298352,1.0,2/12,5.65%,SLC26A6;SLC4A11
prerank,cellular response to decreased oxygen levels (GO:0036294),0.48089761429794303,1.3162464498730087,0.09814612868047982,0.6940343782993106,1.0,22/65,19.00%,VEGFA;P4HB;PTGIS;TWIST1;LMNA;CARD16;MDM4;NDRG1;ANGPT4;RORA;HYOU1;TERT;PICK1;UBQLN1;NDNF;STUB1;SIRT2;PGK1;HMOX1;SUV39H2;NPEPPS;HIPK2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.523342142946513,1.315687920056819,0.12424607961399277,0.6949999796288127,1.0,2/33,0.58%,PKD1;ID2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5740979698335208,1.3156577938446703,0.15334207077326342,0.6938070379235175,1.0,8/19,19.93%,PLCE1;NFAT5;NFATC1;EDN3;PPP3CC;NFATC3;NMUR1;NFATC4
prerank,cellular potassium ion homeostasis (GO:0030007),0.6195948738117543,1.3152837581924761,0.14962962962962964,0.6940254852419545,1.0,3/13,1.20%,KCNJ2;ATP1B1;SLC12A2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.6173057288494465,1.3143705545599167,0.14265927977839335,0.6965059477589555,1.0,7/14,18.69%,IRS1;ACTN3;AKT2;NNMT;PTPN2;ARPP19;AKT1
prerank,gland development (GO:0048732),0.48265298806037654,1.3143533184980052,0.10111111111111111,0.695294805721484,1.0,16/59,12.60%,SIX1;IGSF3;GLI2;TGFB3;DKK3;COBL;PRKCSH;EPHB3;SOX9;CDK5RAP3;ANXA1;FGFR2;RIPK3;SOD1;EZR;TGFBR1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4825549924877743,1.314007199638226,0.09617486338797815,0.6953243381057683,1.0,11/64,9.02%,THBS1;MYOC;EFNA5;LDB1;PKHD1;CD3E;SEMA3E;JAG1;SLC9A1;JUP;RHOA
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3339958105705012,-1.3137996356707653,0.039603960396039604,0.5680857430309841,1.0,11/62,7.85%,ROBO1;AUTS2;LYN;LPAR1;MAP4K4;ARHGEF3;NOTCH1;NET1;F11R;RASGEF1A;PRAG1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.497220024031963,1.313767022448915,0.10555555555555556,0.6950539571408394,1.0,10/54,8.95%,KCNJ2;KCNJ15;FHL1;NEDD4;KCNN1;KCNE5;STK39;KCNIP2;DLG1;WWP2
prerank,positive regulation of heart contraction (GO:0045823),-0.43381558366057077,-1.3132851389920217,0.1417624521072797,0.5659779233548208,1.0,4/19,10.95%,ATP1A2;RYR2;EDN1;ADRA1A
prerank,sensory organ development (GO:0007423),0.49761253586758264,1.3132800321099982,0.11683848797250859,0.6956622621820342,1.0,17/51,20.04%,SMOC1;CHRDL1;PBX3;ECE1;SIX4;TGFB2;PBX1;MEIS3;SH3PXD2B;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3;MAB21L2;HIPK2;MYO7A;ATF6
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4621786235819669,1.3131030667654957,0.07643312101910828,0.6950935432414213,1.0,29/86,24.29%,VEGFA;MUC1;PSMD7;GCN1;ATF4;BAG3;PSMA8;NFE2L2;IMPACT;PSMA4;PSMD12;PSMA6;LIMD1;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;UBC;RPS27A;HIGD1A;HMOX1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;TP53
prerank,negative regulation of proteolysis (GO:0045861),0.5208242306927655,1.3130475496358793,0.13126491646778043,0.6940542013600572,1.0,15/34,24.83%,TIMP2;PTPN3;TIMP3;GAS1;CST3;SERPINE2;CAMK2N1;HDAC6;EFNA1;CLN3;AKT1;CDK5;LRRK2;ROCK1;DNAJC1
prerank,regulation of protein localization to membrane (GO:1905475),0.5398132945119511,1.3125791600521906,0.12425328554360812,0.6947680742051349,1.0,12/28,25.97%,GPC6;GSN;GPC3;MMP14;SPTBN1;CLN3;CDK5;APPL1;CRIPT;GPC1;GPC4;VTI1B
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6082275641922031,1.3125127189148287,0.13865546218487396,0.6937928816974658,1.0,4/13,12.82%,ZMIZ1;ELOF1;SERTAD2;ZMIZ2
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5336950198654877,-1.3120423750808872,0.15789473684210525,0.5658590308370044,1.0,1/10,0.70%,ROCK2
prerank,regulation of MAPK cascade (GO:0043408),-0.28491936424486863,-1.3118595816113894,0.058823529411764705,0.5628540105121969,1.0,28/157,6.71%,FLT1;IGF1R;TGFBR3;KSR1;INSR;LYN;ROCK2;LPAR1;TEK;PHLPP1;MAP4K4;PELI2;KIT;TNIK;LBH;JCAD;EPHA7;KDR;DAG1;CAV2;FAS;ROR2;TBX1;EPHA8;PAK3;ADRA2A;DUSP3;PAK5
prerank,histone mRNA catabolic process (GO:0071044),0.6014758288937833,1.3110554578786582,0.16869095816464239,0.6984500702717884,1.0,8/15,21.96%,TENT4B;SSB;ATM;XRN1;EXOSC4;TUT7;TENT2;UPF1
prerank,positive regulation of bone mineralization (GO:0030501),-0.376705090032524,-1.3106437473919317,0.09333333333333334,0.5628099776362093,1.0,12/35,9.15%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;OSR1;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,aminoglycan biosynthetic process (GO:0006023),0.495166883685824,1.3104371709283973,0.1082004555808656,0.6997152276890553,1.0,12/49,16.69%,EXT1;XYLT1;GPC6;GPC3;SDC1;B3GNT7;HS6ST2;HEXA;B3GNT9;B4GAT1;B3GNT6;XYLT2
prerank,synaptic vesicle membrane organization (GO:0048499),0.5918976150625029,1.3102041619411122,0.1517509727626459,0.6994047854146753,1.0,7/17,15.33%,STX11;PRRT2;STX2;AP3D1;SNAP23;STX4;STX1A
prerank,vascular transport (GO:0010232),0.4655768009187089,1.3101101073624184,0.08917197452229299,0.6985217803089984,1.0,13/81,3.96%,SLC38A2;SLC38A1;SLC4A4;SLC5A6;SLCO3A1;LRP1;SLC12A2;SLC2A13;SLC24A3;SLC16A1;SLC4A8;SLC1A5;ABCC1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.49949398993404354,1.3095757350445818,0.11556064073226545,0.6993832437257429,1.0,5/48,7.13%,SLIT3;SLIT2;GAS6;CARD16;IRAK3
prerank,response to lipid (GO:0033993),0.4613122257141191,1.3090859916328241,0.06434599156118144,0.7000606252337478,1.0,24/105,16.57%,ESR1;FOXP1;ALPL;LBP;SMAD6;CYP19A1;RXRA;STAT3;RXRB;IRAK3;SOX9;LIAS;RARA;SOCS2;ANXA1;FOXA1;IRAK1;TAB2;F2R;SRR;PRDX3;CYP27B1;FOXO3;OTUD5
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.4552809143325204,-1.3090390474784703,0.1583011583011583,0.5635462588008218,1.0,4/17,4.57%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,blood vessel morphogenesis (GO:0048514),-0.3530459318280898,-1.308590677659931,0.06153846153846154,0.5612752787213706,1.0,18/54,11.49%,FLT1;TGFBR3;EFNB2;ENG;LAMA1;CCBE1;KDR;RASIP1;TBX1;PROX1;SOX17;SLC1A1;CDH2;RBPJ;FLT4;CAV1;SYK;SOX18
prerank,autophagy of nucleus (GO:0044804),0.5952416751999209,1.3085202936611795,0.15435356200527706,0.7011738047663485,1.0,8/16,28.38%,ULK2;WIPI2;ATG3;RB1CC1;ATG9A;ATG13;ATG2B;ULK1
prerank,regulation of protein binding (GO:0043393),0.4540200519828792,1.3083232022022466,0.061139896373056994,0.7007564009283611,1.0,43/114,25.49%,PRMT8;PKD1;PRKCD;LRP1;TCF7L2;TIAM1;HDAC4;LRPAP1;CARD16;DACT1;DVL1;TMC8;SYMPK;EFHB;MAPK8;BMP4;GTF2F1;NVL;TERT;CSNK1E;ADD1;USP33;DAB2;MITD1;TFIP11;IDE;STYX;MEN1;AKT1;HIPK2;SNAPIN;CRK;CTSZ;PRKACA;LRRK2;CAMK1;PEX14;DERL1;TAF1;AMFR;ROCK1;PPP2CA;STK3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6155146229928099,1.3082958066217358,0.1676056338028169,0.6996168785639814,1.0,8/13,32.56%,TMEM30B;TM9SF4;SEC16A;SEC16B;SAR1A;GCC2;INSIG1;SAR1B
prerank,epithelial tube morphogenesis (GO:0060562),0.5228974099867945,1.3082309531455627,0.11951219512195121,0.6986362087274066,1.0,5/32,5.63%,SLIT2;PKD1;GLI2;PKHD1;ACVR1
prerank,glycerolipid catabolic process (GO:0046503),0.5646208609782158,1.308153003482653,0.14762516046213095,0.697692777926166,1.0,7/19,16.32%,MGLL;PLA2G4F;PLA2G4A;SMPD4;ABHD6;ENPP6;GDPD3
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.570018681811958,1.3077865272776055,0.12873862158647595,0.6979706053105487,1.0,7/20,12.59%,VEGFA;SMAD9;ATF4;SMAD4;NFE2L2;RUNX2;SESN2
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5586870086905025,1.307673983810993,0.15903307888040713,0.6971201898213432,1.0,3/24,6.47%,SLIT2;CCN3;HMGB1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.46106863123325237,1.3076456049890959,0.08668076109936575,0.6960025162730419,1.0,26/93,21.02%,RASSF2;EGFR;VEGFA;GAS6;NTRK3;DOCK7;DMD;PFN2;RAF1;NSD1;PAQR3;AXIN1;SMAD7;TENM1;AKAP9;EIF4G1;IL6;HDAC6;ARAF;TRIM6;CNOT9;AKT1;MLXIPL;TNKS1BP1;MAD2L2;ATP2B4
prerank,regulation of spindle organization (GO:0090224),0.5733676399425898,1.3073268930279982,0.14602346805736635,0.6960702558803004,1.0,8/18,23.14%,PARP3;RAE1;DYNC1H1;CLTC;DCTN1;NUP62;RNF4;SENP6
prerank,regulation of interleukin-4 production (GO:0032673),-0.43758109726077954,-1.3067224273446194,0.1288888888888889,0.5626690396788295,1.0,7/21,14.89%,LEF1;SLC7A5;SYK;PRKCQ;HAVCR2;LGALS9;PRKCZ
prerank,phagosome-lysosome fusion (GO:0090385),0.6407543225182076,1.3066996609174573,0.15584415584415584,0.6973699331200216,1.0,4/10,18.37%,RAB7B;RAB34;PLA2G5;CLN3
prerank,regulation of leukocyte activation (GO:0002694),-0.47350502767015096,-1.3066567955157562,0.15492957746478872,0.5594854764328379,1.0,5/14,15.51%,LYN;MFHAS1;CD200;CD74;GPER1
prerank,actin polymerization or depolymerization (GO:0008154),0.488536383839597,1.3063696490919348,0.12090395480225989,0.6974209649301611,1.0,12/50,16.86%,PSTPIP1;MICAL2;GSN;VILL;COBL;ABI1;TTC17;SCIN;SPIRE2;MICALL2;WASHC3;WDR1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.48629808665298396,1.305692067055271,0.12794612794612795,0.6989732879396242,1.0,5/54,3.14%,EXT1;XYLT1;GPC6;GPC3;SDC1
prerank,positive regulation of protein import (GO:1904591),0.5253168097850925,1.3050484577685995,0.147239263803681,0.70038007686285,1.0,8/30,10.63%,PRKCD;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;UBR5
prerank,cellular response to pH (GO:0071467),0.5759065244627473,1.3048679394871083,0.1610738255033557,0.6998400125640937,1.0,7/17,20.26%,SLC9A1;IMPACT;RAB11FIP5;CHP1;RAB11B;PKD2L1;HVCN1
prerank,organic substance transport (GO:0071702),0.45156632971459243,1.3044026299198914,0.06832298136645963,0.7004447095047336,1.0,24/121,14.88%,SLC47A1;SLC23A1;ABCD3;SLCO2A1;LMAN2L;FLVCR1;RAMP2;RILP;HIKESHI;DISP1;SLC6A2;ATP8A1;RAMP1;RAB38;PCTP;LRP2;SLC22A18;ABCA1;PICK1;TOM1;CHMP3;ABCB6;SLC50A1;MIA3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.44014000416750204,-1.3043864896333608,0.15178571428571427,0.5621900964457571,1.0,11/20,21.24%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;SEMA4A;SEMA4G;SEMA5B;SEMA6D;SEMA3B
prerank,mRNA catabolic process (GO:0006402),0.49913462713205825,1.3042733531556525,0.1205098493626883,0.6997635938784937,1.0,13/44,16.62%,DDX5;THRAP3;ZC3H12D;AGO1;DIS3L2;METTL16;LSM2;SUPV3L1;XRN1;EXOSC4;MRTO4;TUT7;CNOT10
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.6321674578394377,1.304226545725305,0.1700960219478738,0.6987527545814776,1.0,8/12,25.71%,STX11;PRRT2;STX2;SNAP23;STX4;STX1A;STX1B;STX19
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.5513418866570258,1.3041781445914127,0.14986376021798364,0.6976968372207446,1.0,8/22,17.52%,EDEM3;EDEM2;SYVN1;UGGT2;UGGT1;UBC;RPS27A;TRIM13
prerank,transport across blood-brain barrier (GO:0150104),0.4629732342924325,1.3036986947852334,0.09544008483563096,0.6983755609812892,1.0,13/83,3.96%,SLC38A2;SLC38A1;SLC4A4;SLC5A6;SLCO3A1;LRP1;SLC12A2;SLC2A13;SLC24A3;SLC16A1;SLC4A8;SLC1A5;ABCC1
prerank,positive regulation of protein catabolic process (GO:0045732),0.4687027628245361,1.3035077504241432,0.09925293489861259,0.6979587621463184,1.0,19/84,12.28%,WWP1;ADAM9;GPC3;NEDD4;RDX;STX5;CSNK2A1;RILP;VCP;TNFRSF1B;DACT1;HUWE1;WWP2;NSF;ITCH;VIP;AXIN1;SNX9;EZR
prerank,B cell proliferation (GO:0042100),-0.46728834842513517,-1.3034080817989284,0.13618677042801555,0.5614880986122842,1.0,5/17,15.05%,BCL2;CD180;CD40;CTPS1;CR2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.5044796080560103,1.303322828556661,0.12354312354312354,0.6974553465676743,1.0,3/45,1.55%,SLC38A2;EGFR;DDX5
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.5003891884978169,1.303204953535365,0.11891279728199321,0.6955142131542633,1.0,30/50,30.86%,NUP93;SEC13;RAE1;SEH1L;PUM1;AGO1;NUP37;AGO2;EIF4G1;RANBP2;NUP88;POLR2F;POM121;NUP210;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;NUP160;TPR;TNRC6A;POLR2I;PUM2;NUP50;POLR2L;NUP188
prerank,regulation of gene silencing by RNA (GO:0060966),0.5003891884978169,1.303204953535365,0.11891279728199321,0.6955142131542633,1.0,30/50,30.86%,NUP93;SEC13;RAE1;SEH1L;PUM1;AGO1;NUP37;AGO2;EIF4G1;RANBP2;NUP88;POLR2F;POM121;NUP210;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;NUP160;TPR;TNRC6A;POLR2I;PUM2;NUP50;POLR2L;NUP188
prerank,phagosome maturation (GO:0090382),0.5134681491573856,1.3031393960510147,0.13053613053613053,0.6945709975520246,1.0,9/35,14.53%,ATP6V1C2;RAB34;RAB43;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4971388924306863,1.3026035763118786,0.13099415204678364,0.6955276058298585,1.0,14/43,17.45%,FGF2;NFIB;DDX5;GNL3;KLF5;TGFB2;STAT3;SOX9;BMP4;TERT;SRF;NFATC3;FOXO3;NR3C1
prerank,cartilage development (GO:0051216),0.4930737280821227,1.3024528234218526,0.13157894736842105,0.6949590823480275,1.0,12/49,13.69%,PKD1;SLC39A14;FGF2;NFIB;CCN3;HES5;SULF1;SOX9;BMP4;RUNX2;TRIP11;RUNX1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.4487918450114958,1.3023724744322407,0.060824742268041236,0.6941071187754103,1.0,37/132,18.08%,SRSF6;RPSA;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;RRS1;PRKDC;RRP7A;CELF3;LUC7L;LUC7L3;NLE1;SF3B1;RBM5;CRNKL1;SNUPN;XAB2;DHX29;ZRSR2;GEMIN7;SRPK1;CLP1;EIF2S2;YTHDC1;EIF6;ISY1;PPAN;EIF3A;NCBP1;BOP1;SMN1;SRSF10;CPSF7;CPSF6
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4483955800348096,-1.301656031168543,0.16600790513833993,0.562860268861651,1.0,4/18,4.57%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.5383638685209071,-1.3015159949420227,0.18211920529801323,0.5600733529194114,1.0,6/10,22.00%,RIF1;JARID2;SIRT1;BRCA1;KDM1A;DNMT3B
prerank,photoreceptor cell development (GO:0042461),0.6150962144590957,1.3010625950956973,0.17986577181208055,0.698094578580975,1.0,2/14,3.66%,VEGFA;TOPORS
prerank,response to iron ion (GO:0010039),-0.5016045677221745,-1.300935932396626,0.1644295302013423,0.5583394168479563,1.0,3/12,2.11%,BCL2;BMP6;B2M
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5661894966514089,1.300328384742678,0.16393442622950818,0.6986839108072257,1.0,14/21,33.38%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;GTF2H4;XPA;DDB1;RBX1;ERCC1;RPA3;CUL4B
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5661894966514089,1.300328384742678,0.16393442622950818,0.6986839108072257,1.0,14/21,33.38%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;GTF2H4;XPA;DDB1;RBX1;ERCC1;RPA3;CUL4B
prerank,protein depolymerization (GO:0051261),0.5277797110523034,1.2994700363771532,0.16541353383458646,0.7009289424770049,1.0,3/27,2.00%,MICAL2;GSN;STMND1
prerank,camera-type eye development (GO:0043010),0.5495729423615825,1.2983633319412078,0.15601965601965603,0.7040931709827375,1.0,7/25,8.70%,CACNA1C;VEGFA;CYP1B1;HES5;RAB3GAP1;SKI;TSKU
prerank,lung development (GO:0030324),0.5200774922049579,1.2983547591380558,0.15681544028950542,0.7029485121073742,1.0,7/33,9.70%,PKD1;VEGFA;FGF2;GLI2;CCDC39;BMP4;FGFR2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5832846837974223,1.2978358893532778,0.15508021390374332,0.7038628196835796,1.0,2/16,4.91%,SLC39A14;PRKCA
prerank,embryonic organ development (GO:0048568),0.47662410048014153,1.2977885062679686,0.10244988864142539,0.7028707739097477,1.0,15/61,12.12%,PKDCC;PCSK5;PBX3;RARB;GLI2;COBL;TGFB2;ATF4;TGFBR2;PBX1;TBC1D23;FGFR2;BMPR1A;ERCC3;HEY1
prerank,neural crest cell migration (GO:0001755),-0.37065762559278415,-1.297729124725354,0.10828025477707007,0.563349441525555,1.0,16/36,21.24%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;TBX1;ERBB4;CORO1C;SEMA4D;SEMA3G;FN1;SEMA4A;HTR2B;SEMA4G;SEMA5B;SEMA6D;SEMA3B
prerank,regulation of protein catabolic process (GO:0042176),0.45668004658442385,1.2976522692091461,0.08682008368200837,0.7022220344203738,1.0,18/99,11.35%,EGFR;WWP1;GPC3;NEDD4;STX5;CSNK2A1;RILP;VCP;DACT1;IRAK3;MDM4;HUWE1;WWP2;NSF;ITCH;VIP;AXIN1;CHEK2
prerank,pulmonary valve development (GO:0003177),0.5688014920594546,1.2973295360566226,0.14434330299089726,0.7023416114547172,1.0,9/18,12.12%,SLIT2;SMAD6;TGFB2;TNFRSF1B;JAG1;HEYL;NFATC1;BMP4;HEY1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.4397907508924287,1.297115389376691,0.023069207622868605,0.7020062435433941,1.0,94/241,25.10%,SRSF6;DDX5;HNRNPH1;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;SNRNP70;SNRNP48;PRPF40B;FUS;HNRNPA2B1;SRSF11;CHERP;SYMPK;HNRNPL;RAVER2;HNRNPH2;SF3B2;SF3B1;PPIL3;SF3A1;PNN;RBM10;SNRNP25;GTF2F1;SRRM1;U2AF1;RBM6;RBM5;PABPN1;SFPQ;CRNKL1;XAB2;CWF19L1;HNRNPM;PCBP2;LSM2;ZRSR2;PTBP1;RALY;GEMIN7;RBM4;HNRNPC;U2AF2;RBM17;CLP1;CPSF4;HNRNPK;YTHDC1;POLR2F;TFIP11;SRSF3;ISY1;PCF11;IK;NCBP1;WDR83;SNRPA;SRSF7;SRSF10;CWC25;CPSF7;AQR;U2SURP;RBM22;NCBP2;SYNCRIP;CSTF2;TRA2B;MTREX;HNRNPH3;TRA2A;ZCCHC8;SNRPB2;CSTF2T;DHX8;HNRNPA3;SNRPB;HNRNPA1;SRSF4;POLR2B;DHX16;RBM19;SF3B6;HNRNPU;YBX1;USP49;SF1;SUGP1;UPF3B;SNRNP35;DDX39B
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5737364306244066,1.2968946054817931,0.16226415094339622,0.7016586072470586,1.0,6/17,8.86%,KCNJ2;CACNA1G;CACNA1C;HCN4;ANK2;TRPM4
prerank,chromatin organization (GO:0006325),0.45058217546320467,1.2967971320930256,0.060824742268041236,0.7008641354444729,1.0,51/132,26.74%,ESR1;HDAC4;BAZ2A;CHD1L;TCF7L1;PHF1;SAFB;EZH1;TADA2A;BRWD1;SOX9;EHMT1;HMGN1;SMARCC2;CDAN1;FOXA1;SETD5;KDM5B;PBRM1;KDM4A;KAT2A;HDAC1;BAZ2B;SETDB1;HMGN2;SUPV3L1;KDM5C;HMG20A;KDM6B;GATAD1;SMARCAD1;SUV39H2;HCFC1;BRDT;MPND;BPTF;SUV39H1;LOXL2;FAM50A;SETD2;TOP1;TAF6L;KAT2B;SETDB2;SMARCA4;HDAC2;DAXX;CHD1;ARID1A;SETD7;MYSM1
prerank,smooth muscle tissue development (GO:0048745),-0.5429285212174126,-1.2967817910531043,0.17627118644067796,0.5628432185925917,1.0,4/10,5.88%,ENG;MYLK;PTCH1;PROX1
prerank,regulation of heart contraction (GO:0008016),-0.31896315474985604,-1.296321127159612,0.07142857142857142,0.5608108312833827,1.0,21/90,11.99%,ATP1A2;ITPR1;ATP1B3;CELF2;SLC8A1;PDE4D;TPM1;RYR2;ITPR3;ABCC9;ATP2B1;SLC8A3;ATP1B2;KCNJ12;ATP2A3;DES;NPR1;TBX2;ITPR2;NOS1;ACE2
prerank,heme biosynthetic process (GO:0006783),0.5484867002199415,1.2962516671833877,0.16290726817042606,0.7017545254201726,1.0,11/22,25.82%,FLVCR1;FXN;NFE2L1;HMBS;ABCB6;FECH;UROS;SLC25A38;ABCG2;ABCB10;COX15
prerank,T cell differentiation (GO:0030217),-0.3732342222517307,-1.2961815586864702,0.0916030534351145,0.5580675803146914,1.0,7/40,7.55%,LEPR;CHD7;SOX13;KIT;TCF7;JAG2;RHOH
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.3682220958908261,-1.2961044762911489,0.11764705882352941,0.5551919306415984,1.0,10/37,6.79%,ALCAM;CADM1;IL1RAPL1;GRID2;VCAM1;PTPRD;TENM4;TENM3;CXADR;TENM2
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5027045739194143,1.2960381505428686,0.1320754716981132,0.7013773989363168,1.0,19/41,26.41%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;NUP62;NDC1;NUP35;SCARB2;NUP85;NUP160;TPR
prerank,regulation of peptide hormone secretion (GO:0090276),-0.33047655630474576,-1.296027727004371,0.09195402298850575,0.5524036804295476,1.0,12/67,8.11%,ITPR1;RAPGEF4;CHD7;RAPGEF3;SLC2A1;DPP4;CACNA1D;CACNA1E;ITPR3;ADRA2A;HTR2C;KCNC2
prerank,regulation of mRNA processing (GO:0050684),0.5161564703860426,1.2956438303330198,0.1382716049382716,0.7017283838270918,1.0,15/32,19.46%,RBM39;SAFB;SLTM;PABPN1;METTL16;KHDRBS1;SRPK1;CPSF4;HNRNPK;YTHDC1;SRSF3;NCBP1;SRSF10;SAFB2;LARP7
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5260228690185309,1.2951175982389722,0.14180929095354522,0.7026776411412954,1.0,8/27,15.23%,ID2;PPP1CC;USP2;PER3;BHLHE40;FBXL12;RBM4;PER1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.45208563966571236,1.294900192888176,0.0706967213114754,0.7023787750734917,1.0,34/128,16.52%,TMEM100;GDF10;COL3A1;ADAM9;COL1A2;LTBP2;PDCD4;DDX5;SMAD9;SMAD6;ZMIZ1;ACVR1B;TGFB3;TGFB2;ACVR1;SMAD4;TGFBR2;SKI;CBL;RHOA;BMP4;RUNX2;BMPR1A;SMAD7;RGMA;TGFB1I1;TGFBR1;ZMIZ2;INHBA;BMP5;ID1;STUB1;UBC;RPS27A
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5255064460565725,1.2948535743176817,0.1559074299634592,0.701382496743888,1.0,5/29,7.83%,SLC4A10;EPHB2;ARC;RAB3GAP1;DLG4
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4514796189794077,-1.2945118767475938,0.12546125461254612,0.5532141672953971,1.0,9/17,19.82%,OSR1;AJAP1;APOLD1;CAV1;CEACAM1;PRKX;MAFF;DSPP;DLL1
prerank,negative regulation of phosphorylation (GO:0042326),0.4599322789752188,1.2944840431314661,0.100418410041841,0.7017212314587933,1.0,19/85,13.02%,SLIT2;LRP6;PID1;NTRK3;PLPP3;EPHB2;HDAC4;WWTR1;XDH;ACTN3;PRKDC;IMPACT;CDK5RAP3;BMP4;PAQR3;NIBAN1;GIT1;CHP1;INHBA
prerank,response to purine-containing compound (GO:0014074),-0.45032740635148216,-1.2942708407225922,0.13740458015267176,0.5507815695745535,1.0,4/17,3.96%,STAT1;RYR2;TRPC3;ABCC9
prerank,regulation of nervous system process (GO:0031644),-0.43834338235673165,-1.2939729871326022,0.11382113821138211,0.5486058252926737,1.0,5/18,7.35%,ROCK2;APP;NOS3;HTR2C;SLC8A3
prerank,cell-cell junction assembly (GO:0007043),-0.32470723880485297,-1.2922587918017354,0.03260869565217391,0.5504064392589635,1.0,18/63,9.52%,TJP1;TLN2;GJB6;CDH8;CDH5;CLDN5;EPB41L3;PKP4;GJB2;ARVCF;GJC1;GJD3;PIP5K1C;CDH6;CDH2;CDH7;CDH19;CDH20
prerank,negative regulation of organelle assembly (GO:1902116),0.5114614680246647,1.2919457828439966,0.13859020310633213,0.7106280410135354,1.0,18/35,25.58%,TMEM39A;LIMK2;SMAD4;CDK10;SCFD1;EVI5L;KAT2A;PHF23;SEC22B;CHMP4A;CHMP4B;LRRK2;CDK5RAP2;MTM1;KAT2B;SMCR8;PINK1;CCP110
prerank,regulation of lipase activity (GO:0060191),0.6056895865718723,1.2918113609902433,0.18046132971506107,0.7099655984138145,1.0,3/13,9.02%,PCSK5;LMF1;RHOA
prerank,proteolysis (GO:0006508),0.43830014008549123,1.2917272992027373,0.01901901901901902,0.7091754609943944,1.0,71/252,24.74%,ADAMTS3;CAPN5;HTRA3;TRABD2B;BMP1;PCSK5;F3;HTRA4;HTRA1;ECE1;PRSS38;CPZ;FAP;HM13;CPQ;ADAM10;SPG7;MMP14;PM20D2;BACE2;TASP1;CLPP;MBTPS1;CAPN10;XPNPEP1;DDI2;CAPN2;OGT;BACE1;SDE2;FBXO3;LONP1;PSMA6;MMP16;CASP1;NLN;LNPEP;CPXM2;PSEN2;HGF;LAP3;IDE;CAPN15;PSMC4;DPP8;PCSK7;NAPSA;CLN3;SUFU;FBXW2;NPEPPS;CTSZ;LVRN;CPB2;RNPEPL1;CTSB;SENP1;CTSK;DESI2;DESI1;UBA3;CTSO;CAPN6;MMP2;SENP6;AFG3L2;SPPL2A;PHEX;METAP2;ADAMTS9;VASH1
prerank,neuron differentiation (GO:0030182),0.44537080759645636,1.291649779559165,0.0508646998982706,0.7083403276681509,1.0,32/165,16.22%,LRP6;ID2;WNT9A;VEGFA;PBX3;VSX1;LDB1;GLI2;LHX9;TGFB2;NRBP2;FZD7;PBX1;FZD5;MYEF2;FOXA1;RUNX2;CTF1;NEUROD2;SRF;ERCC3;TENM1;TGFBR1;INHBA;MANF;ERCC2;RUNX1;WNK1;ACSL3;EN2;THOC2;ERBB2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.527723950761352,1.2914435064920058,0.16356877323420074,0.7080257569248031,1.0,5/27,11.27%,SMOC2;FGF2;TOM1L1;SMG6;ATM
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.4306832648488043,-1.2913714910512573,0.13043478260869565,0.5497602739604405,1.0,8/22,23.89%,GCNT2;BMP7;CD44;THY1;AGER;MAPK7;MBP;MYADM
prerank,acute inflammatory response (GO:0002526),0.5439936117797798,1.2913700859942792,0.1677175283732661,0.7071330873956421,1.0,2/23,1.07%,LBP;F3
prerank,renal system development (GO:0072001),0.486678400445964,1.2910669804088304,0.12148481439820022,0.7071514504401805,1.0,9/52,9.70%,SIX1;PKD1;VEGFA;PCSK5;GLI2;TGFB2;SULF1;PYGO1;BMP4
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5443221260812211,1.2910577595147692,0.1493099121706399,0.7060364789680056,1.0,7/24,17.17%,PID1;RHOQ;GDI1;PPFIA1;CLTC;DAB2;LZTFL1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5047778103859436,1.2905975099837788,0.14988290398126464,0.7065644930805733,1.0,5/41,6.98%,KCNJ2;KCNJ15;KCNN1;KCNE5;ANK2
prerank,visual perception (GO:0007601),0.45761291937566023,1.290174522519855,0.08956796628029505,0.7071704237091575,1.0,7/84,6.91%,SLC4A10;COL11A1;COL1A1;PDE6C;PITPNA;CRYZ;CHRNB2
prerank,protein modification by small protein removal (GO:0070646),0.43331302474927214,1.2900076314837705,0.020060180541624874,0.7066336622371147,1.0,106/252,26.82%,ESR1;IL33;PSMD7;USP24;VCP;USP2;PSMA8;SMAD4;OTUB1;USP50;TRRAP;MDM4;GPS1;MBD6;FOXK1;OGT;RHOA;INO80E;RHOT1;PSMA4;USP40;UCHL3;INO80B;WDR48;USP48;USP45;SMAD7;PSMD12;OTUB2;KAT2A;USP34;TRAF3;TGFBR1;USP11;PSMA6;STAM2;SENP5;USP7;USP33;USP36;PSMD1;USP13;PSMC5;USP19;USP35;PSMD11;PSMC4;PSMD14;UBC;RPS27A;OTUD5;CDC25A;POLB;YOD1;USPL1;SENP8;CDC20;USP32;USP10;HCFC1;USP46;ACTR8;USP1;UCHL5;ZRANB1;NFKBIA;TAF9B;OTUD6B;PSMA3;UCHL1;BRCC3;USP5;SMURF2;PSMB1;SENP1;PSMD4;COPS4;USP47;DESI2;DESI1;BIRC3;SENP7;SENP6;PSMA5;CYLD;KAT2B;PSMA7;USP4;USP49;COPS7A;ASXL2;USP14;TP53;SNX3;SENP3;CCP110;SUDS3;PSMC1;COPS3;RIPK1;YY1;ATXN7;TAF10;MYSM1;USP21;USP16
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5402977112256518,1.28965036578965,0.14974619289340102,0.706832508623918,1.0,3/24,2.00%,MAP7D3;FGF13;STMND1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5684562714748058,1.2895244682475104,0.18455497382198952,0.7061573268064,1.0,4/17,14.42%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.47728950190627306,1.289494331393924,0.11495535714285714,0.7051242434806291,1.0,23/63,24.63%,PLAGL1;MUC1;CRADD;PRKDC;MDM4;CARM1;PCBP4;ATM;CHEK2;SDE2;TFDP1;CNOT8;CNOT10;RBL2;E2F1;CNOT9;CDK2;TNKS1BP1;SFN;TRIAP1;PRMT1;TP53;RPS27L
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6133968525643876,1.2894775677251076,0.18169209431345354,0.7040429149558799,1.0,5/13,15.61%,GLI2;BMP4;SOD1;CLPTM1;CAMK4
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5622732265333042,1.2890505449394498,0.18266666666666667,0.704616464704341,1.0,3/19,10.68%,LBP;PRKCE;IRAK1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5377645210094144,1.2881916703555978,0.1791237113402062,0.7069525849668598,1.0,10/24,25.68%,TENT4B;ERCC4;TEN1;HNRNPC;TNKS2;XRN1;PARP1;HNRNPA1;HNRNPU;SLX4
prerank,cellular response to misfolded protein (GO:0071218),0.5517793957704986,1.2880716808081611,0.18170103092783504,0.7063259635628669,1.0,10/20,25.96%,VCP;DNAJB14;UGGT2;UGGT1;STUB1;DNAJC18;DERL1;DNAJB12;UBE2W;RNF126
prerank,pulmonary valve morphogenesis (GO:0003184),0.5659956018269716,1.2879172264908008,0.1588785046728972,0.7058006669753079,1.0,8/17,12.12%,SLIT2;SMAD6;TGFB2;JAG1;HEYL;NFATC1;BMP4;HEY1
prerank,sodium ion import across plasma membrane (GO:0098719),0.5763494606860691,1.2876232806879,0.19262295081967212,0.705774408688483,1.0,6/17,8.86%,SLC12A2;SLC5A2;HCN4;SLC9A4;SLC9A1;TRPM4
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3582599614645509,-1.2872114998251842,0.08955223880597014,0.5572723138609911,1.0,19/47,23.25%,ROCK2;WNT4;RAPGEF2;PROX1;C1QTNF3;ZC3H12A;CAV1;PLEK;CEACAM1;CD34;SIRPA;BRCA1;C1QTNF12;GLA;ERLIN2;TRIB3;SIK1;EP300;APOC1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5606608269831453,1.2865749684764258,0.16601307189542483,0.7087211775061691,1.0,14/22,34.39%,CHD1L;CUL4A;ERCC3;ERCC2;PARP1;UBC;RPS27A;GTF2H4;XPA;DDB1;RBX1;RAD23B;CUL4B;CETN2
prerank,cellular response to amyloid-beta (GO:1904646),-0.36781208864909354,-1.2864598518016452,0.11049723756906077,0.5563065045526914,1.0,13/35,14.20%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;CASP4;GRIN2A;SNX6;ITGA4;IGF1;CACNB1;GRIN1
prerank,regulation of cell killing (GO:0031341),0.5787039143770072,1.2858644966065464,0.1891156462585034,0.7104103481235139,1.0,4/16,9.64%,CFH;TGFB2;FZD7;MAPK8
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6418309429198338,1.2856125424215523,0.18335684062059238,0.7103115988879256,1.0,7/10,26.50%,KMT5A;EHMT1;EEF1AKMT2;SETD4;SETD2;SMYD2;SETD7
prerank,membrane depolarization during action potential (GO:0086010),0.539628989769079,1.2850271323546707,0.14390243902439023,0.7113890247754389,1.0,4/26,2.89%,KCNJ2;CACNA1G;CACNA1C;HCN4
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.44458448164816244,1.2850191164357396,0.07731958762886598,0.7102911420424983,1.0,10/122,4.20%,THBS1;SMOC2;EGFR;IRS1;FGF2;IL33;LDB1;GLI2;SAMD4A;TGFB2
prerank,GTP metabolic process (GO:0046039),0.5714739832682453,1.284949620338213,0.16759776536312848,0.7094802768337477,1.0,7/15,21.87%,RHOQ;AK3;RAB23;EFL1;ENTPD7;LRRK2;MFN1
prerank,carnitine shuttle (GO:0006853),-0.5141631249852272,-1.2841427758205777,0.175,0.5591992247348498,1.0,5/11,14.39%,PRKAA2;PRKAG2;CPT1A;MID1IP1;ACACB
prerank,histone H3 deacetylation (GO:0070932),0.5915087348431732,1.2836744325677254,0.1828410689170183,0.7131664198439218,1.0,12/15,33.13%,HDAC9;HDAC4;SFPQ;HDAC1;PER1;SIRT2;SMARCAD1;HDAC2;PER2;ELK4;HDAC3;SIRT7
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.437844771733809,-1.2836720485095827,0.1522633744855967,0.5574890650174089,1.0,2/18,1.08%,ATP1A2;NEDD4L
prerank,cellular response to amino acid starvation (GO:0034198),0.4669418172571619,1.2834846132914075,0.11650485436893204,0.7128367197781708,1.0,31/71,25.63%,NPRL3;ATP6V1C2;SEC13;MAP3K5;GCN1;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;DAP;IMPACT;CASTOR2;MAPK8;ATP6V0D1;SESN2;ATP6V1B2;ATP6V1E1;FLCN;ATF2;KPTN;ATP6V1C1;RHEB;EIF2AK4;EIF2S1;EIF2AK3;RPTOR;NPRL2;ATP6V0E1;ATP6V0B;LAMTOR2
prerank,negative regulation of cell junction assembly (GO:1901889),0.5340465826479021,1.2823723368813242,0.17639593908629442,0.7159888182470946,1.0,3/25,5.22%,THBS1;SLIT1;BCAS3
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5552480113374564,1.2823488728093688,0.1690694626474443,0.714931689381486,1.0,11/21,17.10%,NUP93;CCN3;TGFB3;WWTR1;SMAD4;BMP4;SH2B1;BMPR1A;TGFBR1;DAB2;SLC2A10
prerank,sulfur compound transport (GO:0072348),0.533592106095299,1.2822777642382566,0.15203955500618047,0.7140806131331087,1.0,4/27,5.40%,SLC26A7;SLC5A6;SLC26A6;LRRC8D
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.4449469132660763,-1.2821061496752093,0.14728682170542637,0.5585735873521426,1.0,8/18,14.89%,NRXN1;SHANK3;RIMS2;RIMS1;CUX2;RELN;GRIN1;PRKCZ
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5892913973855819,1.281793054690653,0.18528610354223432,0.714904751484872,1.0,8/14,23.29%,TSEN54;FAM98B;CLP1;CPSF4;RTCB;CSTF2;RTRAF;TSEN34
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.5533077965041663,1.280411658168135,0.1781767955801105,0.7193982077933408,1.0,7/18,17.52%,EDEM2;SYVN1;UGGT2;UGGT1;UBC;RPS27A;TRIM13
prerank,regulation of organelle assembly (GO:1902115),0.47109814391762844,1.2801708080052603,0.10976948408342481,0.719254208976192,1.0,32/72,26.19%,GSN;NPRL3;RDX;MAPK15;TBC1D2B;DYNLT2B;ATXN2L;ALMS1;IFT20;TBC1D24;TRAPPC12;ATG3;SDCCAG8;EZR;TBC1D9B;TBC1D10A;TBC1D17;IFT88;VPS11;EVI5;TBC1D22B;PDCD6IP;RNF4;ATXN2;RAB1B;SENP6;CYLD;RABGAP1;NPRL2;SPICE1;TBC1D20;RAB5A
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5467864244555742,1.2798585019429167,0.16075949367088607,0.7193901886149742,1.0,7/20,6.98%,CACNA1C;ATP1B1;CAMK2D;CALM2;DMD;SLC9A1;ANK2
prerank,tRNA processing (GO:0008033),0.46741336490963664,1.2796401981915462,0.12334801762114538,0.7190876187481756,1.0,24/61,23.79%,TSEN54;SSB;ANKRD16;ELP5;FAM98B;TRMT1;PUS3;TRUB1;CTU2;CLP1;CPSF4;RTCB;RPP40;ELAC2;ADAT1;TRMT6;SARS1;CSTF2;RTRAF;TRMT61A;METTL1;NSUN6;TSEN34;RPP21
prerank,positive regulation of vacuole organization (GO:0044090),0.631982409584389,1.2789159961153487,0.19943019943019943,0.720836199412191,1.0,4/10,10.05%,ANXA2;LRSAM1;RAB3GAP1;PIP4K2B
prerank,cellular response to purine-containing compound (GO:0071415),-0.5095421731264822,-1.2784138075793396,0.18181818181818182,0.5649034758600471,1.0,2/10,3.25%,SLC8A1;RYR2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.4325934153321225,1.2777777567182969,0.055443548387096774,0.7241942368206842,1.0,68/184,25.77%,PKD1;ID2;ANAPC5;PSMD7;PPP1R9B;CSNK1D;CDC16;DYNC1H1;SFI1;PSMA8;ODF2;CDC14A;ALMS1;CDC6;DCTN2;PSMA4;CKAP5;UBE2C;PSMD12;ANAPC4;ERCC3;SDCCAG8;AKAP9;ZW10;CUL1;CEP164;CSNK1E;PSMA6;YWHAE;ERCC2;PSMD1;CEP41;CEP63;PCM1;ANAPC2;SIRT2;PSMC5;HAUS5;ANAPC1;PSMD11;PSMC4;PSMD14;UBC;RPS27A;ANAPC10;E2F1;CDC20;CDC27;CDK2;DYNC1I2;APPL2;APPL1;PSMA3;DCTN1;PRKACA;PSMB1;PSMD4;ACTR1A;CDK5RAP2;NEDD1;PSMA5;PSMA7;PLK4;CNTRL;RIOK2;TUBB4B;CCP110;PSMC1
prerank,calcium ion transmembrane transport (GO:0070588),0.45759991779120085,1.2776146700805786,0.10367170626349892,0.723736617985871,1.0,17/86,13.03%,CACNA1G;PKD1;CACNA1C;SLC35G1;GAS6;SLC24A3;TRPV3;MCU;SPG7;TRPC4AP;TRPM7;TRPM4;ITGAV;TMEM165;TRPM6;MICU2;LETM1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.5734624700744295,1.276871048358246,0.2011577424023155,0.7256247563016482,1.0,8/15,26.60%,VCP;FAF2;SYVN1;NPLOC4;DERL1;HERPUD1;SELENOS;SEC61B
prerank,positive regulation of phospholipase C activity (GO:0010863),0.490746388922047,1.276756607197327,0.14521841794569068,0.7249172615615173,1.0,5/40,3.19%,ESR1;EGFR;FGF2;NTRK3;EDNRA
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5301880260307803,1.2761098557867787,0.1800518134715026,0.7263791129565745,1.0,7/24,12.59%,VEGFA;MUC1;GCN1;ATF4;NFE2L2;HSPA5;SESN2
prerank,histone H2A acetylation (GO:0043968),0.5843162599513552,1.2761054065052382,0.1831357048748353,0.7252608561446486,1.0,5/16,8.85%,MORF4L2;NAA40;TRRAP;ING3;MORF4L1
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.39432502585483786,-1.2759997482476435,0.12558139534883722,0.5680272616317429,1.0,9/25,13.58%,ERRFI1;PPARA;CBLB;SLC6A9;CNRIP1;SNX6;SOCS5;ACE2;GPRC5A
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.49704551542395536,1.2752295146840782,0.14564220183486237,0.7275984696468698,1.0,7/44,6.98%,KCNJ2;KCNJ15;ATP1B1;KCNN1;KCNE5;ANK2;KCNIP2
prerank,estrogen metabolic process (GO:0008210),0.5777863205437581,1.2751403620351096,0.21333333333333335,0.7268338711217333,1.0,2/15,3.46%,CYP19A1;CYP1B1
prerank,dendritic spine morphogenesis (GO:0060997),0.5878087361448185,1.2748585681156486,0.1963109354413702,0.7267747210139498,1.0,6/15,11.52%,CTNND2;EPHB2;ARC;EPHB3;DLG4;SHANK1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5534418416346607,1.2746756337537894,0.1964512040557668,0.7263524854637119,1.0,4/21,11.34%,LRP6;DVL1;FZD5;AXIN1
prerank,regulation of cell cycle (GO:0051726),0.43146261923501467,1.2741270036620451,0.0321285140562249,0.7274129932078011,1.0,71/271,21.16%,THBS1;PLAGL1;LRP6;PKD1;ID2;TCF7L2;PDCD4;TTC28;GADD45G;PPP1R9B;PRDM11;FAP;CSNK2A2;CSNK2A1;TGFB2;STAT3;EIF4G2;CDC14A;NEK7;ADAM10;PUM1;GBF1;CDK10;SOX9;RARA;SRA1;AKT2;CDK5RAP3;BMP4;FGFR2;TBRG4;CDC123;MADD;FOXM1;ABL1;INTS13;ATM;MAPK12;FBXL12;TAF6;MED25;UHMK1;TGFBR1;INHBA;SND1;RHOB;CAMK2N1;ING4;SIRT2;IQGAP1;APBB1;CDC25A;BOP1;E4F1;MEN1;CITED2;DAPK3;KIF20B;HCFC1;UHRF2;BIRC5;HIPK2;MLXIPL;CKS1B;GMNC;CDK5;DLGAP5;CALR;PRKACA;WDR12;TBRG1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.5189420273371417,1.2740252626477073,0.16324062877871826,0.7267313016294574,1.0,14/31,24.84%,PEX7;TOMM40;PEX5;PEX16;PEX1;AIFM1;HSPD1;PEX10;TOMM70;GRPEL1;PEX6;PEX2;PEX14;TIMM17B
prerank,negative regulation of endocytosis (GO:0045806),-0.4062942796568497,-1.273838178968191,0.145,0.5708429899412345,1.0,7/24,13.30%,MCTP1;PICALM;NR1H3;PACSIN3;CD300A;CAV1;PRKD1
prerank,negative regulation of myotube differentiation (GO:0010832),0.6076977019811408,1.2736549914377728,0.19648093841642228,0.7269854460210835,1.0,4/12,12.68%,CCN3;HDAC4;TMEM119;HDAC1
prerank,cellular response to retinoic acid (GO:0071300),-0.35175375602691517,-1.2736079477967006,0.08527131782945736,0.5686507302763931,1.0,9/42,6.52%,LYN;WNT5B;PTK7;WNT5A;WNT6;BRINP3;TBX1;BRINP1;BRINP2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5904755021319836,1.2735163893286774,0.18019257221458046,0.726425318010274,1.0,6/14,19.72%,PKD1;NFKBIB;G3BP2;MDFI;SUFU;NFKBIA
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.47878882334238276,1.273420097609021,0.12768361581920903,0.7257117508215756,1.0,19/54,24.29%,PLAGL1;MUC1;CRADD;MDM4;CARM1;PCBP4;ATM;CHEK2;TFDP1;CNOT8;CNOT10;RBL2;E2F1;CNOT9;TNKS1BP1;SFN;TRIAP1;PRMT1;TP53
prerank,protein localization to centrosome (GO:0071539),0.5650676646741251,1.273081689231839,0.19380888290713325,0.7259951435009796,1.0,5/17,15.07%,CSNK1D;GOLGB1;DCTN2;NUDCD3;PCM1
prerank,negative regulation of DNA replication (GO:0008156),0.5908615966352188,1.2727112404321885,0.1885245901639344,0.726432350689029,1.0,9/13,30.53%,CDC6;CDAN1;GMNC;PDS5A;GTPBP4;S100A11;WAPL;ATR;RAD17
prerank,photoperiodism (GO:0009648),0.5179557341071754,1.2725894917595781,0.16113161131611317,0.7257780492815967,1.0,8/28,15.23%,ID2;PPP1CC;USP2;PER3;BHLHE40;FBXL12;RBM4;PER1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.6312877517941167,1.272588399200896,0.18311874105865522,0.7246797405667933,1.0,3/10,4.67%,PDE11A;UBE2B;PDE3A
prerank,protein targeting to lysosome (GO:0006622),0.5495761465631251,1.2723000141618561,0.15958815958815958,0.7247033367372269,1.0,11/20,34.65%,NEDD4;NAGPA;ZFYVE16;CLU;LAMP2;SCARB2;GCC2;GGA3;GNPTAB;M6PR;SNX16
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.46247428503258703,1.2722775196992888,0.11302475780409042,0.7237049348697775,1.0,22/74,17.24%,COL1A1;TIAM1;PHLDB1;TGFB3;TWIST1;LDLRAD4;SPRED2;WWTR1;TGFB2;BCL9L;SMAD4;TGFBR2;FOXA1;SMAD7;TGFB1I1;TGFBR1;DAB2;BMP5;IL6;IL17RD;CRB2;EFNA1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.3690282191196773,-1.2722538243638453,0.1348314606741573,0.56907370547588,1.0,6/34,6.43%,ROCK2;APOE;EPHA4;PICALM;ABCG1;GSAP
prerank,cellular response to peptide (GO:1901653),-0.3339534604887088,-1.2711934390779507,0.07692307692307693,0.5687794784226834,1.0,22/56,18.23%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;CASP4;ARHGEF2;VIM;GRIN2A;SNX6;CAV1;ITGA4;IGF1;CACNB1;GRIN1;GPER1;ICAM1;NOD2;PTPN22;CACNA1A;XBP1
prerank,digestive tract morphogenesis (GO:0048546),0.5753104072281421,1.2709779201327198,0.1958904109589041,0.7277873842220005,1.0,4/14,9.70%,ID2;AGR2;EPHB3;FGFR2
prerank,negative regulation of RNA splicing (GO:0033119),0.5532979025738358,1.2708884519310002,0.19293820933165196,0.7270833782362043,1.0,10/19,25.05%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF7;SRSF10;SAP18;SFSWAP;SRSF4;C1QBP
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.511070231267213,-1.2703017300784312,0.20270270270270271,0.5681462928616029,1.0,5/12,19.82%,DOCK11;DOCK10;LFNG;MFNG;DLL1
prerank,mRNA processing (GO:0006397),0.4283545138042289,1.270171127207854,0.022022022022022022,0.7288332386642936,1.0,111/287,25.89%,SRSF6;DDX5;HNRNPH1;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;SNRNP70;SNRNP48;PRPF40B;FUS;HNRNPA2B1;SRSF11;CHERP;SYMPK;HNRNPL;RAVER2;HNRNPH2;SF3B2;SF3B1;PPIL3;SF3A1;PNN;TBRG4;ZC3H11A;RBM10;SNRNP25;GTF2F1;SRRM1;U2AF1;RBM6;CHTOP;RBM5;PABPN1;SFPQ;CRNKL1;ERCC3;XAB2;CWF19L1;HNRNPM;PCBP2;LSM2;ZRSR2;PTBP1;RALY;GEMIN7;RBM4;ERCC2;HNRNPC;U2AF2;RBM17;CLP1;CPSF4;HNRNPK;YTHDC1;POLR2F;SARNP;TFIP11;THOC2;SRSF3;ISY1;PCF11;RPRD1A;IK;NCBP1;WDR83;SNRPA;SRSF7;SRSF10;CWC25;CPSF7;AQR;CPSF6;U2SURP;RBM22;NCBP2;SYNCRIP;CSTF2;TRA2B;RAMAC;MTREX;HNRNPH3;TRA2A;PRKACA;ZCCHC8;SNRPB2;CSTF2T;DHX8;HNRNPA3;SNRPB;GEMIN2;HNRNPA1;SRSF4;POLR2B;DHX16;RBM19;PRMT9;SF3B6;HNRNPU;YBX1;USP49;SF1;SUGP1;UPF3B;SNRNP35;DDX39B;GTF2H4;METTL14;POLR2H;RNMT
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5699247232440006,1.270067884597912,0.18725617685305593,0.7281612394798581,1.0,4/17,8.50%,PCSK5;HDAC9;ANGPTL4;LMF1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.36442868085638136,-1.270064553276302,0.10457516339869281,0.5659402740575122,1.0,14/37,10.82%,PLCB1;GRM7;GRM5;GRM3;APP;GRM8;GRID2;GRM1;GRIK2;GRIN2B;GRIA4;HOMER1;GRIN2A;GRIA3
prerank,positive regulation of lipid transport (GO:0032370),0.6096201372080827,1.2699787503936788,0.1972027972027972,0.7274104769774948,1.0,2/12,2.66%,LRP1;CYP19A1
prerank,response to amino acid starvation (GO:1990928),0.4613350224767539,1.2696977528789082,0.1285097192224622,0.7273879076355276,1.0,31/72,25.63%,NPRL3;ATP6V1C2;SEC13;MAP3K5;GCN1;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;DAP;IMPACT;CASTOR2;MAPK8;ATP6V0D1;SESN2;ATP6V1B2;ATP6V1E1;FLCN;ATF2;KPTN;ATP6V1C1;RHEB;EIF2AK4;EIF2S1;EIF2AK3;RPTOR;NPRL2;ATP6V0E1;ATP6V0B;LAMTOR2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5695716749484059,1.269349131829853,0.20717131474103587,0.7277427482131785,1.0,4/17,5.88%,ADAM9;TGFB2;CD3E;FOXC2
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5634786356373177,1.2690741001324164,0.18985695708712613,0.7278061257292225,1.0,5/18,10.58%,PRKDC;TBX21;IKZF3;CRTAM;ABL1
prerank,microglial cell activation (GO:0001774),-0.41728593175068635,-1.2690715401872428,0.17142857142857143,0.5657114996156842,1.0,10/21,25.05%,APP;CX3CR1;CX3CL1;C1QA;SNCA;TYROBP;ITGAM;AGER;TREM2;GRN
prerank,cellular response to estrogen stimulus (GO:0071391),0.5725123782723788,1.268799275854503,0.21166892808683854,0.7278856712739415,1.0,5/14,12.62%,BCAS3;RARA;SRA1;SFR1;SERPINB9
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5928263306648947,1.2686233616625922,0.21853388658367912,0.7274898426200171,1.0,4/13,11.04%,BLOC1S2;RHOT2;RHOT1;VDAC2
prerank,regulation of histone modification (GO:0031056),0.5894517769941755,1.2685420487640284,0.19027777777777777,0.7267112002027118,1.0,9/13,31.48%,SETD5;NNMT;FLCN;AKAP8;MTHFR;PARG;IGF2;CDK9;UBE2N
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.365077698834244,-1.268347711697418,0.12578616352201258,0.5647157939345614,1.0,11/39,8.55%,ROBO1;TSPAN5;MAML2;ROBO2;NOS3;MAML3;NOTCH1;JAG2;NOTCH4;RBPJ;EPN2
prerank,positive regulation of cell adhesion (GO:0045785),0.46791732144065984,1.2674333052213873,0.12260127931769722,0.73002075076767,1.0,19/74,17.75%,ZFHX3;VEGFA;ADAM9;P4HB;VIT;TGFB2;PRKCA;AGR2;FOXC2;TFE3;ITGAV;ATM;SMAD7;ARL2;NDNF;STX4;ERBB2;FLCN;CITED2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.6156391119596586,1.2673789008759175,0.20714285714285716,0.7291224082430011,1.0,2/11,2.25%,GSN;PRR7
prerank,regulation of trophoblast cell migration (GO:1901163),0.5859658899042224,1.266961974987237,0.19066666666666668,0.7296614039568626,1.0,7/14,25.37%,VEGFA;ACVR1B;AGO2;CALR;SMURF2;C1QBP;ARHGDIB
prerank,protein mannosylation (GO:0035268),-0.41360861998732895,-1.266867040500649,0.14720812182741116,0.5656759334311802,1.0,3/22,2.16%,TMTC2;TMTC4;CRPPA
prerank,purine-containing compound biosynthetic process (GO:0072522),0.5334202116305389,1.2668439818851152,0.1806615776081425,0.7290580674207426,1.0,7/25,18.44%,PRPS2;ADA;AMPD3;DGUOK;MTHFD1;SHMT2;SHMT1
prerank,DNA modification (GO:0006304),0.5424840702492953,1.2664597872636583,0.17866004962779156,0.7294498730920563,1.0,7/22,16.21%,PARP3;MPG;OGG1;TDG;SMUG1;EXOSC4;PARP1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4928882897016775,1.266044621470658,0.17767106842737096,0.7299698366728279,1.0,9/36,13.19%,EGFR;CYGB;NPR3;DNM2;DDAH1;TERT;NOSIP;PIK3CB;S100A1
prerank,regulation of astrocyte differentiation (GO:0048710),0.5997725297251423,1.2660083954241688,0.19549929676511954,0.7290062861572532,1.0,6/12,15.25%,ID2;HES5;NOG;SERPINE2;CLCF1;IL6
prerank,cellular response to mechanical stimulus (GO:0071260),0.47712969626482155,1.265826320250872,0.17257142857142857,0.7286873060307674,1.0,8/46,13.71%,PIEZO2;CRADD;SLC9A1;SOX9;MAPK8;LTBR;TNFRSF10B;CASP1
prerank,regulation of protein kinase B signaling (GO:0051896),0.4315262782657765,1.2650419431994944,0.05555555555555555,0.730645690961958,1.0,17/193,4.54%,THBS1;MYOC;ESR1;EGFR;IRS1;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;NTRK3;NTRK1;FGF17;GAB2;PKHD1;PHLPP2;XDH
prerank,gas transport (GO:0015669),0.6300706545119779,1.2649171483137822,0.18584070796460178,0.7300549842658532,1.0,1/10,1.37%,CYGB
prerank,aminoglycan catabolic process (GO:0006026),0.5157398841735282,1.2646861053926284,0.18034825870646767,0.7298263101939569,1.0,3/28,3.14%,GPC6;GPC3;SDC1
prerank,protein glycosylation (GO:0006486),0.4373732668521233,1.264468637244783,0.10309278350515463,0.7296303495966698,1.0,23/125,11.18%,PLOD2;ST3GAL4;ST8SIA2;GALNT10;PGM3;GFPT1;PLOD1;PLOD3;B3GNT7;POGLUT1;B4GALT1;GFPT2;PMM2;ST3GAL2;B4GALT5;OGT;MGAT4B;FUT8;DOLPP1;GALNT18;NPC1;FUT4;TMEM165
prerank,endocrine system development (GO:0035270),0.5405374935141629,1.26314859601924,0.1905972045743329,0.7336165253080437,1.0,3/21,3.09%,SIX1;GLI2;DKK3
prerank,lysosome organization (GO:0007040),0.4993291548589975,1.263070367213869,0.14387633769322236,0.7328433901910899,1.0,15/36,22.32%,ARSB;GAA;LAMTOR1;MBTPS1;NAGPA;TMEM106B;TMEM165;ABCA1;HPS4;ACP3;CLN3;SNAPIN;MYO7A;LRRK2;ZKSCAN3
prerank,positive regulation of biosynthetic process (GO:0009891),-0.34853209431124205,-1.26295778276833,0.0859375,0.5726651418099393,1.0,12/40,15.81%,SORBS1;WNT4;APOE;PPARA;SLC5A3;ZBTB20;VIM;MTPN;SUCO;ADGRB1;GRIN1;CREBL2
prerank,cellular defense response (GO:0006968),0.4852582628802644,1.262418216634011,0.16627358490566038,0.7343972130953522,1.0,4/40,4.23%,LSP1;LBP;SPN;TCIRG1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5202164536813088,1.2621339429952172,0.18089171974522292,0.7345259182673681,1.0,8/25,15.81%,VCP;CLPP;UGGT2;UGGT1;LONP1;NGLY1;STUB1;HDAC6
prerank,protein maturation (GO:0051604),0.451234797557218,1.2620721386844536,0.11962224554039874,0.7337042191495902,1.0,26/95,18.37%,ADAMTS3;PCSK5;F3;ECE1;CPZ;NAA60;ADAM10;NAA40;MMP14;TASP1;LMF1;DDI2;OGT;BACE1;NAA16;SDE2;HSPD1;MMP16;GCSH;CPXM2;MMS19;PSEN2;STUB1;LIPT1;PCSK7;CLN3
prerank,protein deubiquitination (GO:0016579),0.42498081541707855,1.2618435466442628,0.04522613065326633,0.733537552503361,1.0,113/242,30.64%,ESR1;IL33;PSMD7;USP24;VCP;USP2;PSMA8;SMAD4;OTUB1;USP50;TRRAP;MDM4;MBD6;FOXK1;ENY2;OGT;RHOA;INO80E;RHOT1;PSMA4;USP40;UCHL3;INO80B;WDR48;USP48;USP45;SMAD7;PSMD12;OTUB2;KAT2A;USP34;TRAF3;TGFBR1;USP11;PSMA6;STAM2;USP7;USP33;USP36;PSMD1;USP13;PSMC5;USP19;USP35;PSMD11;PSMC4;PSMD14;UBC;RPS27A;OTUD5;OTULIN;CDC25A;POLB;SHMT2;YOD1;SENP8;CDC20;USP32;USP10;HCFC1;USP46;ACTR8;USP1;UCHL5;ZRANB1;NFKBIA;TAF9B;OTUD6B;PSMA3;UCHL1;BRCC3;USP5;SMURF2;PSMB1;PSMD4;USP47;DESI2;BIRC3;PSMA5;CYLD;KAT2B;PSMA7;USP4;USP49;ASXL2;USP14;TP53;SNX3;CCP110;SUDS3;PSMC1;RIPK1;YY1;ATXN7;TAF10;MYSM1;USP21;USP16;PSMA1;USP22;USP37;USP30;TADA3;NLRP3;FOXO4;ADRM1;PRKN;OTUD3;PSMD2;USP26;SPATA2;KEAP1;COPS5
prerank,regulation of bone mineralization (GO:0030500),-0.33487100352172516,-1.2617965245790823,0.13541666666666666,0.5728588278234409,1.0,16/55,6.42%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;OSR1;BMP7;ENPP1;KL;ANKH;SRGN;BCOR;ATP2B1;NOTUM;FBN2;S1PR1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5189637126596147,1.261347902136439,0.18772563176895307,0.7344138098572515,1.0,6/30,4.29%,DSE;BGN;CHST11;ARSB;CHPF2;CSPG4
prerank,cardiac conduction system development (GO:0003161),0.531175505514633,1.261312717555676,0.19053549190535493,0.7334892939409072,1.0,6/24,12.12%,CACNA1G;HCN4;SMAD4;BMP4;BMPR1A;HEY1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3871540731732801,-1.2610713976560841,0.125,0.5719266373783293,1.0,8/27,11.93%,PPARA;PRKCH;ABCG1;NR1H3;AGTR1;CSF1;ABCA5;LPL
prerank,activation of protein kinase B activity (GO:0032148),-0.3774419395001879,-1.2609420503784003,0.11731843575418995,0.5694580662575685,1.0,8/29,6.60%,INSR;OSBPL8;WNT5A;FGF1;CCDC88A;RICTOR;PPIA;ADRA2A
prerank,cortical cytoskeleton organization (GO:0030865),0.4955201221700507,1.2604094991081753,0.14467592592592593,0.7359948439026666,1.0,10/41,14.75%,RHOBTB1;FMNL2;RHOQ;RND3;LLGL1;DLG1;RHOA;EZR;NLGN1;RHOB
prerank,presynaptic endocytosis (GO:0140238),0.5356129325114264,1.2603415644812759,0.19143576826196473,0.7351927397477099,1.0,10/24,20.58%,STON2;SYT8;CEL;FCHO2;STON1;SYNJ1;NLGN1;STX1A;CDK5;SYNJ2
prerank,regulation of filopodium assembly (GO:0051489),0.4859631375325238,1.2601411613861593,0.16863207547169812,0.7349018468351558,1.0,12/38,13.07%,PRKCD;ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;GAP43;TENM1;NRP1;MIEN1;NLGN1;ARHGAP44
prerank,protein localization to organelle (GO:0033365),0.4360220791307874,1.2601056609530645,0.08375893769152196,0.7339747856761705,1.0,24/133,13.55%,SIX1;ZNF423;COL1A1;CNTLN;TSPAN10;EHD1;STX5;CSNK1D;TOPORS;LMNA;SIX4;DVL1;BBS9;SSB;IFT20;ANK2;GBF1;TRAM2;BMP4;PAQR3;CSRP3;CNEP1R1;ALDH3A2;YWHAE
prerank,endocardial cushion morphogenesis (GO:0003203),0.5469360987650072,1.2596142387492077,0.2078272604588394,0.7348057077958611,1.0,10/18,12.12%,TGFB2;ACVR1;TGFBR2;HEYL;MDM4;SOX9;NOG;BMP4;BMPR1A;HEY1
prerank,epithelial to mesenchymal transition (GO:0001837),-0.34357397914398463,-1.259559372939998,0.109375,0.5700159105209204,1.0,12/47,7.46%,TGFBR3;LEF1;ENG;ROCK2;WNT4;WNT5A;BMP7;TBX3;NOTCH1;NOTCH4;RBPJ;AKNA
prerank,neurogenesis (GO:0022008),0.48147946991588386,1.259348421502645,0.15704387990762125,0.7347749732990166,1.0,10/43,15.83%,SIX1;CIT;SIX4;TGFB2;WDR62;DAGLA;ANXA1;DCHS1;THOC2;CXCR4
prerank,regulation of multicellular organismal development (GO:2000026),-0.3914317413625652,-1.2591217373111425,0.13089005235602094,0.5684693094289186,1.0,7/25,13.72%,INSR;PTN;SOX17;SPAAR;DUSP6;OAS2;RACGAP1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.49578783038695273,1.2589855018351797,0.1697459584295612,0.7351263142003289,1.0,9/39,6.90%,FGF13;FXYD5;NEDD4;PRKCE;PTPN3;CAMK2D;DMD;STK39;SLMAP
prerank,hepaticobiliary system development (GO:0061008),-0.4261746864206798,-1.258674297636634,0.18326693227091634,0.566864899281387,1.0,5/20,5.88%,TGFBR3;WNT4;ARID5B;LSR;PROX1
prerank,regulation of epithelial cell migration (GO:0010632),0.4699267996887052,1.2586193764726403,0.1613995485327314,0.7355065403638883,1.0,8/51,7.68%,BMPER;RHOJ;PRKCE;ARSB;TGFB2;PFN2;DOCK5;SOX9
prerank,protein sumoylation (GO:0016925),0.47809587307686413,1.258332714814848,0.14543404735062007,0.7355559494453188,1.0,22/49,26.41%,NUP93;TOPORS;TRIM28;RAE1;SEH1L;TRPM4;NUP37;RANBP2;PIAS4;NUP88;STX1A;SUMO1;POM121;NUP210;SAE1;NUP62;SUMO2;NDC1;NUP35;NUP85;NUP160;TPR
prerank,negative regulation of cell projection organization (GO:0031345),-0.340162064104647,-1.2576361069222857,0.09090909090909091,0.5667677227820208,1.0,10/48,7.85%,EFNB2;LPAR1;APOE;EPHA4;RAPGEF2;PTPRO;PTPN9;GRIN2B;DCC;PRAG1
prerank,regulation of receptor recycling (GO:0001919),0.5677324682136875,1.2570945609291353,0.19645293315143247,0.7393605141096117,1.0,6/16,20.94%,ECE1;ANXA2;LAMTOR1;NSF;TRAT1;OPTN
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5544492039031645,1.2565598463693881,0.20887728459530025,0.7403580870647624,1.0,5/19,11.94%,GAS6;ZMIZ1;PRKDC;MMP14;CD27
prerank,regulation of cellular response to stress (GO:0080135),0.4393945801151514,1.2563753510761835,0.08178053830227744,0.7399546051595736,1.0,54/115,31.19%,SLC38A2;NUP93;SEC13;CAMK2D;ATF4;RAE1;BAG3;ADCY8;CCAR2;SEH1L;HIKESHI;AKT1S1;SMG1;ABL1;ATM;NUP37;DNAJC7;CHORDC1;EIF4G1;YWHAE;MANF;RANBP2;NUP88;USP19;CREBBP;POM121;NUP210;CLN3;ARMT1;NUP62;NEK4;ABCD1;DNAJC2;NDC1;RPTOR;NUP35;FKBP4;AMFR;PINK1;VASH1;NUP85;NUP160;TPR;HSPB8;NEK6;HSF1;BAG1;ATR;DNAJB1;NUP50;PRKN;HSP90AA1;NUP188;HSPH1
prerank,BMP signaling pathway (GO:0030509),0.4658730193986496,1.256164352426353,0.1456736035049288,0.7397303305679512,1.0,15/62,12.48%,TMEM100;PDCD4;DDX5;SMAD9;SMAD6;TGFB3;TGFB2;ACVR1;SMAD4;NOG;BMP4;RUNX2;BMPR1A;SMAD7;RGMA
prerank,regulation of axonogenesis (GO:0050770),0.4716388698579534,1.255985468270985,0.16609783845278725,0.7393641606997814,1.0,9/51,9.52%,SLIT2;PLXNA4;TIAM1;TIAM2;GDI1;SIPA1L1;EPHB3;RHOA;PAK2
prerank,actin filament polymerization (GO:0030041),0.506505390188028,1.2553506092128914,0.18357487922705315,0.7407717979830248,1.0,7/29,15.63%,PSTPIP1;GSN;COBL;TTC17;SPIRE2;MICALL2;WASHC3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.472590809761119,-1.2552968024930455,0.17582417582417584,0.5700342425701779,1.0,6/14,14.06%,WNT5A;KIT;SEMA7A;GPRC5B;CD74;SIRT1
prerank,zinc ion transport (GO:0006829),0.5415178393407637,1.2552025236227584,0.1922110552763819,0.7403193518188388,1.0,8/21,17.31%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;SLC39A3;SLC30A6;SLC30A9
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5984847410732554,1.2550854982744581,0.2180349932705249,0.7397178230865622,1.0,6/13,20.78%,UPP2;DCTPP1;OGG1;TDG;SMUG1;NT5C
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.4204377146169095,-1.2550128770045794,0.1625615763546798,0.5680302845118438,1.0,7/23,9.59%,UACA;BMP7;DDX3X;C1QTNF3;TMSB4X;ADIPOR1;ZC3H12A
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4791311525263632,1.2546429545079352,0.16704805491990846,0.7404159893361258,1.0,10/44,15.30%,GSN;CTTN;PRKCE;CDC42EP2;PFN2;SNX9;TENM1;CDC42EP5;SCIN;SPIRE2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5974622571201238,1.2542722810622347,0.218705035971223,0.7407660779465313,1.0,7/11,24.63%,MUC1;FOXM1;ING4;HIPK2;MAD2L2;TP53;RPS27L
prerank,response to molecule of bacterial origin (GO:0002237),0.45852887083802324,1.254103669989744,0.14537444933920704,0.740328775367614,1.0,18/69,18.91%,FOXP1;LBP;SMAD6;IRAK3;LIAS;FZD5;IRAK1;TAB2;F2R;SRR;PRDX3;CYP27B1;IL6;SIRT2;OTUD5;TRIM6;ACOD1;ERBIN
prerank,cellular response to heat (GO:0034605),0.5025316217379429,1.2536290242437325,0.19030732860520094,0.7411223582651469,1.0,9/35,17.53%,THBS1;BAG3;VCP;HIKESHI;RBBP7;YWHAE;STUB1;SUMO1;HMOX1
prerank,positive regulation of vasculature development (GO:1904018),0.44562283763219634,1.2534677044236304,0.11758584807492195,0.7406146171233022,1.0,17/94,10.01%,THBS1;SMOC2;PGF;VEGFA;F3;FGF2;PTGIS;TWIST1;CYP1B1;RAMP2;PRKCA;ANGPTL4;JUP;PAK4;STIM1;ANGPT4;AGGF1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.4663706615405069,1.2533315630155994,0.155902004454343,0.7401055093745448,1.0,32/62,29.93%,NUP93;SEC13;STAT3;RAE1;SEH1L;PUM1;AGO1;NUP37;AGO2;EIF4G1;LIMD1;RANBP2;NUP88;POLR2F;POM121;NUP210;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;NUP160;TPR;TNRC6A;FXR1;POLR2I;PUM2;NUP50;POLR2L
prerank,cellular iron ion homeostasis (GO:0006879),0.4600341284175614,1.25320659872005,0.1597300337457818,0.739512943141984,1.0,14/55,15.46%,SCARA5;SLC39A14;FLVCR1;HMOX2;FXN;SMAD4;ACO1;ATP6V0D1;SOD1;CUL1;CYBRD1;ABCB6;FRRS1;IREB2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.44002782242351246,1.2531224133045324,0.09513960703205791,0.7388136453747528,1.0,20/118,9.70%,BMPER;PID1;EFNA5;FGF2;NEDD4;FMNL2;SRCIN1;PROK2;PHLDB1;ARC;SPARC;SIPA1L1;LZTS1;EPHB3;BCL9L;POGLUT1;CHRNB2;TANC2;PAK2;FGFR2
prerank,regulation of angiogenesis (GO:0045765),0.430958574030579,1.25306062832208,0.07272727272727272,0.7380136124615092,1.0,29/192,10.01%,BMPER;THBS1;SMOC2;PGF;RHOJ;HOXA5;VEGFA;F3;FGF2;PTGIS;EMILIN1;PROK2;ISM1;TWIST1;SPARC;CYP1B1;TGFB2;SERPINF1;SEMA3E;RAMP2;PRKCA;THBS2;SULF1;ANGPTL4;JUP;PAK4;STIM1;ANGPT4;AGGF1
prerank,negative regulation of telomere maintenance (GO:0032205),0.5719361775597863,1.2525535224923612,0.21428571428571427,0.7389077188625266,1.0,8/15,27.04%,SMG6;ERCC4;ATM;RAD50;TNKS2;PARP1;SLX4;RTEL1
prerank,cellular protein localization (GO:0034613),0.42245926238195347,1.2525394284329947,0.033066132264529056,0.7379146682456551,1.0,102/285,25.73%,EGFR;SGSM2;CNTLN;ARFGAP3;CTTN;SEC31A;KIF13A;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;RAB43;PTPRU;TM9SF4;COPA;RAB24;STX11;AP2A1;RIC3;PACS2;DMD;RAB21;LAMTOR1;RIC1;TLK1;GGA2;ANK2;WIPI2;ARF4;COPZ2;SNX1;SH3PXD2B;NSF;SCFD1;STX2;VPS26A;ARFIP2;RAB38;CSRP3;ARF1;SNX9;AP3D1;TMED9;WDR11;USO1;EVI5L;TBC1D9B;TBC1D25;ERP29;PICK1;VIPAS39;CLTC;RAB23;TBCK;TBC1D10A;SIL1;STX4;ID1;COPB2;STX1A;SCFD2;TBC1D17;HDAC6;STX16;GGA1;NIPBL;SNX13;NAPA;TMED2;RAB5B;VPS45;SNX15;SEC23IP;RAB3GAP2;MYO7A;COX18;EVI5;TBC1D22B;TM9SF1;VPS26C;IFT27;FBLN5;LRRK2;RAB1A;RAB18;UNC50;RAB1B;COPZ1;RABGAP1;ARF5;USP4;TMED7;ATG9A;AP3B1;STX1B;PRRT1;LAMTOR2;FAM91A1;STX19;ATG13
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5193337623035246,-1.2524570947277758,0.18484848484848485,0.5718440746281533,1.0,2/10,4.88%,LYN;FAS
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6211621017358878,1.2523024410472812,0.21220930232558138,0.7378267106025773,1.0,8/10,33.82%,DGKQ;OGT;USP7;GNMT;SELENOS;ZNF692;SIRT7;SDHAF3
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5361597823333665,1.252275945480994,0.17777777777777778,0.7369027643566347,1.0,7/22,16.85%,ATP1B1;CALM2;SLC9A1;ANK2;P2RY6;STAC3;CALM3
prerank,potassium ion transmembrane transport (GO:0071805),0.43464263149424354,1.2522328381058112,0.0893042575285566,0.7360378724953809,1.0,17/135,7.64%,KCNJ2;KCNJ15;KCNK5;SLC12A7;KCNB1;ATP1B1;SLC12A2;SLC24A3;HCN4;KCNN1;SLC9A8;SLC9A4;KCNE5;SLC9A1;KCNIP2;KCND1;SLC12A4
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6180304347181328,1.2519916369434696,0.21306818181818182,0.7349405125903078,1.0,1/10,0.75%,PRKCD
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6180304347181328,1.2519916369434696,0.21306818181818182,0.7349405125903078,1.0,1/10,0.75%,PRKCD
prerank,myelination (GO:0042552),0.4674152011322422,1.2508846122258077,0.18058690744920994,0.7380698545776698,1.0,18/46,22.78%,MYOC;LGI4;ACER3;MARVELD1;PMP22;HES5;SKI;B4GALT5;PLP1;SIRT2;CXCR4;NF1;SCN8A;ACSBG1;BCAS1;ARHGEF10;ABCD1;GPC1
prerank,protein stabilization (GO:0050821),0.4271044226390792,1.2505756651079227,0.07314629258517034,0.7382866450097509,1.0,51/168,21.47%,RASSF2;PRKCD;ATP1B1;PLPP3;UBE2B;MORC3;P3H1;BAG3;HYPK;USP2;DVL1;RAB21;PER3;PFN2;PRKRA;ANK2;COA8;MDM4;SYVN1;TELO2;CHEK2;NAA16;SMAD7;NCLN;CHP1;PARVA;HSPD1;USP7;IFT46;USP33;SEC16A;USP36;HPS4;USP13;USP19;CREB1;HIP1;SUMO1;EFNA1;PEX6;HCFC1;CCT4;CCT6A;TAF9B;CALR;CLU;LAMP1;CCT8;TBRG1;MUL1;LAMP2
prerank,negative regulation of cyclase activity (GO:0031280),-0.46216856510043347,-1.2500758859542465,0.21978021978021978,0.5751075323343487,1.0,3/14,10.00%,GRM3;ADGRV1;EDNRB
prerank,non-motile cilium assembly (GO:1905515),0.5045675798760408,1.249902806584998,0.18304668304668303,0.7398056977808869,1.0,9/30,16.01%,GORAB;CSNK1D;TMEM107;TMEM216;RPGRIP1L;TMEM80;FUZ;PCM1;IFT88
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5033325385202942,1.2493151075508473,0.19577960140679954,0.7410267488032378,1.0,8/32,11.12%,PEMT;CSNK2A2;CSNK2A1;LPCAT1;STARD7;GPAT4;LPCAT3;PCTP
prerank,protein processing (GO:0016485),0.4415111514737824,1.2490489481388556,0.1311647429171039,0.7410243243664385,1.0,20/102,15.14%,ADAMTS3;PCSK5;F3;ECE1;PRSS12;CPZ;HM13;FXN;ADAM10;SPG7;MMP14;DDI2;OGT;BACE1;SDE2;MMP16;SPCS2;CASP1;CPXM2;PSEN2
prerank,regulation of cell growth (GO:0001558),0.4259225187426341,1.2486533938907445,0.04833836858006042,0.7415711680602322,1.0,48/204,17.71%,SLIT3;SLIT2;EGFR;FHL1;PLCE1;OSGIN2;CCN3;ACVR1B;PPP1R9B;PRDM11;CAMK2D;CSNK2A1;TGFB2;EIF4G2;FXN;DCUN1D5;LAMTOR1;CCAR2;SMAD4;ADAM10;MMP14;CXCL16;TMC8;PAK4;DACT3;SOCS2;NDRG3;SERTAD2;DCBLD2;ITCH;URI1;SESN2;TGFBR1;EIF4G1;INHBA;CGRRF1;RBBP7;SUPV3L1;SERTAD3;CYP27B1;EXOSC4;KLHL22;ERBB2;MINAR1;APBB1;NCBP1;FLCN;HDGFL2
prerank,canonical Wnt signaling pathway (GO:0060070),0.4585701360129575,1.248653000412618,0.15086206896551724,0.7405594537638565,1.0,11/68,8.13%,LRP6;WNT9A;TCF7L2;SFRP4;PLPP3;LRP5;TCF7L1;DVL1;BCL9L;FZD7;FZD5
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.4755049678552099,1.2483255848540478,0.1790193842645382,0.7407561218548417,1.0,12/48,15.18%,SLC26A2;AK5;PAPSS2;ADCY2;ADCY8;ADCY9;PANK4;DCAKD;ACAT1;AMPD3;GUCY2D;SLC35B3
prerank,cellular response to hypoxia (GO:0071456),0.43081355472195604,1.24810455512635,0.10699588477366255,0.7405939107114303,1.0,45/126,24.51%,VEGFA;P4HB;PTGIS;TWIST1;PSMD7;LMNA;CARD16;PSMA8;MDM4;NDRG1;ANGPT4;RORA;PSMA4;HYOU1;TERT;PSMD12;PSMA6;LIMD1;UBQLN1;NDNF;PSMD1;STUB1;SIRT2;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;UBC;RPS27A;HIGD1A;PGK1;HMOX1;SUV39H2;NPEPPS;HIPK2;PSMA3;SUV39H1;PSMB1;PSMD4;PSMA5;PSMA7;TP53;BAD;PINK1
prerank,regulation of protein phosphorylation (GO:0001932),0.42244117348536314,1.2473607527500203,0.04312938816449348,0.7423949258674661,1.0,45/256,12.59%,BMPER;SLIT2;PGF;EGFR;LRP6;PID1;SLCO3A1;VEGFA;EFNA5;PLCE1;GAS6;FGF2;CARD14;NTRK3;NTRK1;FGF17;PLPP3;EPHB2;CSNK1D;WWTR1;LIMK2;ATF4;XDH;MAVS;BRD4;ILK;PRKDC;RSPO1;SOX9;NSD1;AKT2;IMPACT;CDK5RAP3;BMP4;TMEM119;PAQR3;MUSK;ABL1;NIBAN1;AXIN1;ROPN1L;SOD1;PHIP;CHP1;SESN2
prerank,ear morphogenesis (GO:0042471),0.5416562150269005,1.2471490012481297,0.1961783439490446,0.7422160384795299,1.0,6/20,9.70%,SIX1;EPHB2;TWIST1;NOG;ZIC1;FGFR2
prerank,arachidonic acid metabolic process (GO:0019369),0.4902326956776287,1.2468806277091986,0.2060535506402794,0.7422336527553376,1.0,6/35,7.99%,MGLL;PTGIS;PLA2G4A;CYP1B1;PTGES2;DAGLA
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.41590413242735613,1.2467800572061085,0.025025025025025027,0.7415964672500911,1.0,86/327,19.78%,BNC2;ESR1;SIX1;ZFHX3;ZNF423;VSX1;NFIA;LDB1;ZMIZ1;PRRX2;DMTF1;ACVR1B;JMJD1C;APBB3;WWTR1;SBNO1;BAZ2A;STAT3;TCF7L1;MLF2;ATF4;ERC1;CHD3;TCFL5;DNM2;PHF1;DVL1;CCAR2;NFX1;NFXL1;BHLHE40;FZD7;TRRAP;FUS;TBX21;RPS6KA4;NSD1;ESRRB;CARM1;SBNO2;RORA;OGG1;CRABP2;FADS1;ABL1;SPTY2D1;CHEK2;KAT6B;RNF14;SFPQ;NR1D2;TGFBR1;KMT2D;RALY;LIMD1;SERTAD3;USP13;FOXN3;NKX6-2;ZFPL1;CREBBP;APBB1;HMG20A;PRDM2;NFYA;NFKB2;MAGED1;NR3C1;THAP7;SRSF10;HMGA1;DAPK3;E2F1;RYBP;HCFC1;SUFU;BRDT;ATF2;GON4L;ACTR8;GPBP1L1;MLXIPL;TEAD2;ZNF431;WWC2;TCF3
prerank,peroxisome organization (GO:0007031),0.5177608432821539,1.2466128258296933,0.2002503128911139,0.7412751315369542,1.0,14/25,25.84%,ABCD3;PEX7;PEX11A;PEX16;PEX1;PEX10;TMEM135;SEC16B;PEX6;PEX2;ABCD1;PEX14;ACOT8;LONP2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.37799780749075984,-1.2460622539266655,0.13186813186813187,0.5825815937248651,1.0,6/30,7.85%,ROBO1;LPAR1;ARHGEF3;NET1;F11R;PRAG1
prerank,acylglycerol catabolic process (GO:0046464),0.5052394374358297,1.2459782006141407,0.2012121212121212,0.7426201061243085,1.0,4/30,14.81%,MGLL;DAGLA;ABHD6;PNPLA3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.525311142517569,1.2459170854951824,0.2077764277035237,0.7418733820829722,1.0,9/26,13.55%,FHL1;ATP1B1;NEDD4;STK39;ANK2;DLG1;WWP2;AKAP9;YWHAE
prerank,iron ion transport (GO:0006826),0.46982922891919604,1.2442695842442715,0.16308040770101925,0.7471937666805498,1.0,12/47,15.46%,SCARA5;SLC39A14;ATP6V1C2;TCIRG1;DNM2;ATP6V0A1;ATP6V0D1;ATP6V1B2;RAB11B;CLTC;ATP6V1E1;IREB2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.6039317499452677,1.2440189638640755,0.23242467718794835,0.7471441978420282,1.0,7/11,15.99%,RSPO3;PLEKHA4;CSNK1D;LBX2;CSNK1E;DAB2;MLLT3
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.44025765244120474,-1.2438390244333923,0.18,0.585470657557056,1.0,4/15,11.93%,OSBPL8;PPARA;ABHD5;LPL
prerank,positive regulation of heart rate (GO:0010460),-0.43328148740262273,-1.2436374298003423,0.17716535433070865,0.5832555149347352,1.0,7/17,18.42%,PDE4D;TPM1;RYR2;EDN1;ADRA1A;SCN3B;KCNQ1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4420069503551488,1.2436347653622986,0.15434083601286175,0.7466362395749374,1.0,27/78,20.52%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;SEC24C;AP2A2;SEC24B;LAG3;CLTC;KLC1;DCTN5;SEC24A;ACTR1B;ACTR10;DYNC1I2;DCTN1;CLTA;CAPZA1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4420069503551488,1.2436347653622986,0.15434083601286175,0.7466362395749374,1.0,27/78,20.52%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;SEC24C;AP2A2;SEC24B;LAG3;CLTC;KLC1;DCTN5;SEC24A;ACTR1B;ACTR10;DYNC1I2;DCTN1;CLTA;CAPZA1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.455122348649841,1.2432682978625624,0.1646803900325027,0.7470510452858476,1.0,20/63,15.96%,TIMP2;PTPN3;TIMP3;STAT3;EIF4G2;RIC1;EIF4G3;DAP;FOXK1;CST3;CDK5RAP3;RGP1;TAB2;KDM4A;NELL1;EIF4G1;HGF;SIRT2;TLK2;KLHL22
prerank,gliogenesis (GO:0042063),0.5713373056655494,1.2431696551041727,0.20927152317880796,0.7464497649452037,1.0,4/15,9.69%,NFIB;TGFB2;CD9;ANXA1
prerank,positive regulation of axon extension (GO:0045773),0.5278419069368635,1.2427898020032566,0.20277078085642317,0.7468250841225941,1.0,4/22,12.40%,NTN1;VEGFA;GOLGA4;NRP1
prerank,icosanoid metabolic process (GO:0006690),0.48016962778518685,1.2427721595927623,0.18192352259559674,0.7459077985453777,1.0,7/40,10.32%,MGLL;PTGIS;PLA2G4A;CYP1B1;ABCC1;DAGLA;FADS1
prerank,nitrogen compound transport (GO:0071705),0.43202159039157484,1.2426504045292075,0.10051282051282051,0.7454260188162062,1.0,27/141,14.88%,SLC38A2;SLC38A1;SLC23A1;TMEM30B;SLC12A2;LMAN2L;SLC1A5;FLVCR1;ABCC1;RAMP2;RILP;LRRC8D;SLC7A10;HIKESHI;SLC6A2;SLC38A3;SLC43A1;RAMP1;RAB38;SLC25A47;LRP2;SLC1A4;PICK1;TOM1;CHMP3;ABCB6;MIA3
prerank,phosphatidylcholine metabolic process (GO:0046470),0.45530568962550044,1.2425316612637942,0.16080937167199147,0.7448513310156983,1.0,16/70,16.48%,PLA2G4F;PLA2G4A;PEMT;CSNK2A2;CSNK2A1;LPCAT1;MBOAT2;LPCAT4;STARD7;GPAT4;PLA2G5;LPCAT3;PCTP;PLA2G12A;CHKB;PLA2G15
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.4900765003502674,1.241817130500987,0.18544600938967137,0.7464363867615785,1.0,14/36,20.20%,EHMT1;RBBP8;PHC3;RNF2;RBBP7;RING1;L3MBTL2;TFDP1;CBX5;PCGF2;E2F1;RYBP;RAD51;MAX
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5079126056645077,-1.2417952410074389,0.21766561514195584,0.585275789564765,1.0,5/11,14.06%,LYN;RAPGEF2;PIK3CD;LGALS9;SIRT1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.4223471313473441,-1.2415721113840883,0.1950207468879668,0.583178608299809,1.0,4/19,4.57%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,regulation of ATP metabolic process (GO:1903578),0.4647476533611754,1.2414271952765525,0.18140589569160998,0.7468568635676133,1.0,28/54,31.55%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;SHMT2;PRKAG1;POM121;NUP210;NUP62;ABCD1;NDC1;COX7A2L;NUP35;PINK1;NUP85;NUP160;TPR;SPHK2;FIS1;NUP50;ZBTB7A;NUP188;ATP7A
prerank,regulation of monooxygenase activity (GO:0032768),0.5147115016750548,1.241247537791716,0.19350649350649352,0.7465560855324467,1.0,8/23,18.73%,EGFR;CYGB;DNM2;DDAH1;NOSIP;VDR;AKT1;GDNF
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.45329569262171293,1.2411636413860645,0.12633832976445397,0.7458813359369388,1.0,22/78,19.97%,EGFR;PID1;LRP1;RHOQ;PRKCE;EPHB2;PLS1;PPFIA1;AGR2;MMP14;DLG1;PDPK1;CLTC;SQSTM1;DAB2;STAC3;STX4;SPTBN1;CLN3;AKT1;CDK5;APPL1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5178423193299668,1.2409857959552042,0.19975186104218362,0.7455747368237593,1.0,12/26,22.60%,KMT5C;OGT;SETD5;KMT2D;SETD4;WDR82;SUV39H2;SETD1A;TET2;SUV39H1;SETD2;KMT2A
prerank,regulation of integrin activation (GO:0033623),-0.439963754891036,-1.2408235705487436,0.16216216216216217,0.5824789674847817,1.0,7/15,27.06%,RASIP1;PIEZO1;PLEK;FBLIM1;KIF14;SELP;SRC
prerank,myofibril assembly (GO:0030239),-0.3421887995488263,-1.2407747937730997,0.12030075187969924,0.5799741254991072,1.0,8/42,8.20%,ACTN2;TPM1;PGM5;PDGFRB;TMOD3;TMOD1;PDGFRA;LMOD1
prerank,negative regulation of blood coagulation (GO:0030195),-0.3438046842029028,-1.2407113706815984,0.13793103448275862,0.5776101522606811,1.0,10/38,10.56%,VTN;APOE;NOS3;TFPI;PLAT;F8;PDGFRA;A2M;EDN1;SERPINE1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.49046008618002324,-1.2403222207927809,0.2262295081967213,0.5761604173123326,1.0,3/10,8.40%,ACSL1;SLC2A1;SLC27A4
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.595548351242809,1.2400301257090545,0.2191780821917808,0.748230218559669,1.0,4/12,6.89%,IGFBP5;DOCK4;DOCK7;DOCK5
prerank,epithelial cell differentiation (GO:0030855),0.43873925815819836,1.2397887484237844,0.14330874604847207,0.7481552899870436,1.0,22/88,18.87%,SIX1;VEGFA;FSTL1;ANXA7;ANXA4;JAG1;FZD7;AKT2;AKR1C1;ANXA1;BMP4;FGFR2;EHF;HDAC1;DHRS9;BDH2;DAB2;KDM6B;PGK1;DMBT1;AKT1;CNN3
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.31192325490890205,-1.2394144317128737,0.13978494623655913,0.5758700010084687,1.0,13/66,6.90%,ROBO1;TGFBR3;MTSS1;MCC;NR2F2;APOE;CDK6;B2M;STAT1;CAV2;DUSP10;AQP11;PTPRK
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.44766883089148723,1.2393121199975283,0.1563517915309446,0.7488917779902514,1.0,24/73,24.51%,EGFR;VEGFA;GAS6;NTRK3;DOCK7;PFN2;RAF1;AXIN1;TENM1;AKAP9;EIF4G1;IL6;HDAC6;ARAF;TRIM6;CNOT9;AKT1;TNKS1BP1;MAD2L2;ATP2B4;CAMK1;RPTOR;TBK1;PINK1
prerank,positive regulation of neurogenesis (GO:0050769),0.4479455218507912,1.2392262094384565,0.15291529152915292,0.7482157724069719,1.0,8/68,4.55%,SLIT2;PLXNA4;VEGFA;TIAM1;TIAM2;CUX1;FBXW8;SERPINF1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.46983522019999513,-1.2389996896088473,0.25,0.5743374439152215,1.0,3/13,10.00%,GRM3;ADGRV1;EDNRB
prerank,regulation of neurotransmitter transport (GO:0051588),-0.43488116299843743,-1.2386939898092775,0.17813765182186234,0.5726483871939799,1.0,4/16,8.28%,MCTP1;RIMS1;MCTP2;SYN1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.4311136675975251,-1.2386603116749122,0.20675105485232068,0.5702570328068195,1.0,6/16,15.34%,PARP14;ADIPOR1;SH2B3;INPP5F;CAV1;SOCS3
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.549757483692652,1.2383480233435342,0.2130718954248366,0.7504100061561841,1.0,2/19,0.50%,EXT1;XYLT1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.44054695908374153,1.237786868248156,0.14818763326226012,0.7516126375237749,1.0,29/84,23.57%,ECRG4;ANAPC5;PSMD7;CDC16;PSMA8;PSMA4;UBE2C;PSMD12;ANAPC4;PSMA6;PSMD1;ANAPC2;PSMC5;ANAPC1;PSMD11;PSMC4;PSMD14;UBC;RPS27A;ANAPC10;CDC20B;CDC20;CDC27;CDK2;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,eye morphogenesis (GO:0048592),0.5419375833753175,1.2376740314461236,0.22134387351778656,0.7510310451573691,1.0,5/19,7.28%,MFAP5;VEGFA;COL5A2;STAT3;SKI
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5724602859404982,1.2375994350934056,0.21828103683492497,0.7503336097340932,1.0,1/13,0.97%,GAS6
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5081789876416991,1.2374317615321515,0.19853836784409257,0.7499453539259082,1.0,6/27,11.27%,DDX5;TWIST1;SPRED2;KMT5A;YJU2;ATM
prerank,sensory perception of light stimulus (GO:0050953),0.4390307046328318,1.2372275359340303,0.1366982124079916,0.7497271972251939,1.0,7/87,6.91%,SLC4A10;COL11A1;COL1A1;PDE6C;PITPNA;CRYZ;CHRNB2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.44597081605203764,1.2371286355794209,0.16286644951140064,0.7491368075648112,1.0,26/72,23.57%,CARD14;PSMD7;PSMA8;TNFSF15;PSMA4;CHUK;IRAK1;TNFRSF10B;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;NFKB2;AKT1;PSMA3;PSMB1;PSMD4;BIRC3;MAP3K14;ZFP91;PSMA5;PSMA7
prerank,neural tube development (GO:0021915),0.5591807781076572,1.2370291833752125,0.22646657571623466,0.7485336854110384,1.0,4/15,5.69%,PKD1;HES5;DACT1;DVL1
prerank,skeletal muscle tissue development (GO:0007519),0.49839165652243284,1.2369179558696946,0.19304556354916066,0.7479593390826014,1.0,5/32,10.80%,SIX1;SIX4;SKI;SELENON;CSRP3
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5237612372471674,1.2367309606668146,0.20372670807453416,0.7476633791942497,1.0,6/26,9.84%,SMOC2;PRKCA;USP2;PKN2;CDC25B;FOXA1
prerank,monocarboxylic acid transport (GO:0015718),0.4656761611120715,1.2366617754698228,0.15331807780320367,0.7469417537967478,1.0,7/51,3.81%,SLC5A6;SLCO3A1;SLC16A9;SLCO2A1;SLC16A1;SLC26A6;RXRA
prerank,sphingoid metabolic process (GO:0046519),0.590254692931574,1.2366294852418038,0.22496570644718794,0.7460968147319166,1.0,3/12,6.18%,PLPP3;KDSR;PLPP1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5465694083807572,1.2365272976168376,0.19547872340425532,0.7455260151690248,1.0,7/17,12.12%,ACVR1;JAG1;HEYL;NOG;BMP4;BMPR1A;HEY1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.4515032337279316,-1.2363161651615047,0.1752136752136752,0.573469817683922,1.0,4/15,8.07%,ALDH4A1;GGT5;GGACT;PRODH
prerank,heart morphogenesis (GO:0003007),-0.33220431112258275,-1.2363000895988325,0.109375,0.5709853014353514,1.0,10/50,5.92%,TGFBR3;ENG;INSR;CHD7;NOS3;TBX3;NOTCH1;RYR2;TBX1;SOX17
prerank,protein localization to cell junction (GO:1902414),-0.4102169172716344,-1.2361121806641262,0.17410714285714285,0.5689091686285807,1.0,4/22,4.80%,TJP1;CGNL1;HEG1;BSN
prerank,mitochondrial gene expression (GO:0140053),0.4713548366632411,1.23584261139724,0.20135746606334842,0.7470355400593952,1.0,15/42,23.87%,MRPS2;MRPS28;NOA1;MRPS18B;MRPS14;MRPS17;FOXO3;TFB2M;PTCD3;TWNK;MRPL12;MRPL47;MRPS24;MRPS21;MRPS18A
prerank,histone acetylation (GO:0016573),0.45171761006721717,1.2356701492669124,0.17062634989200864,0.7467054005687008,1.0,30/69,23.43%,MORF4L2;TADA1;NAA60;MRGBP;NAA40;TRRAP;TADA2A;ING3;SGF29;KAT14;MORF4L1;BRPF3;ING5;KAT6B;TAF6;WDR5;KAT2A;PER1;ING4;CREBBP;APBB1;ATF2;BRD8;KAT7;YEATS2;KAT8;TAF6L;MEAF6;ZZZ3;KAT2B
prerank,RNA interference (GO:0016246),0.5414710073143906,1.235542605345619,0.23209549071618038,0.7462374512104339,1.0,6/17,16.66%,PRKRA;AGO1;TERT;AGO2;CLP1;TSN
prerank,histone H4 acetylation (GO:0043967),0.4724321637297745,1.2355207343408152,0.1806674338319908,0.7453680819309251,1.0,23/47,23.25%,KANSL2;MORF4L2;NAA60;NAA40;TRRAP;ING3;MORF4L1;OGT;ING5;WDR5;PER1;ING4;APBB1;HCFC1;ATF2;BRD8;KANSL1;KAT7;MSL1;KAT8;KMT2A;MEAF6;ZZZ3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.5560981594979751,1.2353749099002087,0.21220159151193635,0.7449235439700417,1.0,12/16,32.96%,MCMDC2;MCM2;WRN;MCM4;HMGA1;RAD51;TWNK;RECQL5;MCM7;SSBP1;BLM;PURA
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.4129847644812565,1.2349085783665588,0.015,0.745755261823932,1.0,131/417,22.37%,FOXP2;WWP1;FOXP1;ID2;ZFPM2;GAS6;ZNF423;FOXD1;TCF7L2;PDCD4;TWIST2;GCLC;LDB1;PHC2;PRICKLE1;MDFIC;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;RBFOX2;HDAC4;EIF4A2;SIX4;KMT5A;TRIM28;MIDEAS;CCAR2;SMAD4;ERN2;BHLHE40;HEYL;TBX21;SOX9;EHMT1;MAEL;BTAF1;RARA;MBTD1;PA2G4;DAP;RCOR3;FOXK1;SMARCC2;WWP2;EID2B;SBNO2;SPINDOC;ILF3;BMP4;PHC3;TSC22D4;SCMH1;RUNX2;FOXM1;ID4;COMMD7;KAT6B;SFPQ;KDM4A;NR1D2;HEY1;KHDRBS1;HDAC1;NPAS1;NACC1;MAP3K10;LIMD1;PIAS4;HEXIM1;ZNF148;RING1;VDR;YWHAQ;MBD1;L3MBTL2;ID1;PER1;ING4;SIRT2;HDAC6;FOXN3;NKX6-2;KDM5C;SUMO1;DPF3;NIPBL;L3MBTL3;MTA3;CBX5;CALCA;NR3C1;CDKN1C;MEN1;THAP7;CITED2;HMGA1;E2F1;SUV39H2;BIRC5;ZMYND11;CHD8;CBFA2T2;KLF10;MLXIPL;XRCC6;CDK5;SCML2;CALR;IKZF4;KAT7;SUV39H1;IL4;MPHOSPH8;SMURF2;YEATS2;SAMD11;SAP18;CRY2;USP47;ATP8B1;LOXL2;ZKSCAN3;KAT8
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4817698176533864,1.2348723947785756,0.2023121387283237,0.7449447788663325,1.0,6/39,8.17%,THBS1;GAS6;PDCD4;RAMP2;NFE2L2;PAK4
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.4262841941223932,-1.2348090667095184,0.18326693227091634,0.5694291801175099,1.0,5/18,6.43%,ROCK2;EPHA4;PICALM;ABCG1;GSAP
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6194049334455385,1.2344998539353111,0.2289855072463768,0.7454299070772674,1.0,2/10,1.49%,XYLT1;DSE
prerank,lipoxygenase pathway (GO:0019372),-0.4532673060843835,-1.234392910846113,0.1862348178137652,0.5680095353970129,1.0,4/14,12.80%,PON2;HPGD;ALOX12;GPX1
prerank,regulation of cellular response to heat (GO:1900034),0.44410380679296296,1.2340644017171112,0.16274089935760172,0.7461698775763309,1.0,37/77,31.19%,NUP93;SEC13;CAMK2D;RAE1;BAG3;CCAR2;SEH1L;HIKESHI;AKT1S1;ATM;NUP37;DNAJC7;CHORDC1;YWHAE;RANBP2;NUP88;CREBBP;POM121;NUP210;NUP62;DNAJC2;NDC1;RPTOR;NUP35;FKBP4;NUP85;NUP160;TPR;HSPB8;HSF1;BAG1;ATR;DNAJB1;NUP50;HSP90AA1;NUP188;HSPH1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.49356297811571004,1.2336322658430952,0.20408163265306123,0.7468392474251939,1.0,14/30,28.39%,ABLIM3;CSNK2A2;HUWE1;FZD5;USP36;HPS4;MICALL2;VPS11;NPEPPS;SAE1;PINK1;ATG13;HTRA2;SREBF2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5626955727412919,1.2334785931872243,0.2155525238744884,0.7464648579724482,1.0,9/15,26.75%,TSEN54;FAM98B;CLP1;CPSF4;RTCB;CSTF2;RTRAF;TSEN34;ERN1
prerank,Golgi ribbon formation (GO:0090161),0.5796494048710665,1.2334560789235964,0.23119777158774374,0.7455888287058263,1.0,9/13,30.16%,TRIP11;STX16;GOLPH3;OPTN;VAMP4;GOLGA2;GCC2;PRMT5;VTI1A
prerank,tRNA modification (GO:0006400),0.4498483804558428,1.2332670445813414,0.17634408602150536,0.7453424713215595,1.0,24/62,26.15%,TRMT61B;TARBP1;SSB;ANKRD16;ELP5;TRMT1;PUS3;TRUB1;ALKBH1;TYW3;CTU2;THADA;TPRKB;THUMPD3;TRMT44;TRMT6;ALKBH8;TRMT61A;METTL1;NSUN6;PUS1;MTO1;PUS10;TRMT112
prerank,regulation of transmembrane transport (GO:0034762),0.49583112437899013,1.2330234294640816,0.20334928229665072,0.7452752390373171,1.0,3/31,1.35%,KCNJ2;KCNJ15;NEDD4
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4611748249871025,1.2329338020985225,0.16910935738444194,0.7446468086342174,1.0,17/52,16.20%,SRSF6;DDX5;DDX17;RBFOX2;MBNL1;CELF4;THRAP3;CELF3;HNRNPL;MBNL2;RBM25;RBM5;KHDRBS1;PTBP1;RBM4;YTHDC1;ZC3H10
prerank,cilium organization (GO:0044782),0.42028490371995186,1.2328983903210624,0.05846774193548387,0.7438318227139444,1.0,79/209,26.28%,PKD1;GSN;CFAP298;EXOC4;EHD1;ABLIM3;PKHD1;DYNLT2B;RILP;ARMC9;MNS1;BBS9;ODF2;CDC14A;TMEM107;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;RFX2;TCTN1;IFT80;IQCB1;TMEM216;CCDC66;ATP6V0D1;CFAP43;PTPDC1;WDR11;CEP164;PARVA;TRAPPC14;OCRL;BBS5;TTC17;IFT46;MARK4;RAB23;FUZ;NUDCD3;CEP41;PCM1;HDAC6;IFT88;NPHP3;INPP5E;TTLL3;LZTFL1;DYNC2I1;IFT43;CCDC57;TEKT2;TMEM237;PTPN23;TTC29;KIF24;RAB1A;TMEM231;TXNDC15;SPAG16;FAM161B;BBIP1;PLK4;CEP89;DYNC2H1;TCTN3;TMEM67;TMEM138;BBS7;CEP20;FBF1;CCP110;EXOC7;INTU;ACTR2
prerank,histone H3-K4 trimethylation (GO:0080182),0.5855495300369539,1.2328954374371943,0.215007215007215,0.742902874876498,1.0,6/11,22.60%,OGT;KMT2D;WDR82;SETD1A;TET2;KMT2A
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4412225131287541,1.2325970831639046,0.15196599362380447,0.7430897169855478,1.0,30/86,22.71%,PLCE1;ARHGEF28;ARFGAP1;NTRK1;RDX;EPHB2;SHC1;ARHGAP17;TGFB2;EPS8L1;BCR;RAF1;LZTR1;OGT;MADD;FOXM1;SHOC2;ARHGAP44;STK19;SQSTM1;AKAP13;LRRC59;FLCN;ERBIN;RASGRF1;MAPKAP1;NUP62;DENND4B;DENND1A;SYNGAP1
prerank,tRNA aminoacylation (GO:0043039),0.48243253247153045,1.2325025197973203,0.19517795637198623,0.7425037007667219,1.0,12/37,20.24%,VARS1;WARS2;HARS2;PPA2;YARS1;DARS2;YARS2;EPRS1;PPA1;SARS1;SARS2;DARS1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.4120722884340445,1.2322121854760832,0.04804804804804805,0.7426478583663711,1.0,132/314,30.23%,WWP1;ECRG4;NEDD4;ANAPC5;FBXL7;PSMD7;UBXN8;TOPORS;CDC16;COP1;UBE2B;VCP;DNAJB14;PSMA8;ERCC8;NFE2L2;FAF2;TBX21;HUWE1;SYVN1;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;FBXL4;UBE2C;FBXL12;HSPA5;PSMD12;ANAPC4;CUL1;FBXL19;PSMA6;PCBP2;LTN1;RNF103-CHMP3;UBQLN1;FBXL14;PSMD1;KCTD5;ANAPC2;ARRB1;FBXO17;STUB1;SIRT2;FBXL20;PSMC5;ANAPC1;USP19;PSMD11;KLHL22;PPP2R5C;PSMC4;PSMD14;UBC;RPS27A;RNF121;YOD1;ANAPC10;TRIM13;KCTD17;CDC20B;UBE4A;FBXL18;GID4;DNAJC18;NPLOC4;CDC20;UBR2;CDC27;ZFAND2B;CDK2;FBXW4;UBXN4;UBE2G2;DCAF12;PCNP;RMND5B;PSMA3;UCHL1;DCAF11;SMURF2;RNF4;PSMB1;PSMD4;KCTD13;APPBP2;AREL1;ECPAS;DERL1;RNF216;PSMA5;PSMA7;SGTB;TAF1;HERPUD1;FBXO9;RNF122;AMFR;ANKRD9;TMEM67;SELENOS;DNAJB12;UBE2W;UBR3;PSMC1;RNF126;JKAMP;FBXO38;SEC61B;TMUB2;SEL1L2;PSMA1;DMAC2;DDB1;FAM8A1;STT3B;UBXN2A;UBE4B;FBXL8;RBX1;SPOPL;BTRC;UBR1;TMUB1;ZFAND2A;PRKN;ANAPC11;UBE2S;PSMD2;CTNNB1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5933384219068102,1.232210089563692,0.22636103151862463,0.7417175527669834,1.0,8/11,26.41%,TRIM28;RESF1;SETDB1;MPHOSPH8;TASOR;SETDB2;DNMT1;TPR
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.4194710033523773,-1.2320938057721154,0.20614035087719298,0.57141933073629,1.0,8/21,18.03%,EPHA7;GRIN2B;AIM2;SOX2;GRIN1;DELE1;PYCARD;MT3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4129969458311143,1.2318941437644055,0.03815261044176707,0.7419638466999203,1.0,58/308,13.07%,GNAS;SIX1;CMKLR1;BMP1;VEGFA;GAS6;LRP1;LBP;FGF2;FOXD1;IL33;COL1A1;TIAM1;GADD45G;GRB10;GHR;PEMT;ACVR1B;TGFB3;TWIST1;GLMN;WWTR1;LRPAP1;SIX4;TGFB2;DYNC1H1;TLE6;ACVR1;BCL9L;SMAD4;TGFBR2;ALMS1;KMT5C;SOX9;EHMT1;NOG;ESRRB;ADIPOR2;TSKU;TRPM4;B4GALT5;OGT;BMP4;CRTAM;TMEM119;VIP;PLAC8;TERT;BMPR1A;SOD1;KAT2A;TGFB1I1;TGFBR1;AGO2;SMO;NLGN1;INHBA;F2R
prerank,cytoplasmic translation (GO:0002181),-0.2946190338610655,-1.231794186350789,0.1346153846153846,0.5697699411859183,1.0,47/91,24.28%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;EIF2B3;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;GSPT2;RPL11;RPL18A;RPS12;RPL12;RPS11;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37;RWDD1;RPL14
prerank,synaptic membrane adhesion (GO:0099560),0.5702942658517821,1.2315807172224558,0.21768707482993196,0.7421932505218818,1.0,4/14,4.89%,GPC6;PTPRS;PTPRF;LRFN4
prerank,regulation of cytoplasmic transport (GO:1903649),0.5991204521764469,1.2315001958077096,0.2303206997084548,0.7415732834260808,1.0,5/11,21.65%,DNAJC13;ATP9A;USP7;CHMP3;LRRK2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.4309386752362359,1.2311389664085832,0.14181438998957246,0.7419436822448006,1.0,29/110,18.39%,TRABD2B;VEGFA;MPP7;GSN;HJURP;MAPK15;VCP;CDC42EP2;ANKRA2;TMC8;PEX5;RAF1;SLF2;IAPP;IMPACT;SPIDR;LCMT1;HSPA5;NCLN;ABCA1;PREB;FARP2;TFIP11;HDAC6;SUMO1;NAPA;CDT1;BID;HCFC1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.4771830201264371,1.2306083359200868,0.1950354609929078,0.7429565736902234,1.0,18/41,26.41%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4667060369645739,1.2305316836001226,0.16647919010123735,0.7423080882236774,1.0,16/52,18.69%,EGFR;LRP1;PRKCE;EPHB2;PLS1;AGR2;DLG1;PDPK1;SQSTM1;ACSL3;STAC3;STX4;CNST;SPTBN1;CLN3;AKT1
prerank,neuron projection regeneration (GO:0031102),-0.49645110281013516,-1.2303555724153885,0.19931271477663232,0.5708885369879338,1.0,2/10,1.81%,PTN;NREP
prerank,phagosome acidification (GO:0090383),0.5054231547380297,1.2303496573997743,0.21226993865030674,0.7420082488738546,1.0,10/26,25.07%,ATP6V1C2;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,chromosome organization (GO:0051276),0.437492982487859,1.2301380738864196,0.13473684210526315,0.7418694104969658,1.0,35/99,26.55%,TCF7L2;LDB1;TCF7L1;RAE1;PHF1;SAFB;EZH1;BRWD1;EHMT1;GPS1;HMGN1;CDAN1;CUL4A;CENPT;ABL1;HDAC1;LIG4;HMGN2;PARP1;UBC;RPS27A;HMG20A;GATAD1;CDT1;MTHFR;SUV39H1;COPS4;FAM50A;COPS7A;SMARCA4;HDAC2;H3-3A;COPS3;SETD7;XPA
prerank,skeletal muscle organ development (GO:0060538),0.5105861643701953,1.2301020214798692,0.20275344180225283,0.7410807774070951,1.0,4/26,10.80%,SIX1;SIX4;DISP1;CSRP3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.47764097844220327,1.2299068129498856,0.19226260257913247,0.7408405857837274,1.0,9/42,12.40%,MYOC;VEGFA;COL16A1;CD3E;S100A10;GFUS;JUP;ABL1;NRP1
prerank,regulation of transferase activity (GO:0051338),0.5532381623673281,1.229576259686461,0.2192513368983957,0.7411517423200962,1.0,5/17,11.27%,LDB2;LDB1;SMG6;PPP1R3F;ATM
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5774300865791364,1.2285778530816744,0.25,0.7439442317821289,1.0,2/13,11.85%,PRKCD;SOD1
prerank,lytic vacuole organization (GO:0080171),0.4960010189112132,1.2285473310702195,0.197352587244284,0.7431087881466105,1.0,14/32,22.32%,ARSB;GAA;LAMTOR1;MBTPS1;NAGPA;TMEM106B;ABCA1;HPS4;ACP3;CLN3;SNAPIN;MYO7A;LRRK2;ZKSCAN3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.403892206810811,1.2280377454054607,0.0,0.744169374794549,1.0,457/1646,22.68%,TBX15;FOXP2;PLAGL1;BNC2;ESR1;EGFR;LRP6;SIX1;WWP1;FOXP1;KLF12;ZBTB7C;ID2;PRRX1;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;PBX3;GAS6;NFIX;FGF2;HOXA3;ZNF423;FOXD1;NFIB;TCF7L2;PDCD4;COL1A1;TWIST2;ELF4;VSX1;DDX5;GCLC;HOXB6;MKX;SMAD9;NFIA;DDX17;ZIM3;ZFHX4;SMAD6;LDB1;ZMIZ1;PHC2;PRRX2;PRICKLE1;JDP2;GLI2;MDFIC;PRDM5;TCF20;DMTF1;LRP5;NCOR2;ACVR1B;GLIS2;TGFB3;TWIST1;JMJD1C;DKK3;APBB3;HOXC6;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;SP140;CUX1;RBFOX2;NFAT5;HDAC4;CAMK2D;STAT5A;SIX5;ELF1;MAP3K5;HOXB3;RXRA;ONECUT2;MEOX2;MED13L;WWTR1;SBNO1;BAZ2A;HES5;TCEA2;KLF5;SIX4;STAT3;ZBTB25;ANXA4;TCF7L1;ZNF250;TARBP1;KMT5A;MLF2;ATF4;CCNL2;ERC1;TRIM28;MAMSTR;ZFP14;NR2F1;CHD3;TCFL5;GMEB1;TADA1;DNM2;PHF1;ACVR1;BRD4;DVL1;FOXC2;ILK;ZNF25;MIDEAS;CCAR2;RXRB;NFX1;LBX2;NFXL1;GPATCH3;SAFB;SMAD4;ERN2;MRGBP;NFE2L2;BHLHE40;HMGB1;PKNOX2;MEF2B;FZD7;ZNF471;TRRAP;RFX7;TADA2A;E2F3;FUS;TASP1;PBX1;TSHZ2;CREG1;MEIS3;BRWD1;MED27;ZNF691;HEYL;TBX21;THRAP3;MDM4;SOX9;EHMT1;RPS6KA4;HOXA9;HOXA6;PURG;MAEL;CCNL1;BTAF1;IKZF3;MED31;RARA;NSD1;FOXJ3;MBTD1;MED13;PA2G4;SRA1;ESRRB;DAP;TFE3;RCOR3;BRD3;FOXK1;ENY2;ZNF76;CDC6;CARM1;DGKQ;NFATC1;FOXL1;SMARCC2;RFX2;SLTM;WWP2;OGT;EID2B;PSIP1;RBBP8;ZIC1;SBNO2;SPINDOC;RORA;OGG1;ILF3;BMP4;SFR1;PHC3;CRABP2;FOXA1;TSC22D4;ING5;ZBTB2;UBP1;SCMH1;CSRNP1;ZFP90;SREBF1;EHF;CHUK;RUNX2;ZNF260;FADS1;KDM2A;URI1;FOXM1;ABL1;ZIC4;SPTY2D1;RFX5;CCNT2;PHF8;POU6F1;PITHD1;SETD5;MAP3K12;ID4;NFE2L1;NRF1;HSF4;AXIN1;CHEK2;MAZ;COMMD7;KAT6B;NEUROD2;KDM5B;RNF14;TAF15;NAA16;SFPQ;FOXO6;SMAD7;PHIP;FOXP4;SRF;KDM4A;NR1D2;HEY1;GLIS1;TENM1;KAT2A;ZNF112;TGFB1I1;KHDRBS1;TGFBR1;FBXL19;HDAC1;MEF2D;ZMIZ2;CDC45;HSPD1;HOXB4;ZNF740;INHBA;BAZ2B;F2R;CD80;MYPOP;MAPRE3;HR;ARID4B;KMT2D;NPAS1;MEF2A;NACC1;MAP3K10;RUNX1;NFATC3;ZBTB9;NDP;HOXA4;ERF;LIMD1;TIAL1;PIAS4;HEXIM1;ZNF148;RING1;HNRNPK;MMS19;SERTAD3;EN2;VDR;BRD2;ZKSCAN1;USP13;MED21;MAFG;YWHAQ;MBD1;L3MBTL2;TFDP1;ID1;PER1;IL6;ARRB1;ING4;GRHL1;SIRT2;BRD9;PSMC5;CAMK4;FOXO3;HDAC6;FOXN3;NKX6-2;NFE2;CREB1;MLLT3;ZFPL1;CREBBP;MED26;ERBB2;KDM5C;AATF;APBB1;HMG20A;KMT2B;SUMO1;HOXA2;DPF3;NIPBL;PRDM2;L3MBTL3;MTA3;NFYA;CBX5;CALCA;NFKB2;KLF3;MAGED1;NR3C1;RFXANK;E4F1;MED14;CDKN1C;MEN1;LCOR;ZKSCAN7;THAP7;HDGFL2;SRSF10;CITED2;HMGA1;ELP4;DAPK3;CDT1;MED12;E2F1;SUV39H2;CC2D1B;RYBP;HCFC1;BIRC5;ZMYND11;SUFU;HOXC5;BRDT;ZBTB32;AKT1;ZSCAN20;ATF2;GON4L;CHD8;ACTR8;GPBP1L1;CBFA2T2;HIPK2;KLF10;CRK;HOXB2;MLXIPL;SAFB2;FOSL2;CC2D1A;QRICH1;TEAD2;XRCC6;IRF3;CBFB;NR3C2;ZNF431;VEZF1;WWC2;TCF3;CDK5;SCML2;NFATC4;BICRAL;MAP2K3;ATF6;MAX;BPTF;CALR;IKZF4;KAT7;MRPL12;ZBTB24;HOMEZ;HOXC8;SUV39H1;MAD2L2;KLF9;NUP62;IL4;ATP2B4;ZKSCAN5;MPHOSPH8;SMURF2;MAP2K7;YEATS2;RNF4;MED20;BCL11B;SMAD5;NEK4;SAMD11;CHD2;SAP18;NFIC;CEBPD;NR2F6;CRY2;ELP3;ZBTB40;DNAJC2;USP47;TGFBRAP1;ATP8B1;LOXL2;ZNF18;ZNF177;SS18L1;ZKSCAN3;KAT8;NR2C2;CDK5RAP2;KDM3B;MNT;KMT2A;TFCP2;PEX14
prerank,regulation of DNA replication (GO:0006275),0.4594640165563164,1.2279775524836527,0.1789709172259508,0.7434859641924794,1.0,23/49,30.60%,EGFR;GLI2;SMC3;RBBP6;CDC6;BRPF3;CDAN1;CDT1;GMNC;KAT7;PDS5A;GTPBP4;PPP2CA;S100A11;EHMT2;ESCO1;PPP2R1A;USP37;WAPL;ATR;CTC1;RAD17;GLI1
prerank,regulation of urine volume (GO:0035809),0.5994747624389513,1.2275398659946077,0.23391812865497075,0.7441744653055047,1.0,1/10,1.85%,NPR3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5217507184743432,1.2274423336093498,0.20945083014048532,0.7436290958578743,1.0,10/22,27.29%,NEDD4;MVB12B;TOM1L1;RNF115;UBAP1;PTPN23;UBAP1L;MVB12A;RNF126;VPS37B
prerank,chromatin remodeling (GO:0006338),0.43284953312623503,1.2274139094304586,0.14942528735632185,0.7428212702151369,1.0,39/100,26.74%,ESR1;HDAC4;BAZ2A;CHD1L;CHD3;EZH1;TADA2A;SOX9;SMARCC2;FOXA1;INO80B;KDM5B;PBRM1;KDM4A;KAT2A;HDAC1;BAZ2B;HNRNPC;KDM5C;KDM6B;GATAD1;SMARCAD1;SUV39H2;HCFC1;BRDT;CHD8;ACTR8;MPND;BPTF;TOP1;TAF6L;KAT2B;CHD4;SMARCA4;SRCAP;HDAC2;DAXX;ARID1A;MYSM1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5988317447859698,1.227272390996567,0.2471590909090909,0.7424651775291066,1.0,1/10,1.05%,LBP
prerank,icosanoid secretion (GO:0032309),-0.46210928264259143,-1.2267806315676124,0.21568627450980393,0.577431047783388,1.0,4/12,7.77%,ABCC4;BDKRB2;PNPLA8;ACE
prerank,mRNA metabolic process (GO:0016071),0.4363005134420097,1.2266543989947325,0.15491452991452992,0.7438026958883167,1.0,39/90,29.54%,DDX5;SRSF1;SRSF5;SRSF2;SSB;HNRNPA2B1;SRSF11;ZC3H12D;SF3B2;SF3A1;TBRG4;U2AF1;DIS3L2;SFPQ;METTL16;PCBP2;LSM2;PTBP1;U2AF2;PCF11;CNOT10;NCBP1;SRSF7;CPSF6;NCBP2;PRKACA;SNRPB;GEMIN2;SRSF4;PRMT9;TP53;ERN1;RIDA;SON;LSM5;HSF1;DXO;SF3B4;SNRPF
prerank,RNA stabilization (GO:0043489),0.4897828776964412,1.226360823678017,0.20768307322929172,0.7439658174142834,1.0,17/33,28.60%,PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;E2F1;GDNF;ZCCHC17;CIRBP;TENT2;SLC11A1;HNRNPU;YBX1;RBM24;DKC1;LARP1
prerank,regulation of osteoblast proliferation (GO:0033688),0.5432771127126911,1.226252699895333,0.22905759162303665,0.7434484645811039,1.0,5/17,12.39%,NPR3;RHOA;FGFR2;TMEM119;NELL1
prerank,regulation of inclusion body assembly (GO:0090083),0.5955643903270194,1.225923496204442,0.24320457796852646,0.7437213722373481,1.0,2/11,4.35%,HSPA2;SNCAIP
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6051820061699996,1.2257430304139063,0.22869318181818182,0.7435307823406574,1.0,4/10,12.83%,LRTOMT;CHDH;HNMT;SMOX
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4442986231217308,1.2255744425962734,0.17763157894736842,0.7432555037527272,1.0,22/65,23.57%,FHL1;FBXL7;PSMD7;PSMA8;INTS3;CDK5RAP3;PSMA4;PSMD12;CUL1;PSMA6;ZFYVE19;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;PSMB1;PSMD4;USP47;PSMA5;PSMA7
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.4971669670710398,1.2252711770824245,0.2044334975369458,0.7434547480566202,1.0,13/29,24.31%,PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;E2F1;GDNF;CIRBP;SLC11A1;HNRNPU;YBX1;RBM24
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5278559088862302,1.2252513534696408,0.22264631043256997,0.7426050223503439,1.0,4/21,11.75%,RASSF2;DMD;PAQR3;SMAD7
prerank,cellular glucose homeostasis (GO:0001678),0.476892718506091,1.2251152529358442,0.21095571095571095,0.7421706723289686,1.0,7/41,8.57%,SLC39A14;KCNB1;GAS6;UNC13B;ADCY8;LRRC8D;FOXK1
prerank,RNA processing (GO:0006396),0.41727758305651685,1.225095471467556,0.08779011099899092,0.7413342564064653,1.0,67/176,25.10%,DDX17;HNRNPH1;TSEN54;SRSF1;NOL3;SRSF5;PPP1R9B;MBNL1;RBM39;DUSP11;M1AP;SRSF2;TENT4B;SNRNP48;CCAR2;FUS;HNRNPA2B1;YJU2;SRSF11;CELF3;LUC7L3;HNRNPL;CDK12;SF3B2;SF3B1;SF3A1;SNRNP25;SRRM1;U2AF1;RBM6;RBM5;PABPN1;SFPQ;ZRSR2;PTBP1;RBM4;HNRNPC;U2AF2;SRPK1;CLP1;HNRNPK;TFIP11;SCNM1;TUT7;NCBP1;SRSF7;CPSF6;NCBP2;SYNCRIP;HNRNPH3;PRKACA;ZCCHC8;TENT2;DHX8;SNRPB;GEMIN2;SRSF4;DHX16;TSEN34;PPIG;PRMT9;HNRNPU;PABPC4;RBM3;PPP2CA;SNRNP35;DDX39B
prerank,artery morphogenesis (GO:0048844),0.49969441127081754,1.2247174038852708,0.20048602673147023,0.7417658043083412,1.0,11/30,13.14%,VEGFA;LRP1;TGFB2;JAG1;NOG;BMP4;BMPR1A;SMAD7;NRP1;TGFBR1;LRP2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5300264037280877,1.224699976672886,0.23767383059418457,0.740936737370466,1.0,6/20,14.05%,ZMIZ1;DCUN1D5;ITCH;DCUN1D2;TGFBR1;UBQLN1
prerank,regulation of anoikis (GO:2000209),-0.4182677744665981,-1.2245275991398445,0.15948275862068967,0.5806116731995966,1.0,8/19,21.48%,BCL2;NOTCH1;TLE1;CAV1;BRMS1;PTK2;SIK1;MCL1
prerank,negative regulation of growth (GO:0045926),0.4297155219547628,1.2245209016155323,0.14784394250513347,0.7407139730882228,1.0,26/121,17.28%,SLIT3;SLIT2;FHL1;OSGIN2;CCN3;ACVR1B;PPP1R9B;PRDM11;TGFB2;CCAR2;SMAD4;DACT3;NDRG3;SERTAD2;DCBLD2;ING5;SESN2;INHBA;CGRRF1;RBBP7;SERTAD3;CYP27B1;ING4;MINAR1;APBB1;FLCN
prerank,response to retinoic acid (GO:0032526),-0.3097038896392839,-1.2241548332437697,0.09523809523809523,0.5791553846870613,1.0,11/59,6.52%,LYN;WNT5B;PTK7;WNT5A;WNT6;ACER2;RBP4;BRINP3;TBX1;BRINP1;BRINP2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5190748941954704,1.2234623747973523,0.22208281053952322,0.7436372704225906,1.0,12/25,26.31%,LDB1;BRD4;CDK12;HEXIM1;ZMYND11;LARP7;NELFB;HNRNPU;CDK13;EAF1;RECQL5;NELFA
prerank,regulation of lamellipodium assembly (GO:0010591),0.4777757061519423,1.2231406441519659,0.2066905615292712,0.743944828935791,1.0,2/34,0.87%,SLIT2;PLCE1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5613136337251787,1.2227564545895844,0.22631578947368422,0.7444295137984683,1.0,2/15,2.48%,LRP6;GLI2
prerank,negative regulation of cellular component organization (GO:0051129),0.43568708356799996,1.2218940713359383,0.17532467532467533,0.7467483891313201,1.0,15/74,11.90%,VEGFA;TMEFF2;RDX;HSPA2;FAP;LRSAM1;DNM2;IRAK3;TMC8;PEX5;RAF1;IAPP;IMPACT;LCMT1;HSPA5
prerank,substrate-dependent cell migration (GO:0006929),0.5714079264090071,1.2216486763095622,0.2354533152909337,0.7467273849071049,1.0,2/14,0.90%,NTN1;ITGA11
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5910997491318027,1.221525406756049,0.2534435261707989,0.7463016830341057,1.0,5/11,15.81%,PRKCD;CYP1B1;MAP3K5;STK25;GSKIP
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4340368444205846,1.2214142521038722,0.17005347593582887,0.7457920842616035,1.0,27/79,20.52%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;SEC24C;AP2A2;SEC24B;LAG3;CLTC;KLC1;DCTN5;SEC24A;ACTR1B;ACTR10;DYNC1I2;DCTN1;CLTA;CAPZA1
prerank,regulation of hemopoiesis (GO:1903706),-0.49672903212554187,-1.2214045742209294,0.22330097087378642,0.5833009347397782,1.0,4/10,10.57%,PTN;PRKCB;MAFB;IL17D
prerank,negative regulation of anoikis (GO:2000811),-0.4554246299358735,-1.2212573014795076,0.22556390977443608,0.5812851294695276,1.0,5/14,15.88%,BCL2;NOTCH1;TLE1;CAV1;PTK2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5123693422646054,1.221154490102799,0.22778473091364204,0.745820086562649,1.0,5/27,4.29%,XYLT1;BGN;CHST11;CHPF2;CSPG4
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.39322779351064396,-1.2207083848863294,0.14705882352941177,0.5801378625570419,1.0,6/21,4.70%,ROCK2;ENPP1;NOS3;NOTCH1;SRGN;BCOR
prerank,nerve growth factor signaling pathway (GO:0038180),0.6027083542911753,1.22049797386991,0.23595505617977527,0.747414663693554,1.0,2/10,4.63%,NTRK1;KIDINS220
prerank,negative regulation of angiogenesis (GO:0016525),0.435209247379036,1.220478257076914,0.1853813559322034,0.746611200024779,1.0,11/84,6.57%,THBS1;HOXA5;SLC12A2;EMILIN1;ISM1;SPARC;TGFB2;SERPINF1;SEMA3E;THBS2;SULF1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.4853847716519029,-1.2199925944201018,0.22570532915360503,0.5794388518615995,1.0,1/10,1.38%,APOE
prerank,positive regulation of phospholipase activity (GO:0010518),0.5184342887270766,1.2198078797006284,0.23214285714285715,0.7481795958847639,1.0,8/22,11.56%,ESR1;FGF2;NTRK3;FGFR1;ARF4;FGFR2;PLA2G5;PDPK1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5985962147454307,1.2195749172268193,0.2549295774647887,0.7481154475243392,1.0,4/10,6.66%,NEDD4;PRKCE;CAMK2D;STK39
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5011396342619296,1.218990764927161,0.21628189550425272,0.7494241891466262,1.0,6/32,13.59%,CCL13;RNASE7;RNASE3;RNASE6;DEFB1;HMGN2
prerank,inorganic cation transmembrane transport (GO:0098662),0.4126953459239951,1.2184495760090708,0.06006006006006006,0.7505009022164394,1.0,39/268,11.80%,SCARA5;SLC4A4;KCNJ2;CACNA1G;KCNK5;PKD1;CACNA1C;SLC39A14;KCNB1;ATP1B1;GAS6;SLC12A2;SLC24A3;HCN4;SLC4A8;SLC39A11;TRPV3;KCNN1;SLC9A8;SLC39A7;SLC4A11;SLC9A4;SCN11A;SLC9A1;SLC6A2;KCND1;TRPC4AP;TRPM7;TRPM4;SLC6A7;KCNK6;ITGAV;SLC30A5;SLC39A13;ATP6V0D1;TMEM165;ABCB8;TRPM6;NNT
prerank,negative regulation of protein polymerization (GO:0032272),0.5011216526731459,1.2183370274616891,0.2323856613102596,0.7500065585110816,1.0,2/27,0.75%,SLIT2;PRKCD
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5042330017145976,1.217920609335366,0.2196969696969697,0.7505286242575918,1.0,8/26,17.96%,ST3GAL4;TKT;ST3GAL2;B4GALT5;GAL3ST4;B3GNT6;RRM2B;GOLPH3
prerank,microtubule nucleation (GO:0007020),0.5341566545473133,1.2174189718424806,0.2336328626444159,0.7514536455594951,1.0,7/19,18.76%,TUBG2;CSNK1D;TUBGCP3;AKAP9;NDEL1;CCDC57;SLAIN2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.5962081822703529,1.2172589673523602,0.25697503671071953,0.7511759532255533,1.0,4/10,16.66%,PRKRA;TERT;AGO2;TSN
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.450746507009101,1.2172285723057499,0.19686800894854586,0.7503907446110321,1.0,22/55,27.29%,FHL1;FBXL7;PSMD7;PSMA8;PSMA4;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;PSMB1;PSMD4;USP47;PSMA5;PSMA7;PSMC1;ATF5;PSMA1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5389711390649713,1.2171270397038534,0.24178712220762155,0.7498452802590174,1.0,3/19,4.54%,SMOC2;ADAMTS3;XDH
prerank,cellular response to leucine starvation (GO:1990253),0.6016538972090749,1.2169094649685641,0.23529411764705882,0.7497551452226707,1.0,5/10,19.92%,GCN1;SESN3;IMPACT;SESN2;EIF2AK4
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.47289654253428703,1.2167618739711963,0.21133412042502953,0.7494278958481415,1.0,16/40,24.51%,PID1;VCP;SLC4A11;AKT2;PPA2;ABL1;SOD1;PRDX3;AKT1;LRRK2;ABCD1;PYCR1;STOML2;RNF122;BAD;PINK1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5886228565244589,1.2166056920717623,0.26301369863013696,0.7490990703752881,1.0,4/12,9.01%,EPHB2;EPHB6;CHRNB2;B4GALT5
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.45670500444759554,1.2163002240119218,0.20948180815876516,0.7492797192577789,1.0,9/54,9.43%,THBS1;VEGFA;FGF2;STAT5A;PRKCA;HMGB1;FGFR1;JUP;ANGPT4
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.42939446791650315,1.2161763783629447,0.1325678496868476,0.7488277418431449,1.0,28/113,18.13%,ESR1;TRABD2B;VEGFA;MPP7;UNC13B;CHD1L;IL5;VCP;CDC42EP2;USP50;SLF2;ERCC5;ERCC4;CUL4A;SPIDR;ATM;MED25;ERCC3;EIF4G1;ERCC2;ABCA1;STUB1;PSMC5;PARP1;PSMC4;SUMO1;CDT1;BID
prerank,protein heterotetramerization (GO:0051290),0.5655040402338839,1.2158786647008566,0.25105189340813466,0.7490784473190097,1.0,5/13,18.08%,PKD1;CBR4;HSD17B8;CPSF7;CPSF6
prerank,telomere maintenance via recombination (GO:0000722),0.5931638992978131,1.2149932845016573,0.24087591240875914,0.7513959231340092,1.0,9/11,31.98%,ERCC4;RAD50;TPRKB;SMC5;RAD51;XRCC3;SMC6;NSMCE2;ERCC1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.4886557484492083,-1.2148507734747103,0.21283783783783783,0.5899997545864659,1.0,5/10,20.60%,SHQ1;PIH1D1;RUVBL1;ZNHIT6;TAF9
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.48414152199583405,-1.2147475531664653,0.23225806451612904,0.5878361509968254,1.0,4/11,13.17%,ENPP3;SLC19A3;ERH;SLC19A2
prerank,response to nutrient levels (GO:0031667),0.5425777564830085,1.21429068159331,0.24966622162883845,0.753109489758536,1.0,3/17,5.08%,KCNB1;ATF4;MEAK7
prerank,nucleoside salvage (GO:0043174),0.5921114906642801,1.214222625357129,0.23372781065088757,0.7524803575745322,1.0,6/10,26.96%,UCK2;UPP2;TK2;TK1;DCK;UCKL1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.5706834065517505,1.2139729836182716,0.24034334763948498,0.7525114658419273,1.0,8/12,28.37%,SEC61A1;HSPA5;CHMP4A;CHMP4B;SGTB;GET3;SEC61B;SEC62
prerank,regulation of mRNA stability (GO:0043488),0.41388494166473083,1.2138556915682464,0.13401015228426397,0.7520426061336175,1.0,54/145,25.77%,XPO1;PRKCD;PABPC1;SAMD4A;PSMD7;PRKCA;FTO;PSMA8;PUM1;TENT5A;FUS;THRAP3;PSMA4;PCBP4;TBRG4;VIP;TAF15;METTL16;PSMD12;PSMA6;EIF4G1;PSMD1;XRN1;EXOSC4;PSMC5;PSMD11;PSMC4;PSMD14;UBC;RPS27A;RC3H2;DIS3;E2F1;AKT1;GDNF;TNPO1;FASTKD3;PSMA3;CIRBP;PSMB1;PSMD4;FXR2;SLC11A1;DCP1A;PSMA5;PSMA7;ZC3H14;HNRNPU;YBX1;RBM24;ROCK1;YWHAB;METTL14;PSMC1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5685863267372091,1.2135362753742447,0.25338753387533874,0.7523911576233782,1.0,5/14,13.92%,ATP1B1;DMD;SLC9A1;CHP1;WNK1
prerank,inner ear morphogenesis (GO:0042472),0.5111449073135529,1.2132909970750543,0.22433460076045628,0.7524083430011244,1.0,5/22,9.70%,SIX1;EPHB2;SOX9;ZIC1;FGFR2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5848788106072008,1.2131982579388985,0.25285714285714284,0.75185087638484,1.0,3/12,8.56%,IRS1;TWIST1;AKT2
prerank,regulation of phosphatase activity (GO:0010921),0.5145330122469246,1.2131390934792257,0.22125,0.7511928758072055,1.0,11/24,21.94%,PPP6R1;CDK5RAP3;TIPRL;PPP6R3;ZCCHC9;RIPK3;URI1;CHP1;PPP6R2;PPP1R35;PPP1R36
prerank,outflow tract septum morphogenesis (GO:0003148),0.5043950762239856,1.2123204369961023,0.2363405336721728,0.7532294254090831,1.0,12/24,13.14%,ZFPM2;SMAD6;TGFB2;ACVR1;SMAD4;TGFBR2;BMP4;FGFR2;BMPR1A;NRP1;PARVA;LRP2
prerank,synaptic vesicle recycling (GO:0036465),0.49623760165627484,1.212189269918274,0.22800495662949194,0.752834570326146,1.0,11/31,20.58%,STON2;SYT8;CEL;FCHO2;TBC1D24;STON1;SYNJ1;NLGN1;STX1A;CDK5;SYNJ2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5004563407829129,1.2120427300918524,0.22235872235872237,0.7524567730600487,1.0,17/29,34.39%,CHD1L;ERCC5;CUL4A;ERCC3;ERCC2;PARP1;UBC;RPS27A;GTF2H4;XPA;DDB1;RBX1;RAD23B;RPA3;CUL4B;CCNH;CETN2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4862620087784195,1.212008216524423,0.23227383863080683,0.7517032121830148,1.0,12/29,17.60%,TCF7L2;TLE2;TCF7L1;BCL9L;TRRAP;PYGO1;TLE3;TERT;HDAC1;KMT2D;CREBBP;MEN1
prerank,cellular response to fluid shear stress (GO:0071498),-0.46800595129846856,-1.2115057349664842,0.2379421221864952,0.593702997995601,1.0,3/12,8.78%,MTSS1;KLF2;ASS1
prerank,regulation of smooth muscle contraction (GO:0006940),0.534026605929915,1.2112777120421432,0.2408575031525851,0.7535019736195548,1.0,3/20,1.91%,PLCE1;CTTN;PROK2
prerank,inorganic anion transmembrane transport (GO:0098661),0.44738453931791716,1.211051317448869,0.18990120746432493,0.7534717536644946,1.0,7/63,7.64%,SLC26A2;SLC5A6;SLC12A7;SLC12A2;SLC4A8;GABRA3;SLC12A4
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5303806415282778,1.2105172381486842,0.246684350132626,0.754589417987126,1.0,5/18,16.20%,ESR1;NCOR2;TERT;PTBP1;ZC3H10
prerank,anterior/posterior axis specification (GO:0009948),-0.42969360909972465,-1.2104022498008722,0.20905923344947736,0.5940746039674196,1.0,2/15,2.98%,WLS;TBX3
prerank,autophagy of peroxisome (GO:0030242),0.5893512700510297,1.2103155840906323,0.24457308248914617,0.7543860421385945,1.0,6/12,22.03%,NBR1;PEX5;ATM;SQSTM1;RB1CC1;ACBD5
prerank,regulation of superoxide anion generation (GO:0032928),0.5590653115221162,1.2099734098070818,0.2757697456492637,0.7546801402013205,1.0,3/14,16.42%,PRKCD;SOD1;AATF
prerank,organophosphate ester transport (GO:0015748),0.5123688444054045,1.2091663566202508,0.23743718592964824,0.7567225267414798,1.0,5/24,4.74%,TNFAIP8L3;PITPNC1;PRELID3B;PITPNA;PITPNM1
prerank,negative regulation of transferase activity (GO:0051348),0.4996061636224839,1.2088214760194957,0.2257250945775536,0.7570852514273692,1.0,10/28,24.29%,EIF4A2;ERCC4;ABL1;SMAD7;PRDX3;CDKN1C;MEN1;HNRNPU;NPRL2;TP53
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5706530278503245,1.2087922406978324,0.24818577648766327,0.756323023059649,1.0,7/12,26.96%,UCK2;UPP2;CAD;TK2;TK1;DCK;UCKL1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5932976370749491,1.2087465632683188,0.25604551920341395,0.7556218155370296,1.0,4/10,28.44%,PDE6A;SAG;GNB1;PDE6G
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5212371309449678,1.2085029240692113,0.24775353016688062,0.7556600443942398,1.0,5/21,9.54%,ADAM9;HM13;ADAM10;BACE2;BACE1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5991469020899902,1.2082375125752671,0.24851190476190477,0.7557402672668282,1.0,6/10,17.24%,ANXA2;RIC1;CDK5RAP3;RGP1;NELL1;EFNA1
prerank,regulation of telomere capping (GO:1904353),0.5081143647848061,1.2081940613937463,0.22646310432569974,0.7550387147830016,1.0,7/23,14.20%,MAPK15;NEK7;SMG6;ATM;RAD50;USP7;TNKS2
prerank,organelle organization (GO:0006996),0.4027555898488942,1.2079446399669242,0.038,0.7550661297256914,1.0,131/388,24.56%,MICAL2;PLCE1;ABCD3;FMNL2;SEC31A;MARK1;MAPK15;VPS13C;PEX7;ARC;ATL2;CCL13;SEC61A1;CSNK1D;LMAN2L;FGD6;RAB2A;FBXW8;GOLGA8B;GOLGA5;RAB30;RAB34;RAB43;DOP1B;PEX11A;BCAS3;SMPD4;MNS1;RAB3GAP1;MIEF2;GOLGB1;ODF2;ATL3;SIRT5;GBF1;ATP8B2;BRWD1;RHOT2;FAF2;HUWE1;TJAP1;ARHGAP21;PAK4;PALLD;PEX16;PLEKHM2;RHOT1;CENPT;PEX1;RAB38;TRAPPC12;TERT;NRF1;TMED9;PHIP;CIDEA;ZW10;LONP1;LIG4;TRIP11;PEX10;TTC17;PI4K2A;CHMP3;MARK4;NDP;LIMD1;MTFR1;LMAN2;SEC16A;PRDX3;TMEM135;PNPLA3;MIA3;SIPA1L3;STX4;CDC42BPB;PARP1;POLG2;SEC16B;BCS1L;VPS11;GOLPH3;BNIP1;SH3D19;TFB2M;TMED2;NPLOC4;COG2;BLZF1;PEX6;HCFC1;MAST2;ZMYM3;SEC23IP;CLUH;ZFYVE16;ZRANB1;TRAPPC11;TTC29;REEP5;TWNK;NIPSNAP2;FANCG;CHMP4A;CHMP4B;PDCD6IP;OPTN;SNX11;ATL1;ABI2;PEX2;LRRK2;RAB1A;LMAN1;RAB18;ABCD1;MAST4;ATP8B1;EIF2AK3;PRKCI;PEX14;FAM161B;GORASP2;STOML2;VPS13D;DYNC2H1;TMED7;VPS51;PINK1;CHMP2A
prerank,triglyceride homeostasis (GO:0070328),-0.36726125266724297,-1.2079050533902576,0.18181818181818182,0.597825617357785,1.0,9/26,14.60%,APOE;NR1H3;PNPLA8;C1QTNF3;SCARB1;LPL;SIRT1;NR1H4;DGAT2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.34700297754346915,-1.2072818238931744,0.14482758620689656,0.5969826886853637,1.0,6/39,3.15%,TJP1;ROCK2;APOE;RAPGEF2;TIE1;NOTCH1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5594898029297741,1.2072750089722986,0.23045822102425875,0.7566304413595236,1.0,9/16,21.65%,ANK2;GBF1;BCAP31;HSPA5;SEC16A;BCAP29;MIA3;SEC16B;LRRK2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.42422513387981453,1.2071572835762754,0.1731374606505771,0.75619066637499,1.0,20/95,15.39%,LBP;ADAM9;PDCD4;CARD16;SHPK;TNFRSF1B;HMGB1;TRIM41;FZD5;RHOA;SBNO2;MAPK8;NFKBIB;IRAK1;GIT1;PABPN1;CD80;CASP1;IL6;SIRT2
prerank,blood vessel endothelial cell migration (GO:0043534),0.5132277665489451,1.2071075441443904,0.23106546854942234,0.7554940496653441,1.0,3/22,1.12%,SLIT2;VEGFA;FGF2
prerank,regulation of receptor internalization (GO:0002090),0.48349426430407283,1.206646553067233,0.2100238663484487,0.7562968560412139,1.0,9/35,15.60%,VEGFA;SFRP4;LRPAP1;RSPO1;DLG4;ARF1;PICK1;ARRB1;WDR54
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.43080066226200425,1.206504792565491,0.20212765957446807,0.7558939307812316,1.0,30/78,25.08%,RNF144A;PRICKLE1;CSNK1D;COP1;VCP;DVL1;NFE2L2;BCAP31;FBXO22;RNF14;SMAD7;CSNK1E;UBQLN1;DAB2;DDA1;STUB1;SIRT2;SUMO1;CDC20B;HECTD1;CDC20;CLU;USP5;LRRK2;SUMO2;DET1;TAF1;HERPUD1;RCHY1;BBS7
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5217370672263244,1.2061566235074612,0.23337515683814303,0.7562853530802548,1.0,6/20,17.17%,PID1;RHOQ;PPFIA1;CLTC;DAB2;LZTFL1
prerank,regulation of mitochondrion organization (GO:0010821),0.46251301648591053,1.2058805019548686,0.20701357466063347,0.7563933234855008,1.0,21/47,28.50%,PID1;CSNK2A2;MIEF2;RHOT2;FZD5;IAPP;RHOT1;SREBF1;USP36;SQSTM1;HDAC6;PLSCR3;FLCN;GOLPH3;MUL1;LRRK2;PINK1;CYRIB;HTRA2;SREBF2;FIS1
prerank,stress granule assembly (GO:0034063),0.5239223945358793,1.2057860698671046,0.23605706874189364,0.7558342242667124,1.0,7/20,21.60%,DYNC1H1;ATXN2L;UBAP2L;PRRC2C;CIRBP;EIF2S1;ATXN2
prerank,regulation of postsynapse organization (GO:0099175),-0.3675449801978716,-1.2054200258236327,0.19306930693069307,0.5991443782790605,1.0,11/28,10.47%,SHANK3;PPFIA2;IL1RAPL1;WNT5A;EPHA4;ARHGAP22;ABHD17C;HOMER1;ABI3;PDLIM5;KIF1A
prerank,renal absorption (GO:0070293),0.5938088175325138,1.2052508293677497,0.2503617945007236,0.7569039428713263,1.0,2/10,6.71%,GSN;MAGED2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4339738298553786,1.204776172566023,0.18152524167561762,0.757751347458618,1.0,12/76,12.28%,RASSF2;EGFR;PDCD4;CCN3;NFAT5;ILK;DLG1;RHOA;IRAK1;C1QTNF4;CD27;EZR
prerank,cardiolipin metabolic process (GO:0032048),0.5674702797213756,1.2046538295033389,0.2569906790945406,0.7573057981702112,1.0,5/13,15.85%,PLA2G4A;TAMM41;PGS1;PLA2G5;PLSCR3
prerank,T-helper cell differentiation (GO:0042093),0.5567767690236421,1.2045458115977004,0.24250681198910082,0.7568578917910597,1.0,3/14,6.47%,FOXP1;TMEM98;HMGB1
prerank,protein localization to chromatin (GO:0071168),0.5336653371782151,1.2042473740945001,0.24694708276797828,0.7570617746651045,1.0,2/18,7.49%,ESR1;SGF29
prerank,glycosaminoglycan catabolic process (GO:0006027),0.45624465251064256,1.204126225164188,0.20752565564424175,0.7566732265798387,1.0,8/55,6.93%,GPC6;FGF2;GPC3;BGN;SDC1;ARSB;CSPG4;SLC9A1
prerank,T cell migration (GO:0072678),0.5671119059053249,1.203995459456202,0.2524137931034483,0.75630563096065,1.0,2/13,7.21%,SLC12A2;CXCL16
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.43870145385173764,1.203547581285952,0.1827027027027027,0.7570287731891973,1.0,26/72,24.63%,PLAGL1;MUC1;CRADD;MDM4;NDRG1;CARM1;PCBP4;FOXM1;ATM;CHEK2;SESN2;TFDP1;ING4;CNOT8;CNOT10;RBL2;E2F1;USP10;CNOT9;HIPK2;TNKS1BP1;SFN;TRIAP1;PRMT1;TP53;RPS27L
prerank,peptidyl-glutamic acid modification (GO:0018200),0.5015100821158278,1.2034369248336088,0.25157232704402516,0.7566115083013362,1.0,8/24,16.45%,VKORC1L1;TTLL2;GGCX;AGBL5;TPGS1;CEP41;PARP1;TTLL3
prerank,cilium assembly (GO:0060271),0.4055242526743299,1.2025966551111378,0.05805805805805806,0.7587393059721904,1.0,104/296,25.71%,PKD1;GSN;CFAP298;EXOC4;EHD1;GORAB;CSNK1D;ABLIM3;PKHD1;CFAP206;DYNC1H1;DYNLT2B;RILP;ARMC9;SFI1;BBS9;ODF2;CDC14A;DNAAF3;TMEM107;ALMS1;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;CCDC39;RFX2;TCTN1;IFT80;IQCB1;DCTN2;TMEM216;CKAP5;CCDC66;RPGRIP1L;ATP6V0D1;CFAP43;PTPDC1;WDR11;SDCCAG8;AKAP9;CEP164;CSNK1E;PARVA;TRAPPC14;TRIP11;OCRL;BBS5;TMEM80;YWHAE;IFT46;MARK4;RAB23;FUZ;NUDCD3;CEP41;CEP63;PCM1;HAUS5;HDAC6;LRGUK;IFT88;NPHP3;INPP5E;TTLL3;LZTFL1;DYNC2I1;IFT43;CCDC57;TEKT2;TNPO1;TMEM237;DYNC1I2;PTPN23;DCTN1;KIF24;PRKACA;IFT27;RAB1A;ACTR1A;TMEM231;CDK5RAP2;TXNDC15;SPAG16;NEDD1;NPHP4;BBIP1;PLK4;CEP89;DYNC2H1;TCTN3;CNTRL;TMEM67;TMEM138;BBS7;TUBB4B;CEP20;FBF1;CCP110;EXOC7
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5838820337823366,1.2021177959088123,0.25316455696202533,0.7587669213476639,1.0,4/11,20.58%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5838820337823366,1.2021177959088123,0.25316455696202533,0.7587669213476639,1.0,4/11,20.58%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,histone H4-K16 acetylation (GO:0043984),0.518752147767955,1.2015790151363097,0.26397919375812745,0.7599288142435604,1.0,11/19,23.18%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;MSL1;KAT8;KMT2A;MEAF6
prerank,protein complex oligomerization (GO:0051259),0.4314718349324514,1.2014565975363602,0.18336886993603413,0.7595294642849306,1.0,25/85,21.38%,PRMT8;MPP2;EHD1;TRMT61B;NOL3;ARC;ATL2;ADCY8;LRRC8D;MCU;ATL3;SLC9A1;FUS;C9;SPAST;LETM1;MICU1;G3BP2;SHMT2;CPSF7;CPSF6;TWNK;IKZF4;PDCD6IP;ATL1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.4678686924839988,1.20132493353045,0.23563892145369286,0.759155327831746,1.0,7/41,10.32%,MGLL;PLA2G4A;CYP1B1;ELOVL5;SCD5;DAGLA;FADS1
prerank,negative regulation of cell differentiation (GO:0045596),0.40970747540570696,1.201040339268761,0.11313131313131314,0.7593088907775277,1.0,58/181,20.88%,EGFR;GDF10;ID2;WNT9A;ZFPM2;PDCD4;TWIST2;CRIM1;COL5A2;SMAD6;LRP5;TWIST1;LDLRAD4;SPRED2;WWTR1;HES5;XDH;JAG1;NBR1;SKI;SOX9;HOXA9;SRA1;NOG;ESRRB;TSKU;TRPM4;EID2B;IQCB1;RORA;BMP4;ITGAV;FOXA1;ANP32B;SMAD7;HEY1;TGFBR1;PTBP1;ABCA1;LIMD1;BMP5;IL6;SIRT2;IL17RD;NPHP3;TRIO;NEPRO;ANKRD26;EFNA1;MEN1;E2F1;SUFU;NFKBIA;EIF2AK4;CALR;CHRD;MAD2L2;GPS2
prerank,positive regulation of sodium ion transport (GO:0010765),-0.45066850736769326,-1.201005367151779,0.2260536398467433,0.6080375330855093,1.0,7/12,20.86%,CNKSR3;GPD1L;NOS1;PKP2;ANK3;SCN3B;SCN5A
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5947176832039199,1.2007121494277821,0.25936599423631124,0.7596386457191107,1.0,1/10,0.78%,VEGFA
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5820313444360768,1.2002432369981055,0.25889046941678523,0.7604459847770806,1.0,4/12,8.86%,CACNA1C;JUP;DLG1;TRPM4
prerank,response to endoplasmic reticulum stress (GO:0034976),0.41488261537629645,1.1987875693922048,0.16872427983539096,0.76462686048337,1.0,37/107,25.07%,THBS1;P4HB;MAP3K5;ATF4;VCP;AGR2;ERN2;MBTPS1;SYVN1;CDK5RAP3;HYOU1;PDIA3;NIBAN1;BCAP31;AIFM1;TNFRSF10B;HSPA5;UBA5;UBQLN1;SEC16A;USP19;UFL1;TMEM33;QRICH1;ERLEC1;RASGRF1;ATF6;EIF2S1;RCN3;EIF2AK3;DERL1;GORASP2;HERPUD1;CREB3L1;TP53;SELENOS;DNAJB12
prerank,chromosome condensation (GO:0030261),0.4770581050468345,1.1985590462652764,0.2408930669800235,0.7645482734041786,1.0,10/36,18.11%,SMC4;CSNK2A2;CSNK2A1;KMT5A;ERN2;MCPH1;PHF8;AIFM1;ACIN1;DFFB
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5578260566823916,1.1985482078747374,0.2564102564102564,0.7637404822533692,1.0,3/15,8.56%,IRS1;PRKCE;AKT2
prerank,regulation of neuron projection development (GO:0010975),-0.27984342488583774,-1.1983786416550137,0.0,0.6123264454395606,1.0,37/163,10.48%,EFNB2;LYN;PTN;LPAR1;CSMD3;APOE;ITGA6;SHANK3;PPFIA2;IL1RAPL1;PTK7;WNT5A;EPHA4;LRRC4C;RAPGEF2;CCDC88A;CHN1;CAMK1D;CTNNA2;SERPINI1;PTPRO;NTNG1;PTPN9;ROR2;TENM3;PAK3;CDH2;DCC;PRAG1;ATP1B2;PAK1;MFSD2A;ABI3;PDLIM5;PLXNB2;KIF1A;BAG5
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4649674785164228,1.197967678898298,0.22156398104265404,0.7649446326064685,1.0,4/43,1.86%,IRS1;PID1;PRKCD;GRB10
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4282244948561556,1.1975825528318982,0.17796610169491525,0.7654632987569452,1.0,20/87,12.82%,GDF10;COL3A1;ADAM9;COL1A2;LTBP2;SMAD9;SMAD6;ZMIZ1;TGFB3;TGFB2;ACVR1;SMAD4;TGFBR2;SKI;CBL;RHOA;BMPR1A;SMAD7;TGFBR1;ZMIZ2
prerank,regulation of ossification (GO:0030278),0.47304446174851394,1.1972664332088692,0.22964763061968407,0.7657465295244438,1.0,9/36,9.70%,LRP6;DDR2;SMAD6;TWIST1;TGFB2;ACVR1;NBR1;SOX9;BMP4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5846350601227899,1.1971202372615501,0.26804123711340205,0.7654670091814244,1.0,6/10,24.63%,MUC1;FOXM1;ING4;HIPK2;TP53;RPS27L
prerank,regulation of gene expression (GO:0010468),0.39568140435614735,1.1967233615062698,0.007,0.7660150771030133,1.0,213/903,18.89%,SLC38A2;BNC2;ESR1;SIX1;FOXP1;PID1;ID2;ZFHX3;HOXA5;VEGFA;ATP1B1;GAS6;C1D;F3;FGF2;ZNF423;FOXD1;IL33;GSN;SFRP4;SLC24A3;VSX1;AFF3;NFIA;EMILIN1;YBX3;COQ7;CLK1;NTRK3;FGF17;DRD1;HNRNPH1;LDB1;PRRX2;PRDM5;DMTF1;RDX;AHNAK;ACVR1B;AHNAK2;EPHB2;ANXA7;C1QTNF1;TWIST1;JMJD1C;APBB3;PRDM11;CLK3;PRDM10;MBNL1;HDAC4;GLMN;WWTR1;SBNO1;BAZ2A;TGFB2;STAT3;CD3E;TCF7L1;ZC3H7A;MLF2;ATF4;ERC1;XDH;FASTK;RAMP2;CHD3;TCFL5;AGR2;DNM2;PHF1;DVL1;PRDM6;SNRNP70;CCAR2;NFX1;NFXL1;FAM98A;ADAM10;PUM1;NFE2L2;BHLHE40;ANKRA2;FZD7;MATR3;TRRAP;ANK2;FUS;HNRNPDL;TBX21;SOX9;RPS6KA4;TRIM27;NSD1;NOG;ESRRB;BTNL9;TSKU;CARM1;DGKQ;WWP2;HNRNPL;HNRNPH2;SBNO2;MBNL2;EDN3;RORA;OGG1;MAPK8;PCBP4;BMP4;CRABP2;TMEM119;PRDM4;FAM98B;MUSK;FADS1;ABL1;UBR5;AGO1;SPTY2D1;TDG;TERT;ATM;BMPR1A;CHEK2;MAZ;PABPN1;KAT6B;RNF14;SFPQ;FUBP1;METTL16;KDM4A;NR1D2;HEY1;EZR;MARF1;PIK3CB;NELL1;TRAF3;PTRH2;TGFBR1;SERPINB9;HDAC1;AGO2;SMO;VTCN1;INHBA;PCBP2;KMT2D;SETDB1;CLK4;ERP29;PTBP1;RUNX1;TRIM26;LIMD1;USP36;ZNF148;CPSF4;HNRNPK;SERTAD3;VDR;YTHDC1;USP13;CAMK2N1;PER1;IL6;AFF4;UBAP2;HDAC6;FOXN3;NKX6-2;ZFPL1;CREBBP;MED26;ZC3H10;ZNF462;APBB1;HMG20A;FGF5;KDM6B;RBL2;CCN4;SEC16B;PRDM2;NFYA;SLC2A10;FLCN;NFKB2;MAGED1;NR3C1;RFXANK;PRKAG1;THAP7;SRSF10;CITED2;HMGA1;DAPK3;E2F1;TRIM6;RYBP;CLK2;HCFC1;SUFU;BRDT;AKT1;GDNF;ATF2;GON4L;ACTR8;GPBP1L1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.5417851589501533,1.1966372268256051,0.25691699604743085,0.765478342037551,1.0,3/16,8.96%,KLRK1;RAET1E;PLEKHM2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.4748904989488539,-1.1965561609143331,0.2229299363057325,0.6146988905804291,1.0,6/11,21.80%,CYC1;UQCRC2;UQCR11;UQCRB;UQCRC1;UQCRQ
prerank,C21-steroid hormone metabolic process (GO:0008207),0.5176459724907733,1.1961948137667722,0.23076923076923078,0.7661952456450789,1.0,4/20,13.20%,STARD3NL;AKR1C1;FDXR;DHRS9
prerank,inositol phosphate catabolic process (GO:0071545),0.5716343136272443,1.1960976108545138,0.2640218878248974,0.7656997745323757,1.0,4/12,20.58%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,endocardial cushion development (GO:0003197),0.5065394567733522,1.1960509069437648,0.24705882352941178,0.7650313584896783,1.0,10/21,12.12%,TGFB2;ACVR1;HEYL;MDM4;SOX9;NOG;CRELD1;BMP4;BMPR1A;HEY1
prerank,regulation of cell death (GO:0010941),0.426331776674451,1.1960427785536,0.18526315789473685,0.7642296766302499,1.0,14/94,9.70%,SRSF6;LRP1;FGF2;SRGAP2;CCN5;CCN3;ACER3;PRR7;LRPAP1;AGR2;TNFRSF1B;IMPACT;NOA1;BMP4
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.4597700993866782,1.1959144666843824,0.20951302378255945,0.763849751490319,1.0,10/46,11.85%,PDCD4;P4HB;ANXA2;PITPNA;IL12RB2;HNRNPA2B1;HNRNPDL;PAK2;ARF1;SOD1
prerank,lamellipodium organization (GO:0097581),-0.36338663828211093,-1.1958704557890194,0.16042780748663102,0.6140300234217674,1.0,11/29,8.77%,ABLIM1;CDH13;KIT;CCDC88A;PARVB;PTPRO;S1PR1;WHAMM;SPATA13;SPEF1;ARHGEF6
prerank,acyl-CoA biosynthetic process (GO:0071616),0.547967299001853,1.1957533900268336,0.26229508196721313,0.7635725601294018,1.0,8/16,23.19%,SCD5;CBR4;PPT2;ACAT1;ACACA;HSD17B8;GCDH;PPCS
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4319853482339746,1.1950690851078933,0.21172638436482086,0.7652073572221694,1.0,8/66,9.69%,EGFR;PKD1;ID2;FHL1;RDX;DACT1;DLG1;ANXA1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5546093586112809,1.1945559145118347,0.2613333333333333,0.7662457985058394,1.0,3/15,4.29%,DSE;BGN;CSPG4
prerank,neural crest cell development (GO:0014032),-0.3296898399248387,-1.1944884609212272,0.1796875,0.6149235640064362,1.0,19/44,23.37%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;TBX1;ERBB4;CORO1C;CDH2;SEMA4D;SEMA3G;SEMA4A;SOX11;HTR2B;SEMA4G;SEMA5B;SEMA6D;SEMA3B;NRTN;NRG1
prerank,acylglycerol biosynthetic process (GO:0046463),0.5117428953157692,1.1944438092988614,0.2582278481012658,0.7658372396324409,1.0,6/23,16.48%,PLCE1;PLA2G4A;GPAT4;AGMO;PNPLA3;PLA2G15
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5954482305254392,1.194209662418524,0.26629680998613037,0.7658365067518869,1.0,4/10,8.69%,EMILIN1;FAP;TNFRSF1B;CST3
prerank,cellular response to glucose stimulus (GO:0071333),0.4903828797510916,1.1939309220286682,0.23594132029339854,0.7659985912261413,1.0,5/30,5.38%,SLC39A14;KCNB1;GAS6;UNC13B;ADCY8
prerank,positive regulation of rRNA processing (GO:2000234),0.5924344441712927,1.1939229131706908,0.2665684830633284,0.7651941804988577,1.0,9/10,38.90%,RIOK1;WDR75;BUD23;RIOK2;TRMT112;SIRT7;UTP15;DIMT1;WDR43
prerank,morphogenesis of an epithelium (GO:0002009),0.4870832864099642,1.1930519202047984,0.2543640897755611,0.7673890238694407,1.0,3/25,9.70%,LRP6;SOX9;FGFR2
prerank,protein targeting to ER (GO:0045047),-0.2929097964582933,-1.192771398792337,0.16363636363636364,0.6168653336028989,1.0,47/99,23.32%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;RPL11;RPL18A;RPS12;RPL12;SPCS3;RPS11;UBA52;RPL18;SEC61G;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;SRP68;RPS3;RPS18;RPS19;SGTA;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,cellular response to BMP stimulus (GO:0071773),0.44044476456114257,1.19209727084067,0.2098360655737705,0.7698499715526091,1.0,15/66,12.48%,TMEM100;PDCD4;DDX5;SMAD9;SMAD6;TGFB3;TGFB2;ACVR1;SMAD4;SOX9;BMP4;RUNX2;BMPR1A;SMAD7;RGMA
prerank,histone H3-K36 demethylation (GO:0070544),0.5891186356170686,1.1918846533145957,0.28023598820059,0.7697622511642661,1.0,4/10,12.08%,RIOX2;KDM2A;PHF8;KDM4A
prerank,substantia nigra development (GO:0021762),0.47535120824845317,1.1915617718987572,0.23933649289099526,0.7700747422958075,1.0,14/37,16.85%,NDRG2;CALM2;RHOA;RAD1;HSPA5;S100A1;YWHAE;SEC16A;PLP1;ZNF148;YWHAQ;SIRT2;CKB;CALM3
prerank,negative regulation of epithelial cell migration (GO:0010633),0.47807264170008706,1.1915039610189495,0.2484548825710754,0.7694491794421356,1.0,2/33,0.14%,THBS1;SLIT2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.5666909567245741,1.1913477231958725,0.26768377253814146,0.7691920194815998,1.0,6/12,27.44%,GCLC;BDH2;GCLM;CHAC2;HAGH;OPLAH
prerank,folic acid metabolic process (GO:0046655),0.5321665779298375,1.1909604471967636,0.24281984334203655,0.7697232605020673,1.0,9/18,19.87%,SLC25A32;PM20D2;MTRR;MTHFD2;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5034077077518203,1.1909437802120748,0.2618757612667479,0.7689644690042235,1.0,7/21,14.42%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.45425074500866236,-1.1904348924400858,0.2463768115942029,0.6206215452207471,1.0,4/14,11.94%,MOXD1;ALDH9A1;NOS1;SLC22A2
prerank,urogenital system development (GO:0001655),0.5858197240181946,1.1902415209844703,0.27399165507649514,0.7706468582373385,1.0,4/11,9.69%,EPHB2;EPHB3;SOX9;ANXA1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4594796672351964,1.1901858746432767,0.21816037735849056,0.7700314877046491,1.0,12/40,24.15%,XPO1;GLMN;CSNK2A2;CSNK2A1;CDK5RAP3;AXIN1;UFL1;ARAF;HIPK2;CLU;DESI1;TAF1
prerank,peptide metabolic process (GO:0006518),0.4332593148938716,1.1896438884590985,0.21215351812366737,0.7711449961181878,1.0,23/75,19.93%,PCSK5;GSTT1;CPZ;GSTM5;HM13;DMD;CPQ;BACE2;DNPEP;BACE1;SOD1;SPCS2;CARNMT1;NLN;LNPEP;CPXM2;PSEN2;GSR;GSTZ1;IDE;NPEPPS;LVRN;SEC11A
prerank,nucleic acid metabolic process (GO:0090304),0.4399106826814917,1.1895812468785147,0.2094017094017094,0.7705474200924297,1.0,32/69,28.85%,HNRNPH1;RBFOX2;DUSP11;HNRNPA2B1;HNRNPL;HNRNPH2;WRN;GTF2F1;KPNA2;RAD50;HNRNPM;PCBP2;PTBP1;HNRNPC;HNRNPK;MMS19;POLR2F;NCBP1;NCBP2;ATXN2;HNRNPA3;HNRNPA1;POLR2B;TOPBP1;HNRNPU;RECQL5;METTL14;POLR2H;POLG;DNASE1L2;POLR2I;DXO
prerank,endocytic recycling (GO:0032456),0.44796393659008815,1.1894654310300623,0.2139588100686499,0.7701210633099035,1.0,18/50,25.38%,EHD1;ANKRD27;VPS52;EHD2;VPS26A;VPS53;RAB11B;MICALL2;DENND1B;PTPN23;VPS26C;DENND1A;SNX4;VPS51;SNX3;LMTK2;RAB11FIP4;VPS35L
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3940641631361123,1.1893474595712594,0.007,0.7697773136128682,1.0,236/807,22.37%,FOXP2;ESR1;WWP1;FOXP1;KLF12;ID2;ZFHX3;ZFPM2;VEGFA;GAS6;NFIX;ZNF423;FOXD1;SKIL;TCF7L2;PDCD4;IL33;RARB;TWIST2;DDX5;GCLC;MUC1;LDB2;LDB1;PHC2;PRICKLE1;JDP2;GLI2;MDFIC;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;CUX1;RBFOX2;HDAC4;RXRA;HES5;SIX4;STAT3;PHF21A;KMT5A;ATF4;TRIM28;NR2F1;CHD3;TCFL5;USP2;TLE6;DACT1;PRDM6;FOXC2;ZNF25;MIDEAS;CCAR2;NFX1;PER3;SMAD4;ERN2;BHLHE40;HMGB1;EZH1;SKI;HEYL;TBX21;MDM4;SOX9;EHMT1;MAEL;TRIM27;BTAF1;NRIP1;RARA;NSD1;MBTD1;PA2G4;NOG;DAP;RCOR3;FOXK1;IMPACT;DLG1;SMARCC2;WWP2;EID2B;SBNO2;MCPH1;SPINDOC;ILF3;BMP4;FGFR2;PHC3;TSC22D4;ZBTB2;SCMH1;ZFP90;MIER2;RUNX2;KDM2A;URI1;FOXM1;ATN1;POU6F1;CBX2;ID4;HSF4;MAZ;COMMD7;KAT6B;SFPQ;SMAD7;RNF2;MED25;FOXP4;KDM4A;NR1D2;HEY1;GLIS1;EZR;KHDRBS1;HDAC1;MYPOP;NPAS1;MEF2A;NACC1;MAP3K10;RUNX1;ERF;LIMD1;PIAS4;TCF25;FRK;HEXIM1;DAB2;ZNF148;RING1;VDR;YWHAQ;MBD1;L3MBTL2;ID1;PER1;ING4;SIRT2;FOXO3;HDAC6;FOXN3;NKX6-2;CREB1;VPS72;CREBBP;PARP1;KDM5C;SIN3B;UBC;RPS27A;APBB1;SUMO1;DPF3;NIPBL;PRDM2;L3MBTL3;MDFI;MTA3;CBX5;CALCA;EFNA1;FLCN;NR3C1;E4F1;CDKN1C;MEN1;LCOR;ORC2;THAP7;CITED2;HMGA1;PCGF2;E2F1;SUV39H2;HCFC1;BIRC5;ZMYND11;SUFU;ZBTB32;CHD8;CBFA2T2;SARS1;KLF10;MLXIPL;XRCC6;LARP7;CBFB;ZNF431;WWC2;LEFTY1;TCF3;TAF9B;CDK5;SCML2;NOC2L;MAX;BPTF;CALR;IKZF4;KAT7;SUV39H1;MAD2L2;GPS2;IL4;MPHOSPH8;SMURF2;RITA1;YEATS2;MIER1;SAMD11;SAP18;PEX2;PAF1;NFIC;NR2F6;CRY2;USP47;ATP8B1;LOXL2;ZNF177;ZKSCAN3;KAT8;NR2C2
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5399374387295096,1.1893299093476115,0.2743732590529248,0.7682195790784853,1.0,2/16,5.22%,THBS1;BCAS3
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5399374387295096,1.1893299093476115,0.2743732590529248,0.7682195790784853,1.0,2/16,5.22%,THBS1;BCAS3
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5556293572637413,1.1888074067731529,0.2528248587570621,0.7692517679952083,1.0,4/13,11.56%,FGF2;HMGB1;FGFR1;PDPK1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.530526202258491,1.188739817221522,0.25,0.7686990932414153,1.0,9/17,30.72%,DHDDS;ALG13;DOLPP1;ALG1;ALG3;ALG14;ALG12;ALG9;SRD5A3
prerank,calcium ion import (GO:0070509),0.48443981812034476,1.1885199787592706,0.24635922330097088,0.7685908598615849,1.0,3/28,5.91%,CACNA1G;CACNA1C;MCU
prerank,regulation of dendrite development (GO:0050773),-0.3386837431165619,-1.1883768685288085,0.16891891891891891,0.6233173538525534,1.0,16/37,16.05%,PTN;NEDD4L;CSMD3;BMP7;TNIK;HECW2;CAMK1D;DCC;VLDLR;MFSD2A;ADGRB3;SEMA4D;SARM1;LRP8;RTN4IP1;CDKL5
prerank,lysosome localization (GO:0032418),0.4688875228915738,1.1880795743091417,0.23803967327887982,0.7693305039100226,1.0,14/37,19.01%,RAB34;LAMTOR1;BLOC1S2;FAM98A;KLC2;PLEKHM2;TMEM106B;NDEL1;PLEKHM1;HDAC6;SPAG9;FLCN;SYTL4;SNAPIN
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.37058557141795595,-1.187569391443133,0.23529411764705882,0.6231888269609918,1.0,6/24,11.87%,PECAM1;VCAM1;F11R;SYK;SEMA4D;ITGA4
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.5005780092115857,1.1872199756705946,0.25866336633663367,0.7715472412805875,1.0,6/25,12.19%,HSPA2;DNAJB14;ST13;HSPA14;HSPA5;DNAJC7
prerank,neuromuscular synaptic transmission (GO:0007274),0.5307967879415285,1.1868916294340712,0.2692307692307692,0.7718866259414312,1.0,6/18,19.50%,ERC1;CHRNB2;TBC1D24;STAC3;ERC2;KIF1B
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.447948382083614,1.1867473890238478,0.22297297297297297,0.7715800096731806,1.0,27/52,28.52%,ABLIM3;CSNK2A2;HUWE1;FZD5;PPP3CC;MAPK8;YWHAE;USP36;HPS4;YWHAQ;TFDP1;MICALL2;VPS11;E2F1;BID;NPEPPS;SAE1;SFN;TP53;BAD;PINK1;YWHAB;ATG13;NMT1;HTRA2;SREBF2;BBC3
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4421661435000719,1.186533486671817,0.2508551881413911,0.7715144541482837,1.0,8/50,11.94%,EGFR;PDCD4;NFAT5;ILK;RHOA;IRAK1;C1QTNF4;CD27
prerank,regulation of leukocyte migration (GO:0002685),0.5457557221394733,1.1865054441325391,0.2849604221635884,0.770794622800712,1.0,6/16,23.70%,VEGFA;ANXA1;MIA3;HMOX1;TNFSF18;BST1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.576593417774798,1.1864330278558055,0.27125506072874495,0.7694327544396066,1.0,2/11,3.64%,SHC1;STAT5A
prerank,cellular response to interleukin-2 (GO:0071352),0.576593417774798,1.1864330278558055,0.27125506072874495,0.7694327544396066,1.0,2/11,3.64%,SHC1;STAT5A
prerank,regulation of developmental growth (GO:0048638),0.4972619924069159,1.186271034151117,0.2515262515262515,0.7691763210567921,1.0,10/29,11.85%,SIX1;CTTN;GHR;STAT5A;SIX4;AGR2;DNM2;MUSK;ABL1;SOD1
prerank,nuclear pore organization (GO:0006999),0.5464040726349386,1.1859595954192135,0.26790450928381965,0.7694436410559925,1.0,7/14,27.35%,NUP93;SEH1L;TMEM170A;NDC1;NUP35;TPR;AHCTF1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.48259505290475563,1.1857747393002258,0.25696969696969696,0.7693066637308176,1.0,7/30,12.19%,HSPA2;DNAJB14;ST13;HSPA14;UGGT1;HSPA5;DNAJC7
prerank,proteoglycan metabolic process (GO:0006029),0.49239122805080165,1.1857494299814053,0.26707317073170733,0.7685926173993439,1.0,6/26,11.97%,XYLT1;CHST11;HS3ST4;SULF1;FOXL1;GAL3ST4
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.29612023824392425,-1.1856896704927522,0.09836065573770492,0.625576703834319,1.0,44/91,23.32%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;RPL11;RPL18A;RPS12;RPL12;RPS11;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;SRP68;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.42238993405411535,-1.1851928004817878,0.24380165289256198,0.624448310806484,1.0,5/17,12.45%,BCL2;BCL2L1;DNM1L;BOK;MFF
prerank,positive regulation of reproductive process (GO:2000243),0.47989981824862715,1.1849628088693067,0.2431791221826809,0.7705243788003717,1.0,9/31,17.65%,VEGFA;TAC4;ACVR1B;PDE3A;VIP;AGO2;INHBA;SIRT2;LHFPL2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4133414240173843,-1.184958513986837,0.226890756302521,0.6226889736708562,1.0,5/17,16.69%,COX8A;COX6C;COX4I1;COX10;COX5B
prerank,regulation of phospholipase C activity (GO:1900274),0.5348500064159366,1.184913642224325,0.26594301221166894,0.7698823108534482,1.0,5/15,10.58%,ESR1;FGF2;NTRK3;FGFR1;ABL1
prerank,Golgi localization (GO:0051645),0.5739492923801162,1.1841680112841066,0.2778561354019746,0.7716726030948556,1.0,4/11,12.98%,ARCN1;COPG1;ARHGAP21;STK25
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.4519908292175701,1.1840093559196607,0.23726851851851852,0.7714208954418228,1.0,19/48,26.41%,NUP93;SEC13;RAE1;SEH1L;NOA1;OGT;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.48208550097046066,-1.1839512511974986,0.25878594249201275,0.6228003343967287,1.0,3/10,11.13%,ACTN2;SEMA5A;PLEK
prerank,neural crest cell differentiation (GO:0014033),0.5263992972195746,1.183853476024297,0.2921646746347942,0.7711406830313897,1.0,1/18,0.33%,LRP6
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5188943968264748,1.1838042509732338,0.26790450928381965,0.7704996084986487,1.0,3/18,8.56%,CMKLR1;FPR3;FCER1G
prerank,tight junction assembly (GO:0120192),-0.3113702848784945,-1.1837287571494997,0.15789473684210525,0.6210759548812008,1.0,10/49,9.00%,PARD6G;OCLN;PECAM1;CDH5;CLDN5;ESAM;LSR;F11R;APC;CLDN1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.4030054161325967,1.1834678616325134,0.17139959432048682,0.7709141051199484,1.0,51/145,25.77%,FHL1;FBXL7;PSMD7;CSNK1D;DYNC1H1;SFI1;PSMA8;BRD4;ODF2;ALMS1;DCTN2;PSMA4;CDC25B;CKAP5;PSMD12;RCC2;SDCCAG8;AKAP9;CUL1;CEP164;CSNK1E;PSMA6;YWHAE;PSMD1;CEP41;CEP63;PCM1;PSMC5;HAUS5;PSMD11;PSMC4;PSMD14;CDC25A;CDK2;DYNC1I2;PSMA3;DCTN1;PRKACA;PSMB1;PSMD4;USP47;ACTR1A;CDK5RAP2;NEDD1;PSMA5;PSMA7;PLK4;CNTRL;TUBB4B;CCP110;PSMC1
prerank,negative regulation of peptidase activity (GO:0010466),0.44963615536459156,1.1831308839027983,0.23210161662817552,0.7712988035250551,1.0,11/47,18.72%,LRP1;SERPINH1;TIMP2;TIMP3;SERPINF1;CST3;SERPINB9;SERPINE2;CRB2;AKT1;SERPING1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4473581799290091,1.1826706908670648,0.22121896162528218,0.7720523175961608,1.0,12/52,15.15%,EGFR;LRP1;PRKCE;EPHB2;EPB41L2;PLS1;AGR2;DLG1;PDPK1;SQSTM1;STAC3;STX4
prerank,mitotic DNA replication (GO:1902969),0.5825313842508485,1.1825116465353027,0.29873772791023845,0.7717976547867762,1.0,4/10,16.61%,MCMDC2;MCM2;CDC45;MCM4
prerank,mitochondrion disassembly (GO:0061726),0.47450642259052217,1.1822523014159074,0.25301204819277107,0.7719813975086196,1.0,15/34,29.90%,ULK2;WIPI2;ATG3;SQSTM1;RB1CC1;CTSK;ATG9A;PINK1;ATG2B;AMBRA1;ULK1;FIS1;CISD2;USP30;PRKN
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.4903998663033877,1.181879256662486,0.2682926829268293,0.7724478012538784,1.0,7/26,17.34%,EGFR;SOX9;SYAP1;PDPK1;IQGAP1;ERBB2;GAREM1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4270964649443255,1.1818408171537045,0.2232905982905983,0.7717925298693146,1.0,10/75,6.57%,THBS1;HOXA5;EMILIN1;ISM1;SPARC;TGFB2;SERPINF1;SEMA3E;THBS2;SULF1
prerank,negative regulation of autophagy (GO:0010507),0.43933578658966393,1.1816701374619516,0.2420591456736035,0.771552537554193,1.0,27/54,27.01%,STAT3;LZTS1;EIF4G2;NRBP2;SNRNP70;QSOX1;EIF4G3;DAP;FOXK1;SMG1;TAB2;KDM4A;EIF4G1;USP36;HGF;SIRT2;TLK2;KLHL22;AKT1;LRRK2;RUBCN;ZKSCAN3;SMCR8;PINK1;MET;GOLGA2;EIF4E
prerank,sensory perception of sound (GO:0007605),-0.29322844832075007,-1.1816634523581129,0.11594202898550725,0.6240935581406325,1.0,14/88,5.37%,USP53;COL4A3;GRM7;EYA1;CEMIP;DCDC2;RIPOR2;ADGRV1;KIT;CACNA1D;CCDC50;CLIC5;WHRN;TBX1
prerank,sphingosine metabolic process (GO:0006670),0.5247896674510748,1.1815556392037743,0.2712765957446808,0.7711273229127626,1.0,3/17,6.18%,ACER3;PLPP3;PLPP1
prerank,regulation of mitochondrial fusion (GO:0010635),0.5684062914075043,1.1813339466529977,0.2727272727272727,0.7711304095341478,1.0,2/11,7.87%,PID1;HUWE1
prerank,negative regulation of chemotaxis (GO:0050922),0.47741628358162247,1.1812210760322235,0.26153846153846155,0.7707228859586096,1.0,4/31,6.95%,THBS1;SLIT2;SEMA3E;SEMA4B
prerank,positive regulation of synapse assembly (GO:0051965),-0.37408639853065123,-1.1808765386936388,0.18994413407821228,0.6236333450898625,1.0,12/27,12.95%,NRXN1;IL1RAPL1;GRID2;PTPRD;SRPX2;SEMA4D;CLSTN1;CUX2;IL1RAP;EPHB1;SYNDIG1;VSTM5
prerank,regulation of cytokinesis (GO:0032465),0.4215059941066571,1.1807804505866342,0.21143473570658036,0.7714587767819556,1.0,26/78,25.58%,CIT;PRKCE;KIF13A;CALM2;CDC14A;GIPC1;CDC6;RHOA;PKN2;CDC25B;SPAST;GIT1;ZFYVE19;OPN1MW;CSPP1;CALM3;BIRC6;FLCN;KIF20B;DRD2;SETD2;UVRAG;PLK4;SVIL;RAB11FIP4;CCP110
prerank,regulation of B cell proliferation (GO:0030888),-0.3263248205268195,-1.180730714735622,0.11904761904761904,0.621704616484392,1.0,11/44,12.44%,LYN;BCL2;TFRC;AHR;TNFRSF21;NFATC2;CD38;VAV3;CD300A;CD74;CD40
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.39222863292923704,1.180707773390526,0.039,0.7708984749632732,1.0,163/572,22.37%,FOXP2;ESR1;FOXP1;KLF12;ID2;ZFHX3;ZFPM2;VEGFA;NFIX;NFIB;SKIL;TCF7L2;IL33;RARB;NEDD4;DDX5;LDB2;LDB1;JDP2;GLI2;PRDM5;NCOR2;GLIS2;TWIST1;DEAF1;HDAC9;CUX1;HDAC4;RXRA;HES5;STAT3;PHF21A;KMT5A;ATF4;BAG3;NR2F1;CHD3;TCFL5;USP2;TLE6;DACT1;PRDM6;FOXC2;ZNF25;NFX1;PER3;SMAD4;BHLHE40;HMGB1;EZH1;SKI;TBX21;MDM4;SOX9;TRIM27;NRIP1;RARA;NSD1;NOG;IMPACT;DLG1;WWP2;MCPH1;BMP4;FGFR2;ZBTB2;ZFP90;MIER2;URI1;FOXM1;ATN1;POU6F1;CBX2;ID4;HSF4;MAZ;SFPQ;SMAD7;RNF2;MED25;FOXP4;SRF;NR1D2;HEY1;GLIS1;EZR;HDAC1;MYPOP;MEF2A;RUNX1;NFATC3;ERF;TCF25;FRK;HEXIM1;DAB2;ZNF148;VDR;ID1;PER1;SIRT2;FOXO3;VPS72;CREBBP;PARP1;SIN3B;UBC;RPS27A;APBB1;SUMO1;NIPBL;PRDM2;MDFI;MTA3;CBX5;EFNA1;FLCN;NR3C1;E4F1;MEN1;LCOR;ORC2;THAP7;CITED2;PCGF2;E2F1;SUV39H2;HCFC1;SUFU;ZBTB32;CHD8;SARS1;KLF10;CC2D1A;LARP7;CBFB;ZNF431;WWC2;LEFTY1;TCF3;TAF9B;NFATC4;NOC2L;MAX;BPTF;CALR;SUV39H1;MAD2L2;GPS2;IL4;SMURF2;RITA1;YEATS2;MIER1;PEX2;PAF1;NFIC;NR2F6;CRY2;LOXL2;ZNF177;ZKSCAN3;NR2C2
prerank,negative regulation of immune effector process (GO:0002698),-0.44773409596812025,-1.1804820843620616,0.2518248175182482,0.6200555344280082,1.0,6/13,19.64%,ENPP3;CD300A;HAVCR2;CD55;CD47;RPS19
prerank,response to copper ion (GO:0046688),-0.39082718160871255,-1.180005638936055,0.23255813953488372,0.6188377651320981,1.0,10/20,18.03%,MT1A;MT1H;MT1M;MT1E;MT1F;MT1G;MT1X;MT1B;SNCA;MT3
prerank,negative regulation of secretion (GO:0051048),-0.5041580951117661,-1.1799966770519137,0.2703583061889251,0.6165608184502215,1.0,5/10,23.37%,NR1H3;CD74;ERBB3;PTGER3;NRG1
prerank,cell projection organization (GO:0030030),0.47987016824055617,1.1795663297947627,0.2669082125603865,0.7740172722431886,1.0,6/30,14.91%,RHOJ;GSN;RHOQ;CYFIP1;PARVA;SCIN
prerank,regulation of G0 to G1 transition (GO:0070316),0.4660975041068003,1.1792986891615833,0.23702830188679244,0.774105084233347,1.0,14/38,20.20%,EHMT1;RBBP8;PHC3;RNF2;RBBP7;RING1;L3MBTL2;TFDP1;CBX5;PCGF2;E2F1;RYBP;RAD51;MAX
prerank,mesoderm formation (GO:0001707),-0.40933045508186583,-1.179140751215541,0.21875,0.6164329356031257,1.0,4/17,9.15%,ITGB4;ITGA3;ITGA8;BMPR2
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.5596233932263699,1.178229030593391,0.28190743338008417,0.7770247439029644,1.0,3/13,9.70%,ESR1;PLPP1;BMP4
prerank,UV protection (GO:0009650),0.5788992431862394,1.1782116236472067,0.2897058823529412,0.7762992357974245,1.0,6/10,26.55%,SCARA3;ERCC5;ERCC2;CAT;SDF4;XPA
prerank,insulin receptor signaling pathway (GO:0008286),0.4290106752162715,1.1780040872123085,0.22657952069716775,0.7762126389859065,1.0,19/69,15.93%,IRS1;SLC39A14;GRB10;RHOQ;ATP6V1C2;SHC1;TCIRG1;C2CD5;FOXC2;ATP6V0A1;AKT2;ZNF106;ATP6V0D1;PHIP;PTPN2;ATP6V1B2;ATP6V1E1;SOS1;IDE
prerank,regulation of mitotic spindle organization (GO:0060236),0.4660960351010231,1.1779409775595417,0.2609727164887307,0.7756153721720647,1.0,14/35,27.12%,PARP3;RAE1;DYNC1H1;EML3;CHMP3;CLTC;DCTN1;CHMP4B;PDCD6IP;NUP62;HNRNPU;CHMP2A;TPR;DRG1
prerank,regulation of protein transport (GO:0051223),0.48137906715884915,1.1779069398081747,0.2640099626400996,0.7749625061314332,1.0,13/27,26.36%,P3H1;DISP1;LLGL1;WWP2;SCFD1;CHP1;STXBP5;GAPVD1;NDEL1;DNAJA1;SNX3;DNAJC1;NDFIP1
prerank,glycolipid biosynthetic process (GO:0009247),0.4546719682933298,1.177489657049981,0.2413793103448276,0.7755880202074046,1.0,7/38,14.13%,ST3GAL4;ST6GALNAC5;PIGW;ST3GAL2;PIGF;PIGL;PGAP2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5554316493930674,1.1774083762814602,0.28492392807745504,0.775082309382562,1.0,5/13,13.77%,NFIB;SOX9;BMP4;SRF;NFATC3
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3926958422090788,1.1773014204192724,0.052,0.77466461225252,1.0,145/497,22.44%,FOXP2;WWP1;FOXP1;ID2;IGFBP5;ZFPM2;GAS6;ZNF423;FOXD1;TCF7L2;PDCD4;TWIST2;GCLC;LDB1;PHC2;PRICKLE1;MDFIC;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;SAMD4A;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;RBFOX2;HDAC4;SIX4;KMT5A;TRIM28;MIDEAS;CCAR2;SMAD4;ERN2;BHLHE40;HEYL;TBX21;SOX9;EHMT1;MAEL;BTAF1;RARA;MBTD1;PA2G4;DAP;RCOR3;FOXK1;CDC6;SMARCC2;WWP2;EID2B;CDAN1;SBNO2;SPINDOC;ILF3;BMP4;PHC3;TSC22D4;SCMH1;RUNX2;FOXM1;ID4;COMMD7;KAT6B;SFPQ;KDM4A;NR1D2;HEY1;KHDRBS1;HDAC1;NPAS1;RBM4;NACC1;MAP3K10;LIMD1;PIAS4;HEXIM1;ZNF148;RING1;VDR;YWHAQ;MBD1;L3MBTL2;ID1;PER1;ING4;SIRT2;CNOT8;HDAC6;FOXN3;NKX6-2;KDM5C;CNOT10;SUMO1;DPF3;NIPBL;L3MBTL3;MTA3;CBX5;CALCA;NR3C1;EPRS1;CDKN1C;MEN1;THAP7;CITED2;HMGA1;DAPK3;E2F1;SUV39H2;CNOT9;SHMT1;BIRC5;ZMYND11;CHD8;CBFA2T2;KLF10;MLXIPL;SYNCRIP;XRCC6;GMNC;CDK5;SCML2;CALR;IKZF4;KAT7;SUV39H1;IL4;MPHOSPH8;SMURF2;YEATS2;SAMD11;SAP18;CRY2;FXR2;USP47;ATP8B1;LOXL2;ZKSCAN3;KAT8;EIF2AK3
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5290702479807259,1.1772352700283255,0.2693298969072165,0.7740830591253383,1.0,5/17,14.14%,MPG;ERCC5;OGG1;TDG;SMUG1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.39918193041673145,-1.1770332760370408,0.23529411764705882,0.6196699701702345,1.0,5/19,13.12%,SLCO1C1;APP;KLF2;MTPN;PAX8
prerank,organelle assembly (GO:0070925),0.39367623655600326,1.1770291955528827,0.07107107107107107,0.774058877955185,1.0,143/384,28.51%,PKD1;GSN;ULK2;CFAP298;EXOC4;EHD1;CSNK1D;ABLIM3;GOLGA8B;PKHD1;RAB43;DYNC1H1;DYNLT2B;TUBGCP3;RILP;ARMC9;PACS2;ATXN2L;BBS9;CDC14A;NEK7;TMEM107;RAB8A;IFT20;GBF1;WIPI2;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;CENPC;RFX2;TCTN1;UBAP2L;IFT80;IQCB1;SH3PXD2B;PRRC2C;CENPT;TMEM216;RAB38;CCDC66;RCC1;ATP6V0D1;TRAPPC6A;CFAP43;PTPDC1;MIS12;WDR11;ATG3;PATL1;ATG16L2;CEP164;PARVA;TRAPPC14;OCRL;DHX29;STAM2;MAPRE3;BBS5;IFT46;CHMP3;LIMD1;UBQLN1;ABCB6;RAB23;HPS4;FUZ;FARP2;NUDCD3;CEP41;CEP63;PCM1;HAUS5;HDAC6;IFT88;NPHP3;INPP5E;TTLL3;LZTFL1;DYNC2I1;CDS1;IST1;IFT43;CCDC57;RB1CC1;TEKT2;TMEM237;VTA1;PTPN23;DLGAP5;CCDC61;KIF24;CIRBP;CHMP4A;CHMP4B;EIF2A;EIF2S1;PDCD6IP;NUP62;ATG16L1;RUFY4;POGZ;ATXN2;RAB1A;MVB12A;TMEM231;TXNDC15;SPAG16;RAB1B;GORASP2;BBIP1;PLK4;SYNPO;CEP89;DYNC2H1;TCTN3;ATG9A;TMEM67;CHMP2A;TMEM138;FITM2;NCOR1;BBS7;CEP20;FBF1;EXOC7;ATG13;INTU;ACTR2;GOLGA2;ATG2B;AMBRA1;NEK6;VPS37B;YTHDF1;E2F4;TTBK2;DYNC2I2;ULK1;IFT140;UBXN2A
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5285103401482492,1.1769339772719627,0.27636849132176233,0.7736172664950582,1.0,3/17,6.52%,STAT3;GNL1;JAG1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3954465125855137,1.176901238823134,0.09218436873747494,0.7729458570673018,1.0,42/291,12.59%,SLIT2;ESR1;EGFR;IRS1;PID1;WNT9A;IGFBP5;PRKCD;LBP;ADAM9;PDCD4;DRD1;HCN4;SLC26A6;IPO5;CARD16;SHPK;PDE3A;VCP;TNFRSF1B;LAMTOR1;HMGB1;FZD7;TRIM41;SOX9;NRIP1;IMPACT;CAPN2;RHOA;SBNO2;RORA;MAPK8;CHUK;NFKBIB;IRAK1;P2RY6;GIT1;ATM;PABPN1;EZR;AKAP9;SESN2
prerank,lipid translocation (GO:0034204),0.5049771166170987,1.1767845506597208,0.2800528401585205,0.7725918031914415,1.0,6/21,13.70%,TMEM30B;ABCC1;ATP8B2;ATP8A1;ATP9A;ABCA1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.3344869333029302,-1.1764948919567477,0.2158273381294964,0.6187392907640622,1.0,10/41,7.82%,IL34;TGFA;GRM5;EPHA4;NEDD9;GPRC5B;ADRA2A;DOCK3;ACE;HBEGF
prerank,regulation of cell cycle phase transition (GO:1901987),0.4154743556617722,1.1758172469978885,0.2244467860906217,0.7751047203380582,1.0,39/91,30.18%,ANAPC5;PSMD7;CDC16;PSMA8;PSMA4;UBE2C;PSMD12;ANAPC4;ERCC3;CUL1;PSMA6;ERCC2;PSMD1;ANAPC2;PSMC5;ANAPC1;PSMD11;PSMC4;PSMD14;ANAPC10;CDC20;DBF4;CDC27;PSMA3;ATP2B4;PSMB1;PSMD4;PSMA5;PSMA7;TAF1;TP53;PSMC1;PSMA1;DDB1;BTRC;TRIM39;ANAPC11;UBE2S;PSMD2
prerank,glycine metabolic process (GO:0006544),0.5613437508483138,1.1754112251713253,0.29428172942817293,0.7757525374848734,1.0,5/12,26.94%,GCSH;GLYAT;SHMT2;SHMT1;RIDA
prerank,endosome organization (GO:0007032),0.45566323260921027,1.1749875108135452,0.238204833141542,0.7764080798016024,1.0,12/41,21.10%,DNAJC13;RILP;LAMTOR1;USP50;LAPTM4B;EEA1;WASHC4;PI4K2A;SQSTM1;VPS11;PHETA2;ARFGEF2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4800017349704838,1.174958938001346,0.29514321295143214,0.7757352353915583,1.0,3/27,1.12%,IRS1;TNFAIP8L3;FGF2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.4517521311551902,-1.174918361839761,0.2743055555555556,0.6203801997382002,1.0,4/13,12.41%,NOS3;MTHFD1L;GCH1;SPR
prerank,positive regulation of lipid kinase activity (GO:0090218),0.47291053778567693,1.17474433308759,0.27530864197530863,0.7756595226811425,1.0,3/29,1.12%,IRS1;TNFAIP8L3;FGF2
prerank,myeloid cell development (GO:0061515),0.5138799129003386,1.1746608839983845,0.27461139896373055,0.7751578323595109,1.0,2/18,4.03%,FOXP1;ANXA2
prerank,defense response to symbiont (GO:0140546),-0.27493240243353556,-1.1745403294686338,0.16176470588235295,0.619154583490138,1.0,20/92,12.64%,SERINC3;BCL2;BCL2L1;IFNAR2;STAT1;AGBL4;ABCC9;SAMHD1;IFITM1;NLRC5;BST2;IFIT3;IFIT2;RNASEL;IFIT1;PQBP1;CD40;RSAD2;IFITM3;OAS2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5622809875216856,1.1742749157782753,0.3133047210300429,0.77566344456101,1.0,4/12,10.44%,MBTPS1;DGKQ;SREBF1;LPCAT3
prerank,negative regulation of axonogenesis (GO:0050771),0.4813343501232865,1.1741287838187813,0.26838235294117646,0.7753913663352394,1.0,5/27,9.02%,FGF13;ULK2;GDI1;PTPRS;RHOA
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5301912893357531,1.173957883662653,0.2857142857142857,0.7752454926627275,1.0,4/17,6.89%,IGFBP5;DOCK4;DOCK7;DOCK5
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.42927430491851787,1.1737642256606209,0.2275711159737418,0.7751407591651989,1.0,30/66,29.40%,PRKCD;IPO5;WWTR1;LIMK2;TRIM28;BAG3;MAVS;JUP;CDK5RAP3;ZIC1;UBR5;TERT;SESN2;ORMDL3;RBM22;AKT1;CCT4;LARP7;CCT6A;KAT7;CCT8;EIF2AK3;TCP1;EFCAB7;TPR;DKC1;LIF;CCT5;TESK1;MEPCE
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4599937874521917,1.1733441113083691,0.25934579439252337,0.7757996360120886,1.0,8/40,18.50%,LBP;RNASE7;RNASE3;GBP6;RNASE6;DEFB1;IL6;DMBT1
prerank,regulation of protein modification process (GO:0031399),-0.31181281704140884,-1.1730366105664478,0.14782608695652175,0.6208115330852051,1.0,14/50,16.19%,LYN;GRM5;CDH5;PPP1R16B;CCDC88A;CORO1C;HSPB1;SPRED1;PLXNB2;FN1;CCDC88C;CADM4;PTK2;PML
prerank,cellular response to topologically incorrect protein (GO:0035967),0.4734330672090398,1.172854484703819,0.27261462205700127,0.7767206910738332,1.0,15/31,27.83%,HSPA2;BAG3;DNAJB14;HSPA14;HSPA5;STUB1;HDAC6;DNAJC18;OPTN;DNAJB12;UBE2W;DAXX;HSPB8;ERN1;HSF1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5272715661343013,1.1723529960431454,0.2898172323759791,0.7776339495963934,1.0,7/18,12.39%,RDX;DACT1;RIC1;CDK5RAP3;RGP1;EZR;NELL1
prerank,response to lipopolysaccharide (GO:0032496),0.4019367788106384,1.1722741934580816,0.18545081967213115,0.777171006596319,1.0,27/138,15.25%,FOXP1;LBP;ADAM9;PDCD4;SMAD6;CARD16;SHPK;TNFRSF1B;HMGB1;IRAK3;TRIM41;LIAS;RHOA;SBNO2;MAPK8;NFKBIB;IRAK1;TAB2;GIT1;PABPN1;F2R;CD80;CASP1;SRR;PRDX3;CYP27B1;IL6
prerank,water-soluble vitamin metabolic process (GO:0006767),0.43196662770180955,1.1722614927330992,0.23522853957636566,0.77643537327463,1.0,17/68,19.87%,SLC23A1;SLC23A2;SLC5A6;AOX1;ABCC1;SLC25A32;MTRR;MMAB;NNMT;MTHFD2;GSTO2;ALDH1L2;MTHFD1;SHMT2;SHMT1;RFK;MTHFR
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.413789470895381,1.1717674523689197,0.21481481481481482,0.7773511437830719,1.0,38/94,25.58%,CSNK1D;DYNC1H1;SFI1;ODF2;ALMS1;CC2D2A;TCTN1;IQCB1;DCTN2;TMEM216;CKAP5;RPGRIP1L;SDCCAG8;AKAP9;CEP164;CSNK1E;YWHAE;MARK4;CEP41;CEP63;PCM1;HAUS5;DYNC1I2;DCTN1;KIF24;PRKACA;ACTR1A;CDK5RAP2;NEDD1;NPHP4;PLK4;CEP89;TCTN3;CNTRL;TMEM67;TUBB4B;FBF1;CCP110
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.47687824734076945,-1.171519021131446,0.2643312101910828,0.6225261771412126,1.0,4/10,17.81%,CX3CR1;CEACAM1;LGALS9;ARRB2
prerank,response to metal ion (GO:0010038),0.43047752186083477,1.1714837549679744,0.23186813186813188,0.7776022125767059,1.0,8/67,9.75%,THBS1;ADAM9;NEDD4;SEC31A;CALM2;FXN;NDRG1;SLC30A5
prerank,negative regulation of protein secretion (GO:0050709),0.45628766807313187,1.1713888746222734,0.26143024618991795,0.7771658480358064,1.0,3/38,1.72%,IRS1;KCNB1;CCN3
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.2754417811909268,-1.1712453390976236,0.1388888888888889,0.6210357439592347,1.0,26/107,11.55%,ATP1A2;GRM7;GRM5;MCTP1;GRM3;LRRC4C;APP;RIMS2;GRM8;GRID2;NRG3;GRM1;GRIK2;RIMS1;EIF4EBP2;OPHN1;MCTP2;CDH2;SLC8A3;HOMER1;SYN1;LGI1;NMU;CX3CR1;CNTNAP4;CLSTN1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3900240092786504,1.1711848838849448,0.087,0.7770710070856999,1.0,90/366,19.78%,BNC2;ESR1;SIX1;ZFHX3;ZNF423;VSX1;NFIA;LDB1;PRRX2;DMTF1;ACVR1B;JMJD1C;APBB3;WWTR1;SBNO1;BAZ2A;STAT3;TCF7L1;MLF2;ATF4;ERC1;CHD3;TCFL5;DNM2;PHF1;DVL1;TOM1L1;CCAR2;NFX1;NFXL1;BHLHE40;FZD7;TRRAP;FUS;TBX21;RPS6KA4;NSD1;CYFIP1;ESRRB;SMC3;RBBP6;CARM1;SBNO2;RORA;OGG1;CRABP2;FADS1;ABL1;SPTY2D1;CHEK2;KAT6B;RNF14;SFPQ;NR1D2;TGFBR1;KMT2D;NOLC1;LIMD1;SERTAD3;USP13;FOXO3;FOXN3;NKX6-2;ZFPL1;CREBBP;APBB1;HMG20A;PRDM2;NFYA;NFKB2;MAGED1;NR3C1;THAP7;SRSF10;HMGA1;DAPK3;E2F1;RYBP;HCFC1;SUFU;BRDT;ATF2;GON4L;ACTR8;GPBP1L1;MLXIPL;TEAD2;ZNF431;WWC2;TCF3
prerank,NAD biosynthetic process (GO:0009435),0.5175536739466305,1.1708818385326694,0.27054361567635904,0.7773383769518483,1.0,6/20,15.89%,PTGIS;QPRT;NNMT;NMNAT3;NMNAT2;NAPRT
prerank,protein deneddylation (GO:0000338),0.5915325795675097,1.1706694355672078,0.2890855457227139,0.7772514366722555,1.0,7/10,34.49%,GPS1;COPS4;COPS7A;COPS3;COPS5;COPS2;COPS7B
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5486850718745888,1.1706202536284236,0.2673130193905817,0.7766655321655915,1.0,5/13,9.70%,PRICKLE1;SOX9;SRA1;EID2B;BMP4
prerank,negative regulation of kinase activity (GO:0033673),0.4277612317254604,1.1704181895615202,0.23119469026548672,0.7765784442277878,1.0,24/62,25.19%,LRP6;UBASH3B;WWTR1;DVL1;TRIM27;AKT1S1;PAK2;PDPK1;DEPTOR;CHP1;PRDX3;CAMK2N1;GSKIP;NF1;CDKN1C;AKT1;DUSP19;RTRAF;SFN;TSC2;HNRNPU;NPRL2;SMCR8;QARS1
prerank,regulation of defense response to virus (GO:0050688),0.544989329750632,1.1703422368972372,0.28415300546448086,0.7760670675631643,1.0,8/14,27.83%,IFNLR1;ITCH;TRAF3;PCBP2;RNF216;C1QBP;ILRUN;PPM1B
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5179279259634407,1.1698388033945755,0.27897574123989216,0.7770133623992392,1.0,7/17,19.16%,PID1;HDAC4;ACTN3;GIT1;PARP1;FLCN;MLXIPL
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.4644556227112474,1.1697596405139261,0.2528216704288939,0.7765211959652332,1.0,8/39,8.95%,FHL1;FXYD5;NEDD4;PTPN3;KCNE5;STK39;ANK2;WWP2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4198449614936152,1.1694032870683766,0.226215644820296,0.7769782977184193,1.0,15/88,12.60%,THBS1;PGF;VEGFA;F3;FGF2;SPARC;STAT5A;XDH;PRKCA;SULF1;BMP4;AGGF1;VIP;NRP1;TGFBR1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4336381641038691,1.1693928413809374,0.24179431072210067,0.7762434396561032,1.0,13/67,14.31%,MYOC;P4HB;VIT;CD3E;AGR2;ILK;S100A10;DOCK5;JUP;ABL1;NRP1;ARL2;NDNF
prerank,regulation of mitotic cell cycle (GO:0007346),0.4016479571216018,1.1691870086285878,0.17842741935483872,0.7762130091251538,1.0,74/171,30.21%,SMOC2;TTC28;PTPN3;ANAPC5;PSMD7;GAS1;CDC16;PRKCA;USP2;PSMA8;NEK7;GBF1;CDK10;SRA1;CDK5RAP3;PKN2;PSMA4;CDC25B;FOXA1;INTS13;UBE2C;RCC1;PSMD12;ANAPC4;ERCC3;CUL1;PSMA6;ERCC2;PSMD1;ANAPC2;IQGAP1;PSMC5;ANAPC1;PSMD11;PSMC4;PSMD14;ANAPC10;CDKN1C;DAPK3;KIF20B;CDC20;CCDC57;HECA;CDC27;CKS1B;DLGAP5;PSMA3;PSMB1;PSMD4;CUL9;RNF20;PSMA5;CYLD;PSMA7;HNRNPU;RPS6KB1;CDK13;PSMC1;CCDC8;CUL7;EIF4E;NEK6;PSMA1;HSF1;USP22;DDB1;CDK9;BTRC;BTG3;PRMT5;ANAPC11;UBE2S;PSMD2;TTLL12
prerank,glial cell development (GO:0021782),-0.3766215126953019,-1.1691103194812746,0.21890547263681592,0.6240949866411621,1.0,12/25,19.95%,CDK6;APP;EIF2B3;CSPG5;NRROS;EIF2B1;SOX11;MT3;MXRA8;MDK;DLL1;SOX4
prerank,mRNA modification (GO:0016556),0.4936677703716552,1.1690400469942268,0.28192161820480405,0.7759150038962288,1.0,10/22,26.90%,TRMT61B;METTL16;PUS3;TRUB1;TRMT6;TRMT61A;PUS1;METTL8;METTL14;DKC1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4647473055490917,1.1682591173581347,0.2796208530805687,0.7777311892192036,1.0,9/33,15.68%,HOXA5;ACVR1B;RAB7B;STAT3;PRKDC;PITHD1;INHBA;SCIN;FOXO3
prerank,myeloid cell activation involved in immune response (GO:0002275),0.5129697922737654,1.1680639102654744,0.2851351351351351,0.7776028815197905,1.0,3/18,9.20%,LBP;FCER1G;SBNO2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.4674424793389168,1.1679647718276513,0.2623941958887545,0.7771631755986749,1.0,4/32,5.16%,SLC4A4;PID1;ACTN3;VCP
prerank,establishment of epithelial cell polarity (GO:0090162),0.5049796385214679,1.16754711946656,0.29653401797175866,0.7778811687140333,1.0,10/19,26.51%,CYTH3;RHOA;SYNE4;MYO9A;EZR;SIPA1L3;GOLPH3;CAMSAP3;FBF1;PARD3
prerank,positive regulation of DNA repair (GO:0045739),0.44507009649464774,1.1671441604309725,0.2637106184364061,0.778530692657649,1.0,11/46,16.87%,EGFR;EYA2;TRIM28;ERCC8;HMGB1;SLF2;SPIDR;FOXM1;SPIRE2;PARP1;FAM168A
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.45483335338080677,-1.166343162968034,0.23049645390070922,0.6288624229549257,1.0,1/12,1.21%,IL1R1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3977096191492561,1.1659716018520252,0.18014329580348004,0.7817823507127699,1.0,21/151,13.07%,BMPER;EGFR;TNFAIP8L3;GAS6;FGF2;NTRK3;NTRK1;FSHR;CCL13;SHC1;CCL15;PRKCA;HMGB1;ROR1;FGFR2;PLA2G5;MAP3K12;P2RY6;ARHGAP8;NRP1;F2R
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5340054439924175,1.1659686939014398,0.281767955801105,0.7810298525407205,1.0,5/14,14.33%,AK5;AK3;DCTPP1;SMPDL3A;AK1
prerank,lung epithelium development (GO:0060428),0.5836078538485097,1.1659193040771876,0.2691176470588235,0.7804338850052903,1.0,2/10,9.70%,PKD1;BMP4
prerank,myeloid cell differentiation (GO:0030099),-0.3066634722079866,-1.1658001413916015,0.17073170731707318,0.628026719027908,1.0,6/47,3.82%,LYN;MFHAS1;KIT;ZBTB16;SNRK;RPS14
prerank,mitochondrion morphogenesis (GO:0070584),0.5714338393892873,1.165726992578442,0.3024251069900143,0.780324156337447,1.0,1/11,0.49%,PID1
prerank,hemopoiesis (GO:0030097),-0.2831090163384131,-1.1656725783371356,0.11538461538461539,0.626116580104258,1.0,22/87,13.04%,FLT1;TGFBR3;MECOM;TEK;WNT5A;KIT;ZBTB16;SNRK;KDR;MEIS1;NOTCH4;FLT3LG;FLT4;SH2B3;TAL1;HIPK1;PLEK;ETV6;KITLG;SFRP1;PRKX;CD34
prerank,cellular response to interleukin-6 (GO:0071354),0.4787796788067637,1.165646970979513,0.2814814814814815,0.7798354651812448,1.0,6/26,9.20%,PID1;PTGIS;STAT3;SMAD4;CBL;SBNO2
prerank,amyloid fibril formation (GO:1990000),0.4365232598558943,1.1653540292389484,0.25510204081632654,0.7800657173765123,1.0,15/51,17.16%,GSN;TGFBI;SNCAIP;ADAM10;GGA2;IAPP;CST3;BACE1;RIPK3;UBE2L6;GGA1;UBC;RPS27A;SERF1A;CALCA
prerank,cellular response to interleukin-12 (GO:0071349),0.44491253768137806,1.1647427589198145,0.24067796610169492,0.7813285120394682,1.0,10/48,11.85%,PDCD4;P4HB;ANXA2;PITPNA;IL12RB2;HNRNPA2B1;HNRNPDL;PAK2;ARF1;SOD1
prerank,activin receptor signaling pathway (GO:0032924),0.534731229247824,1.1642961676712948,0.2925531914893617,0.7820584003117704,1.0,4/15,13.02%,ACVR1B;ACVR1;TGFBR1;INHBA
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4874707024828306,1.1639432779962007,0.2858926342072409,0.7825373192583044,1.0,3/23,11.17%,GAS6;CARD16;GIT1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.46864751821409223,-1.1635492110676702,0.271523178807947,0.6293981191585487,1.0,4/10,3.11%,ATP1A2;NEDD4L;OSR1;HECW2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.44577692904655036,-1.1634522130499334,0.2527075812274368,0.6274072068944336,1.0,4/12,9.47%,PPARA;ABCG1;NR1H3;ABCA5
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3547129085610277,-1.1634035610198679,0.2393617021276596,0.6253483100641161,1.0,6/28,4.15%,PTN;APOE;SHANK3;EPHA4;APP;ADCY1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4347992455426344,-1.1633660462871633,0.25096525096525096,0.6232718535532163,1.0,5/14,13.30%,LIMS2;LOXL3;EMP2;CD63;PRKD1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.45980959370340035,1.1632118071330568,0.27400468384074944,0.7841637085198787,1.0,7/37,12.73%,IGFBP5;FGF2;PDCD4;TGFB3;P2RY6;BMPR1A;MEF2D
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.4559806697980554,-1.163011758443255,0.25396825396825395,0.6219812531012212,1.0,6/11,20.35%,PPARA;SLC30A10;TRAP1;ABCD2;ABCB7;SLC18A2
prerank,aminoglycan metabolic process (GO:0006022),0.5769050151609364,1.1624141571687578,0.3134978229317852,0.786057190828041,1.0,1/10,0.50%,XYLT1
prerank,response to laminar fluid shear stress (GO:0034616),0.5721406826971159,1.1622061739085014,0.29753265602322204,0.7860216679256717,1.0,4/10,13.70%,SMAD6;NFE2L2;SMAD7;ABCA1
prerank,transferrin transport (GO:0033572),0.45770606265252617,1.1619133874352818,0.2845238095238095,0.7862674435377057,1.0,14/33,25.07%,ATP6V1C2;TCIRG1;DNM2;ATP6V0A1;ATP6V0D1;ATP6V1B2;RAB11B;CLTC;ATP6V1E1;ATP6V1C1;STEAP3;ATP6V0E1;LMTK2;ATP6V0B
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.45994276178097376,1.161856776900824,0.2651869158878505,0.7857235665863836,1.0,15/37,24.93%,ENTPD2;SIDT2;ENTPD6;PPP1R8;RNASE3;RNASE6;SUPV3L1;SND1;NCBP1;DFFB;ENTPD7;MTREX;ENTPD5;PABPC4;NUDT18
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.41788998212353246,1.1611016832550305,0.25813449023861174,0.787545997462188,1.0,24/74,23.57%,VEGFA;PSMD7;PSMA8;NFE2L2;PSMA4;PSMD12;PSMA6;LIMD1;PSMD1;SIRT2;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;UBC;RPS27A;HIGD1A;CITED2;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,limb development (GO:0060173),0.47347256956290856,1.160755699758221,0.28641975308641976,0.7879264605754751,1.0,3/28,2.64%,SMOC1;PCSK5;COMP
prerank,myeloid dendritic cell activation (GO:0001773),0.5584380823136618,1.1607083266850295,0.30428571428571427,0.7873194517703621,1.0,4/12,20.96%,TGFBR2;HMGB1;CAMK4;IL4
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5664569524997339,1.160582891535343,0.3146374829001368,0.7869963545080063,1.0,6/10,29.78%,BAG3;IMPACT;SIRT2;CITED2;NCK1;DNAJB1
prerank,protein localization to microtubule organizing center (GO:1905508),0.525980523778216,1.160291568334012,0.3172043010752688,0.7872216520554769,1.0,7/15,32.66%,CSNK1D;DCTN2;PCM1;NEDD1;STIL;C2CD3;PIBF1
prerank,cell differentiation in hindbrain (GO:0021533),-0.447117782595816,-1.1597902002973532,0.296551724137931,0.6280728605552235,1.0,7/11,24.35%,GRID2;PROX1;OPHN1;FAIM2;LHX1;CBLN1;CEND1
prerank,positive regulation of filopodium assembly (GO:0051491),0.4861135296502359,1.1597384475560364,0.2961104140526976,0.7883427145132291,1.0,10/24,15.88%,ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;TENM1;NRP1;MIEN1;NLGN1;PALM
prerank,kidney development (GO:0001822),0.42512586613221376,1.1595716926351562,0.25732899022801303,0.7881614864601466,1.0,16/65,19.33%,SIX1;PKD1;VEGFA;PCSK5;GLI2;TGFB2;SULF1;PYGO1;BMP4;TGFBR1;IFT88;NPHP3;NF1;NIPBL;GDNF;SULF2
prerank,oligosaccharide metabolic process (GO:0009311),0.4386512174478182,1.1595193726232802,0.267816091954023,0.7875837961892345,1.0,9/46,11.97%,ST3GAL4;ST8SIA2;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;MAN2C1;FUT4;GAL3ST4
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3825976566457528,-1.158993734555336,0.2345132743362832,0.625758396646761,1.0,12/22,28.06%,ZDHHC14;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3825976566457528,-1.158993734555336,0.2345132743362832,0.625758396646761,1.0,12/22,28.06%,ZDHHC14;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,neuron fate commitment (GO:0048663),0.5398704051576139,1.158762534890026,0.28983516483516486,0.7893363521088771,1.0,1/14,0.58%,ID2
prerank,regulation of glucose metabolic process (GO:0010906),0.4619666493992256,1.1583832121302098,0.2747909199522103,0.7898556214285789,1.0,10/34,18.69%,IRS1;AKT2;FOXK1;DGKQ;OGT;RORA;USP7;GNMT;BCKDK;AKT1
prerank,response to amyloid-beta (GO:1904645),-0.32239359720778044,-1.158267986419106,0.1875,0.6254052861153946,1.0,13/44,14.20%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;CASP4;GRIN2A;SNX6;ITGA4;IGF1;CACNB1;GRIN1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4645989596168817,1.158057449905356,0.2845138055222089,0.790225879487055,1.0,6/33,5.88%,ADAM9;MUC1;CYP1B1;TGFB2;ADA;FOXC2
prerank,nucleotide-excision repair (GO:0006289),0.4141797427737614,1.1579351620783376,0.22645502645502646,0.7899204873717319,1.0,56/101,34.68%,CHD1L;ERCC8;GPS1;ERCC5;HMGN1;ERCC4;OGG1;CUL4A;USP45;ERCC3;XAB2;LIG4;USP7;ERCC2;MMS19;POLR2F;ISY1;PARP1;UBC;RPS27A;HUS1;POLB;SLC30A9;AQR;COPS4;POLR2B;COPS7A;TP53;UVSSA;POLD1;GTF2H4;SLX4;RNF111;POLR2H;COPS3;XPA;PNKP;DDB1;POLR2I;RBX1;POLR2L;COPS5;XRCC1;ERCC1;RAD23B;ERCC6;POLR2K;POLK;RPA3;CUL4B;CCNH;COPS2;CETN2;FAN1;COPS7B;RFC4
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5815652524421027,1.1576303464095024,0.321377331420373,0.7902473623293043,1.0,4/10,6.02%,PRKCD;RDX;C1QTNF1;CD9
prerank,regulation of receptor binding (GO:1900120),-0.46559206210104487,-1.1575310551007236,0.2909698996655518,0.6251728419873794,1.0,3/10,8.72%,B2M;GREM2;ATP2A3
prerank,DNA alkylation (GO:0006305),0.5044189232499092,1.157481701814528,0.3013157894736842,0.7892337049056689,1.0,8/19,26.54%,BAZ2A;TEX15;EHMT1;MTRR;FOS;DNMT1;EHMT2;DNMT3A
prerank,DNA methylation or demethylation (GO:0044728),0.5044189232499092,1.157481701814528,0.3013157894736842,0.7892337049056689,1.0,8/19,26.54%,BAZ2A;TEX15;EHMT1;MTRR;FOS;DNMT1;EHMT2;DNMT3A
prerank,DNA metabolic process (GO:0006259),0.39221962341218486,1.1574113121311316,0.1540785498489426,0.7887150963289713,1.0,119/270,33.13%,TCF7L2;HELB;PARP3;CHD1L;UBE2B;TRIM28;MPG;POLE2;VCP;PRKDC;HMGB1;RMI2;INTS3;TRRAP;KMT5C;MCM2;ERCC5;DCTPP1;CDC6;RBBP8;ERCC4;RAD1;OGG1;WRN;TDG;KPNA2;TERT;ATM;USP45;TDP1;ERCC3;RAD50;LONP1;CSNK1E;CDC45;LIG4;ALKBH1;USP7;SUPV3L1;SMUG1;DCLRE1B;MMS19;ATRIP;UBE2V2;PARP1;UBC;RPS27A;HUS1;MCM4;TSN;SUMO1;POLB;SMARCAD1;MEN1;ORC2;CDT1;DFFB;TOP3B;UHRF2;DBF4;RAD51;CDK2;XRCC6;FANCG;XRCC3;ENDOV;UPF1;TOPBP1;TOP1;PDS5A;TOP1MT;UVRAG;PRIMPOL;ALKBH3;SMC1A;DNMT1;TOP3A;PARG;PRIM1;RECQL5;POLD1;GTF2H4;SLX4;MCM7;POLG;XPA;PARP4;ZRANB3;RTEL1;RPAIN;DNASE1L2;NOP53;PNKP;ADPRS;DDB1;ATR;SMARCAL1;IGHMBP2;MBD4;RAD52;PDS5B;TIMELESS;CTC1;RAD17;HINFP;UBE2A;MSH2;UBE2N;BLM;XRCC1;ERCC1;CHRNA4;CNBP;POLK;POLQ;GLRX2;RPA3;PURA;SIRT7
prerank,negative regulation of bone remodeling (GO:0046851),0.5579882224499174,1.1568153072491039,0.29819694868238555,0.7898862792197449,1.0,4/11,17.16%,UBASH3B;TMEM119;IL6;CALCA
prerank,sphingolipid catabolic process (GO:0030149),0.5254744721102418,1.1564304278733144,0.30536451169188444,0.7904397437579611,1.0,4/15,9.60%,ACER3;PDXDC1;SMPD4;SMPDL3A
prerank,negative regulation of catabolic process (GO:0009895),0.4379270051467312,1.1563677827747072,0.2705202312138728,0.7898790899513836,1.0,11/47,16.82%,EGFR;HDAC4;ACTN3;RILP;IRAK3;MDM4;CST3;GIT1;CIDEA;SIRT2;AZIN1
prerank,protein localization to vacuole (GO:0072665),-0.4373510537476241,-1.1562749449493361,0.29454545454545455,0.6261793492579041,1.0,7/13,27.45%,LAMTOR5;SH3BP4;ATP13A2;LAMTOR4;LMBRD1;RTN4;MFSD1
prerank,peptidyl-lysine methylation (GO:0018022),0.48167839285699227,1.1552893466301408,0.29040097205346294,0.7927214138262773,1.0,12/26,26.50%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETD4;SUV39H2;SUV39H1;SETD2;SMYD2;TRMT112;EHMT2;SETD7
prerank,regulation of synapse assembly (GO:0051963),0.441174753228724,1.1551573986072212,0.2706155632984901,0.792428479196963,1.0,11/46,13.02%,SLIT1;GPC6;EPHB2;CLSTN2;LRFN4;EPHB3;CHRNB2;MUSK;SETD5;EIF4G1;NLGN1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5349364673343769,1.1548895467626656,0.29894179894179895,0.7925718032987978,1.0,3/14,8.56%,IRS1;TWIST1;AKT2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3819548748633195,1.1545162467578505,0.035,0.793152030039534,1.0,200/834,20.42%,PLAGL1;ESR1;EGFR;LRP6;SIX1;MICAL2;PKD1;PID1;ZFHX3;HOXA5;ZFPM2;VEGFA;NFIX;FGF2;NFIB;TCF7L2;IL33;RARB;ELF4;SMAD9;NFIA;GALR1;DDX17;RHOQ;MUC1;LDB2;LDB1;ZMIZ1;GLI2;TCF20;LRP5;GNL3;GLIS2;TGFB3;TWIST1;PRDM10;NFAT5;HDAC4;ELF1;HOXB3;GCN1;RXRA;ONECUT2;MEOX2;WWTR1;KLF5;TGFB2;STAT3;DCAF6;ATF4;NR2F1;MAVS;BCAS3;KMT2C;ACVR1;BRD4;DVL1;FOXC2;BCL9L;RXRB;PRKDC;SMAD4;NFE2L2;HMGB1;JAG1;MEF2B;SLC9A1;E2F3;PBX1;MEIS3;SKI;HEYL;THRAP3;JUP;SOX9;ARF4;RPS6KA4;NRIP1;RARA;FOXJ3;MED13;FZD5;ESRRB;TFE3;ZNF76;NFATC1;OGT;SBNO2;CDK12;RORA;BMP4;FGFR2;FOXA1;UBP1;CSRNP1;PRDM4;SREBF1;EHF;CHUK;RUNX2;GTF2F1;FOXM1;ABL1;AGO1;RFX5;CCNT2;CSRP3;PLAC8;TERT;NRF1;ATM;BMPR1A;KAT6B;PAXBP1;SFPQ;TAF6;SMAD7;MED25;PHIP;SRF;NR1D2;HEY1;GLIS1;KAT2A;SSBP3;RGMA;HDAC1;AGO2;PTOV1;MEF2D;ZMIZ2;HOXB4;INHBA;KMT2D;MEF2A;RUNX1;NFATC3;SQSTM1;DAB2;BMP5;VDR;MED21;TFDP1;PER1;HGF;IL6;ARRB1;GRHL1;SIRT2;CRTC2;FOXO3;CREB1;CREBBP;PARP1;AATF;ZNF462;UBC;RPS27A;APBB1;KDM6B;DPF3;PRDM2;FLCN;NFKB2;SLC30A9;NR3C1;RFXANK;E4F1;MED14;MEN1;CITED2;HMGA1;ATAD2B;MED12;E2F1;HCFC1;GDNF;ATF2;CCDC62;CHD8;HIPK2;KLF10;HOXB2;MLXIPL;BRD8;FOSL2;XRCC6;LARP7;IRF3;VEZF1;MPND;NFKBIA;TCF3;DLGAP5;ATF6;MAX;BPTF;TET2;RTRAF;KAT7
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.48942175375208236,1.1543611103016176,0.2893401015228426,0.7929401210502983,1.0,3/24,1.86%,NEDD4;EMILIN1;GRB10
prerank,protein dephosphorylation (GO:0006470),-0.2584392585062973,-1.15435206277422,0.05555555555555555,0.628771404295896,1.0,27/135,10.32%,PTPRG;PTPRB;PPP2R2B;PTPN13;EYA1;PPM1E;PTPN14;PPP1CB;DUSP16;PTPRD;PTPRO;PPP4R1;PTPN9;DUSP10;CTTNBP2NL;PPP2R2C;EYA4;PTPN4;DUSP3;MTMR3;PTPRK;SSH2;PPP2R3A;CTDSP1;PPP2CB;PPM1G;DUSP22
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5553990987947933,1.1536389241651464,0.3090909090909091,0.794561096469302,1.0,1/12,1.29%,IL33
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.4708198154807443,1.15353302971315,0.29044117647058826,0.7941836150891166,1.0,5/29,6.32%,SLIT2;PRKCD;LIMA1;PFN2;SMAD4
prerank,zinc ion transmembrane transport (GO:0071577),0.48883704653172266,1.1535286197945165,0.30287859824780977,0.7934572946830878,1.0,7/22,16.53%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;SLC39A3;SLC30A6
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5524123765129287,1.153301187708552,0.30575035063113604,0.793402762726953,1.0,7/12,24.79%,TRIM28;RESF1;SETDB1;MPHOSPH8;TASOR;SETDB2;DNMT1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.39534711448593784,-1.1531826048901268,0.2783018867924528,0.6294421784124085,1.0,4/19,3.85%,GRM5;RYR2;KDR;VCAM1
prerank,telomere capping (GO:0016233),0.5205416853366387,1.153022277361972,0.3133159268929504,0.7936216632390375,1.0,5/16,15.19%,PRKDC;TEN1;RAD50;DCLRE1B;TFIP11
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.42196992306082937,1.1530210333020068,0.26362625139043383,0.7928848588942665,1.0,32/59,33.56%,TCF7L2;TWIST1;TRIM28;MED27;SOX9;MED31;MED13;RUNX2;AGO1;MED25;IL6;MED26;MED14;MED12;CBFB;MED20;BCLAF1;TP53;MED23;CCNC;MED24;TNRC6A;MED8;SETX;MECP2;MED15;CTNNB1;MOV10;NFKB1;MED1;CEBPB;RELA
prerank,intracellular cholesterol transport (GO:0032367),0.529086305252114,1.1528211321563333,0.3086092715231788,0.7928244969473516,1.0,4/15,13.70%,LRP6;NPC1;OSBP;ABCA1
prerank,natural killer cell activation (GO:0030101),0.4912006108960095,1.1527200035212872,0.299625468164794,0.7924126113282911,1.0,3/23,7.11%,ELF4;KLRK1;PBX1
prerank,protein kinase A signaling (GO:0010737),0.5528787975446937,1.1527150579324064,0.3125,0.7916882906552329,1.0,3/12,12.28%,TCP11;RDX;EZR
prerank,positive regulation of cell junction assembly (GO:1901890),0.42742041524386865,1.1527081423471641,0.27192008879023305,0.7909736767569785,1.0,7/56,5.98%,MYOC;VEGFA;COL16A1;EPHB2;CLSTN2;EPHB3;S100A10
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.45731720998997705,1.152589506015575,0.2764227642276423,0.7906305285662976,1.0,12/37,19.32%,FHIT;CSNK2A2;CSNK2A1;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;RYBP;HIPK2;UCHL5
prerank,fatty acid catabolic process (GO:0009062),0.41847842623226955,1.1525012381598567,0.28039430449069,0.7901842179083711,1.0,30/67,29.63%,ABCD3;EHHADH;ECHDC2;CEL;ECI2;PEX13;AUH;ACAT1;ALDH3A2;BDH2;HACL1;PLA2G15;MCEE;PHYH;SLC27A2;PCCB;PEX2;ABCD1;ACBD5;ECHDC1;MCAT;HADHA;ACOT8;FAAH;MTLN;ACAT2;ABHD3;SCP2;ECI1;CPT2
prerank,regulation of cellular protein localization (GO:1903827),0.44541990385749436,1.152391985500474,0.2637106184364061,0.789830404118024,1.0,12/45,16.21%,GPC6;GPC3;VCP;DVL1;GBF1;SPIDR;CCDC66;RAB11FIP5;CSNK1E;RAB11B;NDEL1;PARP1
prerank,positive regulation of vasculogenesis (GO:2001214),0.5603741943186409,1.1522588994085678,0.3024251069900143,0.7895891811394401,1.0,1/10,0.56%,TMEM100
prerank,positive regulation of cellular metabolic process (GO:0031325),0.40808463779765225,1.1521025022397984,0.23204994797086367,0.7893733594873975,1.0,16/98,13.73%,THBS1;PID1;VEGFA;SFRP4;ECE1;ANXA2;XDH;TGFBR2;IFNLR1;AKR1C1;NSF;DHRS4;EIF4G1;INHBA;ACACA;PICK1
prerank,sodium-independent organic anion transport (GO:0043252),0.5699289561480012,1.1516840792548404,0.3184979137691238,0.7900766789297617,1.0,2/10,1.18%,SLCO3A1;SLCO2A1
prerank,gene silencing by miRNA (GO:0035195),0.46048824660784005,1.1514336811470578,0.29666254635352285,0.7902159691703742,1.0,9/32,15.73%,ZC3H7A;PUM1;PRKRA;AGO1;AGO2;RBM4;LIMD1;CNOT8;EIF6
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4367813127342535,1.15124725079081,0.2901734104046243,0.7901162944833449,1.0,18/46,17.43%,ZNF423;NPR3;DOCK7;ATF4;ACTN3;FOXC2;ACOT11;PGAM5;TFE3;TLE3;IP6K1;PCTP;ABHD6;CIDEA;LNPEP;ID1;FLCN;ACOT13
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5259178208877606,1.1511299074954202,0.30662983425414364,0.7898040997688124,1.0,5/15,16.22%,EGFR;MVB12B;PTPN18;WDR54;ERBB2
prerank,Rho protein signal transduction (GO:0007266),-0.31042798284516404,-1.1507150897301943,0.17346938775510204,0.63351185248184,1.0,15/53,9.23%,ARHGAP29;ROCK2;ARHGAP6;CDH13;ARHGEF3;EPS8;CDC42EP4;ADRA2A;ARHGDIA;GNA13;CDC42EP3;AGTR1;CDC42;EPS8L2;RHOU
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4153874982944499,1.150345113508004,0.2576882290562036,0.791624919833279,1.0,12/80,13.71%,THBS1;VEGFA;GAS6;MAP3K5;CSNK2A1;CARD16;HMGB1;RAF1;BCAP31;F2R;YWHAE;CASP1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.49690839330297065,1.1503003808883236,0.3002680965147453,0.7910398561543498,1.0,3/20,1.20%,KCNJ2;ATP1B1;SLC12A2
prerank,positive regulation of fat cell differentiation (GO:0045600),0.43890594434458724,1.1494222242956984,0.2842582106455266,0.7932069530784476,1.0,8/47,9.74%,SIX1;CMKLR1;ID2;LRP5;TFE3;CARM1;TRPM4;SYAP1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.41402856122927906,1.149263931241138,0.2570806100217865,0.7930059033023845,1.0,31/77,27.87%,THBS1;TCF7L2;NOL3;CSNK2A2;CSNK2A1;FXN;ACVR1;BMP4;ITGAV;URI1;BCL2L2;MAZ;PHIP;TGFBR1;HGF;SLC35F6;BIRC6;ZMYND11;AKT1;NOC2L;CLU;IL4;SH3RF1;TRIAP1;HERPUD1;PINK1;QARS1;RIPK1;PLAUR;SLC25A5;SCG2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.535464615069815,1.1490223695872412,0.3080168776371308,0.7930636939839604,1.0,3/13,8.26%,CHRDL1;FSTL1;NOG
prerank,protein-containing complex disassembly (GO:0032984),0.4353105273831821,1.1489979123558651,0.26719278466741825,0.7924162742073835,1.0,21/54,30.23%,LRP6;VCP;DVL1;LIX1L;WIPI2;FZD5;AXIN1;VIPAS39;CHMP3;UBQLN1;CLN3;PYM1;LAMP2;UVRAG;VTI1B;DVL2;VPS16;CSNK1A1;FZD1;STX17;CTNNB1
prerank,negative regulation of chemokine production (GO:0032682),-0.44112955429427103,-1.1489024941639567,0.27611940298507465,0.635755555093434,1.0,5/14,15.59%,APOD;C1QTNF3;LGALS9;SIGIRR;SIRPA
prerank,GPI anchor biosynthetic process (GO:0006506),0.46029015303447474,1.1488869669842596,0.28174123337363965,0.7920179756275102,1.0,15/30,32.30%,PIGW;GPAA1;PIGF;PIGL;PGAP2;PIGT;DPM3;PIGX;PIGV;PGAP1;PIGQ;PIGB;PIGN;PIGC;PIGO
prerank,regulation of protein targeting to membrane (GO:0090313),0.46823265004160497,1.1488440831713305,0.29926108374384236,0.7914238893667541,1.0,7/28,16.22%,KCNB1;GDI1;C2CD5;MIEF2;AKT2;CHP1;ERBB2
prerank,female gonad development (GO:0008585),0.5000019496059268,1.1484030975420574,0.3135483870967742,0.7922016080054702,1.0,5/19,13.02%,VEGFA;FSHR;CYP19A1;SOD1;INHBA
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.5603233729059742,1.1483962864065145,0.31805157593123207,0.7915062567185908,1.0,1/10,0.33%,LRP6
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5423561097540863,1.1482950059700323,0.3064295485636115,0.7910947523371485,1.0,8/13,14.44%,NUP93;TGFB3;SMAD4;BMP4;SH2B1;BMPR1A;TGFBR1;DAB2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.4688061397173208,1.1480207844535566,0.30875,0.7913114708567184,1.0,9/25,24.56%,RILP;VCP;LAPTM4B;CHMP3;VTA1;CHMP4A;CHMP4B;MVB12A;CHMP2A
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.44342828726775496,-1.147964977006897,0.2870967741935484,0.6358236203635925,1.0,4/12,13.56%,CYP26B1;CNOT1;KLF2;TRIM16
prerank,iron ion homeostasis (GO:0055072),0.41682965573771996,1.147944270491056,0.25278396436525613,0.7908535829435338,1.0,15/58,15.46%,SCARA5;NEO1;FLVCR1;HMOX2;FXN;SMAD4;ACO1;ATP6V0D1;SOD1;CUL1;CYBRD1;BDH2;ABCB6;FRRS1;IREB2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3950455390062211,1.1477442705474525,0.2336065573770492,0.7908201412224509,1.0,21/140,13.07%,ESR1;CACNA1C;CMKLR1;PLCE1;PROK2;TAC4;DRD1;C1QTNF1;EDNRA;ADCY8;HMGB1;FPR3;DLG4;GPR20;IAPP;ACKR4;TRPM4;ABL1;BCAP31;GLP1R;F2R
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3823915810901228,1.1469070727280615,0.1372745490981964,0.7928901679548251,1.0,119/341,26.36%,WWP1;RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;PSMD7;TOPORS;CDC16;MVB12B;COP1;UBE2B;UBR4;VCP;PSMA8;TOM1L1;UBE2R2;ERCC8;UBE3C;NFE2L2;RNF115;TBX21;TRPC4AP;HUWE1;SYVN1;NTAN1;CBL;RBBP6;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;FBXL4;RNF114;UBE2C;FBXO22;RNF14;PSMD12;ANAPC4;MYLIP;TGFB1I1;FBXL19;PSMA6;PCBP2;USP33;UBQLN1;SQSTM1;FBXL14;RNF11;UBAP1;ATE1;PSMD1;KCTD5;UBE2L6;ANAPC2;ARRB1;STUB1;SIRT2;PSMC5;ANAPC1;PSMD11;KLHL22;PPP2R5C;PSMC4;PSMD14;UBL7;RC3H2;BIRC6;ANAPC10;TRIM13;KCTD17;UBE4A;GID4;NPLOC4;CDC20;RNF7;CDC27;ZFAND2B;ZRANB1;FBXW4;PTPN23;UBE2G2;PCNP;RMND5B;PSMA3;UCHL1;UBAP1L;DCAF11;SMURF2;RNF4;PSMB1;PSMD4;KCTD13;MVB12A;APPBP2;AREL1;TTC3;RNF20;RNF216;PSMA5;RNF146;FBXO11;PSMA7;TAF1;HERPUD1;RNF122;AMFR;ANKRD9;PINK1;RCHY1;UBE2W;UBR3;RNF111;PSMC1;COPS3;RNF126;RNF166;NDFIP1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3769643983060091,1.1468570764926054,0.008,0.7923368184202958,1.0,419/1668,21.63%,TBX15;FOXP2;PLAGL1;ESR1;EGFR;LRP6;SIX1;FOXP1;PKD1;PID1;KLF12;ZBTB7C;ID2;PRRX1;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;PBX3;NFIX;FGF2;HOXA3;FOXD1;NFIB;SKIL;TCF7L2;IL33;RARB;TWIST2;ELF4;DDX5;HOXB6;MKX;SMAD9;NFIA;GALR1;DDX17;RHOQ;ZIM3;MUC1;ZFHX4;SMAD6;LDB2;LDB1;ZMIZ1;PRRX2;JDP2;GLI2;PRDM5;TCF20;DMTF1;LRP5;NCOR2;GLIS2;TGFB3;TWIST1;JMJD1C;HOXC6;DEAF1;LHX9;HDAC9;SP140;CUX1;PRDM10;NFAT5;HDAC4;CAMK2D;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;MED13L;WWTR1;HES5;KLF5;SIX4;STAT3;ZBTB25;DCAF6;ANXA4;TCF7L1;ZNF250;PHF21A;TARBP1;KMT5A;ATF4;CCNL2;TRIM28;MAMSTR;ZFP14;NR2F1;MAVS;CHD3;TCFL5;BCAS3;GMEB1;USP2;TLE6;TADA1;KMT2C;DACT1;ACVR1;BRD4;DVL1;PRDM6;FOXC2;ZNF25;MIDEAS;BCL9L;RXRB;NFX1;PRKDC;LBX2;PER3;SAFB;SMAD4;MRGBP;NFE2L2;BHLHE40;HMGB1;PKNOX2;JAG1;MEF2B;ZNF471;SLC9A1;RFX7;EZH1;TADA2A;E2F3;FUS;PBX1;TSHZ2;CREG1;MEIS3;BRWD1;SKI;MED27;ZNF691;HEYL;TBX21;THRAP3;MDM4;JUP;SOX9;ARF4;RPS6KA4;HOXA9;HOXA6;PURG;CCNL1;TRIM27;IKZF3;MED31;NRIP1;RARA;NSD1;FOXJ3;MED13;FZD5;SRA1;NOG;ESRRB;TFE3;RCOR3;BRD3;FOXK1;ENY2;ZNF76;IMPACT;DGKQ;DLG1;NFATC1;FOXL1;SMARCC2;RFX2;SLTM;WWP2;OGT;PSIP1;RBBP8;ZIC1;SBNO2;CDK12;MCPH1;RORA;BMP4;FGFR2;FOXA1;ZBTB2;UBP1;CSRNP1;ZFP90;PRDM4;MIER2;SREBF1;EHF;CHUK;RUNX2;ZNF260;KDM2A;URI1;GTF2F1;FOXM1;ABL1;ZIC4;AGO1;ATN1;RFX5;CCNT2;PHF8;POU6F1;CSRP3;CBX2;PLAC8;ID4;NFE2L1;NRF1;ATM;BMPR1A;HSF4;MAZ;KAT6B;PAXBP1;NEUROD2;KDM5B;RNF14;SFPQ;FOXO6;TAF6;SMAD7;RNF2;MED25;PHIP;FOXP4;SRF;NR1D2;HEY1;GLIS1;EZR;KAT2A;ZNF112;SSBP3;RGMA;FBXL19;HDAC1;AGO2;PTOV1;MEF2D;ZMIZ2;HSPD1;HOXB4;ZNF740;INHBA;BAZ2B;MYPOP;HR;ARID4B;KMT2D;NPAS1;MEF2A;NACC1;RUNX1;NFATC3;ZBTB9;HOXA4;ERF;TIAL1;PIAS4;TCF25;FRK;HEXIM1;SQSTM1;DAB2;BMP5;ZNF148;HNRNPK;EN2;VDR;BRD2;ZKSCAN1;MED21;MAFG;TFDP1;ID1;PER1;HGF;IL6;ARRB1;GRHL1;SIRT2;BRD9;PSMC5;CRTC2;FOXO3;NKX6-2;NFE2;CREB1;VPS72;CREBBP;MED26;PARP1;ERBB2;RPRD1A;AATF;SIN3B;ZNF462;UBC;RPS27A;APBB1;KDM6B;SUMO1;HOXA2;DPF3;NIPBL;PRDM2;MDFI;MTA3;NFYA;CBX5;EFNA1;FLCN;NFKB2;SLC30A9;KLF3;NR3C1;RFXANK;E4F1;MED14;MEN1;LCOR;ZKSCAN7;ORC2;THAP7;HDGFL2;CITED2;HMGA1;ELP4;PCGF2;ATAD2B;MED12;E2F1;SUV39H2;CC2D1B;HCFC1;SUFU;HOXC5;ZBTB32;ZSCAN20;GDNF;ATF2;CCDC62;CHD8;SARS1;HIPK2;KLF10;CRK;HOXB2;MLXIPL;BRD8;SAFB2;FOSL2;CC2D1A;TEAD2;XRCC6;LARP7;IRF3;CBFB;NR3C2;ZNF431;VEZF1;MPND;NFKBIA;WWC2;LEFTY1;TCF3;TAF9B;NFATC4;NOC2L;ATF6;MAX;BPTF;TET2;RTRAF;CALR;IKZF4;KAT7;ZBTB24;HOMEZ;BCL2L12;HOXC8;SUV39H1;MAD2L2;KLF9;GPS2;IL4;ATP2B4;ZKSCAN5;SMURF2;RITA1;YEATS2;RNF4;MED20;BCL11B;SMAD5;IER2;MIER1;CHD2;SENP1;SAP18;POGZ;PEX2;PAF1;NFIC;CEBPD;NR2F6
prerank,DNA-dependent DNA replication (GO:0006261),0.39770032374650616,1.146587653287132,0.22419186652763295,0.7925722715285105,1.0,47/128,27.39%,HELB;REV3L;PSMD7;MCMDC2;POLE2;PSMA8;MCM2;CDC6;PSMA4;WRN;PSMD12;PSMA6;CDC45;GINS4;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;UBC;RPS27A;MCM4;POLG2;POLB;ORC2;HMGA1;CDT1;DBF4;RAD51;CDK2;TWNK;PSMA3;PSMB1;PSMD4;TOPBP1;PSMA5;PSMA7;PRIMPOL;PRIM1;RECQL5;POLD1;PSMC1;MCM7;POLG;RPAIN;PSMA1;PNKP
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5458254249102611,1.1464335013878888,0.3106267029972752,0.7923408455372012,1.0,5/12,16.61%,MCMDC2;MCM2;CDC45;GINS4;MCM4
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5167496651280136,1.1462161561550963,0.32357043235704325,0.7923568796747439,1.0,1/16,0.03%,BOC
prerank,regulation of protein export from nucleus (GO:0046825),0.48017911673289776,1.1460828249703532,0.31155778894472363,0.7920591667628039,1.0,7/23,13.55%,GAS6;TCF7L2;BAG3;ANP32B;XPO4;UHMK1;YWHAE
prerank,membrane protein proteolysis (GO:0033619),0.4539909471612226,1.1456816187345584,0.2778443113772455,0.7926462917235515,1.0,7/37,9.54%,ADAM9;HM13;ADAM10;BACE2;CLPP;MBTPS1;BACE1
prerank,glycine transport (GO:0015816),-0.47104659492502243,-1.1456210098335606,0.3044982698961938,0.6397699827648845,1.0,3/10,8.57%,SLC6A9;SLC38A5;SLC6A17
prerank,histone H4-K5 acetylation (GO:0043981),0.5155845036835711,1.1455335796318376,0.29906542056074764,0.7917381907594057,1.0,9/15,23.18%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;KAT8;MEAF6
prerank,histone H4-K8 acetylation (GO:0043982),0.5155845036835711,1.1455335796318376,0.29906542056074764,0.7917381907594057,1.0,9/15,23.18%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;KAT8;MEAF6
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5588423080166438,1.1455058529777127,0.33480825958702065,0.7904013697496913,1.0,5/10,20.46%,AP2A1;MYLIP;AP2A2;CLTC;CLTA
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5588423080166438,1.1455058529777127,0.33480825958702065,0.7904013697496913,1.0,5/10,20.46%,AP2A1;MYLIP;AP2A2;CLTC;CLTA
prerank,renal filtration (GO:0097205),0.5681865162820876,1.1449996979383672,0.30703012912482064,0.791367699032697,1.0,3/10,6.57%,TBC1D8B;MYO1E;SULF1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.4084785400121147,-1.1446734465323987,0.2867132867132867,0.6399833141478317,1.0,7/16,18.02%,ENG;NOTCH1;PROX1;BMPR2;HEY2;BMP2;DLL4
prerank,response to interferon-beta (GO:0035456),-0.3773705380727495,-1.1442249348590843,0.28773584905660377,0.6389502634133096,1.0,7/22,13.59%,IFNAR2;STAT1;IFITM1;BST2;AIM2;IFITM3;NDUFA13
prerank,neurotransmitter secretion (GO:0007269),-0.3183009860616821,-1.1436649272856685,0.184,0.6382905901271682,1.0,17/44,22.23%,NRXN1;LIN7A;RIMS2;RIMS1;PIP5K1C;SYN2;SYN1;STXBP3;SYT10;SNCA;GAD1;SNAP25;SLC32A1;PTPRN2;GRM4;CPLX2;PDZD11
prerank,selective autophagy (GO:0061912),0.4233074389150981,1.143404661225989,0.28863636363636364,0.7959779105289585,1.0,32/56,33.09%,ULK2;DYNC1H1;STBD1;NBR1;PEX5;LGALS8;ATM;DYNC1LI2;UBA5;UBQLN1;SQSTM1;HDAC6;IFT88;UBC;RPS27A;UFL1;RB1CC1;TEX264;DYNC1I2;ACBD5;ATG13;ATG2B;AMBRA1;UFC1;UBE2V1;ULK1;USP30;PRKN;UBE2N;DYNLL2;MAP1LC3B;UFM1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5576611237747788,1.1433987503531147,0.3194842406876791,0.7952805598604538,1.0,7/11,32.29%,TENT4B;EXOSC4;LARP7;FBL;DKC1;EXOSC2;EXOSC3
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.44641150808943036,1.1433940131085234,0.30455635491606714,0.7945746001614293,1.0,9/33,17.45%,FGF2;GNL3;KLF5;TGFB2;STAT3;TERT;SRF;FOXO3;NR3C1
prerank,RNA methylation (GO:0001510),0.4267387122376243,1.1430861526127603,0.27901785714285715,0.7948267912215928,1.0,27/60,33.87%,TRMT61B;TARBP1;METTL16;TYW3;THADA;THUMPD3;TRMT44;TRMT6;ALKBH8;TFB2M;FBL;TRMT61A;METTL1;NSUN6;METTL8;BUD23;MTO1;METTL14;TRMT112;NSUN3;MEPCE;METTL6;RBM15;TGS1;PCIF1;METTL2A;METTL2B
prerank,mitotic metaphase plate congression (GO:0007080),0.4323785710445407,1.1430538752804484,0.30216647662485746,0.794206651990377,1.0,15/51,20.87%,RRS1;SEH1L;CENPC;MAD1L1;DCTN2;EML3;MIS12;ZW10;CHMP3;RMDN1;CDT1;CHMP4A;CHMP4B;PDCD6IP;NUP62
prerank,negative regulation of protein binding (GO:0032091),0.41116176254668285,1.1430369450422608,0.2794759825327511,0.7935438030876343,1.0,22/71,22.68%,PRKCD;LRPAP1;PTPRF;CARD16;DACT1;DVL1;TMC8;SYMPK;EFHB;MAPK8;GTF2F1;CSNK1E;USP33;DAB2;MITD1;TFIP11;STYX;AKT1;CTSZ;LRRK2;CAMK1;PEX14
prerank,intracellular pH reduction (GO:0051452),0.45734292735750703,1.1430173061221744,0.29432624113475175,0.7928919721508557,1.0,13/33,28.02%,ATP6V1C2;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;SLC11A1;ATP6V0E1;ATP6V0B;GPR89A;GPR89B
prerank,signal peptide processing (GO:0006465),0.5595110521431745,1.1429062441954614,0.31170662905500707,0.7925439498316607,1.0,3/11,13.46%,PCSK5;HM13;SPCS2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.48323956968458925,1.1428371100689874,0.29722589167767505,0.7920574071534602,1.0,2/20,2.21%,LBP;PRKCE
prerank,neuronal action potential (GO:0019228),0.49285036081219424,1.1427957707338319,0.30445859872611464,0.7914763820533024,1.0,2/22,6.62%,CACNA1G;SCN11A
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.5480231761670742,1.1427595620478863,0.3142857142857143,0.7908892726147132,1.0,3/13,6.98%,CACNA1C;KCNE5;ANK2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.39786516437432706,1.1426808361833076,0.20040691759918616,0.7904321972567318,1.0,33/151,17.96%,ST3GAL4;PCSK5;ACER3;GSTT1;PLA2G4A;PEMT;PLPP3;CSNK2A2;CSNK2A1;GSTM5;LPCAT1;KDSR;DMD;ELOVL5;PLPP1;NFS1;NANP;ST3GAL2;B4GALT5;STARD7;GPAT4;LPCAT3;PCTP;GAL3ST4;INHBA;ALDH3A2;GSTO2;CHKB;GSTZ1;B3GNT6;AKR1A1;SLC25A2;GOLPH3
prerank,cellular response to lipid (GO:0071396),0.38622610107255795,1.1426144426986613,0.20222446916076844,0.7899403868641299,1.0,28/191,11.42%,ESR1;EGFR;IRS1;PID1;WNT9A;LBP;ADAM9;PDCD4;CARD16;SHPK;ADCY2;ADCY8;TNFRSF1B;HMGB1;FZD7;TRIM41;SOX9;NRIP1;RHOA;SBNO2;RORA;MAPK8;URI1;NFKBIB;IRAK1;GIT1;ATM;PABPN1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5225326785979666,1.1423917105698593,0.326271186440678,0.7899857874350876,1.0,3/15,5.55%,AK5;ENTPD2;ENTPD6
prerank,kinetochore organization (GO:0051383),0.5283145195761701,1.1415297341360686,0.33607681755829905,0.7922117955313548,1.0,6/13,21.56%,CENPC;CENPT;MIS12;CDT1;DLGAP5;POGZ
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5482029724564113,1.1414283011999724,0.32496513249651326,0.7918110127664715,1.0,8/11,35.58%,ATL2;LPCAT3;BNIP1;ATL1;ARL6IP1;VCPIP1;STX18;MOSPD3
prerank,autophagy of mitochondrion (GO:0000422),0.44826635337911586,1.1411229109329666,0.29245283018867924,0.7921300519512664,1.0,16/38,29.90%,ULK2;WIPI2;ATG3;SQSTM1;RB1CC1;CTSK;ATG9A;PINK1;ATG13;ATG2B;AMBRA1;ULK1;FIS1;CISD2;USP30;PRKN
prerank,regulation of cholesterol storage (GO:0010885),-0.4065742228730152,-1.1405949316772555,0.2682926829268293,0.6438458192885014,1.0,8/15,17.38%,PPARA;ABCG1;NR1H3;PPARD;SCARB1;LPL;MSR1;TTC39B
prerank,positive regulation of intracellular transport (GO:0032388),0.4439003719150417,1.1405032585262649,0.31257208765859285,0.7934625238974052,1.0,14/38,26.41%,NEDD4;EHD1;DYNC1H1;BCAS3;EHD2;CAPN10;TENM1;PCM1;KIF20B;ICE1;PGAP1;TBC1D20;VAMP2;TPR
prerank,negative regulation of axon extension (GO:0030517),-0.34105655398761886,-1.140414776216594,0.2655367231638418,0.64229580621051,1.0,15/30,21.24%,SEMA6A;MAP2;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;SEMA4A;MAG;SEMA4G;SEMA5B;MT3;RTN4R;SEMA6D;SEMA3B
prerank,protein-DNA complex assembly (GO:0065004),0.39899867738893574,1.1402238300917915,0.2520833333333333,0.7936778679202571,1.0,45/116,26.55%,CHAF1B;PSMD7;CHD1L;PSMA8;NAA60;SOX9;MCM2;ERCC5;CDC6;PSMA4;CUL4A;ANP32B;SPTY2D1;KAT6B;PSMD12;ERCC3;PSMA6;ERCC2;BRD2;PSMD1;PSMC5;PSMD11;PARP1;PSMC4;PSMD14;UBC;RPS27A;MCM4;ORC2;NAP1L3;CDT1;NAP1L2;RAD51;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;H3-3A;GTF2H4;DAXX;PSMC1;MCM7;CHAF1A;XPA
prerank,activation of protein kinase activity (GO:0032147),0.4024188794331083,1.1402065355195332,0.2293193717277487,0.7930307806253278,1.0,23/106,11.89%,PRKCD;VEGFA;GAS6;CARD14;NTRK3;GHR;PRRC1;STRADA;TGFB2;ADCY2;ADCY8;TOM1L1;TNFSF15;TGFBR2;ADCY9;PAK4;PAK2;RIPK3;ABL1;IRAK1;AXIN1;PDPK1;TNFRSF10B
prerank,receptor clustering (GO:0043113),0.4652472160870017,1.1401560331264289,0.28287841191067,0.7925075022828472,1.0,8/27,13.73%,DLG2;DVL1;DLG4;DLG1;NRXN2;MUSK;NLGN1;PICK1
prerank,peptidyl-methionine modification (GO:0018206),0.5424520010054871,1.13992964527328,0.31412103746397696,0.7925573631236442,1.0,8/12,33.33%,NAA60;NAA16;METAP1D;METAP2;NAA15;NAA25;METAP1;NAA20
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.41305985390407807,-1.1399191996484386,0.26353790613718414,0.641431874110206,1.0,6/14,22.20%,PPP2R2B;PPP2R2C;PPP2CB;PPP5C;PPP1R15B;PPP1CA
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.40823226107903976,1.139804124742797,0.2616216216216216,0.7922609402817357,1.0,26/76,25.08%,RNF144A;PRICKLE1;CSNK1D;COP1;VCP;DVL1;CDK5RAP3;AXIN1;FBXO22;RNF14;SMAD7;CSNK1E;DAB2;DDA1;STUB1;SIRT2;SUMO1;HECTD1;CLU;USP5;LRRK2;SUMO2;DET1;TAF1;RCHY1;BBS7
prerank,V(D)J recombination (GO:0033151),0.5555999564205523,1.1393027444955877,0.32447552447552447,0.793234183459979,1.0,4/11,19.78%,PRKDC;HMGB1;LIG4;TCF3
prerank,regulation of phosphorylation (GO:0042325),0.3963925100379618,1.1390839483261648,0.24869383490073146,0.7932287512233592,1.0,29/120,18.14%,THBS1;EGFR;NUP93;LDB2;LDB1;SEC13;GLMN;RAE1;ILK;SEH1L;FZD7;OGT;BMP4;ROPN1L;NUP37;PHIP;NRP1;SESN2;INHBA;RANBP2;KCTD20;NUP88;SIRT2;EIF6;FLCN;CDKN1C;PRKAG1;POM121;NUP210
prerank,regulation of actin filament-based process (GO:0032970),0.4150508576250173,1.1387633389847798,0.27771797631862216,0.79351589376729,1.0,14/70,15.54%,PRKCD;RHOBTB1;EFNA5;LRP1;RHOQ;RND3;ARHGAP17;CDK10;RHOA;ABL1;EZR;ARHGAP44;RHOB;IQGAP1
prerank,regulation of spindle assembly (GO:0090169),0.47323628824841124,1.1385270214126728,0.32205513784461154,0.7935786913077537,1.0,11/25,27.12%,DYNC1H1;EML3;CHMP3;CHMP4B;PDCD6IP;RNF4;SENP6;HNRNPU;CHMP2A;TPR;DRG1
prerank,actin cytoskeleton reorganization (GO:0031532),-0.29368656855729786,-1.1383779776426621,0.15384615384615385,0.6433580274323737,1.0,21/63,13.74%,AUTS2;PHACTR1;PTK7;KIT;TNIK;NEDD9;PARVB;RICTOR;CXADR;S1PR1;WHAMM;MYH9;SYDE1;GAB1;PAK1;CDC42BPG;PLEK;DTNBP1;PTPN1;THSD7A;FGF7
prerank,mesenchyme morphogenesis (GO:0072132),0.4957514900540027,1.1380572965557103,0.3252361673414305,0.7943947448157302,1.0,8/17,12.12%,TGFB2;ACVR1;HEYL;MDM4;SOX9;NOG;BMPR1A;HEY1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.46424373095998756,1.1380310797922408,0.3220338983050847,0.7937828180464988,1.0,6/29,12.60%,TOPORS;DCUN1D5;ABL1;AXIN1;SMAD7;DCUN1D2
prerank,proteoglycan biosynthetic process (GO:0030166),0.4585004190134718,1.1377861205016744,0.30759951749095293,0.7939406434625602,1.0,3/31,2.94%,EXT1;XYLT1;CHST11
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.420130051360305,-1.137587514581078,0.2962962962962963,0.6434357209860809,1.0,6/14,12.93%,ZEB1;OSR1;NOTCH4;SPRED1;CAV1;SPRY1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.39638388545026954,1.1375837235729054,0.25914315569487983,0.7938917584435646,1.0,18/101,13.71%,LBP;ADAM9;PDCD4;PRKCE;CARD16;SHPK;TNFRSF1B;HMGB1;TRIM41;RHOA;SBNO2;MAPK8;NFKBIB;IRAK1;GIT1;PABPN1;CD80;CASP1
prerank,phosphate ion homeostasis (GO:0055062),0.5605586725716882,1.1375138871873567,0.3209700427960057,0.793412101788838,1.0,1/10,1.33%,SFRP4
prerank,positive regulation of translation (GO:0045727),0.4020811336479275,1.1369555286157729,0.26476793248945146,0.7945137492077909,1.0,32/94,27.86%,THBS1;YBX3;RCC1L;SAMD4A;MPV17L2;PRKDC;RMND1;CDC123;NIBAN1;KHDRBS1;UHMK1;AGO2;IL6;EIF6;ERBB2;EIF3D;FASTKD3;PYM1;CIRBP;FXR2;UPF3A;RPS6KB1;EIF5A2;RPS9;RPS27L;UPF3B;RBM3;C1QBP;METTL14;USP16;FXR1;YTHDF1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.4172708845195014,1.1367276428318915,0.27838427947598254,0.7945203256148478,1.0,24/72,22.05%,FGF2;FGF17;HNRNPH1;SPRED2;RBFOX2;FGFR1;NOG;CBL;FGFR2;GTF2F1;FLRT2;SHOC2;HNRNPM;PTBP1;TIAL1;POLR2F;GALNT3;FGF5;NCBP1;NCBP2;FGF18;FGFR3;HNRNPA1;POLR2B
prerank,Golgi inheritance (GO:0048313),0.559153303274994,1.1363268370945228,0.342485549132948,0.795122231744959,1.0,3/11,12.98%,STX5;GBF1;STK25
prerank,respiratory system development (GO:0060541),0.4617360272618844,1.1362766231419916,0.3084455324357405,0.7946057281666775,1.0,7/32,9.70%,VEGFA;FGF2;GLI2;DISP1;CCDC39;BMP4;FGFR2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5439218770448098,1.1362699089966808,0.32212885154061627,0.7939361131090362,1.0,6/11,33.36%,IPO4;CABIN1;UBN1;H3-3A;HIRA;HAT1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.39240176916873276,1.1359856107008617,0.22722620266120777,0.7942109379360872,1.0,51/152,22.11%,EGFR;GPC3;COL1A1;SFRP4;RSPO3;PLEKHA4;ATP6V1C2;PSMD7;CSNK1D;CSNK2A1;UBE2B;VCP;PSMA8;DACT1;ILK;CCAR2;LBX2;SULF1;SKI;RSPO1;JUP;TRPM4;PSMA4;FGFR2;CSNK1G1;UBR5;TERT;AXIN1;PSMD12;USP34;CSNK1E;PSMA6;WNK1;TNKS2;PSMD1;PSMC5;GSKIP;PSMD11;PSMC4;PSMD14;DAPK3;SULF2;ZRANB1;PSMA3;DEPDC1B;SMURF2;PSMB1;PSMD4;LRRK2;CSNK1G3;USP47
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5005542508251475,1.1359167547072577,0.3233766233766234,0.7937452223080053,1.0,7/19,22.53%,DLG2;CLIC4;CRB1;DLG1;CRB2;ERBIN;PRKCI
prerank,regulation of TOR signaling (GO:0032006),0.419439526951695,1.1356948038373207,0.2611050920910076,0.7937550373716796,1.0,24/67,24.47%,GAS6;NPRL3;SEC13;PKHD1;LAMTOR1;SEH1L;AKT1S1;DGKQ;TELO2;DEPTOR;TMEM127;TBCK;MINAR1;FLCN;ARAF;GOLPH3;UBR2;RHEB;TSC2;RPTOR;NPRL2;SMCR8;FBXO9;FAM83D
prerank,metanephric mesenchyme development (GO:0072075),0.5684376201684253,1.1352663551295321,0.33954154727793695,0.7944325058443876,1.0,2/10,4.17%,SIX1;SIX4
prerank,phospholipid transport (GO:0015914),0.4296087252460361,1.1347770264690924,0.2852272727272727,0.795321918342212,1.0,11/52,11.37%,TNFAIP8L3;TMEM30B;PITPNC1;PRELID3B;ABCC1;PITPNA;PITPNM1;ATP8B2;ATP8A1;PCTP;ATP9A
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4071243854356532,1.134670050816213,0.26688102893890675,0.7949667868822213,1.0,27/76,27.13%,PRICKLE1;GNL3;HDAC4;DCUN1D5;HUWE1;CDK5RAP3;WDR48;AXIN1;SMAD7;DCUN1D2;TANK;PHF23;UBQLN1;PIAS4;STUB1;RWDD3;SAE1;MYCBP2;MUL1;LRRK2;BIRC3;DERL1;PINK1;RCHY1;XIAP;NDFIP1;RIPK2
prerank,positive regulation of ERAD pathway (GO:1904294),0.5240874609516055,1.1345961639012154,0.32689655172413795,0.7944972473917397,1.0,6/13,25.03%,NFE2L2;BCAP31;UBQLN1;USP13;HERPUD1;RNFT1
prerank,inositol phosphate metabolic process (GO:0043647),-0.30208656890395014,-1.1342937551050674,0.18110236220472442,0.649510532524169,1.0,10/46,8.83%,PLCB1;INPP4B;ITPKB;INPP5D;ISYNA1;NUDT4;PLCB4;PLCH1;IP6K2;PLCD1
prerank,regulation of intracellular transport (GO:0032386),0.44464870902795056,1.1342762048179225,0.30723606168446027,0.7948494139172605,1.0,14/38,21.65%,GAS1;DYNC1H1;DYNLT2B;CAPN10;SCFD1;ATP9A;RAB11B;RBM4;NDEL1;RINT1;GRIPAP1;REEP5;LAMP1;LRRK2
prerank,aorta development (GO:0035904),-0.4235811297287353,-1.134244954818971,0.3111888111888112,0.6475202989843362,1.0,8/14,14.98%,ROBO1;ROBO2;PDGFRB;TBX1;PDE2A;TBX2;EFEMP2;APLNR
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.41549995258555344,1.134233268691484,0.28193832599118945,0.7942892750523892,1.0,24/71,22.56%,FAP;HM13;VCP;PSMA8;CLPP;SOCS6;DDI2;CAPN2;LONP1;PSMA6;ATE1;NGLY1;STUB1;HDAC6;IDE;UBC;RPS27A;CTSZ;ZRANB1;CHMP4B;PDCD6IP;CTSB;CTSK;CTSO
prerank,body fluid secretion (GO:0007589),0.5148270472798943,1.1342011462186616,0.31351351351351353,0.7936938769208326,1.0,3/15,10.43%,VEGFA;GPAT4;VIP
prerank,homotypic cell-cell adhesion (GO:0034109),0.44519505030543993,1.1338594415044945,0.3077844311377245,0.7941104635193454,1.0,4/39,5.92%,GNAS;UBASH3B;PLPP3;ILK
prerank,smoothened signaling pathway (GO:0007224),0.4535737534945908,1.133832859051111,0.30815347721822545,0.7935214157996081,1.0,16/32,31.34%,GLI2;HES5;CC2D2A;SMO;MAP3K10;EVC2;PKD2L1;HIPK2;IFT27;TMEM231;TCTN3;GLI3;TTBK2;STIL;GLI1;ULK3
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4786546555863371,1.1338097629173018,0.3031446540880503,0.7929196195873228,1.0,7/25,11.27%,ZNF423;FOXD1;HES5;SMAD4;SULF1;BMP4;BMPR1A
prerank,polyamine metabolic process (GO:0006595),0.5212368370672923,1.1337742345921573,0.3207810320781032,0.7923498082796943,1.0,5/13,18.58%,SAT2;SMOX;SRM;HDAC6;AOC1
prerank,mitotic sister chromatid segregation (GO:0000070),0.4019804586278976,1.133132067128716,0.2730125523012552,0.7937503958177674,1.0,28/98,24.56%,TUBG2;SMC4;CSNK2A2;CSNK2A1;KMT5A;RRS1;SEH1L;DCTN2;MCPH1;EML3;PHF8;DIS3L2;MIS12;ZW10;CHMP3;KLHL22;HASPIN;NIPBL;DLGAP5;CHMP4A;CHMP4B;PDCD6IP;NUP62;POGZ;PDS5A;WRAP73;SMC1A;CHMP2A
prerank,purine ribonucleotide metabolic process (GO:0009150),0.41755623334343456,1.133026698710236,0.281767955801105,0.7934305699126406,1.0,20/68,24.66%,RHOQ;SULT1C2;SULT1C4;ACSF2;ACOT11;AK3;GPAT4;BPNT1;ACAT1;AMPD3;RAB23;GLYAT;EFL1;ACOT13;ACSL6;ENTPD7;LRRK2;MFN1;BAD;ACOT8
prerank,epidermal cell differentiation (GO:0009913),0.44167965932835423,1.1328546504647978,0.3042973286875726,0.7932724863802143,1.0,14/41,26.22%,ADAM9;CLIC4;JAG1;BCR;ANXA1;ERCC3;HDAC1;ERCC2;PIP5K1A;ASAH1;OPN3;HDAC2;KRT10;CERS3
prerank,amino acid import across plasma membrane (GO:0089718),0.4800401362855731,1.1326588824328614,0.32456140350877194,0.7932380346752644,1.0,2/24,3.80%,SLC47A1;SLC1A5
prerank,DNA strand elongation (GO:0022616),0.5000058927953079,1.1322939811216854,0.3138020833333333,0.7937694122325022,1.0,6/18,16.61%,MCMDC2;TERT;RAD50;DCLRE1B;GINS4;MCM4
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.5007674531548766,1.1321673945519997,0.3208053691275168,0.7934917175176206,1.0,9/16,32.74%,HELB;RMI2;MAD2L2;CGAS;FBH1;SHLD3;SHLD1;PARPBP;POLQ
prerank,regulation of hippo signaling (GO:0035330),0.5039618292939964,1.132003627800656,0.3182406209573092,0.793339250627736,1.0,7/17,23.45%,CIT;MOB3B;LIMD1;WWC2;MAP2K3;NEK8;DLG5
prerank,positive regulation of transport (GO:0051050),0.4020724502679285,1.131841426741267,0.2874058127018299,0.7931528958280438,1.0,17/85,14.91%,GAS6;LRP1;GPC3;RXRA;ANXA2;C2CD5;DYNC1H1;CAPN10;AKT2;FCER1G;ANXA1;PLA2G5;CHP1;LMAN2;DAB2;ACSL3;SCIN
prerank,dicarboxylic acid metabolic process (GO:0043648),0.43169955555719913,1.131693756923678,0.30589543937708563,0.7929225041685203,1.0,27/52,33.95%,ME1;GCLC;SLC25A32;MTRR;MTHFD2;MDH1B;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR;GCLM;PHYH;ACOT8;HOGA1;L2HGDH;ACLY;FPGS;MDH2;NIT2;DGLUCY;IDH2;IDH1;SDHA;ALDH18A1;SDHAF3;DHFR
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.37905351388293207,1.131558860766187,0.12437311935807423,0.7926933589473474,1.0,59/348,13.73%,SLC38A2;PID1;ID2;HOXA5;VEGFA;GAS6;F3;FGF2;FOXD1;IL33;GSN;SFRP4;SLC24A3;EMILIN1;NTRK3;ECE1;FGF17;DRD1;RDX;EPHB2;C1QTNF1;TWIST1;ANXA2;STAT3;CD3E;ATF4;TRIM28;RAMP2;AGR2;FAM98A;NFE2L2;ANK2;SOX9;NOG;DGKQ;NSF;MAPK8;BMP4;ITCH;TMEM119;FAM98B;MUSK;RESF1;UBR5;AGO1;ATM;MAZ;FUBP1;HEY1;EZR;PIK3CB;TGFBR1;SERPINB9;AGO2;SMO;INHBA;SETDB1;ERP29;PICK1
prerank,dicarboxylic acid transport (GO:0006835),0.4708272025908124,1.131405199263173,0.32230392156862747,0.7925250648470928,1.0,4/28,7.57%,SLC26A7;SLC26A6;SLC25A32;GIPC1
prerank,regulation of ion transport (GO:0043269),0.41004537611064984,1.1314049645497517,0.30627705627705626,0.7918491222666199,1.0,5/76,2.08%,KCNJ2;KCNJ15;NEDD4;SYT8;DRD1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4232046592104387,1.1308566359730354,0.2948430493273543,0.7929892710101107,1.0,21/51,30.50%,MAPK15;TENT4B;NEK7;SMG6;ATM;TEN1;HNRNPC;TNKS2;XRN1;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;HNRNPU;PNKP;CCT5;ATR;CTNNB1;CTC1
prerank,purine ribonucleotide transport (GO:0015868),-0.4090026836629698,-1.1304378568137732,0.27615062761506276,0.6552527808860987,1.0,2/16,2.40%,ABCC4;LRRC8C
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4455030831628769,-1.130311876823168,0.2771929824561403,0.6534821952446768,1.0,2/11,3.01%,NOVA1;NOVA2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.44485421465185826,1.130234524597557,0.32742316784869974,0.7942956496929978,1.0,2/35,0.54%,PCDHB16;CDH11
prerank,lymphocyte migration (GO:0072676),0.4559986793750927,1.130229530645251,0.32077764277035237,0.7936318071861869,1.0,4/32,9.77%,CCL13;CCL15;TBX21;CRTAM
prerank,response to X-ray (GO:0010165),0.5205178570656721,1.1301956130891209,0.31090174966352624,0.793064061388894,1.0,6/14,20.55%,ANXA1;ATM;LIG4;NIPBL;XRCC6;BRCC3
prerank,positive regulation of double-strand break repair (GO:2000781),0.4388663860499982,1.1300377201791036,0.3054892601431981,0.7928793667783482,1.0,20/39,30.17%,PARP3;PRKDC;FUS;KMT5C;SLF2;SPIDR;FOXM1;WDR48;MMS19;SPIRE2;PARP1;MAD2L2;SLF1;ACTR2;WAS;SHLD3;PNKP;SHLD1;DDX11;TIMELESS
prerank,response to organophosphorus (GO:0046683),-0.4015717690948985,-1.1299683272507566,0.30612244897959184,0.6523186129308011,1.0,6/16,13.56%,STAT1;TRPC3;ABCC9;TYMS;RFC3;TRIM16
prerank,membrane repolarization (GO:0086009),0.5170046095300792,1.1298981607796554,0.32309746328437916,0.7926535086475628,1.0,4/15,6.98%,KCNJ2;ATP1B1;KCNE5;KCNIP2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4736060822223012,1.1298886168441606,0.30845771144278605,0.79201022944579,1.0,4/24,4.67%,PDE11A;TCP11;UBE2B;PDE3A
prerank,regulation of vasoconstriction (GO:0019229),-0.3521898736474937,-1.1298061872393856,0.2702702702702703,0.6506076497248878,1.0,10/27,11.99%,ATP2B1;BDKRB2;ACE;AGTR1;BMPR2;TBXA2R;CAV1;ADRA1A;CHRM3;ACE2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4962703834534677,1.1297240895627614,0.3446969696969697,0.7918683056311033,1.0,6/18,19.97%,MISP;MMP14;SPTBN1;CLN3;CDK5;APPL1
prerank,vitamin D metabolic process (GO:0042359),0.5270792396691664,1.1295071868312403,0.3389355742296919,0.7918566483647649,1.0,4/13,14.76%,LRP2;PIAS4;VDR;CYP27B1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.387190143462854,-1.1290899115740065,0.2815126050420168,0.6505020472603484,1.0,6/18,8.60%,IL34;PTN;NOTCH1;TNFRSF21;TENM4;SLC45A3
prerank,nuclear envelope organization (GO:0006998),0.48710596590910665,1.1290278320522074,0.3341804320203304,0.792697900295635,1.0,5/20,17.76%,NUP93;TMEM43;DMPK;REEP3;TMEM170A
prerank,protein-containing complex assembly (GO:0065003),0.3775795130933236,1.128312229693521,0.1971971971971972,0.7943283652690184,1.0,104/259,27.14%,TCF7L2;TIAM1;SEC31A;SEC24D;COL16A1;STX5;NOL3;FBXL7;SEC13;TLE2;CSNK1D;SEC23A;HES5;CD3E;TCF7L1;TRAPPC10;ADCY8;DNAJB14;DMD;MCU;BCL9L;CNIH2;GPAA1;ADAM10;SPG7;SLC9A1;TRRAP;LLGL1;MDM4;SOX9;DLG4;PPP6R1;PYGO1;BET1;PPP6R3;TLE3;SH3PXD2B;NSF;ST13;SCFD1;CDC123;WIPF1;TERT;TRAPPC6A;AXIN1;SNX9;SHANK1;USO1;ZW10;CUL1;HDAC1;SEC24C;SEC24B;KMT2D;PREB;SEC16A;SEC22B;FARP2;CNIH1;CREBBP;KPNA3;SEC16B;SEC24A;EPRS1;MEN1;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TEAD2;TRAPPC6B;DARS1;CAPZA1;LRRK2;RAB1A;LMAN1;REPS2;KLHL12;KMT2A;PEX14;RAB1B;AFG3L2;NIFK;STOML2;DET1;ANKRD28;TP53;BAD;SMARCA4;DNAJB12;TRADD;AFDN;TBC1D20;VAMP2;TFG;PPID;RIPK1;GOLGA2;PARD3;PPP2R1A;WAS;CAND1;WDCP
prerank,Wnt signaling pathway (GO:0016055),0.4032730737759805,1.12828546725105,0.30052356020942406,0.7937487107246918,1.0,18/92,12.58%,LRP6;WNT9A;TCF7L2;SFRP4;PLPP3;LRP5;NXN;TCF7L1;DVL1;BCL9L;FZD7;FZD5;VPS26A;CSNK1G1;AXIN1;USP34;CUL1;CSNK1E
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3892136820988022,-1.1278585289700553,0.2629310344827586,0.6516383311565168,1.0,5/20,9.22%,BCL2;BCL2L1;FAS;DCC;BOK
prerank,atrial septum development (GO:0003283),0.5270048132901868,1.1276207617935552,0.34112792297111416,0.7952106054695715,1.0,4/13,16.19%,TGFB2;ANK2;MDM4;NPHP3
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.44231156111536,1.1270703359643384,0.30619684082624543,0.796285804592351,1.0,18/36,29.38%,KIF13A;RAB34;NECTIN3;GGA2;GOLGA4;NSF;GGA1;SPTBN1;GOLPH3;BLZF1;OPTN;VAMP4;GORASP2;AFDN;VAMP2;GCC2;GGA3;ARFRP1
prerank,modification-dependent protein catabolic process (GO:0019941),0.3801798511422529,1.126672722305627,0.22828282828282828,0.7968820403369676,1.0,79/193,30.07%,RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;TOPORS;CDC16;UBE2B;UBR4;UBE2R2;UBE3C;TRPC4AP;SYVN1;NTAN1;CBL;RBBP6;ITCH;FBXL4;RNF114;UBE2C;FBXO22;RNF14;ANAPC4;MYLIP;LONP1;USP33;UBQLN1;SQSTM1;FBXL14;RNF11;UBE2L6;ANAPC2;ARRB1;STUB1;ANAPC1;PSMD11;PSMD14;UBC;RPS27A;UBL7;RC3H2;BIRC6;ANAPC10;UBE4A;NPLOC4;CDC20;RNF7;PCYOX1L;CDC27;FBXW4;UBE2G2;SMURF2;AREL1;TTC3;RNF20;RNF146;FBXO11;TAF1;HERPUD1;AMFR;PINK1;RCHY1;UBR3;RNF111;COPS3;RNF126;RNF166;NDFIP1;RNF167;DDB1;UBE4B;RBX1;BTRC;ADRM1;PRKN;UBE2H;TRIP12;ANAPC11;UBE2S
prerank,platelet aggregation (GO:0070527),0.4527114949647185,1.1265373961145762,0.31403940886699505,0.7966580702602696,1.0,3/33,5.92%,GNAS;UBASH3B;ILK
prerank,DNA replication (GO:0006260),0.39420022666478094,1.126120855182722,0.28735632183908044,0.7973754301777474,1.0,43/105,30.55%,HELB;REV3L;POLE2;RMI2;MCM2;CDC6;RBBP8;RAD1;WRN;ING5;ATM;RAD50;CDC45;ING4;ATRIP;HUS1;MCM4;POLG2;POLB;REV1;ORC2;DBF4;CDK2;KAT7;TBRG1;UPF1;TOPBP1;PTMS;TOP1;DONSON;TOP1MT;TOP3A;RECQL5;POLD1;MCM7;POLG;RPAIN;PNKP;ATR;IGHMBP2;TIMELESS;RAD17;RHNO1
prerank,base conversion or substitution editing (GO:0016553),-0.4468467314078849,-1.1260265774510096,0.296551724137931,0.6543903595516197,1.0,6/11,41.34%,ADARB2;ADAR;METTL3;APOBEC2;ADAD1;A1CF
prerank,RNA catabolic process (GO:0006401),0.42771192375971023,1.1259454422360762,0.319774011299435,0.7972209703690916,1.0,18/46,28.85%,SIDT2;PPP1R8;RNASE3;ZC3H12D;RNASE6;DIS3L2;METTL16;LSM2;SUPV3L1;SND1;CNOT10;NCBP1;MTREX;PABPC4;ERN1;RIDA;LSM5;DXO
prerank,negative regulation of viral release from host cell (GO:1902187),0.5285244021173555,1.1258049597424715,0.34106412005457026,0.797010675779795,1.0,6/13,22.09%,TRIM28;MID2;CHMP3;TRIM26;TRIM13;TRIM8
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3343994783591974,-1.125801019064181,0.2774566473988439,0.6529090913090445,1.0,11/32,17.93%,MCTP1;RIMS2;RIMS1;MCTP2;SYN1;DTNBP1;SLC30A1;GPER1;PREPL;CAMK2A;SYT11
prerank,sodium ion export across plasma membrane (GO:0036376),0.5280516994626158,1.1254017992189524,0.32122905027932963,0.797595434546207,1.0,3/13,6.93%,SLC4A4;ATP1B1;SLC9A1
prerank,chromatin disassembly (GO:0031498),0.5256090896797545,1.125156499810978,0.3429355281207133,0.7970349743836881,1.0,7/14,29.70%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,nucleosome disassembly (GO:0006337),0.5256090896797545,1.125156499810978,0.3429355281207133,0.7970349743836881,1.0,7/14,29.70%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,glutathione biosynthetic process (GO:0006750),0.5454306221173056,1.1251358528877202,0.3502824858757062,0.7964208440862479,1.0,6/11,32.04%,GCLC;GCLM;CHAC2;HAGH;OPLAH;GSS
prerank,keratinocyte differentiation (GO:0030216),0.4607361010040141,1.124685716651251,0.3151515151515151,0.7972217416887718,1.0,10/29,26.22%,ADAM9;CLIC4;JAG1;BCR;ANXA1;PIP5K1A;ASAH1;OPN3;KRT10;CERS3
prerank,histone H3 acetylation (GO:0043966),0.44179591498282755,1.124674821519523,0.31939605110336816,0.796587656471149,1.0,21/40,27.95%,LDB1;TADA1;NAA60;TADA2A;SGF29;KAT14;BRPF3;ING5;KAT6B;WDR5;KAT2A;PER1;ING4;KAT7;YEATS2;TAF6L;MEAF6;KAT2B;BRD1;TAF10;TAF5L
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5087215811080257,1.1246478157054562,0.33070866141732286,0.7959987443825413,1.0,9/16,31.92%,PIGW;PIGF;PIGL;PIGX;PIGV;PIGQ;PIGB;PIGN;PIGC
prerank,angiogenesis involved in wound healing (GO:0060055),0.540169274513403,1.1243436694046351,0.35294117647058826,0.7963148066746893,1.0,4/11,14.31%,VEGFA;ADIPOR2;SRF;NDNF
prerank,negative regulation of hippo signaling (GO:0035331),0.5397529900206971,1.1239883077707329,0.34593837535014005,0.7967973617117533,1.0,5/12,23.45%,CIT;LIMD1;WWC2;MAP2K3;DLG5
prerank,innate immune response in mucosa (GO:0002227),0.5566509815713385,1.1232532743146302,0.34433285509325684,0.7984647131950424,1.0,3/10,20.96%,RNASE3;DEFB1;IL4
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.42389998678037927,1.123057824015054,0.3256325632563256,0.7984270282993959,1.0,6/51,5.51%,DCLK1;SRGAP2;CTTN;ANKRD27;SNX2;DNM2
prerank,P-body assembly (GO:0033962),0.5400294593077362,1.1230445740032362,0.34202898550724636,0.7978009075963212,1.0,4/12,21.60%,DYNC1H1;PATL1;LIMD1;ATXN2
prerank,negative regulation of defense response to virus (GO:0050687),0.5670794760719605,1.1229204754250919,0.36363636363636365,0.7975170388666583,1.0,6/10,27.83%,ITCH;PCBP2;MUL1;C1QBP;ILRUN;PPM1B
prerank,negative regulation of binding (GO:0051100),0.40300154807186067,1.1219915529318725,0.28043478260869564,0.7998675559729925,1.0,30/81,25.06%,PRKCD;LRPAP1;CARD16;DACT1;DVL1;TMC8;BTAF1;SYMPK;EFHB;MAPK8;GTF2F1;CSNK1E;SMO;USP33;DAB2;MITD1;TFIP11;STYX;SUMO1;MDFI;E2F1;AKT1;CTSZ;NFKBIA;LRRK2;CAMK1;PEX14;ROCK1;GTPBP4;ILRUN
prerank,acyl-CoA metabolic process (GO:0006637),0.4457276609749335,1.1218826712050796,0.3108747044917258,0.7995526782615953,1.0,11/35,24.66%,ACSF2;ACOT11;SUCLA2;GPAT4;ACACA;GLYAT;MCEE;ACOT13;ACSL6;HMGCS2;ACOT8
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.43471216071017227,-1.12183155538622,0.3212996389891697,0.6611773838159851,1.0,6/12,23.25%,CEACAM1;SIRT1;BRCA1;ERLIN2;TRIB3;APOC1
prerank,positive regulation of telomere maintenance (GO:0032206),0.4560546045034263,1.1216016036048466,0.3353884093711467,0.7997356481700363,1.0,12/31,27.39%,GNL3;MAPK15;NEK7;HNRNPA2B1;ATM;RAD50;TNKS2;PPP1R10;MAP2K7;SLX4;RTEL1;PNKP
prerank,calcium-mediated signaling (GO:0019722),0.4018245970529696,1.121516443999081,0.26903023983315955,0.7993264761796134,1.0,17/93,13.86%,EGFR;CACNA1C;PLCE1;ATP1B1;PPP1R9B;MCU;SLC9A1;ANK2;ACKR4;TRPM4;PPP3CC;RCAN1;BCAP31;PDPK1;DEFB1;STIMATE;DMPK
prerank,coenzyme A metabolic process (GO:0015936),0.5217889604908249,1.121411275643719,0.340080971659919,0.7989971580326021,1.0,10/14,33.09%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;ACLY;PPCDC;CROT;COASY
prerank,dopamine metabolic process (GO:0042417),0.49069601205436475,1.1209643165347465,0.3289646133682831,0.7997998355932966,1.0,4/18,4.35%,DRD1;LRTOMT;TGFB2;SNCAIP
prerank,response to tumor necrosis factor (GO:0034612),0.39568484391534614,1.1202306062341265,0.3007360672975815,0.8014649235759318,1.0,10/91,7.21%,PID1;ADAM9;AFF3;YBX3;CCL13;CCL15;SMPD4;ADAM10;NFE2L2;CXCL16
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5527675216648933,1.1201982495535903,0.3534361851332398,0.8009034735810726,1.0,4/10,9.70%,LRP5;TGFBR2;SOX9;FGFR2
prerank,positive regulation of receptor internalization (GO:0002092),0.4790689929247477,1.1197820554324054,0.34296482412060303,0.8015472273491834,1.0,2/22,1.33%,VEGFA;SFRP4
prerank,protein localization to plasma membrane (GO:0072659),0.3921775898322353,1.1196790802746215,0.26591375770020537,0.801212507735467,1.0,22/129,7.66%,LRP6;KCNB1;ATP1B1;GAS6;FGF13;TTC7A;EHD1;RDX;RAB34;C2CD5;NECTIN3;RAMP2;PIGW;PACS2;S100A10;PRAM1;RAB8A;SLMAP;ANK2;EHD2;FCHO2;JUP
prerank,protein export from nucleus (GO:0006611),0.45633272097637195,1.1196610187706406,0.3462986198243413,0.8006140812327891,1.0,14/27,27.33%,PKD1;XPO1;STRADA;XPO6;XPO4;CHP1;STYX;CALR;CCHCR1;DESI1;NUTF2;TPR;XPO7;XPO5
prerank,regulation of nervous system development (GO:0051960),0.4369849913231868,1.1195364572349178,0.33060747663551404,0.8003413608089618,1.0,10/37,16.19%,LGI4;DOCK7;HES5;TNFRSF1B;BHLHE40;HEYL;HEY1;SIRT2;NKX6-2;NPHP3
prerank,autophagosome assembly (GO:0000045),0.42008531919241604,1.119486782595043,0.296962879640045,0.7998175551755273,1.0,21/52,30.05%,ULK2;RAB43;PACS2;WIPI2;ATG3;ATG16L2;UBQLN1;RAB23;RB1CC1;ATG16L1;RUFY4;RAB1A;RAB1B;ATG9A;ATG13;ATG2B;AMBRA1;ULK1;UBXN2A;STX17;IRGM
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5323072891717352,1.119313590890642,0.3696612665684831,0.7997023005376588,1.0,4/11,12.70%,NECAB3;SOAT1;BACE2;AGO2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3934911061637102,1.119167669316074,0.28776978417266186,0.799491531158444,1.0,16/113,10.43%,PGF;EGFR;SRSF6;VEGFA;F3;FGF2;TCF7L2;STAT5A;PKHD1;PRKCA;FZD7;SOX9;BMP4;FGFR2;AGGF1;VIP
prerank,AMP metabolic process (GO:0046033),0.5211238648598153,1.1189233886731709,0.3453038674033149,0.79961865736945,1.0,3/13,12.81%,XDH;AK3;AMPD3
prerank,oxoacid metabolic process (GO:0043436),0.4607521124941226,1.118691769754183,0.33495145631067963,0.7996908601697994,1.0,9/27,18.59%,SULT1C2;SULT1C4;LIAS;PPA2;BPNT1;LIPT1;GNMT;PPA1;DAO
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5333513908716956,1.1183795600214814,0.3562874251497006,0.8000721984937147,1.0,6/11,29.22%,STAT3;PUM1;LIMD1;XPO5;FXR1;PUM2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.40050727834073385,1.1183786928950143,0.2864637985309549,0.7994215514536753,1.0,10/88,7.67%,TRABD2B;VEGFA;MPP7;EMILIN1;SDC1;PRKCA;VCP;CDC42EP2;PFN2;SLF2
prerank,positive regulation of cell differentiation (GO:0045597),0.3794010195644515,1.1183151201781296,0.2283702213279678,0.7989585206908117,1.0,52/237,16.05%,BOC;CDON;CMKLR1;TMEM100;PKDCC;ID2;HOXA5;DDR2;COL1A1;TIAM1;LRP5;TGFB3;TWIST1;WWTR1;TGFB2;ACVR1;BCL9L;SMAD4;TGFBR2;FGFR1;HEYL;SOX9;PA2G4;IMPACT;CARM1;TRPM4;RHOA;EDN3;BMP4;SYAP1;PLA2G5;TMEM119;RUNX2;ABL1;BMPR1A;MAPK12;NEUROD2;SRF;NELL1;TGFB1I1;TGFBR1;HOXB4;MEF2A;RBM4;WDFY2;DAB2;NBL1;HGF;IL6;CRB2;CREB1;SPAG9
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.530459739841217,1.118003652454555,0.35195530726256985,0.7992255664401108,1.0,2/13,1.98%,SULT1C2;SULT1C4
prerank,inflammatory response (GO:0006954),0.38096307977253807,1.117913519155643,0.2575452716297787,0.7988382760306734,1.0,20/195,10.26%,THBS1;MGLL;CMKLR1;PROK2;TAC4;CCL13;HDAC9;HDAC4;CCL15;STAT3;ADCY8;NOX4;NFX1;HMGB1;ABCF1;FPR3;LIAS;ANXA1;ITCH;CHUK
prerank,activation of adenylate cyclase activity (GO:0007190),0.4383205204965181,1.1169481752418353,0.32231404958677684,0.8013243184807141,1.0,9/35,12.87%,DRD1;FSHR;EDNRA;ADCY2;ADCY8;ADCY9;RAF1;CAP1;GLP1R
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4569788988972104,1.1167511134458774,0.32484848484848483,0.801272109829722,1.0,12/30,24.28%,FHIT;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;STYX;RYBP;UCHL5;USP14;CAMLG
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4105412126470308,1.1163482470959714,0.3086283185840708,0.8019071757342022,1.0,30/60,33.56%,TCF7L2;TRIM28;MED27;SOX9;MED31;MED13;RUNX2;AGO1;MED25;SRF;IL6;MED26;MED14;MED12;CBFB;MED20;TP53;MED23;CCNC;MED24;TNRC6A;MED8;MECP2;MED15;CTNNB1;MOV10;NFKB1;MED1;CEBPB;RELA
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5439831563021199,1.1159386339703188,0.35878962536023057,0.8018692955832658,1.0,5/10,19.93%,NFAT5;NFATC1;PPP3CC;NFATC3;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),0.5439831563021199,1.1159386339703188,0.35878962536023057,0.8018692955832658,1.0,5/10,19.93%,NFAT5;NFATC1;PPP3CC;NFATC3;NFATC4
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.34299293713423745,-1.1158954379019204,0.265,0.6742423259323422,1.0,1/26,0.01%,ATP1A2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5021915567679747,1.1156728036496242,0.35859269282814615,0.8020758041164344,1.0,5/15,17.74%,ZC3H12D;ZC3H12C;LACTB2;RPP40;KHNYN
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.413362761120858,1.1155542280861495,0.3348164627363737,0.8018056604168938,1.0,22/60,30.44%,SMOC2;FGF2;MAPK15;NEK7;NVL;ATM;TNKS2;HGF;POLG2;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;DKC1;PNKP;CCT5;PRKD2;ATR;CTNNB1;HSP90AA1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5007373785819871,1.1152017222573514,0.3546666666666667,0.8022074292675618,1.0,8/16,26.11%,LRP1;LRPAP1;SRF;HDAC1;CLU;IL4;ROCK1;HMGCR
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.48667254828003703,1.1149289859287823,0.3346456692913386,0.8024389978010029,1.0,1/18,0.08%,MYOC
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.48997624116453053,1.1148507597919166,0.32756324900133155,0.8020094850496527,1.0,9/17,26.13%,EMC2;EMC9;EMC1;CAMLG;EMC8;GET4;EMC4;MMGT1;GET3
prerank,regulation of T cell differentiation (GO:0045580),0.44392749273908455,1.114440435286289,0.31005917159763313,0.8026269467856332,1.0,11/33,20.96%,ZMIZ1;TBX21;CRTAM;ABL1;SOD1;CLPTM1;KAT2A;RUNX1;CAMK4;CBFB;IL4
prerank,regulation of cholesterol transport (GO:0032374),0.4798550360531467,1.1139844961785579,0.33248081841432225,0.8034254348596044,1.0,2/20,5.93%,LRP1;LAMTOR1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.550217862187516,1.1136121755707604,0.34522111269614836,0.8039506212951388,1.0,5/10,25.69%,HMGB1;RUNX1;CBFB;SH3RF1;SOCS1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5353877050378637,1.113499184222621,0.3465491923641703,0.8036764700678763,1.0,3/11,10.66%,VCP;UGGT2;UGGT1
prerank,piRNA metabolic process (GO:0034587),0.48131503253641617,1.1134844611572892,0.3554140127388535,0.8030821763892566,1.0,4/19,20.44%,TEX15;MAEL;TDRD12;TDRKH
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.42870039073820526,1.1129862673201008,0.34705882352941175,0.8039451610624245,1.0,6/41,12.27%,GAS6;LBP;IRAK3;TRIM27;RARA;CIDEA
prerank,RNA metabolic process (GO:0016070),0.3910023448845563,1.1128126281222472,0.2740286298568507,0.8038417378334689,1.0,52/127,25.89%,DDX17;HNRNPH1;SIDT2;RBFOX2;RBM39;DUSP11;M1AP;FTO;PPP1R8;HNRNPA2B1;RNASE3;HNRNPL;HNRNPH2;RNASE6;TBRG4;GTF2F1;AGO1;RBM6;RBM5;PABPN1;AGO2;HNRNPM;PCBP2;ALKBH1;PTBP1;RBM4;HNRNPC;SUPV3L1;CLP1;SND1;HNRNPK;POLR2F;TFIP11;TP53RK;NCBP1;NCBP2;SYNCRIP;MTREX;HNRNPH3;TENT2;DHX8;ATXN2;HNRNPA3;HNRNPA1;POLR2B;HNRNPU;PABPC4;RBM3;DDX39B;METTL14;POLR2H;DDX20
prerank,bicellular tight junction assembly (GO:0070830),-0.3009830194620442,-1.1122063580338921,0.21621621621621623,0.6817766039725057,1.0,9/46,9.00%,PARD6G;OCLN;PECAM1;CDH5;CLDN5;ESAM;F11R;APC;CLDN1
prerank,neuron development (GO:0048666),0.38469683279935973,1.1119203077083202,0.27132579650565264,0.8060092185191915,1.0,31/141,15.53%,MYOC;PBX3;NEDD4;VSX1;LGI4;STMND1;EHD1;GLI2;LRP12;DOCK7;PPP1R9B;TGFB2;BLOC1S2;HMGB1;GPRIN1;PBX1;TBC1D23;TBC1D24;B4GALT5;SRF;TENM1;UHMK1;NLGN1;BLOC1S3;MANF;RUNX1;WNK1;PLP1;IL6;MICALL2;THOC2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.44119504189796077,1.1115950765097429,0.3372093023255814,0.8064264805143191,1.0,8/33,15.56%,GRIK4;ARC;SLC4A8;CEL;BCR;IQSEC2;NLGN1;PSMC5
prerank,phospholipid metabolic process (GO:0006644),0.4060835049313599,1.1115880506571232,0.3081896551724138,0.8057971540011364,1.0,15/71,17.91%,TNFAIP8L3;PLA2G4F;PLA2G4A;PLPP3;LPCAT1;PLPP1;LPCAT4;PLA2G5;PIP4K2B;FADS1;LGALS13;PNPLA3;PIP5K1A;PLA2G15;AGPAT5
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3791551986317243,-1.1111650269290776,0.3206751054852321,0.6823133415164807,1.0,7/18,13.90%,NRXN1;SHANK3;CACNG7;CACNG8;CACNG3;CACNG4;RELN
prerank,regulation of microtubule polymerization (GO:0031113),-0.2987937179537484,-1.1110736263591046,0.20491803278688525,0.6804529718254996,1.0,11/40,15.09%,OCLN;CDH5;MAP2;NAV3;CAMSAP1;EML2;PAK1;CLIP1;PRUNE1;SNCA;TUBB4A
prerank,regulation of B cell apoptotic process (GO:0002902),0.5317080127135069,1.1109968881839636,0.35082872928176795,0.8069863312031724,1.0,1/12,0.44%,FOXP1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4922931124617296,1.110514478867926,0.35723771580345287,0.807778914906982,1.0,6/17,14.05%,P4HB;NOL3;NFE2L2;SFPQ;SOD1;UBQLN1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.532277857103041,1.1100783993045475,0.34156976744186046,0.8084720351089307,1.0,7/11,33.43%,ATF4;HSPA5;ATF6;CREB3L1;TP53;ATF6B;CEBPB
prerank,pharyngeal system development (GO:0060037),0.505443549376019,1.1098619553925353,0.3423545331529093,0.8085330800483601,1.0,7/15,14.52%,SIX4;TGFB2;NOG;BMP4;BMPR1A;TGFBR1;BMP5
prerank,negative regulation of metabolic process (GO:0009892),0.4104739090563214,1.1097580277259562,0.3438556933483653,0.8082106498779552,1.0,18/54,17.43%,ZNF423;NPR3;DOCK7;ATF4;ACTN3;FOXC2;ACOT11;PGAM5;TFE3;TLE3;IP6K1;PCTP;ABHD6;CIDEA;LNPEP;ID1;FLCN;ACOT13
prerank,apical protein localization (GO:0045176),-0.4564872789727501,-1.1097134511013764,0.3247863247863248,0.6819808714060338,1.0,6/10,20.25%,SHROOM2;MAL;INSC;VANGL2;SHROOM3;ACTB
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.43643826244751427,1.1095255869891818,0.3301775147928994,0.8082821594343493,1.0,21/39,34.68%,CHD1L;ERCC5;ERCC4;OGG1;CUL4A;ERCC3;ERCC2;PARP1;UBC;RPS27A;POLD1;GTF2H4;XPA;DDB1;RBX1;ERCC1;POLK;RPA3;CUL4B;FAN1;RFC4
prerank,nucleus organization (GO:0006997),0.42281015683463763,1.1092062007830064,0.3217097862767154,0.808659925923204,1.0,15/47,26.65%,NUP93;SEH1L;CHMP3;DMPK;REEP3;USP36;TMEM170A;CHMP4A;CHMP4B;PDCD6IP;NDC1;NUP35;CHMP2A;TPR;ATXN7
prerank,protein polyubiquitination (GO:0000209),0.3703414563211148,1.1091230180009728,0.22166499498495487,0.8082594482160369,1.0,118/297,30.23%,WWP1;RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;PSMD7;FBXW8;TOPORS;CDC16;UBE2B;LRSAM1;PSMA8;UBE2R2;ERCC8;UBE3C;RNF115;HUWE1;TRIM27;SYVN1;RBBP6;WWP2;SHARPIN;PSMA4;ITCH;FBXL4;RNF114;UBR5;UBE2C;FBXO22;RNF14;FBXL12;PSMD12;ANAPC4;MYLIP;TRAF3;CUL1;FBXL19;PSMA6;TNKS2;FBXL14;LNPEP;PSMD1;DDA1;UBE2L6;ANAPC2;FBXO17;STUB1;FBXL20;PSMC5;ANAPC1;PSMD11;UBE2V2;PSMC4;PSMD14;TRAF3IP2;UBC;RPS27A;RC3H2;ANAPC10;UBE4A;FBXL18;TRIM6;HECTD1;TPP2;FBXW2;NPEPPS;UBR2;CDC27;FBXW4;RUSC1;CBFB;UBE2G2;PSMA3;UBOX5;SMURF2;MUL1;RNF4;PSMB1;PSMD4;AREL1;TTC3;RNF20;RNF216;ZFP91;PSMA5;RNF146;FBXO11;PSMA7;TAF1;FBXO9;AMFR;UBE2W;SHPRH;PSMC1;RNF126;RNF166;FBXO38;FBXW10;PSMA1;RNF167;UBE2V1;UBE4B;FBXL8;FBXO41;RBX1;BTRC;RNF135;UBE2Q2;TRAF5;PRKN;UBE2H;BLMH;TRIP12;ANAPC11;UBE2S;PSMD2;CTNNB1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4494998352493969,1.1090941840544188,0.34793187347931875,0.8077110377124264,1.0,19/32,33.41%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;POLR1C;TAF1C;TBP;TAF1;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;RRN3;POLR2K;TAF1A;CCNH
prerank,protein localization to chromosome (GO:0034502),0.43599564132525315,1.1088951412126338,0.3381818181818182,0.8077025368779949,1.0,3/34,7.67%,ESR1;PARP3;SLF2
prerank,autophagosome organization (GO:1905037),0.41877057379193594,1.1088021422249557,0.3246606334841629,0.8073331276719046,1.0,19/50,28.51%,ULK2;RAB43;PACS2;WIPI2;ATG3;ATG16L2;UBQLN1;RAB23;RB1CC1;ATG16L1;RUFY4;RAB1A;RAB1B;ATG9A;ATG13;ATG2B;AMBRA1;ULK1;UBXN2A
prerank,response to interleukin-4 (GO:0070670),-0.4448626667786537,-1.1087590873990079,0.3235294117647059,0.6825120087028933,1.0,2/10,3.71%,LEF1;TCF7
prerank,protein autoubiquitination (GO:0051865),0.4058195338867936,1.1087256880518033,0.3199566160520607,0.8069349798844513,1.0,19/61,25.03%,SH3RF3;UBE2B;LRSAM1;ERCC8;NFX1;RNF115;WWP2;ITCH;RNF11;STUB1;TRIM13;UHRF2;RNF141;SH3RF1;RNF4;RNF146;RNF122;AMFR;RNFT1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4705799253971107,1.1086674014825058,0.3337393422655298,0.8064661874351485,1.0,11/26,25.06%,CARD16;TRAFD1;IRAK3;ITCH;MAPKBP1;PCBP2;SIRT2;ACOD1;MUL1;C1QBP;ILRUN
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.42165380312326467,-1.1079004176716454,0.3237410071942446,0.6825680418357459,1.0,5/12,26.04%,SLC5A3;ADGRB1;GRIN1;CD36;TLR6
prerank,positive regulation of histone deacetylation (GO:0031065),0.528904857627379,1.1078578284211882,0.3619718309859155,0.8083017444276323,1.0,5/12,27.91%,VEGFA;NIPBL;AKAP8;SAP30BP;PRKD2
prerank,mRNA stabilization (GO:0048255),0.4327739090144741,1.1078255423644152,0.32280701754385965,0.8077519582504059,1.0,16/40,24.31%,YBX3;PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;HNRNPC;E2F1;GDNF;SYNCRIP;CIRBP;SLC11A1;HNRNPU;YBX1;RBM24
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3388683322232815,-1.1074307813311404,0.2702702702702703,0.6817203365004803,1.0,11/29,13.01%,DPP10;CACNA1D;KCNIP3;KCNIP4;KCNIP1;FGF12;KCNN2;HOMER1;DPP6;KCNAB1;CD63
prerank,receptor-mediated endocytosis (GO:0006898),0.38533174008385257,1.1062804687703616,0.3047034764826176,0.8118219084504129,1.0,29/132,16.06%,LRP6;LRP1;NEDD4;CTTN;COLEC11;IGF2R;PDLIM7;SPARC;DNAJC13;RAMP2;AP2A1;DNM2;CD9;CXCL16;FCHO2;FCER1G;SNX1;HYOU1;RAMP1;RABEPK;SNX9;LRP2;AP2A2;SNAP91;CLTC;COLEC12;DAB2;GPR107;PI4KB
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.525428521698356,1.106232896436866,0.36885245901639346,0.8113230982770784,1.0,3/12,8.38%,F3;IFT20;CBL
prerank,T cell activation (GO:0042110),-0.27971192642150156,-1.106171732917854,0.23809523809523808,0.6826821855982685,1.0,19/69,20.76%,LEPR;CHD7;KIT;DPP4;CXADR;JAG2;RHOH;CD74;PIK3CD;LCP1;LFNG;CTPS1;CD44;PTPN22;DLL4;MDK;CD276;SOX4;NHEJ1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.27679066102026767,-1.1055494334448797,0.26582278481012656,0.682189167201647,1.0,22/72,11.65%,NRXN1;SHANK3;APP;RIMS2;SLC24A2;CACNG7;ADCY1;GRIK2;RIMS1;GRIN2B;CACNG8;SLC8A3;ZDHHC3;LGI1;GRIN2A;NMU;CACNG3;ADRA1A;CACNG4;DTNBP1;CLSTN1;PLK2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.45585819754790613,1.105208330005449,0.3566958698372966,0.8138668395087807,1.0,10/26,21.02%,ACTN3;SLC9A1;CHERP;EFHB;RCAN1;CHP1;STIMATE;PTBP1;HOMER2;ATP2B4
prerank,maintenance of protein localization in organelle (GO:0072595),0.4772875145949661,1.1050052046269132,0.3469656992084433,0.8138354001728554,1.0,9/19,28.23%,TOPORS;MORC3;HSPA5;ARL2;AKT1;HNRNPU;PINK1;TAPT1;TAF3
prerank,transcription by RNA polymerase I (GO:0006360),0.43980912870645095,1.1049916652216514,0.35933806146572106,0.8132274936431462,1.0,20/34,34.00%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;POLR1C;TAF1C;TBP;TAF1;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;RRN3;POLR2K;TAF1A;CCNH;TCOF1
prerank,nuclear migration (GO:0007097),0.5158847959143287,1.1049159057322122,0.36608344549125166,0.8127928937444274,1.0,6/13,20.23%,DOCK7;DYNC1H1;CLMN;TMEM201;PCM1;DCTN1
prerank,calcium ion transport (GO:0006816),0.38783457264030347,1.104506266664153,0.31983385254413293,0.8134873894788057,1.0,19/113,11.59%,CACNA1G;PKD1;CACNA1C;GAS6;SLC24A3;GRIN3A;CRACR2A;TRPV3;RAMP2;CHRNB2;ANK2;TRPC4AP;TRPM7;TRPM4;STIM1;ITGAV;RAMP1;TMEM165;TRPM6
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.52213373543496,1.1042969601248416,0.3594405594405594,0.8134909206037253,1.0,5/12,24.99%,TMEFF2;AP2A1;CLTC;SELENOS;HDAC2
prerank,chondrocyte differentiation (GO:0002062),0.4487011715934057,1.104217981975604,0.34474327628361856,0.8131058172895214,1.0,8/32,10.29%,SLC39A14;NFIB;CCN3;HES5;SULF1;SOX9;BMP4;RUNX2
prerank,N-terminal protein amino acid modification (GO:0031365),0.5155298523265388,1.1037209649033,0.3506666666666667,0.8140008246714889,1.0,7/14,26.40%,NAA60;NAA40;NAA16;NTMT1;METAP1D;METAP2;NAA15
prerank,regulation of interleukin-13 production (GO:0032656),-0.4105255722433595,-1.1032004591159073,0.31868131868131866,0.6859835527947034,1.0,4/13,14.89%,LEF1;TNFRSF21;LGALS9;PRKCZ
prerank,positive regulation of calcium ion import (GO:0090280),-0.41694362483171343,-1.1030342565644315,0.3333333333333333,0.6843171856479031,1.0,2/12,4.51%,CXCL12;PDGFRB
prerank,mucosal immune response (GO:0002385),0.5060079964861742,1.1030154646535562,0.34668508287292815,0.8155191708153743,1.0,4/15,20.96%,IFNLR1;RNASE3;DEFB1;IL4
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.47875113395824015,1.1029587120870843,0.35978835978835977,0.8150401736248097,1.0,6/19,23.74%,TENT4B;TEN1;HNRNPC;XRN1;HNRNPA1;HNRNPU
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3788818260418997,1.10262005700081,0.2734611503531786,0.815470576205432,1.0,47/166,24.94%,THBS1;SMOC2;EGFR;IRS1;FGF2;AGXT2;LDB1;GLI2;SAMD4A;ELOVL5;PRKDC;GIPC1;DDAH1;AKT2;BRPF3;SREBF1;NNMT;NIBAN1;CNEP1R1;CHP1;PTPN2;ARPP19;HGF;IL6;EIF6;ERBB2;EIF3D;CDT1;AKT1;MLXIPL;EPM2AIP1;APPL1;KAT7;PYM1;CLU;CIRBP;FXR2;LDLR;OPN3;UPF3A;SLC25A37;PRMT1;ABCB10;RPS6KB1;RPS27L;UPF3B;RBM3
prerank,aorta morphogenesis (GO:0035909),-0.3817509567884478,-1.102356286296305,0.3320610687022901,0.6840323267454566,1.0,10/17,14.31%,ENG;MYLK;PDGFRB;TBX1;PROX1;RBPJ;TBX2;ACVRL1;HEY2;EFEMP2
prerank,cortical actin cytoskeleton organization (GO:0030866),0.47762117311162516,1.1022333760003853,0.3618925831202046,0.8160090049458368,1.0,4/20,8.78%,FMNL2;RHOQ;LLGL1;DLG1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3912634047949779,1.1017939714723954,0.3089005235602094,0.8167208444601605,1.0,16/93,13.66%,RASSF2;VEGFA;SH3RF3;GADD45G;MAP3K5;TGFB2;XDH;MID1;HMGB1;FZD7;LTBR;AXIN1;CD27;TRAF3;STK25;MAP3K10
prerank,vasculogenesis (GO:0001570),-0.33788072258936186,-1.1015494328211428,0.31382978723404253,0.6840764814732332,1.0,13/32,15.10%,TGFBR3;ENG;NOTCH1;KDR;RASIP1;PDGFRB;SOX17;SPRED1;CAV1;SOX18;HEY2;APLNR;ITGB8
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.4857862422533953,1.1013950761411249,0.3875338753387534,0.8172855582995757,1.0,5/18,12.68%,CCN3;HDAC4;FZD7;TMEM119;HDAC1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5211458623506394,1.1008934555227399,0.3638888888888889,0.8168774132293856,1.0,5/12,19.94%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5211458623506394,1.1008934555227399,0.3638888888888889,0.8168774132293856,1.0,5/12,19.94%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5211458623506394,1.1008934555227399,0.3638888888888889,0.8168774132293856,1.0,5/12,19.94%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5
prerank,amino acid import (GO:0043090),0.4764915950258415,1.1008909657144368,0.35822784810126584,0.8162493464537929,1.0,1/21,0.01%,SLC47A1
prerank,melanosome organization (GO:0032438),0.45856774433335773,1.1008185945435607,0.3619402985074627,0.8158462534722138,1.0,8/26,14.45%,KIF13A;BLOC1S2;RAB38;TRAPPC6A;AP3D1;BLOC1S3;ABCB6;HPS4
prerank,regulation of membrane repolarization (GO:0060306),0.5202412294227526,1.1002755754158389,0.37669376693766937,0.816901718077365,1.0,4/13,13.55%,KCNJ2;KCNE5;AKAP9;YWHAE
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4608326284606977,1.100201462242462,0.33754740834386854,0.8164940857315309,1.0,2/23,5.91%,SLIT2;MCU
prerank,cell part morphogenesis (GO:0032990),0.5223672961879916,1.099688259120558,0.3573407202216066,0.8174379946509963,1.0,1/13,0.49%,PID1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.44772633426868497,1.0993258838492164,0.3475682087781732,0.8179625298772213,1.0,4/29,13.02%,THBS1;PAK2;LTBR;INHBA
prerank,tRNA metabolic process (GO:0006399),0.490232271423327,1.0992464570039868,0.3616734143049933,0.8175906611615906,1.0,8/17,27.06%,SSB;DTD1;DARS2;YARS2;ADAT1;SARS1;RPP21;POP5
prerank,regulation of telomere maintenance (GO:0032204),0.4569938932641113,1.0992130495064523,0.35037406483790523,0.8170660929285024,1.0,8/26,21.96%,GNL3;SMG6;ERCC4;SMG1;RAD50;USP7;PPP1R10;UPF1
prerank,ovarian follicle development (GO:0001541),0.5188898962137178,1.0990637748633107,0.36027397260273974,0.8168788236012187,1.0,3/13,13.02%,VEGFA;SOD1;INHBA
prerank,cellular response to organonitrogen compound (GO:0071417),0.39083107949089696,1.0988357083349292,0.3017689906347555,0.816975509108048,1.0,15/99,12.59%,SLIT2;IGFBP5;HCN4;SLC26A6;IPO5;PDE3A;LAMTOR1;JUP;SOX9;IMPACT;CAPN2;P2RY6;EZR;AKAP9;SESN2
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.4460081077502904,1.0987751320556791,0.3619167717528373,0.8165182855426873,1.0,16/30,29.38%,KIF13A;RAB34;GGA2;GOLGA4;NSF;SEC16A;GGA1;SPTBN1;GOLPH3;BLZF1;OPTN;VAMP4;VAMP2;GCC2;GGA3;ARFRP1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3922688884933296,1.0987097305680245,0.3253138075313807,0.81609186776241,1.0,16/86,15.25%,EGFR;PRKCD;VEGFA;EFNA5;GHR;CSPG4;IL5;ACVR1;DGKQ;ANGPT4;PAK2;ABL1;NRP1;CD80;HGF;IL6
prerank,glutathione derivative metabolic process (GO:1901685),0.4784062090139809,1.0983194445017017,0.36538461538461536,0.8160084648448219,1.0,5/20,16.63%,GSTT1;GSTM5;GSTO2;GSTZ1;AKR1A1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.4784062090139809,1.0983194445017017,0.36538461538461536,0.8160084648448219,1.0,5/20,16.63%,GSTT1;GSTM5;GSTO2;GSTZ1;AKR1A1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4493555127556878,1.0981664341209052,0.3548780487804878,0.8158259609398718,1.0,17/30,33.41%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;POLR1C;TAF1C;TBP;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;POLR2K;TAF1A;CCNH
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.39555491843065516,-1.0979312653865698,0.30612244897959184,0.6918970306281311,1.0,5/16,20.77%,TNFRSF21;CD274;TYROBP;DLL1;AGER
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.43022322419387066,1.0978137683326306,0.34498834498834496,0.816243059454177,1.0,13/39,16.06%,TTC7A;PIK3C2B;SOCS7;SOCS4;SOCS6;SOCS2;SMG1;PIP4K2B;IP6K1;PIK3CB;PI4K2A;TTC7B;PI4KB
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5137361815658789,1.0977317519553387,0.35753424657534244,0.8158692368285727,1.0,8/13,31.61%,NFE2L2;HGF;LRRK2;PYCR1;MET;GPR37;GPR37L1;NR4A3
prerank,atrial septum morphogenesis (GO:0060413),0.5375053178545313,1.097675251882898,0.36950146627565983,0.8154137975585173,1.0,2/10,5.63%,TGFB2;ACVR1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.536423144843699,1.0974697471541353,0.37393767705382436,0.814152846888484,1.0,8/11,33.09%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.536423144843699,1.0974697471541353,0.37393767705382436,0.814152846888484,1.0,8/11,33.09%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,coenzyme A biosynthetic process (GO:0015937),0.536423144843699,1.0974697471541353,0.37393767705382436,0.814152846888484,1.0,8/11,33.09%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.44737279340966546,1.0973226830511646,0.36330498177399756,0.8133223282366632,1.0,7/29,18.77%,ACSF2;ACOT11;GPAT4;ACAT1;GLYAT;ACOT13;ACSL6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.44737279340966546,1.0973226830511646,0.36330498177399756,0.8133223282366632,1.0,7/29,18.77%,ACSF2;ACOT11;GPAT4;ACAT1;GLYAT;ACOT13;ACSL6
prerank,histone mRNA metabolic process (GO:0008334),0.4562680740029938,1.0966947229263908,0.355,0.8146953300810601,1.0,11/27,21.96%,TENT4B;SSB;ATM;XRN1;EXOSC4;TUT7;NCBP1;NCBP2;TENT2;SNRPB;UPF1
prerank,positive regulation of vascular permeability (GO:0043117),-0.41774798682764436,-1.0964815079468555,0.3466135458167331,0.6935166978154906,1.0,5/12,9.54%,TJP1;OCLN;BMP6;PDE2A;ANGPT1
prerank,generation of neurons (GO:0048699),0.3744265093909969,1.096160449036384,0.28353658536585363,0.8157598476063985,1.0,35/190,16.32%,SIX1;WNT9A;CIT;FGF13;MAP1B;MARK1;LDB1;LRP12;NAV1;DOCK7;LHX9;HES5;SIX4;TGFB2;NRBP2;BHLHE40;FZD7;FGFR1;HEYL;FZD5;PEX13;MYEF2;RUNX2;CTF1;NEUROD2;HEY1;SDCCAG8;NRP1;RUNX1;NDNF;ACSL3;EN2;THOC2;ERBB2;DNAAF4
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4065418492067195,1.0960586011721356,0.3465783664459161,0.8154248555262311,1.0,16/56,19.94%,EGFR;RDX;ANAPC5;CDC16;BRD4;ANXA1;CDC25B;UBE2C;ANAPC4;RCC2;EIF4G1;TFDP1;CDC25A;AKT1;CDC27;DLGAP5
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5214310289885662,1.095773642897044,0.3565217391304348,0.8156526087588774,1.0,2/12,4.20%,VEGFA;STAT3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.41790145223464464,1.09575159989935,0.3401197604790419,0.8150857152047272,1.0,21/42,32.74%,HELB;RMI2;FUS;SPIDR;WDR48;MMS19;PARP1;RAD51;MAD2L2;SETD2;ACTR2;CGAS;WAS;FBH1;RTEL1;SHLD3;SHLD1;TIMELESS;PARPBP;ERCC6;POLQ
prerank,cellular response to UV (GO:0034644),0.39846370653253527,1.0956651118863376,0.3386752136752137,0.8147162069642578,1.0,24/76,26.56%,PRKCD;NEDD4;CARD16;ATF4;IMPACT;ERCC4;SDE2;N4BP1;CREBBP;PARP1;CDC25A;EIF2AK4;NOC2L;EIF2S1;USP47;TRIAP1;OPN3;MMP2;TAF1;TP53;POLD1;PPID;XPA;YY1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4543340522665234,1.095592375369529,0.37229987293519695,0.8143213852865349,1.0,4/24,5.27%,MYOC;ARAP1;TMEFF2;PPFIA1
prerank,regulation of mRNA catabolic process (GO:0061013),0.37835316390218265,1.0955905686822929,0.32546201232032856,0.813704329128819,1.0,38/121,24.66%,XPO1;PRKCD;PABPC1;SAMD4A;PSMD7;PRKCA;PSMA8;PUM1;PSMA4;PCBP4;PSMD12;PSMA6;EIF4G1;PSMD1;XRN1;EXOSC4;PSMC5;CNOT8;PSMD11;PSMC4;PSMD14;UBC;RPS27A;RC3H2;DIS3;AKT1;TNPO1;PSMA3;PSMB1;PSMD4;FXR2;UPF1;DCP1A;PSMA5;PSMA7;ZC3H14;RBM24;YWHAB
prerank,organelle disassembly (GO:1903008),0.4363256079590764,1.0951729058578945,0.3419506462984724,0.8143550619885684,1.0,9/33,19.31%,ULK2;STX5;VCP;GBF1;UBA5;KLC1;UFL1;RB1CC1;TEX264
prerank,proteasomal protein catabolic process (GO:0010498),0.3718126359695446,1.0949796931073323,0.29120323559150657,0.8142818756185802,1.0,77/201,30.23%,WWP1;NEDD4;PSMD7;TOPORS;COP1;UBE2B;VCP;PSMA8;ERCC8;NFE2L2;TBX21;HUWE1;SYVN1;SOCS6;DDI2;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;PSMD12;FBXL19;PSMA6;PCBP2;ATE1;PSMD1;KCTD5;ARRB1;STUB1;SIRT2;PSMC5;PSMD11;KLHL22;PPP2R5C;PSMC4;PSMD14;TRIM13;KCTD17;GID4;ZFAND2B;ERLEC1;PCNP;RMND5B;PSMA3;UCHL1;RCN3;DCAF11;SMURF2;RNF4;PSMB1;PSMD4;KCTD13;APPBP2;AREL1;DERL1;RNF216;PSMA5;PSMA7;RNF122;ANKRD9;DNAJB12;UBE2W;PSMC1;RNF126;PSMA1;CCDC47;DDB1;NR1D1;UBXN2A;UBE4B;RBX1;SPOPL;BTRC;ZFAND2A;PRKN;PSMD2;CTNNB1
prerank,positive regulation of nervous system development (GO:0051962),-0.3080115176138082,-1.0949010786418154,0.3161764705882353,0.6956511385251591,1.0,14/42,12.29%,NRXN1;IL1RAPL1;TGM2;GRID2;PTPRD;OPRM1;FAIM;SRPX2;CX3CR1;CLSTN1;CUX2;IL1RAP;EPHB1;SYNDIG1
prerank,pre-replicative complex assembly (GO:0036388),0.39799373449690917,1.0947448327487521,0.3581757508342603,0.8143901536939668,1.0,25/64,27.29%,PSMD7;PSMA8;MCM2;CDC6;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;UBC;RPS27A;MCM4;ORC2;CDT1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;PSMC1;MCM7;PSMA1
prerank,striated muscle cell development (GO:0055002),-0.3978525481500784,-1.094418293847914,0.3188405797101449,0.6947836798451035,1.0,4/14,8.20%,PGM5;TMOD3;TMOD1;LMOD1
prerank,regulation of glycogen metabolic process (GO:0070873),0.516747408440132,1.0943771097888617,0.3667621776504298,0.8148644879698781,1.0,4/12,23.12%,PPP1R3C;PPP1R3F;AKT1;PPP1R3B
prerank,ribosomal small subunit assembly (GO:0000028),0.5001339618756782,1.09431507078469,0.3932291666666667,0.8144311998161589,1.0,3/16,6.23%,RPSA;PRKDC;RRP7A
prerank,endodermal cell fate commitment (GO:0001711),-0.44376244240291973,-1.0943032808215443,0.34662576687116564,0.6930293814068316,1.0,4/10,16.69%,SOX17;LEO1;SOX2;CTR9
prerank,filopodium assembly (GO:0046847),0.4995702511970288,1.0941290457714539,0.37582128777923784,0.8143680199417048,1.0,3/16,3.62%,SRGAP2;PPP1R9B;FGD6
prerank,positive regulation of lyase activity (GO:0051349),0.5050288613467513,1.093716785585478,0.36425648021828105,0.815035709594228,1.0,3/14,9.16%,CACNA1C;FXN;STIM1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.42257802061055627,1.0937066788182275,0.3387096774193548,0.8144536055273357,1.0,12/45,14.52%,GDF10;INHBC;TGFB3;TGFB2;ACVR1;SMAD4;BMP4;BMPR1A;TGFBR1;INHBA;DAB2;BMP5
prerank,positive regulation of cellular component movement (GO:0051272),0.46482949860930345,1.0935703328787874,0.36240786240786244,0.8142689414471946,1.0,6/24,12.60%,NTN1;VEGFA;TWIST1;AKT2;CCDC25;TGFBR1
prerank,regulation of glycolytic process (GO:0006110),0.39974688623778587,1.093553741579244,0.34691629955947134,0.8137049052930065,1.0,27/68,26.41%,SLC4A4;NUP93;SEC13;HDAC4;RAE1;ACTN3;SEH1L;OGT;GIT1;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;MLXIPL;NUP62;NDC1;NUP35;PFKFB4;ENTPD5;NCOR1;PFKFB1;NUP85;NUP160;TPR
prerank,axon guidance (GO:0007411),0.3737910953596533,1.0934889049306387,0.3023255813953488,0.8132850217987748,1.0,25/201,8.23%,SLIT3;SLIT2;SLIT1;PLXNA4;EMB;NTN1;VEGFA;EFNA5;NFIB;GRB10;GAB2;GLI2;TMEFF1;PDLIM7;EPHB2;SHC1;NTN4;SEMA3E;PRKCA;EPHB3;EPHB6;GAP43;SEMA4B;PALLD;CYFIP1
prerank,regulation of platelet activation (GO:0010543),-0.3589351301706691,-1.0934288303397788,0.3316582914572864,0.6933525986290444,1.0,8/21,11.13%,LYN;APOE;TEC;NOS3;PDGFRA;SYK;PRKCQ;PLEK
prerank,positive regulation of macroautophagy (GO:0016239),0.41777584887710617,1.093349648399021,0.34797297297297297,0.8130948780272199,1.0,23/48,28.60%,SESN3;BAG3;LRSAM1;RAB3GAP1;PIP4K2B;SESN2;PAFAH1B2;TRIM13;RAB3GAP2;OPTN;IL4;RUFY4;TSC2;UVRAG;VPS13D;SMCR8;TBK1;PINK1;GPSM1;HSPB8;PIP4K2C;SLC25A5;LARP1
prerank,regulation of coagulation (GO:0050818),0.531602534589042,1.093160905475536,0.37679083094555876,0.8130661773046085,1.0,2/11,13.07%,EPHB2;F2R
prerank,defense response to virus (GO:0051607),-0.2580948588226247,-1.0929145420863469,0.21428571428571427,0.6926373988508421,1.0,27/100,18.44%,SERINC3;BCL2;BCL2L1;IFNAR2;STAT1;AGBL4;ABCC9;SAMHD1;IFITM1;NLRC5;BST2;IFIT3;IFIT2;RNASEL;IFIT1;PQBP1;CD40;RSAD2;IFITM3;OAS2;IFI27;MLKL;SERINC5;PYCARD;MYD88;PHB2;ZBP1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.32495914859821307,-1.0926448110342042,0.27976190476190477,0.6913798065215948,1.0,7/30,12.39%,FLT1;KIT;KDR;ACE;FLT4;PLEK;SFRP1
prerank,positive regulation of apoptotic process (GO:0043065),0.36724561315584736,1.0922736814396836,0.27354709418837675,0.8151016131686668,1.0,66/293,18.26%,SLIT2;RASSF2;HOXA5;SFRP4;PTGIS;TIAM1;GADD45G;PRR7;TIAM2;UNC13B;VAV2;TGFB3;PRDM11;CYP1B1;FAP;MAP3K5;CRADD;TGFB2;ATF4;DNM2;CCAR2;HMGB1;ING3;IAPP;KALRN;BACE1;MAPK8;BMP4;FOXA1;ING5;ABL1;RBM5;ATM;AIFM1;SOD1;TNFRSF10B;ERCC3;PTRH2;TGFBR1;PDCD2;HSPD1;MAP3K10;SOS2;SQSTM1;ARHGEF1;RHOB;SCIN;AKAP13;PSEN2;SOS1;IL6;ING4;SIRT2;LATS2;FOXO3;TRIO;UBC;RPS27A;APBB1;NF1;NGEF;FLCN;DAPK3;E2F1;BID;RYBP
prerank,regulation of actin filament polymerization (GO:0030833),0.3963615350900153,1.0922299295918054,0.3542795232936078,0.8146067504403132,1.0,6/69,6.30%,SLIT2;PRKCD;CTTN;PRKCE;CDC42EP2;PFN2
prerank,lymphocyte mediated immunity (GO:0002449),0.521627719522149,1.092062373690125,0.36428571428571427,0.8144830544994619,1.0,2/12,6.52%,GNL1;JAG1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.46894528078234293,1.091735916989843,0.36100131752305664,0.8148550687670092,1.0,10/20,25.93%,MCU;SPG7;MICU2;LETM1;MICU1;PMPCA;AFG3L2;SLC8B1;STOML2;PMPCB
prerank,cellular glucan metabolic process (GO:0006073),0.5362622912620602,1.0917000358331825,0.3704775687409551,0.8143532570916243,1.0,3/11,7.74%,PPP1R3C;PHKA1;PHKB
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.43577035624034793,1.091432386048631,0.36407185628742517,0.8145081563623163,1.0,16/35,30.23%,MAPK15;NEK7;HNRNPA2B1;ATM;TNKS2;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;RTEL1;PNKP;CCT5;ATR;CTNNB1
prerank,macrophage activation involved in immune response (GO:0002281),0.5086124593662258,1.0913489547757365,0.38581560283687943,0.8141436963428296,1.0,2/13,9.20%,LBP;SBNO2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.42948120570463555,1.0910880268139098,0.35903614457831323,0.8143075027506853,1.0,3/34,1.12%,IRS1;TNFAIP8L3;FGF2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5331563287805935,1.0908621097607722,0.3971631205673759,0.8143296958693544,1.0,2/10,7.90%,GFPT1;GFPT2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.40975752265378895,1.0908531180818217,0.36228571428571427,0.8137434605406701,1.0,5/49,6.47%,LBP;F3;STAT3;MAVS;HMGB1
prerank,ncRNA 3'-end processing (GO:0043628),0.5079586849518212,1.0907765460917813,0.3665768194070081,0.8133612483884685,1.0,8/14,33.17%,INTS14;SSB;ELAC2;TOE1;INTS7;ERI1;INTS6;TRNT1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3808966526747108,-1.090761208168473,0.3142857142857143,0.6943138542065035,1.0,6/17,7.53%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.4033069318690562,-1.090530939641377,0.37547892720306514,0.692850855185322,1.0,8/15,26.04%,DDX3X;GBP5;DHX33;MYD88;TREM2;CPTP;CD36;TLR6
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.4231654954684087,1.0905183756370425,0.35058823529411764,0.8135333593330788,1.0,15/40,28.53%,PRKCD;KMT5A;SMG1;ABL1;UBE2V2;ARMT1;USP1;NEK4;FXR2;BCLAF1;SMYD2;PARG;FXR1;UBE2V1;CDK9
prerank,negative regulation of cellular process (GO:0048523),0.36413977506844897,1.0902745812836452,0.201,0.8136947723244907,1.0,97/521,15.39%,SLIT3;SLIT2;PLXNA4;ZBTB7C;SRSF6;FHL1;WNT9A;FGF2;SRGAP2;OSGIN2;PDCD4;SFRP4;CCN5;TGFBI;CCN3;EMILIN1;NTRK1;SMAD6;ACVR1B;VPS13C;EPHB2;TGFB3;P3H3;PPP1R9B;SPN;PRDM11;CYP1B1;SLURP1;GLMN;PKHD1;LMNA;LRPAP1;PTPRU;TGFB2;P3H1;CLMN;AGR2;TMEM98;TNFRSF1B;TMEM115;NOX4;CD9;CCAR2;PLPP1;SMAD4;ADAM10;PRKRA;ABI1;IFNLR1;SKI;TEX15;CDK10;MDM4;RAF1;TES;P3H2;CHERP;DACT3;DDAH1;CDC6;IMPACT;NDRG3;SERTAD2;DCBLD2;BMP4;ING5;ANP32B;LPCAT3;FOXM1;DIS3L2;RBM5;TAF6;PBRM1;TENM1;TGFB1I1;SESN2;PTPN2;PIP4P2;INHBA;F2R;CGRRF1;RBBP7;GSDME;FRK;FUZ;BMP5;TMEM127;SERTAD3;RHOB;VDR;CYP27B1;MIA3;SCIN;CAMK2N1;IL6;ING4;SIRT2
prerank,response to sterol (GO:0036314),0.5383331925024776,1.090273656254213,0.36818851251840945,0.8130876652443872,1.0,3/11,12.60%,TGFBR2;RORA;TGFBR1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.36433301393651873,1.0902596549447214,0.194,0.8125194413279084,1.0,117/476,19.96%,ESR1;EGFR;LRP6;SIX1;ID2;ZFHX3;HIVEP3;FGF2;ZNF423;NFIB;COL1A1;ELF4;ZMIZ1;GLI2;MDFIC;LRP5;GLIS2;TGFB3;DEAF1;SHC1;PRDM11;HDAC4;ELF1;MAP3K5;RXRA;HES5;SIX4;STAT3;ATF4;TRIM28;DNM2;ACVR1;BRD4;FOXC2;ILK;RXRB;GPATCH3;SMAD4;FZD7;TASP1;TBX21;THRAP3;SOX9;RARA;NSD1;MED13;ESRRB;TFE3;FOXK1;ENY2;NFATC1;SMARCC2;ZIC1;RORA;ILF3;BMP4;SFR1;ING5;ZFP90;EHF;CHUK;RUNX2;FOXM1;PHF8;PITHD1;MAP3K12;AXIN1;CHEK2;MAZ;KAT6B;RNF14;TAF15;NAA16;PHIP;NR1D2;HEY1;KAT2A;TGFB1I1;TGFBR1;HDAC1;INHBA;F2R;CD80;MAPRE3;RUNX1;NDP;MMS19;SERTAD3;IL6;PSMC5;CAMK4;FOXO3;NFE2;CREB1;MLLT3;CREBBP;APBB1;KMT2B;NFYA;MED14;CDKN1C;CITED2;HMGA1;MED12;E2F1;RYBP;HCFC1;AKT1;CHD8;HIPK2;MLXIPL;QRICH1;TEAD2;XRCC6;TCF3;BICRAL;MAP2K3
prerank,response to calcium ion (GO:0051592),0.384726622974034,1.0902307820055444,0.3260643821391485,0.8120093591496997,1.0,15/102,13.47%,THBS1;ADAM9;NEDD4;SEC31A;SYT8;CAMK2D;CLIC4;CALM2;ADCY8;KCNIP2;STIM1;NEUROD2;NLGN1;ADD1;MEF2A
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.3686083487621236,-1.0901902814256639,0.32677165354330706,0.6918227360328182,1.0,2/19,2.53%,APOE;PICALM
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.32054444047477637,-1.0890999198585762,0.2822085889570552,0.6926397849559239,1.0,11/34,13.61%,PTPRB;PTPN13;DUSP16;PTPRO;PTPN9;DUSP10;DUSP3;DUSP22;DUSP6;PTPN1;PTPRT
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.512080228757116,1.0890264852315885,0.3876177658142665,0.8149722289883987,1.0,6/13,24.32%,TSR1;RRS1;RPP40;ABT1;TBL3;KRI1
prerank,regulation of vasculogenesis (GO:2001212),0.49402880109537023,1.0888579070642646,0.3825503355704698,0.8148845630303078,1.0,3/14,12.12%,TMEM100;XDH;HEY1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.39775393735629927,1.0885090301227678,0.3484013230429989,0.8153018608940067,1.0,37/68,34.59%,SYMPK;MAZ;PABPN1;ERCC3;ERCC2;CLP1;CPSF4;POLR2F;PCF11;NCBP1;SMN1;CPSF7;NCBP2;POLR1G;CAVIN1;CSTF2;POLR3K;CSTF2T;SNRPB;POLR1C;TAF1C;TBP;GTF2H4;POLR2H;UBTF;SETX;TAF1D;SNRPF;PRMT5;POLR2L;TTF2;TAF1B;POLR2K;TAF1A;CCNH;CPSF3;MTERF2
prerank,axonal transport (GO:0098930),0.4235518317983688,1.0883332823119432,0.3568075117370892,0.8152252077778424,1.0,12/36,22.20%,DYNC1H1;RAB21;BLOC1S2;SYBU;SPAST;AP3D1;SOD1;BLOC1S3;SNAPIN;KIF1B;DCTN1;NEFL
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5197473067875026,1.087901575023581,0.3707250341997264,0.815921841457231,1.0,5/12,13.63%,NEDD4;BMP4;KHDRBS1;UHMK1;RBM4
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.48669240669756414,1.0878058792423964,0.37319884726224783,0.8156240991202173,1.0,4/13,11.27%,ZFPM2;FGF2;FGFR2;BMPR1A
prerank,response to steroid hormone (GO:0048545),0.4388307820253654,1.0877244172529752,0.3614163614163614,0.815251299255072,1.0,5/31,10.48%,THBS1;TGFB3;TGFB2;CATSPER3;URI1
prerank,protein heterooligomerization (GO:0051291),0.4843334997107359,1.0876645012650097,0.37397260273972605,0.8148309759284399,1.0,5/17,18.08%,PKD1;CBR4;HSD17B8;CPSF7;CPSF6
prerank,glycoprotein biosynthetic process (GO:0009101),0.39247662986512943,1.0875565770427515,0.3326157158234661,0.8145435746373438,1.0,13/79,13.43%,ST3GAL4;XYLT1;ST8SIA2;CHST11;B3GNT7;PMM2;ST3GAL2;FOXL1;B4GALT5;NPC1;FUT4;GAL3ST4;B3GNT9
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.42826629686110096,1.0870774979458062,0.3727810650887574,0.8154028280787567,1.0,3/37,2.75%,EFNA5;STMND1;PHLDB1
prerank,positive regulation of programmed cell death (GO:0043068),0.36673253609103723,1.087061331671884,0.2835671342685371,0.8148445821268568,1.0,61/272,18.26%,SLIT2;RASSF2;HOXA5;SFRP4;TIAM1;GADD45G;NTRK1;PRR7;TIAM2;UNC13B;VAV2;TGFB3;CYP1B1;MAP3K5;CRADD;ATF4;DNM2;CCAR2;HMGB1;ING3;IAPP;KALRN;MAPK8;BMP4;FOXA1;ING5;ABL1;RBM5;ATM;AIFM1;SOD1;TNFRSF10B;ERCC3;PDCD2;HSPD1;MAP3K10;MARK4;SOS2;SQSTM1;ARHGEF1;RHOB;SCIN;AKAP13;PSEN2;SOS1;IL6;ING4;LATS2;FOXO3;HDAC6;TRIO;UBC;RPS27A;APBB1;NF1;NGEF;FLCN;DAPK3;E2F1;BID;RYBP
prerank,regulation of hydrolase activity (GO:0051336),0.3999555261433008,1.0870140602280638,0.3538961038961039,0.8143837693353738,1.0,15/71,13.08%,PLXNA4;EFNA5;RDX;VAV2;SIPA1L1;FGD6;RAB3GAP1;EPHB3;CDK5RAP3;ADAP1;WRN;TDG;SOD1;ARHGAP44;OCRL
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.4745006645671177,1.0869741126116317,0.3741851368970013,0.8138971094384991,1.0,4/21,4.29%,BGN;CHST11;CHPF2;CSPG4
prerank,monocyte chemotaxis (GO:0002548),-0.3272795821595025,-1.0866174431684217,0.33727810650887574,0.6972669964134661,1.0,3/32,4.47%,FLT1;IL6R;PTPRO
prerank,DNA biosynthetic process (GO:0071897),-0.3759890377719089,-1.0866084606864077,0.35714285714285715,0.6952664493177096,1.0,10/16,22.74%,PPIA;TYMS;RFC3;SIRT1;POLD2;WRNIP1;POLE;CDKN2D;POLD4;POLL
prerank,telomere maintenance (GO:0000723),0.41057294786767934,1.0864372937141777,0.36312849162011174,0.8148780098676713,1.0,21/50,28.71%,PARP3;PRKDC;ERCC4;WRN;TERT;ATM;TEN1;RAD50;DCLRE1B;PARP1;TPRKB;HUS1;SMC5;RAD51;XRCC6;XRCC3;POLD1;SMC6;RTEL1;NSMCE2;ATR
prerank,regulation of stem cell differentiation (GO:2000736),0.38550571496069364,1.0864315714079795,0.3390374331550802,0.8142901603472,1.0,34/89,24.31%,LDB1;PSMD7;HES5;PSMA8;SLC4A11;PRKDC;JAG1;ESRRB;PSMA4;ITCH;ABL1;BMPR1A;PSMD12;PSMA6;HOXB4;RUNX1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;GDNF;SETD1A;CBFB;TCF3;PSMA3;PSMB1;PSMD4;KMT2A;NELFB;PSMA5;PSMA7;HNRNPU;RBM24
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.37901598375851836,1.0864068702212086,0.327817993795243,0.8137700888948729,1.0,33/129,16.37%,EGFR;GPC3;COL1A1;SFRP4;PLEKHA4;PSMD7;CSNK1D;UBE2B;VCP;PSMA8;DACT1;ILK;CCAR2;RSPO1;JUP;TRPM4;PSMA4;FGFR2;CSNK1G1;UBR5;AXIN1;PSMD12;USP34;CSNK1E;PSMA6;WNK1;TNKS2;PSMD1;PSMC5;GSKIP;PSMD11;PSMC4;PSMD14
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.47489064163507044,1.0863972867210734,0.3709043250327654,0.8132008224065663,1.0,5/20,6.66%,NEDD4;PRKCE;CAMK2D;GOPC;STK39
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5218686802651102,1.0862520741430073,0.3723849372384937,0.8124580435297808,1.0,5/12,21.02%,ACTN3;RCAN1;CHP1;HOMER2;ATP2B4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5218686802651102,1.0862520741430073,0.3723849372384937,0.8124580435297808,1.0,5/12,21.02%,ACTN3;RCAN1;CHP1;HOMER2;ATP2B4
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.38188780846765336,-1.086236388306136,0.3118279569892473,0.6942402936874574,1.0,3/16,3.71%,SOX5;PTN;SOX6
prerank,protein modification by small protein conjugation (GO:0032446),0.3621095977866305,1.086229692400969,0.249,0.8119349860419288,1.0,119/361,25.86%,WWP1;RNF144A;NEDD4;NUP93;FBXO10;FBXL7;FBXW8;TOPORS;CDC16;UBE2B;TRIM28;RAE1;VCP;RNF182;DTX3;DCUN1D5;UBE2R2;NFX1;PRKDC;SEH1L;KLHL7;NFE2L2;TRIM41;PEX5;TRPC4AP;HUWE1;TRIM27;SYVN1;CBL;CDK5RAP3;LZTR1;TRPM4;WWP2;PEX13;ITCH;CUL4A;FBXO25;UCHL3;RNF25;UBE2C;NEUROD2;RNF14;NUP37;SDE2;ATG3;MYLIP;CUL1;DCUN1D2;RNF38;DTX2;PEX10;USP7;RNF103-CHMP3;UBA5;TRIM26;RANBP2;PIAS4;NUP88;ARRB1;STX1A;STUB1;UBE2V2;UBC;RPS27A;OTULIN;SUMO1;BIRC6;UFL1;TRIM13;VPS11;TRIM6;POM121;NUP210;UHRF2;RNF7;UBR2;CDC27;ASB5;SAE1;MYCBP2;UBE2G2;PCNP;TRAIP;TRIM47;NUP62;USP5;SMURF2;TRIM43;MUL1;PEX2;PAF1;KCTD13;CUL9;UBA3;SUMO2;NDC1;AREL1;PEX14;DERL1;RNF20;NUP35;FBXO11;DET1;UBE2Z;FBXO9;AMFR;ANKRD9;PINK1;RCHY1;SELENOS;RNF138;UBE2W;RTF1;UVSSA;UBR3;RNF111;SHPRH;NUP85;CUL7
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.43163771549843755,-1.086185852665655,0.3440514469453376,0.6923737519563996,1.0,7/11,16.08%,WNT4;FGFR4;EGR1;SIRT1;NR1H4;BMP2;STAR
prerank,cAMP metabolic process (GO:0046058),-0.4121975222761305,-1.0859019305159887,0.33079847908745247,0.6911900838146782,1.0,4/13,7.53%,ADCY5;PDE4D;ADCY1;ADCY4
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5503282609063233,1.0855484457303382,0.3815028901734104,0.813403106255062,1.0,3/10,4.20%,GHR;STAT5A;STAT3
prerank,mRNA methylation (GO:0080009),0.49608322397772875,1.0854928624491886,0.38873626373626374,0.8129533267712974,1.0,6/15,25.64%,TRMT61B;METTL16;TRMT6;TRMT61A;METTL8;METTL14
prerank,positive regulation of phosphorylation (GO:0042327),0.3669238027870445,1.0854334842916067,0.28600201409869086,0.81252761575933,1.0,39/240,12.40%,THBS1;SLC4A4;PGF;EGFR;SLCO3A1;VEGFA;EFNA5;GAS6;DDR2;FGF2;CARD14;NTRK3;NTRK1;FGF17;EPHB2;CSNK1D;GLMN;LIMK2;MAVS;EPHB3;EPHB6;ILK;FZD7;FGFR1;RSPO1;SOX9;AKT2;ROR1;BMP4;FGFR2;TMEM119;MUSK;ABL1;LMO4;NIBAN1;AXIN1;DDR1;RAD50;NRP1
prerank,response to peptide (GO:1901652),0.43247287196412465,1.0852770758567691,0.3635280095351609,0.8123781026165279,1.0,3/33,4.20%,IRS1;STAT5A;STAT3
prerank,regulation of DNA metabolic process (GO:0051052),0.4157893127562462,1.08526894164545,0.3449074074074074,0.8118022390398695,1.0,19/44,31.48%,HELB;TOM1L1;SMG6;SMG1;KPNA2;UBE2V2;SMARCAD1;CDT1;WDR70;USP1;KAT7;MPHOSPH8;UPF1;PARG;UBE2V1;CDK9;MPV17;IL7R;UBE2N
prerank,histone H3-K9 demethylation (GO:0033169),0.5280563433680411,1.0851874637349175,0.37209302325581395,0.8114191809180867,1.0,4/11,13.22%,JMJD1C;PHF8;KDM4A;HR
prerank,mammary gland development (GO:0030879),0.4644448531277179,1.0851428996497938,0.3729456384323641,0.810958642330081,1.0,3/21,2.89%,VEGFA;GLI2;TGFB3
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4456505529521497,1.0851054036105658,0.3791411042944785,0.810483472221812,1.0,7/26,15.12%,EGFR;RDX;CDK10;CDC6;ANXA1;EIF4G1;TFDP1
prerank,regulation of mitochondrial translation (GO:0070129),0.4712872349167902,1.0848175695618785,0.37564102564102564,0.8107212661375593,1.0,6/21,18.98%,RCC1L;MPV17L2;RMND1;ALKBH1;SHMT2;FASTKD3
prerank,pentose-phosphate shunt (GO:0006098),0.5250927737797834,1.0838793291564368,0.37815126050420167,0.8129658740768061,1.0,4/11,16.23%,SHPK;TKT;DERA;PGD
prerank,regulation of glucose import (GO:0046324),0.43642153987343835,1.0828226883584045,0.37714987714987713,0.8156304522320827,1.0,6/30,8.56%,IRS1;PID1;GRB10;RHOQ;CAPN10;AKT2
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5071288680461598,1.0827440911250032,0.3950617283950617,0.815278252952398,1.0,3/14,8.34%,RCC1L;MPV17L2;RMND1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5338698042896138,1.0824356722223307,0.3903133903133903,0.8155960943934579,1.0,1/10,1.29%,IL33
prerank,regulation of collagen biosynthetic process (GO:0032965),0.47692131068077964,1.082197913334083,0.3815104166666667,0.8156877989437208,1.0,6/19,15.25%,EMILIN1;TGFB3;BMP4;F2R;RUNX1;IL6
prerank,positive regulation of protein modification process (GO:0031401),0.36762648354682237,1.081966520568857,0.31419939577039274,0.8158120000230886,1.0,45/203,17.28%,PGF;EGFR;TRABD2B;PRKCD;SLCO3A1;VEGFA;EFNA5;GAS6;FGF2;CARD14;NTRK3;NTRK1;FGF17;CSNK1D;LIMK2;CALM2;MAVS;RAB3GAP1;ILK;RSPO1;SOX9;SYMPK;AKT2;BMP4;TMEM119;RAMP1;MUSK;ABL1;NNMT;NIBAN1;AXIN1;CNEP1R1;CHP1;ERP29;PTBP1;WDFY2;DAB2;HGF;ARRB1;NSMF;ERBB2;FGF5;CALM3;EFNA1;FLCN
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.30470219346246585,-1.0816536371239795,0.2808219178082192,0.7002295144697687,1.0,15/38,18.71%,INSR;ROCK2;SMAD3;KLF2;ASS1;ZC3H12A;EDN1;CAV1;CX3CR1;DDAH2;CD34;SIRPA;NOS1AP;CD47;GLA
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.43548777312190906,1.08137946747498,0.3649815043156597,0.8169569594182645,1.0,7/28,21.23%,EGFR;MMP14;WWP2;HEY1;ARRB1;AKT1;RITA1
prerank,vasodilation (GO:0042311),-0.40634401531758063,-1.0813058632397892,0.34814814814814815,0.6991343677610916,1.0,5/13,17.49%,NOS3;KLF2;NOS1;GPER1;SOD2
prerank,positive regulation of neuron projection development (GO:0010976),-0.2667566154848229,-1.0812962421268357,0.28125,0.6971741560978701,1.0,23/85,14.43%,LYN;PTN;APOE;ITGA6;PTK7;WNT5A;BMP7;RAPGEF2;CAMK1D;SERPINI1;ROR2;TENM3;ATP1B2;VLDLR;PLXNB2;CUX2;CX3CL1;STYXL1;PRKD1;LRP8;RELN;SCARF1;RIT2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.541398152785655,1.0812235424512997,0.39020771513353114,0.816837498356985,1.0,4/10,12.28%,RHOA;SYNE4;MYO9A;EZR
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3982106513449012,1.0804522269849945,0.36414253897550114,0.8185176340745494,1.0,30/64,29.93%,ELOF1;TCEA2;CDK12;GTF2F1;CCNT2;ERCC3;ERCC2;POLR2F;AFF4;MLLT3;NCBP1;SSRP1;ELP4;NCBP2;PAF1;POLR2B;SETD2;NELFB;CDK13;EAF1;CTDP1;RTF1;GTF2H4;POLR2H;NELFA;POLR2I;CDK9;MLLT1;ADRM1;POLR2L
prerank,regulation of translation (GO:0006417),0.3706182894138939,1.0804256416720415,0.31955645161290325,0.8179981141809191,1.0,60/173,28.60%,THBS1;IGFBP5;SAMD4A;EIF4A2;EIF4G2;PRKDC;EIF4G3;CYFIP1;GSPT1;IMPACT;ILF3;NIBAN1;EIF4G1;ALKBH1;LTN1;RBM4;NOLC1;ETF1;IL6;FOXO3;CNOT8;EIF6;ERBB2;EIF3D;CNOT10;NCBP1;SHMT2;EPRS1;DAPK3;NCBP2;CNOT9;SHMT1;GLE1;SYNCRIP;EIF2AK4;CALR;PYM1;CIRBP;EIF2A;ATXN2;FXR2;UPF1;SHFL;EIF2AK3;EIF4B;UPF3A;YBX1;RPS6KB1;RPS27L;UPF3B;RBM3;METTL14;MRPL13;RIDA;EIF4E;FXR1;YTHDF1;EIF4H;NSUN3;LARP1
prerank,lipoprotein transport (GO:0042953),0.5324021846719962,1.0797430764190747,0.4065155807365439,0.8193447970993841,1.0,1/10,1.02%,LRP1
prerank,platelet degranulation (GO:0002576),0.3775598400541498,1.0797213781693966,0.3415384615384615,0.8187972743473121,1.0,14/118,7.25%,THBS1;VEGFA;GAS6;CHID1;TIMP3;TGFB3;SPARC;PCDH7;TOR4A;TGFB2;CD9;MAGED2;QSOX1;FAM3C
prerank,inhibitory synapse assembly (GO:1904862),0.5224641837658441,1.0794907156999576,0.3875739644970414,0.818840679178181,1.0,2/11,5.23%,FGF13;LGI2
prerank,regulation of extracellular matrix organization (GO:1903053),0.48983964211188963,1.0794120138696057,0.38294993234100133,0.8184716584009676,1.0,7/15,17.10%,LRP1;DDR2;FAP;RIC1;DDR1;RUNX1;SLC2A10
prerank,regulation of vesicle-mediated transport (GO:0060627),0.38134706142456154,1.0793828578852838,0.3631578947368421,0.8179735005891856,1.0,41/91,29.87%,STON2;ARFGAP1;GAS1;DNAJC13;RAB21;RAB8A;MBTPS1;STON1;NSF;ITGAV;SCFD1;ABL1;ATP9A;RAB3D;NRP1;STXBP5;RAB11B;USP7;CHMP3;RINT1;STX4;RAB3B;RAB4B;HIP1;RAB5B;RUFY2;ZFYVE16;RAB4A;LRRK2;TSC2;BET1L;VAMP2;RAB5A;LGI3;RALA;FES;ABL2;RAB3A;RAB5C;PACSIN2;RUFY1
prerank,DNA geometric change (GO:0032392),0.45603429383483957,1.0793578681737945,0.3757802746566791,0.8174695838089103,1.0,13/24,35.17%,HMGB1;HNRNPA2B1;ANXA1;WRN;RAD50;SUPV3L1;RECQL5;ZRANB3;RTEL1;DDX11;BLM;DHX9;MRE11
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3746461472197231,-1.0787454966662615,0.3235294117647059,0.7017527015592369,1.0,6/17,11.08%,ROCK2;CDH5;CLDN5;F11R;S1PR3;TNFRSF1A
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4126991478454932,1.0784876938496264,0.37718277066356226,0.8194855669100278,1.0,5/43,8.07%,GAS6;LBP;IRAK3;TRIM27;RARA
prerank,negative regulation of protein metabolic process (GO:0051248),0.40560482159681943,1.078343995798954,0.3616532721010333,0.8193148250299909,1.0,15/48,24.46%,EGFR;RILP;IRAK3;MDM4;IAPP;ITGAV;SIRT2;VBP1;AZIN1;CLU;MAD2L2;LDLR;PFDN4;SNX3;ROCK1
prerank,protein localization to cell periphery (GO:1990778),0.3779520821877443,1.078314259705982,0.3432682425488181,0.8188045662871216,1.0,21/133,7.66%,LRP6;KCNB1;ATP1B1;GAS6;FGF13;TTC7A;EHD1;RDX;RAB34;C2CD5;RAMP2;PIGW;PACS2;S100A10;PRAM1;RAB8A;SLMAP;ANK2;EHD2;FCHO2;JUP
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3560053571544147,1.0781825675454992,0.139,0.8185979533880743,1.0,279/1082,22.67%,PLAGL1;ESR1;EGFR;LRP6;SIX1;PKD1;PID1;ID2;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;NFIX;FGF2;ZNF423;NFIB;TCF7L2;IL33;COL1A1;RARB;ELF4;NFIA;GALR1;DDX17;RHOQ;LDB2;LDB1;ZMIZ1;GLI2;MDFIC;TCF20;LRP5;GLIS2;TGFB3;TWIST1;DEAF1;SHC1;PRDM11;PRDM10;NFAT5;HDAC4;ELF1;ELOF1;MAP3K5;HOXB3;RXRA;ONECUT2;MEOX2;WWTR1;HES5;KLF5;SIX4;STAT3;DCAF6;ATF4;TRIM28;NR2F1;MAVS;BCAS3;DNM2;KMT2C;ACVR1;BRD4;DVL1;FOXC2;ILK;BCL9L;RXRB;PRKDC;GPATCH3;SMAD4;NFE2L2;HMGB1;JAG1;MEF2B;FZD7;SLC9A1;E2F3;TASP1;PBX1;MEIS3;SKI;HEYL;TBX21;THRAP3;JUP;SOX9;ARF4;RPS6KA4;NRIP1;RARA;NSD1;FOXJ3;MED13;FZD5;ESRRB;TFE3;FOXK1;ENY2;ZNF76;NFATC1;HMGN1;SMARCC2;OGT;SERTAD2;ZIC1;SBNO2;RORA;ILF3;BMP4;FGFR2;SFR1;FOXA1;ING5;UBP1;CSRNP1;ZFP90;PRDM4;SREBF1;EHF;CHUK;RUNX2;GTF2F1;FOXM1;ABL1;AGO1;RFX5;CCNT2;PHF8;CSRP3;PITHD1;MAP3K12;PLAC8;NRF1;ATM;BMPR1A;AXIN1;CHEK2;MAZ;KAT6B;PAXBP1;RNF14;TAF15;NAA16;SFPQ;TAF6;SMAD7;MED25;PHIP;SRF;NR1D2;HEY1;GLIS1;KAT2A;SSBP3;RGMA;TGFB1I1;TGFBR1;HDAC1;AGO2;PTOV1;MEF2D;ZMIZ2;HOXB4;INHBA;F2R;CD80;MAPRE3;KMT2D;MEF2A;RUNX1;NFATC3;NDP;SQSTM1;DAB2;BMP5;MMS19;SERTAD3;VDR;MED21;TFDP1;PER1;HGF;IL6;ARRB1;GRHL1;SIRT2;PSMC5;CAMK4;CRTC2;FOXO3;NFE2;CREB1;MLLT3;CREBBP;PARP1;ERBB2;AATF;ZNF462;UBC;RPS27A;APBB1;KMT2B;KDM6B;DPF3;PRDM2;NFYA;FLCN;NFKB2;SLC30A9;NR3C1;RFXANK;E4F1;MED14;CDKN1C;MEN1;CITED2;HMGA1;ATAD2B;MED12;E2F1;RYBP;HCFC1;AKT1;GDNF;ATF2;CCDC62;CHD8;HIPK2;KLF10;HOXB2;MLXIPL;BRD8;FOSL2;QRICH1;TEAD2;XRCC6;IRF3;VEZF1;MPND;NFKBIA;TCF3;BICRAL;MAP2K3;ATF6;MAX;BPTF;TET2;RTRAF;KAT7;MRPL12;BCL2L12;MAD2L2;NUP62;GPS2;IL4;MAP2K7;RNF4;BCL11B;SMAD5;IER2;NEK4;SENP1;POGZ;NFIC;DNAJC2;CAMK1;SS18L1;ZKSCAN3;KAT8;NR2C2;EIF2AK3;CDK5RAP2;TRIAP1;KMT2A;SLC11A1;ICE1;TFCP2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4489611258570013,1.0781815952640097,0.36780258519388953,0.818010044570823,1.0,6/27,8.78%,FXYD5;PTPN3;CAMK2D;SLMAP;SNTA1;DLG1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.38160478999034686,1.077956701858603,0.37302423603793466,0.8180910064867145,1.0,28/85,25.08%,RNF144A;PRICKLE1;CSNK1D;COP1;OSBPL7;VCP;DVL1;FBXO22;RNF14;SMAD7;CSNK1E;DAB2;USP13;DDA1;STUB1;SIRT2;PSMC5;SUMO1;HECTD1;CLU;USP5;LRRK2;SUMO2;DET1;TAF1;RCHY1;RNFT1;BBS7
prerank,regulation of cilium assembly (GO:1902017),0.3993465234485818,1.0768668928347418,0.3717105263157895,0.820733160357105,1.0,29/62,30.11%,MAPK15;TBC1D2B;LIMK2;DYNLT2B;IFT20;CDK10;TBC1D24;ATG3;EVI5L;SDCCAG8;TBC1D9B;MARK4;FUZ;TBC1D10A;TBC1D17;IFT88;KCTD17;EVI5;TBC1D22B;CYLD;RABGAP1;ARHGAP35;TBC1D20;CCP110;TAPT1;IFT140;TESK1;TBC1D19;TCHP
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.45412149660142687,1.076815876644324,0.38346883468834686,0.820293141815644,1.0,7/19,13.69%,ZFPM2;FGF2;NOG;FGFR2;BMPR1A;TGFBR1;RUNX1
prerank,positive regulation of gene expression (GO:0010628),0.3579164955031844,1.0768080992498128,0.251,0.819722154332523,1.0,62/442,13.02%,THBS1;SLC38A2;EGFR;PID1;ID2;HOXA5;VEGFA;GAS6;F3;FGF2;FOXD1;IL33;GSN;SFRP4;SLC24A3;DDX5;EMILIN1;NTRK3;FGF17;DRD1;RDX;EPHB2;C1QTNF1;TWIST1;SAMD4A;GLMN;STAT3;CD3E;ATF4;RAMP2;AGR2;TENT4B;PRKDC;FAM98A;NFE2L2;ANK2;SOX9;NOG;DGKQ;SF3B1;MAPK8;BMP4;CRTAM;TMEM119;FAM98B;MUSK;UBR5;AGO1;NIBAN1;ATM;MAZ;FUBP1;SOD1;HEY1;EZR;KAT2A;PIK3CB;TGFBR1;SERPINB9;AGO2;SMO;INHBA
prerank,response to muscle stretch (GO:0035994),0.48831472867494324,1.0765237161576513,0.38231292517006804,0.8200117799197444,1.0,4/15,10.80%,GSN;DMD;SLC9A1;CSRP3
prerank,negative regulation of cytokine production (GO:0001818),0.36990291118814944,1.0764379526368248,0.32961460446247465,0.8197082077757333,1.0,37/163,19.90%,THBS1;CMKLR1;GAS6;PDCD4;CHID1;HDAC9;ANXA4;TAX1BP1;MAVS;GPATCH3;HMGB1;IRAK3;TBX21;RPS6KA4;TRIM27;RARA;ANXA1;ITCH;MAPKBP1;CIDEA;EZR;INHBA;PCBP2;UBE2L6;IL6;ARRB1;N4BP1;OTUD5;SLC2A10;ACOD1;NPLOC4;ADCY7;SARS1;IKBKE;IRF3;HOMER2;APPL2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.43667772525287724,1.0760458329879348,0.38583638583638585,0.8202607778788042,1.0,8/29,16.62%,ZC3H7A;PUM1;PRKRA;HNRNPA2B1;AGO1;DGCR8;AGO2;TUT7
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4596630726028527,1.0757867869694295,0.3887434554973822,0.8204024822479784,1.0,8/21,28.12%,TWIST1;MED13;SRF;MED14;MED12;BCLAF1;MED24;SETX
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.38967372741859635,1.0757660740999067,0.3685897435897436,0.8198847704595129,1.0,14/75,12.60%,PGF;VEGFA;F3;FGF2;STAT5A;PRKCA;HMGB1;FGFR1;BMP4;AGGF1;VIP;PDPK1;NRP1;TGFBR1
prerank,focal adhesion assembly (GO:0048041),-0.36536749311704475,-1.0748630512369657,0.3548387096774194,0.7098855892494154,1.0,6/21,6.90%,SORBS1;ACTN2;PEAK1;THSD1;WHAMM;PTPRK
prerank,DNA integrity checkpoint signaling (GO:0031570),0.42168343963089616,1.0747644551372877,0.38425381903642775,0.8222085801448413,1.0,19/36,32.30%,CDC6;TIPRL;RAD1;ATM;CHEK2;CDC45;CEP63;ATRIP;HUS1;CDT1;E2F1;DONSON;ATR;INTS7;TIMELESS;RAD17;RHNO1;HINFP;ERCC6
prerank,neuron migration (GO:0001764),0.4116731821128272,1.0747213563974498,0.375,0.8217565008672337,1.0,11/48,14.31%,VEGFA;FGF13;MAP1B;MARK1;LRP12;NAV1;FGFR1;PEX13;SDCCAG8;NRP1;NDNF
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4689241510253724,1.074684242407898,0.377431906614786,0.8212787548825378,1.0,9/19,29.90%,CSNK2A2;FZD5;SREBF1;USP36;HDAC6;PINK1;HTRA2;SREBF2;PRKN
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.42737275523600227,1.0744615846174637,0.38555691554467564,0.8213261352811919,1.0,9/32,19.83%,ID2;BRD4;ESRRB;CDC6;CDC45;TFDP1;CDT1;E2F1;CDK5
prerank,regulation of axon regeneration (GO:0048679),-0.41139406120152144,-1.0744193327134846,0.3595505617977528,0.7090559283356037,1.0,7/12,25.05%,PTN;EPHA4;INPP5F;SCARF1;RTN4R;RTN4RL1;GRN
prerank,metal ion transport (GO:0030001),-0.2546270657607117,-1.0741527841066085,0.27586206896551724,0.7077431267981744,1.0,22/86,14.25%,ITPR1;SLC8A1;CALCRL;CACNA1D;RYR2;TRPC3;CACNA1E;CACNA2D1;CACNG7;SLC39A8;TUSC3;SLC41A1;CACNG8;SLC8A3;ATP2A3;CAV1;CACNG3;NDFIP2;SLC30A1;TRPC4;TPT1;NIPAL4
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5278243668456738,1.0736634019981333,0.4133522727272727,0.8230401077295325,1.0,6/10,31.55%,NFE2L2;LRRK2;PYCR1;RIPK1;GPR37;GPR37L1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.3949295761031105,1.0735990099617156,0.3826754385964912,0.8226298819918727,1.0,20/62,23.43%,THBS1;HOXA5;KMT2C;HOXA9;AGO1;WDR5;HDAC1;KMT2D;RUNX1;EIF6;NFE2;CREBBP;KMT2B;SETD1A;CBFB;DPY30;PAF1;KMT2A;PRMT1;KAT2B
prerank,sodium ion transmembrane transport (GO:0035725),0.3855288580287571,1.0735023938722725,0.37697993664202745,0.8223365346613505,1.0,13/84,9.00%,SLC4A4;ATP1B1;SLC12A2;SLC24A3;SLC5A2;HCN4;SLC4A8;SLC9A4;SCN11A;SLC9A1;SLC6A2;TRPM4;SLC6A7
prerank,response to peptide hormone (GO:0043434),0.41417320682387787,1.0734897676887507,0.3781609195402299,0.8217814195803333,1.0,7/43,9.69%,IRS1;IGFBP5;STAT5A;STAT3;MEAK7;OGT;ANXA1
prerank,negative regulation of response to stimulus (GO:0048585),0.3928476996459286,1.0730942123401943,0.389010989010989,0.8223926336779716,1.0,9/60,11.07%,SLIT2;COL3A1;UBASH3B;VPS13C;TWIST1;ACVR1;DDAH1;LPCAT3;TERT
prerank,positive regulation of protein localization to membrane (GO:1905477),0.381633895396202,1.072823107565361,0.34659685863874345,0.8225762957831306,1.0,26/98,18.69%,EGFR;KCNB1;LRP1;PRKCE;EPHB2;PLS1;C2CD5;AGR2;MIEF2;AKT2;DLG1;PPP3CC;MAPK8;PDPK1;CHP1;YWHAE;SQSTM1;STAC3;YWHAQ;TFDP1;STX4;ERBB2;SPTBN1;E2F1;BID;AKT1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3283665194037633,-1.0727239172290624,0.2967741935483871,0.7095383490212325,1.0,12/32,15.09%,CDH5;MAP2;NAV3;CAMSAP1;APC;SPEF1;EML2;ARHGEF2;MID1IP1;CLASP2;SNCA;TUBB4A
prerank,regulation of neuron differentiation (GO:0045664),0.38930743204887125,1.0726559777499507,0.36853448275862066,0.8225023129930533,1.0,13/76,13.02%,SIX1;ID2;ZFHX3;TIAM1;HES5;FGFR1;HEYL;IMPACT;CDK5RAP3;RHOA;NEUROD2;HEY1;NLGN1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5211225984236361,1.0724528138150176,0.41379310344827586,0.8225294786503213,1.0,3/10,12.31%,DLGAP3;DLGAP4;AKAP9
prerank,glucose transmembrane transport (GO:1904659),-0.3664805004726591,-1.0722532536959866,0.36796536796536794,0.7088811393862973,1.0,4/18,6.84%,SLC2A1;SLC5A3;SORT1;PPARD
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4627584795139318,1.0715161700662557,0.39253539253539255,0.8247285607106101,1.0,3/22,4.54%,VEGFA;GADD45G;XDH
prerank,establishment of apical/basal cell polarity (GO:0035089),0.4945598203488446,1.0713563307502003,0.42155525238744884,0.8246193421797485,1.0,4/14,12.28%,RHOA;SYNE4;MYO9A;EZR
prerank,regulation of cell population proliferation (GO:0042127),0.356414559285831,1.0712643165229385,0.227,0.8243135559691271,1.0,133/691,15.71%,THBS1;PGF;EGFR;SIX1;IRS1;ZBTB7C;ID2;WNT9A;ELN;VEGFA;ECRG4;FGF2;TCF7L2;SFRP4;TIAM1;ACER3;NPR3;NTRK3;PROK2;NTRK1;FGF17;BRICD5;SMAD6;GAB2;LRP5;GNL3;MAPK15;TGFB3;P3H3;PPP1R9B;SHC1;CYP1B1;SLURP1;RBFOX2;HDAC4;STAT5A;GLMN;PKHD1;LMNA;WWTR1;PTPRU;HES5;CSNK2A1;SIX4;TGFB2;STAT3;TCIRG1;P3H1;MEAK7;DNAJA2;CLMN;TCFL5;FXN;TMEM115;NOX4;PRKDC;PLPP1;FAM98A;ADAM10;IL12RB2;TGFBR2;JAG1;PRKRA;ABI1;IFNLR1;FGFR1;MEIS3;SKI;CDK10;MDM4;RAF1;JUP;SOX9;TES;P3H2;RARA;S100B;BEX4;CHERP;DDAH1;AKT2;CDC6;TRPM4;RHOA;EDN3;BMP4;FGFR2;ITGAV;CDC25B;TBRG4;ING5;CDC123;FAM98B;VIP;FOXM1;CTF1;DIS3L2;CHTOP;RBM5;BMPR1A;MAZ;PHIP;PBRM1;TENM1;TGFB1I1;TGFBR1;HDAC1;TRAPPC14;PTPN2;INHBA;F2R;CGRRF1;KMT2D;GSDME;NACC1;RUNX1;SETD4;FRK;FUZ;BMP5;CLCF1;TMEM127;PRDX3;VDR;CYP27B1;SCIN;CAMK2N1;STX4;IL6;ING4;SIRT2;SLC35F6;CNOT8
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.385825624066752,1.0711405927458117,0.3673913043478261,0.824099800152514,1.0,15/78,18.69%,EGFR;PKD1;IPO5;CDC6;CDK5RAP3;CCNT2;MAPRE3;CCNG2;CCNE2;HEXIM1;LATS2;CDC25A;CDKN1C;MEN1;AKT1
prerank,positive regulation of dendrite development (GO:1900006),-0.42985590205712315,-1.0709866824087166,0.3488372093023256,0.710233212372589,1.0,4/10,13.76%,PTN;BMP7;VLDLR;LRP8
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5222407398583332,1.0704427441521995,0.39221140472878996,0.8255240857159469,1.0,5/11,20.96%,TBX21;ANXA1;SMAD7;RC3H2;IL4
prerank,snRNA metabolic process (GO:0016073),0.47972606638114257,1.0697890333307924,0.40207522697795073,0.8268900712651306,1.0,11/17,38.03%,INTS3;INTS4;MTREX;ZCCHC8;INTS9;INTS7;MEPCE;INTS6;INTS10;RBM7;INTS8
prerank,negative regulation of cell migration (GO:0030336),0.3723955427400102,1.0697371445917703,0.36205128205128206,0.8264513615756732,1.0,18/137,6.57%,SLIT2;IGFBP5;LRP1;FGF2;COL3A1;SRGAP3;SRGAP2;TMEFF2;DPYSL3;MAPK15;LDLRAD4;CYP1B1;SLURP1;CLIC4;PTPRU;PFN2;JAG1;SULF1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3812003131841235,1.0696526207245796,0.3655685441020191,0.8260996918737287,1.0,33/101,25.64%,THBS1;RDX;SAMD4A;DACT1;PRKDC;OGT;NIBAN1;EZR;EIF4G1;INHBA;TBC1D10A;IL6;STUB1;EIF6;ERBB2;EIF3D;PERP;VPS11;IST1;AKT1;NFKBIA;PYM1;CIRBP;FXR2;CYFIP2;UPF3A;RPS6KB1;BAD;RPS27L;UPF3B;RBM3;HDAC2;METTL14
prerank,positive regulation of protein kinase activity (GO:0045860),0.37034373590139696,1.0696287655460854,0.3408163265306122,0.8255870310677568,1.0,23/148,11.47%,RASSF2;PRKCD;VEGFA;GAS6;DDR2;SRCIN1;CAMKK1;STRADA;TGFB2;CALM2;TOM1L1;NOX4;TGFBR2;DLG4;PAK4;RHOA;PAK2;SYAP1;RIPK3;TAB2;TELO2;AXIN1;SNX9
prerank,I-kappaB phosphorylation (GO:0007252),0.5307777560778726,1.0692970593552387,0.4039829302987198,0.8259696602553398,1.0,2/10,10.26%,ERC1;CHUK
prerank,regulation of signal transduction (GO:0009966),0.36075037966073165,1.069217301333711,0.3440968718466196,0.8256274855201678,1.0,52/190,21.70%,ESR1;MGLL;IGFBP5;PLCE1;RSPO3;UBASH3B;MDFIC;GAS1;ELF1;WWTR1;CD3E;TCF7L1;ACVR1;ILK;SULF1;LLGL1;SOCS2;CASTOR2;DGKQ;FOXL1;OGT;ZIC1;SHARPIN;RORA;FGFR2;IRAK1;GIT1;AXIN1;GRK6;WDR11;NCLN;PTPN2;CD80;SRMS;RUNX1;USP33;FUZ;GSKIP;CREBBP;SIK2;IGFBP6;GDNF;DHRS3;TMEM237;ZFAND2B;CRK;CBFB;CLU;GRK4;NUP62;LRRK2;MTCH1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.33892632535631606,-1.069179906528032,0.3524229074889868,0.7131151889525945,1.0,6/24,12.75%,DACH1;NIBAN2;BMPR2;H1-0;ACVRL1;TERF2IP
prerank,inner dynein arm assembly (GO:0036159),0.5307004987853764,1.0683315587669984,0.4088235294117647,0.8276406266167035,1.0,4/10,24.62%,CCDC39;DNAAF4;CFAP73;DNAAF5
prerank,lipid transport (GO:0006869),0.3766106859403346,1.0682233089692443,0.36058700209643607,0.8273572706782459,1.0,10/97,4.74%,SLCO3A1;TNFAIP8L3;ABCD3;LBP;SLCO2A1;PITPNC1;RXRA;PRELID3B;PITPNA;PITPNM1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4938988148548315,1.0682135507318853,0.4136490250696379,0.8268077456567658,1.0,5/13,19.77%,EDEM2;BCAP31;YOD1;ERLEC1;UBE2G2
prerank,phosphatidylserine metabolic process (GO:0006658),0.4272027042474638,1.0674352225330255,0.39791183294663574,0.8284508587473518,1.0,9/32,17.33%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A;PLA2G15;PTDSS1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3373887798920401,-1.0674277611815768,0.3473684210526316,0.71593337567798,1.0,8/26,12.24%,PRKAA2;PRKAG2;LPGAT1;NR1H3;ADIPOR1;SLC45A3;MID1IP1;CEACAM1
prerank,regulation of feeding behavior (GO:0060259),-0.41321288519427746,-1.067277414508575,0.36451612903225805,0.7143427988263169,1.0,2/11,2.51%,LEPR;SGIP1
prerank,negative regulation of type I interferon production (GO:0032480),0.41456817917484695,1.0672515957163415,0.3707995365005794,0.8284183531969008,1.0,19/40,28.94%,PTPRS;TAX1BP1;MAVS;GPATCH3;ITCH;PCBP2;UBE2L6;OTUD5;ACOD1;NPLOC4;IKBKE;IRF3;RNF216;CYLD;TBK1;ILRUN;YY1;PPM1B;RNF135
prerank,positive regulation of cartilage development (GO:0061036),0.48319537962149756,1.0669037704283297,0.3838120104438642,0.8288850920311633,1.0,4/17,9.70%,PKDCC;BMP1;SOX9;BMP4
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3823790313843194,-1.0663597506718823,0.37254901960784315,0.7147920659961743,1.0,4/16,10.90%,CECR2;KPNA1;H1-0;KPNB1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3818044055694672,1.0663235229480463,0.3641188959660297,0.8300425892039689,1.0,11/90,9.01%,GNAS;CMKLR1;VEGFA;GADD45G;GRB10;PEMT;DYNC1H1;ALMS1;EHMT1;ADIPOR2;OGT
prerank,mitochondrion localization (GO:0051646),0.46774964193024005,1.0659885935019693,0.41655716162943496,0.830418296189277,1.0,7/19,23.26%,MARK1;TLE6;MEF2A;MUL1;LRRK2;MFN1;MTM1
prerank,cardiac muscle cell development (GO:0055013),-0.35890144149239395,-1.0659324001864572,0.33755274261603374,0.7140698773919946,1.0,7/20,9.88%,SORBS2;SLC8A1;PDGFRB;CXADR;PDGFRA;MYH11;PDLIM5
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3660212469108378,1.065666731139308,0.3719512195121951,0.8307899941329514,1.0,24/142,15.83%,ESR1;CACNA1C;CMKLR1;SLC35G1;PLCE1;PROK2;TAC4;C1QTNF1;EDNRA;ADCY8;HMGB1;FPR3;DLG4;IAPP;ACKR4;TRPM4;ABL1;BCAP31;GLP1R;F2R;YWHAE;PTGDR;CALB2;CXCR4
prerank,positive regulation of secretion by cell (GO:1903532),0.39292916980420955,1.065654595018344,0.38293216630196936,0.8302435433002543,1.0,16/70,17.96%,KCNB1;SLC12A2;ADAM9;UNC13B;TGFB3;APBB3;TGFB2;RAB2B;EDN3;EZR;STXBP5;STX1A;APBB1;SYTL4;IER3IP1;GOLPH3
prerank,central nervous system development (GO:0007417),0.3588625112468194,1.0652647439317255,0.32831325301204817,0.8308096520181444,1.0,36/250,13.46%,DCLK1;SLC23A1;WWP1;PKD1;ZFHX3;ECRG4;PBX3;NFIB;GSN;VIT;ADGRL2;GLIS2;HES5;STAT3;PITPNM1;RAB3GAP1;AMIGO3;TGFBR2;PBX1;MEIS3;TBC1D23;SOX9;S100B;CDK5RAP3;HAPLN4;ZIC1;SYNJ1;ZIC4;ATN1;PHF8;POU6F1;SMO;LIG4;PAFAH1B2;NPAS1;ALDH3A2
prerank,macrophage activation (GO:0042116),0.423950285199922,1.065218903601618,0.3973902728351127,0.8303605908410681,1.0,2/34,1.05%,FOXP1;LBP
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.4064245435537551,1.0651499429109201,0.4057142857142857,0.8299795488580834,1.0,23/48,33.07%,ZMIZ1;ELOF1;SERTAD2;SF3B1;KAT2A;ZMIZ2;POLR2F;HMGA1;ATAD2B;POLR1G;POLR1C;TAF1C;TBP;KAT2B;POLR2H;ARID1A;SPHK2;TAF1D;POLR2L;TAF1B;ERCC6;POLR2K;TAF1A
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.36458002340255435,-1.0648401944194996,0.38461538461538464,0.7150154626248132,1.0,8/18,26.51%,PLCB1;OPRM1;CHRM3;RGS8;CHRM2;CHRM1;GNAQ;GNA15
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5047247936544556,1.0647200900185296,0.4131326949384405,0.8306154754058185,1.0,3/13,11.27%,DDX5;SPRED2;ATM
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5089013891055105,1.0645822746190687,0.4124293785310734,0.8304241952259568,1.0,5/11,12.60%,TGFB2;ACVR1;TGFBR2;SMAD7;TGFBR1
prerank,regulation of protein autophosphorylation (GO:0031952),0.4212335276116169,1.0645430258870943,0.411901983663944,0.8299717990312803,1.0,9/36,16.85%,RASSF2;VEGFA;CALM2;TOM1L1;IMPACT;RAD50;CHP1;PPP2R5C;CALM3
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3680362090042669,-1.064380144525563,0.37037037037037035,0.7142411160300673,1.0,3/18,2.72%,FLT1;COL4A3;AKT3
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.27187037028564454,-1.0635302761352543,0.3673469387755102,0.7145723108936755,1.0,13/66,8.97%,FLT1;ROBO1;IL34;PDGFD;KIT;FGF1;TPD52L1;PDGFRB;SASH1;ADRA2A;PIK3R6;PDGFC;PAK1
prerank,adenine nucleotide transport (GO:0051503),-0.385638035607706,-1.0634688886129,0.3424657534246575,0.7128154328672668,1.0,2/17,2.40%,ABCC4;LRRC8C
prerank,regulation of apoptotic process (GO:0042981),0.3527209436372714,1.0632000647493767,0.258,0.8332980854988202,1.0,165/676,20.47%,THBS1;SLIT2;RASSF2;EGFR;HOXA5;VEGFA;FSTL1;GAS6;SFRP4;GCLC;TIAM1;GADD45G;CARD14;PROK2;NTRK1;SMAD6;PRR7;TIAM2;FBXO10;UNC13B;VAV2;COMP;TGFB3;NOL3;SHC1;GAS1;CYP1B1;TOPORS;MAP3K5;PKHD1;CRADD;SIX4;CD3E;ANXA4;ATF4;ERC1;ACTN3;BAG3;TAX1BP1;HYPK;VCP;DNM2;FXN;CCAR2;GLO1;PRKDC;ADAM10;HMGB1;ANGPTL4;ING3;RAF1;SOX9;ARF4;NDRG1;IKZF3;ERCC5;PA2G4;SRA1;IAPP;CBL;SOCS2;AKT2;AKT1S1;KALRN;RBM25;ANGPT4;PAK2;MAPK8;ANXA1;BMP4;WRN;ITCH;FOXA1;ING5;ANP32B;MADD;VIP;RIPK3;ABL1;IRAK1;RBM5;LCMT1;BCL2L2;ATM;AIFM1;NAA16;SOD1;PHIP;TNFRSF10B;HSPA5;CD27;ERCC3;CIDEA;MIEN1;SERPINB9;HDAC1;PDCD2;VTCN1;HSPD1;LRP2;MAP3K10;CASP1;SUPV3L1;SOS2;USP36;SQSTM1;ARHGEF1;DAB2;PRDX3;HNRNPK;RHOB;SCIN;CAT;AKAP13;PSEN2;HGF;SOS1;IL6;ING4;TOMM70;LATS2;FOXO3;PLSCR3;NSMF;CREBBP;TRIO;AATF;HIP1;UBC;RPS27A;HIGD1A;APBB1;NF1;PERP;NGEF;BIRC6;FLCN;MAGED1;PRLR;IER3IP1;CITED2;DAPK3;ARAF;GOLPH3;BNIP1;E2F1;BID;RYBP;CLN3;BIRC5;AKT1;GDNF;DNAJA1;PRDX2;QRICH1;IRF3;NFKBIA;STEAP3;TAF9B;CDK5;ATF6;RTKN;CALR;TNFSF18;CLU
prerank,DNA repair (GO:0006281),0.35858082671579306,1.062798332834645,0.3410230692076229,0.8338330081002945,1.0,122/284,33.49%,PARP3;CHD1L;UBE2B;TRIM28;MPG;POLE2;FTO;VCP;ERCC8;PRKDC;RMI2;INTS3;TRRAP;KMT5C;HUWE1;ERCC5;FAAP20;RBBP8;ERCC4;RAD1;OGG1;MAPK8;WRN;ABL1;WDR48;TDG;KPNA2;ATM;USP45;CHEK2;PMS2;TDP1;KDM4A;ERCC3;RAD50;CSNK1E;LIG4;ALKBH1;ERCC2;SMUG1;PIAS4;DCLRE1B;MMS19;FANCE;ATRIP;UBE2V2;FAAP24;PARP1;UBC;RPS27A;HUS1;APBB1;SUMO1;POLB;SLC30A9;MEN1;ACTR8;RAD51;USP1;TEX264;TNKS1BP1;TRAIP;FANCG;BRCC3;XRCC3;MAD2L2;APEX2;ENDOV;UPF1;USP47;TOPBP1;SETD2;PDS5A;UVRAG;PRIMPOL;ALKBH3;SMC1A;TP53;RECQL5;POLD1;GTF2H4;SLX4;XPA;PARP4;ZRANB3;FBH1;RPAIN;NOP53;PNKP;ADPRS;UBE2V1;SETX;DDB1;ATR;SMARCAL1;IGHMBP2;MBD4;RAD52;PDS5B;TIMELESS;RAD17;RHNO1;HINFP;TDP2;UBE2A;MSH2;UBE2N;MTA1;BLM;XRCC1;ERCC1;RAD23B;ERCC6;HERC2;CHRNA4;POLK;POLQ;RPA3;VCPIP1;ALKBH5;CUL4B;FANCA
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.36100200488700074,1.0627145206676958,0.3393574297188755,0.833494038775402,1.0,68/259,18.92%,PKD1;NTN1;SRGAP2;FXYD5;GSN;CFAP298;EXOC4;EHD1;PMP22;PPP1R9B;ABLIM3;FGD6;PKHD1;DYNLT2B;RILP;ARMC9;BBS9;CDC14A;TMEM107;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;CYFIP1;RFX2;TCTN1;IFT80;IQCB1;ABLIM2;TMEM216;ARFIP2;CCDC66;ATP6V0D1;CFAP43;PTPDC1;WDR11;EZR;NRP1;CEP164;PARVA;TRAPPC14;OCRL;BBS5;IFT46;EMP3;RAB23;FUZ;NUDCD3;CEP41;PCM1;HDAC6;PIP5K1A;IFT88;NPHP3;INPP5E;EMP1;TTLL3;LZTFL1;DYNC2I1;GOLPH3;IFT43;CCDC57;TEKT2;TMEM237
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.41891134852211565,1.0626100236937945,0.41134751773049644,0.8332108516765326,1.0,19/37,34.68%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;UBC;RPS27A;POLD1;GTF2H4;XPA;DDB1;RBX1;ERCC1;POLK;RPA3;CUL4B;RFC4
prerank,leukotriene metabolic process (GO:0006691),0.4611664922335016,1.0623108252612337,0.40025252525252525,0.8335208646090505,1.0,3/19,9.98%,PLA2G4A;ABCC1;PLA2G5
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.4678328663171532,1.0622248142316777,0.40784313725490196,0.8331800545627535,1.0,7/18,24.29%,MORC3;SKI;MED25;NF1;PEX2;B4GALT7;TP53
prerank,regulation of macrophage migration (GO:1905521),0.5251151474765573,1.0618851489861425,0.4220314735336195,0.8336035029418881,1.0,2/10,10.11%,EMILIN1;MTUS1
prerank,positive regulation of cyclase activity (GO:0031281),0.48747690094777557,1.0614304399800896,0.42163661581137307,0.8343642119637035,1.0,3/14,9.64%,CACNA1C;STIM1;MAPK8
prerank,axonemal dynein complex assembly (GO:0070286),0.44175429715619074,1.0613513116671494,0.4014778325123153,0.8340269707959332,1.0,9/27,26.04%,DNAH8;DNAAF3;ODAD2;CCDC39;DNAAF4;CFAP73;TTC12;DNAAF5;DNAL1
prerank,cellular response to starvation (GO:0009267),0.3649002004083761,1.0612818259864327,0.3550356052899288,0.8336530151252097,1.0,52/147,26.40%,NPRL3;ATP6V1C2;SEC13;MAP3K5;GCN1;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;WIPI2;DAP;CLEC16A;IMPACT;CASTOR2;MAPK8;WRN;SREBF1;FADS1;ATP6V0D1;HSPA5;SESN2;ATP6V1B2;USP33;PICK1;ATP6V1E1;VPS41;FOXO3;FLCN;SIK2;PRKAG1;AOC1;ATF2;KLF10;KPTN;ATP6V1C1;RHEB;EIF2AK4;EIF2S1;LAMP2;LRRK2;HNRNPA1;EIF2AK3;RPTOR;NPRL2;ATP6V0E1;TP53;ATP6V0B;STK24;LAMTOR2;NIM1K;EHMT2
prerank,sulfur amino acid metabolic process (GO:0000096),0.4465471877131166,1.0612659953999621,0.39012345679012345,0.8331158189644431,1.0,4/24,7.73%,GCLC;MPST;NOX4;MTRR
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4537423683313652,1.0609132302411184,0.3939393939393939,0.833559165473467,1.0,7/22,25.10%,BRD4;HMGN1;CDK12;CCNT2;KAT7;CDK13;DDX39B
prerank,artery development (GO:0060840),-0.34155769607106823,-1.0608134974667536,0.36486486486486486,0.7180117305124526,1.0,11/23,17.44%,ROBO1;ENG;ROBO2;TBX1;PDE2A;BMPR2;ACVRL1;EFEMP2;APLNR;ACVR2B;STRA6
prerank,tRNA wobble uridine modification (GO:0002098),0.4799044670499224,1.0607887398470737,0.4190340909090909,0.8333656406888543,1.0,7/14,24.87%,TRMU;CTU2;ELP1;ELP4;ALKBH8;ELP3;MTO1
prerank,regulation of necroptotic process (GO:0060544),0.4483830222952205,1.060683153001002,0.4076923076923077,0.8330741942670206,1.0,10/23,30.57%,YBX3;OGT;RIPK3;STUB1;PDCD6IP;BIRC3;CYLD;RIPK1;HSP90AA1;SPATA2
prerank,calcium ion transport into cytosol (GO:0060402),-0.34859938174975585,-1.0606701392564497,0.35864978902953587,0.7164389485228261,1.0,10/21,14.20%,SLC8A1;RYR2;CACNA2D1;ITPR3;GRIN2B;GRIN2A;ADRA1A;JPH1;JPH2;GRIN1
prerank,endothelial cell migration (GO:0043542),0.42017558072598116,1.060383732767448,0.3922018348623853,0.8333718738533865,1.0,10/37,12.40%,VEGFA;FSTL1;CCN3;CYP1B1;FAP;GIPC1;RHOA;LGALS8;ABL1;NRP1
prerank,neuromuscular junction development (GO:0007528),-0.34035224308968237,-1.0603728734268538,0.3557692307692308,0.715233232133094,1.0,6/24,4.19%,UNC13C;PPFIBP1;PDZRN3;CACNB2;CACNB4;PPFIBP2
prerank,protein localization to membrane (GO:0072657),0.3649116434133408,1.0601006951388066,0.3671399594320487,0.8336005750017034,1.0,39/187,14.25%,LRP6;KCNB1;ATP1B1;GAS6;FGF13;DLG2;TTC7A;EHD1;RDX;RAB34;C2CD5;TM9SF4;RAMP2;PIGW;PACS2;DVL1;S100A10;PRAM1;RAB8A;SLMAP;ANK2;EHD2;FCHO2;JUP;DLG4;DLG1;SH3PXD2B;NRXN2;NPC1;RAMP1;RAB38;RAB3D;AP3D1;EZR;NLGN1;RAB11B;PICK1;SEC16A;TTC7B
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.31058617323025606,-1.059596113824245,0.3407821229050279,0.7153744020300451,1.0,6/32,8.39%,AUTS2;OCLN;PIK3R1;ENPP2;CORO1C;CDC42
prerank,rRNA modification (GO:0000154),0.460625190284273,1.0594332217740563,0.4015645371577575,0.8349883459334544,1.0,14/21,41.21%,TFB2M;TSR3;FBL;BUD23;TRMT112;DKC1;NSUN3;NOP10;THUMPD1;MRM2;ZCCHC4;DIMT1;NSUN4;MTERF4
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.45047690510075494,1.0593683897829518,0.4073604060913706,0.8346055144713436,1.0,4/24,9.33%,PID1;GFPT1;GFPT2;COQ10B
prerank,regulation of fat cell differentiation (GO:0045598),0.38598557992810145,1.0590918845701254,0.40502183406113534,0.8348007362306632,1.0,19/74,18.69%,CMKLR1;ID2;ZFPM2;LRP5;WWTR1;FTO;CARM1;TRPM4;RORA;SYAP1;WDFY2;IL6;SIRT2;CREB1;TRIO;ANKRD26;E2F1;CDS1;AKT1
prerank,cellular macromolecule catabolic process (GO:0044265),0.4023092454996606,1.0588074382289885,0.4082774049217002,0.8351009959006919,1.0,22/49,28.40%,SIDT2;PPP1R8;RNASE3;RNASE6;CHEK2;SUPV3L1;SND1;NGLY1;FBXO17;IDE;NCBP1;DFFB;UBE2G2;MTREX;PABPC4;OGA;ADAMTS9;HTRA2;RIPK1;DNASE1L2;MANBA;STT3B
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4054566032119631,-1.0585053669923281,0.36742424242424243,0.716326158137714,1.0,5/13,13.58%,ERRFI1;CBLB;SNX6;SOCS5;GPRC5A
prerank,sulfur amino acid catabolic process (GO:0000098),0.5243687878063966,1.058502748947551,0.4247159090909091,0.8354261271042221,1.0,2/10,7.73%,MPST;MTRR
prerank,dorsal/ventral pattern formation (GO:0009953),0.4573099114092516,1.058457449161296,0.4052980132450331,0.8349702955108298,1.0,7/20,19.61%,GLI2;ACVR1;NOG;BMPR1A;NBL1;MDFI;AIDA
prerank,positive regulation of ruffle assembly (GO:1900029),0.4958863333022413,1.0584081050861494,0.4154057771664374,0.8345328307284839,1.0,5/13,14.67%,EPS8L1;FAM98A;NLGN1;NDEL1;PLEKHM1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3805712890159979,1.0582001028642105,0.3925531914893617,0.8345637703713052,1.0,12/68,15.25%,LBP;IL33;TWIST1;RAB7B;STAT3;MAVS;HMGB1;C1QTNF4;HSPD1;F2R;SETD4;IL6
prerank,positive regulation of cell motility (GO:2000147),0.35768796861403,1.0581598910804173,0.3595166163141994,0.8341019678594919,1.0,24/205,7.56%,THBS1;MYOC;EGFR;NTN1;VEGFA;F3;ADAM9;COL1A1;TWIST2;TIAM1;NTRK3;DRD1;RDX;EPHB2;TWIST1;STAT3;SEMA3E;PRKCA;ACVR1;ADAM10;MMP14;SEMA4B;CXCL16;ELP5
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.42321304700426304,1.0581205045871296,0.41262135922330095,0.8336455636571902,1.0,8/31,22.41%,CYP19A1;LIAS;NFS1;FDXR;LSS;PRLR;NOXRED1;PYCR1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.40950314576160757,1.0579063114915044,0.38908659549228947,0.8337076700269471,1.0,17/40,31.68%,TONSL;WRN;RAD51;TRAIP;DONSON;PRIMPOL;BOD1L1;POLD1;ZRANB3;FBH1;RTEL1;CDK9;ATR;SMARCAL1;DDX11;TIMELESS;BLM
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.32690627354958485,-1.0578982902953435,0.38333333333333336,0.7161513858013003,1.0,13/28,17.63%,PRKAA2;PRKAG2;MITF;ADIPOR1;FGFR4;CX3CR1;SIRT1;NR1H4;SIRPA;AVIL;C3;NOS1AP;CD47
prerank,regulation of axon extension (GO:0030516),0.41789865187643005,1.0577662877969207,0.4002375296912114,0.8335418680310815,1.0,6/37,10.58%,NTN1;CTTN;PTPRS;DNM2;GOLGA4;ABL1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.381861487935841,1.057698435375275,0.3963083604777416,0.8331927984795867,1.0,14/72,13.07%,MYOC;FGF2;NEDD4;NTRK3;NTRK1;FSHR;TGFB2;FGFR1;SOX9;CBL;ROR1;MAZ;PIK3CB;F2R
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.38473094601616475,1.0576686433080809,0.391304347826087,0.8327090553218145,1.0,40/72,34.68%,ERCC8;GPS1;ERCC5;HMGN1;ERCC4;CUL4A;ERCC3;XAB2;USP7;ERCC2;POLR2F;ISY1;UBC;RPS27A;AQR;COPS4;POLR2B;COPS7A;UVSSA;POLD1;GTF2H4;POLR2H;COPS3;XPA;DDB1;POLR2I;RBX1;POLR2L;COPS5;XRCC1;ERCC1;ERCC6;POLR2K;POLK;RPA3;CUL4B;CCNH;COPS2;COPS7B;RFC4
prerank,mitotic spindle organization (GO:0007052),0.36301282164116583,1.0575414406476573,0.3637284701114488,0.832467581506405,1.0,37/153,21.34%,XPO1;TUBG2;PPP1CC;TBCE;SEC13;DYNC1H1;MISP;VCP;WDR62;SEH1L;CENPC;MAD1L1;SMC3;RHOA;DCTN2;SPAST;CENPT;CKAP5;INTS13;RCC1;CHEK2;NUP37;MIS12;RCC2;ZW10;DYNC1LI2;RANBP2;NDEL1;RMDN1;CDC20;BIRC5;DYNC1I2;DLGAP5;STAG1;CCDC61;ARHGEF10;SBDS
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.43427584982986983,1.057460658802625,0.42803030303030304,0.8321308076288307,1.0,6/27,16.72%,AK5;AK6;DTYMK;AK1;GSR;RRM2B
prerank,actin filament capping (GO:0051693),0.4630172201361024,1.0574470381805958,0.410427807486631,0.831044805380919,1.0,8/18,25.88%,GSN;VILL;ADD1;SCIN;CAPZA1;ADD3;SVIL;TWF1
prerank,barbed-end actin filament capping (GO:0051016),0.4630172201361024,1.0574470381805958,0.410427807486631,0.831044805380919,1.0,8/18,25.88%,GSN;VILL;ADD1;SCIN;CAPZA1;ADD3;SVIL;TWF1
prerank,regulation of cell size (GO:0008361),0.4512743646368777,1.0572740697086274,0.40025412960609913,0.8309953093644163,1.0,6/23,12.28%,RDX;VAV2;AKT1S1;RHOA;EZR;DEPTOR
prerank,nuclear transport (GO:0051169),0.47022108998647505,1.0572293791795753,0.423841059602649,0.8305677858881687,1.0,2/16,9.11%,XPO1;PSIP1
prerank,neuron projection development (GO:0031175),0.3655866630759351,1.0569381373085176,0.3640973630831643,0.830863398826361,1.0,22/168,7.83%,MYOC;DCLK1;CTNND2;SRGAP2;NEDD4;CTTN;STMND1;EHD1;ANKRD27;LRP12;EPHB2;ARC;DOCK7;PPP1R9B;DNM2;EPHB3;BLOC1S2;HMGB1;GPRIN1;TBC1D23;TBC1D24;DLG4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.517099886672327,1.0565033897442648,0.4248175182481752,0.831512551836012,1.0,6/10,26.01%,EMC2;EMC9;EMC1;EMC8;EMC4;MMGT1
prerank,protein ubiquitination (GO:0016567),0.3493472144563989,1.0562044322765,0.313,0.8317834990555162,1.0,179/471,30.23%,WWP1;RNF144A;SH3RF3;NEDD4;FBXO10;FBXL7;PSMD7;FBXW8;TOPORS;CDC16;UBE2B;VCP;RNF182;DTX3;LRSAM1;PSMA8;UBE2R2;ERCC8;NFX1;PRKDC;KLHL7;UBE3C;NFE2L2;RNF115;TRIM41;PEX5;TRPC4AP;HUWE1;TRIM27;SYVN1;CBL;RBBP6;LZTR1;WWP2;PEX13;PSMA4;ITCH;CUL4A;FBXO25;UCHL3;FBXL4;RNF114;UBR5;RNF25;UBE2C;FBXO22;NEUROD2;RNF14;FBXL12;SDE2;ATG3;PSMD12;MYLIP;CUL1;FBXL19;RNF38;PSMA6;DTX2;PEX10;USP7;RNF103-CHMP3;TRIM26;TNKS2;FBXL14;RNF11;LNPEP;PSMD1;DDA1;UBE2L6;ARRB1;FBXO17;STUB1;FBXL20;PSMC5;PSMD11;KLHL22;UBE2V2;PSMC4;PSMD14;UBC;RPS27A;OTULIN;RC3H2;BIRC6;TRIM13;VPS11;UBE4A;FBXL18;TRIM6;TPP2;UHRF2;RNF7;FBXW2;NPEPPS;UBR2;CDC27;RNF141;ASB5;MYCBP2;FBXW4;RUSC1;CBFB;UBE2G2;PCNP;TRAIP;PSMA3;TRIM47;USP5;UBOX5;SMURF2;TRIM43;MUL1;SH3RF1;RNF4;PSMB1;PEX2;PAF1;PSMD4;KCTD13;KLHL12;CUL9;AREL1;PEX14;DERL1;RNF20;PSMA5;RNF146;FBXO11;DET1;UBE2Z;PSMA7;TAF1;FBXO9;RNF122;AMFR;ANKRD9;PINK1;RCHY1;SELENOS;RNF138;RNFT1;UBE2W;RTF1;UVSSA;UBR3;RNF111;SHPRH;PSMC1;CUL7;RNF126;RNF166;FBXW10;FBH1;CAND1;PSMA1;RNF167;UBE2V1;USP22;TRIM7;DDB1;UBE4B;FBXL8;FBXO41;RBX1;BTRC;RNF135;UBE2Q2;UBR1;TRIM39;KLHL9;VPS18;PRKN;UBE2H;BLMH;TRIP12;ANAPC11;UBE2S;PSMD2;CTNNB1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.33557099108980426,-1.0555735089273957,0.3827751196172249,0.7201074092931617,1.0,4/23,7.11%,PARP14;STAT1;NR1H3;NLRC5
prerank,regulation of neuron death (GO:1901214),-0.26557282907504354,-1.0553762336864527,0.35384615384615387,0.7187162055709233,1.0,20/82,15.02%,EFNB2;WNT5A;PICALM;RRAS2;GRID2;GRIN2B;PPARGC1A;LANCL1;DCC;CSF1;CD200;EGR1;FAIM2;EPHB1;SARM1;BTBD10;CD34;C1QA;SNCA;TYROBP
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4485641589401813,1.0548165550133062,0.4125159642401022,0.835132028679053,1.0,3/23,5.16%,GPC3;GLIS2;VCP
prerank,negative regulation of cell cycle process (GO:0010948),0.3908081799706148,1.0545058165270706,0.4083885209713024,0.8354601542515926,1.0,27/61,32.07%,TOM1L1;EHMT1;RBBP8;BMP4;PHC3;RNF2;ZFYVE19;RBBP7;RING1;L3MBTL2;TFDP1;CBX5;PCGF2;E2F1;RYBP;RAD51;MAX;PPP1R10;CHMP2A;CCP110;EHMT2;E2F8;WAPL;FOXO4;SUZ12;CHMP4C;MGA
prerank,regulation of insulin secretion (GO:0050796),0.3734908238667402,1.0544326047314068,0.4105263157894737,0.8350892787562096,1.0,11/101,7.96%,IRS1;CACNA1C;EFNA5;KCNB1;TCF7L2;CCN3;LRP5;PRKCA;MCU;AACS;CAPN10
prerank,regulation of T cell cytokine production (GO:0002724),0.482742355501937,1.0542928619337666,0.40878828229027964,0.8349248968443455,1.0,4/15,11.75%,TNFRSF1B;FZD5;TRPM4;SMAD7
prerank,folic acid-containing compound metabolic process (GO:0006760),0.46615120072602806,1.0541630325073015,0.40616966580976865,0.8347082645077679,1.0,8/19,19.87%,SLC25A32;MTRR;MTHFD2;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,muscle filament sliding (GO:0030049),-0.3109169693240453,-1.054064024940226,0.35443037974683544,0.7182717423679945,1.0,8/38,11.62%,ACTN2;TPM1;MYL6;TMOD1;DES;TPM3;VIM;TPM2
prerank,actin-myosin filament sliding (GO:0033275),-0.3109169693240453,-1.054064024940226,0.35443037974683544,0.7182717423679945,1.0,8/38,11.62%,ACTN2;TPM1;MYL6;TMOD1;DES;TPM3;VIM;TPM2
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5219182278407417,1.0538111422215055,0.4232424677187948,0.8351991518335941,1.0,2/11,4.91%,ID2;PRKCA
prerank,metal ion homeostasis (GO:0055065),0.41114062395947726,1.0538044462644842,0.4264018691588785,0.8346541086995556,1.0,8/40,14.76%,SLC12A7;SLC12A2;CNNM2;SLC12A4;SELENON;SCNN1A;LETM1;CYP27B1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.49008306600548407,1.0535800088851979,0.4323943661971831,0.8347187266233833,1.0,5/13,17.10%,IL33;SOAT1;RAMP1;CHP1;SLC2A10
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5161083293892761,1.0533655335909062,0.426917510853835,0.8347523956050888,1.0,1/10,0.64%,BMP1
prerank,nitric oxide metabolic process (GO:0046209),-0.3975501127034107,-1.0530619607684586,0.3819444444444444,0.7189113976190158,1.0,6/14,12.41%,NOS3;CYB5B;GCH1;NOS1;DDAH2;SPR
prerank,striated muscle tissue development (GO:0014706),0.42882809835914665,1.0528229794940662,0.414004914004914,0.8357662313522233,1.0,3/29,4.17%,SIX1;SGCD;SIX4
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3591530383153562,-1.0525872934297331,0.3677685950413223,0.7182889508404532,1.0,5/17,10.90%,APOE;FGF1;ABCG1;PRKAA1;KPNB1
prerank,positive regulation of cell population proliferation (GO:0008284),0.350883564431073,1.052169678553268,0.3263263263263263,0.836967645987325,1.0,89/423,18.73%,THBS1;PGF;EGFR;IRS1;FOXP1;PID1;ID2;ZFPM2;VEGFA;GAS6;DDR2;FGF2;TCF7L2;TIAM1;ACER3;NTRK3;PROK2;FGF17;GAB2;LRP5;MAPK15;TGFB3;SHC1;HDAC4;PKHD1;WWTR1;HES5;CSNK2A1;TGFB2;TCIRG1;DNAJA2;FXN;FAM98A;ADAM10;IL12RB2;TGFBR2;FGFR1;MEIS3;SOX9;RARA;S100B;AKT2;TRPM4;EDN3;BMP4;FGFR2;ITGAV;CDC25B;TBRG4;CDC123;TMEM119;FAM98B;VIP;FOXM1;CTF1;CHTOP;TERT;BMPR1A;MAZ;PHIP;TGFBR1;HDAC1;LIG4;F2R;KMT2D;NACC1;BMP5;CLCF1;PRDX3;STX4;IL6;MAP3K3;SLC35F6;CNOT8;ERBB2;FGF5;CCN4;SSR1;GAREM1;UFL1;PRLR;HMOX1;E2F1;KIF20B;BIRC5;SAAL1;AKT1;OSMR;GDNF
prerank,bile acid and bile salt transport (GO:0015721),-0.35092526606943614,-1.0516176821232068,0.37755102040816324,0.7191064544338817,1.0,3/24,2.24%,ABCC4;SLCO2B1;SLCO1C1
prerank,clathrin coat assembly (GO:0048268),-0.3757170250289489,-1.0516004041936597,0.37735849056603776,0.7172691710043633,1.0,5/15,12.55%,SGIP1;PICALM;HIP1R;NSG1;PIK3C2A
prerank,phospholipid dephosphorylation (GO:0046839),0.41828198661435445,1.0514962649175612,0.40930232558139534,0.8383837132274466,1.0,9/37,13.08%,PLPP3;PLPP5;PLPP1;MTMR11;SYNJ1;INPP5B;MTMR10;PIP4P2;OCRL
prerank,keratan sulfate biosynthetic process (GO:0018146),0.43812859171008245,1.0513881069946798,0.42676767676767674,0.8381177460474606,1.0,5/26,9.01%,ST3GAL4;B3GNT7;B4GALT1;ST3GAL2;B4GALT5
prerank,protein insertion into membrane (GO:0051205),0.4187197630314291,1.051337078613559,0.4023809523809524,0.8377010187539129,1.0,11/32,27.76%,EGFR;STX5;TRAM2;ALDH3A2;STX1A;HMOX1;COX18;VAMP2;GET4;SEC61B;CCDC47
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3617941790440712,-1.0510886660704648,0.3905579399141631,0.7167301307378845,1.0,4/18,5.21%,APOE;CTSC;VGLL4;FAF1
prerank,negative regulation of nervous system development (GO:0051961),0.46914546282201386,1.0508007495732992,0.40691489361702127,0.838684753215286,1.0,1/17,0.27%,SLIT1
prerank,positive regulation of protein metabolic process (GO:0051247),0.36781768989680663,1.0505414353809335,0.40932642487046633,0.8388184416138532,1.0,32/110,23.28%,WWP1;GPC3;NEDD4;LDB1;STX5;CSNK2A1;RILP;VCP;DACT1;HUWE1;WWP2;NSF;MAPK8;ITCH;VIP;AXIN1;EIF4G1;INHBA;CD80;SEC22B;IDE;AKT1;ASB5;NFKBIA;CLU;SMURF2;RAB1A;AREL1;SLC25A37;RAB1B;PRMT1;ABCB10
prerank,megakaryocyte differentiation (GO:0030219),-0.42458520842966874,-1.0503756993584907,0.391025641025641,0.7167096020092202,1.0,3/11,9.77%,KIT;SH2B3;TAL1
prerank,regulation of neuroinflammatory response (GO:0150077),0.45790406634173936,1.0503329516528686,0.4211212516297262,0.8388705383469157,1.0,3/19,7.99%,IL33;TNFRSF1B;DAGLA
prerank,regulation of wound healing (GO:0061041),0.4069838433146403,1.0502833933752507,0.4039580908032596,0.8384337499558902,1.0,4/42,2.84%,SRSF6;FGF2;PRKCE;EPHB2
prerank,positive regulation of cell communication (GO:0010647),-0.3298912858306037,-1.0502273801038036,0.390625,0.7152384081285195,1.0,9/28,11.55%,WLS;RIMS2;GRIK2;RIMS1;HOMER1;LGI1;NMU;EDN1;CLSTN1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.383049969144811,1.0499370595253485,0.39872068230277186,0.8389005497221007,1.0,13/85,9.70%,EGFR;SRSF6;VEGFA;FGF2;TCF7L2;DEAF1;PKHD1;SIX4;TGFB2;PRKDC;SOX9;BMP4;FGFR2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3636883945770663,-1.049799491247673,0.34439834024896265,0.7145562242061005,1.0,8/17,17.08%,BMP6;SASH1;LY86;CD180;CACTIN;CX3CL1;SIGIRR;CD55
prerank,maturation of SSU-rRNA (GO:0030490),0.4233675264763235,1.0497963714636087,0.4184971098265896,0.8387360442425473,1.0,12/34,24.71%,HELB;TSR1;SRFBP1;WDR3;RIOK1;DCAF13;TSR2;NOB1;TSR3;NGDN;WDR46;RIOK2
prerank,cytosolic calcium ion transport (GO:0060401),0.420682193922082,1.0497154482827422,0.4129353233830846,0.838415358254894,1.0,3/28,5.91%,CACNA1C;SLC35G1;MCU
prerank,inositol lipid-mediated signaling (GO:0048017),0.3954948190782826,1.0495502246769564,0.4069119286510591,0.8383172400988558,1.0,11/50,12.36%,IRS1;PLCE1;TNFAIP8L3;NTRK1;GAB2;PIK3C2B;FGFR1;OGT;RHOA;EZR;PIK3CB
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4314174100748258,1.049498548095348,0.4187192118226601,0.8379228211074992,1.0,13/26,30.04%,ANAPC5;CDC16;CDC6;UBE2C;LCMT1;ANAPC4;CDC27;DLGAP5;CDK5RAP2;RIOK2;NEK6;NSMCE2;ANAPC11
prerank,methylguanosine-cap decapping (GO:0110156),0.521390074078898,1.048707833686248,0.4228571428571429,0.8395733419962663,1.0,6/10,36.24%,PNRC2;PATL1;DCP1A;EDC4;DCPS;DCP1B
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.45355026733218695,1.0483315330798255,0.42509603072983354,0.8400634032086957,1.0,13/21,33.16%,RAB34;ARMC9;TEDC1;EVC;PDCL;SMO;UCHL5;TXNDC15;DLG5;TUBD1;GLI1;ULK3;GAS8
prerank,maturation of 5.8S rRNA (GO:0000460),0.469426702494345,1.0482632918836767,0.418086500655308,0.8397163683172121,1.0,9/17,26.99%,C1D;PRKDC;LAS1L;EXOSC4;EIF6;MTREX;WDR12;RRP15;MAK16
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.36595750094846496,1.048157954971657,0.3857290589451913,0.8394447002398112,1.0,27/124,15.42%,MYOC;NEDD4;CTTN;STMND1;EHD1;LRP12;LIMA1;DOCK7;PPP1R9B;MNS1;ODF2;BLOC1S2;HMGB1;GPRIN1;TBC1D23;TBC1D24;CYFIP1;ARFIP2;UHMK1;NLGN1;BLOC1S3;MANF;TTC17;MARK4;PLP1;IL6;MICALL2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4028953348492926,1.0481209416705368,0.3965714285714286,0.8389892363317625,1.0,24/42,32.30%,CHD3;SMARCC2;INO80B;SPTY2D1;ACTR6;PBRM1;ZNHIT1;HDAC1;HNRNPC;VPS72;SMARCAD1;CHD8;ACTR8;CHD4;SMARCA4;SRCAP;HDAC2;ANP32E;ARID1A;SMARCD2;SMARCC1;MBD3;GATAD2B;ERCC6
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3674665770935251,-1.048102885917254,0.3448275862068966,0.717094755327938,1.0,7/17,21.04%,ITGA1;PDGFRB;CD300A;PTPA;PPP1R12A;PPP1R15B;PPP1R15A
prerank,superoxide metabolic process (GO:0006801),0.4271253555024228,1.0475527915316631,0.4400494437577256,0.8400721930613274,1.0,4/29,11.85%,SH3PXD2A;NOX4;SH3PXD2B;SOD1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.3124767179816663,-1.0471941781236251,0.3503184713375796,0.71773831091741,1.0,12/32,19.67%,BCL2;BCL2L1;DNM1L;ERBB4;HK2;IFIT2;BOK;MFF;CAMK2A;SOD2;BIK;NDUFS1
prerank,central nervous system myelination (GO:0022010),0.516809486227004,1.0470941149479012,0.4400564174894217,0.8408063947790395,1.0,4/11,20.47%,HES5;B4GALT5;PLP1;CLU
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.33795543260172006,-1.0470654786671045,0.3788546255506608,0.7162691579251136,1.0,6/21,10.31%,PLTP;APOE;PTCH1;NR1H3;CAV1;EEPD1
prerank,regulation of cytoskeleton organization (GO:0051493),0.36902135440752165,1.046768824681692,0.4118257261410788,0.8411608021455527,1.0,18/108,13.07%,PRKCD;RHOBTB1;EFNA5;LRP1;RHOQ;RND3;PHLDB1;SORBS3;CLIC4;ARHGAP17;CDK10;CAPN2;RHOA;PAK2;ABL1;KATNBL1;EZR;ARHGAP44
prerank,protein phosphorylation (GO:0006468),0.349561350765803,1.046670103427014,0.34,0.8409188075075744,1.0,145/479,22.62%,DCLK1;EGFR;PKD1;PKDCC;PRKCD;GAS6;CIT;DDR2;ULK2;NTRK1;MARK1;PRKCE;ACVR1B;MAPK15;EPHB2;CLK3;CSNK1D;CAMK2D;MAP3K5;STRADA;TNK1;CSNK2A2;CSNK2A1;TGFB2;LIMK2;MORC3;ERC1;FASTK;PRKCA;DYRK4;NRBP2;ACVR1;EPHB3;ILK;NEK7;PRKDC;ERN2;ADAM10;TGFBR2;TLK1;STK39;ABI1;BCR;FGFR1;IRAK3;CDK10;RPS6KA4;RARA;PAK4;AKT2;DGKQ;CDK12;GMFB;PKN2;PAK2;ILF3;MAPK8;BMP4;FGFR2;CDC25B;SMG1;CSNK1G1;CHUK;MUSK;TNNI3K;RIPK3;ABL1;IRAK1;MAP4K5;MAP3K12;ATM;BMPR1A;CHEK2;MAPK12;PDPK1;GRK6;DDR1;SMAD7;NRBP1;UHMK1;CSNK1E;TGFBR1;STK25;STK19;SRMS;MAP3K10;PICK1;DMPK;MARK4;WNK1;FRK;SRPK1;TBCK;BRD2;EEF2K;MAP3K3;LATS2;CAMK4;CDC42BPB;TLK2;CREB1;COQ8B;ERBB2;TP53RK;STK16;HASPIN;MKNK2;BIRC6;SIK2;PRKAG1;DAPK3;BCKDK;CAD;VRK2;CLK2;BIRC5;CDK20;MAST2;CDKL2;AKT1;HIPK2;CDK2;IKBKE;CDK5;PRKAB1;EIF2AK4;SGK3;FGFR3;MAPK9;GRK4;PRKACA;VRK3;NEK4;ABI2;LRRK2;CSNK1G3;MAST4;JAK1;CAMK1;CDKL3;STK38;EIF2AK3;PRKCI;TOP1;FAM20A
prerank,neurotransmitter transport (GO:0006836),0.37743601286802864,1.0466220528681935,0.4143947655398037,0.8404982083935316,1.0,9/73,9.82%,SLC38A2;SLC38A1;UNC13B;PPFIA1;DVL1;SLC6A2;SLC28A2;SYNJ1;NRXN2
prerank,response to growth factor (GO:0070848),0.40903789333892404,1.046604815264947,0.41762013729977115,0.8399963507445224,1.0,11/41,18.69%,ACVR1B;SHC1;ACVR1;TGFBR2;URI1;BMPR1A;TGFBR1;LRP2;HDAC6;ERBB2;AKT1
prerank,DNA methylation (GO:0006306),0.4370582200877867,1.0465288865737534,0.4120603015075377,0.8396514272802311,1.0,9/23,26.54%,BAZ2A;TEX15;EHMT1;MTRR;PICK1;FOS;DNMT1;EHMT2;DNMT3A
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.37299806557441145,1.0463045064030214,0.4188034188034188,0.8397266988754571,1.0,30/82,26.63%,CSNK1D;DYNC1H1;SFI1;ODF2;ALMS1;DCTN2;CKAP5;SDCCAG8;AKAP9;CEP164;CSNK1E;YWHAE;CEP41;CEP63;PCM1;HAUS5;CDK2;DYNC1I2;DCTN1;PRKACA;ACTR1A;CDK5RAP2;NEDD1;PLK4;CNTRL;TP53;TUBB4B;CCP110;PPP2R1A;ATF5
prerank,immunoglobulin mediated immune response (GO:0016064),0.5109714799258942,1.0461262948909622,0.41893830703012913,0.8396688549571061,1.0,2/10,11.94%,FCER1G;CD27
prerank,hyaluronan metabolic process (GO:0030212),0.43755312200440766,1.0459573521238654,0.42910915934755334,0.8395702877196156,1.0,5/23,13.27%,FGF2;SLC9A1;ABCC5;CHP1;HEXA
prerank,cellular response to alcohol (GO:0097306),0.40002134473246126,1.0458139968444309,0.4068965517241379,0.839410691402887,1.0,14/42,20.86%,LRP6;GRAMD1A;OSBPL7;ADCY2;ADCY8;JUP;SPIDR;SMO;GRAMD1C;GOLPH3;ADCY7;RAD51;KLF9;GNB1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3538695031632911,1.0456030926808377,0.39152371342078707,0.8394583211239343,1.0,30/214,13.07%,BMPER;EGFR;TNFAIP8L3;GAS6;FGF2;EMILIN1;NTRK3;NTRK1;FSHR;TIMP3;EPHB2;CCL13;SHC1;SPRED2;PKHD1;CCL15;PRKCA;SMAD4;HMGB1;DLG1;ROR1;FGFR2;PLA2G5;MAP3K12;P2RY6;ARHGAP8;EZR;NRP1;PTPN2;F2R
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5146302222530318,1.0455265525613013,0.4366812227074236,0.8390993543476398,1.0,4/10,16.62%,DIS3L2;UBC;RPS27A;TUT7
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.4485085772816867,1.0453626589616742,0.4289405684754522,0.8379132038667642,1.0,7/20,20.80%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.4485085772816867,1.0453626589616742,0.4289405684754522,0.8379132038667642,1.0,7/20,20.80%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,spindle assembly checkpoint signaling (GO:0071173),0.4485085772816867,1.0453626589616742,0.4289405684754522,0.8379132038667642,1.0,7/20,20.80%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,cellular response to oxidative stress (GO:0034599),0.3591533276885726,1.0453535734144188,0.41286307053941906,0.8373885088770588,1.0,39/118,24.90%,EGFR;PRKCD;VKORC1L1;ATF4;SLC4A11;NOX4;NFE2L2;MAPK8;STX2;CHUK;ABL1;SOD1;LONP1;SESN2;SRXN1;PRDX3;CAT;STX4;SIRT2;GSR;TXNRD2;FOXO3;PARP1;HMOX1;VRK2;AKT1;PRDX2;EIF2S1;MAPK9;LRRK2;PYCR1;PRDX1;GPX7;FOS;PYROXD1;PXN;TP53;PINK1;SELENOS
prerank,positive regulation of monooxygenase activity (GO:0032770),0.43307704088547905,1.0453096959243775,0.4329501915708812,0.8369698941706601,1.0,8/26,18.73%,NPR3;TERT;PIK3CB;S100A1;VDR;CYP27B1;AKT1;GDNF
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5123777226283589,1.045230116012741,0.4431314623338257,0.8366322922760328,1.0,2/10,3.46%,MUC1;CYP1B1
prerank,N-glycan processing (GO:0006491),0.4620065373699954,1.0451945141176773,0.4182058047493404,0.8361846509966747,1.0,4/18,9.50%,ST8SIA2;PRKCSH;MGAT4B;FUT8
prerank,renal water homeostasis (GO:0003091),-0.3433786937318115,-1.0451861993535234,0.35071090047393366,0.7194581926349244,1.0,6/23,7.53%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,keratan sulfate metabolic process (GO:0042339),0.42556748371502295,1.044987987415568,0.42700729927007297,0.8361975295036773,1.0,9/31,18.00%,ST3GAL4;B3GNT7;B4GALT1;ST3GAL2;B4GALT5;HEXA;B4GAT1;CHST5;GLB1
prerank,response to reactive oxygen species (GO:0000302),0.3847508990672395,1.0445128934810566,0.42105263157894735,0.8369879776376258,1.0,12/54,18.69%,EGFR;ADAM9;COA8;MAPK8;CHUK;SOD1;STK25;PRDX3;CAT;TXNRD2;HMOX1;AKT1
prerank,positive regulation of kinase activity (GO:0033674),0.36682265455599355,1.0444680008803262,0.4181438998957247,0.8365572943257233,1.0,20/107,13.18%,RASSF2;EGFR;GAS6;DDR2;NTRK3;NTRK1;EPHB2;CAMKK1;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;TAB2;LMO4;SNX9;DDR1;RAD50;MAPRE3
prerank,defense response to bacterium (GO:0042742),0.3683966405371772,1.044436185068659,0.4139004149377593,0.8360834886696091,1.0,10/105,9.26%,PRKCD;LBP;SPN;SHC1;RNASE7;MAVS;RNASE3;GBP6;FCER1G;RNASE6
prerank,positive regulation of stem cell proliferation (GO:2000648),0.46981037105285967,1.0442910837703296,0.4283837056504599,0.8359282857149455,1.0,5/17,23.74%,LTBP3;TERT;PDCD2;KAT7;HNRNPU
prerank,positive regulation of insulin secretion (GO:0032024),0.4078808477843724,1.0441868340103204,0.4290697674418605,0.8356905859697867,1.0,6/36,8.86%,TCF7L2;ADCY8;MCU;AACS;CAPN10;TRPM4
prerank,potassium ion transport (GO:0006813),0.36378451873133155,1.0441696698787613,0.3912133891213389,0.8352020060141925,1.0,12/120,7.44%,KCNJ2;KCNJ15;KCNK5;KCNB1;SLC24A3;HCN4;KCNN1;SLC9A8;SLC9A4;SLC9A1;KCNIP2;KCND1
prerank,positive regulation of signal transduction (GO:0009967),0.35031612861132966,1.0440228855480096,0.41146881287726356,0.8350808491106312,1.0,43/238,13.12%,SMOC2;ADAMTS3;IRS1;SLC39A14;GAS6;F3;RSPO3;PTGIS;CCN3;GRB10;NTRK3;ATP6V1C2;ZMIZ1;RAB34;CSNK2A1;CRADD;TGFB2;STAT3;PRKCA;ARMC9;DACT1;ILK;POGLUT1;JAG1;SULF1;SKI;RSPO1;DLG4;TEDC1;EVC;FGFR2;ITGAV;ING5;TERT;P2RY6;SHANK1;PHIP;PDCL;NRP1;TGFBR1;SMO;NLGN1;CD80
prerank,regulation of establishment of planar polarity (GO:0090175),0.37179970184326594,1.0440084374537004,0.42217484008528783,0.8345718574746961,1.0,22/88,16.37%,TIAM1;PRICKLE1;PSMD7;PKHD1;AP2A1;PSMA8;DACT1;DVL1;FZD7;FZD5;RHOA;PSMA4;PSMD12;PSMA6;AP2A2;CLTC;PSMD1;PSMC5;PSMD11;NPHP3;PSMC4;PSMD14
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.35237265250293043,1.0436709138509854,0.3947633434038268,0.8349799464618984,1.0,51/234,20.47%,ESR1;LRP6;SLCO3A1;VEGFA;DDR2;CARD14;NTRK1;PLPP3;RAB7B;HDAC4;CARD16;STAT3;ERC1;MAVS;ADCY8;IRAK3;TRIM41;JUP;RPS6KA4;TRIM27;ROR1;FOXA1;CHUK;RIPK3;NFKBIB;IRAK1;TAB2;RNF25;NEUROD2;SRF;MID2;PSMA6;SMO;TRIM26;PRDX3;TFDP1;IL6;CRTC2;UBC;RPS27A;NFKB2;TRIM13;TRIM6;AKT1;ATF2;HIPK2;IKBKE;NFKBIA;TCF3;TNFSF18;CLU
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.3800179021877974,-1.0436219657656371,0.3829787234042553,0.7215971938627758,1.0,6/14,11.99%,NOS3;ENPEP;ACE;AGTR1;EDN1;ACE2
prerank,regulation of interleukin-8 production (GO:0032677),0.37938043527678755,1.0435168125754208,0.43435448577680524,0.8348565747816665,1.0,11/69,15.26%,LBP;F3;STAT3;ANXA4;MAVS;HMGB1;ANXA1;MAPKBP1;F2R;IL6;ARRB1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.3046343781321617,-1.0435056805281278,0.3841059602649007,0.7200853990125039,1.0,16/35,18.54%,SEMA6A;PLXNA2;SEMA3D;SEMA7A;SEMA5A;PLXND1;NRP2;ARHGDIA;PLXNB2;SEMA4D;SEMA3G;SEMA4A;PLXNB1;SEMA4G;SEMA5B;PLXNA3
prerank,regulation of proteolysis (GO:0030162),0.39849340534063843,1.0434516401640535,0.42390078917700114,0.8344966120253078,1.0,21/48,28.94%,CST3;OGT;ITCH;TRAF3;SERPINE2;TBC1D10A;CAMK2N1;STUB1;HDAC6;PERP;IST1;CLN3;AKT1;CDK5;CYFIP2;BAD;DNAJC1;HDAC2;PLAUR;SPOPL;BTRC
prerank,regulation of cellular respiration (GO:0043457),0.45960603077062334,1.0434338202167335,0.4147651006711409,0.8340055304618886,1.0,7/17,20.96%,ACTN3;VCP;IFNLR1;NOA1;IDE;SHMT2;IL4
prerank,regulation of programmed cell death (GO:0043067),0.3576062343362692,1.0426839565469934,0.3979695431472081,0.8355439700385466,1.0,72/161,30.44%,ACER3;NTRK1;FBXO10;GAS1;CRADD;CD3E;ACTN3;VCP;RAF1;SOX9;NDRG1;IKZF3;SRA1;AKT1S1;RBM25;WRN;ANP32B;MADD;RIPK3;ABL1;LCMT1;ATM;TNFRSF10B;CIDEA;CASP1;MARK4;USP36;TOMM70;PSMC5;PLSCR3;CREBBP;HIP1;PERP;MAGED1;DAPK3;BID;BIRC5;AKT1;PRDX2;ASAH1;IRF3;STEAP3;CDK5;RTKN;CALR;CLU;NUP62;CTSB;LRRK2;HS1BP3;BIRC3;TRIAP1;FBXO11;TP53;PINK1;ANP32E;FANK1;DAXX;RIPK1;SGK1;RABGGTB;OSGIN1;NOP53;KANK2;BCL6;BCAR1;CASP2;PRKN;ZBTB7A;DFFA;CASP6;HSP90AA1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.426377906685591,1.0426508294073433,0.4217016029593095,0.8350845672650279,1.0,11/29,25.00%,LDLRAD4;SPRED2;FOXA1;SMAD7;FUZ;BMP5;IL17RD;EFNA1;MAD2L2;ZNF750;PPP2CA
prerank,establishment of vesicle localization (GO:0051650),0.46165427113264296,1.0421451852619201,0.42503259452411996,0.836006999525322,1.0,6/18,19.83%,LIMK2;DNM2;SYNJ1;CCDC186;SNAPIN;CDK5
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4691361537602342,1.0420823394676628,0.4262948207171315,0.8356565095999964,1.0,4/17,12.31%,KCNE5;ANK2;SNTA1;AKAP9
prerank,phospholipid biosynthetic process (GO:0008654),0.41328811388661035,1.0419871975622856,0.4145758661887694,0.8353678548080025,1.0,16/36,30.72%,DHDDS;LPCAT1;DOLPP1;FADS1;FAR1;HDHD5;PIP5K1A;AGPAT5;CLN3;MBOAT1;FITM2;PCYT2;SPHK2;AGPAT3;SGMS2;SRD5A3
prerank,long-term memory (GO:0007616),0.4484650031366425,1.0418005008029836,0.41460234680573665,0.8353539933618692,1.0,8/19,21.92%,ARC;SHANK1;KAT2A;CAMK4;EIF2AK4;NFATC4;RASGRF1;LDLR
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.36154680022718666,1.0417677148937317,0.404320987654321,0.8349052351700397,1.0,22/125,14.15%,XPO1;TUBG2;PPP1CC;TBCE;SEC13;DYNC1H1;WDR62;SEH1L;CENPC;MAD1L1;DCTN2;CENPT;CKAP5;INTS13;RCC1;NUP37;MIS12;RCC2;ZW10;DYNC1LI2;RANBP2;NDEL1
prerank,negative regulation of cartilage development (GO:0061037),0.4922354695886168,1.041629694953878,0.4320652173913043,0.8347266078634337,1.0,3/13,12.60%,WNT9A;SOX9;TGFBR1
prerank,anion transmembrane transport (GO:0098656),0.384686986525866,1.0414805523671933,0.4200863930885529,0.834642944212871,1.0,6/67,5.40%,SLC23A1;SLC23A2;SLC5A6;ABCC1;SFXN3;LRRC8D
prerank,regulation of myoblast differentiation (GO:0045661),0.4153369057314722,1.041393780592068,0.4325980392156863,0.8343539454842306,1.0,5/32,9.70%,BOC;SOX9;SRA1;EID2B;BMP4
prerank,glutathione metabolic process (GO:0006749),0.4045820207120854,1.0413783197183326,0.42607683352735737,0.8338548607604125,1.0,10/38,23.50%,GCLC;GSTT1;GSTM5;SOD1;GSR;GSTZ1;GCLM;CHAC2;HAGH;DPEP1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.5154286275814071,1.0413399125136849,0.4624277456647399,0.8334194531667002,1.0,1/10,3.32%,HSPA2
prerank,secretion (GO:0046903),-0.3863133376142844,-1.041225336880976,0.3979591836734694,0.7239329106777457,1.0,5/14,13.06%,SLC22A6;RIMS1;NPR1;SLC22A2;SLC22A4
prerank,regulation of cell motility (GO:2000145),0.3617452798730249,1.04110923634336,0.39241803278688525,0.833518111636912,1.0,20/121,12.02%,EGFR;PLXNA4;NTN1;FGF2;SRCIN1;FGF17;LDB2;LDB1;TWIST1;LMNA;MEAK7;RAF1;BEX4;AKT2;RHOA;PKN2;ABL1;LMO4;CCDC25;RCC2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.44939669406714877,1.040947239713924,0.4234828496042216,0.8334207225465541,1.0,9/22,27.29%,PSMA8;NFE2L2;PSMA4;PSMA6;PSMA3;PSMB1;PSMA5;PSMA7;PSMA1
prerank,diterpenoid metabolic process (GO:0016101),0.3855547252298819,1.0408771236421928,0.43561030235162373,0.8330480633161504,1.0,8/55,13.50%,GPC6;LRP1;GPC3;SDC1;AKR1C1;LRP2;ALDH3A2;OPN1MW
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.49287373862466255,1.0407940848592436,0.4328767123287671,0.8327445282013719,1.0,4/13,12.40%,VEGFA;SEMA3E;TGFBR2;NRP1
prerank,positive regulation of protein transport (GO:0051222),0.38181107182414764,1.0405897531781594,0.43135135135135133,0.8327427109330532,1.0,18/67,18.37%,ADAM9;UNC13B;TGFB3;APBB3;TGFB2;BCAS3;TENM1;EZR;CHP1;ACSL3;PCM1;APBB1;CNST;SYTL4;IER3IP1;GOLPH3;KIF20B;CLN3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.36353158416654946,1.0405648308587623,0.4408376963350785,0.8317363773144456,1.0,29/104,23.81%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;PSMA3;PRKACA;PSMB1;PSMD4;PSMA5;PSMA7;NRAS;KRAS
prerank,cellular response to lectin (GO:1990858),0.36353158416654946,1.0405648308587623,0.4408376963350785,0.8317363773144456,1.0,29/104,23.81%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;PSMA3;PRKACA;PSMB1;PSMD4;PSMA5;PSMA7;NRAS;KRAS
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4129035589615125,-1.0404112937247871,0.41304347826086957,0.7241034003960634,1.0,4/12,11.13%,PLEKHH2;SEMA5A;MTPN;PLEK
prerank,positive regulation of protein phosphorylation (GO:0001934),0.34885724090103487,1.0402771345636899,0.3913913913913914,0.8319918054867536,1.0,77/348,18.69%,RASSF2;PGF;EGFR;GDF10;SLCO3A1;VEGFA;EFNA5;GAS6;DDR2;FGF2;CARD14;NTRK3;NTRK1;FGF17;GHR;INHBC;TGFB3;CAMKK1;DOCK7;CSNK1D;TGFB2;CSPG4;LIMK2;IL5;CALM2;MAVS;ACVR1;TOM1L1;ILK;PFN2;SMAD4;RSPO1;RAF1;SOX9;RPS6KA4;AKT2;DGKQ;ANGPT4;PAK2;BMP4;TMEM119;MUSK;ABL1;TAB2;NIBAN1;BMPR1A;AXIN1;SNX9;TENM1;AKAP9;RAD50;NRP1;TGFBR1;EIF4G1;INHBA;CD80;MAPRE3;ERP29;WDFY2;DAB2;BMP5;HGF;IL6;ARRB1;IQGAP1;HDAC6;ERBB2;FGF5;CALM3;EFNA1;FLCN;PRKAG1;ARAF;TRIM6;CNOT9;RB1CC1;AKT1
prerank,negative regulation of programmed cell death (GO:0043069),0.34748191034200215,1.0401807912578072,0.3867735470941884,0.8317199778044012,1.0,83/355,19.82%,THBS1;EGFR;VEGFA;FSTL1;GAS6;GCLC;CARD14;PROK2;NTRK1;SMAD6;COMP;NOL3;SHC1;TOPORS;PKHD1;SIX4;ANXA4;ERC1;BAG3;TAX1BP1;HYPK;FXN;GLO1;PRKDC;ADAM10;ANGPTL4;RAF1;SOX9;ARF4;ERCC5;PA2G4;CBL;SOCS2;AKT2;ANGPT4;PAK2;MAPK8;ANXA1;BMP4;ITCH;VIP;RIPK3;IRAK1;BCL2L2;NAA16;PHIP;HSPA5;CD27;MIEN1;SERPINB9;HDAC1;VTCN1;HSPD1;LRP2;SUPV3L1;SQSTM1;DAB2;PRDX3;HNRNPK;CAT;PSEN2;HGF;IL6;PSMC5;AATF;UBC;RPS27A;HIGD1A;BIRC6;PRLR;CITED2;ARAF;GOLPH3;BNIP1;BID;CLN3;BIRC5;AKT1;GDNF;DNAJA1;PRDX2;NFKBIA;TAF9B
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.3914078487004699,1.0401177430892867,0.40066592674805773,0.8313775625722141,1.0,28/58,32.74%,ERCC8;PRKDC;HMGB1;ERCC4;KDM2A;ATM;RAD50;LIG4;PIAS4;DCLRE1B;UBE2V2;PSMD14;SMC5;SUMO1;POLB;XRCC6;BRCC3;UVRAG;IFFO1;ATP23;NSMCE2;SMARCAL1;ZBTB7A;UBE2N;ERCC1;ERCC6;HERC2;POLQ
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.37196035445888975,1.040035851899428,0.4329140461215933,0.8310656031584766,1.0,32/88,28.90%,IGFBP5;SAMD4A;RIC1;CST3;CDK5RAP3;ILF3;RGP1;NELL1;SERPINE2;RBM4;CAMK2N1;CNOT8;HDAC6;CNOT10;EPRS1;DAPK3;CLN3;CNOT9;SHMT1;AKT1;SYNCRIP;CDK5;CALR;FXR2;EIF2AK3;YBX1;DNAJC1;MRPL13;RIDA;FXR1;LARP1;ATRAID
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.371502463369932,-1.039520481970885,0.40160642570281124,0.7245352676503579,1.0,5/15,15.94%,PRKCH;AGTR1;CSF1;LPL;MSR1
prerank,heart process (GO:0003015),0.48333892489164665,1.0394816314656359,0.436241610738255,0.8320579814634737,1.0,3/14,11.85%,SGCD;NOX4;SOD1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.284738029670189,-1.0393218854136739,0.3275862068965517,0.7233005961145558,1.0,10/47,10.39%,GRM5;APOE;APP;WDR91;NR1H3;AGTR1;CSF1;EDNRB;EDN1;MTPN
prerank,ncRNA catabolic process (GO:0034661),0.42621364501647546,1.0390822726514948,0.427536231884058,0.8326529916571637,1.0,9/28,20.93%,TENT4B;ERN2;DIS3L2;SND1;XRN1;EXOSC4;DIS3;MTREX;ZCCHC8
prerank,polarized epithelial cell differentiation (GO:0030859),0.49132647008336583,1.0388597320747592,0.4289772727272727,0.8327098869789709,1.0,4/13,12.28%,RHOA;SYNE4;MYO9A;EZR
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4545924251773185,1.0383172442258788,0.4383916990920882,0.8337024955249078,1.0,3/18,10.11%,SLIT2;EDN3;MTUS1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.37626403408461934,1.0383036035769073,0.43073593073593075,0.8332124315076902,1.0,27/73,25.77%,LDB1;PSMD7;PSMA8;PRKDC;PSMA4;ITCH;ABL1;PSMD12;PSMA6;PDCD2;RUNX1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;SETD1A;CBFB;TCF3;PSMA3;PSMB1;PSMD4;KMT2A;PSMA5;PSMA7;METTL14;PSMC1
prerank,ethanol metabolic process (GO:0006067),-0.4126707477009249,-1.0382568288443392,0.3862815884476534,0.7242592652897082,1.0,5/12,15.15%,ALDH1A1;ACSS2;ALDH2;SULT1A1;ADH1A
prerank,synaptic vesicle endocytosis (GO:0048488),0.4184723905705686,1.0382399123373327,0.4375,0.8328642317428026,1.0,10/33,15.33%,STON2;SYT8;CEL;DNM2;FCHO2;STON1;SYNJ1;NLGN1;SNAP91;STX1A
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3299022485007762,-1.0382347013687963,0.41148325358851673,0.7225186182612084,1.0,9/25,17.19%,VCAM1;CTNNA3;CXADR;CD200;ITGA7;ITGA4;PKP2;DSP;NINJ1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.4691731808401583,1.0378203281740594,0.42609853528628494,0.8334943412232996,1.0,8/15,27.27%,CDC16;CDC6;UBE2C;ANAPC1;CDC27;RIOK2;TPR;NEK6
prerank,regulation of tube diameter (GO:0035296),-0.3972449324722787,-1.037776687088334,0.4075342465753425,0.7200535856595753,1.0,6/13,11.99%,ROCK2;NOS3;ACE;AGTR1;NPR1;ACE2
prerank,vascular process in circulatory system (GO:0003018),-0.3972449324722787,-1.037776687088334,0.4075342465753425,0.7200535856595753,1.0,6/13,11.99%,ROCK2;NOS3;ACE;AGTR1;NPR1;ACE2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.4721587720097441,1.0375829341700717,0.420391061452514,0.8335689450681334,1.0,4/15,14.76%,SFRP4;BMP4;VDR;CYP27B1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.37074436721188875,1.0374662534510293,0.42168674698795183,0.8333589772097355,1.0,17/74,18.73%,THBS1;EYA2;TCF7L2;NOL3;ACVR1;BMP4;ITGAV;TERT;PHIP;TNFRSF10B;TGFBR1;BMP5;BIRC6;HMOX1;ZMYND11;AKT1;GDNF
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.4101984713343232,-1.0374634313234297,0.42474916387959866,0.7190658144778183,1.0,6/11,17.41%,CACNB2;CACNA2D1;SESTD1;NOS1;CACNB1;NOS1AP
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3623595961005672,1.0370963693649495,0.45073375262054505,0.8337800572686397,1.0,29/105,23.81%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;PSMA3;PRKACA;PSMB1;PSMD4;PSMA5;PSMA7;NRAS;KRAS
prerank,double-strand break repair via homologous recombination (GO:0000724),0.36840200879264784,1.0370884988330278,0.41718426501035194,0.8332734242075515,1.0,41/95,32.95%,REV3L;MCMDC2;TONSL;MCM2;ERCC5;MORF4L1;RBBP8;ERCC4;SFR1;WRN;SPIDR;SWI5;SFPQ;RAD50;CDC45;GINS4;PARP1;PSMD14;HUS1;MCM4;SMC5;NIPBL;RAD51;XRCC3;RNF138;RECQL5;SMC6;SLX4;MCM7;YY1;FBH1;SWSAP1;NSMCE2;RAD52;AP5Z1;UBE2N;ZFYVE26;BLM;XRCC1;POLQ;RPA3
prerank,regulation of organelle organization (GO:0033043),0.37358304861308883,1.036910831361541,0.4517497348886532,0.8332586156876812,1.0,35/80,28.50%,RDX;MAPK15;STX5;CLIC4;MAVS;MIEF2;RHOT2;CLEC16A;CAPN2;RHOT1;PAK2;TMED9;EZR;AKAP9;TBC1D25;PREB;SQSTM1;VPS11;CDT1;GOLPH3;CLN3;TMEM33;ARMH3;MUL1;LMAN1;CAMSAP3;CAPN6;MTM1;PINK1;SCARB2;TAOK1;SAR1A;SURF4;MYO5A;FIS1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.37798364013993796,1.0367498843837055,0.43278688524590164,0.8331500860974342,1.0,36/73,33.07%,HDAC4;GLMN;PHF1;TRIM27;SF3B1;TDG;KAT2A;RBBP7;POLR2F;HDAC6;POLR1G;MPHOSPH8;POLR1C;TASOR;TAF1C;TBP;KAT2B;DNMT1;H3-3A;POLR2H;IGF2;DNMT3A;SPHK2;MECP2;TAF1D;POLR2L;SUZ12;TAF1B;MTF2;CTCF;SPI1;MTA1;ERCC6;POLR2K;CREBZF;TAF1A
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3482284081100398,1.0365003508890849,0.39039039039039036,0.8332758952689643,1.0,84/390,17.48%,PGF;EGFR;IRS1;SLC39A14;VEGFA;EFNA5;DDR2;FGF2;ARHGEF28;COL1A1;TIAM1;UBASH3B;GRB10;NTRK3;RHOQ;ATP6V1C2;NTRK1;FGF17;GHR;HNRNPH1;VAV2;EPHB2;SIPA1L1;SHC1;SPRED2;RBFOX2;TNK1;STAT3;CD3E;TCIRG1;ARPC1B;CLNK;AP2A1;EPHB3;EPHB6;FOXC2;ATP6V0A1;GIGYF1;SULF1;ABI1;FGFR1;CYFIP1;CBL;SOCS2;AKT2;KALRN;RHOA;ROR1;PAK2;ZNF106;FGFR2;ITGAV;MUSK;GTF2F1;FLRT2;ATP6V0D1;GIT1;SHOC2;DDR1;PHIP;PIK3CB;NRP1;PTPN2;AP2A2;HNRNPM;ATP6V1B2;PTBP1;SRMS;TIAL1;FRK;ATP6V1E1;POLR2F;PSEN2;HGF;SOS1;SIRT2;IDE;GALNT3;ERBB2;FGF5;NCBP1;NGEF;EFNA1;PRLR
prerank,embryonic hemopoiesis (GO:0035162),-0.40544949473026815,-1.036328751555391,0.45051194539249145,0.7203616076084721,1.0,6/12,12.22%,KIT;KDR;FLT3LG;SH2B3;TAL1;KITLG
prerank,protein localization to cell surface (GO:0034394),0.4278355273265014,1.0361940744294544,0.42643391521197005,0.8335887864107433,1.0,12/26,30.23%,PTPRU;RIC3;GGA2;ANK2;GGA1;FBLN5;UNC50;USP4;PRRT1;WNT11;GGA3;CTNNB1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3829284549461306,1.035761679684834,0.4382647385984427,0.8342274812480109,1.0,29/62,29.93%,ELOF1;CDK12;GTF2F1;CCNT2;ERCC3;ERCC2;POLR2F;AFF4;MLLT3;NCBP1;SSRP1;ELP4;NCBP2;PAF1;POLR2B;SETD2;NELFB;CDK13;EAF1;CTDP1;RTF1;GTF2H4;POLR2H;NELFA;POLR2I;CDK9;MLLT1;ADRM1;POLR2L
prerank,cardiac muscle contraction (GO:0060048),0.4111120787186186,1.0355464290917282,0.4306049822064057,0.834277818897655,1.0,6/34,6.19%,ATP1B1;GSN;CAMK2D;DMD;GAA;KCNE5
prerank,regulation of cellular localization (GO:0060341),0.3949063246310668,1.0355034310746443,0.4322799097065463,0.8338615097311398,1.0,7/46,8.04%,EFNA5;GSN;LRP5;CAMK2D;DYNC1H1;DVL1;MAD1L1
prerank,cellular response to calcium ion (GO:0071277),-0.26339948479419184,-1.0354697807652167,0.32608695652173914,0.7209378238686354,1.0,25/67,20.86%,ADGRV1;WNT5A;ITPKB;CPNE4;PRKAA2;ADCY1;KCNH1;RASGRP2;BRAF;PRKAA1;MCOLN1;SYT10;SYT13;SLC25A24;SYT3;SYT2;CPNE7;SYT11;SYT12;HPCA;ECT2;SYT7;SYT15;PPIF;SCN5A
prerank,regulation of catecholamine secretion (GO:0050433),0.41923616049697077,1.0353218540535323,0.4170731707317073,0.8338236794646217,1.0,3/29,6.91%,KCNB1;SYT8;CHRNB2
prerank,regulation of synapse organization (GO:0050807),-0.3157480077170894,-1.0352231066958804,0.40654205607476634,0.719794321248586,1.0,8/26,10.58%,IL1RAPL1;WNT5A;EPHA4;ARHGAP22;CTNNA2;ABHD17C;PDLIM5;YWHAZ
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.28962908634173845,-1.0351818319961634,0.37583892617449666,0.7181323966326438,1.0,13/37,19.72%,BCL2;BCL2L1;DNM1L;NUPR1;BOK;CAV1;RPS7;BCL2L11;STYXL1;EIF5A;RACK1;RPS3;MSX1
prerank,regulation of translational initiation (GO:0006446),0.37990871655488984,1.0351729717667677,0.42810457516339867,0.8337354513572699,1.0,24/63,28.60%,EIF4A2;ATF4;EIF4G2;EIF4G3;IMPACT;CDC123;KHDRBS1;UHMK1;AGO2;EIF4G1;ALKBH1;RBM4;NCBP1;NCBP2;GLE1;EIF2AK4;EIF2AK3;EIF4B;RPS6KB1;NCK1;TPR;YTHDF1;EIF4H;LARP1
prerank,epiboly involved in wound healing (GO:0090505),0.4742984613359573,1.035171962449373,0.43478260869565216,0.8332106251467041,1.0,4/16,17.43%,TMEFF2;RHOA;DDR1;CD151
prerank,cellular response to DNA damage stimulus (GO:0006974),0.34816008655446085,1.0351699109832957,0.39579158316633267,0.8326877219820593,1.0,131/336,30.17%,FOXP1;HELB;MAPK15;PARP3;TOPORS;CHD1L;UBE2B;TRIM28;POLE2;VCP;CBX1;TNFRSF1B;PHF1;GNL1;DCUN1D5;ERCC8;PRKDC;RMI2;INTS3;OTUB1;TRRAP;KMT5C;SLF2;RBBP6;FAAP20;RBBP8;ERCC4;RAD1;OGG1;WRN;CUL4A;SPIDR;ABL1;UBR5;WDR48;BCL2L2;ATM;USP45;CHEK2;MAPK12;ZDHHC16;TDP1;ERCC3;RAD50;CSNK1E;TANK;ALKBH1;MMS19;CEP63;TLK2;ATRIP;PARP1;AATF;HUS1;APBB1;SMC5;SUMO1;POLB;NIPBL;CBX5;UFL1;MEN1;ALKBH8;E2F1;BID;USP10;ATF2;RAD51;IKBKE;IRF3;MTREX;TRAIP;FANCG;XRCC3;SUV39H1;ENDOV;SLF1;NEK4;SFN;UPF1;ZBTB40;USP47;TOPBP1;PDS5A;UVRAG;ALKBH3;BOD1L1;TAOK3;SMC1A;TAF1;TP53;RBM24;TAOK2;XIAP;RECQL5;POLD1;GTF2H4;SMC6;SLX4;SHPRH;TAOK1;HTRA2;MCM7;CGAS;SETD7;XPA;YY1;PARP4;USP16;ZRANB3;FBH1;RTEL1;RPAIN;NOP53;PNKP;ADPRS;SETX;DDB1;ATR;SMARCAL1;IGHMBP2;GRB2;BCL6;HMCES;MBD4;DDX11;RAD52;PDS5B;CASP2;TRIP12;TIMELESS
prerank,recombinational repair (GO:0000725),0.3750957043071025,1.035070114729373,0.43889479277364507,0.8324455520402009,1.0,40/77,35.50%,REV3L;TONSL;ERCC5;MORF4L1;RBBP8;ERCC4;SFR1;WRN;SPIDR;SWI5;SFPQ;RAD50;PARP1;PSMD14;HUS1;SMC5;RAD51;XRCC3;RNF138;RECQL5;SMC6;SLX4;YY1;FBH1;SWSAP1;NSMCE2;RAD52;RHNO1;AP5Z1;UBE2N;ZFYVE26;BLM;XRCC1;POLQ;RPA3;MMS22L;FAN1;MRE11;NSMCE1;SEM1
prerank,DNA conformation change (GO:0071103),0.45823753835804437,1.034812926640347,0.43586206896551727,0.8326207011033212,1.0,7/17,24.80%,HMGB1;ABL1;ERCC3;TOP3B;TOP1;TOP1MT;TOP3A
prerank,negative regulation of apoptotic process (GO:0043066),0.34361931046891264,1.034778531952652,0.388,0.832177104070894,1.0,96/444,18.73%,THBS1;EGFR;SIX1;PRKCD;VEGFA;FSTL1;GAS6;GCLC;CARD14;PROK2;NTRK1;SMAD6;COMP;TGFB3;NOL3;SHC1;TOPORS;PKHD1;CSNK2A2;CSNK2A1;SIX4;CARD16;ANXA4;ERC1;BAG3;TAX1BP1;PRKCA;HYPK;NRBP2;FXN;GLO1;PRKDC;ADAM10;ANGPTL4;RAF1;SOX9;ARF4;TRIM27;ERCC5;PA2G4;CBL;SOCS2;AKT2;ANGPT4;PAK2;MAPK8;ANXA1;BMP4;ITCH;VIP;IRAK1;BCL2L2;MAZ;NAA16;SFPQ;SOD1;PHIP;HSPA5;CD27;CIDEA;PTRH2;MIEN1;SERPINB9;HDAC1;VTCN1;HSPD1;LIG4;F2R;LRP2;YWHAE;SUPV3L1;NDNF;SQSTM1;DAB2;CLCF1;PRDX3;HNRNPK;CAT;PSEN2;HGF;IL6;AATF;UBC;RPS27A;HIGD1A;BIRC6;PRLR;CITED2;ARAF;GOLPH3;BNIP1;BID;CLN3;BIRC5;AKT1;GDNF
prerank,autophagosome maturation (GO:0097352),0.41066949586539353,1.0346269008314526,0.44208037825059104,0.832054441327092,1.0,17/32,36.62%,VCP;LIX1L;WIPI2;VIPAS39;CHMP3;UBQLN1;CLN3;LAMP2;UVRAG;VTI1B;VPS16;STX17;MAP1LC3B;GABARAPL2;TSG101;EPG5;ATG14
prerank,intermediate filament organization (GO:0045109),-0.35555890205512386,-1.034614630652619,0.4046692607003891,0.7177543374846063,1.0,6/17,16.84%,DES;VIM;PKP2;KLHL24;DSP;GFAP
prerank,triglyceride catabolic process (GO:0019433),-0.35412534011909863,-1.0345939343691926,0.39737991266375544,0.716035726642173,1.0,9/19,36.70%,LPL;FABP5;FABP7;FABP3;LIPH;LIPC;FABP4;FABP12;PNPLA2
prerank,regulation of centrosome cycle (GO:0046605),0.43938839996516815,1.0345250722970871,0.44005102040816324,0.8318126530218493,1.0,8/21,26.63%,PKHD1;CHMP3;MARK4;CHMP4B;PDCD6IP;XRCC3;CHMP2A;ATF5
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3680544909725228,1.0344256833874215,0.422550052687039,0.8315554843631947,1.0,18/94,12.55%,PRKCD;DDX5;FHIT;CYP1B1;TOPORS;MAP3K5;ATF4;TNFRSF1B;PRKDC;ERN2;CUL4A;ABL1;BCL2L2;ATM;CHEK2;AIFM1;TNFRSF10B;CUL1
prerank,regulation of endocytic recycling (GO:2001135),0.5047018735800128,1.03442559361581,0.44201909959072305,0.831032164360449,1.0,4/11,13.44%,EHD1;EHD2;ATP9A;RAB11B
prerank,signal release from synapse (GO:0099643),-0.2894917005221435,-1.034098033853741,0.43609022556390975,0.7155426952287568,1.0,16/43,22.23%,NRXN1;LIN7A;RIMS1;PIP5K1C;SYN2;SYN1;STXBP3;SYT10;SNCA;GAD1;SNAP25;SLC32A1;PTPRN2;GRM4;CPLX2;PDZD11
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3736391026015843,1.0340661530280324,0.43797195253505933,0.8315032993120577,1.0,24/70,23.57%,LDB1;PSMD7;PSMA8;PRKDC;PSMA4;ITCH;ABL1;PSMD12;PSMA6;RUNX1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;SETD1A;CBFB;TCF3;PSMA3;PSMB1;PSMD4;KMT2A;PSMA5;PSMA7
prerank,hippo signaling (GO:0035329),-0.32733460184753327,-1.0339073257317595,0.38461538461538464,0.7142873158052468,1.0,3/26,4.47%,TJP1;TEAD4;AMOTL2
prerank,regulation of viral release from host cell (GO:1902186),0.4477745268771509,1.0338439926513963,0.4427672955974843,0.8316062556355657,1.0,9/21,28.33%,TRIM28;MID2;CHMP3;TRIM26;TRIM13;TRIM8;CHMP2A;VPS37B;DDB1
prerank,organonitrogen compound catabolic process (GO:1901565),0.3902516059503917,1.0338422317272922,0.44579646017699115,0.831090148082485,1.0,15/57,19.40%,PLA2G4A;PDXDC1;LRSAM1;MPST;CPQ;GNPDA1;PLA2G5;UCHL3;LNPEP;IDE;PLA2G15;RENBP;BCKDK;NPEPPS;LVRN
prerank,negative regulation of interferon-gamma production (GO:0032689),0.44155198734530277,1.0335639340160898,0.44046094750320103,0.8313458383659336,1.0,4/23,13.02%,GAS6;HMGB1;RARA;INHBA
prerank,protein K48-linked deubiquitination (GO:0071108),0.4401873695701764,1.0331340147143178,0.4417098445595855,0.8320056043919328,1.0,8/23,21.03%,OTUB1;USP50;OTUB2;USP34;USP33;OTUD5;YOD1;USP5
prerank,plasma membrane invagination (GO:0099024),0.4219534640365552,1.0328106846645781,0.4410377358490566,0.8323397295709868,1.0,5/29,15.30%,GSN;SNX18;RHOA;SNX9;SPIRE2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.4960824173366485,1.0327855135538995,0.4437869822485207,0.8318831354570734,1.0,1/11,0.97%,GAS6
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4305754028625496,-1.032695064571149,0.40202702702702703,0.7156660802130346,1.0,2/10,2.33%,SHANK3;APP
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3707090384915578,1.0325331787960945,0.42336548767416937,0.8320640733824397,1.0,20/80,15.88%,PLCE1;ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;EPS8L1;CDC42EP2;FAM98A;CYFIP1;TENM1;NRP1;MIEN1;CDC42EP5;NLGN1;MARK4;NDEL1;FUZ;PLEKHM1;PALM
prerank,cell-matrix adhesion (GO:0007160),0.3681082361267141,1.0323855610383328,0.43143459915611815,0.8319430259619963,1.0,12/95,6.77%,PKD1;ITGA11;COL3A1;ADAM9;TIAM1;CTTN;EMILIN1;ACTN3;PPFIA1;THBS3;ILK;BCR
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.33548555779551104,-1.0321850071820122,0.41232227488151657,0.7152813247885138,1.0,4/21,7.04%,PDE4D;NT5C2;NUDT4;PDE2A
prerank,positive regulation of binding (GO:0051099),0.36839388542562074,1.0321224682704726,0.4337606837606838,0.832111861620005,1.0,20/84,19.00%,PKD1;LRP1;TCF7L2;TIAM1;DACT1;HMGB1;SKI;RARA;BMP4;NVL;TERT;MED25;ADD1;USP33;SIRT2;IDE;NCBP1;MEN1;CDT1;HIPK2
prerank,positive regulation of neuron migration (GO:2001224),-0.41081769416193,-1.0319480292685128,0.43434343434343436,0.7141343170129765,1.0,3/11,9.32%,SEMA6A;RAPGEF2;ARHGEF2
prerank,reticulophagy (GO:0061709),0.49084685404654055,1.0318535140534855,0.44157608695652173,0.8323190929790747,1.0,8/12,28.38%,ULK2;UBA5;UFL1;RB1CC1;TEX264;ATG2B;UFC1;ULK1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.41234719727312613,-1.031756678877014,0.40878378378378377,0.7129068010209231,1.0,4/11,19.08%,EFNB2;MYOCD;GPER1;TGFB1
prerank,lipid biosynthetic process (GO:0008610),0.37689144531402097,1.031709309270763,0.4302575107296137,0.8321838001814064,1.0,20/77,18.77%,ABCD3;CYP19A1;ACSF3;LPCAT1;SCD5;DOLPP1;GPAT4;SREBF1;OLAH;FADS1;CBR4;FDXR;ACACA;PIP5K1A;LSS;HSD17B8;PRLR;AGPAT5;AGPS;ACSL6
prerank,protein localization to kinetochore (GO:0034501),0.4716269853349877,1.0313692244916313,0.4388888888888889,0.8326090190507306,1.0,5/14,16.57%,CENPT;MIS12;RCC2;ZW10;IK
prerank,carbohydrate homeostasis (GO:0033500),0.3782853040728424,1.0311856674308004,0.43973941368078173,0.8325930468127902,1.0,9/67,8.46%,IRS1;KCNB1;TCF7L2;STAT3;ADCY8;TENT4B;MCU;BACE2;ADIPOR2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5126635401202103,1.031176474278724,0.453125,0.8321044095345673,1.0,5/10,23.94%,TBX21;SMAD7;RC3H2;IL4;NFKBID
prerank,mitotic cytokinetic process (GO:1902410),0.44304509784705937,1.0307933417203514,0.45103092783505155,0.8325692317910517,1.0,7/20,24.56%,RHOA;CHMP3;MITD1;CHMP4A;CHMP4B;PDCD6IP;CHMP2A
prerank,nitric oxide biosynthetic process (GO:0006809),-0.402879527684469,-1.030644046239326,0.4131944444444444,0.7139149882293633,1.0,6/13,12.41%,NOS3;CYB5B;GCH1;NOS1;DDAH2;SPR
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.32123104396982083,-1.0305893358770883,0.40588235294117647,0.712353771671371,1.0,8/29,12.94%,IFNAR2;WNT5A;SAMHD1;USP18;NLRC5;RNASEL;CACTIN;PTPN1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.48433646370178796,1.0304987159356154,0.4414535666218035,0.832837440455842,1.0,3/13,15.89%,PTGIS;NNMT;NAPRT
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.41749912073650947,-1.0303971423554668,0.41694915254237286,0.7094851601949574,1.0,4/10,8.39%,CDC42EP4;APC;CDC42EP3;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),-0.41749912073650947,-1.0303971423554668,0.41694915254237286,0.7094851601949574,1.0,4/10,8.39%,CDC42EP4;APC;CDC42EP3;CDC42
prerank,snRNA processing (GO:0016180),0.46534721500447046,1.0302656913963761,0.42800528401585203,0.8329490811045542,1.0,3/16,9.08%,INTS14;INTS3;INTS4
prerank,striated muscle contraction (GO:0006941),-0.27442479440847256,-1.0302073728159877,0.4044943820224719,0.7082955974040047,1.0,4/53,3.25%,ATP1A2;SLC8A1;TPM1;RYR2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5088418432539563,1.0300067026099848,0.4361851332398317,0.8331020955264516,1.0,3/11,15.61%,MAVS;STX4;CAMK4
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.36082833445861817,1.029955405674241,0.43775933609958506,0.8327304519212133,1.0,22/112,12.82%,GDF10;COL3A1;ADAM9;COL1A2;LTBP2;SMAD9;SMAD6;ZMIZ1;TGFB3;TGFB2;PDE3A;ACVR1;SMAD4;TGFBR2;SKI;SOX9;CBL;RHOA;BMPR1A;SMAD7;TGFBR1;ZMIZ2
prerank,serine family amino acid catabolic process (GO:0009071),0.5189387820080802,1.0299420935925938,0.46099290780141844,0.8322404561976458,1.0,4/10,18.59%,GCSH;SHMT2;SHMT1;DAO
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.44727139433159113,1.0297868030409412,0.44473007712082263,0.8321468689060137,1.0,9/20,24.81%,SCD5;CBR4;FAR1;PPT2;ACACA;ACSL3;HSD17B8;GCDH;FITM2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4356688370330536,1.0296033848285118,0.4581772784019975,0.8321300364286564,1.0,6/22,14.76%,VKORC1L1;UBIAD1;LRP2;PIAS4;VDR;CYP27B1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4759324455717278,1.0295160571436086,0.44583333333333336,0.8318525677152268,1.0,4/14,12.31%,ATP1B1;ANK2;KCNIP2;AKAP9
prerank,response to histamine (GO:0034776),-0.4150355764692459,-1.0292754925626655,0.41935483870967744,0.7090337256604641,1.0,3/10,8.61%,GABRB1;GABRB3;GABRB2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3586524693867414,1.02923504854182,0.44123711340206184,0.8320914957428137,1.0,35/140,17.28%,SLIT2;RHOJ;PLCE1;SRGAP3;SRGAP2;TIAM1;ARAP1;RHOQ;TIAM2;VAV2;ARHGAP17;BCR;RHOT2;ARHGAP21;KALRN;RHOA;RHOT1;ITGAV;INPP5B;FOXM1;MYO9A;ARHGAP20;ARHGAP8;ARHGAP44;OCRL;SOS2;SQSTM1;ARHGEF1;RHOB;AKAP13;SOS1;TAGAP;TRIO;NGEF;FLCN
prerank,myeloid leukocyte differentiation (GO:0002573),0.37693475486079764,1.0291679452201552,0.43969298245614036,0.8317446841354704,1.0,15/65,19.13%,FOXP1;VEGFA;GAB2;RXRA;GLO1;TGFBR2;RARA;SBNO2;BMP4;RUNX1;FARP2;CAMK4;PARP1;E2F1;CDK2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.41499046847676624,1.0291144412586217,0.44430844553243576,0.8313754903548779,1.0,4/27,5.27%,MYOC;ARAP1;TMEFF2;PPFIA1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.39996959468568516,1.0291117513035164,0.4466824644549763,0.8308699694848896,1.0,4/35,6.57%,THBS1;SPARC;XDH;SULF1
prerank,ribosome assembly (GO:0042255),0.39452224135037406,1.0284628785421275,0.45017182130584193,0.8321119906258279,1.0,13/47,21.34%,RPSA;MRPS2;RRS1;MPV17L2;RRP7A;NLE1;DHX29;EIF6;PPAN;EFL1;BOP1;EIF2A;SBDS
prerank,nuclear pore complex assembly (GO:0051292),0.5012247228318698,1.0283157127493467,0.4703389830508475,0.8320035605831623,1.0,5/10,27.35%,NUP93;TMEM170A;NDC1;TPR;AHCTF1
prerank,protein insertion into ER membrane (GO:0045048),0.3985410842556181,1.02806730286574,0.4406580493537015,0.8321701702637392,1.0,17/37,27.76%,STX5;TRAM2;EMC2;ALDH3A2;STX1A;EMC9;EMC1;HMOX1;CAMLG;EMC8;VAMP2;GET4;EMC4;MMGT1;GET3;SEC61B;CCDC47
prerank,glycoprotein metabolic process (GO:0009100),0.3899780730691565,1.0277204542507974,0.43946188340807174,0.8325756625424932,1.0,17/53,24.58%,ST3GAL4;ST8SIA2;PRKCSH;ST3GAL2;B4GALT5;MGAT4B;FUT8;GAL3ST4;NGLY1;FBXO17;B3GNT6;GOLPH3;GANAB;MAN2B1;B4GALT7;OGA;ADAMTS9
prerank,mammary gland epithelium development (GO:0061180),0.47643850027567014,1.027678165480985,0.44506258692628653,0.8321618681169591,1.0,2/14,8.56%,ID2;AKT2
prerank,positive regulation of cell projection organization (GO:0031346),0.3568305116734811,1.0276559405629084,0.44881075491209926,0.8317105239661247,1.0,16/115,9.47%,SLIT2;PLXNA4;TIAM1;NTRK3;NTRK1;TIAM2;DPYSL3;CUX1;ARSB;FBXW8;KIDINS220;P3H1;DVL1;DLG4;RHOA;ROR1
prerank,synaptic vesicle localization (GO:0097479),0.4884021744357728,1.0276117245541105,0.45604395604395603,0.8313088146289306,1.0,5/13,19.83%,DNM2;SYNJ1;NLGN1;SNAPIN;CDK5
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4598322471446963,1.027514978706695,0.4587280108254398,0.8310621033244637,1.0,5/16,6.98%,CACNA1C;CAMK2D;CALM2;DMD;ANK2
prerank,cholesterol homeostasis (GO:0042632),0.3786093561247911,1.0274905052762289,0.4412393162393162,0.8306085918787748,1.0,12/64,13.70%,EHD1;LRP5;LIMA1;HDAC9;SOAT1;LAMTOR1;TSKU;AKR1C1;RORA;NPC1;RALY;ABCA1
prerank,response to organonitrogen compound (GO:0010243),0.404691375628013,1.0274565556266086,0.44739884393063584,0.8302003398984509,1.0,12/38,25.07%,MEAK7;VCP;IRAK3;SYVN1;IL6;ERLEC1;GLRB;KAT7;RCN3;DRD2;DERL1;DNAJB12
prerank,glucose metabolic process (GO:0006006),0.384495640251803,1.026757475254708,0.4522502744237102,0.8315355079243583,1.0,13/58,18.37%,SLC39A14;LRP5;ATF4;SORD;GAA;ADPGK;CRTC2;AKR1A1;HECTD4;PGK1;SLC37A4;ENO2;GDPGP1
prerank,response to glucagon (GO:0033762),-0.35152344516053896,-1.0266659232271214,0.41304347826086957,0.7139127104475598,1.0,6/19,7.53%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,cellular response to interleukin-4 (GO:0071353),-0.41863540014525613,-1.026383071211274,0.41333333333333333,0.7128706646020081,1.0,2/10,3.71%,LEF1;TCF7
prerank,myotube differentiation (GO:0014902),-0.3528372599252365,-1.0259034996622736,0.38823529411764707,0.7123244820360439,1.0,9/17,17.40%,JAM2;KCNH1;SORT1;ADGRB3;NOS1;ADAMTS15;IGF1;PLD3;ADAMTS5
prerank,activation of phospholipase C activity (GO:0007202),0.41675432033657434,1.0258901843849528,0.43866171003717475,0.8332898203368706,1.0,2/29,3.19%,EGFR;EDNRA
prerank,regulation of neuron apoptotic process (GO:0043523),0.359861678027226,1.0255286718493812,0.4527098831030818,0.8337290605335421,1.0,22/96,19.93%,SIX1;KCNB1;NTRK1;TGFB3;SIX4;TGFB2;ATF4;NRBP2;AKT1S1;BACE1;SOD1;LIG4;F2R;NDNF;CLCF1;FOXO3;NSMF;NF1;CLN3;GDNF;CDK5;NFATC4
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3791882462356897,1.0252411583959908,0.45352743561030234,0.8339564065808973,1.0,15/53,24.51%,PKD1;XPO1;GLMN;OSBPL7;PSMC5;USP19;DNAAF4;PSMD14;UFL1;ARAF;UCHL5;PRKACA;DESI1;USP14;PINK1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4828074340664764,1.0251028104076847,0.4535367545076283,0.833775673478949,1.0,1/13,0.43%,IRS1
prerank,cellular response to unfolded protein (GO:0034620),0.4228385232619464,1.0250570836176898,0.4518987341772152,0.8334011480170679,1.0,12/26,29.90%,HSPA2;BAG3;HSPA14;HSPA5;HSPD1;OPTN;ABCB10;DAXX;HSPB8;ERN1;HSF1;PRKN
prerank,connective tissue development (GO:0061448),0.40693096537670687,1.0249880836802687,0.4352517985611511,0.8330661038588367,1.0,8/35,12.95%,PKD1;LRP5;HES5;SULF1;SOX9;SH3PXD2B;SLC39A13;TRIP11
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.34580659263763536,-1.0247562799682477,0.4279661016949153,0.713574282771791,1.0,2/20,6.20%,WNT4;C1QTNF3
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4712365104688224,1.0242966536762341,0.44192634560906513,0.8343785688156494,1.0,2/13,5.16%,PID1;VCP
prerank,regulation of cell migration (GO:0030334),0.3428434006800025,1.0242316643381473,0.4288577154308617,0.8340317660439515,1.0,48/382,8.56%,THBS1;MYOC;SLIT2;EGFR;PLXNA4;IGFBP5;VEGFA;F3;FGF2;SRGAP3;SRGAP2;ADAM9;COL1A1;TWIST2;SRCIN1;TIAM1;NTRK3;FGF17;DRD1;TMEFF2;LDB2;LDB1;DPYSL3;RDX;MAPK15;EPHB2;LDLRAD4;CYP1B1;SLURP1;ARSB;LMNA;CLIC4;PTPRU;STAT3;SEMA3E;PRKCA;MEAK7;ACVR1;ADAM10;JAG1;SULF1;MMP14;SEMA4B;CXCL16;ELP5;BEX4;NOG;AKT2
prerank,translesion synthesis (GO:0019985),0.3921753236150626,1.0240014611543433,0.44883720930232557,0.8341503690046739,1.0,14/42,25.47%,REV3L;POLE2;VCP;FAAP20;UBE2L6;UBC;RPS27A;REV1;NPLOC4;USP10;MAD2L2;PRIMPOL;RCHY1;POLD1
prerank,protein targeting to membrane (GO:0006612),0.3629783228993408,1.0239238215999062,0.45589798087141337,0.8338448813208476,1.0,33/83,30.32%,ABCD3;PXMP2;SEC61A1;RABGEF1;PEX5;SSR2;PEX16;PEX13;ATG3;ALDH3A2;SIL1;SSR1;ZDHHC4;ZDHHC20;CHMP4A;CHMP4B;PEX2;ABCD1;ACBD5;PRKCI;PEX14;ZDHHC9;SGTB;TAOK2;GET3;PARD3;VPS37B;SEC62;FIS1;SRPRA;PIKFYVE;ATAD1;SRP14
prerank,positive regulation of actin nucleation (GO:0051127),0.48814198097549233,1.0238174066651262,0.4702627939142462,0.8336054166459204,1.0,4/11,21.50%,GSN;CYFIP1;SCIN;ABI2
prerank,anion transport (GO:0006820),0.404567844965909,1.0238104230824538,0.4488095238095238,0.8331189907284975,1.0,6/33,12.01%,SLC26A7;LRRC8D;SLC4A2;SLC26A4;VDAC2;SLC17A5
prerank,pyruvate metabolic process (GO:0006090),0.3869964254367165,1.0238003819933412,0.44271412680756395,0.8326361933104046,1.0,4/52,6.10%,ME1;SLC16A1;LDHC;GLO1
prerank,receptor internalization (GO:0031623),0.39422706433575444,1.0237574976482542,0.4608187134502924,0.8322365035769778,1.0,10/44,15.26%,LRP1;NEDD4;RAMP2;DNM2;CD9;FCER1G;SNX1;RAMP1;CLTC;ARRB1
prerank,regulation of chemokine production (GO:0032642),0.40283536449946267,1.0237256072395406,0.44350961538461536,0.8318233533492506,1.0,2/36,1.29%,FOXP1;IL33
prerank,RNA biosynthetic process (GO:0032774),0.41438685765983846,1.0236290120822822,0.45072115384615385,0.8315797863751841,1.0,12/31,30.87%,HELB;TCEA2;TERT;TAF6;TAF13;SMN1;TBP;PRIM1;TAF10;SETX;PRMT5;TTF2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4914094962150525,1.02344444671822,0.45365168539325845,0.8315666645785862,1.0,1/12,0.43%,IRS1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.34188829707267915,-1.0226828244285717,0.42790697674418604,0.7169498647025335,1.0,10/20,15.96%,TGFBR3;ENG;TBX3;NOTCH1;RBPJ;ACVRL1;SPRY1;HEY2;OLFM1;BMP2
prerank,regulation of macrophage differentiation (GO:0045649),0.4763991337527575,1.0223399797718953,0.4576502732240437,0.8339698661545237,1.0,4/15,13.02%,ID2;PRKCA;PTPN2;INHBA
prerank,negative regulation of neurogenesis (GO:0050768),-0.29465473781293416,-1.0223310967974657,0.4470588235294118,0.7160681875300318,1.0,5/34,6.93%,PTN;B2M;RAPGEF2;NOTCH1;ARHGDIA
prerank,histone exchange (GO:0043486),0.4010647066287663,1.0220524550461598,0.46347305389221555,0.8342196591267481,1.0,8/37,16.10%,HJURP;CENPC;CENPT;SPTY2D1;ACTR6;ZNHIT1;RBBP7;VPS72
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.37295610584299105,1.0219845756375792,0.46673936750272627,0.8338833372309118,1.0,24/70,23.60%,PSMD7;PSMA8;FCER1G;PSMA4;ITGAV;PDIA3;CHUK;PSMD12;PSMA6;SEC22B;LNPEP;SNAP23;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;CALR;PSMB1;PSMD4;PSMA5;PSMA7;ITGB5
prerank,regulation of secretion by cell (GO:1903530),0.3827528003609629,1.0219194195702561,0.43575418994413406,0.8335516525488922,1.0,13/54,15.40%,SNCAIP;P3H1;RAB21;RIC1;RAB8A;DISP1;LLGL1;NSF;ANXA1;RAB3D;STXBP5;STX4;RAB3B
prerank,ameboidal-type cell migration (GO:0001667),0.3831402105739143,1.021888396950619,0.45413363533408835,0.8331400618397924,1.0,8/51,9.52%,SRGAP2;GPC3;CCN3;PDXDC1;SEMA3E;FAT2;SEMA4B;PKN2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.4655674475404504,1.0218413248778095,0.45517241379310347,0.832769401167033,1.0,1/15,0.75%,PRKCD
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.4980981447119761,1.0216248126476157,0.4435028248587571,0.832359115373188,1.0,8/11,29.40%,CCT4;LARP7;CCT6A;CCT8;TCP1;DKC1;CCT5;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),0.4980981447119761,1.0216248126476157,0.4435028248587571,0.832359115373188,1.0,8/11,29.40%,CCT4;LARP7;CCT6A;CCT8;TCP1;DKC1;CCT5;MEPCE
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5106266196899587,1.020777251015587,0.47467438494934877,0.8341261693743972,1.0,2/10,11.50%,ADAM9;IQSEC1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3288713856310541,-1.020520721258346,0.4449760765550239,0.7189214489855328,1.0,4/23,3.97%,CEMIP;BMP7;APP;PRKAG2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4869988900730942,1.020435412770812,0.4836879432624113,0.8345558611925752,1.0,4/12,18.27%,ADCY8;TRPM4;STX4;C2CD2L
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4262607937775664,1.020303526354039,0.4510532837670384,0.834420101315788,1.0,6/24,16.22%,KCNB1;C2CD5;MIEF2;AKT2;CHP1;ERBB2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.38408632841538065,1.0202685039870358,0.4523809523809524,0.8340109278018745,1.0,17/54,26.25%,GAS6;CARD16;TAX1BP1;SHARPIN;MADD;CHUK;PTPN2;CASP1;OTULIN;TRAIP;CCDC3;GPS2;BIRC3;CYLD;SPPL2A;TRADD;RIPK1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5086748511304225,1.0199712501299694,0.46835443037974683,0.8342686532623184,1.0,3/10,16.48%,PLA2G4A;PLA2G5;PLA2G15
prerank,alanine transport (GO:0032328),0.500413283750537,1.0196572556245431,0.468232044198895,0.8346071415132091,1.0,3/10,13.61%,SLC7A10;SLC38A3;SLC1A4
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.36885852295510246,1.0195131889245945,0.4645922746781116,0.8344398681991876,1.0,14/76,12.98%,CTTN;NTRK3;PRKCE;SORBS3;DYNC1H1;BCAS3;CDC42EP2;PFN2;ABL1;KATNBL1;SNX9;TENM1;NRP1;CDC42EP5
prerank,regulation of cell development (GO:0060284),0.4017105436782625,1.0194477615517437,0.44758539458186103,0.8341180424128251,1.0,7/36,12.12%,DOCK7;HDAC9;HES5;BHLHE40;HEYL;FBXO22;HEY1
prerank,regulation of autophagy (GO:0010506),0.3447068834902887,1.0193566648900383,0.44064386317907445,0.8338679396842452,1.0,95/216,28.89%,NEDD4;ATP6V1C2;EXOC4;MAPK15;CSNK2A2;STAT3;OSBPL7;EIF4G2;LAMTOR1;ATP6V0A1;HMGB1;RAB8A;EIF4G3;TRIM27;FZD5;DAP;FOXK1;MAPK8;PIP4K2B;VPS26A;SREBF1;ABL1;TAB2;ATP6V0D1;ATM;MID2;KDM4A;PIK3CB;SNX32;EIF4G1;ATP6V1B2;USP33;WDR41;UBQLN1;USP36;TRIM65;ATP6V1E1;USP13;HGF;SIRT2;FOXO3;TLK2;HDAC6;KLHL22;ORMDL3;FLCN;UFL1;PRKAG1;DAPK3;TRIM6;USP10;RB1CC1;AKT1;ATP6V1C1;DCAF12;CDK5;PRKAB1;RHEB;ATF6;UCHL1;PRKACA;OPTN;CAPNS1;LRRK2;TRIM8;RUBCN;ZKSCAN3;KAT8;RPTOR;NPRL2;ATP6V0E1;SMCR8;BAD;ROCK1;PINK1;ATP6V0B;LAMTOR2;EXOC7;ATG13;MET;HTRA2;GOLGA2;ERN1;EIF4E;PIP4K2C;CAPN1;LAMTOR3;ABL2;SNX5;TFEB;ULK1;SREBF2;PLEKHF1;CISD2;DRAM1
prerank,pre-miRNA processing (GO:0031054),0.4742152163619422,1.0193295463694378,0.46056338028169014,0.8334282230762884,1.0,4/14,16.62%,PRKRA;AGO1;AGO2;TUT7
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.4226039111017684,1.0190367495392694,0.4568345323741007,0.833715905153759,1.0,11/29,24.32%,HELB;TSR1;RRS1;DCAF13;RPP40;TSR2;ABT1;NGDN;WDR46;TBL3;KRI1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.3887284850362141,-1.0189356997768453,0.4178082191780822,0.7213570327677551,1.0,3/12,4.47%,PODXL;PROM1;PTPRO
prerank,ganglioside biosynthetic process (GO:0001574),0.4658595543512972,1.0189194284907412,0.4542974079126876,0.8335065860612297,1.0,4/15,9.01%,ST8SIA2;ST6GALNAC5;ST3GAL2;B4GALT5
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3974437832492664,1.0187515851171465,0.46252927400468385,0.83343267101537,1.0,6/35,13.07%,MYOC;EPHB2;TGFB2;LZTR1;SCAI;ARHGAP44
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.4137630218481353,-1.0185254742180616,0.4354243542435424,0.720680041123316,1.0,2/11,1.32%,NEDD4L;ACTN2
prerank,establishment of spindle localization (GO:0051293),0.46899729560688397,1.018409247451968,0.451568894952251,0.8338256189337836,1.0,3/14,7.48%,DYNC1H1;TLE6;LLGL1
prerank,mitotic recombination (GO:0006312),0.4668105133316402,1.018346063154161,0.43610013175230566,0.8334858009573951,1.0,9/15,31.98%,RAD50;TPRKB;SMC5;RAD51;XRCC3;SMC6;NSMCE2;RAD52;ERCC1
prerank,synaptic vesicle transport (GO:0048489),0.49723482509920014,1.018336819325809,0.47579529737206083,0.8330138681486753,1.0,4/11,19.83%,DNM2;SYNJ1;SNAPIN;CDK5
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.41661525903214475,1.0182163913333204,0.4512040557667934,0.8328181245039563,1.0,7/27,17.74%,ZC3H12D;RNASE6;ZC3H12C;LACTB2;XRN1;PCF11;KHNYN
prerank,liver development (GO:0001889),-0.30281409671967335,-1.0178554402741355,0.4603960396039604,0.7206642946410063,1.0,5/32,5.88%,TGFBR3;WNT4;ARID5B;LSR;PROX1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3817483244810976,1.0176498864537171,0.4551569506726457,0.8337602251603352,1.0,22/50,29.58%,PRR7;NXN;OGT;ABL1;SMAD7;CHP1;U2AF2;SQSTM1;ARRB1;N4BP1;MINAR1;UFL1;AKT1;DNAJA1;USP4;TAF1;CAMLG;GTPBP4;SVBP;PER2;SPOPL;PRMT3
prerank,negative regulation of viral entry into host cell (GO:0046597),0.47944343405048084,1.017377119137477,0.43988684582743987,0.8339712519441709,1.0,3/12,13.93%,GSN;MID2;TRIM26
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3567373308459973,1.016849536003698,0.46996838777660693,0.8347995795497305,1.0,20/91,17.53%,SCARA5;SLC39A14;FLVCR1;HMOX2;FXN;SLC39A7;SMAD4;ACO1;SLC30A5;SLC39A13;ATP6V0D1;ARF1;SOD1;CUL1;CYBRD1;ABCB6;FRRS1;IREB2;SLC30A9;HMOX1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3677203902460689,1.0167177448547435,0.46254071661237783,0.8346538257662982,1.0,8/72,8.29%,SLIT2;PRKCD;FGF13;EMILIN1;LIMA1;PFN2;SMAD4;IAPP
prerank,lipoprotein localization (GO:0044872),0.49087229383928244,1.0166614155387088,0.4710860366713681,0.8343143386650673,1.0,1/11,1.02%,LRP1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3519978197611392,1.0162851956109384,0.4685890834191555,0.8348039240661638,1.0,56/148,26.71%,CSNK2A2;CSNK2A1;KMT5A;RRS1;CHD3;USP2;RMI2;MDM4;EHMT1;CDK5RAP3;RBBP8;RAD1;WRN;ING5;PIP4K2B;ATM;CHEK2;PDPK1;TAF15;TAF6;RAD50;HDAC1;TAF13;RBBP7;USP7;HEXIM1;ATRIP;TTC5;PPP2R5C;TP53RK;HUS1;SSRP1;BOP1;PRKAG1;AKT1;HIPK2;CDK2;TAF9B;CDK5;PRKAB1;NOC2L;MAPKAP1;PAK1IP1;TOPBP1;TBP;MEAF6;TAF1;SMYD2;TP53;CHD4;TOP3A;HDAC2;DAXX;EHMT2;SGK1;TAF10
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.4963193366434671,1.0162618058703827,0.4714881780250348,0.8343679142866164,1.0,4/10,16.01%,PLS1;TSKU;SOD1;IFT88
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3613372608212446,1.0161389459496657,0.47065101387406616,0.8341930779791915,1.0,33/88,28.94%,FBXL7;PSMD7;PSMA8;PSMA4;CUL4A;FBXL4;FBXL12;PSMD12;CUL1;PSMA6;FBXL14;PSMD1;FBXO17;FBXL20;PSMC5;PSMD11;PSMC4;PSMD14;FBXL18;FBXW4;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;FBXO9;PSMC1;FBXO38;PSMA1;DMAC2;FBXL8;RBX1;BTRC
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5030146116328502,1.016135503230227,0.45863570391872277,0.8337057329951718,1.0,3/10,10.19%,ETFDH;ETFA;ETFB
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3601227581234462,1.0160068742166586,0.4605543710021322,0.8335481040336241,1.0,17/100,13.07%,MYOC;EGFR;FGF2;NEDD4;NTRK3;NTRK1;FSHR;TWIST1;TGFB2;FGFR1;SOX9;CBL;ROR1;PIP4K2B;MAZ;PIK3CB;F2R
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.49704318651534685,1.0159694461625932,0.4433285509325681,0.8331529960176798,1.0,2/10,12.91%,LRP1;PTPN2
prerank,response to unfolded protein (GO:0006986),0.38453933625370224,1.015873270401156,0.48236632536973834,0.8328993329226371,1.0,19/48,31.19%,SERPINH1;HSPA2;BAG3;HSPA14;HSPA5;HSPD1;DNAJA1;OPTN;DERL1;HERPUD1;DAXX;HSPB8;ERN1;HSF1;STT3B;DNAJB1;PRKN;HSP90AA1;HSPH1
prerank,motile cilium assembly (GO:0044458),0.48142648222153994,1.01581333279399,0.4675862068965517,0.8325441506301683,1.0,3/12,13.29%,DNAAF3;CCDC39;BBS5
prerank,DNA damage checkpoint signaling (GO:0000077),0.4129436799605458,1.0158039057980297,0.4493975903614458,0.8320787555600454,1.0,15/28,32.30%,TIPRL;RAD1;ATM;CHEK2;CEP63;ATRIP;HUS1;E2F1;DONSON;ATR;INTS7;RAD17;RHNO1;HINFP;ERCC6
prerank,regulation of cell aging (GO:0090342),0.49237630186329606,1.0155761413310027,0.4661016949152542,0.832153749529937,1.0,5/11,27.27%,LMNA;FOXM1;NEK4;VASH1;NEK6
prerank,nervous system development (GO:0007399),0.3388083404463736,1.0149837219816946,0.46,0.8331954112964686,1.0,67/429,13.89%,DCLK1;PCDHB16;NAV2;WWP1;PKD1;ST8SIA2;VEGFA;EFNA5;ECRG4;FGF13;FGF2;GSN;CRIM1;FARP1;FGF17;DRD1;LDB2;LDB1;CNTFR;ACVR1B;GLIS2;EPHB2;NAV1;PMP22;RBFOX2;MBNL1;HDAC4;WWTR1;HES5;STAT3;PCDHB12;DACT1;DVL1;WDR62;SPG7;JAG1;SCD5;DLG4;DAGLA;S100B;FZD5;CHERP;NOG;RBM45;HAPLN4;KALRN;ZIC1;GMFB;NRXN2;ZIC4;ATN1;NEUROD2;BPNT1;TENM1;MYLIP;NELL1;TGFBR1;SMO;RAPGEFL1;LIG4;NLGN1;INHBA;DCHS1;NPAS1;ALDH3A2;MARK4;NDP
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.38548186423309594,1.014751753341053,0.47580645161290325,0.83329859270493,1.0,9/48,13.07%,UBASH3B;DRD1;CAMK2D;CALM2;DMD;ANK2;SELENON;PDPK1;F2R
prerank,steroid catabolic process (GO:0006706),0.49653010715445184,1.0147432077298415,0.45296671490593343,0.8328303121605931,1.0,2/10,14.76%,CYP19A1;CYP27B1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.34327054479064406,1.014716256630201,0.45235707121364094,0.8323938496305159,1.0,58/248,16.60%,EGFR;LRP6;CTNND2;TCF7L2;GPC3;COL1A1;SFRP4;PLEKHA4;PRICKLE1;DKK3;PSMD7;TLE2;CSNK1D;WWTR1;PTPRU;UBE2B;VCP;TLE6;PSMA8;DACT1;DVL1;ILK;CCAR2;FZD7;RSPO1;JUP;SOX9;NOG;DACT3;TRPM4;TLE3;PSMA4;FGFR2;CSNK1G1;TPBG;UBR5;AXIN1;INVS;PSMD12;USP34;CSNK1E;HDAC1;PSMA6;WNK1;LIMD1;TNKS2;DAB2;FUZ;PSMD1;PSMC5;LATS2;GSKIP;PSMD11;MLLT3;NPHP3;PSMC4;PSMD14;OTULIN
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.39799616208033417,-1.0146363363311197,0.44642857142857145,0.7268693958986614,1.0,2/12,4.77%,AXIN2;RB1
prerank,DNA dealkylation (GO:0035510),0.5058809089969621,1.0145440954312013,0.4727272727272727,0.8318512355770468,1.0,3/10,13.49%,MPG;FTO;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5058809089969621,1.0145440954312013,0.4727272727272727,0.8318512355770468,1.0,3/10,13.49%,MPG;FTO;ALKBH1
prerank,regulation of protein dephosphorylation (GO:0035304),0.4069308613706325,1.0143554192588455,0.4887839433293979,0.8318659929303043,1.0,13/37,18.29%,PRKCD;CALM2;PPP1R8;PPP6R1;SYMPK;TIPRL;PPP6R3;CNEP1R1;PTBP1;ARPP19;NSMF;CALM3;PPP6R2
prerank,positive regulation of cell cycle process (GO:0090068),0.3571807069380346,1.0143530770258806,0.4651898734177215,0.8313805216002399,1.0,23/91,21.32%,CIT;PRKCE;LRP5;DYNC1H1;CDC14A;GIPC1;CDC6;RHOA;EDN3;PKN2;CDC25B;SPAST;PHIP;RCC2;OPN1MW;CSPP1;SIRT2;USP19;KIF20B;DBF4;XRCC3;NUP62;DRD2
prerank,cellular response to acid chemical (GO:0071229),0.4256039165040246,1.0142771324139257,0.4690157958687728,0.8311185271429824,1.0,6/27,15.92%,VEGFA;IPO5;LAMTOR1;CAPN2;SESN2;NSMF
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.4476209932411992,1.013484445301273,0.4888304862023653,0.8326742867946932,1.0,11/18,35.52%,ATF4;PHF8;ERBB2;EIF2AK3;WDR75;UBTF;POLR2L;POLR2K;SIRT7;LYAR;UTP15
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.4128710622740636,1.013482925545168,0.4605263157894737,0.8321874352823094,1.0,13/31,22.63%,DLG2;CRB1;DLG1;RHOA;SYNE4;MYO9A;EZR;CRB2;WDR1;ERBIN;PDCD6IP;PRKCI;CAMSAP3
prerank,microtubule anchoring at centrosome (GO:0034454),0.5072947966832551,1.0132653376836456,0.4806312769010043,0.8322647703884444,1.0,3/10,20.23%,NIN;PCM1;DCTN1
prerank,regulation of axon guidance (GO:1902667),0.5118215865662015,1.0127959020900326,0.4844632768361582,0.8329498883891531,1.0,3/10,19.09%,VEGFA;NRP1;MYCBP2
prerank,cellular amide metabolic process (GO:0043603),0.3586804176367206,1.0125776416320404,0.47584033613445376,0.8329838760847068,1.0,27/102,21.30%,SLC5A6;PLPP3;CPZ;ATF4;ACSF2;SLC25A32;ACOT11;PLPP1;MTRR;DNPEP;GPAT4;NNMT;MTHFD2;NLN;CPXM2;GLYAT;PLA2G15;ALDH1L2;MTHFD1;ORMDL3;SHMT2;ACOT13;SHMT1;ACSL6;MTHFR;ORMDL1;PCCB
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.4131600425044076,-1.0125140648448487,0.42474916387959866,0.730486824485994,1.0,3/10,3.54%,LYN;RAPGEF2;CXCL12
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.45421836201325894,1.012408199070367,0.46620689655172415,0.8329269843932454,1.0,5/15,13.52%,EGFR;NTRK1;ABL1;DDR1;SRMS
prerank,receptor catabolic process (GO:0032801),0.4214999781083825,1.0122710389854355,0.47692307692307695,0.8327793735958747,1.0,9/24,23.06%,NEDD4;AP2A1;MYLIP;AP2A2;CLTC;GPRASP1;CLTA;MVB12A;UVRAG
prerank,negative regulation of cell motility (GO:2000146),0.3575415395932964,1.012003576450111,0.4636929460580913,0.8329714520036793,1.0,14/108,6.57%,SLIT2;IGFBP5;SRGAP3;SRGAP2;TMEFF2;DPYSL3;MAPK15;LDLRAD4;CYP1B1;SLURP1;CLIC4;PTPRU;JAG1;SULF1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.348546039750009,1.0119275437864133,0.5045317220543807,0.832673636188053,1.0,45/170,23.94%,FOXP1;ATP1B1;C1D;AFF3;YBX3;COQ7;PRDM5;PRDM11;PRDM10;PRDM6;LAMTOR1;ANKRA2;HNRNPDL;RSPO1;TRIM27;TSKU;EDN3;PCBP4;PRDM4;ARF1;FUBP1;MARF1;NELL1;PCBP2;TRIM26;HNRNPK;AFF4;UBAP2;ZNF462;HMG20A;KDM6B;PRDM2;RFXANK;TRIM6;GDNF;CDK2;MTMR1;AFF2;TRIM43;POGZ;LDLR;ZNF711;CAVIN4;YBX1;NFKBID
prerank,negative regulation of cell death (GO:0060548),0.362294987577023,1.0112376045043345,0.4654427645788337,0.8339852228366021,1.0,27/88,26.37%,SRSF6;FGF2;SRGAP2;CCN5;CCN3;LRPAP1;AGR2;TNFRSF1B;IMPACT;BMP4;EIF4G1;PSMC5;CCN4;AKT1;CDK5;CLU;CHMP4A;CHMP4B;NUP62;LRRK2;GPNMB;PINK1;CHMP2A;NENF;HTRA2;NCK1;WNT11
prerank,wound healing (GO:0042060),0.37068578787931267,1.0111875492237623,0.45879732739420936,0.8336141190278135,1.0,16/62,17.53%,FGF2;COL3A1;AHNAK2;TGFB2;FZD7;RAF1;NOG;TSKU;DCBLD2;SRF;TGFBR1;MIA3;ERBB2;NF1;SYTL4;HMOX1
prerank,double-strand break repair (GO:0006302),0.3488085067451822,1.0108758789814731,0.48577235772357724,0.8339027856893276,1.0,42/158,20.80%,REV3L;PARP3;VCP;PRKDC;HMGB1;TONSL;ERCC5;MORF4L1;RBBP8;ERCC4;MAPK8;SFR1;WRN;SPIDR;KDM2A;SWI5;KPNA2;ATM;CHEK2;SFPQ;TDP1;KDM4A;RAD50;LIG4;PIAS4;DCLRE1B;UBE2V2;PARP1;PSMD14;HUS1;APBB1;SMC5;SUMO1;POLB;SMARCAD1;ACTR8;RAD51;XRCC6;TNKS1BP1;BRCC3;XRCC3;MAD2L2
prerank,regulation of brown fat cell differentiation (GO:0090335),0.45905830114086343,1.0106671975553039,0.489851150202977,0.8339436434151134,1.0,3/16,8.31%,SIX1;FTO;TFE3
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4297011889616423,1.0105841542379166,0.4682741116751269,0.8336542966458867,1.0,7/21,20.80%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.49305005624955167,1.0105700461761047,0.4642356241234222,0.8332026386566345,1.0,2/11,14.05%,P4HB;UBQLN1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3598711818265214,1.0104236616012279,0.4808510638297872,0.833073705192258,1.0,33/88,25.43%,VPS13A;EXOC4;VPS13C;DOP1B;AP2A1;GOPC;DNM2;GOLGB1;PUM1;GBF1;MON2;LLGL1;SCFD1;STEAP2;ARF1;BLOC1S3;CLTC;SNAP23;STX4;ARRB1;SCAMP2;NAPA;SH3D19;SCAMP3;CORO7;CLTA;ARFGEF2;CLINT1;SCAMP1;CHMP2A;ACBD3;VPS35L;VAMP2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4481307376668649,1.0103215230844993,0.468586387434555,0.8328540847502548,1.0,5/18,17.72%,DDR2;EMILIN1;RUNX1;IL6;IER3IP1
prerank,regulation of microtubule-based movement (GO:0060632),0.4974689972043031,1.0099821746900695,0.4757834757834758,0.8331957233280753,1.0,2/11,4.94%,CFAP298;DYNLT2B
prerank,midbody abscission (GO:0061952),0.4438030538466155,1.0095146983812069,0.48353096179183136,0.8338806963266207,1.0,6/17,24.56%,CHMP3;MITD1;CHMP4A;CHMP4B;PDCD6IP;CHMP2A
prerank,lipid oxidation (GO:0034440),-0.38194807761255567,-1.0094908217023475,0.4160839160839161,0.7365064661904727,1.0,4/12,19.41%,PPARGC1A;ADIPOR1;ALOX12;PLA2G7
prerank,cellular protein catabolic process (GO:0044257),0.3693617779659959,1.0093777772274473,0.4810267857142857,0.8337365550415009,1.0,18/59,22.56%,FAP;TCIRG1;AP2A1;CLPP;CAPN2;CHEK2;MYLIP;LONP1;PSMA6;AP2A2;CLTC;IDE;CTSZ;UBE2G2;CLTA;CTSB;CTSK;CTSO
prerank,cellular response to osmotic stress (GO:0071470),0.4334488506757669,1.0092166790805461,0.46871008939974457,0.8336570656095167,1.0,4/21,6.66%,YBX3;LRRC8D;SLC4A11;STK39
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.45654848674576864,1.0090845184691821,0.47050938337801607,0.8334958047555703,1.0,5/16,21.66%,SRSF1;PSIP1;RBM22;NCBP2;SFSWAP
prerank,cellular response to ketone (GO:1901655),-0.29406254543803023,-1.0087441968964181,0.3855421686746988,0.7366044174847644,1.0,4/35,4.23%,ADCY5;ROCK2;ADCY1;AHR
prerank,cellular response to leucine (GO:0071233),0.4976153913718082,1.0087014947864916,0.4569343065693431,0.8334626465607513,1.0,5/10,23.01%,SESN3;SESN2;KLHL22;UBR2;RPTOR
prerank,response to leucine (GO:0043201),0.4976153913718082,1.0087014947864916,0.4569343065693431,0.8334626465607513,1.0,5/10,23.01%,SESN3;SESN2;KLHL22;UBR2;RPTOR
prerank,regulation of ATP biosynthetic process (GO:2001169),0.44887361504326284,1.008660700537679,0.46987951807228917,0.8330913916239344,1.0,8/16,28.37%,PID1;VCP;PARP1;FLCN;IL4;PINK1;DNAJC30;SPHK2
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3808082400143927,-1.0084238219542547,0.41947565543071164,0.735754235814979,1.0,8/14,12.44%,ADGRV1;WNT5A;DGKD;DGKG;GPD1L;FLT4;ADRA1A;CD40
prerank,negative regulation of transport (GO:0051051),-0.2682195401250059,-1.0078414163393796,0.46153846153846156,0.7355686478368855,1.0,16/51,18.91%,MCTP1;NR1H3;CTTNBP2NL;BST2;DYSF;PACSIN3;NDFIP2;YRDC;PRKD1;SNCA;SIRPA;CRYAB;ERBB3;SYT11;PXK;RACK1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.35971755643360825,1.0076590533585323,0.47690655209452204,0.8351823638619205,1.0,24/83,21.05%,ACVR1B;ACVR1;BRD4;E2F3;GSPT1;CDC6;CUL4A;PHF8;RCC1;CUL1;KHDRBS1;CDC45;INHBA;CCNE2;TFDP1;LATS2;CDC25A;CDT1;E2F1;DBF4;CDK2;CDK5;MAX;BCAT1
prerank,peptidyl-proline modification (GO:0018208),0.4218234491236231,1.0074654431769106,0.4817610062893082,0.8352105675211192,1.0,12/25,30.69%,FKBP5;FKBP10;P3H2;PPIL3;NKTR;NTMT1;FKBP4;PPIG;FKBP1B;PPID;PPIC;PPIH
prerank,DNA recombination (GO:0006310),0.3978743605114441,1.0074522703193731,0.477803738317757,0.8347550511978025,1.0,18/37,31.98%,HMGB1;WRN;RAD50;LIG4;SUPV3L1;TSN;RAD51;XRCC3;RECQL5;FBH1;RTEL1;RPAIN;IGHMBP2;RAD52;RHNO1;MSH2;BLM;ERCC1
prerank,membrane lipid biosynthetic process (GO:0046467),0.375610532099519,1.0074382752498676,0.5005574136008919,0.8343058459968175,1.0,7/58,8.59%,ST3GAL4;ACER3;PLPP3;KDSR;ELOVL5;PLPP1;ST3GAL2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.32934047968355185,-1.007281376694433,0.42272727272727273,0.7352674501412205,1.0,2/23,3.43%,ATP1A2;CACNA2D1
prerank,ncRNA transcription (GO:0098781),0.46785056066343256,1.0072112745014346,0.4506849315068493,0.8343957666147627,1.0,10/13,36.12%,USPL1;POLR1G;CAVIN1;GTF3C1;GTF3A;NIFK;RPAP2;SIRT7;BRF1;SNAPC3
prerank,presynapse assembly (GO:0099054),-0.35835940999984023,-1.006745554255359,0.43356643356643354,0.7349281247820165,1.0,4/16,4.80%,IL1RAPL1;WNT5A;PTPRD;BSN
prerank,dendrite morphogenesis (GO:0048813),0.40287783291776935,1.0065276729745767,0.4782608695652174,0.8356407170211235,1.0,10/35,13.47%,CTNND2;FARP1;EPHB2;ARC;DVL1;EPHB3;DLG4;TMEM106B;SHANK1;MEF2A
prerank,regulation of kinase activity (GO:0043549),0.3587256640208267,1.0063778548099682,0.48261327713382507,0.8355317693423927,1.0,18/89,12.33%,EGFR;PLCE1;DDR2;NTRK3;NTRK1;LDB2;LDB1;EPHB2;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;LMO4;DDR1;SOD1;RAD50
prerank,regulation of keratinocyte migration (GO:0051547),0.48268269547761145,1.0063720726585408,0.47191011235955055,0.8350641171813187,1.0,2/12,11.50%,ADAM9;IQSEC1
prerank,negative regulation of lyase activity (GO:0051350),-0.35930125493158854,-1.006261102974321,0.43873517786561267,0.7344465965799467,1.0,2/16,1.93%,GRM3;ADGRV1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.3574938630879557,-1.0060614318567018,0.4314516129032258,0.7332362582079414,1.0,6/17,14.89%,SLC7A5;SYK;PRKCQ;HAVCR2;LGALS9;PRKCZ
prerank,regulation of execution phase of apoptosis (GO:1900117),0.48195022505832985,1.0059745627174126,0.4643356643356643,0.8355535264606375,1.0,4/11,15.39%,PTGIS;FAP;CIDEA;SIRT2
prerank,protein localization to phagophore assembly site (GO:0034497),0.49116279702301463,1.0059555629993804,0.49372384937238495,0.8351186715936866,1.0,5/11,29.79%,PACS2;WIPI2;ATG9A;ATG13;STX17
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.4646716596310333,1.005451495910714,0.49039692701664533,0.8359196201298514,1.0,3/14,12.60%,WNT9A;SOX9;TGFBR1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4258712132154436,1.0054149016145946,0.47022332506203474,0.8355236190610773,1.0,6/23,22.48%,PKHD1;MISP;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.342269238304164,1.0049454921141647,0.49747729566094856,0.8361778750267103,1.0,42/186,16.37%,LRP6;TRABD2B;LRP1;TCF7L2;SFRP4;GRB10;PRICKLE1;NXN;DKK3;PSMD7;TLE2;WWTR1;PTPRU;TLE6;PSMA8;DACT1;DVL1;SOX9;NOG;DACT3;TSKU;NFATC1;TLE3;PSMA4;TPBG;AXIN1;INVS;PSMD12;HDAC1;PSMA6;LIMD1;DAB2;FUZ;WIF1;PSMD1;PSMC5;LATS2;PSMD11;MLLT3;NPHP3;PSMC4;PSMD14
prerank,sterol homeostasis (GO:0055092),0.370640654742937,1.0045906484621665,0.4758324382384533,0.8365979662053495,1.0,12/65,13.70%,EHD1;LRP5;LIMA1;HDAC9;SOAT1;LAMTOR1;TSKU;AKR1C1;RORA;NPC1;RALY;ABCA1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3417527304033646,1.0045057684205771,0.4847870182555781,0.8363355591269885,1.0,34/199,12.27%,EGFR;SRSF6;GAS6;ZNF423;NFIB;NPR3;SMAD6;DOCK7;LDLRAD4;HDAC9;SPRED2;PARP3;TRPV3;LRPAP1;ATF4;ACTN3;FOXC2;ACOT11;PFN2;SOX9;RPS6KA4;PGAM5;TFE3;TLE3;BMP4;FOXA1;IP6K1;PCTP;RAB11FIP5;ABHD6;SMAD7;SRF;HEY1;CIDEA
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.4570193659801851,1.0042452122992047,0.4582743988684583,0.8364909256379068,1.0,8/14,32.30%,FUS;WDR48;MMS19;PARP1;ACTR2;WAS;TIMELESS;ERCC6
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4326059605293954,1.0042114538157467,0.48010610079575594,0.8360957360321719,1.0,10/20,30.57%,OGT;RIPK3;STUB1;ASAH1;PDCD6IP;BIRC3;CYLD;RIPK1;HSP90AA1;SPATA2
prerank,lipoprotein biosynthetic process (GO:0042158),-0.3889792266801211,-1.0040378343690355,0.4153846153846154,0.7366705939086703,1.0,1/11,1.38%,APOE
prerank,GPI anchor metabolic process (GO:0006505),0.4114484492475931,1.0040086317244354,0.4833948339483395,0.8361116825278818,1.0,12/26,32.30%,PIGW;PIGF;PIGL;PGAP2;DPM3;PIGV;PGAP1;PIGQ;PIGB;PIGN;PIGC;PIGO
prerank,regulation of oxidoreductase activity (GO:0051341),0.4720556565952969,1.0039249809033153,0.47875354107648727,0.8358358280008229,1.0,3/13,15.81%,ECSIT;ABL1;HDAC6
prerank,cell cycle G1/S phase transition (GO:0044843),0.3702588814682854,1.0034811965480055,0.4943946188340807,0.8364735208408584,1.0,18/61,21.05%,ACVR1B;ACVR1;E2F3;GSPT1;CUL4A;PHF8;RCC1;CUL1;KHDRBS1;INHBA;CCNE2;LATS2;CDC25A;E2F1;DBF4;CDK2;MAX;BCAT1
prerank,negative regulation of hydrolase activity (GO:0051346),0.38176819903693965,1.0034052115981598,0.4793296089385475,0.8361657105071362,1.0,11/49,13.92%,SLC39A14;RDX;KLRK1;BCAS3;CST3;ZCCHC9;URI1;RCC2;CHP1;ARL2;WNK1
prerank,respiratory electron transport chain (GO:0022904),0.4664958869798842,1.0029569918420973,0.4884979702300406,0.8368293774873959,1.0,4/14,10.19%,ETFRF1;ETFDH;ETFA;ETFB
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4066761368013505,1.002861479238271,0.474390243902439,0.8365754777487683,1.0,14/32,30.23%,MAPK15;NEK7;ATM;TNKS2;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;PNKP;CCT5;ATR;CTNNB1
prerank,protein localization to synapse (GO:0035418),0.4704215469734071,1.0026161683992951,0.4837340876944837,0.8367145602466266,1.0,5/12,13.02%,DLG4;MPP4;NRXN2;SHANK1;NLGN1
prerank,regulation of interleukin-6 production (GO:0032675),0.35290185947022773,1.002071905600235,0.5025960539979232,0.8375641489989192,1.0,15/96,15.26%,GAS6;LBP;IL33;TWIST1;RAB7B;STAT3;MAVS;HMGB1;IRAK3;C1QTNF4;HSPD1;F2R;SETD4;IL6;ARRB1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.3145626991346997,-1.0012073194290845,0.4793814432989691,0.7421733995880688,1.0,12/25,25.72%,DNM1L;PDCD5;FAM162A;BCL2L11;MFF;GPER1;PYCARD;BIK;PPIF;BNIP3;HRK;PMAIP1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4484168211673035,1.0011685197036448,0.4888304862023653,0.8393890839666511,1.0,7/16,24.51%,ACTN3;VCP;SHMT2;MLXIPL;ABCD1;COX7A2L;PINK1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.30719655333187224,-1.0009100291291704,0.45263157894736844,0.7412869470741593,1.0,7/27,10.31%,PLTP;APOE;PTCH1;NR1H3;ABCA5;CAV1;EEPD1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.39002153880887813,1.0008764383315862,0.5011682242990654,0.839608485361748,1.0,7/39,13.17%,EGFR;PTPN3;RNF115;CBL;PTPN18;PTPN2;STAM2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.4567309940096621,1.0007681225881575,0.4691689008042895,0.8394158835224618,1.0,9/15,30.32%,SEC61A1;RAB3GAP1;SPCS2;ZFAND2B;RAB3GAP2;SPCS1;SRPRA;ZFAND2A;SRP14
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3972464106387261,1.0007002129210256,0.4673913043478261,0.8391117884300326,1.0,12/33,21.75%,SYMPK;MAZ;PABPN1;CLP1;CPSF4;PCF11;NCBP1;CPSF7;NCBP2;CSTF2;CSTF2T;SNRPB
prerank,positive regulation of cellular process (GO:0048522),0.3332563469187771,1.0006727337831094,0.497,0.8386963913250315,1.0,115/565,18.73%,THBS1;PGF;EGFR;LRP6;IRS1;ZFHX3;PRKCD;VEGFA;GAS6;LRP1;LBP;FGF2;P4HB;TIAM1;ACER3;NTRK3;PROK2;FGF17;PRR7;GAB2;LRP5;MAPK15;TGFB3;SHC1;HDAC4;PKHD1;LMNA;WWTR1;HES5;CSNK2A1;TGFB2;TCIRG1;DYNC1H1;PRKCA;DNAJA2;EIF4G2;TNFRSF1B;FXN;FAM98A;ADAM10;IL12RB2;TGFBR2;FZD7;MMP14;FGFR1;MEIS3;CXCL16;SOX9;CAPN10;RARA;S100B;PA2G4;TFE3;AKT2;FCER1G;CDC6;TRPM4;EDN3;MAPK8;BMP4;FGFR2;ITGAV;CDC25B;TBRG4;PLA2G5;CDC123;FAM98B;VIP;FOXM1;CTF1;CHTOP;ATM;MAZ;PHIP;SRF;TGFBR1;HDAC1;NCMAP;EIF4G1;F2R;KMT2D;ACACA;NACC1;SUPV3L1;LMAN2;COLEC12;BMP5;CLCF1;PRDX3;CSPP1;STX4;IL6;EXOSC4;SIRT2;SLC35F6;CNOT8;KLHL22;ERBB2;SMC5;FGF5;NCBP1;SSR1;FLCN;GAREM1;UFL1;PRLR;TRIM13;HDGFL2;CITED2;KIF20B;HCFC1;BIRC5;AKT1;OSMR;GDNF
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.47613332373122547,1.0003092461018783,0.48514851485148514,0.839093313667761,1.0,5/12,24.63%,PRKDC;SDE2;CDK2;TP53;RPS27L
prerank,protein oxidation (GO:0018158),0.48547000585732014,1.000157506101404,0.4793741109530583,0.8390027264105351,1.0,4/11,22.19%,LOXL1;LOX;PRDX3;LOXL2
prerank,macrophage differentiation (GO:0030225),0.4729998563889719,1.0001066732343666,0.46657381615598886,0.8386569114573735,1.0,3/13,16.21%,VEGFA;BMP4;PARP1
prerank,regulation of microtubule depolymerization (GO:0031114),0.41260341368400366,1.0000206553900446,0.4560099132589839,0.8383865121578566,1.0,2/25,1.27%,FGF13;MAP1B
prerank,acute-phase response (GO:0006953),0.47857244680528,0.9992169780636663,0.49135446685878964,0.8399386220861096,1.0,1/12,1.05%,LBP
prerank,embryonic axis specification (GO:0000578),0.45923239234072943,0.9991800725621425,0.4943019943019943,0.8395417725283911,1.0,3/15,8.13%,SMAD6;COBL;FZD5
prerank,ceramide biosynthetic process (GO:0046513),-0.2847910689944112,-0.9991090579433387,0.5,0.7443153581773088,1.0,6/40,5.41%,ST6GALNAC3;CERS4;SGMS1;ST8SIA4;DEGS2;ST8SIA6
prerank,regulation of lymphocyte migration (GO:2000401),0.49884579728740597,0.9989685118493081,0.481962481962482,0.839633313845618,1.0,4/10,23.25%,SPN;MIA3;AKT1;SLC8B1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4803210068319259,0.9985891688503453,0.48535564853556484,0.8400853934083279,1.0,3/12,20.23%,NIN;PCM1;DCTN1
prerank,negative regulation of ossification (GO:0030279),-0.3209356144933181,-0.9982698209743912,0.4423076923076923,0.7447386703330519,1.0,5/23,7.38%,ENPP1;NOTCH1;SRGN;BCOR;RBPJ
prerank,regulation of establishment of cell polarity (GO:2000114),-0.3562646075243324,-0.9979181223857716,0.4290909090909091,0.7440464088496733,1.0,3/16,1.91%,ROCK2;CDH5;RIPOR2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.35860380956608795,-0.9977433166487106,0.45934959349593496,0.7427971106396247,1.0,2/16,0.76%,AUTS2;ARHGAP24
prerank,positive regulation by host of viral transcription (GO:0043923),-0.36564815626704017,-0.9975456303653062,0.45849802371541504,0.7416283749013424,1.0,1/15,0.50%,LEF1
prerank,proton transmembrane transport (GO:1902600),-0.29344267478644087,-0.9972369910638751,0.45098039215686275,0.7408184823582987,1.0,1/36,0.01%,ATP1A2
prerank,hyaluronan catabolic process (GO:0030214),0.43558996152921714,0.9970498469295447,0.48634590377113135,0.843341682270092,1.0,4/18,13.27%,FGF2;SLC9A1;CHP1;HEXA
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4274026289360093,0.9968980368062671,0.5,0.8432473925797314,1.0,14/23,33.90%,MTMR11;SYNJ1;INPP5B;MTMR10;PIP4P2;OCRL;MTMR1;SYNJ2;MTM1;SACM1L;MTMR2;MTMR12;MTMR9;MTMR4
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.28933769019389444,-0.9968354927523072,0.47368421052631576,0.740227066673694,1.0,8/33,10.48%,TGFA;AFAP1L2;CCDC88A;DGKD;HIP1R;ADRA2A;HBEGF;SHKBP1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.39880478766707167,0.9964528504541595,0.47165259348612787,0.8438862853387342,1.0,4/34,4.72%,PGF;VEGFA;GAS1;RAMP2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.26452946684489165,-0.9963470506742776,0.45054945054945056,0.7397420902850032,1.0,19/55,19.03%,BCL2;BCL2L1;WWOX;TPD52L1;DNM1L;FAS;TNFSF12;NUPR1;BOK;CAV1;BCL2L11;STYXL1;TRAF7;GPER1;HYAL2;PML;PYCARD;RACK1;RPS3
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3753947016978832,0.995919786243654,0.4960091220068415,0.8447315206042025,1.0,18/50,27.29%,PSMD7;PSMA8;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;AZIN1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;PSMC1;PSMA1
prerank,error-prone translesion synthesis (GO:0042276),0.4291456078860225,0.9958735928587539,0.4880952380952381,0.8443674538133249,1.0,7/21,23.62%,REV3L;POLE2;UBC;RPS27A;REV1;MAD2L2;PRIMPOL
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3556904131881149,0.9958661717843876,0.5091496232508074,0.8439020787826396,1.0,13/85,13.61%,PIEZO2;COL11A1;COL1A1;LRTOMT;LHFPL5;CDC14A;CHRNB2;TIMM9;ROR1;SLC26A4;SOD1;LRP2;GSDME
prerank,microvillus assembly (GO:0030033),-0.3565725322159176,-0.9956450534735762,0.43283582089552236,0.7397366360407093,1.0,3/14,2.55%,MAP4K4;TNIK;RAPGEF2
prerank,negative regulation of T cell proliferation (GO:0042130),0.40257084867148674,0.9956318534757645,0.47368421052631576,0.8440330929437964,1.0,5/28,13.12%,SPN;GLMN;CRTAM;VTCN1;CD80
prerank,positive regulation of protein binding (GO:0032092),0.3697473399672211,0.9955015256067181,0.49284928492849284,0.8438788974163124,1.0,11/56,13.72%,PKD1;LRP1;TCF7L2;TIAM1;DACT1;BMP4;ABL1;NVL;TERT;ADD1;USP33
prerank,neutrophil degranulation (GO:0043312),0.33269060265539907,0.9954171336076868,0.534,0.8436148656963002,1.0,122/425,28.48%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;COPB1;RAB24;DYNC1H1;UBR4;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;LAMTOR1;ATP6V0A1;ADAM10;HMGB1;ARSA;QSOX1;PTGES2;CREG1;CKAP4;FAF2;RNASE3;B4GALT1;JUP;HUWE1;GDI2;PA2G4;CYFIP1;FCER1G;CST3;RHOA;ATP8A1;ITGAV;COMMD9;PLAC8;GHDC;GLIPR1;RAB3D;PSMD12;CAP1;AMPD3;AP2A2;PAFAH1B2;DERA;TOM1;FRK;SNAP23;MLEC;PSMD1;CAT;RAB4B;IQGAP1;NAPRT;PSMD11;STOM;PSMD14;ACP3;ORMDL3;ACTR1B;GLB1;RAB5B;IST1;AOC1;ACTR10;CTSZ;PTAFR;ASAH1;XRCC6;HVCN1;DOK3;SLC27A2;LAIR1;LAMP1;CCT8;CTSB;PSMB1;LAMP2;RAB18;SLC11A1;MAGT1;VNN1;PSMA5;MAN2B1;PYGL;BST1;NRAS;SCAMP1;ROCK1;CDK13;GNS;KCMF1;S100A11;TUBB4B;VPS35L;VAMP2;GUSB;LAMTOR2;ACTR2;CYSTM1;CAND1;CAPN1;PLAUR;LAMTOR3;NPC2;SURF4;CANT1;QPCT;ABCA13;MANBA;ACLY;RAB3A
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.41335953839909423,0.9953771103820196,0.4731585518102372,0.8432321628424851,1.0,9/25,29.94%,SF3B1;SRRM1;WDR83;SRSF10;TRA2B;GEMIN2;SRSF4;SF3B4;KHSRP
prerank,peptidyl-lysine acetylation (GO:0018394),0.4911682530813237,0.9953550428901442,0.49056603773584906,0.8428121370798061,1.0,5/10,26.59%,KAT2A;CREBBP;KAT7;KAT2B;ESCO1
prerank,protein K63-linked ubiquitination (GO:0070534),0.38548808637556664,0.9947257435435204,0.4994152046783626,0.843881690448066,1.0,19/41,30.07%,NEDD4;UBE2B;RNF115;TRIM27;WWP2;ITCH;TRAF3;STUB1;UBE2V2;TRAF3IP2;HECTD1;RNF4;ZFP91;RNF126;UBE2V1;RNF135;TRAF5;PRKN;UBE2S
prerank,positive regulation of cell migration (GO:0030335),0.33484227351146123,0.9943140000289913,0.5171026156941649,0.8444068530757027,1.0,28/253,7.68%,THBS1;MYOC;EGFR;VEGFA;F3;DDR2;ADAM9;COL1A1;TWIST2;TIAM1;NTRK3;DRD1;PRKCE;RDX;ACVR1B;EPHB2;TGFB2;STAT3;SEMA3E;PRKCA;ACVR1;ADAM10;MMP14;DOCK5;SEMA4B;CXCL16;ELP5;SOX9
prerank,phosphorylation (GO:0016310),0.33189539268203705,0.9940662695034533,0.532,0.8445083735427937,1.0,145/385,27.51%,DCLK1;PRKCD;GAS6;NTRK1;MARK1;PRKCE;ACVR1B;EPHB2;CLK3;CSNK1D;CAMK2D;MAP3K5;NADK;STRADA;TNK1;CSNK2A1;TGFB2;STAT3;LIMK2;MORC3;SHPK;FASTK;PRKCA;NRBP2;ACVR1;ILK;NEK7;PRKDC;ERN2;ADAM10;TGFBR2;TLK1;STK39;BCR;FGFR1;IRAK3;CDK10;RPS6KA4;RARA;PAK4;DGKQ;CDK12;GMFB;PKN2;PAK2;ILF3;MAPK8;CDC25B;CHUK;TNNI3K;ABL1;IRAK1;MAP4K5;MAP3K12;ATM;BMPR1A;CHEK2;PDPK1;GRK6;NRBP1;PIK3CB;CSNK1E;TGFBR1;STK25;STK19;PICK1;DMPK;MARK4;WNK1;LIMD1;FRK;SRPK1;TBCK;BRD2;LATS2;CAMK4;CDC42BPB;TLK2;CREB1;COQ8B;ERBB2;TP53RK;HASPIN;PGK1;MKNK2;BIRC6;SIK2;PRKAG1;DAPK3;BCKDK;VRK2;CLK2;BIRC5;CDK20;MAST2;CDKL2;AKT1;HIPK2;CDK2;IKBKE;CDK5;PRKAB1;EIF2AK4;SGK3;MAPK9;GRK4;PRKACA;NEK4;LRRK2;PANK3;JAK1;CAMK1;CDKL3;STK38;EIF2AK3;PRKCI;TOP1;FAM20A;PLK4;TAOK3;TAF1;CSK;TBK1;ROCK1;PINK1;LMTK2;CDK13;TAOK2;TYK2;STK3;STK24;TKFC;PRRT1;TAOK1;NIM1K;WNT11;SGK1;ERN1;CCL2;NEK6;MAP3K11;MEX3B;PNKP;CSNK1A1;PI4KA
prerank,L-amino acid transport (GO:0015807),0.4112398856367276,0.993674516605709,0.4817073170731707,0.8450100998651959,1.0,1/28,0.09%,SLC38A2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4295449895134973,0.9936397264292625,0.4968394437420986,0.8446222858730973,1.0,6/21,20.10%,SAMD4A;CNOT8;TUT7;CNOT10;CNOT9;TNKS1BP1
prerank,detection of calcium ion (GO:0005513),0.4737913581487253,0.9936236397575269,0.49719101123595505,0.8441927880560264,1.0,4/13,16.85%,CALM2;KCNIP2;STIM1;CALM3
prerank,regulation of lymphocyte activation (GO:0051249),0.47420147482200525,0.9936142742026831,0.48717948717948717,0.8437401996839599,1.0,3/12,12.33%,IKZF3;CRTAM;KAT2A
prerank,cellular protein modification process (GO:0006464),0.32845998267179227,0.9932243951136897,0.547,0.8442429114668966,1.0,213/983,18.69%,PLOD2;THBS1;DCLK1;ST3GAL4;ST8SIA2;IGFBP5;CHRDL1;PRKCD;FSTL1;GAS6;COL3A1;GPC3;P4HB;NTRK1;MARK1;PRKCE;PTPN3;FBXO10;PPP1CC;LOXL1;DMP1;ACVR1B;TGM5;TGM6;FBXL7;PSMD7;CLK3;CSNK1D;PARP3;CAMK2D;RAB2A;FBXW8;CEL;MAP3K5;STRADA;PTPRS;PTPRF;PTP4A2;DUSP11;TNK1;PTPRU;CSNK2A1;COP1;TGFB2;DCAF6;LIMK2;MORC3;GGCX;P3H1;FASTK;PRKCA;PSMA8;NRBP2;ACVR1;B3GNT7;PRKCSH;ILK;ERCC8;NEK7;GPAA1;PRKDC;PPM1H;ERN2;ADAM10;TGFBR2;SIRT5;TLK1;STK39;BCR;RAB8A;LOX;QSOX1;FGFR1;IRAK3;CKAP4;WIPI2;CDK10;ARF4;RPS6KA4;GPS1;MBTPS1;NAGPA;RARA;SOCS6;PAK4;PMM2;SOCS2;AKT2;ST3GAL2;CST3;WWP2;PPM1M;B4GALT5;DAPP1;CDK12;PTPN18;GMFB;PPP3CC;PKN2;PAK2;ILF3;CALU;MAPK8;PSMA4;ANXA1;BMP4;CDC25B;CUL4A;NPC1;CHUK;TNNI3K;RIPK3;UCHL3;RAB38;RCN1;FBXL4;ABL1;IRAK1;MAP4K5;MAP3K12;LCMT1;FUT4;ATM;BMPR1A;CHEK2;FBXO22;FBXL12;PDPK1;GRK6;ATG3;PSMD12;NRBP1;WDR5;TULP4;CUL1;CSNK1E;TGFBR1;FBXL19;PSMA6;PPEF2;STK25;RBBP7;B3GNT9;RAB11B;STK19;PICK1;DMPK;MARK4;NUCB1;WNK1;DCAF13;TNKS2;FRK;SRPK1;FBXL14;TBCK;ATE1;BRD2;PSMD1;MIA3;NGLY1;DDA1;UBE2L6;IL6;FBXO17;SIRT2;FBXL20;PSMC5;LATS2;CAMK4;CDC42BPB;TLK2;PSMD11;KLHL22;CREB1;COQ8B;PPP2R5C;B3GNT6;PARP1;ILKAP;ERBB2;TP53RK;PSMC4;PSMD14;VCAN;LIPT1;HASPIN;STT3A;MKNK2;GNMT;BIRC6;NTAQ1;UFL1;SIK2;ALG1;MEN1;PRKAG1;CHST5;DAPK3;ARAF;FBXL18;BCKDK;SUMF2;SENP8;VRK2;CLK2;BIRC5;RNF7;CDK20;MAST2;CDKL2;FBXW2;AKT1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.28136960090236046,-0.9930173922788407,0.4315068493150685,0.7446583735899097,1.0,5/41,5.23%,TJP1;PODXL;GCNT2;BMP7;PIEZO1
prerank,cardiac cell development (GO:0055006),0.4865693975911966,0.9929346537207248,0.49426934097421205,0.8444591178974074,1.0,3/11,9.62%,VEGFA;JAG1;ALPK3
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.40185476942708503,-0.9927791211826269,0.4882943143812709,0.7435660215578384,1.0,2/10,2.55%,ZEB2;RAPGEF2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.3970985864843888,-0.9927343493488575,0.453416149068323,0.7420803182888378,1.0,3/10,10.27%,CACNB2;CACNA2D1;PDE4B
prerank,regulation of establishment of protein localization (GO:0070201),0.47114988697317395,0.9926651431803013,0.511049723756906,0.8446319341408701,1.0,5/13,24.21%,SCFD1;SPIDR;GAPVD1;DNAJA1;PTP4A3
prerank,protein N-linked glycosylation (GO:0006487),0.3581507330968464,0.9922076418051224,0.5076754385964912,0.8452548246229311,1.0,23/66,25.47%,PGM3;GFPT1;B4GALT1;GFPT2;PMM2;MGAT4B;UGGT2;ALG13;FUT8;DOLPP1;UGGT1;TMEM165;STT3A;ALG1;ALG3;DPM3;LMAN1;ALG14;MAGT1;B4GALT7;ENTPD5;ALG12;MGAT5
prerank,protein-DNA complex disassembly (GO:0032986),0.45099557386301287,0.9921807679768239,0.4712950600801068,0.844851046909866,1.0,7/16,29.70%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,negative regulation of viral transcription (GO:0032897),0.4667778424668345,0.9921613196331647,0.49538866930171277,0.844419752296054,1.0,6/13,19.46%,TRIM27;UBP1;MID2;HEXIM1;TRIM13;LARP7
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.38047048740563416,-0.9920755845307436,0.4631578947368421,0.7421992265145254,1.0,5/13,16.01%,CNOT1;PRR5L;ZC3H12A;ZC3HAV1;GTPBP1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4113049043694922,-0.9918963723268117,0.4524590163934426,0.7409858301574338,1.0,3/11,12.41%,NOS3;GCH1;SPR
prerank,regulation of neuron projection arborization (GO:0150011),-0.3656757456156665,-0.9915951070731298,0.5150375939849624,0.7400866283043824,1.0,5/15,9.28%,WNT5A;GRIP1;NTNG1;MACF1;MFSD2A
prerank,regulation of transport (GO:0051049),-0.28189420637176554,-0.9914775270662859,0.43312101910828027,0.7387611897569528,1.0,4/36,2.87%,LEPR;EPB41;ICA1;MYO6
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.42770692936143584,0.9913857002032538,0.47685834502103785,0.8458663748781488,1.0,4/16,11.27%,ZFPM2;FGF2;FGFR2;BMPR1A
prerank,protein tetramerization (GO:0051262),0.3613762291580275,0.9910589822606863,0.5044150110375276,0.8461658776469665,1.0,16/67,19.90%,KCNJ2;PKD1;CRYZ;TRPM4;CBR4;ACACA;PKD2L1;SHMT2;GNMT;ACOT13;HSD17B8;CPSF7;CPSF6;SHMT1;TK1;APPL2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.31526754731577544,-0.9909782085739307,0.46938775510204084,0.7383840540990635,1.0,5/24,10.40%,ITPR1;RYR2;ITPR3;HTR2C;ITPR2
prerank,microvillus organization (GO:0032528),-0.36751362552132844,-0.990484908501705,0.4548872180451128,0.7379511580599799,1.0,3/13,2.55%,MAP4K4;TNIK;RAPGEF2
prerank,translational termination (GO:0006415),0.3497050582995259,0.9898512441636078,0.4968220338983051,0.8486849464859295,1.0,30/95,28.45%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;GSPT1;MRPS18B;MTRF1L;MRPL39;ABCE1;MRPS14;MRPL35;ETF1;MRPS17;MRPL45;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;TRMT112;MRPL30;MRPL4;MRPL11
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.45262234121924483,0.9898116757461807,0.49162011173184356,0.8482932156850795,1.0,3/15,7.40%,ADAM9;EHD1;EHD2
prerank,negative regulation of TOR signaling (GO:0032007),0.38666948685366476,0.9898053776820158,0.48936170212765956,0.847831077810453,1.0,14/36,23.76%,NPRL3;SESN3;CASTOR2;AKT1S1;ATM;DEPTOR;SESN2;TMEM127;MINAR1;FLCN;UBR2;KPTN;TSC2;NPRL2
prerank,signal transduction in response to DNA damage (GO:0042770),0.3752110662769121,0.9897467592309687,0.5057077625570776,0.8475116268802003,1.0,24/49,30.65%,MDM4;NDRG1;TIPRL;RAD1;ABL1;ATM;CHEK2;SESN2;CEP63;ATRIP;HUS1;E2F1;BID;USP10;MAD2L2;TRIAP1;DONSON;TP53;ATR;GRB2;INTS7;RAD17;RHNO1;HINFP
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.2883619580205407,-0.9895459346318531,0.4444444444444444,0.7386942896753685,1.0,3/34,1.46%,LYN;MFHAS1;LGR4
prerank,neutrophil mediated immunity (GO:0002446),0.3304350107879341,0.989469648580868,0.557,0.847716874009966,1.0,109/432,25.63%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;COPB1;RAB24;DYNC1H1;UBR4;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;LAMTOR1;ATP6V0A1;ADAM10;HMGB1;ARSA;QSOX1;PTGES2;CREG1;CKAP4;FAF2;RNASE3;B4GALT1;JUP;HUWE1;GDI2;PA2G4;CYFIP1;FCER1G;CST3;RHOA;ATP8A1;ITGAV;COMMD9;PLAC8;GHDC;GLIPR1;RAB3D;PSMD12;CAP1;AMPD3;AP2A2;PAFAH1B2;DERA;TOM1;FRK;SNAP23;MLEC;PSMD1;CAT;IL6;RAB4B;IQGAP1;NAPRT;PSMD11;STOM;PSMD14;ACP3;ORMDL3;ACTR1B;GLB1;RAB5B;IST1;AOC1;ACTR10;CTSZ;PTAFR;ASAH1;XRCC6;HVCN1;DOK3;SLC27A2;LAIR1;LAMP1;CCT8;CTSB;PSMB1;LAMP2;RAB18;SLC11A1;MAGT1;VNN1;PSMA5;MAN2B1;PYGL;BST1;NRAS;SCAMP1;ROCK1;CDK13;GNS;KCMF1;S100A11;TUBB4B;VPS35L;VAMP2;GUSB;LAMTOR2
prerank,neutrophil activation involved in immune response (GO:0002283),0.33076023722861025,0.9894061571139993,0.553,0.8474022992846133,1.0,122/428,28.48%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;COPB1;RAB24;DYNC1H1;UBR4;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;LAMTOR1;ATP6V0A1;ADAM10;HMGB1;ARSA;QSOX1;PTGES2;CREG1;CKAP4;FAF2;RNASE3;B4GALT1;JUP;HUWE1;GDI2;PA2G4;CYFIP1;FCER1G;CST3;RHOA;ATP8A1;ITGAV;COMMD9;PLAC8;GHDC;GLIPR1;RAB3D;PSMD12;CAP1;AMPD3;AP2A2;PAFAH1B2;DERA;TOM1;FRK;SNAP23;MLEC;PSMD1;CAT;RAB4B;IQGAP1;NAPRT;PSMD11;STOM;PSMD14;ACP3;ORMDL3;ACTR1B;GLB1;RAB5B;IST1;AOC1;ACTR10;CTSZ;PTAFR;ASAH1;XRCC6;HVCN1;DOK3;SLC27A2;LAIR1;LAMP1;CCT8;CTSB;PSMB1;LAMP2;RAB18;SLC11A1;MAGT1;VNN1;PSMA5;MAN2B1;PYGL;BST1;NRAS;SCAMP1;ROCK1;CDK13;GNS;KCMF1;S100A11;TUBB4B;VPS35L;VAMP2;GUSB;LAMTOR2;ACTR2;CYSTM1;CAND1;CAPN1;PLAUR;LAMTOR3;NPC2;SURF4;CANT1;QPCT;ABCA13;MANBA;ACLY;RAB3A
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.35515931553771124,0.9893465195409853,0.5080906148867314,0.8470914156029083,1.0,12/76,17.16%,ESR1;CMKLR1;PLCE1;DRD1;FPR3;GPR20;VIP;P2RY6;F2R;GNA11;GPR157;CALCA
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.47230070281995384,0.9890242553428483,0.4986111111111111,0.8474283926643875,1.0,7/12,27.67%,GNL3;CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5
prerank,cellular response to radiation (GO:0071478),0.38629949251569906,0.9889108612813067,0.5083135391923991,0.8472507188699709,1.0,19/40,31.68%,RAD1;SPIDR;SWI5;LIG4;TANK;OPN1MW;OPN1MW3;RHOB;HUS1;RAD51;TNKS1BP1;OPN3;TP53;RRH;GPR52;GRB2;INTS7;RHNO1;BLM
prerank,negative regulation of cell development (GO:0010721),-0.30996147589539647,-0.9886895284843192,0.4336734693877551,0.7391396536336545,1.0,5/25,13.95%,B2M;NOTCH1;RFLNA;RFLNB;IGF1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4122750906063385,0.9884499836770745,0.5075,0.8479111825223943,1.0,4/26,8.86%,EFNA5;LRP5;ADCY8;TRPM4
prerank,response to insulin (GO:0032868),0.35529212851485,0.9883353762211305,0.5270562770562771,0.8477167771027474,1.0,12/80,9.74%,IRS1;SLC39A14;RHOQ;HDAC9;C2CD5;MEAK7;PRKDC;RAB8A;CAPN10;AKT2;OGT;SYAP1
prerank,cardiac muscle tissue development (GO:0048738),0.3769570933711508,0.9883352440906883,0.4852941176470588,0.8472445114887626,1.0,11/50,16.74%,CACNA1G;SGCD;HCN4;SMAD4;BMP4;CSRP3;BMPR1A;HEY1;BMP5;AKAP13;KDM6B
prerank,fat cell differentiation (GO:0045444),0.36495596156271215,0.9876478919763035,0.5066964285714286,0.8484219973706313,1.0,5/57,8.56%,PID1;TCF7L2;SMAD6;BBS9;AKT2
prerank,post-translational protein modification (GO:0043687),0.3305647218215873,0.98760455255086,0.539,0.8480640766382624,1.0,113/332,29.04%,IGFBP5;CHRDL1;FSTL1;GAS6;GPC3;P4HB;FBXO10;DMP1;FBXL7;PSMD7;RAB2A;FBXW8;PTP4A2;COP1;DCAF6;PSMA8;PRKCSH;ERCC8;ADAM10;RAB8A;QSOX1;CKAP4;GPS1;MBTPS1;SOCS6;SOCS2;CST3;CALU;PSMA4;BMP4;CUL4A;UCHL3;RAB38;RCN1;FBXL4;FBXO22;FBXL12;PSMD12;WDR5;TULP4;CUL1;FBXL19;PSMA6;RBBP7;RAB11B;NUCB1;DCAF13;FBXL14;PSMD1;MIA3;DDA1;IL6;FBXO17;FBXL20;PSMC5;PSMD11;KLHL22;PSMC4;PSMD14;VCAN;STT3A;MEN1;FBXL18;SUMF2;SENP8;RNF7;FBXW2;ASB5;FBXW4;APLP2;PSMA3;DCAF11;PENK;PSMB1;PSMD4;RAB1A;COPS4;CUL9;UBA3;ASB6;RAB1B;PSMA5;FBXO11;PSMA7;VGF;COPS7A;FBXO9;ANKRD9;PSMC1;CCDC8;CUL7;COPS3;RAB5A;DCAF5;FBXW10;ESCO1;DCAF4;RABGGTB;SDC2;DCAF17;CAND1;PSMA1;SCG2;KCTD7;DDB1;STT3B;RAB3A;FBXL8;FBXO41;RBX1;BTRC;ANO8;WDTC1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4763669469917725,0.9874483210418332,0.4887323943661972,0.8479719762800051,1.0,4/11,9.70%,LRP5;TGFBR2;SOX9;FGFR2
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4589990389877518,0.9873246103755229,0.4893048128342246,0.8478057678525746,1.0,7/13,23.04%,IPO5;RGPD1;KPNA2;RANBP2;KPNA3;KPNA4;NUP35
prerank,glial cell differentiation (GO:0010001),0.4062002104238982,0.9871308559615944,0.5030674846625767,0.8478085621286765,1.0,9/28,23.13%,NFIB;HES5;STAT3;SOX9;PICK1;GPR157;CDK5;GPC1;SOX8
prerank,positive regulation of lipid localization (GO:1905954),0.47597306746829166,0.9868624624934187,0.4881450488145049,0.8479568434287653,1.0,1/11,1.02%,LRP1
prerank,regulation of protein neddylation (GO:2000434),0.48966627858790956,0.9867824273886387,0.5036496350364964,0.8476875301600355,1.0,2/10,12.60%,DCUN1D5;DCUN1D2
prerank,positive regulation of JNK cascade (GO:0046330),0.35747237545942845,0.9864114148623775,0.5032051282051282,0.8481727883699277,1.0,11/70,13.66%,RASSF2;SH3RF3;GADD45G;MAP3K5;HMGB1;FZD7;LTBR;AXIN1;CD27;TRAF3;MAP3K10
prerank,cellular response to interleukin-15 (GO:0071350),0.45864160945356414,0.9862524983432446,0.4925170068027211,0.8476342658139737,1.0,3/13,4.20%,SHC1;STAT5A;STAT3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.45864160945356414,0.9862524983432446,0.4925170068027211,0.8476342658139737,1.0,3/13,4.20%,SHC1;STAT5A;STAT3
prerank,cellular response to insulin stimulus (GO:0032869),0.3414121577163139,0.986061605661599,0.5103305785123967,0.847634939117722,1.0,26/124,16.21%,IRS1;SLC39A14;GRB10;RHOQ;ATP6V1C2;SHC1;HDAC9;TCIRG1;C2CD5;FOXC2;ATP6V0A1;PRKDC;RAB8A;CAPN10;AKT2;ZNF106;SYAP1;ATP6V0D1;PDPK1;PHIP;PTPN2;ATP6V1B2;ATP6V1E1;SOS1;IDE;PARP1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.368225462933599,0.9860578830579908,0.5112107623318386,0.8471724713248275,1.0,17/53,23.57%,PSMD7;PSMA8;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;AZIN1;BCKDK;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,regulation of viral entry into host cell (GO:0046596),0.4003590499072918,0.9859502898195232,0.4975429975429975,0.8469513251005295,1.0,5/30,13.93%,GSN;P4HB;TRIM27;MID2;TRIM26
prerank,mononuclear cell differentiation (GO:1903131),0.4209746604993822,0.9859127620546075,0.49746192893401014,0.8465613437389835,1.0,2/24,0.97%,VEGFA;GAS6
prerank,acylglycerol homeostasis (GO:0055090),-0.3330505158987378,-0.9858982592834443,0.47619047619047616,0.7442725647629016,1.0,5/20,11.93%,APOE;NR1H3;PNPLA8;SCARB1;LPL
prerank,regulation of actin filament bundle assembly (GO:0032231),0.40546223600915965,0.985481149807835,0.47718865598027127,0.8471565370913082,1.0,6/26,11.52%,ASAP3;RDX;PFN2;ALMS1;SLC9A1;SHANK1
prerank,regulation of immune response (GO:0050776),0.34228328220460674,0.9850555732179548,0.5302564102564102,0.8477065118136675,1.0,24/135,21.29%,FOXP1;COL3A1;COL1A2;COL1A1;SPN;TGFB2;CD3E;KLRK1;NPDC1;RAET1E;CRTAM;RIPK3;TRAF3;LAG3;COLEC12;N4BP1;DENND1B;ADCY7;CLEC2D;APPL2;APPL1;LAIR1;IL4;CD300LB
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.45827506962171155,0.9848087717522589,0.4798890429958391,0.8478605473043586,1.0,2/13,5.14%,GAS6;MAVS
prerank,positive regulation of histone acetylation (GO:0035066),0.41325795486627437,0.9845121873787702,0.5175,0.8481067343957248,1.0,4/23,7.76%,MUC1;SMAD4;TADA2A;RPS6KA4
prerank,TOR signaling (GO:0031929),0.40596580427616435,0.9844824583882777,0.5152671755725191,0.8477084033361095,1.0,11/26,24.51%,NPRL3;MEAK7;TIPRL;SYAP1;SMG1;FLCN;AKT1;MAPKAP1;RPTOR;RPS6KB1;PINK1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.41828736937005895,0.9837438823523931,0.5138539042821159,0.8490862911376972,1.0,1/23,0.21%,SLC4A4
prerank,regulation of primary metabolic process (GO:0080090),0.3412684364286187,0.9835047225563164,0.548918640576725,0.8491980806731178,1.0,35/126,23.75%,ID2;TNFAIP8L3;CHD9;NCOR2;PSMD7;RXRA;PSMA8;PLPP1;CARM1;PSMA4;SREBF1;PSMD12;NR1D2;PSMA6;ACACA;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;SIN3B;AZIN1;NFYA;LSS;PRKAB1;PSMA3;SC5D;GPS2;PSMB1;PSMD4;LDLR;PSMA5;PSMA7;TM6SF2
prerank,cellular response to organic cyclic compound (GO:0071407),0.33701834073715004,0.9834554253730029,0.5310907237512742,0.8488628638154349,1.0,19/141,12.31%,ESR1;EGFR;IGFBP5;DRD1;HCN4;SLC26A6;CYP1B1;PDE3A;ADCY2;ADCY8;JUP;NRIP1;IMPACT;RORA;SPIDR;URI1;P2RY6;EZR;AKAP9
prerank,regulation of actin filament-based movement (GO:1903115),-0.39538111249750024,-0.9831538333673384,0.4823943661971831,0.7496525569897184,1.0,5/10,23.28%,PDE4D;PDE4B;SCN5A;STC1;SRI
prerank,negative regulation of B cell activation (GO:0050869),0.4175463889449507,0.9830627557259954,0.5019255455712451,0.8493637485425888,1.0,4/21,13.02%,ID2;PARP3;ATM;INHBA
prerank,cellular response to growth factor stimulus (GO:0071363),0.33928581232041305,0.9830595615361372,0.534020618556701,0.8489039289669581,1.0,32/151,15.54%,EGFR;TMEM100;VEGFA;SMAD9;NTRK3;NTRK1;EHD1;ACVR1B;SHC1;GAS1;KIDINS220;PDE3A;RAMP2;ACVR1;SMAD4;TGFBR2;SOX9;ANXA1;BMP4;SYAP1;RUNX2;URI1;BMPR1A;PDPK1;SMAD7;NRP1;TGFBR1;LRP2;NDNF;HGF;SIRT2;IQGAP1
prerank,cellular response to cadmium ion (GO:0071276),0.4071160382413479,0.9828873168950428,0.5070242656449553,0.8488436833521079,1.0,9/24,27.83%,EGFR;MAPK8;CHUK;SUMO1;AKT1;MAPK9;FOS;DAXX;HSF1
prerank,positive regulation of bone resorption (GO:0045780),0.48416726294229995,0.9826546356138857,0.5205091937765205,0.8489514693391028,1.0,3/11,14.67%,PRKCA;MC4R;PLEKHM1
prerank,DNA double-strand break processing (GO:0000729),0.4346375294229391,0.982652091712847,0.5033112582781457,0.8484909926990326,1.0,10/18,31.68%,RBBP8;ATM;RAD50;UBE2V2;SMARCAD1;RNF138;SLX4;RAD52;UBE2N;BLM
prerank,epithelial structure maintenance (GO:0010669),-0.39923376107854885,-0.9826031697995673,0.4895833333333333,0.7494162942037171,1.0,2/11,5.80%,RBP4;CXADR
prerank,translational elongation (GO:0006414),0.3434285181488198,0.9822908488016798,0.5220588235294118,0.848873206158034,1.0,49/101,37.68%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;MRPS18B;MRPL39;MRPS14;EEF1G;MRPL35;LTN1;MRPS17;EEF2K;EEF1B2;MRPL45;TUFM;EEFSEC;PTCD3;MRPL12;MRPL47;GTPBP2;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;EEF1D;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2;NEMF
prerank,positive regulation of glycolytic process (GO:0045821),0.4320076941709031,0.9821445559243237,0.5098554533508541,0.8482945063183285,1.0,1/20,0.21%,SLC4A4
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.4320076941709031,0.9821445559243237,0.5098554533508541,0.8482945063183285,1.0,1/20,0.21%,SLC4A4
prerank,dendritic cell chemotaxis (GO:0002407),0.46522213565928616,0.981981049541325,0.5364511691884457,0.848210239485651,1.0,3/14,15.83%,HMGB1;TRPM4;CXCR4
prerank,prostanoid metabolic process (GO:0006692),-0.37695033135158157,-0.9818817873813231,0.4583333333333333,0.7495711349186992,1.0,5/13,16.50%,PTGS1;HPGD;GSTM1;PTGR2;CYP2S1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3964042100607815,0.9818637344720844,0.5196195005945303,0.8480339054978266,1.0,7/34,11.75%,ATP1B1;HCN4;CALM2;SLC9A1;ANK2;TNNI3K;SMAD7
prerank,regulation of acute inflammatory response (GO:0002673),0.4341774686120322,0.9815102665583498,0.48556430446194226,0.8483967927610184,1.0,4/18,20.96%,IL6;PTGES;OSMR;IL4
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.43689282353955267,0.9811877203295734,0.4810951760104302,0.8487560148557003,1.0,5/17,13.73%,CYFIP1;GMFB;ARFIP2;ARF1;PICK1
prerank,neuron projection morphogenesis (GO:0048812),0.34274159482254557,0.9811404767431707,0.5462012320328542,0.8484076324759882,1.0,24/137,13.47%,DCLK1;CTNND2;SRGAP2;MAP1B;FARP1;CTTN;ANKRD27;EPHB2;ARC;DOCK7;DNM2;DVL1;EPHB3;RAB8A;LLGL1;DLG4;S100B;IMPACT;FGFR2;TMEM106B;SHANK1;NLGN1;LRP2;MEF2A
prerank,positive regulation of cell death (GO:0010942),-0.2542837645174715,-0.9808225180178702,0.4909090909090909,0.7505516621775404,1.0,16/59,15.02%,SLC6A13;EFNB2;WNT5A;ACER2;PICALM;AXIN2;FAF1;GRIN2B;APC;PRODH;ZC3H12A;EGR1;SARM1;C1QA;SNCA;TYROBP
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4711459619865247,0.9808166603539532,0.5142045454545454,0.8487316319146654,1.0,8/12,34.21%,ACO1;IREB2;IDH3B;ACLY;IDH3G;IDH2;IDH1;GLUD1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4033946753040152,0.9807052447920745,0.504914004914005,0.8485331974082123,1.0,6/27,8.09%,AHNAK;CAMK2D;CALM2;DMD;ANK2;SELENON
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.35989240567275127,0.9803043875007115,0.5334063526834611,0.8490328807775185,1.0,22/67,23.60%,PSMD7;PSMA8;PSMA4;ITGAV;PDIA3;CHUK;PSMD12;PSMA6;SEC22B;SNAP23;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;CALR;PSMB1;PSMD4;PSMA5;PSMA7;ITGB5
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.4728262725858128,0.9800855702584511,0.5151933701657458,0.8490979700606054,1.0,6/13,28.73%,TGFBR2;RUNX1;CBFB;GLI3;SOCS1;NKAP
prerank,keratan sulfate catabolic process (GO:0042340),-0.38923055184089445,-0.9798612341586335,0.5032894736842105,0.7513283630301816,1.0,3/11,9.20%,FMOD;LUM;OGN
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.46415246687601747,0.979833347554215,0.5171428571428571,0.8492319423501232,1.0,1/13,0.51%,PLXNA4
prerank,cGMP metabolic process (GO:0046068),-0.3804889523344661,-0.9796442125971528,0.4756944444444444,0.7503543295788184,1.0,5/12,21.18%,GUCY1B1;PDE2A;NPR1;PDE9A;NPPC
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4009784670872467,0.9792082396744268,0.4920049200492005,0.8502378052486907,1.0,2/27,1.09%,GAS6;DDR2
prerank,negative regulation of DNA recombination (GO:0045910),0.3806035708682073,0.9791851332795387,0.5130023640661938,0.8498297425427446,1.0,21/43,32.74%,HELB;PARP3;RMI2;POLR2F;MAD2L2;POLR2B;DAXX;POLR2H;CGAS;ZRANB3;FBH1;RTEL1;SHLD3;SHLD1;POLR2I;POLR2L;PARPBP;MSH2;BLM;POLR2K;POLQ
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4648868335140547,0.9789812177786236,0.5105189340813464,0.8498308358067164,1.0,3/12,8.28%,HES5;JAG1;ESRRB
prerank,regulation of histone deacetylation (GO:0031063),0.45308696073782684,0.9788191059022268,0.49658002735978113,0.8497560809889235,1.0,5/13,28.37%,CAMK2D;NIPBL;AKAP8;SAP30BP;SPHK2
prerank,cellular response to oxygen levels (GO:0071453),0.4783629759340018,0.9786602603122214,0.5176470588235295,0.8496754512664517,1.0,2/10,13.73%,ATP6V0D1;PICK1
prerank,positive regulation of organelle assembly (GO:1902117),0.3777695735615587,0.9783031048505044,0.5317919075144508,0.8500733078076674,1.0,18/44,27.18%,SDC1;IL5;DYNC1H1;LRSAM1;RAB3GAP1;PIP4K2B;MARK4;G3BP2;FUZ;KCTD17;RAB3GAP2;PDCD6IP;NUP62;PLK4;ARHGAP35;CCP110;TAPT1;PIP4K2C
prerank,regulation of endocytosis (GO:0030100),0.3557864941521464,0.9778206749359513,0.5162374020156775,0.8507411729501212,1.0,18/61,22.77%,STON2;LRP1;GPC3;ARFGAP1;LRPAP1;LRSAM1;STON1;ABL1;DAB2;RAB4B;HIP1;CD151;RAB5B;RUFY2;ZFYVE16;RAB4A;RUBCN;TSC2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.47364664056011,0.9776656285680546,0.5117891816920943,0.8506450035152451,1.0,2/11,6.35%,STAT3;IL12RB2
prerank,positive regulation of catalytic activity (GO:0043085),0.38196106263778606,0.9773414558233676,0.5107142857142857,0.8509325475018383,1.0,9/37,15.15%,BCAS3;FXN;MAPK8;WRN;ABL1;CHTOP;SOD1;PSEN2;STX4
prerank,lymphocyte differentiation (GO:0030098),-0.24640034896712087,-0.9772917685563205,0.5434782608695652,0.7545183210550832,1.0,20/68,20.76%,LEPR;CHD7;KIT;VCAM1;KLF6;JAG2;RHOH;IKZF1;HHEX;PIK3CD;ITGA4;LFNG;AXL;CR2;PTPN22;DLL4;ADGRG3;TOX;SOX4;NHEJ1
prerank,regulation of DNA repair (GO:0006282),0.375064708168245,0.976796268642241,0.5104408352668214,0.851739801412533,1.0,4/44,6.12%,EGFR;EYA2;TRIM28;ERCC8
prerank,cytoskeleton organization (GO:0007010),0.3402594326735699,0.9767151579287094,0.5442247658688866,0.8514780962935972,1.0,13/114,9.02%,MICAL2;RHOBTB1;PLCE1;FMNL2;MARK1;RND3;ARC;CCL13;FGD6;BRWD1;PAK4;PALLD;RHOA
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.46626291803311265,0.9765682049265698,0.5054794520547945,0.8513526076309392,1.0,5/12,22.06%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,regulation of multicellular organism growth (GO:0040014),0.4505799002019884,0.9765271068825185,0.5020297699594046,0.8509824920007306,1.0,3/15,11.85%,GHR;STAT5A;SOD1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.39356449561054474,0.976315476197332,0.5006045949214026,0.851028217328597,1.0,13/31,32.06%,TOPORS;DCUN1D5;UBE2C;AXIN1;DCUN1D2;CDC20;RAB1A;PINK1;GOLGA2;BTRC;UBE2S;UBE2N;GORASP1
prerank,regulation of cell communication (GO:0010646),0.38705555948018305,0.9762177768528919,0.5172004744958482,0.8507879273030979,1.0,7/35,11.93%,MGLL;CAMK2D;ANK2;SOCS2;ANXA1;GRK6;NCLN
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4470183166556001,0.9758443088670481,0.5226666666666666,0.8512433175597224,1.0,5/14,27.98%,ETNK1;ETNPPL;CHKB;PCYT2;SELENOI
prerank,regulation of telomerase activity (GO:0051972),0.3730307083404955,0.9753816506023795,0.5265588914549654,0.8518278645494731,1.0,16/45,30.44%,MAPK15;NEK7;SMG6;ERCC4;NVL;ATM;MEN1;CCT4;MAP2K7;TCP1;TP53;PARP4;DKC1;PNKP;CTNNB1;HSP90AA1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4462821208331604,0.9752234182811083,0.5265251989389921,0.8517488331083203,1.0,7/16,28.67%,NAA60;NAA40;NAA16;CREBBP;KAT2B;NAA15;NAA25
prerank,regulation of lysosomal lumen pH (GO:0035751),0.45466538495252873,0.9749627621430352,0.5278551532033426,0.8518961240369133,1.0,4/12,27.88%,TMEM165;CLN3;LRRK2;CLN5
prerank,regulation of potassium ion transport (GO:0043266),0.39138720119668624,0.974508618360921,0.5042424242424243,0.8525056911911367,1.0,7/31,10.43%,FHL1;DRD1;KCNE5;ANK2;KCNIP2;DLG1;VIP
prerank,regulation of GTPase activity (GO:0043087),0.33500692652975117,0.9743843081989865,0.5587044534412956,0.8523271140558857,1.0,33/177,14.15%,PLXNA4;SGSM2;EFNA5;SRGAP2;ASAP3;ARAP1;NTRK1;RDX;VAV2;CCL13;SIPA1L1;FGD6;CCL15;KLRK1;BCAS3;SNX18;RAB3GAP1;EPHB3;S100A10;RIC1;ADAP1;RGP1;ZC3H15;SNX9;SOD1;RCC2;EVI5L;F2R;ARHGAP44;OCRL;ARL2;WNK1;NDEL1
prerank,carboxylic acid catabolic process (GO:0046395),0.46761466367037724,0.9742369575834984,0.46458923512747874,0.8522120376861807,1.0,6/12,31.48%,GNPDA1;RENBP;BCKDK;ACOT8;PON3;NAGK
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.39089448277766,0.9741642689752029,0.5164835164835165,0.8519260299169344,1.0,14/33,30.50%,PPP6R3;TERT;TELO2;RAD50;DCLRE1B;RAD51;CDK2;TNKS1BP1;ANKRD28;DKC1;RTEL1;NOP10;HSP90AA1;CTC1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.41239692972914177,0.9737023668016598,0.5138888888888888,0.8525610661304154,1.0,7/22,23.50%,FXN;NFS1;GLRX5;ISCA2;MMS19;ISCU;NUBP2
prerank,regulation of aerobic respiration (GO:1903715),0.4422625947002421,0.9736090008936577,0.5137362637362637,0.8523266003428649,1.0,8/15,27.36%,ACTN3;VCP;IDE;SHMT2;ABCD1;COX7A2L;PINK1;NOP53
prerank,axoneme assembly (GO:0035082),0.3993278255040809,0.9735685755776046,0.4926829268292683,0.8519692539618466,1.0,8/30,22.72%,CFAP206;DNAAF3;CCDC39;LRGUK;TTLL3;SPAG17;TTC12;SPAG16
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4643299428541102,0.9735454989373918,0.5123287671232877,0.8515635999059987,1.0,4/13,20.99%,GAB2;STX4;IL4;LAMP1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3406126479549708,-0.9735032921481794,0.5042735042735043,0.7625392081952643,1.0,4/18,7.69%,APOE;ABCG1;TMCC2;NSG1
prerank,response to cadmium ion (GO:0046686),0.3978893852870437,0.9731640759991739,0.5149625935162094,0.8520049448497167,1.0,9/26,27.83%,EGFR;MAPK8;CHUK;SUMO1;AKT1;MAPK9;FOS;DAXX;HSF1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.37493187194428235,0.9730734197510453,0.5179190751445086,0.8517531076450979,1.0,11/45,18.91%,EGFR;PLCE1;SHC1;SOX9;CBL;PDPK1;SOS1;IQGAP1;GAREM1;AKT1;ERBIN
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3273756748440938,-0.9727109649278141,0.488,0.7628407064160495,1.0,3/18,6.99%,PTN;ELAVL1;CNOT1
prerank,C4-dicarboxylate transport (GO:0015740),-0.3496348567865228,-0.9719443648031789,0.48727272727272725,0.7631151655680869,1.0,6/14,16.41%,SLC25A13;SLC1A1;SLC1A2;SLC25A14;SLC13A5;SLC25A30
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3158405925331953,-0.9718326261083926,0.49222797927461137,0.7618030240703322,1.0,8/21,21.04%,ITGA1;PDGFRB;CD300A;PLEK;BMP2;PTPA;PPP1R15B;PPP1R15A
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3375990323859637,0.9717891231110483,0.5648148148148148,0.854295997121001,1.0,39/132,24.46%,SLC4A4;IRS1;PRKCD;ADAM9;RDX;TWIST1;TNFRSF1B;DACT1;HMGB1;TRIM27;AKT2;ITCH;SNX9;MID2;EZR;PIK3CB;SUPV3L1;TRIM65;FOXO3;CNOT8;ORMDL3;FLCN;UFL1;VPS11;SH3D19;TRIM6;MLXIPL;ATF6;DAGLB;OPTN;LRRK2;UPF1;ABCD1;TRIM8;PFKFB4;NPRL2;ENTPD5;BAD;ROCK1
prerank,regulation of chemotaxis (GO:0050920),0.39829324650964626,0.9711642315533916,0.49516908212560384,0.8553037977900314,1.0,1/30,0.08%,THBS1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.33423413977513167,-0.9708076450190402,0.5238095238095238,0.7625766614197815,1.0,6/18,14.42%,VCAM1;JAM2;SLC39A8;CX3CR1;ITGA4;GCNT1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4548420070140921,0.9707938023548328,0.49931787175989084,0.8556728208363922,1.0,5/13,22.06%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.45469960315060665,0.9704506729584407,0.5305555555555556,0.8560201146693602,1.0,3/13,14.66%,GLRX5;ISCA2;MMS19
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.41240876460193704,0.9700414234973369,0.5133418043202033,0.8565834622616989,1.0,5/22,14.28%,DDX5;SPRED2;CDK5RAP3;ATM;HEXIM1
prerank,regulation of myelination (GO:0031641),0.4033307608683734,0.9697534209431795,0.5246305418719212,0.856830800154489,1.0,7/25,15.94%,LGI4;HES5;TMEM98;TNFRSF1B;NCMAP;SIRT2;NKX6-2
prerank,secretory granule organization (GO:0033363),0.4852515997777417,0.9693464920249496,0.5072046109510087,0.8573563699298976,1.0,4/10,13.70%,BLOC1S2;F2R;BLOC1S3;ABCA1
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3033524301355646,-0.9692852713569694,0.47533632286995514,0.7646314079281016,1.0,3/24,2.56%,AUTS2;OCLN;PIK3R1
prerank,regulation of stress fiber assembly (GO:0051492),0.3511287181230991,0.9692145435032004,0.5321701199563795,0.8572028063672793,1.0,16/74,12.60%,MYOC;ASAP3;ARAP1;TMEFF2;TGFB3;SORBS3;PPFIA1;S100A10;PFN2;ALMS1;SLC9A1;RHOA;PAK2;ABL1;NRP1;TGFBR1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3463208197916818,0.9692081597648486,0.5519412381951732,0.8567658885963474,1.0,8/87,4.61%,PRKCD;RHOBTB1;EFNA5;LRP1;RHOQ;RND3;ARHGAP17;SEMA3E
prerank,cranial nerve development (GO:0021545),-0.38112511585089504,-0.969137469193211,0.49324324324324326,0.7633967267046636,1.0,2/11,8.86%,CHD7;SALL1
prerank,glucose homeostasis (GO:0042593),0.34715277032755826,0.9689969890269244,0.5506329113924051,0.8568201456434292,1.0,10/83,8.57%,IRS1;KCNB1;TCF7L2;STAT3;ADCY8;LRRC8D;MCU;BACE2;ADIPOR2;FOXK1
prerank,cardiac muscle cell differentiation (GO:0055007),0.4141292778027169,0.9689211193681811,0.5120405576679341,0.8565358674386946,1.0,5/21,16.74%,VEGFA;ACVR1;ALPK3;AKAP13;KDM6B
prerank,pseudouridine synthesis (GO:0001522),0.4573066345798507,0.96881628785244,0.5248618784530387,0.8563235878889075,1.0,8/13,34.69%,PUS3;TRUB1;PUS1;PUS10;DKC1;NOP10;PUS7;PUS7L
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3836397349603347,0.9686447112148322,0.5272067714631197,0.8563010285151917,1.0,9/31,13.14%,ZFPM2;TGFB2;SMAD4;NOG;FGFR2;BMPR1A;SMAD7;TGFBR1;LRP2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.3341428151267746,-0.9685526971408175,0.5064377682403434,0.7632401149203523,1.0,2/18,1.64%,BCL2;BCL2L1
prerank,positive regulation of chromosome organization (GO:2001252),0.4482135761060036,0.9685316095445906,0.5445945945945946,0.8561262359813481,1.0,6/15,29.21%,GNL3;RAD50;LIG4;PPP1R10;RTEL1;DDX11
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.23706568361514962,-0.9681380595929858,0.5076923076923077,0.7626219696239005,1.0,19/86,12.97%,OCLN;APOE;APP;EVL;SEMA5A;NAV3;RB1;PROX1;CDC42EP4;BAIAP2;SYNPO2;CDC42EP3;LMOD1;PAK1;CLIP1;EDN1;PLEK;GPX1;CX3CL1
prerank,positive regulation of cellular respiration (GO:1901857),0.47423555680039303,0.9678784607194615,0.533724340175953,0.8571573736573592,1.0,5/11,24.51%,VCP;IFNLR1;IL4;ISCU;PINK1
prerank,homeostasis of number of cells (GO:0048872),0.44989436817561007,0.9672887681948199,0.509915014164306,0.8580877840670831,1.0,4/12,13.07%,CCN3;UBAP2L;LPCAT3;F2R
prerank,phospholipid homeostasis (GO:0055091),0.4626554482685294,0.9671040132790782,0.5131034482758621,0.8580749280977156,1.0,5/11,26.42%,TLCD2;ABCA1;TLCD1;RCN3;ANGPTL3
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.36934317626589347,0.966916296424473,0.5285388127853882,0.8580615564050886,1.0,12/43,16.80%,DDR2;LRP5;WWTR1;ACVR1;BMP4;TMEM119;RUNX2;BMPR1A;NELL1;HGF;IL6;CCN4
prerank,mitotic cell cycle phase transition (GO:0044772),0.32692879443410255,0.9668725015320894,0.5835866261398176,0.8576989901764667,1.0,66/203,25.58%,ACVR1B;FBXL7;CSNK1D;PPP1R12B;CDC16;DYNC1H1;SFI1;DNM2;ACVR1;ODF2;ALMS1;E2F3;GSPT1;DCTN2;CDC25B;CUL4A;SPAST;CKAP5;FOXM1;PHF8;UBE2C;RCC1;LCMT1;CHEK2;FBXL12;SDCCAG8;AKAP9;CUL1;CEP164;KHDRBS1;CSNK1E;INHBA;YWHAE;CCNG2;CCNE2;PPP2R2D;ARPP19;CEP41;CEP63;PCM1;LATS2;HAUS5;ANAPC1;CDC25A;E2F1;CCDC57;DBF4;CDC27;CDK2;DYNC1I2;MAX;DCTN1;CHMP4B;PRKACA;OPTN;BCAT1;ACTR1A;CDK5RAP2;NEDD1;PLK4;RPS6KB1;CNTRL;CHMP2A;CTDP1;TUBB4B;CCP110
prerank,long-chain fatty acid transport (GO:0015909),-0.2884702546486937,-0.9668345904779111,0.5487804878048781,0.7642088528638051,1.0,8/30,10.23%,APOE;ACSL1;PRKAA2;PRKAG2;CPT1A;SLC27A4;MFSD2A;MID1IP1
prerank,regulation of biomineral tissue development (GO:0070167),0.3994982634009426,0.9667949600089369,0.5156445556946183,0.8574293529166637,1.0,5/26,7.68%,GAS6;DDR2;TWIST1;NBR1;SOX9
prerank,regulation of viral life cycle (GO:1903900),-0.3184115495376856,-0.9665625643295624,0.4786729857819905,0.7632597880920995,1.0,6/21,14.58%,PPIA;TRIM14;NECTIN2;TRIM21;TRIM68;AXL
prerank,heme catabolic process (GO:0042167),0.4422475969728083,0.9665319063133422,0.5303867403314917,0.8571371065382426,1.0,2/14,4.28%,ABCC1;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.4422475969728083,0.9665319063133422,0.5303867403314917,0.8571371065382426,1.0,2/14,4.28%,ABCC1;HMOX2
prerank,regulation of intracellular signal transduction (GO:1902531),0.3238361996722991,0.9659309770356976,0.6146146146146146,0.858102090990572,1.0,108/420,20.97%,MYOC;RASSF2;EGFR;CMKLR1;RHOJ;VEGFA;SRGAP3;SRGAP2;TIAM1;ARAP1;NTRK3;RHOQ;NTRK1;TIAM2;TCP11;FSHR;VAV2;PRDM11;PKHD1;ARHGAP17;CSNK2A2;CSNK2A1;KMT5A;RRS1;CHD3;USP2;RMI2;MOB3B;BCR;RHOT2;MDM4;EHMT1;ARHGAP21;PAK4;CASTOR2;DLG1;KALRN;RHOA;RHOT1;RBBP8;RAD1;PAK2;ITGAV;WRN;ING5;PIP4K2B;INPP5B;MYO9A;ARHGAP20;ULK4;ATM;TELO2;CHEK2;PDPK1;TAF15;TAF6;ARHGAP8;EZR;RAD50;TRAF3;HDAC1;TAF13;NLGN1;ARHGAP44;OCRL;RBBP7;USP7;SOS2;SQSTM1;ARHGEF1;TMEM127;TBCK;RHOB;AKAP13;SOS1;WDR54;PIP5K1A;ATRIP;TTC5;TAGAP;PPP2R5C;TRIO;TP53RK;HUS1;SSRP1;NGEF;FLCN;UFL1;BOP1;PRKAG1;ARAF;TRIM6;VRK2;AKT1;HIPK2;CRK;CDK2;NFKBIA;WWC2;TAF9B;CDK5;PRKAB1;NOC2L;MAPKAP1;DEPDC1B;RCN3;OPTN;PRKAR2A
prerank,polyol biosynthetic process (GO:0046173),0.4333899744352353,0.965740271507031,0.5371120107962213,0.8580760825355231,1.0,2/16,1.73%,FGF2;ACER3
prerank,regulation of chondrocyte differentiation (GO:0032330),0.40847042631016556,0.9656917173278187,0.5416149068322982,0.8577289006665074,1.0,4/24,7.68%,PKDCC;WNT9A;MBOAT2;SOX9
prerank,positive regulation of growth (GO:0045927),0.35256126391225256,0.9654188924265529,0.5437636761487965,0.8579108121235253,1.0,22/64,23.01%,EGFR;CSNK2A1;TGFB2;AGR2;EIF4G2;FXN;ADAM10;MMP14;CXCL16;TGFBR1;EIF4G1;SUPV3L1;EXOSC4;KLHL22;ERBB2;NCBP1;HDGFL2;AKT1;TAF9B;DDX49;USP47;RPTOR
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.34680892281864345,0.9654111045270283,0.5526036131774708,0.8574713564767409,1.0,24/87,22.05%,FGF2;FGF17;HNRNPH1;SPRED2;RBFOX2;FGFR1;CBL;FGFR2;GTF2F1;FLRT2;SHOC2;HNRNPM;PTBP1;TIAL1;NDNF;POLR2F;GALNT3;FGF5;NCBP1;NCBP2;FGF18;FGFR3;HNRNPA1;POLR2B
prerank,neuron cell-cell adhesion (GO:0007158),-0.36023581909688307,-0.9650729442170533,0.4979919678714859,0.7654771632671188,1.0,6/14,15.19%,NRXN1;ASTN2;NCAM2;CNTN4;NRXN3;ASTN1
prerank,ERBB signaling pathway (GO:0038127),0.3562012035991735,0.9647891335036239,0.5543358946212953,0.8584925918680079,1.0,15/64,18.91%,EGFR;PLCE1;SHC1;PRKCA;SOX9;CBL;PTPN18;PDPK1;SOS1;STUB1;IQGAP1;ERBB2;GAREM1;AKT1;ERBIN
prerank,homocysteine metabolic process (GO:0050667),0.4661152044052318,0.9646112953550957,0.5366847826086957,0.8584480250043159,1.0,3/11,7.73%,MPST;NOX4;MTRR
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.35952387946148595,0.9644376260885273,0.5404494382022472,0.8583961407647759,1.0,12/56,22.11%,LBP;HMGB1;ALPK1;IRAK1;TAB2;TRAF3;S100A1;UBC;RPS27A;CTSB;TLR1;CTSK
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4642538001260707,0.9643483119242414,0.5055401662049861,0.858145576415324,1.0,5/11,36.39%,ATF4;PINK1;PRKN;NR4A3;NONO
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.4493292004156232,0.96416828659627,0.5306406685236769,0.8581186038125903,1.0,2/13,7.26%,TWIST1;YJU2
prerank,glycerophospholipid catabolic process (GO:0046475),0.3951368092538151,0.964141925649756,0.5416666666666666,0.8577219193245454,1.0,7/27,16.48%,PLA2G4F;PLA2G4A;SMPD4;PLA2G5;ENPP6;GDPD3;PLA2G15
prerank,anterograde axonal transport (GO:0008089),0.37876899700685546,0.9639774096177697,0.5484247374562428,0.8576374568692576,1.0,11/37,22.20%,DLG2;RAB21;BLOC1S2;SPAST;AP3D1;SOD1;BLOC1S3;SNAPIN;KIF1B;MAPK8IP3;NEFL
prerank,snRNA transcription (GO:0009301),0.34795023371644807,0.9638156696884604,0.5224358974358975,0.8575530833686361,1.0,33/70,34.40%,INTS14;INTS3;INTS4;GTF2F1;CCNT2;INTS13;TAF6;TAF13;SNAPC4;POLR2F;RPRD1A;NCBP1;USPL1;NCBP2;POLR2B;TBP;ICE1;POLR2H;INTS9;SRRT;POLR2I;CDK9;INTS7;POLR2L;INTS6;SNAPC1;GTF2A2;RPAP2;POLR2K;RPRD2;ZC3H8;GTF2E2;INTS10
prerank,regulation of gluconeogenesis (GO:0006111),0.4007184197948252,0.9637819182623848,0.5244055068836045,0.8571772489291208,1.0,8/27,18.34%,DGKQ;OGT;NNMT;PTPN2;USP7;ARPP19;GNMT;CLK2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.39965763770724483,-0.9637730302563169,0.48220064724919093,0.7670482787153817,1.0,5/10,28.09%,ANO6;CD300A;C3;TREM2;NCKAP1L
prerank,nuclear membrane organization (GO:0071763),0.42138071105286046,0.963743471470714,0.5430038510911425,0.8568143881579878,1.0,8/19,28.97%,SPAST;TMEM43;DCTN1;CHMP4B;NEMP1;CHMP2A;UBXN2A;TOR1AIP1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.293280489729337,-0.9636772056355573,0.55,0.7656565047998212,1.0,4/26,5.05%,DNAJC6;SGIP1;PICALM;PIP5K1C
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.47476095871404034,0.9635232224366121,0.5197183098591549,0.8568646780570368,1.0,1/10,0.78%,VEGFA
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3378300750404312,0.9632794163393242,0.5575501583949314,0.8569840228331924,1.0,14/102,9.74%,IRS1;SLC39A14;PRKCD;RHOQ;HDAC9;C2CD5;ADCY2;ADCY8;PRKDC;RAB8A;ADCY9;CAPN10;AKT2;SYAP1
prerank,positive regulation of viral life cycle (GO:1903902),0.41421191401451835,0.9632089831944793,0.5252918287937743,0.8566956161310512,1.0,7/22,28.33%,P4HB;KPNA2;CHMP3;CHMP2A;VPS37B;KPNA6;DDB1
prerank,positive regulation of metabolic process (GO:0009893),0.3409570614453641,0.9631549086084994,0.5857740585774058,0.8563735176236873,1.0,11/103,9.01%,GNAS;CMKLR1;VEGFA;GADD45G;GRB10;PEMT;DYNC1H1;ALMS1;EHMT1;ADIPOR2;OGT
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.39487993802502264,0.9631406322113264,0.5173652694610779,0.8559566221753084,1.0,13/29,34.14%,NT5C3B;PATL1;LSM2;EXOSC4;CNOT8;DIS3;DCP1A;LSM5;EDC4;EXOSC2;DCPS;EXOSC3;CNOT6
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3293932858396288,0.9629990272715887,0.595166163141994,0.855843182204911,1.0,37/182,18.30%,ESR1;FOXP1;ID2;VEGFA;FGF2;SLC24A3;EMILIN1;ANXA7;LRPAP1;TGFB2;CD3E;XDH;ADAM10;DLG4;DGKQ;WWP2;BMP4;AGO1;TERT;BMPR1A;KDM4A;PTRH2;HDAC1;AGO2;SMO;SETDB1;ERP29;RUNX1;ZNF148;VDR;WDR54;RBL2;SLC2A10;FLCN;CITED2;TRIM6;TRAT1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3443183138136989,0.9629503276562207,0.5550755939524838,0.8555162930241738,1.0,11/75,14.03%,MGLL;SLC39A14;PLCE1;PPP1R9B;PDE6A;DGKQ;RPGRIP1L;GIT1;GRK6;USP33;GUCY2D
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.45139385228631934,0.9628906159177575,0.5326975476839237,0.8552095784357155,1.0,3/13,15.15%,TM9SF4;RIC3;STX4
prerank,regulation of cell cycle process (GO:0010564),0.34034823799208824,0.962554451520259,0.5777096114519428,0.8555369589842337,1.0,33/104,27.35%,KIF13A;CSNK2A2;CSNK2A1;DYNC1H1;CALM2;HORMAD1;RMI2;SOX9;MAD1L1;RCC1;GIT1;MARK4;SND1;USP19;CALM3;BIRC6;FLCN;E4F1;DAPK3;KIF20B;DBF4;CUL9;SETD2;UVRAG;TXLNG;PLK4;RAB11FIP4;CDK13;CCP110;CCDC8;CUL7;ATF5;AHCTF1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3071474384118615,-0.9624452336792235,0.5152838427947598,0.7670637293374544,1.0,7/22,14.31%,AEBP1;APOE;MAP2;CAMSAP1;PRUNE1;GPX1;EFEMP2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.3957026264935113,-0.9621517041854353,0.5079872204472844,0.7662397505374627,1.0,2/10,2.19%,VTN;PRKCB
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4141264715749589,0.9619530999881113,0.5299479166666666,0.8564692862377454,1.0,7/22,21.82%,MDFIC;GDI1;CHP1;RAB23;SUFU;LRRK2;LMAN1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.4532693739827116,0.9619430497157939,0.5355113636363636,0.8560463538440178,1.0,2/12,6.98%,UBASH3B;ANK2
prerank,peptidyl-amino acid modification (GO:0018193),0.4804688282449804,0.9616352840829001,0.5385735080058224,0.8562941417698826,1.0,6/10,34.32%,FKBP10;METAP1D;METAP2;ATP7A;METAP1;FKBP7
prerank,regulation of NMDA receptor activity (GO:2000310),-0.28455236541858814,-0.9615490076907044,0.5157232704402516,0.7661073040623065,1.0,11/32,14.20%,ACTN2;APP;GRIA1;SLC6A9;GRIN2B;GRIA4;OPRM1;GRIN2A;GRIA3;RELN;GRIN1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.34412877268500314,0.9615288590453869,0.5631067961165048,0.8560783950319366,1.0,22/80,25.64%,THBS1;PRKCD;SLC2A13;SAMD4A;PRKDC;NIBAN1;IL6;EIF6;ERBB2;EIF3D;EFNA1;PYM1;CLU;CIRBP;FXR2;UPF3A;NSMAF;RPS6KB1;RPS27L;UPF3B;RBM3;METTL14
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.34264256895841694,0.9615092162572589,0.5617615467239527,0.855679220875997,1.0,31/85,28.10%,TIAM1;PRICKLE1;PSMD7;AP2A1;PSMA8;DVL1;FZD7;FZD5;RHOA;PSMA4;PSMD12;PSMA6;AP2A2;CLTC;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;SMURF2;PSMB1;PSMD4;PSMA5;PSMA7;PSMC1;DVL2;WNT11;CELSR3;PSMA1;FZD1
prerank,cellular response to cAMP (GO:0071320),0.39255711446048475,0.9613926623650936,0.5293398533007335,0.8554796200189296,1.0,3/30,2.98%,IGFBP5;HCN4;SLC26A6
prerank,amide transport (GO:0042886),0.40108784195568115,0.9613331252458496,0.5256570713391739,0.855162770699759,1.0,3/26,7.03%,SLC5A6;SLC25A32;DISP1
prerank,vacuolar acidification (GO:0007035),0.4119759981170718,0.9612807484082466,0.5426751592356688,0.8548285905113451,1.0,8/21,30.40%,TCIRG1;ATP6V0A1;ATP6V0D1;CLN3;SLC11A1;ATP6V0E1;CLN5;ATP6V1H
prerank,regulation of mast cell degranulation (GO:0043304),-0.3512619841222403,-0.9609671852701713,0.5101214574898786,0.7659483470740718,1.0,5/14,13.02%,LYN;CD300A;SYK;CD84;LGALS9
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3268348409368178,0.9608335605970204,0.5912778904665315,0.8553773616792063,1.0,42/175,23.57%,PID1;CARD14;YBX3;CCL13;PSMD7;CCL15;PSMA8;SMPD4;TNFRSF1B;ILK;TNFSF15;NFE2L2;TXNDC17;PSMA4;LTBR;CHUK;COMMD7;CD27;PSMD12;TRAF3;PSMA6;TANK;GSDME;PSMD1;PSMC5;FOXO3;PSMD11;PSMC4;PSMD14;ACOD1;AKT1;ERBIN;ASAH1;NFKBIA;PSMA3;TNFSF18;PSMB1;PSMD4;BIRC3;MAP3K14;PSMA5;PSMA7
prerank,cell cycle G2/M phase transition (GO:0044839),0.33209524462462664,0.9608149006573863,0.5724563206577595,0.8549749219899929,1.0,40/129,23.99%,FBXL7;CSNK1D;PPP1R12B;DYNC1H1;SFI1;DNM2;ODF2;ALMS1;DCTN2;CDC25B;CKAP5;FOXM1;LCMT1;CHEK2;FBXL12;SDCCAG8;AKAP9;CUL1;CEP164;KHDRBS1;CSNK1E;YWHAE;ARPP19;CEP41;CEP63;PCM1;HAUS5;CDC25A;CCDC57;CDK2;AKAP8;DYNC1I2;DCTN1;PRKACA;OPTN;ACTR1A;CDK5RAP2;NEDD1;PLK4;CNTRL
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.28496981043481495,-0.9608005190949039,0.49473684210526314,0.7647931908852842,1.0,5/27,8.00%,IL1RAPL1;CCDC88A;CTNNA2;NTNG1;HOMER1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.44665931019628835,0.9606112896921299,0.5095890410958904,0.8549852182999016,1.0,1/13,1.29%,IL33
prerank,B cell mediated immunity (GO:0019724),0.46961145724239467,0.9605042555063044,0.5303703703703704,0.8547720873286571,1.0,2/10,11.94%,FCER1G;CD27
prerank,phospholipid catabolic process (GO:0009395),0.39673199100774875,0.9605040243670472,0.5143929912390488,0.8543281061616181,1.0,6/24,16.32%,PLA2G4F;PLA2G4A;SMPD4;SMPDL3A;ENPP6;GDPD3
prerank,regulation of mRNA polyadenylation (GO:1900363),0.42167096106004,0.9605032477527784,0.5255376344086021,0.8538856221715857,1.0,8/17,28.53%,NCBP1;CPSF7;CPSF6;NCBP2;RNF20;ZC3H14;HSF1;CDK9
prerank,integrin-mediated signaling pathway (GO:0007229),0.34610186273081756,0.9597609232647503,0.5498392282958199,0.8550930618124697,1.0,12/73,12.40%,ITGA11;COL3A1;ADAM9;PLPP3;COL16A1;ILK;PRAM1;ADAM10;ITGAV;ABL1;RCC2;NRP1
prerank,aerobic electron transport chain (GO:0019646),-0.2465333995212039,-0.9594803337806295,0.5194805194805194,0.766266574037137,1.0,21/68,24.19%,COX8A;COX6C;NDUFC2;COX4I1;CYC1;UQCRC2;UQCR11;COX10;NDUFA13;NDUFB2;UQCRB;NDUFAF1;NDUFB7;COX5B;UQCRC1;NDUFS1;NDUFA8;NDUFB11;UQCRQ;NDUFS6;NDUFA4
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.3614172551000147,-0.9593352041160985,0.5166051660516605,0.765067903916615,1.0,3/12,4.13%,APP;CXCL12;JAM2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.38409620812370426,0.95930462370708,0.5366430260047281,0.8556753942707408,1.0,3/33,2.89%,IGFBP5;PDCD4;TGFB3
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.41749214684734803,0.9591838760350085,0.538558786346397,0.855510541279987,1.0,3/19,8.42%,RIC3;CHRNB2;CHRNA5
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.46103357974051673,0.9591662411028903,0.5193905817174516,0.8551086688789928,1.0,2/11,10.45%,YBX3;RIPK3
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.37137884535692955,0.9591605565152077,0.5468384074941453,0.854680355826324,1.0,6/38,13.24%,HJURP;IPO4;CENPC;CENPT;CABIN1;RBBP7
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3547672085907614,0.9586744104423554,0.5742793791574279,0.855294217026709,1.0,20/64,27.55%,MGLL;PLA2G4A;CYP1B1;ELOVL5;DAGLA;FADS1;ACAD9;ACSL3;PNPLA3;HACL1;ACSL6;ACSBG1;SLC27A2;DAGLB;ABCD1;ACOT8;FAAH;ALOXE3;ELOVL1;SLC27A3
prerank,negative regulation of receptor internalization (GO:0002091),0.45439439787274966,0.9585615747696654,0.5291666666666667,0.8550932703374441,1.0,4/12,21.60%,LRPAP1;DLG4;WDR54;ATXN2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4142802148403294,0.9584712927743164,0.5420560747663551,0.8548419945530924,1.0,3/20,7.78%,HOXA5;LDB1;HOXA9
prerank,regulation of lipid metabolic process (GO:0019216),0.342462485064958,0.9582002869901054,0.569593147751606,0.8550084673839508,1.0,15/88,17.14%,ID2;TNFAIP8L3;CHD9;NCOR2;RXRA;PLPP1;CARM1;RORA;SREBF1;NR1D2;ACACA;CREBBP;SIN3B;NFYA;LSS
prerank,protein deacylation (GO:0035601),0.3996729726951183,0.957763005526044,0.5538656527249683,0.8555616468809394,1.0,5/23,15.81%,HDAC4;SIRT5;HDAC1;SIRT2;HDAC6
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.37147115880205683,0.9577127222149076,0.5293440736478712,0.8552265923076317,1.0,10/40,16.45%,VEGFA;SFRP4;ANXA2;RAB21;CBL;PICK1;DAB2;HNRNPK;ARRB1;HIP1
prerank,regulated exocytosis (GO:0045055),0.32849219479057795,0.9576045468699071,0.5868686868686869,0.855016421754222,1.0,38/173,21.49%,THBS1;VEGFA;GAS6;SYT8;CHID1;TIMP3;TGFB3;SPARC;PCDH7;TOR4A;ARHGAP17;TGFB2;CD9;MAGED2;QSOX1;FAM3C;BRPF3;STEAP2;RAB11FIP5;SOD1;RAB11B;MANF;SCIN;HGF;STX1A;CD109;WDR1;SYTL4;LHFPL2;SERPING1;PCYOX1L;SNAPIN;TEX264;CDK5;APLP2;CLU;LAMP2;GTPBP2
prerank,regulation of type I interferon production (GO:0032479),0.34519042470401945,0.9574606685693766,0.5636942675159236,0.854906767178183,1.0,38/84,32.37%,TAX1BP1;MAVS;PRKDC;GPATCH3;POLR3H;ITCH;IRAK1;TRAF3;CRCP;PCBP2;POLR3GL;POLR2F;UBE2L6;CREBBP;OTUD5;NFKB2;ACOD1;NPLOC4;IKBKE;XRCC6;IRF3;POLR3K;POLR1C;RNF216;CYLD;TBK1;ILRUN;POLR2H;CGAS;DDX41;POLR3E;RNF135;POLR2L;CTNNB1;NFKB1;POLR3F;POLR2K;IFIH1
prerank,negative regulation of cellular senescence (GO:2000773),-0.354508321210773,-0.9571373980654351,0.5642023346303502,0.7689249743398414,1.0,3/13,2.72%,CDK6;SLC30A10;AKT3
prerank,ephrin receptor signaling pathway (GO:0048013),0.3457721151003277,0.9569926907086069,0.5746268656716418,0.8555226043471248,1.0,12/82,9.02%,EFNA5;ARHGEF28;TIAM1;VAV2;EPHB2;SIPA1L1;ARPC1B;AP2A1;EPHB3;EPHB6;KALRN;RHOA
prerank,oligodendrocyte development (GO:0014003),0.43687007670476974,0.9569895156459073,0.5449591280653951,0.8550901208755293,1.0,3/15,14.27%,HES5;B4GALT5;PLP1
prerank,mitotic nuclear division (GO:0140014),0.3487590872184397,0.9567614283520258,0.551462621885157,0.8551490450034656,1.0,24/71,26.49%,TUBG2;SMC4;MISP;SMC3;RHOA;SPAST;UBE2C;CHEK2;MIS12;ZW10;NDEL1;PPP2R2D;KLHL22;STAG1;CCDC61;CHMP4B;NUP62;ARHGEF10;WRAP73;SMC1A;CHMP2A;CTDP1;SPICE1;GOLGA2
prerank,gene expression (GO:0010467),0.323165716824116,0.9565572931370283,0.6336336336336337,0.8551709512682379,1.0,118/348,28.79%,SRSF6;RRBP1;RPSA;NUP93;DDX17;HNRNPH1;SRSF1;SRSF5;SEC13;TOPORS;RBM39;BAZ2A;DUSP11;RAE1;M1AP;SRSF2;CASC3;NOX4;SEH1L;ABCF1;TASP1;HNRNPA2B1;SMG6;SRSF11;SYMPK;HARS2;LMF1;GSPT1;HNRNPL;MRPS18B;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;NFKBIB;RBM6;CHTOP;RBM5;PABPN1;NUP37;MRPS14;XAB2;AGO2;EIF4G1;MRPL35;HSPD1;MEF2A;RBM4;RANBP2;U2AF2;CLP1;CPSF4;HNRNPK;MMS19;NUP88;YTHDC1;POLR2F;MRPS17;SARNP;TFIP11;STUB1;THOC2;SRSF3;FYTTD1;RPS27A;YARS2;NCBP1;SRSF7;GOLPH3;E2F1;POM121;NUP210;NCBP2;SARS1;GLE1;SYNCRIP;RPL7A;HNRNPH3;DARS1;NUP62;DHX8;MED20;UPF1;SRSF4;POLR2B;MRPS21;ASMT;NDC1;NUP35;GALNT2;HNRNPU;MRPS18A;RPS9;MRPL37;PABPC4;UPF3B;RBM3;DDX39B;NUP85;POLR2H;DDX20;MRPL13;NUP160;TPR;DKC1;SRBD1;EIF4E;DRG1;RPL41;RPL30;SETX;DEDD2;MRPL11;POLR2I;PWP1;WARS1;IGHMBP2
prerank,RNA modification (GO:0009451),0.3555796614174764,0.9565370948969533,0.5487404162102957,0.8547762550920279,1.0,23/54,35.07%,SSB;ANKRD16;ELP5;TRMT1;PUS3;TRUB1;ALKBH1;CTU2;TRMT6;TSR3;TRMT61A;METTL1;NSUN6;DTWD1;NSUN3;MEPCE;NOP10;RBM15;THUMPD1;PUS7;PUS7L;AARS1;MRM2
prerank,regulation of platelet aggregation (GO:0090330),0.43115644980601353,0.9565177326849296,0.5393700787401575,0.8543809396600927,1.0,4/17,6.02%,PRKCD;C1QTNF1;PRKCA;CD9
prerank,growth hormone receptor signaling pathway (GO:0060396),0.451702793801222,0.9562223658880105,0.5383580080753702,0.8546251204282257,1.0,4/14,8.51%,GHR;STAT5A;STAT3;SOCS2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.30326909930507473,-0.9558781428695434,0.5513513513513514,0.7703810107717955,1.0,6/25,12.06%,INSR;SMAD3;KLF2;ASS1;EDN1;DDAH2
prerank,cellular metal ion homeostasis (GO:0006875),0.33515878576290814,0.9555920945770326,0.5596620908130939,0.8555692795994987,1.0,15/102,11.18%,KCNJ2;ATP1B1;SLC12A2;SLC24A3;CCL13;PKHD1;CCL15;SLC10A7;SLC9A1;ANK2;CHERP;STIM1;EDN3;CSRP3;TMEM165
prerank,regulation of small molecule metabolic process (GO:0062012),-0.29378362272645386,-0.9555796301912985,0.5263157894736842,0.7695184341242858,1.0,5/28,7.50%,APOE;PDK1;PPARA;FMO5;ADIPOR1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.38360932999055986,0.9548794238496225,0.5533980582524272,0.8566814201217424,1.0,5/35,6.17%,HOXA5;LDB1;ACVR1B;STAT3;PRKDC
prerank,tRNA 5'-leader removal (GO:0001682),0.4478619323388724,0.9543665318187067,0.528169014084507,0.8574009586087596,1.0,6/13,30.83%,SSB;RPP40;RPP14;RPP21;POP5;PRORP
prerank,positive regulation of TOR signaling (GO:0032008),0.38057478860550303,0.9542878859193012,0.5643105446118193,0.8571387987138721,1.0,18/40,32.53%,GAS6;SEC13;LAMTOR1;SEH1L;CLEC16A;TELO2;KLHL22;FLCN;GOLPH3;RHEB;RPTOR;SMCR8;LAMTOR2;LAMTOR3;GPR137B;HTR6;HDAC3;PIK3CA
prerank,mesoderm development (GO:0007498),0.4211235472445723,0.9542509256993222,0.5161290322580645,0.8567879613321224,1.0,3/18,8.03%,VEGFA;FOXC2;IKZF3
prerank,vasoconstriction (GO:0042310),-0.37668489909851666,-0.9540758134810704,0.5083056478405316,0.7718331623855941,1.0,6/11,16.74%,SLC8A1;EDNRB;EDN1;ACTA2;PIK3C2A;HTR2B
prerank,sympathetic nervous system development (GO:0048485),0.4376631111016036,0.9540412521041434,0.550561797752809,0.8568283411587347,1.0,4/15,18.73%,NTRK1;NRP1;NF1;GDNF
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.318632030744991,-0.9536951468173224,0.5208333333333334,0.7695833536182674,1.0,4/21,5.73%,EYA1;BCL2;BCL2L1;EYA4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.318632030744991,-0.9536951468173224,0.5208333333333334,0.7695833536182674,1.0,4/21,5.73%,EYA1;BCL2;BCL2L1;EYA4
prerank,muscle tissue development (GO:0060537),-0.35292027370940443,-0.9534936727427795,0.4982078853046595,0.7684947947102424,1.0,3/13,3.22%,ENG;PTCH1;PGM5
prerank,ribosomal small subunit biogenesis (GO:0042274),0.3805765678311891,0.953374918200577,0.5679156908665105,0.8578803025883451,1.0,7/39,10.41%,RPSA;LTV1;RRP7A;EMG1;SRFBP1;WDR3;RIOK1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.40870783613191514,0.9533368745268501,0.5402298850574713,0.857521968516828,1.0,12/22,35.52%,ATF4;PHF8;ERBB2;EIF2AK3;WDR75;SMARCA4;UBTF;PWP1;DDX11;NCL;LYAR;UTP15
prerank,cilium movement (GO:0003341),0.36683129468547643,0.9531969505939334,0.5692665890570431,0.8574165206251065,1.0,12/47,24.62%,CFAP251;CFAP206;ODAD2;CCDC39;ROPN1L;DNAAF4;TEKT2;TTC29;CFAP73;SPAG17;CAMSAP3;DNAAF5
prerank,negative regulation of JNK cascade (GO:0046329),0.38530798850525155,0.9531459927192897,0.5569007263922519,0.8570970315810157,1.0,15/31,25.14%,PDCD4;DACT1;ITCH;PER1;MEN1;ZMYND11;DNAJA1;AIDA;DUSP19;GPS2;CYLD;TAOK3;PINK1;NCOR1;MAPK8IP1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.38621330646324575,0.9531041206761027,0.5352286773794809,0.856745763448414,1.0,8/28,23.32%,MAP1B;STMND1;ABL1;MAPRE3;ARL2;STMN2;CAMSAP3;FKBP4
prerank,iron-sulfur cluster assembly (GO:0016226),0.39831489668446574,0.9526521179586235,0.5334174022698613,0.8572938703316266,1.0,7/24,23.50%,FXN;NFS1;GLRX5;ISCA2;MMS19;ISCU;NUBP2
prerank,positive regulation of cell growth (GO:0030307),0.33459034694108314,0.9526363937816491,0.5726315789473684,0.8568873690146528,1.0,24/96,23.01%,EGFR;NTN1;CSNK2A1;TGFB2;EIF4G2;FXN;ADAM10;MMP14;CXCL16;GOLGA4;TGFBR1;EIF4G1;SUPV3L1;EXOSC4;KLHL22;ERBB2;NCBP1;HDGFL2;AKT1;TAF9B;DDX49;SHTN1;USP47;RPTOR
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3857167272270993,0.9520899687222493,0.5477326968973747,0.8576653469351044,1.0,14/31,34.14%,NT5C3B;DIS3L2;PATL1;LSM2;EXOSC4;CNOT8;DIS3;DCP1A;LSM5;EDC4;EXOSC2;DCPS;EXOSC3;CNOT6
prerank,organelle fusion (GO:0048284),0.4017982279680715,0.9517674373839049,0.5284450063211125,0.8579242902317088,1.0,11/22,30.35%,MIEF2;SPG7;EEA1;STX4;VPS11;MFN1;AFG3L2;FIS1;USP30;VPS18;MIEF1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3333804257887617,0.9516903260748137,0.5761658031088083,0.8576655016631317,1.0,18/117,15.65%,ME1;SLC5A6;SLC16A1;AGXT2;LDHC;ACSF3;CPT1C;ACSF2;ACOT11;GLO1;AKR1C1;NPC1;DLAT;ACSL3;GLYAT;CKB;SCPEP1;HACL1
prerank,epithelium development (GO:0060429),0.3327572508027021,0.9516685792182514,0.5778474399164054,0.8572825026480584,1.0,13/107,10.25%,SIX1;PKD1;VEGFA;ANXA7;MEOX2;HES5;ANXA4;DACT1;DVL1;SOX9;AKR1C1;FGFR2;EHF
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.24837717017361644,-0.9512762973092342,0.5714285714285714,0.772256292852679,1.0,19/57,17.20%,ACTN2;APP;GRIA1;CACNG7;GRIN2B;CACNG8;GRIA4;OPRM1;GRIN2A;CACNG3;GRIA3;CACNG4;SHISA6;RELN;GRIN1;DLGAP1;DLGAP2;CAMK2A;CNIH3
prerank,tRNA 5'-end processing (GO:0099116),0.43747825585362954,0.9511708635977656,0.5349162011173184,0.8579220949503925,1.0,6/15,30.83%,SSB;RPP40;RPP14;RPP21;POP5;PRORP
prerank,macroautophagy (GO:0016236),0.33187815061152165,0.9511484134709166,0.592173017507724,0.8575302196993064,1.0,41/118,27.29%,CSNK2A2;CSNK2A1;TCIRG1;VCP;LIX1L;TOMM40;NBR1;WIPI2;PGAM5;PIP4K2B;ATG3;STAM2;VIPAS39;CHMP3;UBQLN1;SQSTM1;PLEKHM1;VPS41;TOMM70;YOD1;PRKAG1;CLN3;RB1CC1;VTA1;PRKAB1;CHMP4A;CHMP4B;ATG16L1;LAMP2;MFN1;ACBD5;MVB12A;UVRAG;PINK1;CHMP2A;ILRUN;ATG13;VTI1B;AMBRA1;VPS16;VPS37B
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.39340430917815744,0.9508327112436135,0.5389369592088998,0.8577941526827729,1.0,13/26,31.55%,NOL3;ATF4;NFE2L2;AKT1;LRRK2;PYCR1;VNN1;PINK1;HTRA2;NME5;PRKN;GPR37;GPR37L1
prerank,defense response to tumor cell (GO:0002357),-0.3860093342468094,-0.9507958215887684,0.5065359477124183,0.7718552785956213,1.0,2/10,9.41%,RBMS3;ABI3
prerank,mitochondrial translational elongation (GO:0070125),0.3347996083764707,0.95066966637692,0.559322033898305,0.8577135474068096,1.0,41/88,37.64%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;MRPS18B;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;TUFM;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3489646114241286,-0.9501455979011717,0.5169491525423728,0.7718146488772616,1.0,4/15,12.82%,SAMHD1;USP18;NLRC5;CACTIN
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3387203606270878,-0.9495207485669338,0.5103734439834025,0.7717195603392113,1.0,8/17,20.86%,NEDD4L;RYR2;GPD1L;KCNJ8;PKP2;SCN3B;KCNQ1;SCN5A
prerank,hydrogen peroxide catabolic process (GO:0042744),0.46106630420582484,0.9489519298229362,0.5384615384615384,0.8609533588184125,1.0,6/11,30.51%,PRDX3;CAT;PRDX2;PRDX1;PXDN;PRDX5
prerank,negative regulation of developmental growth (GO:0048640),0.3840239018520231,0.9489205150626369,0.5421686746987951,0.8605825192922886,1.0,3/30,3.93%,FGF13;ULK2;PTPRS
prerank,cell chemotaxis (GO:0060326),0.354162556794251,0.9486709053219684,0.5572687224669604,0.8607193207206387,1.0,11/60,15.88%,PRKCD;VEGFA;CCN3;DOCK4;ABCC1;ACKR4;NRP1;PARVA;HGF;CXCR4;PIP5K1A
prerank,mitochondrial translational termination (GO:0070126),0.33507919019156157,0.9485857440694353,0.5648936170212766,0.860465355462249,1.0,41/88,37.64%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;MRPS18B;MTRF1L;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2
prerank,neurotransmitter uptake (GO:0001504),0.4472535579016533,0.948532850544297,0.5399129172714079,0.860139327556824,1.0,1/12,0.11%,SLC38A1
prerank,phospholipid translocation (GO:0045332),0.3924978965439721,0.9482893354364947,0.5509950248756219,0.8602311578083004,1.0,7/28,15.85%,TMEM30B;ABCC1;ATP8B2;ATP8A1;ATP9A;ABCA1;PLSCR3
prerank,negative regulation of response to wounding (GO:1903035),0.419611562288536,0.9476965874080012,0.5577172503242542,0.8610665856875755,1.0,5/19,19.11%,FGF2;PTPRS;GIT1;CD109;CRK
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3239890136039094,0.9475500152120034,0.6182741116751269,0.8609462710211435,1.0,13/190,4.67%,THBS1;SLIT2;ESR1;PDE11A;CIT;CCN3;NPRL3;TWIST1;PKHD1;PHLPP2;UBE2B;XDH;PDE3A
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4251700971832789,0.947494833646423,0.5320600272851296,0.8606373156581683,1.0,2/16,2.56%,PDCD4;CHID1
prerank,membrane assembly (GO:0071709),0.3777268065496214,0.9474615018657199,0.5774818401937046,0.8602807497204987,1.0,11/34,17.37%,CEL;ANXA2;TLCD2;S100A10;NRXN2;SPAST;STX2;NLGN1;STX4;SPTBN1;TLCD1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4515028753171084,0.9471040025135804,0.5604551920341394,0.8606107635747523,1.0,2/13,8.31%,SIX1;TFE3
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3627999982888412,0.9470030929746068,0.549263873159683,0.860398196661463,1.0,9/44,12.60%,MYOC;TGFB3;SORBS3;S100A10;PFN2;RHOA;ABL1;NRP1;TGFBR1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.36283845213264254,0.9465571372194573,0.5498839907192575,0.8609474272410319,1.0,7/43,13.17%,EGFR;PTPN3;SOCS4;RNF115;CBL;PTPN2;STAM2
prerank,regulation of cellular component organization (GO:0051128),0.32459395667502605,0.9465302460877226,0.602880658436214,0.8605727981083054,1.0,48/135,26.63%,PLCE1;STON2;NEDD4;ARFGAP1;HJURP;CAMK2D;SNCAIP;DCUN1D5;LAMTOR1;ANKRA2;IRAK3;TMC8;PAK4;SOCS2;STON1;ITCH;URI1;ABL1;SETD5;NCLN;MARK4;RAB4B;MLLT3;HIP1;SSRP1;SLC2A10;RAB5B;RUFY2;HCFC1;SLITRK2;SETD1A;ZFYVE16;SGK3;MAD2L2;RAB4A;CAMSAP3;TSC2;RPTOR;HNRNPU;ROCK1;PINK1;IL17RB;TAOK2;PTPN11;LAMTOR2;RAB5A;SGK1;ATF5
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3276635204163324,0.9464012012047844,0.5973223480947477,0.8604043493955457,1.0,39/128,23.99%,FBXL7;CSNK1D;PPP1R12B;DYNC1H1;SFI1;DNM2;ODF2;ALMS1;DCTN2;CDC25B;CKAP5;FOXM1;LCMT1;CHEK2;FBXL12;SDCCAG8;AKAP9;CUL1;CEP164;KHDRBS1;CSNK1E;YWHAE;ARPP19;CEP41;CEP63;PCM1;HAUS5;CDC25A;CCDC57;CDK2;DYNC1I2;DCTN1;PRKACA;OPTN;ACTR1A;CDK5RAP2;NEDD1;PLK4;CNTRL
prerank,striated muscle cell differentiation (GO:0051146),0.43234998924214435,0.9461682676011257,0.5529100529100529,0.8604815002873447,1.0,5/16,16.74%,SDC1;SKI;MYEF2;AKAP13;KDM6B
prerank,regulation of cellular senescence (GO:2000772),-0.28876857727132504,-0.9459937006096663,0.519774011299435,0.7783601228394361,1.0,6/28,9.41%,CDK6;B2M;SLC30A10;AKT3;NUAK1;ABI3
prerank,proteasome assembly (GO:0043248),0.44946644256563234,0.9457529292723906,0.5374449339207048,0.8609582004592404,1.0,5/11,29.85%,PSMD11;OTUD6B;PSMD4;PSMG2;ADRM1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.2951945123614047,-0.9457281765833246,0.5684210526315789,0.7774403953724289,1.0,4/26,7.03%,ITPR1;RYR2;ITPR3;HTR2C
prerank,positive regulation of hydrolase activity (GO:0051345),0.3281875391680861,0.9455914682882397,0.6051282051282051,0.8608827603292925,1.0,29/137,17.71%,SGSM2;SRGAP2;ASAP3;ARAP1;NTRK1;CCL13;CCL15;CALM2;BCAS3;SNX18;RAB3GAP1;S100A10;RIC1;RHOA;MAPK8;WRN;RGP1;RIPK3;ZC3H15;MAPK12;SNX9;EVI5L;F2R;NDEL1;ERBB2;CALM3;NF1;FLCN;SNX13
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3228701239984678,0.9455254519802413,0.6267748478701826,0.8605844332527878,1.0,51/166,25.86%,ESR1;RARB;NCOR2;HDAC9;RXRA;WWTR1;NR2F1;RXRB;E2F3;POLR3H;MED27;RARA;ESRRB;RORA;GTF2F1;MAZ;TAF15;TAF6;NRBP1;ERCC3;NR1D2;HDAC1;TAF13;CRCP;ERCC2;VDR;POLR2F;NRBF2;CREBBP;MED26;NR3C1;TFB2M;POLR1G;TEAD2;CAVIN1;GTF3C1;NR3C2;TAF9B;NR2F6;POLR1C;POLR2B;TAF1C;NR2C2;TBP;KAT2B;NR5A1;TAF1;NCOR1;MED23;GTF2H4;POLR2H
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.43277536571458974,0.945467144031751,0.560875512995896,0.8602803837666083,1.0,3/15,11.47%,ADAM9;TNFRSF1B;SNX9
prerank,central nervous system neuron development (GO:0021954),-0.34780239778172317,-0.9454261868716805,0.5171102661596958,0.7766449686387186,1.0,2/15,2.55%,MAP2;RAPGEF2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3836605034119302,-0.9453366953459135,0.5432525951557093,0.7753228387939245,1.0,4/10,15.34%,PARP14;SH2B3;INPP5F;SOCS3
prerank,telomere organization (GO:0032200),0.3647709232948113,0.9452887056620531,0.5453514739229025,0.8602385086631198,1.0,11/43,19.45%,PARP3;PRKDC;ERCC4;WRN;TERT;ATM;RAD50;DCLRE1B;PARP1;HUS1;XRCC6
prerank,copper ion transport (GO:0006825),0.45447922351724757,0.944973447095997,0.5586924219910847,0.8604804741797805,1.0,4/11,31.55%,STEAP2;STEAP3;SLC31A2;ATP7A
prerank,membrane raft organization (GO:0031579),0.4348403678692469,0.9449130900079152,0.5704607046070461,0.8601764346555822,1.0,3/15,9.92%,ANXA2;S100A10;NPC1
prerank,DNA replication initiation (GO:0006270),0.36673763202615295,0.9448031534069058,0.5736160188457008,0.8599919166094998,1.0,12/37,26.10%,POLE2;MCM2;CDC6;CDC45;MCM4;ORC2;CDT1;DBF4;CDK2;TOPBP1;PRIM1;MCM7
prerank,male meiosis I (GO:0007141),0.418627023327242,0.9447448630981095,0.5336927223719676,0.8597019458394085,1.0,3/16,18.60%,FOXJ3;HSF2BP;BRDT
prerank,positive regulation of response to stimulus (GO:0048584),0.36373498596444587,0.944736556072844,0.5412311265969802,0.8592911687348942,1.0,5/40,8.09%,PRKCD;TGFB2;MAVS;ILK;SELENON
prerank,regulation of DNA binding (GO:0051101),0.35912450062928475,0.9446192694772345,0.5645879732739421,0.8591178761835078,1.0,11/44,19.72%,HJURP;HMGB1;SKI;MAPK8;SMO;SIRT2;SUMO1;MDFI;CDT1;E2F1;NFKBIA
prerank,granulocyte chemotaxis (GO:0071621),0.3573113147384452,0.9439746801246016,0.5584269662921348,0.8601080276508609,1.0,7/55,9.69%,CCL13;CCL15;TGFB2;GBF1;FCER1G;EDN3;ANXA1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.32628844232044174,-0.9438698424805186,0.5476190476190477,0.7773710282594929,1.0,7/18,15.10%,LTBP1;SMAD3;CD200;FN1;LGALS9;CD34;ITGB8
prerank,negative regulation of phosphatase activity (GO:0010923),0.39322863905601446,0.943681218688096,0.5561035758323057,0.8603087374855919,1.0,10/25,24.17%,TGFB2;TIPRL;ZCCHC9;URI1;CHP1;PPP1R35;CRY2;PPP1R36;BOD1L1;FKBP1B
prerank,positive regulation of dephosphorylation (GO:0035306),0.38896463558458666,0.943429006494027,0.5669856459330144,0.8604283432982701,1.0,8/27,16.85%,PRKCD;CALM2;SYMPK;RIPK3;CNEP1R1;PTBP1;NSMF;CALM3
prerank,regulation of chromatin binding (GO:0035561),0.4707105989801746,0.9433286245746885,0.5706214689265536,0.8602133988617396,1.0,5/10,29.21%,BTAF1;MED25;CDT1;WAPL;DDX11
prerank,positive regulation of neuron death (GO:1901216),-0.2570912753846907,-0.942932406584985,0.5588235294117647,0.7782076988013361,1.0,11/46,15.02%,EFNB2;WNT5A;PICALM;EPHA7;GRIN2B;NUPR1;EGR1;SARM1;C1QA;SNCA;TYROBP
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.45083477759187457,0.9428637285155294,0.5607344632768362,0.8608123754399224,1.0,5/11,30.27%,NRP1;HGF;SIRT2;BCAR1;RAC1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.28819098649903335,-0.9428328653696835,0.5290697674418605,0.7768663492636061,1.0,4/31,13.02%,PLCB1;SYK;CD40;LGALS9
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4571973872658866,0.9427019170735308,0.5499316005471956,0.8607261057080559,1.0,6/12,26.31%,HEXIM1;LARP7;NELFB;HNRNPU;RECQL5;NELFA
prerank,stem cell differentiation (GO:0048863),0.3654129332080238,0.9425850905810492,0.5810968494749125,0.8605487149505571,1.0,8/39,17.34%,LRP6;TGFB2;PUM1;FGFR2;HOXB4;PSMD11;MLLT3;UFL1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.32836484892043094,0.9425411675474545,0.6108220603537982,0.8602155801466116,1.0,32/109,23.95%,GAB2;VAV2;PSMD7;SHC1;PSMA8;FCER1G;NFATC1;PAK2;MAPK8;PSMA4;CHUK;TAB2;PDPK1;PSMD12;PIK3CB;CUL1;PSMA6;NFATC3;PSMD1;SOS1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;MAPK9;MAP2K7;PSMB1;PSMD4;PSMA5;PSMA7;FOS
prerank,transcription by RNA polymerase II (GO:0006366),0.3158011255965604,0.9424103975875396,0.678,0.8600610274436692,1.0,97/305,25.89%,ESR1;PRRX1;NFIX;RARB;DDX5;NCOR2;DEAF1;HDAC9;ELOF1;RXRA;WWTR1;ATF4;INTS14;NR2F1;TCFL5;RXRB;NFX1;INTS3;E2F3;MED27;RARA;ESRRB;SYMPK;INTS4;HSF2BP;CDK12;RORA;GTF2F1;CCNT2;INTS13;MAZ;PABPN1;TAF15;TAF6;NRBP1;ERCC3;NR1D2;HDAC1;TAF13;TRIP11;ERCC2;CLP1;CPSF4;VDR;SNAPC4;POLR2F;MBD1;TFDP1;AFF4;NRBF2;PCF11;MLLT3;CREBBP;MED26;PARP1;RPRD1A;NCBP1;SSRP1;NFYA;NR3C1;ELP4;CPSF7;NCBP2;TEAD2;CSTF2;CBFB;NR3C2;TAF9B;ABT1;CSTF2T;MED20;PAF1;NFIC;CEBPD;NR2F6;SNRPB;POLR2B;TAF1C;NR2C2;MNT;SETD2;TBP;ICE1;TFCP2;NELFB;KAT2B;NR5A1;TAF1;CDK13;EAF1;NCOR1;CTDP1;MED23;RTF1;GTF2H4;POLR2H;RNMT
prerank,glucan biosynthetic process (GO:0009250),0.45142886933481013,0.9422405327177872,0.5459610027855153,0.8595643657419562,1.0,1/12,2.86%,PPP1R3C
prerank,glycogen biosynthetic process (GO:0005978),0.45142886933481013,0.9422405327177872,0.5459610027855153,0.8595643657419562,1.0,1/12,2.86%,PPP1R3C
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.34048184156111266,0.9420553340534192,0.5562700964630225,0.8595247155283013,1.0,32/69,34.40%,INTS14;INTS3;INTS4;GTF2F1;CCNT2;INTS13;TAF6;TAF13;SNAPC4;POLR2F;RPRD1A;NCBP1;NCBP2;POLR2B;TBP;ICE1;POLR2H;INTS9;SRRT;POLR2I;CDK9;INTS7;POLR2L;INTS6;SNAPC1;GTF2A2;RPAP2;POLR2K;RPRD2;ZC3H8;GTF2E2;INTS10
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.33274965576123516,0.9419425725318011,0.5985090521831736,0.8593454733573593,1.0,23/87,23.57%,FHL1;FBXL7;PSMD7;PSMA8;DACT1;DLG1;PSMA4;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;RBL2;PSMA3;PSMB1;PSMD4;USP47;GPNMB;PSMA5;PSMA7
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3589618130059896,0.9417561640800836,0.5590643274853802,0.8593059717941591,1.0,12/44,20.28%,PRKCD;PDCD4;IRAK3;CDK5RAP3;BMP4;PAQR3;PIK3CB;NF1;DNAJA1;AIDA;DUSP19;UCHL1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.46943064488950703,0.9415854905527988,0.5587808417997098,0.8592397032329607,1.0,4/10,13.73%,PLPP1;GAP43;F2R;PICK1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.42459034171628296,0.9413843494294868,0.547144754316069,0.8592484218765456,1.0,3/16,7.58%,PARP3;PRKDC;KMT5C
prerank,early endosome to late endosome transport (GO:0045022),0.4070347262344905,0.9413150113327728,0.5589005235602095,0.8589620594899673,1.0,3/20,8.52%,ANKRD27;RILP;EEA1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3910059592286326,0.9412136705915547,0.5760309278350515,0.8587508286928695,1.0,4/24,10.04%,IRS1;PPP1R3C;AKT2;PPP1R3F
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.32819696838546514,0.9411558098110261,0.6150627615062761,0.8584476586031573,1.0,35/114,26.51%,CARD14;PSMD7;PSMA8;TNFRSF1B;ILK;TNFSF15;TXNDC17;PSMA4;LTBR;CHUK;COMMD7;CD27;PSMD12;TRAF3;PSMA6;PSMD1;PSMC5;FOXO3;PSMD11;PSMC4;PSMD14;NFKBIA;PSMA3;TNFSF18;PSMB1;PSMD4;BIRC3;MAP3K14;PSMA5;PSMA7;TP53;TRADD;PSMC1;RIPK1;CDIP1
prerank,response to cAMP (GO:0051591),0.37105993543733934,0.9411393574663007,0.5639810426540285,0.8580601140143569,1.0,6/37,12.31%,IGFBP5;HCN4;SLC26A6;DGKQ;EZR;AKAP9
prerank,response to nitric oxide (GO:0071731),-0.3506350142202554,-0.9409763601555926,0.5384615384615384,0.7797835814643745,1.0,6/13,27.33%,GUCY1B1;KCNC2;FOXO1;MT3;MMP3;AQP1
prerank,fatty acid biosynthetic process (GO:0006633),0.34504507949309604,0.9408786890494889,0.5647442872687704,0.8581728382946253,1.0,8/63,10.36%,ABCD3;ACSF3;ELOVL5;SCD5;LIAS;OLAH;FADS1;CBR4
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3725699128354427,0.9408126077855461,0.5774647887323944,0.8578798058711578,1.0,9/36,19.32%,FHIT;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;RYBP;UCHL5
prerank,negative regulation of endopeptidase activity (GO:0010951),0.35786660898015266,0.9402764485260513,0.5712630359212051,0.8586120451193316,1.0,9/47,18.72%,SERPINH1;TIMP2;TIMP3;SERPINF1;SERPINB9;SERPINE2;CRB2;AKT1;SERPING1
prerank,cellular response to cytokine stimulus (GO:0071345),0.3121650479896337,0.9399100801880202,0.7,0.8589714268661761,1.0,86/416,19.77%,PID1;VEGFA;GAS6;LBP;F3;FGF2;SLC12A2;COL1A2;PTGIS;YBX3;GRB10;GHR;MUC1;GAB2;CNTFR;DPYSL3;SLC26A6;TWIST1;CCL13;SDC1;SHC1;NFAT5;STAT5A;CCL15;STAT3;IL5;SHPK;SMPD4;TNFRSF1B;TXLNA;IL12RB2;NFE2L2;STK39;IFNLR1;IRAK3;SOX9;SOCS6;CBL;GBP6;SOCS2;RHOA;SBNO2;PTPN18;RORA;MAPK8;ANXA1;CHUK;CTF1;IRAK1;IL20RB;PIK3CB;PTPN2;TANK;CD80;GSDME;CASP1;WNK1;CLCF1;STX4;HGF;SOS1;IL6;STX1A;FOXO3;CXCR4;UBC;RPS27A;PRLR;HMOX1;EPRS1;DAPK3;TRIM6;ACOD1;USP10;SHMT1;BIRC5;AKT1;OSMR;ERBIN;CRK;PLP2;SYNCRIP;PTAFR;ASAH1;PTPN23;UBE2G2
prerank,tryptophan catabolic process (GO:0006569),0.4496360572196404,0.9398702675631827,0.5488505747126436,0.8586275572032672,1.0,3/11,20.64%,IDO2;AFMID;KYAT1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.32465542915750006,0.9397443409461874,0.6184074457083765,0.8584736122850395,1.0,43/138,25.86%,ESR1;RARB;NCOR2;HDAC9;RXRA;WWTR1;NR2F1;RXRB;E2F3;MED27;RARA;ESRRB;RORA;GTF2F1;MAZ;TAF15;TAF6;NRBP1;ERCC3;NR1D2;HDAC1;TAF13;ERCC2;VDR;POLR2F;NRBF2;CREBBP;MED26;NR3C1;TEAD2;NR3C2;TAF9B;NR2F6;POLR2B;NR2C2;TBP;KAT2B;NR5A1;TAF1;NCOR1;MED23;GTF2H4;POLR2H
prerank,response to hydroxyurea (GO:0072710),0.45263416546226,0.9396051024766879,0.5328571428571428,0.8583435061183057,1.0,6/11,31.68%,DDI2;SPIDR;KAT7;DDX11;TIMELESS;BLM
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.38520239251309196,0.9391137252444163,0.5614906832298137,0.8589632222012181,1.0,6/27,16.52%,IRAK3;IRAK1;TAB2;HSPD1;UBC;RPS27A
prerank,heart looping (GO:0001947),0.36320626916966536,0.9390871051361261,0.5712589073634204,0.8585973603265888,1.0,8/39,16.19%,MICAL2;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5;NPHP3
prerank,alcohol catabolic process (GO:0046164),-0.384382457879679,-0.939049293244123,0.535031847133758,0.7829517272648231,1.0,5/10,20.71%,APOE;CYP27A1;SCARF1;MT3;CYP46A1
prerank,organic hydroxy compound transport (GO:0015850),-0.2801386235956687,-0.9387193677579674,0.5460122699386503,0.782251618084918,1.0,4/36,2.34%,ABCC4;SLCO2B1;SLCO1C1;RBP4
prerank,regulation of mitotic spindle assembly (GO:1901673),0.4123918424205936,0.9384906099164557,0.5616797900262467,0.8594824129054033,1.0,12/19,38.60%,EML3;CHMP3;CHMP4B;PDCD6IP;HNRNPU;CHMP2A;TPR;DRG1;CHMP4C;CCSAP;VPS4B;CHMP1B
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.4093762552454858,0.9382950173835338,0.5492227979274611,0.8594648450663773,1.0,1/20,0.38%,PSTPIP1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.4349051750060259,0.9381781683535737,0.5644257703081232,0.8592789469264561,1.0,4/13,15.25%,NFAT5;RHOA;IRAK1;IL6
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.39154222530620836,-0.9369681014992327,0.5183946488294314,0.7847909017656142,1.0,3/10,5.23%,PODXL;DPP4;PIEZO1
prerank,membrane lipid metabolic process (GO:0006643),-0.30742290320572024,-0.9368972304663349,0.5660377358490566,0.7834715259390594,1.0,5/22,9.48%,ST3GAL6;CERK;SERINC1;GAL3ST1;SPHK1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3319825538605614,-0.9368263838588484,0.5391304347826087,0.7821158635227375,1.0,9/17,29.31%,CXCL12;ANO6;SERPINE1;PLA2G7;CREB3;CCR2;CXCL10;LGMN;CCL5
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3672777740295079,0.9368039614569376,0.5777511961722488,0.8618425369803276,1.0,7/38,17.53%,THBS1;TMC8;MADD;TNFRSF10B;BMP5;STX4;HMOX1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3584290880036076,0.9366506946177452,0.5641931684334511,0.8617584263305396,1.0,8/43,13.29%,MICAL2;ACVR1;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5
prerank,cellular response to amino acid stimulus (GO:0071230),0.38494561763107915,0.936408922240729,0.5819277108433735,0.8618380735287883,1.0,9/33,18.72%,IPO5;SESN3;LAMTOR1;CASTOR2;CAPN2;SESN2;NSMF;KLHL22;UBR2
prerank,negative regulation of protein kinase activity (GO:0006469),0.3318477430100367,0.9363934229162353,0.6140724946695096,0.8614455281303355,1.0,21/88,20.30%,LRP6;SRCIN1;UBASH3B;LRP5;WWTR1;DVL1;TRIM27;AKT1S1;CDK5RAP3;PAK2;ABL1;PDPK1;DEPTOR;CHP1;CAMK2N1;GSKIP;NF1;CDKN1C;AKT1;DUSP19;RTRAF
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.393946933359965,0.9361787736790981,0.5522755227552275,0.8614820402521172,1.0,7/25,13.92%,ATP1B1;DMD;STK39;ANK2;COA8;AKAP9;WNK1
prerank,Golgi to plasma membrane transport (GO:0006893),0.3552554819964722,0.936103252375233,0.5780346820809249,0.8612127544114746,1.0,21/47,28.26%,KIF13A;EXOC4;RAB34;GOPC;GGA2;LLGL1;GOLGA4;NSF;STEAP2;GGA1;SPTBN1;GOLPH3;BLZF1;OPTN;ARFGEF2;VAMP4;VPS35L;VAMP2;GCC2;OSBPL5;GGA3
prerank,purine-containing compound catabolic process (GO:0072523),-0.350267970624658,-0.9360626597865881,0.564,0.7825210019465217,1.0,4/13,12.80%,NT5C2;DPYD;GDA;GPX1
prerank,peptide catabolic process (GO:0043171),0.3943560887959179,0.9359847339068444,0.5658536585365853,0.8610246741766162,1.0,9/23,23.50%,ECE1;CPQ;XPNPEP1;LNPEP;IDE;NPEPPS;LVRN;CHAC2;DPEP1
prerank,dendritic spine organization (GO:0097061),0.3917398718433294,0.9359428488926669,0.5548780487804879,0.8606887064517504,1.0,8/26,13.73%,CTNND2;EPHB2;ARC;EPHB3;DLG4;ARF1;SHANK1;PICK1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.416476786137748,0.93497863837194,0.5659121171770972,0.8622726557114229,1.0,5/16,19.01%,IGFBP5;PHIP;BMP5;IGFBP6;ZFAND2B
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.45224157773059714,0.9349670718869996,0.5625942684766214,0.8614560570798278,1.0,1/12,0.86%,EFNA5
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.45224157773059714,0.9349670718869996,0.5625942684766214,0.8614560570798278,1.0,1/12,0.86%,EFNA5
prerank,prostaglandin biosynthetic process (GO:0001516),0.4125268419571609,0.9349176298107762,0.556,0.8611425579836884,1.0,3/18,7.01%,PTGIS;PLA2G4A;PTGES2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4486218985453083,0.934189436659576,0.5738161559888579,0.8622482549255323,1.0,3/12,21.97%,STARD3NL;FDXR;STARD3
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3094473071566733,0.9341340863453026,0.725,0.8619366302223269,1.0,88/532,16.52%,IRS1;PRKCD;VEGFA;LBP;F3;FGF2;COL1A2;PDCD4;IL33;P4HB;CARD14;GRB10;GHR;MUC1;GAB2;CNTFR;TWIST1;CCL13;SDC1;PSMD7;SHC1;CAMK2D;STAT5A;ANXA2;CCL15;STAT3;PITPNA;IL5;MID1;PSMA8;TNFRSF1B;ILK;TXLNA;TNFSF15;SMAD4;IL12RB2;IFNLR1;IRAK3;BRWD1;HNRNPA2B1;HNRNPDL;RPS6KA4;SOCS6;CBL;ADIPOR2;SOCS2;FCER1G;JAGN1;TXNDC17;RORA;PAK2;PSMA4;ANXA1;LTBR;CHUK;CTF1;IRAK1;TAB2;ARF1;COMMD7;SOD1;CD27;PSMD12;IL20RB;PIK3CB;TRAF3;CUL1;PSMA6;CD80;CASP1;TRIM26;SQSTM1;CLCF1;PSMD1;STX4;HGF;SOS1;IL6;STX1A;MAP3K3;PSMC5;FOXO3;PSMD11;PSMC4;PSMD14;TRAF3IP2;UBC;RPS27A
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4100795877162057,0.9340149295479063,0.5673202614379085,0.8617675005928469,1.0,9/18,33.68%,FXN;EDN3;ABL1;GDNF;RFK;ABL2;PDP2;ATP7A;PDP1
prerank,small GTPase mediated signal transduction (GO:0007264),0.3313663554961274,0.9338346095205043,0.6296680497925311,0.8617162372915642,1.0,19/103,15.24%,NTN1;PLCE1;FGF2;TIAM1;MRAS;TIAM2;SHC1;TRIM28;BCR;USP50;RRAD;ARFIP2;RAB38;SHOC2;CHP1;SETDB1;NUCB1;G3BP2;SOS1
prerank,regulation of dendritic spine development (GO:0060998),0.3989252661811491,0.9337479721971104,0.5501955671447197,0.8614526813260935,1.0,6/19,13.02%,GRIN3A;PTPRS;TANC2;SHANK1;FOXO6;NLGN1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3826995989519335,0.933354274536787,0.5821596244131455,0.8618968465290676,1.0,2/30,1.45%,PRKCD;SRCIN1
prerank,blood circulation (GO:0008015),0.34604267349481105,0.9332999794681844,0.5649717514124294,0.8615905454969003,1.0,5/49,3.89%,ELN;SGCD;GCLC;HCN4;MEOX2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.39253551261322506,0.9332601379224822,0.5610972568578554,0.8612523739151231,1.0,8/26,22.44%,CYP1B1;ATF4;SULF1;RORA;IL6;SARS1;SULF2;EIF2AK3
prerank,membrane organization (GO:0061024),0.31798662092217495,0.9331941560678756,0.6824120603015076,0.8609715342685046,1.0,68/227,26.28%,EGFR;STON2;NUP93;CTTN;IGF2R;TLCD2;STX11;AP2A1;DNM2;ANK2;FCHO2;HUWE1;CBL;SYNJ1;NPC1;SPAST;LPCAT3;SNX9;AP3D1;USO1;TMEM43;CHP1;REPS1;OCRL;LRP2;AP2A2;STAM2;GAPVD1;PICK1;CHMP3;DMPK;REEP3;CLTC;DAB2;SNAP23;MITD1;ARRB1;HIP1;UBC;RPS27A;SPTBN1;TLCD1;TMEM170A;NAPA;CLN3;TMEM33;COX18;CLTA;CHMP4A;CHMP4B;SYNJ2;PDCD6IP;ARPC1A;MTCH1;LDLR;REPS2;PRKCI;VAMP4;NEMP1;SNX3;CHMP2A;PLEKHA3;SCARB2;VAMP2;VTI1B;DVL2;RAB5A;ACTR2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.4509134725006829,0.9330406217217015,0.5558546433378196,0.860461783096791,1.0,4/11,15.73%,AGO1;AGO2;RBM4;EIF6
prerank,miRNA mediated inhibition of translation (GO:0035278),0.4509134725006829,0.9330406217217015,0.5558546433378196,0.860461783096791,1.0,4/11,15.73%,AGO1;AGO2;RBM4;EIF6
prerank,steroid hormone biosynthetic process (GO:0120178),0.3784957603692878,0.9325408595189809,0.5714285714285714,0.8610525331387733,1.0,5/29,21.97%,CYP19A1;STARD3NL;FDXR;HSD17B8;STARD3
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3567311136477091,-0.9322541142728146,0.5517241379310345,0.7899253187006273,1.0,5/13,15.30%,NEDD4L;ACTN2;CAV1;NOS1;CASQ2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.43119573641115244,0.9315476291688181,0.5593922651933702,0.862723615206327,1.0,4/14,18.57%,AGR2;HSPA5;UFL1;TMEM33
prerank,peptidyl-tyrosine modification (GO:0018212),0.3506208590938417,0.9312869729167258,0.5887541345093715,0.8628796582209973,1.0,9/56,10.58%,EGFR;PKDCC;DDR2;NTRK1;EPHB2;ABI1;FGFR1;FGFR2;ABL1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3197058838524114,0.931108911722225,0.6521739130434783,0.8628611595956671,1.0,42/172,18.37%,FGF2;PLEKHA4;PLA2G4A;PEMT;PIK3C2B;CSNK2A2;CSNK2A1;PITPNM1;LPCAT1;GPD1;TAMM41;LPCAT4;DGKQ;ETNK1;PGS1;STARD7;SYNJ1;GPAT4;PLA2G5;PIP4K2B;LPCAT3;PCTP;FAR1;ARF1;INPP4A;ETNPPL;PIK3CB;OCRL;PI4K2A;PLA2G12A;CDIPT;PNPLA3;HDHD5;CHKB;PIP5K1A;PI4KB;INPP5E;PTDSS1;VAC14;AGPAT5;CDS1;CLN3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.37295595015135435,0.9309912597364395,0.5695121951219512,0.8626790561204963,1.0,11/31,21.65%,SRCIN1;ARC;SIPA1L1;TANC2;NLGN1;ARHGAP44;NGEF;EFNA1;CDK5;ABI2;LRRK2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.2002957090292507,-0.9309280585063826,0.7142857142857143,0.7915077626921538,1.0,29/163,11.76%,PDE4D;BCL2;TEC;PRKCB;PIK3R1;RFTN1;INPP5D;PSMC6;FYB1;PAG1;TNFRSF21;BMX;PAK3;NFATC2;CD38;SKP1;THEMIS;EIF2B3;VAV3;PAK1;PSME3;ZC3H12A;PSME1;SPPL3;PDE4B;SYK;PRKCQ;PIK3CD;SH2B2
prerank,DNA replication checkpoint signaling (GO:0000076),0.4224140657817808,0.9308981194179522,0.5625841184387618,0.8624505420793684,1.0,7/16,30.53%,CDC6;CDC45;HUS1;CDT1;TOPBP1;TIMELESS;RAD17
prerank,spindle assembly (GO:0051225),0.3398869002702395,0.9308666622036444,0.5952121871599565,0.8620966212815621,1.0,27/67,32.66%,CSNK1D;GOLGA8B;MISP;TUBGCP3;NEK7;SMC3;RHOA;RCC1;CHEK2;MAPRE3;CEP63;HAUS5;STAG1;CCDC61;ARHGEF10;WRAP73;SMC1A;NCOR1;SPICE1;GOLGA2;NEK6;TOGARAM1;TUBGCP2;KIF2A;BCCIP;HDAC3;PIBF1
prerank,stabilization of membrane potential (GO:0030322),0.42253971240657456,0.9305510019914957,0.5654596100278552,0.862319979581671,1.0,1/16,0.40%,KCNK5
prerank,prostanoid biosynthetic process (GO:0046457),0.4297634928409899,0.9304445169509625,0.5716234652114598,0.8621249252829336,1.0,2/15,1.79%,PTGIS;PLA2G4A
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4129760308347176,0.9304390427923822,0.5496688741721855,0.8617150102775211,1.0,5/16,18.69%,NPR3;TERT;PIK3CB;S100A1;AKT1
prerank,regulation of double-strand break repair (GO:2000779),0.36041845833447755,0.9304128609966577,0.5873015873015873,0.8613568095383876,1.0,17/39,30.17%,TWIST1;OTUB1;SLF2;SPIDR;FOXM1;UBR5;OTUB2;SPIRE2;RAD51;SLF1;SETD2;ACTR2;WAS;RTEL1;DDX11;TRIP12;TIMELESS
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.2160593095454953,-0.9302291146122321,0.7111111111111111,0.7916185216355347,1.0,48/110,23.32%,RPS14;RPS15;RPS25;RPL8;SMG7;RPS8;RPL4;RPS20;CTIF;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;GSPT2;RPL11;RPL18A;RPS12;RPL12;SMG8;RPS11;UBA52;RPL18;RPS15A;RPS28;EIF4A3;RPL21;RPL7;RPL10;RPL15;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3899800490328731,0.9300766484288647,0.5771567436208992,0.8616304164554505,1.0,6/25,18.85%,EXT1;B3GNT7;B3GNT9;B4GAT1;B3GNT6;EXT2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.3689008623497363,-0.9294844904461956,0.532051282051282,0.791816737874394,1.0,4/11,22.81%,C1QTNF3;C1QTNF12;SIK1;EP300
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.26002236872227225,-0.9292364126305189,0.577639751552795,0.7909109383405653,1.0,6/38,8.74%,BMP6;SASH1;LY86;CD180;DDX60;GBP5
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.39264158725791126,0.9289685934811274,0.5848101265822785,0.8634915553659885,1.0,7/23,20.96%,GHR;CYP1B1;HES5;F2R;IL6;PRLR;IL4
prerank,actin filament organization (GO:0007015),0.31845692738212694,0.928874477670949,0.6223350253807106,0.863253865949228,1.0,20/151,9.02%,RHOBTB1;GSN;RND3;DPYSL3;VILL;PLS1;PPP1R9B;COBL;ARHGAP17;CORO6;FAT1;TLE6;MYO1E;CDC42EP2;MCU;ABI1;ELMO3;DLG1;GAS2;RHOA
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3292756594996473,-0.9286210467997094,0.5163934426229508,0.7908801840824289,1.0,6/16,18.51%,AUTS2;BCOR;PIH1D1;CTR9;BRCA1;KDM1A
prerank,cellular calcium ion homeostasis (GO:0006874),0.3199264030177271,0.9284014446786545,0.6404494382022472,0.8638513303434838,1.0,36/133,24.42%,SLC35G1;ATP1B1;SLC24A3;CCL13;CAMK2D;PKHD1;CCL15;PACS2;ADCY8;SLC10A7;MCU;ANK2;CHERP;STIM1;EDN3;CSRP3;TMEM165;MICU2;LETM1;YWHAE;DMPK;MICU1;CALB2;CALCA;KCTD17;CLN3;CALR;PRKACA;ATP2B4;ANXA6;AFG3L2;SLC8B1;STOML2;FKBP1B;HERPUD1;STIM2
prerank,regulation of fatty acid oxidation (GO:0046320),-0.3344470787092299,-0.928365044591729,0.5454545454545454,0.7900398336897212,1.0,3/16,6.44%,PPARA;PRKAG2;PPARGC1A
prerank,diacylglycerol metabolic process (GO:0046339),0.3959484755465788,0.9282378409805255,0.5883838383838383,0.8637851403009432,1.0,4/23,9.36%,PLCE1;DAGLA;DGKQ;PGS1
prerank,negative regulation of MAPK cascade (GO:0043409),0.3304835136936119,0.9282005910888833,0.6159574468085106,0.8634467687779189,1.0,16/87,12.91%,PRKCD;EMILIN1;TIMP3;EPHB2;SPRED2;SMAD4;IRAK3;CDK5RAP3;DLG1;BMP4;PAQR3;FOXM1;EZR;PIK3CB;PPEF2;PTPN2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.42622574956976744,0.9281185302418125,0.5633608815426997,0.8631864028453351,1.0,6/15,21.84%,ATL2;REEP3;TMEM170A;TMEM33;ATL1;RAB18
prerank,positive regulation of developmental process (GO:0051094),0.3198642208471535,0.9280781814455946,0.6574923547400612,0.8628640802962324,1.0,31/164,13.02%,BMP1;VEGFA;FOXD1;ACVR1B;PHLDB1;LMNA;COBL;AGR2;TLE6;ACVR1;DVL1;MIEF2;MCU;FGFR1;KMT5C;SOX9;DLG4;PA2G4;ESRRB;TRPM4;B4GALT5;EDN3;BMP4;TMEM119;BMPR1A;NEUROD2;SHANK1;FOXO6;SRF;AGO2;NLGN1
prerank,receptor metabolic process (GO:0043112),0.34929623145745353,0.9280681386135374,0.5968645016797313,0.862465912925274,1.0,16/53,23.06%,LRP1;NEDD4;RAMP2;DNM2;CD9;FCER1G;SNX1;RAMP1;RAB11B;CLTC;PHETA2;GRK4;ARFGEF2;ACKR3;MVB12A;UVRAG
prerank,cellular response to drug (GO:0035690),-0.29021900553183383,-0.9279675569600715,0.5786802030456852,0.789460451913196,1.0,5/25,10.27%,PPM1E;ACER2;TFRC;AIM2;PDE4B
prerank,axonogenesis (GO:0007409),0.3147604744139866,0.9278618240935862,0.6639919759277834,0.8624713732334395,1.0,25/237,8.23%,SLIT3;SLIT2;SLIT1;EMB;EFNA5;MAP1B;ULK2;GRB10;GAB2;GLI2;PDLIM7;EPHB2;DOCK7;SHC1;NTN4;SEMA3E;PRKCA;EPHB3;EPHB6;RAB8A;SEMA4B;LLGL1;S100B;PALLD;CYFIP1
prerank,regulation of Notch signaling pathway (GO:0008593),0.3293393820365055,0.9277328222195278,0.6179039301310044,0.8623299590272893,1.0,10/76,8.95%,EGFR;CCN3;ZMIZ1;TGFB2;STAT3;POGLUT1;JAG1;MMP14;LLGL1;WWP2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3616644593535592,0.9276887442551044,0.5893886966551326,0.8620028973944457,1.0,9/42,22.64%,LBP;RNASE7;RNASE3;RNASE6;DEFB1;IL6;DMBT1;OPTN;SLC11A1
prerank,calcium import into the mitochondrion (GO:0036444),0.4474626367045121,0.9262039975401677,0.5722543352601156,0.8646434126447646,1.0,4/10,23.18%,MCU;MICU2;MICU1;AFG3L2
prerank,negative regulation of receptor binding (GO:1900121),0.4514812755077362,0.9261775680294949,0.588495575221239,0.8642785253989567,1.0,2/10,8.26%,PTPRF;NOG
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4145024258116225,0.9261401309005407,0.574496644295302,0.8639375400475213,1.0,2/17,0.95%,CACNA1C;ATP1B1
prerank,regulation of biosynthetic process (GO:0009889),-0.36473806964999556,-0.925718779660409,0.5486111111111112,0.7932027085290096,1.0,3/11,15.01%,SLC25A33;MID1IP1;SNCA
prerank,brain development (GO:0007420),0.31874491170289304,0.9256966149648028,0.6332992849846782,0.864456759393868,1.0,31/136,20.91%,SLC23A1;ZFHX3;PBX3;NFIB;ADGRL2;HES5;PITPNM1;RAB3GAP1;AMIGO3;TGFBR2;PBX1;MEIS3;TBC1D23;CDK5RAP3;ZIC1;SYNJ1;PHF8;POU6F1;PAFAH1B2;ABCB6;CXCR4;PHGDH;NF1;NIPBL;IER3IP1;CHD8;PAFAH1B3;SETD1A;BPTF;SYNJ2;AFF2
prerank,JNK cascade (GO:0007254),0.35693426260461814,0.9256247153762696,0.5844004656577415,0.8641827571120388,1.0,16/40,28.98%,MAP3K5;GPS1;MAPK8;IRAK1;TAB2;MAP3K12;MAP3K10;UBC;RPS27A;MAPK9;GPS2;MAP2K7;RIPK2;MAP3K11;UBE2V1;MAP2K4
prerank,cell proliferation in forebrain (GO:0021846),0.4566939102339424,0.9255576473666266,0.5726618705035971,0.8638922217837763,1.0,2/10,15.07%,DOCK7;PCM1
prerank,lysine metabolic process (GO:0006553),0.43120515849158214,0.9245869373999472,0.5437037037037037,0.8650380204339041,1.0,4/12,24.48%,HYKK;PHYKPL;GCDH;CRYM
prerank,lysine catabolic process (GO:0006554),0.43120515849158214,0.9245869373999472,0.5437037037037037,0.8650380204339041,1.0,4/12,24.48%,HYKK;PHYKPL;GCDH;CRYM
prerank,response to interferon-alpha (GO:0035455),0.41209914011059573,0.9244004733818593,0.5873655913978495,0.8650024392176408,1.0,1/16,0.97%,GAS6
prerank,organophosphate biosynthetic process (GO:0090407),0.36157164795043445,0.9241624906383001,0.5934195064629847,0.8651000519570895,1.0,12/37,26.43%,FGF2;LPCAT1;TKT;NFS1;FADS1;IP6K1;PIP5K1A;AGPAT5;MBOAT1;PPIP5K1;FITM2;PCYT2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.2809451416598423,-0.923717198272404,0.6149068322981367,0.7962897486460795,1.0,11/32,18.88%,CEMIP;TRPC3;AKAP6;CAV1;CX3CL1;GRIN1;APLNR;SNCA;GPER1;THY1;P2RX7
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.34952375913554334,0.9237049429444805,0.5814732142857143,0.8656514369818653,1.0,24/52,37.00%,SAMD4A;NT5C3B;PATL1;LSM2;EXOSC4;CNOT8;TUT7;CNOT10;RC3H2;DIS3;CNOT9;TNKS1BP1;DCP1A;LSM5;EDC4;EXOSC2;DCPS;EXOSC3;CNOT4;CNOT6;PAN2;RC3H1;DCP1B;PNLDC1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.40506040438125124,0.9236144348619436,0.5669700910273082,0.865415586133428,1.0,2/18,2.58%,GRIK4;UNC13B
prerank,cellular response to catecholamine stimulus (GO:0071870),0.38596402052359713,0.9233167539194599,0.5730337078651685,0.8655941712896303,1.0,9/23,21.65%,DRD1;ATF4;SLC9A1;ABL1;SIRT2;PRKACA;GNB1;ATP2B4;LRRK2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3339933135314281,0.9232175237014627,0.6182212581344902,0.8653676576420274,1.0,11/71,13.12%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;FCER1G;WIPF1;ABL1;PIK3CB;MYH2
prerank,retinoid metabolic process (GO:0001523),0.3347222312938259,0.9231521091513275,0.62882096069869,0.8650835422441159,1.0,5/71,3.46%,GPC6;LRP1;GPC3;SDC1;CYP1B1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.39228805911324177,0.9231461690792635,0.5749354005167958,0.8646831613961531,1.0,5/21,6.98%,CACNA1C;CAMK2D;CALM2;DMD;ANK2
prerank,negative regulation of developmental process (GO:0051093),0.33767718052272316,0.9229758410802456,0.6158008658008658,0.8646297459635355,1.0,13/69,12.12%,GAS6;NFIB;GRIN3A;PARP3;PTPRS;SOX9;HUWE1;CST3;BMP4;ANP32B;FOXM1;NEUROD2;HEY1
prerank,histone H2A ubiquitination (GO:0033522),0.4138813644242837,0.922639455445014,0.5929319371727748,0.8649328177226665,1.0,5/17,18.72%,UBE2B;RNF2;RING1;RYBP;UBR2
prerank,epidermis development (GO:0008544),0.3367046381274392,0.9225812731040953,0.5973303670745272,0.8646480237188056,1.0,9/56,16.37%,KRTDAP;TGM5;PLOD1;FGFR2;CRABP2;HDAC1;ALDH3A2;GRHL1;EMP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4381756376283033,0.9219387504709462,0.5805515239477503,0.8651470268352058,1.0,4/12,13.51%,SLC9A1;CHERP;STIMATE;PTBP1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4381756376283033,0.9219387504709462,0.5805515239477503,0.8651470268352058,1.0,4/12,13.51%,SLC9A1;CHERP;STIMATE;PTBP1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.39328722184350945,0.9217913703389191,0.5745501285347043,0.8650273193753415,1.0,3/22,14.75%,SRSF6;FGFR2;VDR
prerank,determination of heart left/right asymmetry (GO:0061371),0.352963792734865,0.9217593831233758,0.5856807511737089,0.8646763821505179,1.0,8/42,16.19%,MICAL2;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5;NPHP3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.37678046773667084,0.9216598945125217,0.5809987819732034,0.8644704201027907,1.0,8/33,14.31%,GAS6;TCF7L2;PKHD1;RAMP2;NFE2L2;PAK4;PDPK1;NDNF
prerank,mesenchymal to epithelial transition (GO:0060231),0.46118651649254716,0.9213087687584031,0.5857988165680473,0.8647606662035534,1.0,2/10,9.70%,FZD7;BMP4
prerank,signal transduction by p53 class mediator (GO:0072331),0.3743890112735604,0.9202056731068026,0.5824175824175825,0.8665831168579984,1.0,5/30,12.59%,DDX5;FHIT;MDM4;NDRG1;SESN2
prerank,protein K63-linked deubiquitination (GO:0070536),0.36933319928651714,0.9201893003782952,0.5802615933412604,0.8662059761425666,1.0,12/31,23.22%,USP50;OTUB2;USP7;USP33;USP13;PSMD14;OTUD5;SHMT2;YOD1;ZRANB1;BRCC3;CYLD
prerank,nucleoside phosphate catabolic process (GO:1901292),0.43051148852608945,0.9201244783811676,0.59500693481276,0.8659331941798541,1.0,4/13,9.60%,ENTPD2;ENTPD6;DCTPP1;SMPDL3A
prerank,telomere maintenance via telomere trimming (GO:0090737),0.4518870283127337,0.9199796761865,0.5702127659574469,0.8650101845535987,1.0,6/10,31.98%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.4518870283127337,0.9199796761865,0.5702127659574469,0.8650101845535987,1.0,6/10,31.98%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,t-circle formation (GO:0090656),0.4518870283127337,0.9199796761865,0.5702127659574469,0.8650101845535987,1.0,6/10,31.98%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3731186839371217,0.9198911027274898,0.5746268656716418,0.864766455304071,1.0,10/29,26.25%,CHUK;TRAF3;TANK;UBC;RPS27A;IKBKE;IRF3;BIRC3;TBK1;RIPK1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.44254993575003837,0.9198128093446755,0.5726375176304654,0.8645059027290213,1.0,3/11,6.22%,IRS1;GHR;GIGYF1
prerank,negative regulation of translation (GO:0017148),0.32814017664529527,0.9190418166177995,0.6293558606124604,0.8656704438671592,1.0,30/87,28.60%,IGFBP5;SAMD4A;FTO;PUM1;ILF3;METTL16;AGO2;RBM4;CNOT8;CNOT10;EPRS1;DAPK3;CNOT9;SHMT1;SYNCRIP;EIF2AK4;UNK;CALR;FXR2;EIF2AK3;YBX1;RBM24;ROCK1;METTL14;MRPL13;TPR;RIDA;FXR1;YTHDF1;LARP1
prerank,regulation of monocyte differentiation (GO:0045655),0.4280804949163852,0.9189186321497415,0.5826330532212886,0.865507209846927,1.0,1/14,0.44%,FOXP1
prerank,"phototransduction, visible light (GO:0007603)",0.42478146302933345,0.9184970690134298,0.582089552238806,0.8659946136465374,1.0,4/14,20.86%,PDE6A;GNA11;SAG;GNB1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.3879498539313052,0.918493188428768,0.5816582914572864,0.8655902252411921,1.0,7/24,22.44%,CYP1B1;ATF4;SULF1;RORA;IL6;SULF2;EIF2AK3
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3645407090195799,-0.9184494660309528,0.5282392026578073,0.8068457701576621,1.0,5/10,17.21%,PRKAA2;PRKAA1;MYOCD;SIRT1;KLF15
prerank,regulation of centriole replication (GO:0046599),0.4077125605164761,0.9183416130687635,0.5949197860962567,0.8654820866108124,1.0,8/17,28.53%,ALMS1;KAT2A;NUP62;CDK5RAP2;KAT2B;PLK4;SPICE1;STIL
prerank,pigment granule transport (GO:0051904),0.40271044655882166,0.9174588167333678,0.5797872340425532,0.8664017135296034,1.0,7/18,31.14%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,melanosome transport (GO:0032402),0.40271044655882166,0.9174588167333678,0.5797872340425532,0.8664017135296034,1.0,7/18,31.14%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,SNARE complex assembly (GO:0035493),-0.3701348915897018,-0.9173985796612193,0.5425867507886435,0.8078103428888536,1.0,1/10,1.48%,STXBP6
prerank,regulation of protein secretion (GO:0050708),0.32084358107940764,0.9173810878260767,0.6376811594202898,0.866150340926853,1.0,25/119,17.96%,CACNA1C;KCNB1;SLC12A2;ADAM9;UNC13B;TGFB3;APBB3;TGFB2;P3H1;PRKCA;DISP1;LLGL1;CACNA2D2;EZR;STXBP5;GLP1R;ERP29;PICK1;IL6;STX1A;APBB1;SLC2A2;SYTL4;IER3IP1;GOLPH3
prerank,epithelial cell development (GO:0002064),0.3974121439223172,0.9172903219452995,0.5943877551020408,0.8659345864484824,1.0,2/20,3.83%,LRTOMT;PKHD1
prerank,regulation of TORC1 signaling (GO:1903432),0.368275893423752,0.9172824199179995,0.5971563981042654,0.8655403334509834,1.0,11/33,19.27%,SESN3;SEH1L;CLEC16A;CASTOR2;DGKQ;ATM;TELO2;SESN2;KLHL22;FLCN;KPTN
prerank,neuropeptide signaling pathway (GO:0007218),-0.23890261193055695,-0.9169800135156146,0.6354166666666666,0.807250838061463,1.0,15/58,23.92%,SORCS1;RAPGEF2;GLRA2;SORT1;OPRM1;CYSLTR1;NMU;NTS;GLRA1;NXPH2;PNOC;NMUR2;CYSLTR2;NXPH4;KISS1R
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.38998680868662894,0.9166579462827504,0.5923566878980892,0.8664335413370905,1.0,5/22,15.25%,GHR;CYP1B1;HES5;F2R;IL6
prerank,cytoplasmic microtubule organization (GO:0031122),0.34361867470551694,0.915467604650982,0.6218302094818081,0.8684201892780532,1.0,16/54,22.63%,LIMK2;DYNC1H1;CLIP4;TUBGCP3;DLG1;RHOA;SPAST;EZR;CHP1;PCM1;KATNA1;SLAIN2;DCTN1;CLIP2;CRIPT;CAMSAP3
prerank,establishment of spindle orientation (GO:0051294),0.3777767875881473,0.9154674018355461,0.5848375451263538,0.8680111952894243,1.0,7/28,22.48%,PKHD1;MISP;LLGL1;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3549545916911826,0.9153719755261134,0.5937859608745685,0.8677955420019571,1.0,4/39,7.96%,TCF7L2;MCU;AACS;CAPN10
prerank,regulation of actomyosin structure organization (GO:0110020),0.4251308019995167,0.915288612894643,0.5899864682002707,0.8675457532939593,1.0,3/13,6.93%,ASAP3;ALMS1;SLC9A1
prerank,response to cytokine (GO:0034097),0.3129095126432621,0.9152037860641079,0.6591375770020534,0.8672858564731385,1.0,20/141,10.68%,PID1;COL3A1;ADAM9;AFF3;TIMP2;TIMP3;DPYSL3;NFAT5;HDAC4;STAT3;PRKCA;ADAM10;IFNLR1;IRAK3;CXCL16;RHOA;PTPN18;MAPK8;ANXA1;IRAK1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.44430303430806695,0.9146683862844736,0.5994397759103641,0.8679247574570056,1.0,2/11,6.32%,LMNA;SMAD4
prerank,base-excision repair (GO:0006284),0.351369701252254,0.9146180629956613,0.6082949308755761,0.8676132564150788,1.0,24/48,34.68%,MPG;HUWE1;ERCC5;OGG1;WRN;TDG;SMUG1;PARP1;POLB;APEX2;USP47;PARG;POLD1;POLG;XPA;PNKP;ADPRS;MBD4;XRCC1;ERCC6;POLQ;RPA3;PRMT6;RFC4
prerank,regulation of response to biotic stimulus (GO:0002831),0.3716717804794827,0.9145767832280797,0.5850673194614443,0.8672856160673672,1.0,8/28,25.59%,FOXP1;TRAF3;N4BP1;APPL2;APPL1;BIRC3;XIAP;TKFC
prerank,hexose metabolic process (GO:0019318),0.3593420567218014,0.9143566803777621,0.5905963302752294,0.867311659904714,1.0,11/39,20.88%,FUOM;SORD;GAA;PMM2;ADPGK;AKR1A1;HECTD4;SLC37A4;SLC35A2;GDPGP1;FPGT
prerank,positive regulation of nuclear division (GO:0051785),-0.28873398682870366,-0.9141894523070377,0.5477386934673367,0.812089220727526,1.0,3/25,4.51%,INSR;TGFA;PDGFRB
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.39279115752282884,0.9137194147235455,0.5822454308093995,0.8681773131981917,1.0,1/21,0.44%,FOXP1
prerank,apoptotic process (GO:0006915),0.30959336189659736,0.913216674604976,0.6984924623115578,0.8687631868874824,1.0,43/203,20.15%,PLAGL1;PRKCD;EFNA5;CIT;PDCD4;PRKCE;MAGI3;FAP;RELT;TGFBR2;RAF1;MCM2;PAK4;IAPP;DAP;OGT;CSRNP1;ATN1;YARS1;AIFM1;TNFRSF10B;ERCC3;HSPD1;LIG4;ERCC2;MAP3K10;CASP1;DMPK;RHOB;ING4;CXCR4;PLSCR3;PARP1;HIP1;DAPK3;BNIP1;BID;AKT1;RFK;IRF3;NFKBIA;CDK5;TRAIP
prerank,cellular response to chemokine (GO:1990869),0.35109121808494315,0.9130875011110843,0.6050516647531573,0.868610420336626,1.0,5/46,9.02%,SLC12A2;CCL13;CCL15;STK39;RHOA
prerank,female gamete generation (GO:0007292),-0.28059651176048855,-0.912989744427189,0.5930232558139535,0.8133769826425407,1.0,13/29,22.56%,DIAPH2;PTN;FMN2;TOB2;SPO11;MEI4;MCM8;PRDM9;DMC1;MDK;NANOS3;NANOS1;TRIP13
prerank,regulation of macrophage cytokine production (GO:0010935),0.420832242810221,0.9127883228373891,0.5752461322081576,0.8687875564302185,1.0,3/13,7.13%,TGFB3;TGFB2;IRAK3
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3383765879793812,0.9127842945718195,0.6273637374860956,0.8683839734766006,1.0,15/57,21.81%,XPO1;LTV1;RRS1;EMG1;CUL4A;RIOK1;NVL;MRTO4;BYSL;BOP1;METTL17;NOC2L;WDR12;GTF3A;PAK1IP1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3457373120576382,0.9125512981184989,0.6133486766398158,0.8684239350105534,1.0,10/46,12.70%,SRGAP2;SRCIN1;TMEFF2;NTN4;EPHB3;ILK;RHOA;ITGAV;NRP1;PARVA
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.30717410039737236,0.9123168110595166,0.7326633165829146,0.8684895851586629,1.0,73/306,22.96%,ST3GAL4;EXT1;RRBP1;RPSA;HELB;TOPORS;BAZ2A;POLE2;EIF4G2;RMI2;ABCF1;MCM2;HARS2;ST3GAL2;GSPT1;CDC6;B4GALT5;RBBP8;RAD1;WRN;MRPS18B;ING5;NFKBIB;TERT;ATM;GAL3ST4;RAD50;MRPS14;EEF1G;XAB2;AGO2;EIF4G1;CDC45;MRPL35;INHBA;MEF2A;MMS19;POLR2F;MRPS17;ING4;EEF2K;ATRIP;B3GNT6;RPS27A;HUS1;MCM4;EEF1B2;YARS2;REV1;TUFM;ORC2;GOLPH3;E2F1;EEFSEC;DBF4;EXT2;SARS1;CDK2;RPL7A;DARS1;KAT7;TBRG1;MED20;GTPBP2;UPF1;POLR2B;TOPBP1;MRPS21;ASMT;PTMS;TOP1;DONSON;TOP1MT
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.4499580034342662,0.9122469715188238,0.5874125874125874,0.8682073325303941,1.0,3/10,13.92%,ADAM10;STK39;WNK1
prerank,regulation of microtubule-based process (GO:0032886),0.36198067532556555,0.9121801084574767,0.6197183098591549,0.8679300177709751,1.0,10/36,26.63%,EFNA5;PHLDB1;MARK4;HDAC6;ERBB2;CAMSAP3;CYLD;ROCK1;TAOK1;ATF5
prerank,cellular protein metabolic process (GO:0044267),0.3049776488969209,0.9120459327691343,0.765,0.867793557144969,1.0,94/396,24.20%,PLOD2;ST8SIA2;IGFBP5;CHRDL1;FSTL1;PCSK5;GAS6;RRBP1;RPSA;GPC3;P4HB;DMP1;TGM5;PAPPA;GGCX;HM13;PRKCSH;PRKDC;ADAM10;SPG7;LOX;ABCF1;QSOX1;CKAP4;MBTPS1;NAGPA;HARS2;AKT2;GSPT1;CST3;WWP2;CALU;BMP4;MRPS18B;RIPK3;RCN1;ABL1;LCMT1;FDXR;CHEK2;FBXO22;ATG3;MRPS14;AGO2;EIF4G1;CCDC59;MRPL35;SPCS2;NUCB1;MIA3;MRPS17;UBE2L6;PSEN2;IL6;IDE;VCAN;LIPT1;RPS27A;YARS2;GNMT;NTAQ1;PCMT1;MEN1;NAPSA;ARAF;IGFBP6;DMBT1;FBXW2;SARS1;UBE2G2;RPL7A;APLP2;SEC11A;DARS1;PENK;CSNK1G3;MRPS21;LOXL2;ASMT;CDKL3;STK38;UBA3;MMP2;AFG3L2;MAN2B1;B4GALT7;STOML2;FBXO11;MRPS18A;VGF;RPS9;PHEX;PHKA2;MRPL37
prerank,protein homotetramerization (GO:0051289),0.34504110465166765,0.9118761252773069,0.6189931350114416,0.8677141826956517,1.0,12/49,19.90%,KCNJ2;CRYZ;TRPM4;CBR4;ACACA;PKD2L1;SHMT2;GNMT;ACOT13;SHMT1;TK1;APPL2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.2892621206564325,-0.9114343506671216,0.6457142857142857,0.8155303664242181,1.0,6/26,12.06%,INSR;SMAD3;KLF2;ASS1;EDN1;DDAH2
prerank,transcription by RNA polymerase III (GO:0006383),0.3782963890636229,0.9113612831194222,0.6102564102564103,0.8683231950569946,1.0,10/27,22.66%,POLR3H;CRCP;POLR3GL;SNAPC4;GTF3C1;GTF3C4;POLR3K;GTF3A;TBP;ICE1
prerank,Fc receptor signaling pathway (GO:0038093),0.31758555228541846,0.9110123234881644,0.6670146137787056,0.8686079319570864,1.0,32/110,23.95%,GAB2;VAV2;PSMD7;SHC1;PSMA8;FCER1G;NFATC1;PAK2;MAPK8;PSMA4;CHUK;TAB2;PDPK1;PSMD12;PIK3CB;CUL1;PSMA6;NFATC3;PSMD1;SOS1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;MAPK9;MAP2K7;PSMB1;PSMD4;PSMA5;PSMA7;FOS
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3287256710578768,0.9108367869760662,0.6314655172413793,0.8685497337790558,1.0,11/73,13.12%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;FCER1G;WIPF1;ABL1;PIK3CB;MYH2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3342512684536295,0.9107225116949398,0.6278563656147987,0.868373226623299,1.0,11/67,12.40%,PGF;VEGFA;VAV2;SULF1;ABI1;CYFIP1;RHOA;PAK2;ITGAV;PIK3CB;NRP1
prerank,myelin assembly (GO:0032288),0.4518805027004487,0.9105107517270884,0.5949008498583569,0.8683664283723996,1.0,3/10,12.74%,PMP22;CD9;NCMAP
prerank,negative regulation of protein transport (GO:0051224),0.37624398974744183,0.9104008062420433,0.5933926302414231,0.8681794639026785,1.0,8/25,26.36%,PKDCC;WWP2;ERP29;DRD2;CSK;SNX3;HMGCR;NDFIP1
prerank,heterochromatin assembly (GO:0031507),0.3942863768283279,0.9101348803216133,0.5875486381322957,0.868275138348701,1.0,6/20,20.79%,BAZ2A;EZH1;HDAC1;SIRT2;HMGA1;SUV39H1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.22973543849866582,-0.910049647838828,0.7,0.8170812073774829,1.0,21/69,24.19%,COX8A;COX6C;NDUFC2;COX4I1;CYC1;UQCRC2;UQCR11;COX10;NDUFA13;NDUFB2;UQCRB;NDUFAF1;NDUFB7;COX5B;UQCRC1;NDUFS1;NDUFA8;NDUFB11;UQCRQ;NDUFS6;NDUFA4
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.33301522036444775,0.9094090323358979,0.6418554476806904,0.8692967923228947,1.0,37/72,37.42%,CHD1L;HORMAD1;PNRC2;ERCC5;ERCC4;RNASE6;OGG1;CUL4A;ERCC3;RAD50;ERCC2;PARP1;UBC;RPS27A;DCP1A;POLD1;GTF2H4;XPA;FBH1;DNASE1L2;DDB1;EDC4;DXO;RBX1;RNASE1;IHO1;ERCC1;POLK;RPA3;CUL4B;FAN1;RFC4;MRE11;DCP1B;POLD3;REXO4;MUS81
prerank,regulation of synapse maturation (GO:0090128),-0.3666062425577757,-0.9092111916628528,0.5432098765432098,0.8175022993168751,1.0,4/10,13.90%,NRXN1;ARHGEF15;YWHAZ;RELN
prerank,glycolipid metabolic process (GO:0006664),0.3438762332175522,0.9090746276677409,0.6141367323290846,0.8695699167992558,1.0,10/47,19.41%,ST3GAL4;PIGW;SMPD4;ARSA;ST3GAL2;GALC;HEXA;GLB1;SUMF2;ASAH1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.35574807422130106,-0.90898490199349,0.5985130111524164,0.8164279288906138,1.0,9/11,42.08%,PRKCQ;NFKBIZ;MALT1;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,positive regulation of transferase activity (GO:0051347),0.31366348145337797,0.9089316376254771,0.6776180698151951,0.8694510497768675,1.0,23/142,12.60%,EGFR;DDR2;NTRK3;NTRK1;MAPK15;EPHB2;TOPORS;EPHB3;EPHB6;DCUN1D5;NEK7;FGFR1;HNRNPA2B1;ROR1;FGFR2;MUSK;NVL;LMO4;AXIN1;PABPN1;DDR1;RAD50;DCUN1D2
prerank,pancreas development (GO:0031016),0.4287485891363604,0.9087354656229107,0.6047819971870605,0.8694042875174532,1.0,3/12,16.19%,TCF7L2;CCDC39;NPHP3
prerank,regulation of T cell proliferation (GO:0042129),0.3326612950242298,0.9085473849456263,0.6299126637554585,0.8693724251760908,1.0,13/61,23.45%,SPN;GLMN;CD3E;TNFRSF1B;ANXA1;RIPK3;VTCN1;CD80;IL6;TNFSF18;IL4;GPNMB;DLG5
prerank,negative regulation of neuron death (GO:1901215),0.3193091671747485,0.9084191242542828,0.6497890295358649,0.8692171567316036,1.0,23/93,22.98%,SIX1;NTRK1;TGFB3;SIX4;ATF4;TNFRSF1B;NRBP2;SOD1;EIF4G1;LIG4;F2R;NDNF;CLCF1;CLN3;AKT1;GDNF;CDK5;NFATC4;CHMP4A;CHMP4B;LRRK2;PRKCI;GPNMB
prerank,positive regulation of cation channel activity (GO:2001259),0.3486856767728226,0.9079771008457763,0.6118881118881119,0.8697025796912674,1.0,8/40,16.85%,EPHB2;ARC;CALM2;ANK2;KCNIP2;P2RY6;STAC3;CALM3
prerank,regulation of protein ubiquitination (GO:0031396),0.316277331504195,0.9078779839453959,0.6501547987616099,0.8694823963777881,1.0,40/108,30.44%,PRR7;PRICKLE1;NXN;HUWE1;CDK5RAP3;OGT;AXIN1;SMAD7;CHP1;TGFBR1;PHF23;UBQLN1;U2AF2;SQSTM1;ARRB1;STUB1;N4BP1;MINAR1;UFL1;AKT1;DNAJA1;MYCBP2;LRRK2;BIRC3;DERL1;USP4;CAMLG;GTPBP4;PINK1;RCHY1;XIAP;DAXX;NDFIP1;RIPK2;SVBP;PER2;SPOPL;PRMT3;PRKN;HSP90AA1
prerank,aggrephagy (GO:0035973),0.36788284072205657,0.907337315770561,0.5961538461538461,0.8701280431024236,1.0,10/27,22.03%,DYNC1H1;DYNC1LI2;UBQLN1;SQSTM1;HDAC6;IFT88;UBC;RPS27A;DYNC1I2;ACBD5
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.41214675425697267,0.9071270206800516,0.6090534979423868,0.8701186142378928,1.0,5/15,16.21%,CAMK2D;PRKCA;SLC9A1;MEF2A;PARP1
prerank,heterocycle biosynthetic process (GO:0018130),0.41670236155314544,0.9071194738304248,0.5953360768175583,0.8697304878413881,1.0,4/14,22.41%,LIAS;NFS1;NOXRED1;PYCR1
prerank,negative regulation of gene expression (GO:0010629),0.30574645864377675,0.9069473600785017,0.759,0.8696523024739006,1.0,57/302,18.44%,ESR1;FOXP1;ID2;IGFBP5;VEGFA;FGF2;SLC24A3;EMILIN1;NCOR2;ANXA7;SAMD4A;HDAC9;TGFB2;CD3E;XDH;PHF1;ADAM10;RPS6KA4;TRIM27;DGKQ;ZC3H12D;WWP2;ILF3;BMP4;AGO1;DIS3L2;TERT;BMPR1A;METTL16;KDM4A;CIDEA;PTRH2;HDAC1;AGO2;SMO;RBBP7;SETDB1;LSM2;ERP29;PTBP1;RBM4;RUNX1;ZNF148;VDR;CNOT8;N4BP1;ZC3H10;CNOT10;RBL2;SLC2A10;FLCN;EPRS1;CITED2;DAPK3;TRIM6;CNOT9;SHMT1
prerank,cholesterol transport (GO:0030301),0.34940115831659035,0.9068881478020877,0.6346368715083799,0.8693660483830279,1.0,16/45,28.04%,LIMA1;SOAT1;CEL;TSKU;AKR1C1;NPC1;OSBP;ABCA1;CLU;STARD5;LDLR;STARD3;SERAC1;SOAT2;NPC2;OSBPL5
prerank,outer dynein arm assembly (GO:0036158),0.41524075613744904,0.9068445093158897,0.5951417004048583,0.8690541699459123,1.0,5/14,26.04%,DNAH8;ODAD2;DNAAF4;DNAAF5;DNAL1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3096583929390859,0.906823537895226,0.6899696048632219,0.8686963701013577,1.0,16/159,6.39%,PCDHB16;PKD1;CDH11;GPC6;EMB;HMCN1;PTPRS;PTPRF;TGFB2;NECTIN3;LRFN4;CRB1;ACVR1;AMIGO3;FAT2;TGFBR2
prerank,positive chemotaxis (GO:0050918),0.40124442954115414,0.9065351986198295,0.610608020698577,0.8688335893730978,1.0,1/17,0.78%,VEGFA
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.4279681498818088,0.9064451932555713,0.5884831460674157,0.8686188821338343,1.0,4/12,22.12%,CDC6;CHEK2;HUS1;TOPBP1
prerank,regulation of cell adhesion (GO:0030155),0.31559703172726344,0.9063201313314254,0.676560900716479,0.8684662101107067,1.0,12/129,6.35%,PLXNA4;ZFHX3;VEGFA;EFNA5;P4HB;TGFBI;EPHB2;SPN;PKHD1;PRKCA;EPHB3;ADAM10
prerank,actin filament network formation (GO:0051639),0.43973968979454536,0.9059891686085874,0.6026587887740029,0.8686937506381636,1.0,2/11,4.03%,PLS1;COBL
prerank,axonal transport of mitochondrion (GO:0019896),0.43515483684601197,0.9056016278083588,0.5955882352941176,0.8690036063790376,1.0,4/11,22.20%,SYBU;SPAST;ACTR10;NEFL
prerank,second-messenger-mediated signaling (GO:0019932),-0.22950605519358244,-0.9053861346560804,0.6888888888888889,0.8230139071896401,1.0,18/82,12.06%,APOE;MCTP1;NOS3;CCR9;RYR2;GUCY1B1;DGKD;NUDT4;MCTP2;AGTR1;SPHK1;KSR2;EDNRB;EDN1;CX3CR1;NOS1;CHRM3;DDAH2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.36450592329546216,0.9051380056943957,0.5950617283950618,0.8694975053825245,1.0,10/30,26.25%,CHUK;TRAF3;TANK;UBC;RPS27A;IKBKE;IRF3;BIRC3;TBK1;RIPK1
prerank,regulation of Golgi organization (GO:1903358),0.40132610210374264,0.9049843716017134,0.6007957559681698,0.869382479647016,1.0,7/17,33.62%,STX5;AKAP9;ARMH3;CAMSAP3;MYO5A;EHD3;STX18
prerank,monocyte differentiation (GO:0030224),0.4475993580898447,0.904405115087772,0.5857558139534884,0.8700875305732214,1.0,2/10,9.70%,VEGFA;BMP4
prerank,negative regulation of ATPase activity (GO:0032780),-0.3160809894975566,-0.9042300303224764,0.6307053941908713,0.8240778231389435,1.0,5/16,20.67%,IFIT1;SIRT1;VCPKMT;PXK;PPIF
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3022865517256816,-0.9038950839763664,0.6093023255813953,0.8232482750947472,1.0,5/21,9.39%,ADCY5;GUCY1B1;ADCY1;ADCY4;NPR1
prerank,lipid droplet organization (GO:0034389),0.37404980428052254,0.9037099162687238,0.5791505791505791,0.8710183417903303,1.0,10/22,29.50%,RAB3GAP1;FAF2;CIDEA;PNPLA3;CDS1;RAB18;FITM2;PPID;ZFYVE1;SQLE
prerank,regulation of Rho protein signal transduction (GO:0035023),0.3243768979828629,0.9036961002252716,0.6451259583789705,0.8706433480423542,1.0,14/72,15.26%,MYOC;COL3A1;ARHGEF28;EPS8L1;BCR;RAF1;GPR20;ABL1;NRP1;SCAI;F2R;ABCA1;AKAP13;ARRB1
prerank,synapse organization (GO:0050808),0.3106022461789954,0.9035465477540369,0.6683778234086243,0.8705142130160698,1.0,13/125,5.69%,PCDHB16;GPC6;CTNND2;NEDD4;FARP1;DRD1;UNC13B;PTPRS;PTPRF;SEMA3E;LRFN4;PPFIA1;DVL1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.28994605271100216,-0.9034161810940733,0.5771144278606966,0.8227760195631333,1.0,6/23,17.83%,CECR2;KPNA1;H1-0;KPNB1;DNASE1L1;FOXL2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4272116944284177,0.9034112146088595,0.5895627644569816,0.8703700319876265,1.0,4/13,14.76%,DKK3;SOD1;BMP5;CYP27B1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4526626774709109,0.9028775757884826,0.6073446327683616,0.8709783787883013,1.0,5/10,19.87%,MTHFD2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.30840867406820144,0.9027796377846514,0.6842105263157895,0.8707670843689678,1.0,35/161,16.37%,LRP6;TCF7L2;SFRP4;PRICKLE1;DKK3;PSMD7;TLE2;WWTR1;PTPRU;TLE6;PSMA8;DACT1;DVL1;SOX9;NOG;DACT3;TLE3;PSMA4;TPBG;AXIN1;INVS;PSMD12;HDAC1;PSMA6;LIMD1;DAB2;FUZ;PSMD1;PSMC5;LATS2;PSMD11;MLLT3;NPHP3;PSMC4;PSMD14
prerank,rRNA methylation (GO:0031167),0.38727656270896704,0.9026097158105632,0.6122715404699739,0.8706941178289016,1.0,12/22,38.19%,EMG1;METTL16;TFB2M;FBL;BUD23;TRMT112;NSUN3;METTL15;MRM2;ZCCHC4;NSUN5;DIMT1
prerank,neutrophil chemotaxis (GO:0030593),0.34188319938717016,0.9024282685924044,0.6351351351351351,0.8706381904915361,1.0,6/53,9.28%,CCL13;CCL15;TGFB2;GBF1;FCER1G;EDN3
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.30771912934949297,-0.9024200793316682,0.5967078189300411,0.8234169655177503,1.0,4/18,8.78%,PPARA;PAG1;DUSP3;ASS1
prerank,tRNA wobble base modification (GO:0002097),0.4082192664416775,0.9021757589102007,0.605890603085554,0.8707249056405292,1.0,6/14,24.87%,ALKBH1;CTU2;ELP4;ALKBH8;ELP3;MTO1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.42850788651649757,0.902153084190281,0.6104972375690608,0.8703610506926953,1.0,4/12,21.41%,RDX;BRD8;KLF9;CTSB
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3295863658295989,0.9020564024673303,0.6473799126637555,0.8701230416128581,1.0,9/66,15.25%,FOXP1;CARD16;STAT3;USP50;FZD5;GIT1;F2R;CASP1;IL6
prerank,regulation of centrosome duplication (GO:0010824),0.3648895676602504,0.9018728937534011,0.6177184466019418,0.8700615273476868,1.0,10/29,28.53%,PKHD1;ALMS1;CHMP3;CHMP4B;PDCD6IP;XRCC3;TMEM67;CHMP2A;SPICE1;STIL
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3685314377127868,0.9017901831371905,0.6132530120481928,0.8698160944683925,1.0,2/27,7.13%,GAS6;IRAK3
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.31390203916212345,0.9015808228828077,0.6820512820512821,0.8698307125689025,1.0,26/124,16.37%,TCF7L2;SFRP4;TIAM1;PRICKLE1;PSMD7;PDE6A;AP2A1;PSMA8;DVL1;FZD7;FZD5;NFATC1;RHOA;PSMA4;AGO1;PSMD12;AGO2;PSMA6;AP2A2;CLTC;GNAO1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14
prerank,negative regulation of blood pressure (GO:0045776),-0.3484500505198259,-0.9015753666825405,0.5698529411764706,0.8237533202095555,1.0,7/13,29.23%,NOS3;BMPR2;NOS1;APLN;PRCP;NOS2;DRD3
prerank,genitalia development (GO:0048806),0.4308914645899445,0.9015186076379889,0.5949367088607594,0.8695581771167533,1.0,1/12,0.46%,PKD1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.4047684568992711,0.9001128167552724,0.5963060686015831,0.8718397182091245,1.0,4/17,15.26%,ANXA4;ANXA1;MAPKBP1;ARRB1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.36852357662693636,-0.900093697977572,0.584192439862543,0.825527428051714,1.0,4/10,18.25%,MTMR3;MFSD2A;DNAJC19;PHB2
prerank,protein neddylation (GO:0045116),0.42903782979580407,0.900019625250355,0.6166902404526167,0.8716126493684793,1.0,5/13,28.90%,DCUN1D5;DCUN1D2;RNF7;UBA3;RBX1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.39876919121624216,0.8998396594901347,0.6142131979695431,0.8715542743804577,1.0,3/18,7.76%,VEGFA;ADCY8;RPS6KA4
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.43500831647893,0.8992618292656465,0.6043478260869565,0.8722476300279355,1.0,4/10,27.83%,NCBP1;NCBP2;PAF1;HSF1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.41744311218469865,0.8990759070303278,0.5997191011235955,0.8722200381814015,1.0,4/14,18.37%,ADAM10;BACE1;PSEN2;CLN3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3437618316919404,-0.8989678177706426,0.5616883116883117,0.8266291960284137,1.0,10/13,36.62%,UNC93B1;MYD88;PIK3R4;TLR7;PIK3AP1;IRAK2;TNIP2;TRAF6;IRAK4;PIK3C3
prerank,positive regulation of protein secretion (GO:0050714),0.3321582948335777,0.8989239231130355,0.6454445664105378,0.8721227075739453,1.0,9/69,7.96%,ADAM9;TCF7L2;UNC13B;TGFB3;APBB3;TGFB2;MCU;AACS;CAPN10
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3921493607086055,0.898532275307272,0.5961290322580645,0.8724639123077711,1.0,4/19,9.84%,VEGFA;PTPRU;DENND6A;FOXA1
prerank,nucleocytoplasmic transport (GO:0006913),0.3488373313367755,0.8983693967371413,0.6210892236384704,0.8723651925269037,1.0,12/40,25.89%,XPO1;SNUPN;GEMIN7;NCBP1;SMN1;NCBP2;RITA1;SNRPB;GEMIN2;HNRNPA1;NUTF2;DDX20
prerank,toll-like receptor signaling pathway (GO:0002224),0.3192494167866111,0.8981879155754457,0.6445147679324894,0.8723089104192912,1.0,17/84,22.33%,LBP;SCARA3;HMGB1;IRAK3;CHUK;IRAK1;TAB2;TRAF3;HSPD1;S100A1;COLEC12;UBC;RPS27A;CTSB;TLR1;CTSK;BIRC3
prerank,regulation of cartilage development (GO:0061035),0.40125971990693166,0.8977684924479802,0.611764705882353,0.8727100961933174,1.0,6/18,14.91%,BMP1;MBOAT2;SOX9;BMP4;KAT2A;SCIN
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.313324078228887,0.8977257283358225,0.6770186335403726,0.8723875722315362,1.0,16/107,11.18%,SLC39A14;ATP1B1;SLC24A3;CCL13;PKHD1;CCL15;SLC39A7;SLC10A7;ANK2;CHERP;STIM1;EDN3;SLC30A5;SLC39A13;CSRP3;TMEM165
prerank,macromolecule catabolic process (GO:0009057),0.36995381890483436,0.8975294651132202,0.5965130759651308,0.8723950185139081,1.0,7/26,23.52%,NEDD4;LRSAM1;UCHL3;IDE;MVB12A;UVRAG;USE1
prerank,regulation of rRNA processing (GO:2000232),0.4080092431520263,0.8968294488156286,0.6013422818791946,0.8732864952079892,1.0,12/16,38.90%,RIOK1;USP36;KAT2B;WDR75;BUD23;RIOK2;TRMT112;SIRT7;UTP15;DIMT1;YTHDF2;WDR43
prerank,neuron projection extension (GO:1990138),-0.2660893081142702,-0.896753391292993,0.6888888888888889,0.8302209607818178,1.0,6/32,7.63%,ALCAM;AUTS2;SEMA5A;NRP2;FLRT1;SH3GL2
prerank,regulation of RNA export from nucleus (GO:0046831),0.431635251700201,0.896282741632258,0.6191176470588236,0.873964541528002,1.0,5/11,26.41%,KHDRBS1;CPSF6;NCBP2;SETD2;TPR
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.36672644700334206,0.8960157041313924,0.6371158392434988,0.8740457318406425,1.0,11/29,22.71%,ACSF3;ELOVL5;SCD5;CBR4;PPT2;ACACA;ACSL3;HSD17B8;ACSL6;ACSBG1;GCDH
prerank,positive regulation of DNA recombination (GO:0045911),0.3656102503205044,0.8957957655064847,0.6015037593984962,0.8740605792671138,1.0,13/27,30.17%,FUS;KMT5C;WDR48;ERCC2;MMS19;PARP1;MAD2L2;ACTR2;WAS;SHLD3;SHLD1;HMCES;TIMELESS
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.36213565881184706,-0.8957020028579398,0.5866261398176292,0.8310454741069856,1.0,5/10,16.31%,LPGAT1;NR1H3;SLC45A3;MID1IP1;ABCD2
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.3525031000772093,-0.8948587260303621,0.6164874551971327,0.8313312976510573,1.0,2/11,8.10%,ABCG1;AGTR1
prerank,ganglioside metabolic process (GO:0001573),0.3866348879174499,0.8948163813124459,0.6074646074646075,0.8755195082574411,1.0,2/20,4.39%,ST8SIA2;ST6GALNAC5
prerank,negative regulation of cell aging (GO:0090344),-0.3143597940847213,-0.8946189344883024,0.6401673640167364,0.8303257644762078,1.0,3/16,2.72%,CDK6;SLC30A10;AKT3
prerank,membrane depolarization (GO:0051899),0.36719797342292765,0.8946015616624795,0.6248477466504263,0.8754946717790428,1.0,4/32,10.58%,CACNA1G;SCN11A;CHRNB2;ABL1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.33612711707825776,0.8942876737421613,0.6349557522123894,0.8756987628461791,1.0,9/51,12.60%,MYOC;TGFB3;SORBS3;S100A10;PFN2;RHOA;ABL1;NRP1;TGFBR1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.32534807865606263,0.8941306734698993,0.6553238199780461,0.8756036414363725,1.0,16/70,17.24%,SRGAP2;SRCIN1;TMEFF2;PKHD1;NTN4;ATF4;EPHB3;ILK;RHOA;ITGAV;NRP1;PARVA;SIPA1L3;MICALL2;TBCD;EFNA1
prerank,negative regulation of neuron projection development (GO:0010977),-0.2334958789063527,-0.8941122344840655,0.7380952380952381,0.8299632467298065,1.0,20/56,20.00%,EFNB2;LPAR1;APOE;EPHA4;PTPRO;PTPN9;ARHGDIA;DCC;PRAG1;BAG5;MCF2;DENND5A;SPOCK1;MAG;TRPV4;MT3;LRP4;THY1;RTN4R;BCL11A
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.34676625982557163,0.8938633088876206,0.6326530612244898,0.87572054734464,1.0,10/37,21.99%,PDCD4;CHID1;STAT3;PER1;IL6;ADCY7;APPL2;APPL1;IL17RA;ABCD1
prerank,eosinophil migration (GO:0072677),0.40869373624270244,0.8937008723708335,0.6081632653061224,0.8752323769173571,1.0,1/14,3.10%,CCL13
prerank,eosinophil chemotaxis (GO:0048245),0.40869373624270244,0.8937008723708335,0.6081632653061224,0.8752323769173571,1.0,1/14,3.10%,CCL13
prerank,positive regulation of cellular protein localization (GO:1903829),0.327623767844032,0.8936461787934658,0.6579520697167756,0.874944982128239,1.0,16/69,20.87%,GNL3;WWTR1;LIMK2;TM9SF4;MEAK7;RIC3;CDK5RAP3;TRAPPC12;SESN2;MARK4;STX4;ORMDL3;CDT1;AKT1;KAT7;NUP62
prerank,steroid metabolic process (GO:0008202),0.32086428171242526,0.8935742247002857,0.6347826086956522,0.8746885870674649,1.0,13/72,17.48%,CYP19A1;CYP1B1;AKR1C1;NPC1;FDXR;DHRS4;LRP2;DHRS9;PIAS4;VDR;CYP27B1;LSS;PRLR
prerank,protein autophosphorylation (GO:0046777),0.3058198422319927,0.8930346080963467,0.7142857142857143,0.875296790938905,1.0,40/157,18.69%,EGFR;DDR2;ULK2;NTRK1;ACVR1B;MAPK15;CAMK2D;TNK1;EPHB3;STK39;FGFR1;CDK12;PAK2;FGFR2;SMG1;MUSK;RIPK3;ABL1;IRAK1;MAP3K12;ATM;CHEK2;PDPK1;DDR1;UHMK1;STK25;SRMS;MAP3K10;EEF2K;MAP3K3;CAMK4;ERBB2;STK16;MKNK2;SIK2;DAPK3;CAD;VRK2;CLK2;AKT1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.410662009865581,0.8929117171558846,0.5902964959568733,0.8751226661174328,1.0,3/15,12.70%,PABPC1;TENT4B;AGO2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3490034867222872,0.8928215987856262,0.6163742690058479,0.8748823390721334,1.0,4/39,6.52%,VEGFA;FXYD5;RDX;JAG1
prerank,positive regulation of telomere capping (GO:1904355),0.3974822265932358,0.8925132637521378,0.6310810810810811,0.8750600633569272,1.0,6/17,27.39%,MAPK15;NEK7;TNKS2;MAP2K7;RTEL1;PNKP
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.3993450594202529,0.8924808351982331,0.6203208556149733,0.8747392496659064,1.0,2/17,2.89%,PDCD4;TGFB3
prerank,retrograde axonal transport (GO:0008090),0.4033861477310824,0.8918690134810936,0.6196808510638298,0.8754686765078509,1.0,5/16,22.20%,DLG2;DYNC1H1;SOD1;ACTR10;NEFL
prerank,response to interleukin-1 (GO:0070555),0.3214973283311313,0.8918140666310264,0.6566523605150214,0.8752006898084479,1.0,10/73,13.03%,PTGIS;CCL13;HDAC4;CCL15;PRKCA;IRAK3;SOX9;ANXA1;IRAK1;TANK
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.34861293205761307,-0.891433006805718,0.6,0.8341359096824968,1.0,2/12,3.61%,SEMA6A;ADAMTS12
prerank,protein acetylation (GO:0006473),0.36403727938546715,0.8913784561772394,0.6243961352657005,0.8756297270192643,1.0,9/30,26.59%,NAA60;NAA40;ING5;NAA16;ING4;CREBBP;KAT2B;NAA15;ESCO1
prerank,negative regulation of cation channel activity (GO:2001258),0.36954148118905517,0.8911974575974999,0.6260762607626076,0.8755843108850543,1.0,7/26,24.25%,EPHB2;CALM2;UBQLN1;CALM3;DRD2;FKBP1B;CBARP
prerank,negative regulation of wound healing (GO:0061045),0.3619553454428534,0.8910145039325471,0.6289537712895377,0.8755267857391972,1.0,2/28,1.20%,FGF2;SLC12A2
prerank,leukotriene biosynthetic process (GO:0019370),0.41516210640865714,0.890482112824967,0.6443850267379679,0.8761242187797982,1.0,2/14,9.98%,PLA2G4A;PLA2G5
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.25231209032738233,-0.8903599566450523,0.7155963302752294,0.8350141275057708,1.0,14/45,18.88%,WNT5A;APP;AIM2;GBP5;HSPB1;EGR1;LPL;LGALS9;TRIM16;TYROBP;NOD2;PYCARD;MYD88;P2RX7
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.41583636649419475,0.8898185755935629,0.635116598079561,0.8769558013506201,1.0,6/13,23.14%,UBA5;SAE1;DESI2;DESI1;UBA3;SENP6
prerank,androgen metabolic process (GO:0008209),0.38888355571629885,0.8897141852809516,0.6188579017264276,0.8767593225404101,1.0,2/18,13.20%,CYP19A1;DHRS9
prerank,protein catabolic process (GO:0030163),0.32804559855997234,0.8892961262491806,0.6545253863134658,0.8771492136671931,1.0,25/59,30.44%,VCP;LRSAM1;PSMA8;SOCS6;DDI2;UCHL3;CHEK2;ATE1;NGLY1;FBXO17;IDE;UBE2G2;LAMP2;USE1;OGA;ADAMTS9;HTRA2;RIPK1;CLN5;MANBA;DDB1;STT3B;NR1D1;PRKN;HSP90AA1
prerank,positive regulation of cellular component organization (GO:0051130),0.31448369431716117,0.8892083135764848,0.7004175365344467,0.8769047831274649,1.0,31/107,22.66%,TRABD2B;VEGFA;LRP1;MPP7;GPC3;TGFB3;TGFB2;VCP;CDC42EP2;SLF2;PLEKHM2;SPIDR;NEUROD2;TMED9;TGFBR1;ADD1;RUNX1;DAB2;ANAPC2;SUMO1;CD151;CDT1;BID;CDC20;PTPN23;DCTN1;CLU;SLF1;LMAN1;CAMK1;ICE1
prerank,cellular lipid catabolic process (GO:0044242),0.372825466427926,0.8886367813811245,0.6254728877679697,0.8776250121603439,1.0,9/27,26.42%,CYP1B1;CEL;SIRT2;PLA2G15;ACBD5;ABHD12;ACOT8;FAAH;ANGPTL3
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.31623184422820855,0.8882129514192257,0.6796116504854369,0.878022509949058,1.0,18/75,20.97%,LRP6;PRKCD;LRP5;IPO5;IRAK3;CDK5RAP3;BMP4;PAQR3;ABL1;PIK3CB;HEXIM1;LATS2;NF1;CDKN1C;MEN1;AKT1;UCHL1;PRKAR2A
prerank,regulation of store-operated calcium entry (GO:2001256),0.4394856715438935,0.8879700777413393,0.6215827338129496,0.8780775350686032,1.0,5/10,23.25%,STIM1;EFHB;SARAF;HOMER2;SLC8B1
prerank,regulation of ruffle assembly (GO:1900027),0.3833641125033279,0.8876454565308006,0.6254728877679697,0.8783037152664102,1.0,7/23,14.67%,RDX;EPS8L1;PFN2;FAM98A;NLGN1;NDEL1;PLEKHM1
prerank,regulation of lipid storage (GO:0010883),0.3779827061868409,0.8874030664869534,0.6354430379746835,0.8783361655607698,1.0,7/22,19.72%,FTO;ITGAV;PTPN2;IL6;MEST;IKBKE;NFKBIA
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.41966184079603375,0.8869809802597973,0.638095238095238,0.8787227780402507,1.0,3/14,13.12%,RARA;ANXA1;CD80
prerank,protein localization to mitochondrion (GO:0070585),0.43083168652459614,0.8869500398649014,0.6178977272727273,0.8783821805104429,1.0,6/11,27.27%,AKT1;DNAJA1;COX18;LRRK2;PINK1;RALA
prerank,sulfur compound catabolic process (GO:0044273),0.35234289364525484,0.8869332683869645,0.6507566938300349,0.8780235465043986,1.0,12/38,25.11%,BGN;ARSB;CSPG4;MPST;ACAT1;HEXA;VCAN;GLB1;CHAC2;DPEP1;FITM2;GNS
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.2864048219531281,-0.8866578273547847,0.6170212765957447,0.8416524867917543,1.0,5/23,7.32%,ACSL1;ELOVL7;HACD1;FAR2;HSD17B12
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3230836883570635,0.8856543402965031,0.6634512325830654,0.8799583414176201,1.0,11/67,11.74%,EGFR;PKDCC;DDR2;NTRK1;GHR;EPHB2;ABI1;FGFR1;FGFR2;ABL1;DDR1
prerank,isotype switching (GO:0045190),0.4441936375248156,0.8854585651720424,0.6507936507936508,0.879901028949694,1.0,6/10,38.41%,HSPD1;LIG4;MSH2;EXOSC3;RNF8;RNF168
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3412358683295621,0.8854472806488922,0.6501726121979287,0.8795225383143233,1.0,19/43,32.51%,INTS3;CDC6;CDK5RAP3;ATM;RINT1;FOXN3;HUS1;BRCC3;TOPBP1;DONSON;TAOK3;TAOK2;TAOK1;NOP53;TRIM39;PABIR1;RAD17;BLM;CHFR
prerank,oligodendrocyte differentiation (GO:0048709),-0.30443967571499464,-0.8852350354300248,0.6473029045643154,0.8432369261874719,1.0,4/19,8.51%,SOX13;SOX6;SLC8A3;EIF2B3
prerank,ether lipid metabolic process (GO:0046485),0.41608212255663635,0.8850023186556327,0.6471389645776566,0.8799446447923512,1.0,6/14,27.70%,PEX7;FAR1;AGMO;AGPS;NCEH1;TMEM86B
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3975588475721062,0.8847807675066227,0.6205533596837944,0.8799824928070079,1.0,2/16,4.39%,ST8SIA2;ST6GALNAC5
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.373226816870259,0.8839316477394259,0.6298200514138818,0.8811464462231432,1.0,1/21,0.78%,VEGFA
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3695033715290534,0.8838908301169609,0.6246851385390428,0.8808211465527366,1.0,5/26,8.56%,IRS1;RHOQ;C2CD5;CAPN10;AKT2
prerank,regulation of myoblast fusion (GO:1901739),0.4328447892405701,0.883860588857362,0.6340740740740741,0.8804823190088775,1.0,2/11,7.40%,EHD1;EHD2
prerank,regulation of defense response (GO:0031347),0.3189284153750418,0.8836369807358717,0.6854663774403471,0.8804984713098916,1.0,22/76,25.59%,MGLL;FOXP1;SHPK;BRD4;SBNO2;ANXA1;NR1D2;TRAF3;PSMA6;CASP1;N4BP1;PTGES;UFL1;APPL2;APPL1;DAGLB;BIRC3;AREL1;CYLD;BST1;XIAP;TKFC
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3204964446388612,-0.883621491400439,0.64,0.8453555427198527,1.0,5/15,15.92%,DGKD;HIP1R;AAK1;TNK2;BMP2K
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.36040815630423906,0.8834968423882694,0.6280193236714976,0.8803622910363453,1.0,11/28,27.83%,PARP3;PRKDC;KMT5C;TFIP11;MAD2L2;ACTR2;WAS;SHLD3;PNKP;SHLD1;HSF1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.4253766904593207,0.8828216914274992,0.6395663956639567,0.881221645222807,1.0,6/13,26.31%,HEXIM1;LARP7;NELFB;HNRNPU;RECQL5;NELFA
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3078808715146034,0.8823055255421383,0.7079463364293086,0.881789216941936,1.0,22/121,15.25%,VEGFA;EFNA5;GAS6;SRCIN1;GHR;HES5;STAT3;CSPG4;IL5;ACVR1;NOX4;DLG4;DGKQ;ANGPT4;PAK2;ABL1;CTF1;NRP1;CD80;CLCF1;HGF;IL6
prerank,negative regulation of response to external stimulus (GO:0032102),0.31144306973540564,0.8820456910042576,0.6975051975051975,0.8818892648163237,1.0,25/105,21.32%,PRKCD;FGF2;PTGIS;CCN3;DRD1;PTPRS;CARD16;TRAFD1;IRAK3;SHARPIN;RORA;ITCH;MAPKBP1;LPCAT3;PTPN2;PCBP2;SIRT2;CD109;OTULIN;ACOD1;CRK;GPS2;IL4;MUL1;DRD2
prerank,T cell differentiation in thymus (GO:0033077),0.4068579235200952,0.8817805907721075,0.6297297297297297,0.8819772197501475,1.0,5/14,31.06%,RIPK3;LIG4;GLI3;ZFP36L1;PTPRC
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.42106213279025706,0.881629500383255,0.6445698166431594,0.8818682352598044,1.0,2/12,7.71%,SOX9;MUC13
prerank,protein polyglutamylation (GO:0018095),0.4240752360438429,0.8814754788128403,0.6346704871060171,0.88174735499814,1.0,3/11,14.96%,TTLL2;TPGS1;CEP41
prerank,defense response to fungus (GO:0050832),0.39377993707777126,0.8812425751851163,0.6245059288537549,0.8818112803762188,1.0,1/17,4.59%,RNASE7
prerank,negative regulation of T cell differentiation (GO:0045581),0.44656852563744276,0.8812217191541528,0.6286919831223629,0.8814584322692279,1.0,3/10,24.23%,BMP4;LAG3;GLI3
prerank,neuromuscular process (GO:0050905),0.3985239475161523,0.8806484548992373,0.6403162055335968,0.8821390194457119,1.0,6/16,20.23%,PRRT2;SHANK1;UBA5;CLN3;MYCBP2;DCTN1
prerank,modified amino acid transport (GO:0072337),0.4080781794644932,0.8805377038741934,0.6377005347593583,0.8819597060402681,1.0,2/15,5.92%,SLC5A6;SLC25A32
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4352168549795152,0.8803918268552916,0.6339031339031339,0.8818040415190802,1.0,5/10,25.14%,PDCD4;DNAJA1;AIDA;DUSP19;MAPK8IP1
prerank,mitochondrial translation (GO:0032543),0.3095860724259786,0.8801163196823746,0.71413390010627,0.8819245033511691,1.0,44/104,37.64%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;NOA1;MRPS18B;MTRF1L;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;TUFM;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;NDUFA7;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.3621313321747456,-0.8800453335243488,0.6406779661016949,0.8516789864652705,1.0,2/10,11.30%,RB1;EGR1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.33221187904592336,-0.8797509129545604,0.6167883211678832,0.8507812009206648,1.0,4/12,11.65%,PRCC;ZWILCH;NABP2;PLK2
prerank,microtubule bundle formation (GO:0001578),0.3387130228163528,0.8795469040154146,0.6532258064516129,0.8825465520737059,1.0,11/42,22.74%,NAV1;CFAP206;SPAST;CCDC66;CHP1;MARK4;LRGUK;TTLL3;CDK5RAP2;SPAG16;CAPN6
prerank,positive regulation of dendritic spine development (GO:0060999),-0.29798791020710197,-0.8795194767290476,0.6299559471365639,0.8497149527627361,1.0,5/20,13.90%,APOE;SHANK3;CUX2;LRP8;RELN
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3082294582922003,0.8793992048557568,0.7402061855670103,0.8824165053793023,1.0,57/119,32.53%,FGF2;PLEKHA4;TTC7A;PIK3C2B;PITPNM1;PIGW;SOCS7;SOCS4;SOCS6;SOCS2;PIGF;SYNJ1;SMG1;PIP4K2B;IP6K1;ARF1;INPP4A;PIK3CB;OCRL;PIGL;PI4K2A;PGAP2;TTC7B;CDIPT;PIP5K1A;PI4KB;INPP5E;VAC14;CDS1;MTMR1;SYNJ2;DPM3;RAB4A;PIGV;MTM1;TMEM150A;PLEKHA3;PIGQ;SOCS1;RAB5A;PIGB;PIP4K2C;PI4KA;PIK3C2G;SACM1L;RUFY1;FIG4;PIKFYVE;SBF1;PIGN;PLEKHA1;MTMR2;PIGC;MTMR12;MTMR9;PIGO;PIK3CA
prerank,positive regulation of innate immune response (GO:0045089),0.3476368810409125,0.8792467068549865,0.6399026763990268,0.8822998464232565,1.0,3/30,9.98%,LBP;MAVS;PLA2G5
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.32729954950753243,0.8787369765779692,0.659217877094972,0.8828651815721168,1.0,9/46,14.81%,PLA2G4A;LPCAT1;GPD1;LPCAT4;DGKQ;GPAT4;PLA2G5;PLA2G12A;PNPLA3
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3837666262895407,0.8786120063724567,0.6306179775280899,0.8826949431861826,1.0,8/18,29.22%,GPATCH3;PUM1;NPLOC4;BIRC3;SEC14L1;C1QBP;NOP53;PUM2
prerank,T cell proliferation (GO:0042098),-0.334103168530704,-0.8785268061452515,0.6131386861313869,0.8504247147044232,1.0,1/13,0.49%,CADM1
prerank,embryonic heart tube development (GO:0035050),-0.3257059377883297,-0.878378669040067,0.6091954022988506,0.8492573691408742,1.0,5/14,17.06%,RYR2;SOX17;TBX2;SOX18;NDRG4
prerank,zinc ion homeostasis (GO:0055069),0.3591458399735411,0.8783242948467711,0.6380597014925373,0.882818665796701,1.0,5/28,9.85%,SLC39A14;SLC39A7;TMC8;SLC30A5;SLC39A13
prerank,positive regulation of type I interferon production (GO:0032481),0.3200718643777976,0.8780776172254989,0.6808743169398908,0.882886634135289,1.0,33/73,32.37%,MAVS;PRKDC;POLR3H;CHUK;IRAK1;CRCP;HSPD1;POLR3GL;POLR2F;TOMM70;CREBBP;NFKB2;XRCC6;IRF3;POLR3K;POLR1C;SETD2;TBK1;PTPN11;POLR2H;CGAS;DDX41;RIPK2;POLR3E;RNF135;POLR2L;CTNNB1;HSP90AA1;RIOK3;NFKB1;POLR3F;POLR2K;IFIH1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.34743766420917593,0.8777769411524943,0.6548463356973995,0.8830317921540366,1.0,7/38,18.49%,ESR1;RORA;MAPKBP1;TANK;PER1;USP10;ZMYND11
prerank,regulation of T cell chemotaxis (GO:0010819),0.42392426744520634,0.8775066027205877,0.6244897959183674,0.8831185789030898,1.0,3/11,13.92%,ADAM10;STK39;WNK1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.4298542143487429,0.8774591871816396,0.6471449487554904,0.8828035038949243,1.0,4/10,30.39%,RPUSD1;TSR3;DKC1;NOP10
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.23198079067479294,-0.8773754534609877,0.7181818181818181,0.8499399763350652,1.0,12/49,13.59%,SGMS1;BCL2;BCL2L1;DNM1L;DAPK2;DDX3X;NUPR1;BOK;CAV1;BCL2L11;STYXL1;NDUFA13
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.3278345682299445,-0.8773447975600303,0.6387832699619772,0.8484893245728325,1.0,12/14,43.80%,PAEP;IL17D;CD84;RASGRP1;IL18;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,retinal metabolic process (GO:0042574),0.4168019225850624,0.8772464867610926,0.6146272855133614,0.8827990605423596,1.0,2/12,8.80%,CYP1B1;AKR1C1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.2621510454524868,-0.8770517483100071,0.6394557823129252,0.8476448415603897,1.0,9/34,18.25%,WNT5A;RBP4;SLC7A5;LACC1;GPI;NOD2;PTPN22;XBP1;PHB2
prerank,negative regulation of transposition (GO:0010529),0.3978025912250559,0.8767969294866369,0.64,0.8832286585224507,1.0,6/16,33.99%,TEX15;TUT7;UBR2;MOV10;SIRT7;DDX4
prerank,CENP-A containing chromatin organization (GO:0061641),0.35676503495807343,0.8766779461229115,0.6478527607361964,0.8826748091129125,1.0,4/29,13.24%,HJURP;CENPC;CENPT;RBBP7
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.35676503495807343,0.8766779461229115,0.6478527607361964,0.8826748091129125,1.0,4/29,13.24%,HJURP;CENPC;CENPT;RBBP7
prerank,lipid modification (GO:0030258),0.3470906792214121,0.8747209597974948,0.6589057043073341,0.8858824518429014,1.0,6/37,10.44%,PLPP3;PLPP5;PLPP1;MBOAT2;DGKQ;LPCAT3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.35620787729572523,0.8739574579483143,0.6568265682656826,0.8868734019221949,1.0,4/30,6.32%,FSTL1;SFRP4;DKK3;SMAD4
prerank,cellular response to chemical stress (GO:0062197),0.30695350689406936,0.8737817935734209,0.7001055966209081,0.8867884724729129,1.0,41/96,31.02%,VKORC1L1;ATF4;LRRC8D;SLC4A11;NOX4;NFE2L2;STX2;ABL1;ATM;SOD1;LONP1;SESN2;SRXN1;PRDX3;CAT;STX4;SIRT2;GSR;TXNRD2;FOXO3;PARP1;VRK2;PRDX2;EIF2S1;LRRK2;PYCR1;PRDX1;GPX7;PYROXD1;PINK1;SELENOS;HTRA2;AIF1;SETX;NOX1;RAD52;PRDX5;PRDX6;KEAP1;ADNP2;CYBA
prerank,regulation of cellular component movement (GO:0051270),0.3284223483394382,0.8736756313870149,0.6533637400228051,0.8865805633091284,1.0,9/49,10.58%,EGFR;VEGFA;ARAP1;PKHD1;CD9;RAF1;RHOA;PKN2;ABL1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.31760120157427435,0.873576456535435,0.6823144104803494,0.8863715196254977,1.0,10/70,13.12%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;WIPF1;ABL1;PIK3CB;MYH2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.3367322717516582,-0.8734830020757411,0.6132404181184669,0.8535308662710924,1.0,3/12,9.62%,LYN;ELF2;CD300A
prerank,dendritic cell differentiation (GO:0097028),0.3756390142512006,0.8734075555904297,0.621656050955414,0.8862943882474221,1.0,2/22,6.39%,GAS6;TGFBR2
prerank,vesicle organization (GO:0016050),0.3351928764956415,0.8733973224180033,0.648,0.8859232617931181,1.0,12/46,21.10%,DNAJC13;LAMTOR1;USP50;LAPTM4B;WASHC4;PI4K2A;SQSTM1;VPS11;PHETA2;ZFYVE16;SNX11;ARFGEF2
prerank,central nervous system neuron differentiation (GO:0021953),0.3465021005061111,0.873299119779239,0.6625916870415648,0.8857108353285753,1.0,1/33,0.33%,LRP6
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.25162812245886695,-0.873269985507826,0.7245508982035929,0.8524856178530386,1.0,18/36,22.43%,PARP14;WNT5A;TRIM44;NLRC5;CASP4;CSF1;EDN1;CD74;AGPAT2;AXL;HSPA1A;AGPAT1;ZBP1;TXK;HSPA1B;IL7;CD300LF;PARP9
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.32286905793655196,0.8731530060570066,0.6699889258028793,0.8855792823788845,1.0,21/54,30.23%,PRR7;NXN;OGT;SMAD7;CHP1;U2AF2;SQSTM1;ARRB1;N4BP1;MINAR1;UFL1;AKT1;DNAJA1;USP4;CAMLG;GTPBP4;SVBP;PER2;SPOPL;PRMT3;CTNNB1
prerank,cognition (GO:0050890),0.3370375743009053,0.8731375970424475,0.6646989374262101,0.8852269315131728,1.0,9/42,16.93%,ST3GAL4;DOP1B;SOBP;CHRNB2;CYFIP1;SETD5;SLC1A4;NF1;NIPBL
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.404146189906488,0.8726068668023137,0.643646408839779,0.8858151132694927,1.0,2/14,5.55%,ENTPD2;ENTPD6
prerank,negative regulation of cell adhesion (GO:0007162),0.31515046718974743,0.8718240203718798,0.6801310043668122,0.8868231959599175,1.0,9/72,6.69%,PLXNA4;TGFBI;MUC1;EPHB2;SPN;CYP1B1;ADAM10;JAG1;FZD7
prerank,chloride transmembrane transport (GO:1902476),0.3313843495069982,0.871235880724468,0.668918918918919,0.8874968326320722,1.0,5/48,7.64%,SLC12A7;SLC12A2;SLC4A8;GABRA3;SLC12A4
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.42209434789016304,0.8710671410026606,0.637906647807638,0.8870377897056211,1.0,3/11,24.17%,CALM2;CALM3;FKBP1B
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.42209434789016304,0.8710671410026606,0.637906647807638,0.8870377897056211,1.0,3/11,24.17%,CALM2;CALM3;FKBP1B
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.3023366001752819,-0.8710135404610172,0.6203007518796992,0.8558465510371239,1.0,14/18,41.07%,IGFBP2;IGF1;PYCARD;RPS3;AGER;FADD;IL27RA;IL18;IL12RB1;TNFSF9;IL23A;IL23R;IL12B;IL2
prerank,gluconeogenesis (GO:0006094),0.3403811003658483,0.8705512411800096,0.6578341013824884,0.8875451964170369,1.0,12/39,29.33%,SLC39A14;ATF4;CRTC2;PGK1;SLC37A4;ENO2;SLC25A11;SLC25A12;PFKFB1;PER2;MDH2;GAPDHS
prerank,positive regulation of signaling (GO:0023056),0.3369015573818239,0.8703372067273928,0.6437054631828979,0.8875426451269929,1.0,7/37,9.50%,ECE1;CLSTN2;ANXA2;ILK;DLG4;EDN3;NSF
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.2890442612007148,-0.8701577788249915,0.6528925619834711,0.8563233157326926,1.0,6/18,17.07%,SLC25A13;ASPG;ASS1;SMS;MSRA;FOLH1
prerank,autonomic nervous system development (GO:0048483),0.3920757921814385,0.8701028411207593,0.633423180592992,0.8875593145469698,1.0,5/17,23.13%,NTRK1;NRP1;NF1;GDNF;SOX8
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3015369024993093,-0.8700725010170646,0.6607142857142857,0.8549898010858764,1.0,2/20,2.11%,IL1R1;B2M
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3616611698001247,0.8700108155373016,0.6380208333333334,0.8873345339404791,1.0,6/24,19.83%,TGFB2;ATF4;BACE1;FOXO3;NF1;CDK5
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3216066688125417,0.8699178284455283,0.6843267108167771,0.8871173690651039,1.0,23/57,32.81%,PRKDC;CDK5RAP3;ATM;CHEK2;SDE2;RINT1;FOXN3;HUS1;ATF2;CDK2;BRCC3;TOPBP1;DONSON;TAOK3;TP53;RPS27L;TAOK2;TAOK1;NOP53;TRIM39;RAD17;BLM;WAC
prerank,sensory perception (GO:0007600),0.3347120021451309,0.8696766706524942,0.6788571428571428,0.8871464166615123,1.0,2/45,1.91%,GNAS;PROK2
prerank,phosphatidic acid metabolic process (GO:0046473),0.3237849621912201,0.8694722678637351,0.6655480984340044,0.8871126521163525,1.0,9/48,14.81%,PLA2G4A;LPCAT1;GPD1;LPCAT4;DGKQ;GPAT4;PLA2G5;PLA2G12A;PNPLA3
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3716714638460282,0.8692244516484217,0.6322418136020151,0.8871721843320414,1.0,4/21,12.31%,KCNE5;ANK2;SNTA1;AKAP9
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.32677505273396856,-0.8690761324326401,0.6283524904214559,0.8555272916884572,1.0,6/14,17.88%,GMPS;ADK;IMPDH1;ADSS1;LHPP;PPAT
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3654308386229563,0.8686721784825151,0.6309067688378033,0.8877818747320095,1.0,1/22,0.58%,ID2
prerank,regulation of MAP kinase activity (GO:0043405),0.3038439790992753,0.8683389964176453,0.7191489361702128,0.8879786637207319,1.0,15/92,12.78%,EGFR;PRKCD;VEGFA;FGF2;FGFR1;IRAK3;CDK5RAP3;EDN3;CDK12;BMP4;PAQR3;IRAK1;TENM1;PIK3CB;PPEF2
prerank,positive regulation of T cell migration (GO:2000406),0.3794062565221609,0.868174961043696,0.6670870113493065,0.8878788707968214,1.0,5/20,13.92%,SPN;ADAM10;STK39;RHOA;WNK1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.2927200018131374,-0.8680969815248,0.6666666666666666,0.8560950723322514,1.0,1/20,0.15%,PLCB1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3692924072675474,0.8678343312292613,0.6474278544542033,0.8880906729012279,1.0,4/21,9.02%,EFNA5;LDB1;SLC9A1;RHOA
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3768182813416206,0.8673499782795598,0.6587926509186351,0.888547995588222,1.0,5/20,15.73%,AGO1;AGO2;LIMD1;CNOT8;EIF6
prerank,transition metal ion homeostasis (GO:0055076),0.3503660663251178,0.8672606379800013,0.6444174757281553,0.8883055074748694,1.0,8/28,17.53%,SLC39A14;NEO1;HMOX2;TMC8;CYBRD1;BDH2;IREB2;HMOX1
prerank,positive regulation of proteolysis (GO:0045862),0.31979541228057357,0.866786530059942,0.6767001114827201,0.8887410471995909,1.0,17/55,24.99%,ADAM9;TNFRSF1B;OGT;WDR48;MAPK12;SNX9;TANK;TBC1D10A;STUB1;PERP;SH3D19;IST1;RCN3;CYFIP2;BAD;PINK1;HDAC2
prerank,organelle transport along microtubule (GO:0072384),0.35205921242632066,0.8667401730124624,0.6839506172839506,0.8884300656393078,1.0,9/31,22.68%,COPG1;RHOT2;ARHGAP21;RHOT1;TMEM201;NDEL1;CLN3;RAB1A;PEX14
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.31350986604355646,-0.8665283393450659,0.6090225563909775,0.857949468975686,1.0,3/14,9.05%,TFRC;RIF1;NECTIN2
prerank,negative regulation of cell population proliferation (GO:0008285),0.29071619248707076,0.866108033005973,0.847,0.889124774699121,1.0,74/351,18.03%,ZBTB7C;WNT9A;IGFBP5;SFRP4;CCN3;NTRK1;SMAD6;TGFB3;P3H3;CYP1B1;SLURP1;GLMN;FAP;LMNA;PTPRU;TGFB2;MORC3;P3H1;CLMN;TMEM115;NOX4;PLPP1;PRKRA;ABI1;IFNLR1;E2F3;SKI;CDK10;MDM4;RAF1;SOX9;TES;P3H2;CHERP;NOG;DDAH1;CDC6;BMP4;ING5;VIP;DIS3L2;RBM5;MED25;PBRM1;TENM1;NELL1;TGFB1I1;PTPN2;INHBA;F2R;CGRRF1;GSDME;FRK;FUZ;BMP5;TMEM127;VDR;CYP27B1;SCIN;TFDP1;CAMK2N1;IL6;ING4;SIRT2;PPP2R5C;MINAR1;NF1;FLCN;MAGED1;HMOX1;CDKN1C;MEN1;HMGA1;E2F1
prerank,"transcription, DNA-templated (GO:0006351)",0.29560223101389393,0.8660372758250073,0.8010101010101011,0.8888633649117115,1.0,80/207,29.55%,NFIX;DDX5;DEAF1;TOPORS;BAZ2A;TCEA2;ATF4;TCFL5;NFX1;POLR3H;HSF2BP;GTF2F1;NFKBIB;CCNT2;TAF15;TAF6;ERCC3;XAB2;TAF13;CRCP;TRIP11;MEF2A;ERCC2;POLR3GL;MMS19;POLR2F;MBD1;TFDP1;AFF4;FOXO3;MLLT3;PARP1;NCBP1;SSRP1;NFYA;SMN1;E2F1;TFB2M;NCBP2;GTF3C1;GTF3C4;CBFB;TAF9B;POLR3K;TWNK;MRPL12;ABT1;MED20;PAF1;NFIC;CEBPD;GTF3A;POLR1C;POLR2B;TAF1C;MNT;TBP;NELFB;TAF1;TP53;EAF1;CTDP1;RTF1;GTF2H4;POLR2H;RNMT;NELFA;TAF10;UBTF;DRG1;HSF1;TAF5L;SETX;TAF3;POLR2I;CDK9;PWP1;NFE2L3;MLLT1;PRMT5
prerank,error-free translesion synthesis (GO:0070987),0.36045336390236826,0.8660017286779925,0.6553030303030303,0.8885462301430139,1.0,7/22,25.47%,VCP;UBC;RPS27A;REV1;NPLOC4;RCHY1;POLD1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.42342878124652267,0.8658369271897634,0.6547277936962751,0.8884552521156027,1.0,2/11,10.98%,FGF2;IP6K1
prerank,erythrocyte differentiation (GO:0030218),0.32860725394233653,0.8656277663606095,0.6737907761529809,0.8884414919699626,1.0,10/44,19.00%,ID2;VEGFA;FLVCR1;CDK5RAP3;PTPN2;INHBA;UBA5;UFL1;ACIN1;HIPK2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.31249174200622476,0.8654685662521199,0.703344120819849,0.8883320120557527,1.0,24/72,26.25%,GAS6;ELF1;TAX1BP1;IRAK3;SHARPIN;MADD;CHUK;IRAK1;ABCE1;PTPN2;RUNX1;OTULIN;SUMO1;VRK2;CBFB;JAK1;BIRC3;CYLD;SPPL2A;TRADD;PTPN11;SOCS1;IFNGR2;RIPK1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.2942627935919151,0.8654067887045866,0.7955689828801611,0.8880619891188828,1.0,20/224,8.78%,PCDHB16;LRP6;GRIK4;SLC12A7;DLG2;EXOC4;UNC13B;CAMKK1;PMP22;CEL;KCNN1;GABRA3;CHRNB2;KCNIP2;SLC6A2;GIPC1;SLC12A4;DLG4;CHRNA5;DLG1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.3436137316575039,-0.8653406427339675,0.652027027027027,0.8588406131437775,1.0,3/11,6.40%,PARP14;PARP16;PARP11
prerank,activation of GTPase activity (GO:0090630),0.30985389557132115,0.8651695676971016,0.7104700854700855,0.8880903992362342,1.0,18/89,15.88%,SGSM2;TIAM1;NTRK3;TIAM2;TBC1D8B;TBC1D2B;DOCK7;SIPA1L1;BCAS3;BCR;EVI5L;TBC1D9B;TBC1D25;TBCK;TBC1D10A;SIPA1L3;TBC1D17;PIP5K1A
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.39646800487767186,0.8645304217491978,0.6463576158940397,0.8888585494765605,1.0,3/14,13.92%,ADAM10;STK39;WNK1
prerank,chromatin remodeling at centromere (GO:0031055),0.3472261289970575,0.8644766886411054,0.6682808716707022,0.8885665960156542,1.0,4/31,13.24%,HJURP;CENPC;CENPT;RBBP7
prerank,ESCRT III complex disassembly (GO:1904903),0.42844033324431785,0.8642665217153237,0.6494845360824743,0.8881683653528111,1.0,3/10,24.56%,IST1;VTA1;CHMP2A
prerank,ESCRT complex disassembly (GO:1904896),0.42844033324431785,0.8642665217153237,0.6494845360824743,0.8881683653528111,1.0,3/10,24.56%,IST1;VTA1;CHMP2A
prerank,mitochondrial transcription (GO:0006390),0.4250237754286441,0.8641764085701616,0.6493506493506493,0.8879353919373224,1.0,4/10,20.43%,FOXO3;TFB2M;TWNK;MRPL12
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3465182314422889,0.8641696856857272,0.675577156743621,0.8875614630750567,1.0,16/36,25.19%,DACT1;DLG1;ITCH;FOXM1;EZR;PER1;MEN1;ZMYND11;AIDA;DUSP19;GPS2;CYLD;TAOK3;PINK1;NCOR1;QARS1
prerank,cellular component assembly (GO:0022607),0.290088648862922,0.8641445466171985,0.8190954773869347,0.8872159047455229,1.0,62/253,23.54%,RHOJ;GAS6;CHAF1B;GSN;RHOQ;DPYSL3;PLS1;LIMA1;CFAP206;TLCD2;HES5;CD3E;M1AP;HORMAD1;DVL1;ILK;GPAA1;SPG7;QSOX1;LLGL1;MDM4;SOX9;DLG4;CYFIP1;RHOA;CDAN1;ST13;WIPF1;MYO9A;SNX9;SHANK1;EZR;ZW10;PARVA;STK25;NLGN1;ADD1;SCIN;LRGUK;CREBBP;TTLL3;KPNA3;SPTBN1;TLCD1;EPRS1;TEAD2;NOC2L;DARS1;CAPZA1;TEX11;CALD1;SPAG17;REPS2;KMT2A;BAIAP2L1;PEX14;SPAG16;AFG3L2;NIFK;GORASP2;DET1;GPM6B
prerank,secondary alcohol metabolic process (GO:1902652),0.3352086152406904,0.863607191463773,0.6762013729977117,0.8877530855008874,1.0,19/42,33.41%,SOAT1;RXRA;TSKU;NSDHL;ABCA1;EBP;IL4;IDH3B;STARD3;APOF;ANGPTL3;SOAT2;OSBPL5;SQLE;OSBPL1A;IDH3G;IDH2;IDH1;GBA2
prerank,positive regulation of response to external stimulus (GO:0032103),0.29801625246488184,0.8634292415167605,0.7440904419321686,0.8876733091756457,1.0,7/128,6.37%,THBS1;PDCD4;IL33;ABCC1;PRKCA;LRSAM1;PUM1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3100186217388722,0.8633166540311856,0.6875,0.8874694948988773,1.0,10/69,14.52%,SIX1;NTRK1;TGFB3;SIX4;NRBP2;SOD1;LIG4;F2R;NDNF;CLCF1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3143832939570525,0.863303268475785,0.6825053995680346,0.8871090672608357,1.0,17/69,20.25%,IRS1;PLCE1;NTRK1;GAB2;PIK3C2B;FGFR1;OGT;RHOA;EZR;PIK3CB;SIRT2;PI4KB;ERBB2;NF1;AKT1;PTAFR;PLCB2
prerank,telomere maintenance via telomerase (GO:0007004),0.35787251624951755,0.8632225551842919,0.6628930817610063,0.8868673536294432,1.0,11/28,30.44%,PPP6R3;TERT;TELO2;RAD50;CDK2;TNKS1BP1;ANKRD28;DKC1;RTEL1;NOP10;HSP90AA1
prerank,positive regulation of developmental growth (GO:0048639),0.32340652110643264,0.8627980800664774,0.6780045351473923,0.8872081374232441,1.0,5/49,7.80%,NTN1;GHR;ACTN3;AGR2;GOLGA4
prerank,response to thyroid hormone (GO:0097066),0.40606906609536203,0.8626184376043949,0.6519337016574586,0.8871326402680032,1.0,4/13,21.41%,RDX;BRD8;KLF9;CTSB
prerank,interstrand cross-link repair (GO:0036297),0.32474469780712656,0.8625610739028923,0.674364896073903,0.8868404897788369,1.0,14/53,20.73%,VCP;FAAP20;ERCC4;WDR48;DCLRE1B;FANCE;ATRIP;FAAP24;UBC;RPS27A;RAD51;USP1;FANCG;XRCC3
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.36592864752450066,0.8625275920464702,0.6582597730138714,0.8865232324809146,1.0,4/21,16.23%,SHPK;TKT;DERA;PGD
prerank,negative regulation of centrosome duplication (GO:0010826),0.4127806800399845,0.8622844862107187,0.6340057636887608,0.8865783050711181,1.0,4/11,24.46%,KAT2A;CDK5RAP2;KAT2B;TMEM67
prerank,positive regulation of GTPase activity (GO:0043547),0.2951738316597935,0.8619667344683195,0.7963525835866262,0.8867406904342099,1.0,38/188,17.71%,SGSM2;SRGAP2;ASAP3;TIAM1;ARAP1;NTRK3;NTRK1;TIAM2;TBC1D8B;TBC1D2B;CCL13;DOCK7;SIPA1L1;CCL15;BCAS3;SNX18;RAB3GAP1;S100A10;RIC1;BCR;RGP1;ZC3H15;SNX9;EVI5L;TBC1D9B;F2R;TBC1D25;NDEL1;TBCK;TBC1D10A;SIPA1L3;TBC1D17;PIP5K1A;ERBB2;NF1;NGEF;FLCN;SNX13
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.34461308521924117,0.861652228382674,0.6770334928229665,0.8868917752149375,1.0,2/33,2.63%,EGFR;RDX
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.31483614784002145,0.8612359912669433,0.6963696369636964,0.887240960714314,1.0,25/67,28.42%,RDX;MAPK15;TBC1D2B;DYNLT2B;GAP43;IFT20;TBC1D24;ATG3;SDCCAG8;TBC1D9B;TBC1D10A;TBC1D17;IFT88;EVI5;TBC1D22B;FXR2;ATP8B1;CYLD;RABGAP1;TBC1D20;TWF1;RAB5A;WAS;FXR1;IFT140
prerank,endothelial tube morphogenesis (GO:0061154),0.4270691927524097,0.8612267186448864,0.6451149425287356,0.8868753208338079,1.0,6/10,30.23%,RHOA;BMP4;RHOB;PRKD2;CCM2;CTNNB1
prerank,triglyceride biosynthetic process (GO:0019432),-0.2942496835578787,-0.8606737282238542,0.7075098814229249,0.8671148683386225,1.0,6/18,18.30%,LPGAT1;GK;MOGAT3;LPIN2;DGAT2;DGAT1
prerank,negative regulation of cilium assembly (GO:1902018),0.4053135445914612,0.8603670176745367,0.6476964769647696,0.8879294274624767,1.0,3/12,12.04%,LIMK2;CDK10;EVI5L
prerank,positive regulation of MAPK cascade (GO:0043410),0.2887768520504862,0.8601808336226824,0.8058350100603622,0.8878633397063096,1.0,31/245,13.07%,BMPER;EGFR;VEGFA;TNFAIP8L3;GAS6;FGF2;NTRK3;NTRK1;FSHR;CCL13;SHC1;CCL15;TGFB2;MID1;PRKCA;LAMTOR1;HMGB1;FGFR1;IAPP;EDN3;ROR1;FGFR2;PLA2G5;IRAK1;MAP3K12;P2RY6;ARHGAP8;TENM1;NRP1;STK25;F2R
prerank,regulation of amyloid fibril formation (GO:1905906),-0.31608531234534804,-0.8601583180488352,0.669260700389105,0.8666925919917199,1.0,2/15,2.33%,APOE;APP
prerank,cellular response to hydroxyurea (GO:0072711),0.4229846643083423,0.859938075120033,0.6378299120234604,0.8879078187509591,1.0,6/10,36.14%,DDI2;SPIDR;DDX11;TIMELESS;BLM;RTF2
prerank,lipid catabolic process (GO:0016042),-0.2922783071125609,-0.8595944329788957,0.6311111111111111,0.8663852181388834,1.0,8/18,26.88%,PLA1A;PLAAT3;LPL;LIPE;MT3;LIPH;LIPC;HSD17B14
prerank,glycerolipid metabolic process (GO:0046486),-0.3493128831873194,-0.8595237844491214,0.6160990712074303,0.8650173749374356,1.0,5/11,14.58%,DGKB;DGKG;GAL3ST1;DGKZ;DGKA
prerank,cellular response to ionizing radiation (GO:0071479),0.3239799665591505,0.8594277142955757,0.6786922209695603,0.8883752709445897,1.0,22/47,31.80%,RAD1;WRN;SPIDR;SWI5;ATM;LIG4;TANK;RHOB;TLK2;HUS1;NIPBL;RAD51;XRCC6;TNKS1BP1;TP53;HSF1;ATR;GRB2;INTS7;RHNO1;BLM;YAP1
prerank,neuron projection organization (GO:0106027),-0.31388171215688326,-0.8593746968159911,0.6715867158671587,0.8638097112646166,1.0,2/15,2.33%,INSR;APP
prerank,hexose biosynthetic process (GO:0019319),0.3319155259965323,0.8592051388507398,0.6670454545454545,0.8883784072108079,1.0,13/42,29.33%,SLC39A14;ATF4;SORD;CRTC2;PGK1;SLC37A4;ENO2;SLC25A11;SLC25A12;PFKFB1;PER2;MDH2;GAPDHS
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.29933905868964344,-0.8587983382226445,0.6525821596244131,0.8635107064092489,1.0,4/18,7.32%,ACSL1;ELOVL7;HACD1;HSD17B12
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3183702760275517,0.8587341735663846,0.7017937219730942,0.888822155728631,1.0,18/61,23.57%,NCOR2;PSMD7;PSMA8;SIRT5;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;AZIN1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,regulation of cell-substrate adhesion (GO:0010810),0.33742263642465775,0.8586300527282477,0.6857142857142857,0.8886241264924946,1.0,10/42,16.85%,VIT;PKHD1;AGR2;FZD7;RHOA;PIK3CB;ARL2;NDNF;TBCD;NF1
prerank,amyloid-beta metabolic process (GO:0050435),0.38703502835439074,0.8585081840810724,0.6522346368715084,0.8884455008164456,1.0,4/16,15.93%,BACE2;BACE1;PSEN2;IDE
prerank,catecholamine biosynthetic process (GO:0042423),-0.34891885528213373,-0.8583003407684735,0.6125827814569537,0.8630472946658639,1.0,3/11,15.01%,MOXD1;GCH1;SNCA
prerank,regulation of fibroblast proliferation (GO:0048145),0.3272063373906518,0.8575513243194625,0.6897347174163783,0.8896777456939534,1.0,8/45,18.03%,GAS6;DDR2;MORC3;SKI;MED25;LIG4;NF1;E2F1
prerank,Notch signaling pathway (GO:0007219),0.3193065970554028,0.8572858948229567,0.682068206820682,0.8897606019898275,1.0,14/59,16.11%,ZNF423;HES5;GMDS;DTX3;ADAM10;JAG1;PBX1;HEYL;NLE1;ITCH;HEY1;DTX2;PSEN2;CREBBP
prerank,mesenchymal cell differentiation (GO:0048762),0.3217898893549506,0.8568076999188137,0.6964078794901506,0.8902369568965461,1.0,10/51,9.70%,LRP6;DDX5;DDX17;TGFB2;TRIM28;FGFR1;HEYL;SOX9;NOG;FGFR2
prerank,regulation of cation channel activity (GO:2001257),0.30739990314409477,0.8564610183084759,0.7420718816067653,0.8904470807329042,1.0,13/89,8.78%,FGF13;DLG2;AHNAK;CAMK2D;CALM2;DMD;CNIH2;KCNE5;SLMAP;ANK2;DLG4;SELENON;DLG1
prerank,heart contraction (GO:0060047),0.33160592528522004,0.8562240074875923,0.683066361556064,0.8904727768327287,1.0,7/41,11.85%,SGCD;ATP1B1;DMD;GAA;KCNE5;CSRP3;SOD1
prerank,organophosphate catabolic process (GO:0046434),-0.33580319142923387,-0.8561140160605437,0.6477987421383647,0.8660625697577716,1.0,2/11,8.98%,ENPP2;PLBD2
prerank,positive regulation of B cell proliferation (GO:0030890),-0.26848829435560867,-0.8558089186035359,0.725609756097561,0.8651946955643602,1.0,7/29,12.44%,BCL2;TFRC;NFATC2;CD38;VAV3;CD74;CD40
prerank,cellular response to virus (GO:0098586),0.34972201768692857,0.8554433945922227,0.6695869837296621,0.891392437945829,1.0,8/30,19.54%,GBF1;LGALS8;CHUK;ARF1;GSDME;IL6;TOMM70;IRF3
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.34092373322275404,-0.8552739980659536,0.6401384083044983,0.8647622941152672,1.0,5/11,27.06%,ENPP2;CORO1C;CD44;CORO1B;SRC
prerank,mRNA destabilization (GO:0061157),0.3349553156749666,0.8548630598624255,0.6963226571767497,0.8920006600975542,1.0,18/38,31.77%,FTO;PUM1;ZC3H12D;DIS3L2;METTL16;TUT7;RC3H2;UPF1;RBM24;ROCK1;METTL14;RIDA;YTHDF1;ZFP36L1;KHSRP;PLEKHN1;MOV10;DCPS
prerank,manganese ion transport (GO:0006828),0.3915027688935506,0.8541805776129061,0.6550335570469799,0.8927842805996077,1.0,1/14,0.72%,SLC39A14
prerank,regulation of viral transcription (GO:0046782),0.3417578381176495,0.8541320796935202,0.6976744186046512,0.8924874771974335,1.0,17/39,29.93%,MDFIC;TRIM27;UBP1;GTF2F1;MID2;HEXIM1;POLR2F;TRIM13;LARP7;POLR2B;NELFB;CTDP1;POLR2H;NELFA;POLR2I;CDK9;POLR2L
prerank,dicarboxylic acid catabolic process (GO:0043649),0.4093983491455191,0.8538974624372999,0.672108843537415,0.8925007559281771,1.0,3/13,7.22%,ACSF3;PM20D2;QPRT
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3775642410759739,0.8538578770588316,0.6644562334217506,0.8921805042583432,1.0,4/18,16.77%,BRD4;CDC25B;RCC2;CDC25A
prerank,regulation of exosomal secretion (GO:1903541),0.3761516490287394,0.8535104574789489,0.6689098250336474,0.8923580396758747,1.0,5/19,24.56%,SDC1;ATP9A;CHMP3;PDCD6IP;CHMP2A
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.33555999921356605,0.853444654670548,0.6785290628706999,0.8920921027308526,1.0,19/37,34.26%,IFT20;IFT80;TRIP11;IFT46;PCM1;IFT88;DYNC2I1;IFT43;TNPO1;IFT27;DYNC2H1;KIF17;DYNC2I2;IFT140;KIFAP3;DYNLL2;IFT52;WDR35;DYNLRB1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3624981520073617,0.8530819820952011,0.6802030456852792,0.8923757401138315,1.0,6/22,16.21%,CAMK2D;PRKCA;SMAD4;SLC9A1;MEF2A;PARP1
prerank,plasma membrane organization (GO:0007009),0.3170362166666898,0.8529092898205257,0.7152173913043478,0.8922794703110043,1.0,18/61,22.14%,AHNAK2;TLCD2;ANK2;EHD2;NSF;STX2;SNX9;STX4;CXCR4;PLSCR3;SPTBN1;SYTL4;TLCD1;CLN3;CHMP4A;ANXA6;ABCD1;PLSCR4
prerank,pore complex assembly (GO:0046931),0.3745177002022062,0.852704269513823,0.6640726329442282,0.8922380431333155,1.0,8/19,27.35%,NUP93;ADAM10;TMEM170A;NDC1;BAD;AFDN;TPR;AHCTF1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.3775259082119521,0.8526586959305201,0.6747311827956989,0.891932299948334,1.0,9/19,31.02%,SOD1;PRDX3;CAT;PRDX2;PRDX1;PXDN;NOX1;PRDX5;CYBA
prerank,positive regulation of immune effector process (GO:0002699),0.35076395891898354,0.8523548473659981,0.6787878787878788,0.892042897691555,1.0,2/27,9.98%,LBP;PLA2G5
prerank,regulation of isotype switching (GO:0045191),0.3924315691081811,0.8523536593303515,0.6662030598052852,0.8916650008042192,1.0,7/14,29.08%,PARP3;KMT5C;MAD2L2;IL4;SHLD3;SHLD1;HMCES
prerank,negative regulation of cell activation (GO:0050866),0.39064031770407276,0.8519331004969525,0.6666666666666666,0.8920336992278106,1.0,2/14,2.99%,EMILIN1;C1QTNF1
prerank,response to ATP (GO:0033198),-0.2969516509516992,-0.8514294597209537,0.6854460093896714,0.8710731001904973,1.0,5/18,18.88%,TRPC3;ABCC9;CIB2;P2RY1;P2RX7
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.38038046204534914,0.8510107872852235,0.6557161629434954,0.8932378435040175,1.0,4/17,12.40%,NTRK3;BCAS3;ABL1;NRP1
prerank,ruffle organization (GO:0031529),0.38229072160966643,0.8508796963464871,0.6543046357615894,0.8931004221428632,1.0,4/16,15.88%,LIMA1;CYFIP1;ARFIP2;PIP5K1A
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.422985187044941,0.8501029475793769,0.6680911680911681,0.8936576628382081,1.0,10/10,57.73%,CEP250;TULP1;GRM6;RPE65;CACNA2D4;CNGB1;CACNA1F;GNAT2;REEP6;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.422985187044941,0.8501029475793769,0.6680911680911681,0.8936576628382081,1.0,10/10,57.73%,CEP250;TULP1;GRM6;RPE65;CACNA2D4;CNGB1;CACNA1F;GNAT2;REEP6;GNAT1
prerank,regulation of protein kinase A signaling (GO:0010738),-0.28818216388098594,-0.8499243937431777,0.75,0.872656185160022,1.0,4/20,6.41%,ADGRV1;AKAP6;PRKAR2B;PRKAR1B
prerank,negative regulation of immune system process (GO:0002683),0.3883271122784861,0.8498600312134307,0.6776859504132231,0.8936999618793577,1.0,2/16,7.68%,COL3A1;SOX9
prerank,negative regulation of cellular metabolic process (GO:0031324),0.33294251710243056,0.8498436707732194,0.6877880184331797,0.8933474235400485,1.0,12/37,24.97%,LRPAP1;SIRT5;DLG4;ITGAV;SIRT2;WDR54;AATF;TRAT1;OPTN;ATXN2;PINK1;NCOR1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.34272313728520826,-0.8498395922977872,0.6190476190476191,0.8713091530449035,1.0,4/11,17.38%,SEMA5A;NES;PLEK;TRPV4
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.28921659898668234,0.8496824179883375,0.7686796315250768,0.8932254578357399,1.0,29/149,20.47%,SLCO3A1;CARD14;NTRK1;RAB7B;CARD16;STAT3;ERC1;IRAK3;RPS6KA4;TRIM27;ROR1;CHUK;RIPK3;NFKBIB;IRAK1;TAB2;RNF25;MID2;PSMA6;PRDX3;IL6;UBC;RPS27A;NFKB2;TRIM13;TRIM6;NFKBIA;TNFSF18;CLU
prerank,positive regulation of cellular senescence (GO:2000774),-0.35930661798413027,-0.8496594859698563,0.6655052264808362,0.8701110659734616,1.0,3/10,14.06%,B2M;ABI3;SIRT1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.2839135255077899,0.8492393880571819,0.916,0.8935913997308675,1.0,62/509,13.14%,THBS1;MYOC;ESR1;EGFR;IRS1;VEGFA;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;PDCD4;NEDD4;NTRK3;NTRK1;FGF17;GAB2;FSHR;SHC1;SEC13;NFAT5;CARD16;TGFB2;MAVS;BRD4;ILK;LAMTOR1;SEH1L;PUM1;HMGB1;FGFR1;SOX9;TRIM27;S100B;IAPP;CBL;AKT2;CDK5RAP3;RHOA;SHARPIN;ROR1;FGFR2;ITGAV;LTBR;CHUK;ALPK1;IRAK1;TAB2;BCAP31;MAZ;C1QTNF4;NEUROD2;PDPK1;TNFRSF10B;CD27;MID2;PIK3CB;TGFBR1;NLGN1;F2R;CD80;LRP2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.35493313979665597,0.849137909272834,0.6654275092936803,0.8933765582936481,1.0,4/24,8.09%,CAMK2D;CALM2;DMD;SELENON
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3773975478706105,0.8491195852340419,0.6588235294117647,0.8930331938718334,1.0,6/17,25.87%,TGFB2;MID1;STK25;TAOK3;TAOK2;TAOK1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.4061343538424741,0.849089298874828,0.6507713884992987,0.8927057269707767,1.0,6/11,31.68%,DONSON;ZRANB3;FBH1;SMARCAL1;TIMELESS;BLM
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.29786579326302337,0.8485190429638622,0.7626050420168067,0.8932719635104799,1.0,18/108,13.71%,F3;GSN;PRR7;MAP3K5;CRADD;XDH;VCP;TNFSF15;HMGB1;DAP;ANP32B;BCAP31;AIFM1;TNFRSF10B;PDCD2;HSPD1;F2R;CASP1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.4001335007729478,0.8480108344915971,0.664804469273743,0.8937395236126039,1.0,2/13,8.56%,IRS1;AKT2
prerank,regulation of striated muscle contraction (GO:0006942),0.3496239737395274,0.8478441865095369,0.6907090464547677,0.8936371315248118,1.0,7/27,11.75%,HCN4;CALM2;TNNT3;DMD;ANK2;TNNI3K;SMAD7
prerank,positive regulation of protein polymerization (GO:0032273),0.30858327584561823,0.846789958021097,0.7183406113537117,0.8950120158972998,1.0,22/65,30.44%,CTTN;PRKCE;CDC42EP2;PFN2;SNX9;TENM1;AKAP9;CDC42EP5;ARL2;SLAIN2;DCTN1;CDK5RAP2;BAIAP2L1;PINK1;MET;NCK1;DRG1;FES;TOGARAM1;VASP;RAC1;HSP90AA1
prerank,negative regulation of viral life cycle (GO:1903901),0.3830701489625725,0.84675133812171,0.6749311294765841,0.8947037667637477,1.0,3/15,13.93%,GSN;MID2;TRIM26
prerank,response to ethanol (GO:0045471),0.3934082530472402,0.8464150429565296,0.6844262295081968,0.8948846733378473,1.0,4/14,18.48%,GRIN3A;CHRNB2;SOD1;ADCY7
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3408471639954709,0.8457304737007303,0.7050970873786407,0.8956516857483969,1.0,3/31,8.78%,FHL1;DACT1;DLG1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.4028612366776126,0.8455440170745446,0.6737588652482269,0.8955688811490999,1.0,2/12,2.58%,SYT8;UNC13B
prerank,monocarboxylic acid catabolic process (GO:0072329),0.36386592756735414,0.8454778506730793,0.6931818181818182,0.895309240614996,1.0,2/21,3.75%,AGXT2;CEL
prerank,regulation of protein localization to nucleus (GO:1900180),0.328606924844903,0.8453829205861926,0.7050113895216401,0.8950972820087383,1.0,17/43,28.80%,WWTR1;LIMK2;CDK5RAP3;BMP4;NVL;SESN2;LATS2;BYSL;ORMDL3;FLCN;AKT1;KAT7;EIF2AK3;ILRUN;TPR;LIF;TESK1
prerank,positive regulation of viral process (GO:0048524),0.31327529851561703,0.8452849723004479,0.7312295973884657,0.8948699676089816,1.0,24/60,30.69%,MDFIC;PABPC1;TMEM39A;PKN2;GTF2F1;KPNA2;SRPK1;POLR2F;POLR2B;NELFB;STAU1;CTDP1;TBC1D20;POLR2H;PPID;NELFA;KPNA6;HACD3;DDB1;POLR2I;CDK9;LARP1;POLR2L;PPIH
prerank,regulation of pH (GO:0006885),0.41644263535923526,0.8450721307765162,0.6974431818181818,0.8948300187598796,1.0,2/11,10.27%,SLC9A1;SLC26A4
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.32522405852985836,0.8450638816741337,0.702054794520548,0.8944683500833794,1.0,10/46,17.28%,EMILIN1;TIMP3;EPHB2;SPRED2;SMAD4;DLG1;EZR;PTPN2;CAMK2N1;FLCN
prerank,negative regulation of nuclear division (GO:0051784),0.40895070642754705,0.8449033413729432,0.6796116504854369,0.8943552229810899,1.0,2/11,9.70%,TOM1L1;BMP4
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.35981720108405185,0.8448424262765712,0.6854636591478697,0.894072018971049,1.0,2/21,3.71%,FOXP1;ELF1
prerank,muscle cell development (GO:0055001),0.3403948600741419,0.8445614914893036,0.6796116504854369,0.8941543922203297,1.0,6/30,9.62%,VEGFA;SDC1;RAMP2;DMD;ANK2;ALPK3
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3028528561163105,0.8435486167062717,0.7262931034482759,0.8954624966447351,1.0,24/73,25.17%,F3;CRADD;XDH;VCP;TNFSF15;DAP;ANP32B;AIFM1;TNFRSF10B;PDCD2;HSPD1;F2R;CASP1;HIP1;BID;MUL1;SENP1;DIABLO;MTCH1;EIF2AK3;BAD;RPS27L;BCL2L13;TRADD
prerank,protein kinase B signaling (GO:0043491),0.3545451493740234,0.8435238546145583,0.6700251889168766,0.8951243458408064,1.0,7/23,29.77%,GAS6;SIRT2;AKT1;TSC2;CCL2;SETX;ZFP36L1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.29297611023750725,-0.8433203570006633,0.6883116883116883,0.8815340776324108,1.0,9/20,21.05%,PRKAA2;RPS6KA5;PPARGC1A;PRKAA1;NOS1;BRCA1;MAPK3;SOX4;GLYR1
prerank,synapse assembly (GO:0007416),0.3064213577310618,0.8431788187138648,0.7417582417582418,0.8953371447212465,1.0,8/67,9.82%,PCDHB16;FGF13;FARP1;DRD1;LGI2;DVL1;FZD5;NRXN2
prerank,intraciliary retrograde transport (GO:0035721),0.4025925354107424,0.8431674057599682,0.6615598885793872,0.894979672089952,1.0,7/12,32.88%,DYNLT2B;DYNC2I1;IFT43;DYNC2H1;DYNC2I2;IFT140;WDR35
prerank,response to amino acid (GO:0043200),0.34549023720087074,0.8426722748189857,0.693950177935943,0.8953821649231194,1.0,10/31,27.42%,IPO5;MEAK7;LAMTOR1;CAPN2;SESN2;NSMF;GLRB;RPTOR;LAMTOR2;LAMTOR3
prerank,regulation of water loss via skin (GO:0033561),-0.31018153060268167,-0.8420367088611661,0.6877637130801688,0.8811187114794832,1.0,3/15,12.66%,LSR;CLDN1;ALOX12
prerank,establishment of skin barrier (GO:0061436),-0.31018153060268167,-0.8420367088611661,0.6877637130801688,0.8811187114794832,1.0,3/15,12.66%,LSR;CLDN1;ALOX12
prerank,regulation of dephosphorylation (GO:0035303),-0.3057455428787584,-0.8419397944234591,0.6589147286821705,0.8797808314324779,1.0,3/15,6.61%,PPP1R16B;SMG7;MTMR3
prerank,positive regulation of TORC1 signaling (GO:1904263),0.38374643240232054,0.8417609285305541,0.6782945736434108,0.8965123234598943,1.0,5/16,17.28%,SEH1L;CLEC16A;TELO2;KLHL22;FLCN
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3891658462936689,0.8415707952962053,0.6831550802139037,0.8964280078412369,1.0,4/14,20.43%,FOXO3;TFB2M;TWNK;MRPL12
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.3185850231326332,-0.8415267314240168,0.6610169491525424,0.8791044057110454,1.0,9/12,43.80%,PRKCQ;CCR2;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,sterol transport (GO:0015918),0.36872395964399285,0.8414946368442282,0.6628930817610063,0.8961809136882618,1.0,6/19,28.04%,NPC1;OSBP;LDLR;STARD3;NPC2;OSBPL5
prerank,cellular protein-containing complex assembly (GO:0034622),0.28747846389343845,0.8413119850884986,0.7969387755102041,0.8961193464605212,1.0,55/159,27.83%,NUP93;TIAM1;TBCE;CD3E;DNAJB14;DMD;DNAAF3;SMAD4;FCHO2;CENPC;CCDC39;CENPT;AXIN1;SNX9;AIFM1;MIS12;LONP1;HSPD1;ARL2;CHMP3;CLTC;PTGES3L;PSMD11;TBCD;HIP1;HIGD1A;VBP1;PRLR;TMEM170A;DLGAP5;OTUD6B;CLTA;CLU;CHMP4A;CHMP4B;POGZ;PSMD4;TTC12;NDC1;COX7A2L;EIF4B;UVRAG;VAMP4;TCP1;PSMG2;PXN;CHMP2A;DNAJB12;VAMP2;NCK1;TPR;EID2;AHCTF1;RAB5IF;HSF1
prerank,regulation of interferon-gamma production (GO:0032649),0.3039425771559814,0.8409618986270876,0.7202185792349727,0.8963160852468007,1.0,10/71,13.02%,GAS6;IL12RB2;HMGB1;TRIM27;RARA;FZD5;CRTAM;RIPK3;HSPD1;INHBA
prerank,mesenchyme development (GO:0060485),0.38732042625760155,0.840938639685625,0.676,0.8959838555002143,1.0,4/15,12.60%,CRELD1;BMP4;FGFR2;TGFBR1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.31622314209617863,-0.8404009169557478,0.6713286713286714,0.8798830119011395,1.0,2/13,1.29%,SLC8A1;PDE4D
prerank,epithelial cell migration (GO:0010631),0.33105716632213755,0.8403590041380737,0.6948356807511737,0.8965694197333285,1.0,9/37,12.40%,FSTL1;CYP1B1;FAP;FAT2;GIPC1;RHOA;PKN2;ABL1;NRP1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.33848881347001397,-0.8402179152152671,0.6344827586206897,0.8787877085285549,1.0,5/10,20.15%,SIRT1;SNCA;KLF15;BRCA1;TAF7
prerank,negative regulation of biosynthetic process (GO:0009890),-0.30167792575643326,-0.8401912486006851,0.7038461538461539,0.8773478712618935,1.0,9/16,20.35%,PPARA;SLC30A10;ASXL3;TRAP1;CEACAM1;GPER1;ABCD2;ABCB7;SLC18A2
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.2263279377049239,-0.8396593089487834,0.7920792079207921,0.8769027421616779,1.0,15/51,18.88%,WNT5A;APP;AIM2;GBP5;HSPB1;EGR1;LPL;LGALS9;TRIM16;TYROBP;S100A13;NOD2;PYCARD;MYD88;P2RX7
prerank,sister chromatid segregation (GO:0000819),0.33393938307570475,0.8395728042690038,0.7017964071856287,0.8974757612862896,1.0,5/31,15.96%,TUBG2;SMC4;MIS12;ZW10;KLHL22
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4020114112650059,0.8395270676266327,0.6825842696629213,0.8971759515464024,1.0,7/12,32.06%,UBE2C;CDC20;RAB1A;GOLGA2;BTRC;UBE2S;GORASP1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3541596467523803,0.8392567857584677,0.6940298507462687,0.8972381923810184,1.0,12/24,32.45%,PHF1;TRIM27;RBBP7;MPHOSPH8;TASOR;DNMT1;H3-3A;DNMT3A;SUZ12;MTF2;SPI1;CREBZF
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.3391198640817932,-0.8390573777587625,0.6720257234726688,0.8766591424691951,1.0,3/10,13.56%,PRKCH;NME2;TRIM16
prerank,placenta development (GO:0001890),0.3966773310340223,0.8388153848795424,0.6879334257975035,0.8976054314195827,1.0,4/12,27.82%,SOD1;PLAC1;CUL7;E2F8
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.27848475520518856,-0.8387289920213438,0.7085201793721974,0.8758223985585202,1.0,9/21,25.70%,PAG1;DUSP3;TNFAIP3;PTPN22;SOX11;SAMSN1;LST1;LAX1;IL4I1
prerank,replication fork processing (GO:0031297),0.32470496130545556,0.8373942659152322,0.7105575326215896,0.8995194415644686,1.0,16/38,35.17%,TONSL;WRN;RAD51;TRAIP;PRIMPOL;BOD1L1;ZRANB3;FBH1;RTEL1;CDK9;ATR;SMARCAL1;DDX11;BLM;MMS22L;MRE11
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.39363109533905033,0.8372805554341163,0.6912378303198887,0.8993240658576318,1.0,8/13,33.73%,ALG13;ALG1;ALG3;ALG14;ALG12;ALG9;SRD5A3;ALG8
prerank,negative regulation of fat cell differentiation (GO:0045599),0.33134604801019046,0.8372608645800415,0.6978672985781991,0.8989812988893241,1.0,9/34,18.03%,ZFPM2;WWTR1;RORA;IL6;SIRT2;TRIO;ANKRD26;FLCN;E2F1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4018323824444652,0.8372288598447815,0.6781609195402298,0.8986645770948906,1.0,2/12,8.56%,IRS1;AKT2
prerank,granulocyte differentiation (GO:0030851),-0.2814844592731698,-0.8368051351249742,0.692,0.8779975968970596,1.0,3/18,4.58%,LEF1;CBFA2T3;DEK
prerank,cellular response to nutrient levels (GO:0031669),0.31047241604853826,0.8367954797221896,0.7206703910614525,0.8989818661358965,1.0,20/62,29.18%,KCNB1;WIPI2;CLEC16A;WRN;SREBF1;FADS1;EIF4G1;USP33;VPS41;FLCN;KLF10;LAMP2;LRRK2;RPTOR;STK24;EHMT2;TFEB;ULK1;SREBF2;ZFYVE1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3538376980626065,0.8362885525256427,0.690566037735849,0.89906210349023,1.0,13/23,28.52%,PPP3CC;MAPK8;YWHAE;YWHAQ;TFDP1;E2F1;BID;SFN;TP53;BAD;YWHAB;NMT1;BBC3
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3538376980626065,0.8362885525256427,0.690566037735849,0.89906210349023,1.0,13/23,28.52%,PPP3CC;MAPK8;YWHAE;YWHAQ;TFDP1;E2F1;BID;SFN;TP53;BAD;YWHAB;NMT1;BBC3
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3328760151758854,0.8360649594502232,0.7051744885679904,0.8990523983832142,1.0,3/33,8.78%,FHL1;DACT1;DLG1
prerank,regulation of protein processing (GO:0070613),0.35382025924414595,0.8353444741994336,0.6842800528401585,0.8998391633929397,1.0,5/21,21.65%,GAS1;SERPINE2;RUNX1;CLN3;LRRK2
prerank,positive regulation of cilium assembly (GO:0045724),0.3705071321029773,0.8348696219502891,0.6947368421052632,0.9002066939291722,1.0,8/18,29.61%,MARK4;FUZ;KCTD17;WRAP73;ARHGAP35;CCP110;TAPT1;SEPTIN9
prerank,protein prenylation (GO:0018342),0.41327042178881807,0.8344272554119468,0.6690442225392297,0.9005440918727989,1.0,7/10,41.91%,RABGGTB;PTAR1;FNTB;RABGGTA;CHM;FNTA;PGGT1B
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3230428720837292,-0.83381014584311,0.6666666666666666,0.8822067950864202,1.0,6/13,21.72%,NOTCH1;RYR2;RBPJ;HEY2;FOXF1;NPY5R
prerank,regulation of muscle contraction (GO:0006937),0.35018237102135463,0.8330189717075427,0.7091136079900124,0.9024265972238651,1.0,3/26,5.09%,PLCE1;PPP1R12B;TNNT3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.39219413808824005,0.8322365499298835,0.6894243641231593,0.9032868140466094,1.0,8/13,39.84%,LCMT1;XRCC3;CDK5RAP2;TPR;DYNC1LI1;PCID2;NDC80;DUSP1
prerank,regulation of neurogenesis (GO:0050767),0.30989491737689795,0.8320602109625638,0.7538975501113586,0.9031905605101477,1.0,10/55,15.25%,DOCK7;HES5;SERPINF1;BHLHE40;HEYL;HEY1;LIG4;LRP2;PCM1;IL6
prerank,anterograde synaptic vesicle transport (GO:0048490),0.37736523645039904,0.8319506487936793,0.6954787234042553,0.9026088667105249,1.0,5/15,24.97%,BLOC1S2;AP3D1;BLOC1S3;SNAPIN;AP3B1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.37736523645039904,0.8319506487936793,0.6954787234042553,0.9026088667105249,1.0,5/15,24.97%,BLOC1S2;AP3D1;BLOC1S3;SNAPIN;AP3B1
prerank,RNA destabilization (GO:0050779),0.3628620400409568,0.8316648209408971,0.7028423772609819,0.9026969025118015,1.0,10/18,28.85%,FTO;PUM1;METTL16;RBM24;ROCK1;METTL14;RIDA;YTHDF1;ZC3H18;DXO
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.3874187669410703,0.8313695843187267,0.6813793103448276,0.9027997355106195,1.0,6/13,32.31%,PGM3;RENBP;CHST5;OGA;NAGK;CHST7
prerank,regulation of p38MAPK cascade (GO:1900744),0.3358856871338411,0.831072930306507,0.7146311970979444,0.9029041348361905,1.0,7/35,15.23%,VEGFA;GADD45G;XDH;DLG1;ULK4;EZR;PER1
prerank,regulation of protein localization to cell surface (GO:2000008),0.33431331936138836,0.8305521336074732,0.7120853080568721,0.9032787784618636,1.0,7/33,15.15%,TM9SF4;RIC3;GOPC;GBF1;RAB11FIP5;RAB11B;STX4
prerank,positive regulation of glucose import (GO:0046326),0.3572010392142111,0.8303295630157912,0.681045751633987,0.9032611913443809,1.0,4/21,8.56%,IRS1;RHOQ;CAPN10;AKT2
prerank,cellular response to increased oxygen levels (GO:0036295),-0.3293087801970737,-0.8299872713449431,0.6611842105263158,0.8880322144291506,1.0,3/11,15.61%,FAS;CAV1;FOXO1
prerank,negative regulation of ion transport (GO:0043271),-0.2670412947973353,-0.8298456623051167,0.7684210526315789,0.8868006079909376,1.0,10/24,18.75%,ACTN2;WNK2;ADRA2A;PACSIN3;NOS1;WNK4;SNCA;CASQ2;SYT11;PXK
prerank,cAMP biosynthetic process (GO:0006171),0.40710673895377747,0.8295460339809944,0.6738197424892703,0.9041174458953376,1.0,3/10,7.52%,ADCY2;ADCY8;ADCY9
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.29390595271654685,0.8289359447708781,0.7637130801687764,0.9047326755294327,1.0,32/84,34.37%,IGFBP5;SAMD4A;ILF3;RBM4;CNOT8;CNOT10;ORMDL3;EPRS1;DAPK3;CNOT9;SHMT1;SYNCRIP;CALR;CLU;ORMDL1;FXR2;EIF2AK3;YBX1;ROCK1;MRPL13;RIDA;FXR1;GGA3;LARP1;CAPRIN1;DAPK1;PRNP;NCL;PCIF1;PUS7;DHFR;RTN3
prerank,protein localization to lysosome (GO:0061462),0.34206437746295887,0.8288474807009552,0.7194513715710723,0.9044915974607852,1.0,7/28,28.26%,NEDD4;NAGPA;KPTN;ZFYVE16;SCARB2;GCC2;GGA3
prerank,regulation of dendrite morphogenesis (GO:0048814),0.32952630679533135,0.8286299370515686,0.7151300236406619,0.9044677719331691,1.0,5/32,6.91%,NEDD4;CUX1;FBXW8;LZTS1;CHRNB2
prerank,positive regulation of DNA binding (GO:0043388),0.33382891651280605,0.8285145370768991,0.7139334155363748,0.9042743475495395,1.0,5/31,18.05%,TWIST1;HMGB1;SKI;SIRT2;TRIM6
prerank,centromere complex assembly (GO:0034508),0.32316748982593835,0.828472776604397,0.7181286549707603,0.9039605059980539,1.0,5/36,13.24%,HJURP;CENPC;CENPT;MIS12;RBBP7
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.39913227633960635,0.828264433948538,0.6771117166212534,0.9039175955495992,1.0,2/12,5.71%,ATP1B1;DMD
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.33203088728947366,0.8281487051487738,0.7274853801169591,0.9037262824585766,1.0,5/38,7.83%,GAS6;SRCIN1;SHC1;NOX4;DLG4
prerank,tetrapyrrole metabolic process (GO:0033013),0.36941295611036573,0.8279230937414191,0.6990679094540613,0.9037389912199849,1.0,4/18,14.15%,ABCC1;MTRR;MMAB;ABCB6
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.37189105592700594,0.8276812725408631,0.6878453038674033,0.9037484027267838,1.0,4/15,20.27%,STAT3;IL6;APPL1;IL17RA
prerank,regulation of inflammatory response (GO:0050727),0.2810186327736495,0.8273805242753497,0.8412537917087968,0.9038658146028073,1.0,27/190,17.34%,MGLL;FOXP1;PRKCD;PDCD4;IL33;PTGIS;CCN3;ABCC1;SHPK;TNFRSF1B;BRD4;DAGLA;SBNO2;SHARPIN;RORA;ANXA1;LPCAT3;NR1D2;PSMA6;PTPN2;CASP1;SETD4;IL6;PTGES;OTULIN;CCN4;UFL1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.32952453632663814,-0.8272663578890626,0.7007042253521126,0.890312294770475,1.0,1/11,1.25%,CDH13
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.40819016024973354,0.826832341608883,0.6937590711175616,0.9040264871886192,1.0,3/10,11.17%,HDAC4;ACTN3;GIT1
prerank,negative regulation of glycolytic process (GO:0045820),0.40819016024973354,0.826832341608883,0.6937590711175616,0.9040264871886192,1.0,3/10,11.17%,HDAC4;ACTN3;GIT1
prerank,regulation of histone methylation (GO:0031060),0.3927448324277293,0.8266656075118631,0.6968838526912181,0.9039192765356306,1.0,5/13,21.58%,NSD1;NNMT;CHTOP;MTHFR;PAF1
prerank,regulation of JNK cascade (GO:0046328),0.2922146748133881,0.8264968660878215,0.7924528301886793,0.9037998540834291,1.0,14/101,12.52%,RASSF2;EGFR;SH3RF3;GADD45G;MAP3K5;DACT1;HMGB1;FZD7;ITCH;LTBR;ULK4;AXIN1;CD27;TRAF3
prerank,oogenesis (GO:0048477),-0.30408733847509745,-0.8264070635255482,0.6679841897233202,0.8904344834701482,1.0,7/15,22.56%,PTN;FMN2;MEI4;MDK;NANOS3;NANOS1;TRIP13
prerank,positive regulation of glial cell differentiation (GO:0045687),0.3678052261219182,0.8258772124449058,0.7090909090909091,0.9044358514100823,1.0,5/17,15.83%,ID2;TNFRSF1B;SERPINE2;CLCF1;CXCR4
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.31546209588165697,-0.8250327531923293,0.6925795053003534,0.8915211981652227,1.0,3/13,4.15%,SHANK3;APP;ADCY1
prerank,response to UV-B (GO:0010224),-0.31368487131198997,-0.8241820799740383,0.6714801444043321,0.8915112975107785,1.0,12/12,68.66%,CRIP1;HYAL2;MME;STK11;CDKN1A;IL12A;IL12B;MFAP4;HYAL1;HYAL3;RELA;MSH2
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.29301540661038855,-0.8241794864704717,0.7053571428571429,0.8900369667868472,1.0,8/17,30.36%,ADRA2A;PRKAA1;MFSD2A;BSCL2;ALK;APOC1;GPLD1;PDE3B
prerank,regulation of cell-cell adhesion (GO:0022407),0.32039417875906967,0.8238602301880783,0.7243816254416962,0.9072314845594585,1.0,7/39,11.75%,EFNA5;PKHD1;ADA;EPHB3;JAG1;FUT4;SMAD7
prerank,negative regulation of platelet activation (GO:0010544),0.37630645668137475,0.8236457646610821,0.6986666666666667,0.9071837382328094,1.0,3/16,6.02%,PRKCD;C1QTNF1;CD9
prerank,cobalamin metabolic process (GO:0009235),0.36898237551909024,0.8234146422173153,0.6798941798941799,0.9071655027183207,1.0,3/17,9.56%,ABCC1;MTRR;MMAB
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.2723430975582724,-0.8231756362463847,0.7379032258064516,0.8903954823449172,1.0,5/20,13.95%,RB1;LAMTOR5;NIBAN2;H1-0;IGF1
prerank,mitotic cytokinesis (GO:0000281),0.30877540846395674,0.8225364446268035,0.733934611048478,0.9081452219323511,1.0,16/47,27.72%,CIT;SNX18;SPAST;SNX9;RHOB;MITD1;SPTBN1;TTC19;RTKN;CHMP4B;PDCD6IP;ROCK1;JTB;CUL7;EFHC1;SON
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.35777118422722587,0.8221618163045994,0.6894664842681258,0.9083720015472572,1.0,6/18,21.65%,SLC4A8;RAB3GAP1;RIMS4;NLGN1;SNAPIN;LRRK2
prerank,response to chemokine (GO:1990868),0.3875321813042605,0.8218232700731636,0.7111111111111111,0.9085098803272108,1.0,4/13,13.92%,SLC12A2;STK39;RHOA;WNK1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3272201286924291,0.8217093901043664,0.7213316892725031,0.9083182693340969,1.0,6/32,16.85%,DRD1;CALM2;P2RY6;PDPK1;F2R;CALM3
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2911416377743716,0.8215417515087371,0.8115942028985508,0.9082142319728791,1.0,30/109,21.25%,FGF2;PLA2G4F;PLEKHA4;PLA2G4A;PIK3C2B;PITPNM1;PIGW;MTMR11;SYNJ1;PLA2G5;PIP4K2B;INPP5B;ARF1;MTMR10;INPP4A;PIK3CB;PIP4P2;OCRL;PI4K2A;PLA2G12A;CDIPT;PIP5K1A;PI4KB;INPP5E;VAC14;CDS1;PLCB2;MTMR1;SYNJ2;RAB4A
prerank,defense response to protozoan (GO:0042832),-0.3256200788298802,-0.8211862698332848,0.6993006993006993,0.8925945287785813,1.0,5/12,18.15%,GBP7;GBP4;CD40;BATF;MYD88
prerank,regulation of regulated secretory pathway (GO:1903305),-0.2435126282621392,-0.8205478381141147,0.7544910179640718,0.8922717381477345,1.0,14/34,20.12%,RIMS2;RIMS1;SYN1;DTNBP1;SYT10;SYT13;SYT3;SYT2;PREPL;RAB15;SYT11;SYT12;SYT7;SYT15
prerank,positive regulation of protein ubiquitination (GO:0031398),0.29357601572120706,0.8203968415505468,0.7789473684210526,0.909554511081272,1.0,20/80,27.13%,PRICKLE1;TOPORS;DCUN1D5;HUWE1;CDK5RAP3;AXIN1;SMAD7;DCUN1D2;PHF23;UBQLN1;STUB1;MYCBP2;LRRK2;BIRC3;DERL1;PINK1;RCHY1;XIAP;NDFIP1;RIPK2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.32676804728774383,0.8203517777755877,0.7204819277108434,0.9092525061355488,1.0,2/32,2.82%,DDX5;FHIT
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3008751169327804,0.820347196954386,0.7649667405764967,0.9088875106195377,1.0,7/65,8.38%,EGFR;ARAP1;PTPN3;MVB12B;AGR2;RNF115;CBL
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.34664693806256164,0.8198867999917085,0.724223602484472,0.9092552577896529,1.0,6/24,14.31%,GAS6;RAMP2;NFE2L2;PAK4;PDPK1;NDNF
prerank,purine-containing compound salvage (GO:0043101),0.38760892113038825,0.8198766140064283,0.6884561891515995,0.9089015664567155,1.0,3/12,12.97%,ADA;AMPD3;DGUOK
prerank,positive regulation of autophagy (GO:0010508),0.29290681188022083,0.8196454059778814,0.7776606954689147,0.9088969724029201,1.0,37/81,31.58%,SESN3;HMGB1;TRIM27;MID2;PIK3CB;SESN2;PAFAH1B2;TRIM65;FOXO3;ORMDL3;FLCN;UFL1;TRIM13;TRIM6;EIF2AK4;ATF6;OPTN;IL4;RUFY4;LRRK2;TRIM8;TSC2;NPRL2;BAD;TBK1;ROCK1;PINK1;GPSM1;TFEB;ULK1;LARP1;PLEKHF1;PRKN;IRGM;MTDH;PIM2;DAPK1
prerank,negative regulation of immune response (GO:0050777),0.28408369442260023,0.8189544742847594,0.8277268093781855,0.9095432784157164,1.0,31/154,21.21%,COL3A1;GPR27;DRD1;FSHR;RAMP2;TRAFD1;ADCY2;ADCY8;IRAK3;ADCY9;TRIM27;GPR20;IAPP;ITCH;MAPKBP1;RAMP1;VIP;GLP1R;MC4R;PCBP2;PTGDR;IL6;SIRT2;CREB1;CALCA;ACOD1;ADCY7;PRKACA;GNB1;PRKAR2A;MUL1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3127629968662076,0.818824025817253,0.7396449704142012,0.9093694574245287,1.0,9/41,12.12%,TGFB2;TGFBR2;JAG1;HEYL;BMP4;FGFR2;BMPR1A;SMAD7;HEY1
prerank,regulation of presynapse organization (GO:0099174),0.3566993590238181,0.8186624537941946,0.7014531043593131,0.9088912451373433,1.0,2/18,4.89%,GPC6;LRFN4
prerank,regulation of presynapse assembly (GO:1905606),0.3566993590238181,0.8186624537941946,0.7014531043593131,0.9088912451373433,1.0,2/18,4.89%,GPC6;LRFN4
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3467610743378359,0.8185940812499511,0.7238219895287958,0.9086284391712023,1.0,8/21,23.25%,MCU;BCAP31;MICU2;LETM1;MICU1;ANXA6;AFG3L2;SLC8B1
prerank,multivesicular body assembly (GO:0036258),0.33261683450107205,0.818575054573576,0.7050805452292441,0.9082906472956379,1.0,12/30,32.86%,STAM2;CHMP3;IST1;VTA1;CHMP4A;CHMP4B;PDCD6IP;MVB12A;CHMP2A;VPS37B;CHMP4C;VPS37C
prerank,neuron projection fasciculation (GO:0106030),0.4082660953563594,0.818452842512169,0.7157142857142857,0.9081006260619235,1.0,2/10,5.73%,EPHB2;EPHB3
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2844824171836384,0.8182739446451649,0.7917981072555205,0.9079879295872642,1.0,16/104,16.85%,LRP6;LRP5;CALM2;CDC6;CDK5RAP3;RHOA;CDK12;SYAP1;ABL1;CCNT2;TELO2;PPEF2;CCNG2;CCNE2;CDC25A;CALM3
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3312215971103546,0.8176085032210013,0.7287933094384708,0.9082818636687134,1.0,15/31,33.41%,GTF2F1;ERCC3;ERCC2;POLR2F;NCBP1;NCBP2;RAMAC;POLR2B;GTF2H4;POLR2H;RNMT;POLR2I;POLR2L;POLR2K;CCNH
prerank,7-methylguanosine RNA capping (GO:0009452),0.3312215971103546,0.8176085032210013,0.7287933094384708,0.9082818636687134,1.0,15/31,33.41%,GTF2F1;ERCC3;ERCC2;POLR2F;NCBP1;NCBP2;RAMAC;POLR2B;GTF2H4;POLR2H;RNMT;POLR2I;POLR2L;POLR2K;CCNH
prerank,regulation of immunoglobulin production (GO:0002637),0.3471955467060485,0.8175048609477344,0.7245283018867924,0.9080913441704778,1.0,5/23,20.96%,EPHB2;CLCF1;STX4;IL6;IL4
prerank,regulation of response to external stimulus (GO:0032101),0.28634962254966434,0.8166323267383704,0.800417972831766,0.9090744845209943,1.0,34/121,26.02%,MGLL;FOXP1;EPHB2;SHPK;PDE6A;BRD4;SBNO2;ANXA1;NR1D2;TRAF3;PSMA6;F2R;CASP1;GUCY2D;CXCR4;N4BP1;PTGES;UFL1;SAG;APPL2;APPL1;GRK4;DAGLB;BIRC3;AREL1;CYLD;BST1;USP14;METAP2;XIAP;STK24;TKFC;NMT1;CYRIB
prerank,negative regulation of GTPase activity (GO:0034260),0.3512362843904445,0.8165183405003426,0.7047496790757382,0.9088712323220414,1.0,6/22,13.92%,RDX;KLRK1;BCAS3;RCC2;ARL2;WNK1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3662256143046014,0.8164012482859033,0.7031039136302294,0.9086762487553214,1.0,3/15,7.13%,TGFB2;CELF4;FGFR1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.29994089647704614,0.816237225648374,0.7618522601984564,0.9085522989332885,1.0,19/56,27.72%,CIT;SNX18;RHOA;SPAST;SNX9;RHOB;MITD1;SPIRE2;SPTBN1;IST1;TTC19;RTKN;CHMP4B;PDCD6IP;ROCK1;JTB;CUL7;EFHC1;SON
prerank,ATP transport (GO:0015867),-0.3413477763322471,-0.8162131500076928,0.6797385620915033,0.8987280724207053,1.0,3/10,28.50%,SLC25A24;CD47;SLC17A9
prerank,synaptonemal complex organization (GO:0070193),0.3773603209305329,0.8160310804386617,0.7306666666666667,0.9081339296650119,1.0,4/15,28.83%,HORMAD1;TEX11;P3H4;SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.3773603209305329,0.8160310804386617,0.7306666666666667,0.9081339296650119,1.0,4/15,28.83%,HORMAD1;TEX11;P3H4;SYCP2
prerank,positive regulation of endocytosis (GO:0045807),0.31454491615255625,0.8155288406487271,0.7603686635944701,0.9085390429113561,1.0,13/45,20.96%,LRP1;GPC3;RAB21;CBL;NLGN1;DAB2;HNRNPK;HIP1;CD151;CLN3;APPL2;CLU;IL4
prerank,Notch signaling involved in heart development (GO:0061314),0.39030968224710305,0.8153816339967613,0.7106741573033708,0.9084080718024303,1.0,3/11,12.12%,JAG1;HEYL;HEY1
prerank,regulation of calcium ion import (GO:0090279),-0.27381197987411526,-0.8152628504147905,0.7309417040358744,0.8989265524616783,1.0,4/21,11.89%,CXCL12;PDGFRB;PLPP4;SLC30A1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.34195662647925845,0.8151110932377962,0.7361111111111112,0.9084655547271496,1.0,3/23,11.75%,ID2;FGFR2;SMAD7
prerank,T cell mediated immunity (GO:0002456),0.38840472571663887,0.8148688759956269,0.717391304347826,0.9084777412550642,1.0,3/13,9.77%,GNL1;JAG1;CRTAM
prerank,peripheral nervous system development (GO:0007422),0.3425755539226267,0.8147733427603212,0.7164556962025317,0.9082411450141337,1.0,8/23,23.13%,PMP22;ALDH3A2;GFRA3;NF1;SCN8A;GDNF;GPC1;SOX8
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.35332624903473026,0.814199394090013,0.7334200260078023,0.9087394534970165,1.0,9/20,30.69%,FKBP5;PPIL3;NKTR;FKBP4;PPIG;FKBP1B;PPID;PPIC;PPIH
prerank,activation of protein kinase A activity (GO:0034199),0.3624589657855756,0.8137907062679857,0.7079407806191117,0.9089633648835937,1.0,4/16,7.52%,PRRC1;ADCY2;ADCY8;ADCY9
prerank,nucleic acid-templated transcription (GO:0097659),0.3200672109619152,0.8131534748491013,0.731651376146789,0.9095464901369817,1.0,17/42,30.90%,TOPORS;BAZ2A;NFKBIB;TERT;XAB2;MEF2A;MMS19;POLR2F;E2F1;MED20;POLR2B;POLR2H;DRG1;POLR2I;PWP1;POLR2L;TAF1B
prerank,regulation of chromosome organization (GO:0033044),0.34565716018971904,0.8131526638555963,0.6962676962676962,0.9091800145086189,1.0,6/22,21.96%,RMI2;SMG6;SMG1;LIG4;CDT1;UPF1
prerank,lymphocyte proliferation (GO:0046651),0.3422677047744749,0.8129993004268806,0.7169811320754716,0.9090415502921385,1.0,1/22,1.42%,ELF4
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.29343659788080123,-0.8129304114207148,0.7226277372262774,0.901555019083284,1.0,9/15,34.49%,KLHL18;STXBP4;PHB2;CUL3;CRNN;DYRK3;ATAD5;CDC73;NPM1
prerank,neutrophil migration (GO:1990266),0.30500569297583446,0.8122049260728859,0.75,0.9098648541546979,1.0,6/58,9.28%,CCL13;CCL15;TGFB2;GBF1;FCER1G;EDN3
prerank,regulation of cytoplasmic translation (GO:2000765),0.3762094747664498,0.8121216402804288,0.7351274787535411,0.9096247422843285,1.0,1/14,1.81%,YBX3
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.3209815112065298,0.812090883647786,0.7168674698795181,0.9093083405684025,1.0,11/35,20.96%,LRPAP1;RAB21;RSPO1;CBL;ARF1;PIK3CB;SNAP91;HNRNPK;HIP1;CLU;IL4
prerank,L-serine metabolic process (GO:0006563),0.40126249131640096,0.8113068380231451,0.7377049180327869,0.9100927150309222,1.0,5/10,19.03%,SRR;PHGDH;SHMT2;SHMT1;PSAT1
prerank,regulation of neuroblast proliferation (GO:1902692),0.37640984077725415,0.8109213844469848,0.7271487039563438,0.9103322502278042,1.0,1/15,0.78%,VEGFA
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.35265730202584566,0.8107558802842871,0.7198007471980075,0.9102081304268412,1.0,10/22,32.29%,ERI3;RRS1;RPP40;WDR12;ABT1;KRI1;ERI1;EXOSC2;NOP14;EXOSC3
prerank,regulation of blood circulation (GO:1903522),0.3207230904814625,0.8097972544941076,0.7287735849056604,0.9112837738498732,1.0,6/34,13.86%,ECE1;CAMK2D;KCNE5;KCNIP2;S100A1;DMPK
prerank,endothelial cell differentiation (GO:0045446),0.39389340063056705,0.8096344913847405,0.7191977077363897,0.9111613791422754,1.0,2/12,6.52%,FSTL1;JAG1
prerank,maintenance of protein location in nucleus (GO:0051457),0.3486655991220955,0.8095649374277134,0.7259740259740259,0.9108780522464677,1.0,3/20,13.59%,TOPORS;MORC3;ARL2
prerank,positive regulation of viral transcription (GO:0050434),0.34553811989851213,0.8094020539353852,0.7255639097744361,0.9107507012820397,1.0,14/25,35.34%,MDFIC;GTF2F1;POLR2F;POLR2B;NELFB;CTDP1;POLR2H;NELFA;POLR2I;CDK9;POLR2L;POLR2K;DHX9;SUPT4H1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.33382513947012515,-0.8093116677560136,0.7098976109215017,0.9063439163125664,1.0,5/10,19.56%,APC;CDC42;RACGAP1;ECT2;KNSTRN
prerank,regulation of cholesterol metabolic process (GO:0090181),0.3525775676815971,0.8092544262155559,0.7221510883482715,0.9106021866595101,1.0,4/20,10.44%,MBTPS1;DGKQ;SREBF1;LPCAT3
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3571722175712004,0.8091722070412515,0.7070572569906791,0.9103479043265856,1.0,2/17,7.26%,TWIST1;YJU2
prerank,negative regulation of complement activation (GO:0045916),-0.3377916982555353,-0.8088488246196646,0.7142857142857143,0.9056843550553435,1.0,4/10,23.39%,A2M;CR2;CD55;SUSD4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.39369179161692813,0.8076180666030803,0.7195994277539342,0.9122852925695221,1.0,3/11,19.65%,HMGB1;RUNX1;CBFB
prerank,regulation of peptidase activity (GO:0052547),0.3559880230202463,0.8076001972155475,0.7333333333333333,0.9119419685916883,1.0,7/19,27.76%,CST3;MAPK12;HDAC1;PSMA3;RCN3;PINK1;SVBP
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.35835426884604465,0.80745072186787,0.7003994673768309,0.9117916114193908,1.0,6/18,18.52%,MDFIC;CHP1;RAB23;LATS2;FLCN;SUFU
prerank,fibrinolysis (GO:0042730),-0.31191984356734137,-0.8073829926760223,0.7116788321167883,0.9067548551519302,1.0,2/13,10.56%,PLAT;SERPINE1
prerank,neurotrophin signaling pathway (GO:0038179),0.34923590862047615,0.8070197131503247,0.735632183908046,0.9121010841057003,1.0,2/21,4.63%,NTRK1;KIDINS220
prerank,axonal fasciculation (GO:0007413),0.3890818903745492,0.8069101256997557,0.721606648199446,0.9118983468172965,1.0,2/12,5.73%,EPHB2;EPHB3
prerank,positive regulation of chemokine production (GO:0032722),0.30768116869863676,0.8068934191860643,0.7418981481481481,0.9115573302507542,1.0,4/44,6.47%,IL33;TWIST1;MAVS;HMGB1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.31215352373950406,-0.806783430102216,0.7121771217712177,0.9063134436622262,1.0,5/13,21.17%,ELOVL7;HACD1;TECRL;ELOVL6;HACD4
prerank,multivesicular body organization (GO:0036257),0.32650500448012393,0.8066830032294486,0.7311960542540074,0.9114941604901705,1.0,10/31,27.29%,STAM2;CHMP3;IST1;VTA1;CHMP4A;CHMP4B;PDCD6IP;MVB12A;CHMP2A;VPS37B
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3866322897109879,0.8066657659378063,0.7430555555555556,0.911152380404415,1.0,6/12,28.84%,ELOVL5;FADS1;ABCD1;ACOT8;ELOVL1;SCP2
prerank,cochlea morphogenesis (GO:0090103),-0.3212019430908907,-0.8059265747960597,0.7227414330218068,0.9064365558316996,1.0,2/10,5.37%,TBX18;TBX1
prerank,regulation of catabolic process (GO:0009894),-0.2896111553051861,-0.8058921072078031,0.7573221757322176,0.9050112288371315,1.0,3/18,8.32%,NEDD4L;FAF1;HPGD
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.32387885842092207,0.8056993576427172,0.717948717948718,0.9122671635374338,1.0,9/30,24.29%,TENT4B;ERCC4;TEN1;HNRNPC;XRN1;MEN1;HNRNPA1;HNRNPU;TP53
prerank,phosphate-containing compound metabolic process (GO:0006796),0.27395259938460326,0.8056511323378834,0.8954773869346734,0.9119700893481476,1.0,28/198,14.36%,ALPL;PLCE1;TNFAIP8L3;PLA2G4F;PLA2G4A;PLPP3;EPHB2;NADK;GFPT1;STAT3;LIMK2;SHPK;PLPP1;LPCAT4;GFPT2;PAK2;SYNJ1;PLA2G5;PIP4K2B;PPA2;INPP5B;IP6K1;LGALS13;INPP4A;PIK3CB;OCRL;LIMD1;DUSP18
prerank,retina homeostasis (GO:0001895),-0.25561511515175567,-0.8055433849624541,0.7882882882882883,0.904192933265274,1.0,4/23,9.30%,B2M;WHRN;ATP1B2;HSPB1
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.3206126035651519,-0.8054879053421485,0.6689655172413793,0.9028300773144196,1.0,10/10,67.97%,NCKAP1L;IL12A;FOXP3;TLR4;IL12B;VSIR;IFNG;TNFSF4;DDIT3;PRNP
prerank,synaptic vesicle exocytosis (GO:0016079),0.3159873140743411,0.8050617594758507,0.7334878331402086,0.9124675005457898,1.0,15/40,26.91%,SYT8;UNC13B;STX11;PRRT2;STX2;SNAP23;STX4;STX1A;SNAPIN;CDK5;STX1B;VAMP2;STX19;PCLO;SNPH
prerank,histone H2B ubiquitination (GO:0033523),-0.31893095270150845,-0.8048884940754278,0.6811145510835913,0.9023805251017207,1.0,4/10,16.69%,RNF40;UBE2E1;LEO1;CTR9
prerank,Ras protein signal transduction (GO:0007265),0.28029867968989,0.8047385874102055,0.8309572301425662,0.91258531127073,1.0,22/137,15.24%,NTN1;PLCE1;FGF2;COL1A2;TIAM1;MRAS;GDI1;SHC1;TRIM28;EPS8L1;CDC42EP2;USP50;CYFIP1;RHOA;SHOC2;CDC42EP5;SETDB1;ARHGEF1;G3BP2;RHOB;FARP2;SOS1
prerank,calcium ion homeostasis (GO:0055074),0.28321771020260567,0.804348134633897,0.806282722513089,0.9127963936444571,1.0,13/95,11.18%,ATP1B1;SLC24A3;CCL13;PKHD1;CCL15;SLC10A7;ANK2;SELENON;CHERP;STIM1;EDN3;CSRP3;TMEM165
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.317685051288368,0.804102288620902,0.7634408602150538,0.912791135564997,1.0,15/37,27.13%,SPRED2;CALM2;DGKQ;AXIN1;SMAD7;PPEF2;EIF4G1;SIRT2;CALM3;TRIM6;TNKS1BP1;RPTOR;S1PR2;PARD3;RIPK2
prerank,necroptotic process (GO:0070266),0.3586167280130256,0.804020814070648,0.7195767195767195,0.9125351115223526,1.0,7/16,32.21%,PGAM5;TRPM7;RIPK3;CYLD;RIPK1;ITPK1;IPMK
prerank,cilium-dependent cell motility (GO:0060285),0.34133430193135567,0.8038679140512626,0.7196382428940569,0.9124012397999889,1.0,4/22,18.64%,DNAH8;CCDC39;DNAH2;TEKT2
prerank,ribosome biogenesis (GO:0042254),0.27457366165839625,0.8037965175136507,0.8665318503538928,0.9121328288098157,1.0,54/187,27.93%,XPO1;C1D;LTV1;RRS1;RRP7A;LAS1L;EMG1;CUL4A;WDR3;RIOK1;NVL;ABCE1;WDR55;ESF1;RRP12;DHX29;NOLC1;UTP14A;DCAF13;EXOSC4;NOC4L;MRTO4;EIF6;BYSL;DIS3;BOP1;METTL17;NOB1;RPL7A;NOC2L;MTREX;EIF2A;WDR12;NOP56;DDX49;FBL;SBDS;WDR36;GTF3A;PAK1IP1;WDR46;WDR75;RPS9;TBL3;SENP3;RIOK2;UTP11;NOP58;DKC1;POP5;FCF1;NOP53;RPL41;RPL30
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.39538561062455874,0.8034848316123877,0.726207906295754,0.9122301824398782,1.0,5/10,30.82%,CDT1;DBF4;STOML2;E2F8;SSBP1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.32055552250415575,0.8033111838177918,0.7464622641509434,0.9121045538683386,1.0,12/33,24.51%,NOL3;FXN;HUWE1;IAPP;HGF;SLC35F6;FLCN;AKT1;CLU;MUL1;TRIAP1;PINK1
prerank,cyclooxygenase pathway (GO:0019371),0.39259194805688935,0.8032844038154721,0.7001455604075691,0.9117900304399329,1.0,2/10,7.01%,PTGIS;PTGES2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.2130468744495427,-0.8032699432762326,0.851063829787234,0.9037210842831465,1.0,20/48,29.80%,IL1R1;PDE4D;SLC7A5;PDE4B;LGALS9;PTPN22;PYCARD;TXK;CD276;ISG15;TLR7;CCR2;TLR3;RASGRP1;FADD;ZFPM1;CD14;SLAMF6;IL18;TLR8
prerank,regulation of interferon-alpha production (GO:0032647),0.3445821624511025,0.8029758285913297,0.712468193384224,0.911893767937177,1.0,8/23,27.13%,PTPRS;MAVS;CHUK;HSPD1;IRF3;SETD2;TBK1;RIPK2
prerank,protein monoubiquitination (GO:0006513),0.3156815629426403,0.8028590009114939,0.7485380116959064,0.9116893081528302,1.0,12/36,29.90%,TOPORS;UBE2B;UBE2R2;HUWE1;KLHL22;PAF1;KLHL12;RNF20;UBE2W;RNF126;RBX1;PRKN
prerank,mRNA polyadenylation (GO:0006378),0.33238669013941324,0.8025148016401219,0.7422166874221668,0.9114596402426741,1.0,7/26,21.58%,PABPC1;TENT4B;SYMPK;CLP1;PCF11;TENT2;PAF1
prerank,RNA polyadenylation (GO:0043631),0.33238669013941324,0.8025148016401219,0.7422166874221668,0.9114596402426741,1.0,7/26,21.58%,PABPC1;TENT4B;SYMPK;CLP1;PCF11;TENT2;PAF1
prerank,negative regulation of defense response (GO:0031348),0.28930609340203567,0.8024748082452849,0.801063829787234,0.9111575163045229,1.0,18/77,21.21%,PRKCD;PTGIS;CCN3;TRAFD1;IRAK3;SHARPIN;RORA;ITCH;MAPKBP1;LPCAT3;PTPN2;PCBP2;SIRT2;OTULIN;ACOD1;GPS2;IL4;MUL1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.30285066079739137,0.8021554966139309,0.7511415525114156,0.9112533604808054,1.0,4/49,4.20%,VEGFA;GHR;HES5;STAT3
prerank,mitochondrion organization (GO:0007005),0.2760862870966838,0.8020316987271044,0.85,0.9110582919249998,1.0,44/165,24.88%,PID1;VPS13C;DNM2;MIEF2;SPG7;TOMM40;SIRT5;RHOT2;TIMM9;RHOT1;RAB38;TERT;NRF1;BCAP31;AIFM1;LONP1;HSPD1;MEF2A;SUPV3L1;MTFR1;PRDX3;TOMM70;PARP1;HIGD1A;POLG2;BCS1L;TFB2M;BID;HCFC1;CLUH;TWNK;NIPSNAP2;FANCG;MUL1;LRRK2;MFN1;COX7A2L;AFG3L2;MTM1;STOML2;VPS13D;PINK1;TIMM17B;TIMM22
prerank,positive regulation of protein deacetylation (GO:0090312),0.3705564407020927,0.8017411191331902,0.7307171853856563,0.9111231631288313,1.0,4/14,24.33%,NNMT;NIPBL;AKAP8;SAP30BP
prerank,negative regulation of TORC1 signaling (GO:1904262),0.37090177510854516,0.8014451370652319,0.7174515235457064,0.911176485374172,1.0,4/13,12.59%,SESN3;CASTOR2;ATM;SESN2
prerank,epithelial cell morphogenesis (GO:0003382),0.3590615993187042,0.8011251999656753,0.720626631853786,0.9112646397712484,1.0,2/17,3.83%,COL15A1;PKHD1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3436635373054804,0.8009682870839974,0.7484197218710493,0.9111415791114301,1.0,2/22,3.26%,LBP;RAB7B
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3606742127299293,0.8006321621179218,0.7224435590969456,0.9112649201438552,1.0,4/16,13.69%,TGFB3;BMP4;F2R;RUNX1
prerank,cardiac ventricle development (GO:0003231),-0.26423962713910454,-0.8004395083152783,0.7913043478260869,0.907054064615358,1.0,9/20,21.71%,ENG;NOTCH1;PDE2A;SALL1;HEY2;STRA6;DLL4;SCN5A;GJA5
prerank,response to ionizing radiation (GO:0010212),0.29043414297302617,0.8000958515771943,0.7956989247311828,0.911660493937411,1.0,19/70,22.12%,COP1;INTS3;RAD1;ANXA1;SPIDR;SWI5;ATM;LIG4;TANK;RHOB;AEN;HUS1;TRIM13;MEN1;CLK2;RAD51;TNKS1BP1;BRCC3;TOPBP1
prerank,toxin transport (GO:1901998),0.3968757155292012,0.800090334370829,0.7252440725244073,0.9113019976046394,1.0,4/10,30.20%,ADAM10;SLC22A3;ANTXR1;RAB40B
prerank,regulation of cell division (GO:0051302),0.2887009473407604,0.8000206317736449,0.8068669527896996,0.911045037829877,1.0,25/72,31.73%,KIF13A;CALM2;TLE6;ESRRB;FGFR2;GIT1;CSPP1;SIRT2;MLLT3;CALM3;BIRC6;FLCN;SFN;SETD2;UVRAG;PLK4;RAB11FIP4;CCP110;EFHC1;AHCTF1;PRDM15;KLHL9;ZFYVE26;BLM;RAB11FIP3
prerank,membrane fusion (GO:0061025),0.32299504047217154,0.7999923371777987,0.763855421686747,0.9107329318184924,1.0,8/33,17.80%,STX11;DNM2;HUWE1;NSF;USO1;CHP1;SNAP23;NAPA
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3450188640861835,0.799707208482096,0.7188703465982028,0.9107826828323096,1.0,13/20,35.94%,CAMK2D;PACS2;BCAP31;THADA;KCTD17;HERPUD1;CCDC47;FIS1;TMCO1;SELENOK;RAP1GDS1;WFS1;BAK1
prerank,cellular response to glucose starvation (GO:0042149),0.31048086791825763,0.7992986565901963,0.7514654161781946,0.9110220159207789,1.0,14/41,26.32%,SESN3;ATF4;IMPACT;HSPA5;SESN2;PICK1;FOXO3;SIK2;PRKAG1;KPTN;HNRNPA1;EIF2AK3;TP53;NIM1K
prerank,glycerophospholipid metabolic process (GO:0006650),0.2909190094207757,0.7990208600861937,0.802801724137931,0.9110577918275452,1.0,20/75,22.84%,PLA2G4F;PLA2G4A;PIGW;SMPD4;PIGF;SYNJ1;FAR1;ABHD6;PIGL;ENPP6;PNPLA3;HDHD5;PIP5K1A;GDPD3;PLA2G15;CLN3;PLCB2;PIGX;ABHD12;PIGV
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.38641848785513755,0.7987538254346479,0.7289325842696629,0.9110864342129762,1.0,2/11,4.91%,RDX;PRKCA
prerank,positive regulation of leukocyte migration (GO:0002687),0.32547876385401286,0.7987438050161917,0.7214111922141119,0.9107409963465203,1.0,6/27,20.96%,VEGFA;EDN3;MIA3;IL6;TNFSF18;IL4
prerank,positive regulation of collagen metabolic process (GO:0010714),0.3569703303955525,0.797983906962259,0.7217043941411452,0.9114737798909541,1.0,4/17,13.69%,TGFB3;BMP4;F2R;RUNX1
prerank,rRNA transcription (GO:0009303),0.3627102164101123,0.797904078645644,0.7142857142857143,0.9112451640472685,1.0,10/17,35.74%,POLR1G;CAVIN1;GTF3C1;GTF3C4;GTF3A;NIFK;TAF1B;SIRT7;TCOF1;BRF1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.34448655553474006,0.7978117452420369,0.7522123893805309,0.9110198819285007,1.0,5/22,16.85%,CACNA1C;STIM1;CAP1;PALM;NF1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.26447166764513064,-0.7976731830094014,0.7729468599033816,0.9101918327134347,1.0,4/22,10.60%,WNT5A;SLC7A5;LACC1;TRIL
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3422602236450111,0.7970999043276946,0.7300771208226221,0.9117000783064516,1.0,4/21,16.77%,BRD4;CDC25B;RCC2;CDC25A
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.39589868477026735,0.7967898308019542,0.721030042918455,0.9117811675204865,1.0,2/10,7.68%,PKDCC;SOX9
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3476006816444385,0.7967191108634937,0.7258953168044077,0.9115272049258692,1.0,4/19,13.69%,ELF1;MAVS;IRAK1;RUNX1
prerank,blood vessel diameter maintenance (GO:0097746),0.3172095606767061,0.7966456911230676,0.7754854368932039,0.9112687211179152,1.0,3/34,3.19%,GCLC;ECE1;EDNRA
prerank,positive regulation of ion transport (GO:0043270),0.3063650823201762,0.7965697394423378,0.7882882882882883,0.9110234212698307,1.0,8/48,13.07%,FHL1;DRD1;CRACR2A;CHRNB2;ANK2;DLG1;PRSS8;F2R
prerank,rRNA 3'-end processing (GO:0031125),0.4015947231302341,0.7965300085148956,0.7232267037552156,0.9107181593946696,1.0,1/10,2.55%,ERI3
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3126546288455333,-0.7960907486563439,0.75,0.9113960325311157,1.0,5/12,17.88%,GMPS;IMPDH1;ADSS1;LHPP;PPAT
prerank,extracellular transport (GO:0006858),0.3824625474778913,0.7958861058896698,0.7376586741889986,0.9112640244479774,1.0,4/12,21.82%,WWP2;ROPN1L;DNAAF4;SPAG17
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.3295920373764975,0.7956662566438741,0.7321196358907672,0.9112354846990833,1.0,9/24,26.52%,PKD1;DNAAF4;PSMD14;EFNA1;UCHL5;PRKACA;USP14;PINK1;TMF1
prerank,arachidonic acid secretion (GO:0050482),-0.3247433699190869,-0.7956501750352875,0.6805111821086262,0.9092010050251257,1.0,3/10,7.77%,BDKRB2;PNPLA8;ACE
prerank,arachidonate transport (GO:1903963),-0.3247433699190869,-0.7956501750352875,0.6805111821086262,0.9092010050251257,1.0,3/10,7.77%,BDKRB2;PNPLA8;ACE
prerank,fatty acid metabolic process (GO:0006631),0.28003965690047655,0.7955292092141335,0.8328173374613003,0.9110781588478604,1.0,32/115,28.47%,ABCD3;CEL;ACSF3;CPT1C;ACSF2;ACOT11;ADIPOR2;CBR4;SLC27A6;ACAD9;ACACA;ACSL3;PNPLA3;CRAT;HACL1;PLA2G15;HSD17B8;ACSL6;ACSBG1;SLC27A2;PEX2;ACBD5;MCAT;ACOT8;FA2H;FAAH;ANGPTL3;ALOXE3;SLC27A3;PON3;PER2;ACLY
prerank,cellular zinc ion homeostasis (GO:0006882),0.3308950422210804,0.7952467550904109,0.7610619469026548,0.9111384321205046,1.0,4/26,9.85%,SLC39A14;SLC39A7;SLC30A5;SLC39A13
prerank,gonad development (GO:0008406),0.3058933200522847,0.7948553688577301,0.755608028335301,0.9113234410542079,1.0,7/41,13.14%,FSHR;CYP19A1;SIX4;TGFB2;SOX9;INHBA;LRP2
prerank,positive regulation of transporter activity (GO:0032411),0.3668145029622897,0.7943471467164347,0.7039030955585465,0.9116757930632803,1.0,2/13,6.66%,RXRA;STK39
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3738177189960689,0.7934103002280875,0.7296137339055794,0.9126591341743264,1.0,2/12,5.05%,CAMK2D;CALM2
prerank,mitochondrion distribution (GO:0048311),-0.3107045975658173,-0.7923307754410142,0.7615894039735099,0.9131329173346996,1.0,4/12,13.09%,DNM1L;TRAK2;TRAK1;ARMC1
prerank,establishment of protein localization to membrane (GO:0090150),0.28955478638795085,0.7920197307387994,0.7973713033953997,0.9142382292806345,1.0,19/66,27.29%,EGFR;NECTIN3;RABGEF1;RAB3GAP1;NPC1;ATG3;RAB11B;ZDHHC4;BID;RAB3GAP2;COX18;ZDHHC20;PRKCI;ZDHHC9;GORASP2;TAOK2;AFDN;PARD3;VPS37B
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.35112313049026717,0.7917713093583736,0.7252604166666666,0.9142324972640684,1.0,5/18,21.82%,CCDC39;ROPN1L;NPHP3;DNAAF4;SPAG17
prerank,male gonad development (GO:0008584),0.31518597484518357,0.7913849149183502,0.7466007416563659,0.9144135765875159,1.0,6/34,13.14%,FSHR;SIX4;TGFB2;SOX9;INHBA;LRP2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.3922260135176947,0.7912224382159765,0.7206303724928367,0.9142801594243278,1.0,6/10,27.67%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5
prerank,regulation of T cell activation (GO:0050863),0.30348158537401193,0.7904667727205057,0.7869615832363213,0.9149772301010378,1.0,7/42,12.92%,TNFRSF1B;TBX21;CRTAM;ABL1;KAT2A;VTCN1;HSPD1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.3414024123807584,0.7904631090983251,0.7433155080213903,0.9146230780438606,1.0,8/19,33.57%,ZNF76;TENM1;CHD8;ICE1;RPTOR;PRDX5;POLR3F;ZC3H8
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3388101528694389,0.7903449165681048,0.7484276729559748,0.9144263915108557,1.0,3/23,8.38%,SRCIN1;SOCS4;CBL
prerank,sphingolipid biosynthetic process (GO:0030148),0.2875222601667686,0.7902719917951444,0.8071120689655172,0.914165367339326,1.0,7/71,6.18%,ACER3;PLPP3;ST6GALNAC5;KDSR;SMPD4;ELOVL5;PLPP1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3180915257071387,-0.7900558408673156,0.7244897959183674,0.9153062710781458,1.0,2/10,5.46%,DPYD;UPB1
prerank,cellular respiration (GO:0045333),0.30940165207064135,0.7899744182793113,0.7782857142857142,0.9142218020604242,1.0,8/41,14.01%,ETFRF1;COQ10B;ETFDH;ETFA;ETFB;NDUFS7;SURF1;MTFR1
prerank,sphingoid biosynthetic process (GO:0046520),0.38312570519042666,0.7898947830503726,0.740029542097489,0.9136134683449915,1.0,1/11,1.73%,ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.38312570519042666,0.7898947830503726,0.740029542097489,0.9136134683449915,1.0,1/11,1.73%,ACER3
prerank,negative regulation of viral process (GO:0048525),0.2925058358257591,0.7898556224874435,0.7951807228915663,0.9133106345301091,1.0,16/57,22.09%,TRIM28;MAVS;TRIM27;ILF3;UBP1;MID2;CHMP3;TRIM26;SRPK1;HEXIM1;N4BP1;TRIM13;TRIM6;LARP7;SHFL;TRIM8
prerank,basement membrane organization (GO:0071711),0.36278524042125826,0.7893812152813671,0.7266666666666667,0.9136247783540221,1.0,3/14,10.90%,NTN4;RAMP2;FLRT2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.33673731463709905,0.7892052812174954,0.7563775510204082,0.9135116892243063,1.0,6/22,17.60%,IPO5;HEXIM1;CAMK2N1;LATS2;CDKN1C;MEN1
prerank,leukocyte tethering or rolling (GO:0050901),-0.2732160290951492,-0.7889356683575434,0.7717842323651453,0.9157553406500502,1.0,5/17,14.42%,VCAM1;JAM2;CX3CR1;ITGA4;GCNT1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.3518898541761452,0.7885078214970545,0.7359249329758714,0.9141724216352067,1.0,3/16,9.77%,KLRK1;RAET1E;CRTAM
prerank,regulation of JUN kinase activity (GO:0043506),0.3200287366304888,0.7880794880882285,0.7871581450653984,0.9144207903951896,1.0,11/33,27.36%,PDCD4;MAP3K5;PPEF2;MAP3K10;DNAJA1;AIDA;DUSP19;TAOK3;MAPK8IP1;DVL2;MAP3K11
prerank,positive regulation of transmembrane transport (GO:0034764),0.37032427220448627,0.7879133127856734,0.7272727272727273,0.9142884379358431,1.0,2/13,4.37%,SLC26A6;C2CD5
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.34564683055678724,0.7873643626789397,0.7389558232931727,0.9147191644161214,1.0,5/17,25.57%,DRD1;ADCY9;AKAP13;DRD2;ADRB1
prerank,carbohydrate derivative transport (GO:1901264),0.3463897682340572,0.7872669932357431,0.7294117647058823,0.9145132436140081,1.0,2/18,5.76%,LBP;SLC10A7
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3223076861726197,0.7872611910205952,0.7582017010935601,0.9141650990329804,1.0,8/30,20.02%,NTRK1;SHC1;ITGAV;SHOC2;STK19;LRRC59;ERBIN;RASGRF1
prerank,MAPK cascade (GO:0000165),0.26575201435266627,0.787016073338242,0.9317953861584755,0.914173048767984,1.0,74/295,23.87%,EGFR;IRS1;FGF13;FGF2;DLG2;FGF17;MRAS;PTPN3;PPP1CC;PSMD7;SHC1;MAP3K5;IL5;PSMA8;FGFR1;RAF1;SOX9;DLG4;PDE6D;DLG1;MAPK8;PSMA4;FGFR2;ITGAV;CHUK;PAQR3;SHOC2;PABPN1;MAPK12;PSMD12;PIK3CB;CUL1;PSMA6;MEF2A;YWHAE;ARL2;PSMD1;HGF;SOS1;MAP3K3;PSMC5;PSMD11;IL17RD;ERBB2;PSMC4;PSMD14;GFRA3;UBC;RPS27A;FGF5;NF1;SPTBN1;WDR83;MEN1;ARAF;GDNF;PEBP1;RASGRF1;PSMA3;FGF18;FGFR3;MAP2K7;PSMB1;PSMD4;LRRK2;JAK1;NEFL;SYNGAP1;PSMA5;ZDHHC9;PSMA7;NRAS;KRAS;TAOK3
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3161700297408815,0.786854529347135,0.7660606060606061,0.9140472707736137,1.0,12/32,29.22%,CDK5RAP3;ATM;RINT1;FOXN3;BRCC3;TOPBP1;DONSON;TAOK3;TAOK2;TAOK1;NOP53;TRIM39
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.3493100977440605,0.7864290201711562,0.7419354838709677,0.914269752976338,1.0,4/16,20.78%,DPYSL3;UPP2;TET2;NT5C
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.27383925652319907,0.7860061925830727,0.8347368421052631,0.9145371186865541,1.0,13/101,13.18%,EGFR;PKD1;VEGFA;FGF2;CALM2;FGFR1;RHOA;EDN3;SYAP1;IRAK1;TELO2;TENM1;MAPRE3
prerank,positive regulation of inflammatory response (GO:0050729),0.2809507683458007,0.7859830957872361,0.8431163287086446,0.9142086684548544,1.0,4/86,3.96%,LBP;PDCD4;IL33;ABCC1
prerank,prostaglandin metabolic process (GO:0006693),0.32600202892576136,0.7850460514548818,0.7639751552795031,0.9151911541458235,1.0,2/26,1.79%,PTGIS;PLA2G4A
prerank,translation (GO:0006412),0.2672502935078467,0.7848242830537442,0.9059656218402427,0.9151529054692727,1.0,58/208,28.79%,RRBP1;RPSA;VARS1;MRPS2;MRPS28;WARS2;ABCF1;HARS2;GSPT1;NOA1;MRPS18B;PPA2;ZC3H15;YARS1;ABCE1;DARS2;MRPS14;EEF1G;AGO2;EIF4G1;MRPL35;ETF1;MRPS17;EEF2K;RPS27A;EEF1B2;YARS2;TUFM;EPRS1;PPA1;EEFSEC;SARS1;SARS2;DRG2;PTCD3;RPL7A;DARS1;MRPL47;GTPBP2;MRPS24;MRPS21;ASMT;MRPS18A;RPS9;MRPL37;PABPC4;TMA7;QARS1;CARS1;MRPL13;TRMT112;SRBD1;DRG1;RPL41;RPL30;MRPL11;WARS1;IGHMBP2
prerank,regulation of protein localization (GO:0032880),0.2950050732408895,0.7848061709624593,0.8087248322147651,0.9148214965528738,1.0,15/58,22.43%,DVL1;TRIM27;DLG1;PLEKHM2;MAPK8;SLC26A4;VIP;CSNK1E;PARP1;SUMO1;UFL1;TRIM6;TRIM46;CAMK1;TMEM231
prerank,regulation of exocytosis (GO:0017157),0.2978254139730116,0.784778407356542,0.7958715596330275,0.9145050768723236,1.0,11/46,17.29%,RAB2B;RAB21;RAB8A;NSF;ANXA1;RAB3D;STXBP5;CHMP3;STX4;RAB3B;SYTL4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2958996359398785,0.7846636436496948,0.7801339285714286,0.9143136834235074,1.0,16/48,26.51%,TOPORS;TNFRSF1B;PRKDC;ABL1;BCL2L2;ATM;CHEK2;AEN;E2F1;HIPK2;IKBKE;SFN;TP53;RPS27L;HTRA2;CDIP1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2048849989354537,-0.7844046486416493,0.9175257731958762,0.9216875455346248,1.0,15/57,17.85%,UACA;DDX3X;GRIN2B;PDCD5;AIM2;GRIN2A;SOX7;SYK;ACVR1C;NDUFA13;SIRT1;GRIN1;GPER1;FOXL2;PYCARD
prerank,respiratory chain complex IV assembly (GO:0008535),0.33450984615617557,0.7843717731085698,0.748378728923476,0.9143602809927147,1.0,10/21,32.50%,COA8;SURF1;BCS1L;COA6;FASTKD3;COX18;COX15;COA5;COX16;TIMM21
prerank,nucleotide catabolic process (GO:0009166),0.3498500889619833,0.7841815713449635,0.7382198952879581,0.9142639601616571,1.0,3/16,13.67%,XDH;VCP;DERA
prerank,positive regulation of myelination (GO:0031643),0.37276069231747677,0.7839143651583542,0.7187928669410151,0.9142846075442072,1.0,2/11,12.74%,TNFRSF1B;NCMAP
prerank,regulation of hormone secretion (GO:0046883),0.35329011518381037,0.7835746111674998,0.7292225201072386,0.9143915206741213,1.0,5/15,27.31%,EDN3;ANXA1;NMB;VAMP2;LIF
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.33333135171329265,0.783062515560492,0.7417302798982188,0.9147427854116581,1.0,3/24,6.95%,VEGFA;SEMA3E;SEMA4B
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.34625144258508583,0.7808024089556547,0.7503267973856209,0.9175615318106654,1.0,3/17,9.77%,KLRK1;RAET1E;CRTAM
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.25173071645182,-0.7805934806940977,0.8177339901477833,0.9262549241909147,1.0,9/24,19.50%,BCL2L1;NR1H3;AQP11;UBXN1;OPA1;HSPA1A;XBP1;RACK1;CREB3
prerank,regulation of DNA recombination (GO:0000018),0.30951187316941714,0.7805177782117306,0.7672727272727272,0.9175797086460787,1.0,12/32,31.68%,SPIDR;KPNA2;RAD50;SMARCAD1;RAD51;IL4;SETD2;ZRANB3;RTEL1;IL7R;MSH2;BLM
prerank,cardiocyte differentiation (GO:0035051),0.3938188838928633,0.7802843998720875,0.7349926793557833,0.9175175181293397,1.0,3/10,16.74%,TGFB2;AKAP13;KDM6B
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.254811820304265,-0.7800121898935393,0.765,0.925707593132975,1.0,10/24,20.60%,BCL2;BCL2L1;CXCL12;CD74;TPT1;SIRT1;CD44;KDM1A;CDKN2D;TAF9
prerank,exit from mitosis (GO:0010458),0.3675020769627312,0.7797373903595688,0.7263888888888889,0.9179369223269812,1.0,8/12,33.13%,SPAST;UBE2C;PPP2R2D;CHMP4B;CHMP2A;CTDP1;UBE2S;SIRT7
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2841276113462565,0.7794273372413638,0.8118279569892473,0.9179943060575966,1.0,22/70,26.25%,ACVR1B;CRADD;TGFB2;BAG3;TNFRSF1B;BLOC1S2;ITGAV;BCL2L2;PDPK1;TNFRSF10B;CD27;INHBA;DEDD;BID;APPL1;FGFR3;IL4;DIABLO;BAD;TRADD;DAXX;RIPK1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.37941338713223416,0.7789720744721266,0.7702702702702703,0.9182893381035584,1.0,5/10,25.59%,GPATCH3;NPLOC4;SEC14L1;C1QBP;TKFC
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3785244296500956,0.7785434170695144,0.7386363636363636,0.9185216557986032,1.0,6/11,27.67%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3321343523974347,0.7785334599588625,0.7525906735751295,0.9181812278441193,1.0,8/21,24.46%,SFRP4;BMP4;RUNX1;MAFG;CBFB;SFN;CTSK;ROCK1
prerank,embryonic digit morphogenesis (GO:0042733),0.3403791197969011,0.778471961290614,0.7603195739014648,0.9179131362679964,1.0,5/18,16.11%,ECE1;TWIST1;NOG;HDAC1;CREBBP
prerank,acylglycerol metabolic process (GO:0006639),0.3059898758340832,0.7782789983922914,0.7649164677804295,0.9178155404997443,1.0,6/37,14.81%,MGLL;LMF1;DGKQ;PGS1;ABHD6;PNPLA3
prerank,establishment of mitotic spindle localization (GO:0040001),0.3208300351383108,0.7780704385941567,0.787515006002401,0.9177499850677607,1.0,6/28,22.48%,PKHD1;MISP;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,cellular response to superoxide (GO:0071451),-0.31638030919763604,-0.7769124550536172,0.7064846416382252,0.9291373843160486,1.0,2/10,4.82%,NOS3;SOD3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3470459706948736,0.7768655394188999,0.7567204301075269,0.9189945341971497,1.0,6/15,22.51%,NOL3;FXN;HGF;AKT1;CLU;TRIAP1
prerank,regulation of cholesterol efflux (GO:0010874),0.3174317407816974,0.7768246717608785,0.7797029702970297,0.9186961417766912,1.0,3/30,5.93%,LRP1;RXRA;LAMTOR1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3542433780556508,0.7764565572258448,0.741514360313316,0.9188418924363053,1.0,10/16,22.07%,IRAK3;CLEC16A;GSPT1;TBC1D25;ETF1;HDAC6;CLN3;GLE1;UPF1;SHFL
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.2663426349013367,-0.776104357327759,0.7791666666666667,0.9289257423514423,1.0,4/16,11.88%,NR1H3;ABHD5;MFSD2A;SCARB1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.30436768884089965,0.7748982102063213,0.7847953216374269,0.9205971503634715,1.0,3/42,6.66%,CCL13;CCL15;STK39
prerank,histone ubiquitination (GO:0016574),0.3338126353438453,0.7742546427340716,0.7297979797979798,0.921095681252318,1.0,12/21,37.66%,UBE2B;HUWE1;UBR2;PAF1;RNF20;USP22;UBE2A;UBE2N;WAC;DTX3L;ATXN7L3;RNF8
prerank,chemical synaptic transmission (GO:0007268),0.2611166234162057,0.7741928134028642,0.9407035175879397,0.9208196082712349,1.0,24/284,8.78%,PCDHB16;LRP6;GRIK4;SLC12A7;DLG2;EXOC4;UNC13B;CAMKK1;PMP22;CEL;KCNN1;ERC1;RIC3;GABRA3;DVL1;CHRNB2;KCNIP2;SLC6A2;GIPC1;SLC12A4;TBC1D24;DLG4;CHRNA5;DLG1
prerank,positive regulation of telomerase activity (GO:0051973),0.30960526150480827,0.7740783105109477,0.7871046228710462,0.9206270934711507,1.0,10/33,30.44%,MAPK15;NEK7;NVL;CCT4;MAP2K7;TCP1;DKC1;PNKP;CTNNB1;HSP90AA1
prerank,cGMP biosynthetic process (GO:0006182),-0.31319335426683304,-0.7733128439416042,0.752442996742671,0.9315467477955935,1.0,2/10,9.39%,GUCY1B1;NPR1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3100892653419729,0.7731695419217911,0.7826617826617827,0.921489771728666,1.0,2/33,4.91%,ID2;PRKCA
prerank,cholesterol efflux (GO:0033344),0.3305236944364791,0.7723419822390097,0.7753246753246753,0.9222335799109279,1.0,4/20,13.70%,SOAT1;TSKU;NPC1;ABCA1
prerank,pinocytosis (GO:0006907),0.3836383855821279,0.7722323905362802,0.7478386167146974,0.9220123539604352,1.0,1/10,3.99%,RAB34
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.30818547717327005,0.7711824246032254,0.7696969696969697,0.9230897903628855,1.0,7/33,18.69%,IRS1;PIK3C2B;PIK3CB;SIRT2;ERBB2;NF1;AKT1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2947412174171793,0.7710253597061099,0.8037383177570093,0.9229431566973134,1.0,10/45,16.20%,ZC3H7A;PUM1;MATR3;CYFIP1;METTL16;NOLC1;YTHDC1;PER1;FOXO3;ZC3H10
prerank,positive regulation of nervous system process (GO:0031646),0.3361603916358106,0.770605914066983,0.7741514360313316,0.9231645015917151,1.0,3/18,12.74%,UNC13B;TNFRSF1B;NCMAP
prerank,actin crosslink formation (GO:0051764),0.3587597120556567,0.7704454854398299,0.7457865168539326,0.9230194841385823,1.0,2/12,8.82%,DPYSL3;GAS2
prerank,long-term synaptic potentiation (GO:0060291),0.3324916421890133,0.7704333580232441,0.7701298701298701,0.9226785338802942,1.0,2/21,3.05%,MPP2;ARC
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.33625385477188185,0.770135620339516,0.758893280632411,0.9227473900882224,1.0,5/18,19.49%,COA8;SURF1;BCS1L;FASTKD3;COX18
prerank,negative regulation of cell communication (GO:0010648),0.3323238772770947,0.7696090181451576,0.7782101167315175,0.9230943471605236,1.0,3/21,13.52%,UBASH3B;ACVR1;SRMS
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.30136599221320853,0.769170426173511,0.7840490797546013,0.923332419780513,1.0,3/34,5.57%,MPP2;GABRA3;RAB3GAP1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3225967800979445,0.7687540975981458,0.7735148514851485,0.9234819957909963,1.0,1/25,0.51%,CMKLR1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2678041763236468,0.7687534552826809,0.8528183716075156,0.9231285284378837,1.0,15/110,13.81%,GNAS;DRD1;FSHR;ADGRL2;RAMP2;ADCY2;ADCY8;ADCY9;IAPP;RAMP1;VIP;GLP1R;MC4R;ABCA1;GPR12
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.2758096610097394,-0.7680118757271812,0.7890625,0.9379897641107128,1.0,2/16,9.00%,CLDN5;CLDN1
prerank,postreplication repair (GO:0006301),0.2932585227832307,0.7676987823353711,0.822429906542056,0.924200641548644,1.0,20/45,35.30%,UBE2B;VCP;FAAP20;UBE2L6;UBE2V2;UBC;RPS27A;REV1;USP10;PRIMPOL;POLD1;UBE2V1;UBE2A;MSH2;UBE2N;POLK;RPA3;PARP10;RFC4;NSMCE1
prerank,transport along microtubule (GO:0010970),0.36297467643097286,0.7675170003340445,0.7645429362880887,0.9240824026380896,1.0,3/13,8.00%,BAG3;COPG1;ARHGAP21
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.33476692742560016,0.7672443441789805,0.7601043024771839,0.9240722826006523,1.0,4/19,12.97%,ADA;TERT;AMPD3;DGUOK
prerank,dendrite self-avoidance (GO:0070593),0.34695590957176975,0.7671661663713776,0.7486702127659575,0.9238252096742159,1.0,3/16,14.31%,EMB;PALLD;IGSF9
prerank,homologous chromosome segregation (GO:0045143),-0.2579292514657298,-0.7665924613874926,0.8253275109170306,0.9385987110767869,1.0,14/20,40.84%,FMN2;MEI4;FANCD2;PRDM9;SGO1;MAJIN;MEIOB;TERB1;PTTG1;RNF212B;MEIKIN;ANKRD31;TERB2;ZCWPW1
prerank,regulation of endopeptidase activity (GO:0052548),0.2848251606413698,0.7663983707622081,0.8263337116912599,0.9244678277912954,1.0,11/59,20.19%,SERPINH1;TIMP2;TIMP3;SERPINF1;SERPINB9;HDAC1;SERPINE2;CRB2;AKT1;SERPING1;PSMA3
prerank,regulation of tissue remodeling (GO:0034103),0.3325046038455477,0.7660798460179233,0.7548387096774194,0.9245311602742533,1.0,3/18,13.69%,DDR2;CST3;RUNX1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3130446035774388,0.7658941120990206,0.7817745803357314,0.9244088285333939,1.0,8/30,21.99%,ABCD3;ELOVL5;SLC27A6;ACSL6;ACSBG1;SLC27A2;PEX2;ABCD1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2931718144555243,-0.7651450412972567,0.7720588235294118,0.9392025576120215,1.0,9/12,40.33%,PAEP;IL17D;RASGRP1;IL18;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,positive regulation of hormone secretion (GO:0046887),0.337076266701422,0.765078610150944,0.7786774628879892,0.9251434491309294,1.0,2/17,9.28%,CYP19A1;EDN3
prerank,cellular response to interferon-gamma (GO:0071346),0.27281173214380217,0.7648777765281656,0.8665966386554622,0.9250324023549089,1.0,15/88,19.54%,PRKCD;SLC26A6;CCL13;CAMK2D;CCL15;MID1;GBP6;CASP1;TRIM26;EPRS1;DAPK3;ACOD1;SYNCRIP;PTAFR;IRF3
prerank,myoblast fusion (GO:0007520),0.3655818783260096,0.7647439213223381,0.7576974564926372,0.9248510101519201,1.0,2/12,6.02%,PTGFRN;CD9
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3230981139390173,0.7646475852660114,0.7786357786357786,0.924618000516166,1.0,7/23,28.44%,PDE6A;GUCY2D;SAG;GRK4;METAP2;NMT1;PDE6G
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.30202265942075407,-0.7645048455219777,0.7766666666666666,0.9387093831606766,1.0,7/12,20.60%,BCL2;RPL26;CD74;SIRT1;CD44;KDM1A;TAF9
prerank,Golgi to lysosome transport (GO:0090160),-0.31122713363600735,-0.7640570229613219,0.77491961414791,0.9379300953486175,1.0,2/11,6.74%,ANKFY1;SORT1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.34765231117641865,0.7639535406005075,0.7735849056603774,0.9251258340192163,1.0,9/16,35.54%,ZC3H12D;UPF1;RBM24;ZFP36L1;KHSRP;PLEKHN1;MOV10;TARDBP;RC3H1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3025990352130421,0.762828366265662,0.7932692307692307,0.9262679477622673,1.0,6/34,11.98%,LRP5;ANAPC5;CDC16;EDN3;PHIP;ANAPC4
prerank,protein auto-ADP-ribosylation (GO:0070213),0.37020812944522513,0.7625959114185333,0.7580419580419581,0.9262220649964362,1.0,4/12,20.30%,PARP3;TNKS2;PARP1;PARP12
prerank,mitochondrial fusion (GO:0008053),0.33116462213340014,0.7618432023329778,0.7680209698558322,0.9268696776337279,1.0,8/18,30.35%,MIEF2;SPG7;MFN1;AFG3L2;STOML2;FIS1;USP30;MIEF1
prerank,ceramide catabolic process (GO:0046514),0.3478606935573251,0.7617337032501845,0.7694483734087695,0.9266576132343566,1.0,3/14,19.41%,ACER3;HEXA;ASAH1
prerank,development of primary male sexual characteristics (GO:0046546),0.302160681955279,0.7615348409699174,0.8002450980392157,0.9265603764527304,1.0,6/34,13.14%,FSHR;SIX4;TGFB2;SOX9;INHBA;LRP2
prerank,postsynaptic membrane organization (GO:0001941),0.33973607434994746,0.7613184757848914,0.7619047619047619,0.9265083794973994,1.0,5/17,13.02%,CEL;DLG4;NRXN2;MUSK;NLGN1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.30163101314699037,-0.761284877289261,0.7824675324675324,0.9404426411725477,1.0,3/11,17.07%,AGBL4;TTL;FOLH1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3531323229729235,0.7611766682734992,0.7605633802816901,0.9260059072501698,1.0,2/15,12.70%,PABPC1;AGO2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3531323229729235,0.7611766682734992,0.7605633802816901,0.9260059072501698,1.0,2/15,12.70%,PABPC1;AGO2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.37819784938035145,0.7592551451868834,0.7539797395079595,0.928190555091034,1.0,2/10,8.70%,LAPTM4B;TSKU
prerank,stress-activated MAPK cascade (GO:0051403),0.2769639016978443,0.7581907446782583,0.8407079646017699,0.9291934390711309,1.0,23/61,29.77%,MAP3K5;GPS1;MAPK8;CHUK;IRAK1;TAB2;MAP3K12;CUL1;MAP3K10;UBC;RPS27A;MAP2K3;MAPK9;GPS2;MAP2K7;TAOK2;RIPK2;MAP3K11;UBE2V1;BTRC;MAP2K4;CCM2;ZFP36L1
prerank,amino sugar metabolic process (GO:0006040),0.368405877155101,0.7568349933005443,0.7766714082503556,0.9305357429856871,1.0,2/10,7.90%,GFPT1;GFPT2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.34505360009393327,0.7563081293166749,0.7855227882037533,0.9308773153052287,1.0,1/15,2.02%,NTRK1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.3741259335596292,0.756117001393967,0.7670043415340086,0.9307602226496051,1.0,3/10,16.88%,GNPDA1;NANP;RENBP
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.30942487222845416,0.7545990295325485,0.7848101265822784,0.9323838168552394,1.0,11/26,32.37%,ITCH;ALPK1;IRAK1;TAB2;UBC;RPS27A;CYLD;RIPK2;UBE2V1;UBE2N;IFIH1
prerank,skeletal muscle contraction (GO:0003009),0.3294868332481109,0.7541889239891729,0.7794871794871795,0.932549926560514,1.0,2/19,14.72%,TNNT3;STAC3
prerank,protein destabilization (GO:0031648),0.30243625124342044,0.7538096652533467,0.8028335301062574,0.9326905772418838,1.0,12/32,32.05%,GSN;CREBBP;SERF1A;MUL1;PEX2;DERL1;GGA3;NR1D1;BTRC;PRKN;IRGM;PRNP
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.3102567570585904,0.7534563978354394,0.7992471769134254,0.9327653561315056,1.0,11/29,30.44%,PPP6R3;TERT;TELO2;RAD50;CDK2;TNKS1BP1;ANKRD28;DKC1;RTEL1;NOP10;HSP90AA1
prerank,regulation of neuron migration (GO:2001222),0.3128215999738838,0.7534285371538197,0.7927590511860175,0.9324486600181021,1.0,2/26,1.17%,COL3A1;SRGAP2
prerank,negative regulation of interferon-beta production (GO:0032688),0.3687996569587945,0.7532254908126705,0.778236914600551,0.9323708937605448,1.0,1/10,3.93%,PTPRS
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.28363846496471856,-0.75265495002309,0.7857142857142857,0.9514804205831262,1.0,1/14,0.35%,AUTS2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.3389304821684929,0.7525357268746781,0.7651006711409396,0.9329127140665175,1.0,3/17,12.91%,UBASH3A;EZR;PTPN2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.30072386159001024,0.751924266612489,0.7934782608695652,0.9333209060999351,1.0,5/31,13.12%,SPN;GLMN;ATM;VTCN1;CD80
prerank,positive regulation of type 2 immune response (GO:0002830),0.34776482563415634,0.7517893168355447,0.7797783933518005,0.9331470777681472,1.0,4/14,20.96%,RARA;IL6;DENND1B;IL4
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.2726601348624985,-0.7516280883699668,0.812,0.9513207807602657,1.0,2/16,3.54%,BCL2L1;CXCL12
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.31267096884267903,0.7513240779527769,0.8074454428754814,0.9333900785796857,1.0,11/27,29.14%,MAP3K5;MAPK8;CHUK;CUL1;UBC;RPS27A;KAT7;MAP2K7;TAOK2;BTRC;CCM2
prerank,regulation of embryonic development (GO:0045995),0.2992011548532184,0.7509353430000983,0.8054892601431981,0.9335284778157572,1.0,9/34,16.93%,PHLDB1;TLE6;POGLUT1;EHMT1;B4GALT5;TDG;CRB2;NPHP3;NIPBL
prerank,ketone body metabolic process (GO:1902224),0.37809674292134937,0.7505171900413772,0.773224043715847,0.9337067149230538,1.0,4/10,14.02%,AACS;HMGCL;ACAT1;BDH2
prerank,regulation of cellular component size (GO:0032535),0.3056854611900929,0.7499641000600786,0.8134777376654633,0.934068634240177,1.0,3/30,4.64%,RDX;VAV2;PEX11A
prerank,epithelial cell-cell adhesion (GO:0090136),0.3635279878098853,0.7499379116414894,0.7866473149492017,0.9337453686739248,1.0,2/11,7.66%,CCN3;JUP
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3130040404674166,0.7493974743129531,0.7841191066997518,0.9340787707164467,1.0,5/23,17.92%,INTS3;CDK5RAP3;ZW10;ZFYVE19;WEE2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.27480071135081846,-0.7482683611146453,0.79296875,0.9543377672751366,1.0,4/14,14.49%,DPYD;UPB1;ERH;UMPS
prerank,protein K48-linked ubiquitination (GO:0070936),0.2754813765332471,0.7448247722689467,0.8283499446290143,0.9394397149404723,1.0,20/54,30.00%,TOPORS;UBE2B;UBE2R2;RNF115;SYVN1;ITCH;UBR5;UBE2C;UBE2G2;RNF4;TTC3;RNF216;RNF146;AMFR;RNF126;FBXO38;RBX1;UBE2Q2;PRKN;UBE2H
prerank,positive regulation of secretion (GO:0051047),0.36044363390170764,0.7446651622109797,0.7754237288135594,0.9392851636159132,1.0,2/11,14.91%,ACSL3;SCIN
prerank,positive regulation of protein processing (GO:0010954),0.3255941022696201,0.7445641112018774,0.787598944591029,0.9390438813794736,1.0,2/19,10.44%,GSN;LPCAT3
prerank,cellular response to interleukin-1 (GO:0071347),0.2547033340820811,0.7445497255084984,0.9091836734693878,0.93870544337471,1.0,32/143,21.96%,PTGIS;CCL13;PSMD7;CCL15;PSMA8;IRAK3;SOX9;RPS6KA4;PSMA4;CHUK;IRAK1;TAB2;PSMD12;CUL1;PSMA6;TANK;SQSTM1;PSMD1;MAP3K3;PSMC5;PSMD11;PSMC4;PSMD14;UBC;RPS27A;ACOD1;USP10;NFKBIA;PSMA3;PSMB1;PSMD4;UPF1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.2891805799532537,0.7443991652336246,0.8170011806375442,0.9385438301584755,1.0,8/36,12.60%,CSNK2A2;CSNK2A1;CRADD;ING5;MADD;MAZ;DEPTOR;TGFBR1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.27266193367136615,0.7442089366220629,0.8324205914567361,0.9384161372236633,1.0,17/59,27.13%,ERC1;SHARPIN;CHUK;TAB2;TANK;UBC;RPS27A;NKIRAS1;AKT1;NFKBIA;BIRC3;MAP3K14;TBK1;ROCK1;TRADD;RIPK1;RIPK2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.34542156879954744,0.7438071417333387,0.7904509283819628,0.9385554476420171,1.0,2/15,7.94%,ARPC1B;TRIM27
prerank,programmed necrotic cell death (GO:0097300),0.32655190260300115,0.743576463718475,0.783180026281209,0.9384882626430242,1.0,3/18,10.45%,PGAM5;TRPM7;RIPK3
prerank,copper ion homeostasis (GO:0055070),0.337415888478956,0.7424996809586845,0.8010899182561307,0.9394425639945736,1.0,8/17,33.20%,ARF1;ABCB6;ANKRD9;XIAP;SLC31A2;ATP7A;PRNP;MT2A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.31032964140571306,0.7423415783379917,0.7975,0.9392843522361787,1.0,2/26,6.47%,LBP;HMGB1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.35767873693790947,0.7423157575748921,0.7897810218978102,0.9389639573233565,1.0,6/10,36.21%,YOD1;ERLEC1;UBE2G2;INSIG1;OS9;UBAC2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.29544217004985496,0.7420327331589182,0.8131609870740305,0.9389592931405374,1.0,3/35,4.11%,GHR;CYP1B1;HES5
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.30550215852278517,0.7418686808826396,0.8026796589524969,0.9388063106477814,1.0,2/29,6.47%,GAS6;HMGB1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.3424197745459169,0.7411293738695479,0.786013986013986,0.939359204642522,1.0,2/14,18.71%,IL6;OSMR
prerank,actin nucleation (GO:0045010),0.3262665614081786,0.7405512850318314,0.8220230473751601,0.9397279173387899,1.0,4/21,15.30%,ARPC1B;TRIM27;SCIN;SPIRE2
prerank,mitochondrial protein processing (GO:0034982),0.3649661372067148,0.7405320620344363,0.7965116279069767,0.939403093762427,1.0,6/11,27.80%,SPG7;PMPCA;AFG3L2;STOML2;PMPCB;ATP23
prerank,excitatory postsynaptic potential (GO:0060079),0.3223055470384988,0.7405265353948738,0.8043478260869565,0.9390571967512684,1.0,5/19,21.65%,MPP2;RAB3GAP1;AKT1;DRD2;LRRK2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.28885181598146437,0.7402234086158546,0.8476190476190476,0.9390936312881917,1.0,11/38,22.77%,PKHD1;PHLPP2;XDH;PIK3CB;PPP2R5C;FLCN;AKT1;MUL1;BANK1;DRD2;TSC2
prerank,hexose transmembrane transport (GO:0008645),0.3264530933013323,0.7400163624538666,0.8117797695262484,0.938985413846925,1.0,5/21,17.10%,SLC5A2;SLC2A9;SLC50A1;SLC2A2;SLC2A10
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3482099345690241,0.7386021024617119,0.7659279778393352,0.9403644476723396,1.0,5/13,27.13%,TBC1D10A;PERP;CYFIP2;BAD;RIPK2
prerank,modulation by symbiont of host process (GO:0044003),-0.3096220789142218,-0.7385963847663501,0.8119402985074626,0.9658465915989227,1.0,3/10,14.75%,B2M;MRC1;UBA52
prerank,regulation of cytokine production (GO:0001817),0.2562989907928546,0.7378104559482274,0.9214876033057852,0.9409668399559196,1.0,19/126,16.80%,FOXP1;IL33;HDAC9;GLMN;TNFRSF1B;RPS6KA4;BTNL9;ANXA1;CRTAM;RIPK3;SOD1;CIDEA;KAT2A;TRAF3;VTCN1;PER1;IL6;N4BP1;CCN4
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.2699042627626523,-0.7370915849552828,0.7816593886462883,0.9662149150286486,1.0,11/15,40.33%,SYK;CD55;CCR2;SHH;IL12A;IL23A;PNP;EBI3;IHH;IL23R;IL12B
prerank,nuclear body organization (GO:0030575),-0.2777321323557377,-0.735527992029657,0.8327868852459016,0.9666858530250302,1.0,1/12,0.62%,ETS1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.2573381840986819,-0.735490145188241,0.8582089552238806,0.9652466846416411,1.0,1/17,1.38%,APOE
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2818846393398869,0.7350995641574607,0.8618721461187214,0.9439100371630519,1.0,8/47,15.23%,EGFR;TGFB2;MID1;NBR1;FOXM1;ULK4;STK25;PER1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2691454301308671,0.7344753043661677,0.8702882483370288,0.9443001952406916,1.0,21/62,27.22%,YBX3;NOL3;CCAR2;NFE2L2;SYVN1;HYOU1;URI1;BCL2L2;AKT1;DNAJA1;NOC2L;CLU;ACKR3;LRRK2;VNN1;HERPUD1;CREB3L1;PINK1;SELENOS;HTRA2;PLAUR
prerank,regulation of transposition (GO:0010528),0.35146708139183946,0.7341169038433468,0.8016528925619835,0.944371512743728,1.0,2/13,18.72%,TEX15;UBR2
prerank,regulation of complement activation (GO:0030449),0.28726382766922987,0.7338275626615972,0.8245614035087719,0.9443723048263352,1.0,7/40,20.47%,CFH;C9;C8B;SERPING1;C8G;CPB2;CLU
prerank,negative regulation of signaling (GO:0023057),0.30689146757047203,0.7335491074522981,0.8320610687022901,0.9443358234725494,1.0,5/25,20.94%,UBASH3B;ACVR1;SRMS;TRAT1;OPTN
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2934302991296841,0.7331639527147782,0.8303249097472925,0.9444510131470921,1.0,12/35,29.11%,MPG;OGG1;TDG;SMUG1;PARP1;POLB;PARG;POLD1;POLG;PNKP;ADPRS;MBD4
prerank,positive regulation of interleukin-2 production (GO:0032743),0.3055226020442488,0.7331588384689186,0.8108776266996292,0.9441042789937375,1.0,5/25,17.09%,GLMN;ANXA1;CD80;RUNX1;SPTBN1
prerank,diol metabolic process (GO:0034311),0.3194148981088322,0.7329990311092734,0.8082368082368082,0.9439499162434768,1.0,2/19,6.18%,PLPP3;PLPP1
prerank,cellular copper ion homeostasis (GO:0006878),0.3431996837716008,0.732644885266795,0.810958904109589,0.9440282760076744,1.0,7/14,33.20%,ARF1;ABCB6;ANKRD9;SLC31A2;ATP7A;PRNP;MT2A
prerank,protein palmitoylation (GO:0018345),-0.21919435464850345,-0.7326052682290285,0.8810810810810811,0.9674462758126303,1.0,13/30,28.06%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.27976755505561224,0.7325550276577626,0.8536866359447005,0.9437825369178534,1.0,3/45,4.57%,PRKCD;CAMK2D;MID1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.24586135397070844,-0.7321610167795655,0.8378378378378378,0.9665173585186646,1.0,3/18,12.07%,PIK3R1;BOK;BCL2L11
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3208908758563708,0.7318392869869244,0.823915900131406,0.9442800248150448,1.0,8/18,29.90%,NOL3;NFE2L2;AKT1;VNN1;PINK1;HTRA2;NME5;PRKN
prerank,negative regulation of protein depolymerization (GO:1901880),0.30259486203641917,0.7313286708675817,0.8225,0.9445172847824342,1.0,2/24,3.11%,FGF13;LIMA1
prerank,intestinal absorption (GO:0050892),0.34301925646087006,0.7311815271619732,0.7980900409276944,0.9443444750542944,1.0,1/13,2.98%,SLC26A6
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.30137263735289394,0.7302776994853595,0.8246268656716418,0.9450547966159973,1.0,9/28,25.57%,CRADD;BAG3;BLOC1S2;TNFRSF10B;DEDD;BID;DIABLO;TRADD;DAXX
prerank,positive regulation of peptidase activity (GO:0010952),0.31259979496600937,0.7301706414140902,0.8065359477124183,0.9448228724311434,1.0,5/20,24.51%,VCP;MAPK12;TANK;RCN3;PINK1
prerank,protein autoprocessing (GO:0016540),0.3263184639573744,0.7301154551279472,0.7979139504563233,0.9445387817445826,1.0,7/17,37.13%,FXN;CASP1;AFG3L2;HTRA2;PIDD1;MYRF;CTSL
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2782425972650068,0.72989795861931,0.8542141230068337,0.9444370944136711,1.0,13/46,28.50%,TOMM40;TIMM9;BCAP31;AIFM1;HSPD1;TOMM70;GRPEL1;AKT1;PINK1;TIMM17B;TIMM22;RALA;FIS1
prerank,regulation of immune effector process (GO:0002697),0.28364443952587065,0.7297315324601903,0.8362168396770473,0.9442898590901115,1.0,7/41,20.47%,CFH;C9;C8B;SERPING1;C8G;CPB2;CLU
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.2992150367716804,-0.7290440649022742,0.7956656346749226,0.9689175843637027,1.0,3/10,12.75%,RIF1;DCLRE1C;TERF2IP
prerank,regulation of interleukin-2 production (GO:0032663),0.28301241509564,0.7288784579117986,0.8597701149425288,0.9449414073081676,1.0,9/43,19.83%,GLMN;TBX21;TRIM27;ANXA1;EZR;CD80;RUNX1;SPTBN1;HOMER2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.2939571756786136,-0.728604224803391,0.8135048231511254,0.9679752210846826,1.0,2/10,9.05%,RAPGEF3;PIH1D1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.328666209830975,0.7281553624361958,0.8119891008174387,0.9454412461636523,1.0,5/16,16.21%,CAMK2D;PRKCA;SLC9A1;MEF2A;PARP1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3146583089977547,0.7276238423582038,0.8199481865284974,0.9457347093372445,1.0,2/19,11.17%,CARD16;GIT1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.32889892788369823,0.727513427249071,0.7989130434782609,0.9455231360537592,1.0,6/15,32.31%,GNPDA1;RENBP;CHST5;OGA;NAGK;CHST7
prerank,glucose import (GO:0046323),0.34435300780587846,0.7267477092006968,0.8137254901960784,0.9460788474960132,1.0,3/13,17.10%,SLC5A2;RAB4B;SLC2A10
prerank,negative regulation of inflammatory response (GO:0050728),0.2476707516531015,0.7265747624102294,0.9394550958627649,0.9459354015458205,1.0,34/182,20.97%,PRKCD;PTGIS;GPR27;CCN3;DRD1;FSHR;RAMP2;ADCY2;ADCY8;TNFRSF1B;ADCY9;GPR20;IAPP;SHARPIN;RORA;RAMP1;VIP;LPCAT3;GIT1;GLP1R;PTPN2;MC4R;PTGDR;IL6;CREB1;OTULIN;CALCA;ACOD1;ADCY7;PRKACA;GNB1;GPS2;IL4;PRKAR2A
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.26194357518985867,0.7260133740201193,0.882921589688507,0.9462460034276761,1.0,18/75,21.38%,MAP1B;FARP1;DOCK7;DVL1;RAB8A;LLGL1;S100B;FGFR2;TMEM106B;MEF2A;TBCD;APBB1;SLITRK2;CDK5;UNK;DRD2;SHTN1;ATL1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.32365658446052553,0.7257729430363541,0.8076923076923077,0.9461828535099691,1.0,6/16,34.34%,VTA1;CHMP4A;CHMP4B;TMEM50B;CHMP4C;TMEM50A
prerank,modulation by host of symbiont process (GO:0051851),-0.21966977832755796,-0.7257236974134137,0.9122807017543859,0.9700169510222392,1.0,13/31,31.67%,LEF1;NAPEPLD;CX3CR1;EP300;NUCKS1;HMGA2;POU2F3;AQP1;HPN;CCL5;JUN;SAP30;CCL4
prerank,regulation of stem cell proliferation (GO:0072091),-0.245978671686583,-0.725552905926172,0.8648648648648649,0.9687803039931325,1.0,4/17,18.51%,FBLN1;ACE;SOX11;KDM1A
prerank,positive regulation of cell killing (GO:0031343),0.34006388267667276,0.7254250021479185,0.8050490883590463,0.9462458132996506,1.0,7/13,31.82%,FZD7;MAPK8;DVL2;NOX1;RAC1;CYBA;NOXO1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2314899324046653,-0.724098019778507,0.8669527896995708,0.9691778932992301,1.0,6/22,21.04%,ROCK2;PPP4R4;STYXL1;PTPA;PPP1R11;PPP1R15A
prerank,regulation of intracellular protein transport (GO:0033157),0.29169338607646,0.7238143981699993,0.8434163701067615,0.9477300104237181,1.0,12/32,28.34%,BCAS3;BMP4;TENM1;UHMK1;NDEL1;PCM1;KIF20B;ICE1;VAMP2;TPR;GCC2;B3GAT3
prerank,fatty acid elongation (GO:0030497),-0.27832664050106415,-0.7224480188476428,0.8327137546468402,0.9697091571453123,1.0,2/13,4.87%,ELOVL7;HACD1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.30564189403857933,0.7221301664524408,0.8246505717916137,0.9493209751098116,1.0,8/25,25.32%,ACVR1B;STAT3;PRKDC;INHBA;FOXO3;PRMT1;ABCB10;BRD1
prerank,cellular response to metal ion (GO:0071248),0.25021543633404175,0.7209690947105897,0.9210799584631361,0.9502704381177981,1.0,14/123,13.47%,EGFR;SLC12A2;DLG2;SYT8;CAMK2D;CLIC4;ADCY8;DLG4;MAPK8;CHUK;NEUROD2;NLGN1;ADD1;MEF2A
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.2671868815213639,0.7194084804228303,0.8686534216335541,0.9517012916184583,1.0,4/57,4.20%,VEGFA;GHR;HES5;STAT3
prerank,positive regulation of exocytosis (GO:0045921),0.28381123456982527,0.7193554780303384,0.8375149342891278,0.9514045288327042,1.0,9/35,28.48%,SDC1;RAB2B;RAB3D;STXBP5;SYTL4;PDCD6IP;CHMP2A;RAB5A;RAB3A
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.34053259359563054,0.7182076682028348,0.8237762237762237,0.952350321548831,1.0,4/12,18.69%,FUT4;WNK1;MIA3;AKT1
prerank,neuromuscular process controlling balance (GO:0050885),-0.2776302956992005,-0.7173317110271722,0.8652482269503546,0.9744139721250499,1.0,1/12,1.57%,NRXN1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.27008833024449125,-0.7172104233731567,0.8107142857142857,0.9730545037055413,1.0,4/12,12.94%,PIK3R1;BOK;BCL2L11;PTPN1
prerank,axon development (GO:0061564),0.25922603259076765,0.7171034293197726,0.8974630021141649,0.9532552228420257,1.0,21/78,25.04%,MAP1B;EPHB2;DOCK7;EPHB3;GAP43;RAB8A;LLGL1;S100B;FGFR2;PLP1;APBB1;SLITRK2;CDK5;MAPK8IP3;DRD2;SHTN1;ATL1;AFG3L2;LMTK2;TAOK2;ARHGAP35
prerank,negative regulation of histone modification (GO:0031057),0.335319034642586,0.7168008940520563,0.8155339805825242,0.9532538250040559,1.0,3/14,19.97%,TWIST1;THAP7;NOC2L
prerank,positive regulation of T cell differentiation (GO:0045582),0.28235033000619236,0.7164491523405022,0.8613396004700352,0.9533088018598671,1.0,2/36,2.48%,ZMIZ1;GLI2
prerank,protein targeting (GO:0006605),0.24982784230334365,0.7161061981618988,0.9111570247933884,0.9533357458172276,1.0,36/118,30.32%,LTBP2;SEC61A1;RABGEF1;TOMM40;GIPC1;TIMM9;PEX16;PEX1;BCAP31;ATG3;NLGN1;SPCS2;HPS4;TOMM70;HACL1;ZDHHC4;PEX6;ZFAND2B;ZDHHC20;LAMP2;PRKCI;ZDHHC9;TAOK2;TIMM17B;TIMM22;LONP2;KATNB1;PARD3;VPS37B;KIF13B;FIS1;SPCS1;SRPRA;ZFAND2A;PIKFYVE;SRP14
prerank,adipose tissue development (GO:0060612),0.35668522155667587,0.7159984482095973,0.820979020979021,0.9530961053910634,1.0,2/11,9.25%,LRP5;SH3PXD2B
prerank,regulation of lymphocyte proliferation (GO:0050670),0.32873456207562474,0.7159561209639155,0.8209959623149394,0.9527970184102355,1.0,2/16,8.03%,TNFRSF1B;IKZF3
prerank,lipid droplet formation (GO:0140042),-0.28467109169513416,-0.7157490417936151,0.8144654088050315,0.9732533452784051,1.0,1/10,2.46%,CDS2
prerank,peptide hormone secretion (GO:0030072),0.29690032270946587,0.7156913414995771,0.8523153942428036,0.952741709433415,1.0,6/26,23.61%,EDN3;ANXA1;VIP;IL6;RAB1A;FAM3B
prerank,negative regulation of catalytic activity (GO:0043086),-0.23033172012025976,-0.7153720087850841,0.9195979899497487,0.9722464961629389,1.0,8/24,18.42%,NOTCH1;NES;IFIT1;NOS1;SIRT1;CAMK2A;MT3;PPP1R12A
prerank,positive regulation of cell development (GO:0010720),0.2908895546627084,0.7151879684890202,0.845223700120919,0.9529420450788076,1.0,5/31,13.14%,SERPINF1;PDE3A;BMP4;LIG4;LRP2
prerank,glutamate metabolic process (GO:0006536),0.3122351101097977,0.7149272747924749,0.8170266836086404,0.9528826793702677,1.0,1/19,1.56%,GCLC
prerank,positive regulation of microtubule polymerization (GO:0031116),0.2922034117776249,0.7148373337863585,0.8477722772277227,0.9526263753595445,1.0,13/28,30.27%,CKAP5;GIT1;AKAP9;ARL2;SLAIN2;DCTN1;CDK5RAP2;MET;DRG1;FES;TOGARAM1;MECP2;RAC1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.3512721643580471,0.7148098259408121,0.8149210903873745,0.9523081751032103,1.0,2/10,15.81%,AOC3;HDAC6
prerank,magnesium ion transport (GO:0015693),0.34195303263790544,0.7140923205743366,0.8103932584269663,0.9528153819591901,1.0,7/12,28.20%,NIPA2;MRS2;CNNM4;MAGT1;MMGT1;NIPAL2;NIPAL1
prerank,regulation of cellular catabolic process (GO:0031329),0.26396689873504636,0.7139957460944053,0.8758241758241758,0.9525803106260244,1.0,29/62,30.61%,MAPK15;OSBPL7;RAB8A;PIP4K2B;ABL1;ATM;USP33;WDR41;USP13;HDAC6;DAPK3;USP10;DCAF12;LRRK2;ABCD1;KAT8;RPTOR;SMCR8;ROCK1;SCARB2;LONP2;PIP4K2C;ABL2;CISD2;DRAM1;GPR137B;DRAM2;PRKN;KEAP1
prerank,sarcomere organization (GO:0045214),0.29135542550870275,0.7123454185020281,0.8322903629536921,0.9540837136904817,1.0,5/27,20.46%,SIX4;TNNT3;CSRP3;WDR1;CSRP2
prerank,regulation of sodium ion transport (GO:0002028),0.29152017344888165,0.7119209450953847,0.842603550295858,0.9541975681211716,1.0,7/34,15.23%,NEDD4;SLMAP;SNTA1;DLG1;PRSS8;WNK1;PER1
prerank,macrophage migration (GO:1905517),-0.2698223366187457,-0.7114237117235807,0.8528301886792453,0.9754710384454646,1.0,13/13,73.05%,EDNRB;TAFA4;CCR2;CCL5;CCL3;EDN2;SAA1;CXCL17;LGALS3;P2RX4;P2RY12;CKLF;CCL2
prerank,positive regulation of exosomal secretion (GO:1903543),0.324578020697393,0.7113956392701061,0.8145604395604396,0.9544631493755541,1.0,1/15,3.14%,SDC1
prerank,dephosphorylation (GO:0016311),0.24569792312531952,0.7112727752979853,0.9402834008097166,0.9542461456191261,1.0,15/147,9.48%,ALPL;PLPP3;PTPN3;PPP1CC;PLPP5;PTPRS;PTPRF;DUSP11;PTPRU;PLPP1;PPM1H;PPM1M;DAPP1;PTPN18;PPP3CC
prerank,regulation of lamellipodium organization (GO:1902743),-0.25891511803114015,-0.7111240491623578,0.8505338078291815,0.9743194619789652,1.0,14/14,74.14%,CDC42;CAPZB;CD44;CARMIL2;VIL1;PDPN;EPHA2;DMTN;FER;TWF2;CARMIL1;RAC1;WAS;TWF1
prerank,apical junction assembly (GO:0043297),0.2666216595398301,0.7101509843418925,0.8741648106904232,0.9551172102519533,1.0,17/53,26.51%,MPP7;RAMP2;DLG1;RHOA;PKN2;PAK2;CLDN11;ARL2;MICALL2;TBCD;WDR1;CLDN15;PDCD6IP;PRKCI;AFDN;FBF1;PARD3
prerank,positive regulation of ATPase activity (GO:0032781),0.2781857616899891,0.7100766032330644,0.8630609896432682,0.9548473801346231,1.0,4/41,10.99%,ATP1B1;TNNT3;PFN2;CHTOP
prerank,protein-containing complex subunit organization (GO:0043933),0.2454846922393843,0.710052828539604,0.9313929313929314,0.9545231915080608,1.0,35/109,26.88%,HES5;CD3E;GPAA1;SEH1L;SPG7;LLGL1;MDM4;SOX9;DLG4;ST13;WIPF1;SNX9;SHANK1;ZW10;CREBBP;KPNA3;EPRS1;TEAD2;DARS1;CAPZA1;REPS2;NDC1;KMT2A;PEX14;NUP35;AFG3L2;NIFK;DET1;TP53;VAMP2;PPID;TPR;PARD3;PPP2R1A;WAS
prerank,regulation of ERAD pathway (GO:1904292),0.34568909918947266,0.7098942263279131,0.8306801736613604,0.9543632174927891,1.0,7/11,37.20%,USP13;USP19;HERPUD1;RNFT1;TMEM259;USP25;RNF185
prerank,ncRNA processing (GO:0034470),0.24258442823185553,0.7092002574570094,0.9588353413654619,0.954756212244306,1.0,56/200,27.93%,C1D;RRP7A;SSB;INTS3;PRKRA;HNRNPA2B1;LAS1L;EMG1;INTS4;WDR3;AGO1;NVL;DGCR8;WDR55;ESF1;RRP12;AGO2;NOLC1;UTP14A;DCAF13;EXOSC4;NOC4L;MRTO4;BYSL;TUT7;ADAT1;DIS3;BOP1;SARS1;NOB1;RPL7A;MTREX;WDR12;ZCCHC8;NOP56;DDX49;FBL;SBDS;WDR36;WDR46;WDR75;RPP21;RPS9;TBL3;SENP3;UTP11;NOP58;PUS10;DKC1;INTS9;POP5;FCF1;NOP53;SRRT;RPL41;RPL30
prerank,negative regulation of innate immune response (GO:0045824),-0.21048988051838263,-0.7090713930686205,0.9324324324324325,0.9750383018945026,1.0,8/34,13.39%,SAMHD1;USP18;NLRC5;TRIM21;A2M;DHX58;CACTIN;TNFAIP3
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2678840831106158,0.7085359022907053,0.88268156424581,0.9551247789506796,1.0,29/54,39.26%,RRS1;LAS1L;NLE1;NVL;MRTO4;EIF6;PPAN;BOP1;RPL7A;NOC2L;WDR12;GTF3A;PAK1IP1;RRP15;MAK16;NOP53;RPF2;RSL1D1;HEATR3;RPLP0;MALSU1;RPL3;RPL10A;MDN1;LTO1;RSL24D1;RPL5;PES1;MRPL20
prerank,positive regulation of vasoconstriction (GO:0045907),0.3289794735895552,0.708440751666686,0.8204022988505747,0.9548733563322231,1.0,2/13,13.07%,TRPM4;F2R
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.29639954159191995,0.7083683393744915,0.850383631713555,0.9546020166829581,1.0,7/25,20.87%,ARAP1;AGR2;CBL;HIP1;CNOT9;AKT1;NUP62
prerank,protein localization to condensed chromosome (GO:1903083),0.33420615462274983,0.7079621001649539,0.8195804195804196,0.9547031653180984,1.0,3/12,16.57%,MIS12;ZW10;IK
prerank,neuron apoptotic process (GO:0051402),0.3124327732778216,0.7070924668481511,0.8305304010349288,0.9552961827201418,1.0,6/19,21.68%,CIT;ATN1;LIG4;BID;CDK5;DIABLO
prerank,glycolytic process (GO:0006096),-0.2159969051581564,-0.7061148873742128,0.9248554913294798,0.9767965531139395,1.0,5/28,11.13%,HK2;PGAM4;PGAM1;GPI;ALDOC
prerank,positive regulation of interferon-alpha production (GO:0032727),0.31435639325639814,0.7059787957864255,0.8246318607764391,0.9561322738274438,1.0,7/19,27.13%,MAVS;CHUK;HSPD1;IRF3;SETD2;TBK1;RIPK2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.30810884298640406,0.7038510998829193,0.8704188481675392,0.9580903269104828,1.0,5/20,17.60%,IPO5;HEXIM1;LATS2;CDKN1C;MEN1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.23070501744532024,-0.7038119985339614,0.8888888888888888,0.9777312643641219,1.0,7/21,19.50%,BCL2L1;BOK;BCL2L11;OPA1;HSPA1A;XBP1;CREB3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.34689511893904534,0.7032287528841037,0.8267605633802817,0.9584465133280325,1.0,2/10,12.36%,XDH;PIK3CB
prerank,regulation of secretion (GO:0051046),-0.2592255667823946,-0.702666228902196,0.89419795221843,0.9774903299911835,1.0,7/13,30.34%,MYO6;OAS2;ERBB3;KCNQ1;NRG1;OPRK1;GPLD1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.29905183850951056,0.7023594068646106,0.8543563068920677,0.9590613611063014,1.0,5/20,23.24%,LONP1;HSPD1;PTGES3L;CLU;PSMG2
prerank,rRNA catabolic process (GO:0016075),0.3214780316822461,0.7018541560589299,0.8180574555403557,0.9592503342308656,1.0,4/16,17.06%,ERN2;XRN1;EXOSC4;DIS3
prerank,mitochondrial membrane organization (GO:0007006),-0.20582993735915378,-0.7017130468171264,0.95,0.9770137696858305,1.0,10/32,22.04%,BCL2;BCL2L1;CHCHD3;GHITM;MTX2;OPA1;MFN2;PPIF;SAMM50;BNIP3
prerank,indolalkylamine catabolic process (GO:0046218),0.3405889733258797,0.7014402572722556,0.8280346820809249,0.9593364048593979,1.0,2/10,20.64%,IDO2;KYAT1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.34858116754491736,0.70116827606899,0.8305084745762712,0.959265044012198,1.0,1/10,6.08%,CCAR2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.25381544215535,-0.7010863852026947,0.8888888888888888,0.9761747491096281,1.0,6/15,20.67%,CPEB2;DDX3X;ZC3H12A;ZFAND1;ATF3;PPIF
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2606365078584513,0.7009828155241281,0.889261744966443,0.9591169005498027,1.0,16/59,28.84%,ABCD3;ACSF3;OSBPL7;CBR4;OSBP;ACACA;SRR;HSD17B8;SLC27A2;HSD3B7;MCAT;ACOT8;HOGA1;PER2;ACLY;SCP2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.32955481256384717,0.700297081211789,0.8446043165467626,0.9594937718393447,1.0,5/12,20.13%,SRR;PHGDH;MTHFD1;PSAT1;SEPHS2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.31034489497486145,0.6999961421843545,0.858793324775353,0.9594610029737203,1.0,10/18,40.58%,ANXA1;NR3C1;KLF9;HNRNPU;ZFP36L1;SSTR2;FAM107A;PCK2;UBE2L3;REST
prerank,positive regulation of cytokine production (GO:0001819),0.2345572562360344,0.6999606316176402,0.986986986986987,0.9591492640642706,1.0,54/292,22.64%,FOXP1;LBP;F3;IL33;TWIST1;RAB7B;CYP1B1;GLMN;STAT3;ATF4;MAVS;PRKDC;IL12RB2;HMGB1;SULF1;POLR3H;TRIM27;RARA;FZD5;FCER1G;RORA;ANXA1;CRTAM;IRAK1;C1QTNF4;SOD1;KAT2A;CRCP;HSPD1;F2R;CD80;RUNX1;POLR3GL;SETD4;POLR2F;IL6;CREBBP;SPTBN1;NFKB2;HMOX1;TRIM6;SULF2;XRCC6;IRF3;POLR3K;APPL1;IL17RA;IL4;DRD2;RAB1A;TLR1;POLR1C;EIF2AK3;SLC11A1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.18465247997694242,-0.6987352862704754,0.9489795918367347,0.9772172940992917,1.0,9/57,12.45%,KDR;DNM1L;HIP1R;PDCD5;PPARGC1A;BOK;FAM162A;BCL2L11;MFF
prerank,innate immune response (GO:0045087),0.23651981178976864,0.6986772100412508,0.9669669669669669,0.960179489375717,1.0,40/217,23.22%,LBP;COLEC11;TNK1;TRIM28;RNASE7;MAVS;HMGB1;IFNLR1;CXCL16;RNASE3;TRIM27;S100B;FCER1G;RNASE6;CHUK;ALPK1;IRAK1;MID2;DEFB1;SRMS;TRIM26;FRK;SRPK1;COLEC12;CYP27B1;OTULIN;SHMT2;TRIM13;TRIM6;DMBT1;CAPZA1;IL4;TRIM43;CD300LB;SHFL;TRIM8;SETD2;SLC11A1;VNN1;CYLD
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2438299400079521,0.6980454165041257,0.9301587301587302,0.9605158035279681,1.0,20/94,16.52%,PSMD7;PSMA8;IRAK3;RPS6KA4;PSMA4;CHUK;IRAK1;TAB2;PSMD12;CUL1;PSMA6;SQSTM1;PSMD1;MAP3K3;PSMC5;PSMD11;PSMC4;PSMD14;UBC;RPS27A
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.27848650438832206,-0.6973832306332812,0.8307210031347962,0.9772533260853302,1.0,5/11,23.35%,AKAP6;NOS1AP;LRRC38;LRRC55;TREM2
prerank,response to axon injury (GO:0048678),0.31133460751461567,0.6969993341239644,0.8507078507078507,0.9612791708650228,1.0,3/18,11.85%,DPYSL3;GAP43;SOD1
prerank,glycoprotein catabolic process (GO:0006516),0.3136822064003006,0.6963722914258427,0.8571428571428571,0.9615865080021015,1.0,7/17,28.40%,EDEM2;NGLY1;FBXO17;OGA;ADAMTS9;MANBA;STT3B
prerank,regulation of humoral immune response (GO:0002920),0.26745165690538575,0.6962679097982393,0.8668941979522184,0.96134899479517,1.0,7/44,20.47%,CFH;C9;C8B;SERPING1;C8G;CPB2;CLU
prerank,negative regulation of cell cycle (GO:0045786),0.2502852226572486,0.6950723617885038,0.9056399132321041,0.962303951807923,1.0,15/73,19.68%,PDCD4;PTPN3;GAS1;IPO5;BMP4;TAF6;INHBA;HEXIM1;RHOB;CAMK2N1;LATS2;CDKN1C;MEN1;HECA;GMNC
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.2883541406867451,0.6944981944086137,0.8646616541353384,0.9625605108597993,1.0,5/25,20.80%,TWIST1;NSD1;HEY1;TRIM6;MAD2L2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.26034277104651893,-0.6944388671275672,0.8783269961977186,0.978851969922596,1.0,13/13,73.99%,NECTIN2;FADD;IL12A;IL12RB1;IL23A;IL23R;IL12B;XCL1;PVR;SLC22A13;MR1;STX7;CYRIB
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.32992574377739137,0.6941961290528635,0.8347222222222223,0.962519479205135,1.0,4/13,18.52%,MDFIC;CHP1;RAB23;SUFU
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.27980115160359154,0.6940197641189977,0.8716136631330977,0.9623298295690033,1.0,9/35,14.02%,SCD5;AACS;HMGCL;CBR4;FAR1;PPT2;ACAT1;ACACA;BDH2
prerank,spliceosomal snRNP assembly (GO:0000387),0.2712994513006068,0.6935607525373109,0.8729216152019003,0.9624541769482369,1.0,14/38,32.69%,SNUPN;LSM2;GEMIN7;SMN1;SRSF10;SNRPB;GEMIN2;WDR77;USP4;DDX20;SNRPF;PRMT5;SART3;TGS1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.19792796053851422,-0.6929435771324609,0.9383561643835616,0.9788975661146783,1.0,16/40,22.04%,BCL2L1;DNM1L;PDCD5;GHITM;FAM162A;BCL2L11;MFF;GPX1;IGF1;OPA1;GPER1;PYCARD;BIK;PRELID1;PPIF;BNIP3
prerank,regulation of interferon-beta production (GO:0032648),0.2646882139377669,0.6928878875578272,0.8826879271070615,0.9628059532948468,1.0,17/46,32.37%,PTPRS;MAVS;TRAF3;TOMM70;IRF3;RNF216;TBK1;PTPN11;YY1;RIPK2;PPM1B;RNF135;HSP90AA1;LILRB1;RIOK3;POLR3F;IFIH1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.23776585882901902,0.6928589245784791,0.9563894523326572,0.9624910988596155,1.0,32/168,21.06%,RPSA;DDX5;PABPC1;SAMD4A;CASC3;TENT4B;THRAP3;PNRC2;SMG6;GSPT1;SMG1;AGO1;DIS3L2;ATM;PATL1;EIF4G1;ETF1;XRN1;EXOSC4;MRTO4;CNOT8;RPS27A;TUT7;CNOT10;RC3H2;NCBP1;NCBP2;CNOT9;RPL7A;TNKS1BP1;PYM1;TENT2
prerank,positive regulation of interleukin-10 production (GO:0032733),0.2782265178756159,0.6928252463765285,0.8846153846153846,0.9621746630992768,1.0,4/30,15.25%,STAT3;HMGB1;HSPD1;IL6
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.3212327329173411,0.6927996751995145,0.8305322128851541,0.9618476003059294,1.0,3/13,13.70%,CD9;FCER1G;ABCA1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.28715983519112925,0.6927710037170834,0.8538163001293662,0.9615229456259681,1.0,8/24,27.75%,ITCH;IRAK1;TAB2;UBC;RPS27A;CYLD;RIPK2;UBE2V1
prerank,protein ADP-ribosylation (GO:0006471),0.28494142202887396,0.6926677995552847,0.8725728155339806,0.9612802560323684,1.0,6/28,16.21%,PARP3;SIRT5;ARF4;TNKS2;SIRT2;PARP1
prerank,dendritic cell migration (GO:0036336),0.31793911786909296,0.6923760015130216,0.8291390728476821,0.9612058415936278,1.0,3/16,15.83%,HMGB1;TRPM4;CXCR4
prerank,T cell activation involved in immune response (GO:0002286),0.32498008310994,0.6921983985053151,0.8321579689703809,0.9610447518127496,1.0,4/12,22.64%,FCER1G;EIF2AK4;TNFSF18;SLC11A1
prerank,ribosomal large subunit assembly (GO:0000027),0.28775912804080295,0.6921107102403742,0.8612862547288777,0.9607894949060687,1.0,4/24,17.46%,RRS1;NLE1;PPAN;BOP1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.32737207536860613,0.6913139793973552,0.8406961178045516,0.9612606156993914,1.0,5/13,22.44%,LPCAT3;MANF;USP19;CLU;EIF2AK3
prerank,fatty acid transmembrane transport (GO:1902001),0.29987963439339876,0.6911628347114753,0.8695652173913043,0.9610787443658594,1.0,1/19,0.93%,ABCD3
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.31911887384278326,0.6911149829581789,0.8353413654618473,0.9607779247220543,1.0,1/14,1.81%,YBX3
prerank,"wound healing, spreading of cells (GO:0044319)",0.29170722148238226,0.6909075886365644,0.8724747474747475,0.9606443353391704,1.0,4/24,17.43%,TMEFF2;RHOA;DDR1;CD151
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.27978435234283544,0.6907512945896139,0.8685857321652065,0.9604462975022571,1.0,5/27,15.25%,NFAT5;RHOA;IRAK1;HSPD1;IL6
prerank,positive regulation of establishment of protein localization (GO:1904951),0.30999139561032407,0.6905863596683519,0.8305084745762712,0.960267867640663,1.0,8/18,27.67%,CHP1;CCT4;CCT6A;CCT8;TCP1;PTP4A3;DKC1;CCT5
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.3273325657214731,0.6898256693937632,0.8522099447513812,0.9606949155692227,1.0,1/12,2.60%,DPYSL3
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.22657565614869438,-0.6897540011446719,0.915,0.9804723818708078,1.0,7/22,19.57%,BMP7;DYNLL1;PLEK;ANKLE2;SIRT1;CDKN2C;CDKN2D
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.23443720113852834,0.6894702552846065,0.9797979797979798,0.9606850967338757,1.0,59/208,28.50%,ESR1;CARD16;MAVS;BRD4;TRIM27;S100B;RHOA;SHARPIN;RORA;ROR1;LTBR;MAPKBP1;CHUK;ALPK1;IRAK1;TAB2;PDPK1;TNFRSF10B;MID2;TRAF3;TANK;F2R;CASP1;SQSTM1;AKAP13;PER1;ZDHHC13;MAP3K3;TRAF3IP2;UFL1;TRIM13;HMOX1;TRIM6;USP10;ZMYND11;IKBKE;CC2D1A;NUP62;OPTN;MUL1;MIER1;TRIM8;BIRC3;MAP3K14;TBK1;PINK1;TRADD;TFG;RIPK1;TMEM106A;NDFIP1;RIPK2;NEK6;CANT1;UBE2V1;PPM1B;GPR89A;SPHK2;NR1D1
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.23858624562966846,-0.6893567064730926,0.8825910931174089,0.9779547197089514,1.0,6/19,17.18%,POLR2G;POLR2E;POLR2C;TERF2IP;POLR2D;POLR2A
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.23858624562966846,-0.6893567064730926,0.8825910931174089,0.9779547197089514,1.0,6/19,17.18%,POLR2G;POLR2E;POLR2C;TERF2IP;POLR2D;POLR2A
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.24171059956319887,0.6892289191077448,0.9410548086866598,0.9605791473262358,1.0,21/117,20.97%,GPR27;DRD1;FSHR;RAMP2;ADCY2;ADCY8;ADCY9;GPR20;IAPP;RAMP1;VIP;GLP1R;MC4R;PTGDR;IL6;CREB1;CALCA;ADCY7;PRKACA;GNB1;PRKAR2A
prerank,negative regulation of cholesterol transport (GO:0032375),-0.28401958322872206,-0.6891879048359508,0.8401253918495298,0.9766668798389074,1.0,10/10,71.62%,APOC1;SHH;ABCG5;APOA2;PLA2G10;ABCG8;APOC3;ABCA2;NFKB1;SREBF2
prerank,diol biosynthetic process (GO:0034312),0.314606315726118,0.6891495297811462,0.8433566433566434,0.9603055442510017,1.0,1/15,1.73%,ACER3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.30314026446939385,0.6888379424236184,0.8445322793148881,0.9602843628761835,1.0,8/18,30.35%,MIEF2;MCU;MUL1;PINK1;RALA;FIS1;PRKN;MIEF1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.2475577427957361,-0.6885881044467778,0.8970588235294118,0.9758200131853385,1.0,3/16,9.15%,KLK2;ACE;BMPR2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.28030605372969364,0.6879224543256075,0.8814627994955864,0.9608602593102241,1.0,2/26,3.46%,ACER3;CYP1B1
prerank,pyroptosis (GO:0070269),-0.25559818522139666,-0.6876188717391383,0.8902439024390244,0.975338662743503,1.0,6/15,26.38%,CASP4;AIM2;ZBP1;TREM2;NLRC4;APIP
prerank,negative regulation of histone acetylation (GO:0035067),-0.26248600584280324,-0.6876145727159934,0.88,0.9739031058375579,1.0,6/11,27.72%,SIRT1;SNCA;BRCA1;TAF7;SIN3A;SET
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.27872326923478385,0.6872433786126543,0.8875598086124402,0.9612023944619528,1.0,7/32,16.85%,PRKCD;CALM2;SYMPK;CNEP1R1;PTBP1;NSMF;CALM3
prerank,replicative senescence (GO:0090399),0.33091323220095226,0.6871788645351822,0.8647887323943662,0.9609250077759395,1.0,3/12,11.35%,TERT;ATM;CHEK2
prerank,intracellular lipid transport (GO:0032365),0.29114510954562955,0.6870061250874366,0.8491547464239272,0.9607599187259405,1.0,1/21,0.93%,ABCD3
prerank,mitotic sister chromatid cohesion (GO:0007064),0.31235629809260823,0.686547434125155,0.8474801061007957,0.9608697042468289,1.0,7/16,29.82%,HASPIN;NIPBL;POGZ;PDS5A;SMC1A;MAU2;PDS5B
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.24049379508950114,0.6864368930869771,0.938860103626943,0.9606340255638005,1.0,21/116,20.97%,GPR27;DRD1;FSHR;RAMP2;ADCY2;ADCY8;ADCY9;GPR20;IAPP;RAMP1;VIP;GLP1R;MC4R;PTGDR;IL6;CREB1;CALCA;ADCY7;PRKACA;GNB1;PRKAR2A
prerank,sterol metabolic process (GO:0016125),0.25447570730842023,0.6856744062194143,0.9130434782608695,0.961089755797648,1.0,20/60,30.60%,CYP19A1;CYP1B1;SOAT1;RXRA;TSKU;NSDHL;FDXR;ABCA1;EBP;SC5D;IL4;STARD3;APOF;HMGCR;ANGPTL3;SOAT2;OSBPL5;SQLE;INSIG1;OSBPL1A
prerank,negative regulation of neuron differentiation (GO:0045665),0.2921833348991149,0.6853359559388565,0.879245283018868,0.9610762459777237,1.0,6/22,20.36%,HES5;SOX9;HEY1;NEPRO;EIF2AK4;CALR
prerank,negative regulation of viral genome replication (GO:0045071),0.26176116101486524,0.6847524784014494,0.8894009216589862,0.9613349539700754,1.0,10/40,22.17%,MAVS;ILF3;RESF1;SETDB1;SRPK1;N4BP1;TRIM6;MPHOSPH8;SHFL;TASOR
prerank,regulation of response to oxidative stress (GO:1902882),-0.26753530084188853,-0.6839198514155057,0.8706293706293706,0.975976064298969,1.0,1/11,1.66%,MCTP1
prerank,rRNA processing (GO:0006364),0.23614452822078053,0.6838255497178727,0.9706477732793523,0.9618917572391946,1.0,62/172,32.65%,C1D;PRKDC;RRP7A;LAS1L;EMG1;SRFBP1;WDR3;RIOK1;NVL;WDR55;ESF1;RRP12;NOLC1;UTP14A;DCAF13;EXOSC4;NOC4L;MRTO4;EIF6;BYSL;DIS3;BOP1;NOB1;RPL7A;TSR3;MTREX;WDR12;NOP56;DDX49;FBL;SBDS;WDR36;WDR46;WDR75;RPS9;TBL3;SENP3;RIOK2;UTP11;NOP58;RRP15;DKC1;MAK16;POP5;FCF1;NOP53;RPL41;RPL30;ERI1;PIH1D2;THUMPD1;EXOSC2;RIOK3;RPL27;RPL37A;RRP1B;NOP14;UTP3;RPL36A;EXOSC3;MPHOSPH6;UTP4
prerank,somite development (GO:0061053),0.3384036438896855,0.6834728485368343,0.8539638386648123,0.9619019851302767,1.0,3/11,16.72%,MEOX2;SMO;MTHFD1
prerank,cellular response to dsRNA (GO:0071359),0.3092224405056368,0.6834377926342953,0.8252427184466019,0.9615922852486859,1.0,7/15,34.59%,MAVS;COLEC12;MUL1;CGAS;RIOK3;IFIH1;DHX9
prerank,UV-damage excision repair (GO:0070914),-0.2655994978028876,-0.68336074378598,0.8525641025641025,0.9750694836908044,1.0,12/12,73.47%,ACTR5;SIRT1;INO80;MC1R;DDB2;POLA1;XPC;POLD3;CUL4B;ERCC1;DDB1;XPA
prerank,cellular response to UV-A (GO:0071492),0.33138355707291356,0.6833523657924678,0.8444444444444444,0.9613361686034783,1.0,4/11,30.12%,OPN3;MMP2;PPID;TIMP1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.28628700569037324,0.682964646405399,0.8807106598984772,0.9613881126519751,1.0,4/25,13.07%,DRD1;ANK2;PDPK1;F2R
prerank,negative regulation of dephosphorylation (GO:0035305),0.29932944177182985,0.6826813460236553,0.8629242819843342,0.9613122606877267,1.0,8/18,24.66%,PPP1R8;ZCCHC9;URI1;CHP1;ARPP19;PPP1R35;PPP1R36;YWHAB
prerank,positive regulation of immunoglobulin production (GO:0002639),0.27693619034805234,0.6825317915958408,0.8890214797136038,0.9611227021934796,1.0,11/31,31.90%,EPHB2;KMT5C;CLCF1;STX4;IL6;MAD2L2;SHLD3;SHLD1;HMCES;PTPRC;SASH3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.29592959624974596,0.6825081229189911,0.8626666666666667,0.9608027519119741,1.0,2/19,3.64%,CUX1;FBXW8
prerank,calcium-ion regulated exocytosis (GO:0017156),0.28307168566047336,0.6823955473612752,0.8525641025641025,0.9605638222275728,1.0,2/27,4.13%,SYT8;ARHGAP17
prerank,protein lipidation (GO:0006497),0.25096855400925644,0.6814374473243217,0.9230769230769231,0.9611434047341426,1.0,14/59,26.68%,PIGW;WIPI2;PIGF;ZDHHC16;HHAT;PIGL;PGAP2;ZDHHC13;ZDHHC20;DPM3;PIGV;ZDHHC9;PIGQ;PIGB
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.28014564402514985,0.6804007859511098,0.8730964467005076,0.9618161648135438,1.0,2/25,5.57%,MPP2;RAB3GAP1
prerank,vesicle transport along microtubule (GO:0047496),0.2872908357407721,0.6802866424043518,0.881979695431472,0.9615714152461107,1.0,2/23,4.81%,KIF13A;DYNC1H1
prerank,mismatch repair (GO:0006298),0.27996355289045516,0.6800101366485024,0.8651685393258427,0.9614931890573418,1.0,9/27,32.95%,ABL1;TDG;PMS2;MSH4;SETD2;POLD1;MSH2;ERCC1;RPA3
prerank,regulation of defense response to virus by host (GO:0050691),0.27243523770371,0.6798181862314402,0.8658536585365854,0.9613472189075714,1.0,9/30,23.03%,MAVS;IFNLR1;TOMM70;TRAF3IP2;TRIM6;EIF2AK4;IL4;MUL1;RNF216
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3380569904583779,0.6784224441993987,0.8477611940298507,0.9623417689844262,1.0,4/10,24.29%,HOXB4;MLLT3;UFL1;TP53
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.301179934964228,0.6778592742110973,0.8495339547270306,0.9625397057296234,1.0,3/18,16.61%,MCMDC2;GINS4;MCM4
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.27414535355458863,0.6772508981576173,0.8698884758364313,0.9627998811765401,1.0,5/28,11.89%,MAP3K5;ATF4;ERN2;AIFM1;TNFRSF10B
prerank,regulation of keratinocyte differentiation (GO:0045616),0.28396832397035315,0.6771295571861823,0.87125,0.9625638569509372,1.0,7/24,24.46%,SRSF6;RUNX1;VDR;CYP27B1;CBFB;CTSK;ROCK1
prerank,regulation of innate immune response (GO:0045088),-0.17755441898042348,-0.6770602433963625,0.9782608695652174,0.9794013392078287,1.0,11/57,13.76%,IFNAR2;SAMHD1;USP18;GBP5;RNASEL;TRIM21;DHX58;CACTIN;PTPN1;TNFAIP3;LRP8
prerank,negative regulation of establishment of protein localization (GO:1904950),0.33084447765107844,0.6764141851427528,0.838855421686747,0.9629039836664769,1.0,4/10,26.36%,WWP2;DNAJA1;SNX3;NDFIP1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.30885348018006414,0.6762574939933056,0.8434547908232118,0.9627204342455882,1.0,4/15,27.97%,IDO2;GSTZ1;KYAT1;HGD
prerank,protein acylation (GO:0043543),0.26311904519634655,0.6758451482294312,0.9082240762812872,0.9627854688446368,1.0,10/38,23.43%,ING5;ZDHHC16;KAT2A;HHAT;ING4;ZDHHC13;CREBBP;ZDHHC20;ZDHHC9;KAT2B
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.29560383994536293,0.6756204682519951,0.8721227621483376,0.9626675642046333,1.0,4/18,15.25%,STAT3;SMAD4;CBL;IL6
prerank,negative regulation of reproductive process (GO:2000242),0.2972782684797683,0.6750747345281292,0.875,0.9628627557977008,1.0,7/17,33.67%,SULF1;WEE2;CALR;WDR77;ARHGDIB;TIMP1;HYAL3
prerank,lipid homeostasis (GO:0055088),0.2508463308581095,0.6747498131884737,0.9240780911062907,0.9628355777159322,1.0,17/57,26.42%,ACOXL;TLCD2;ACOX3;NR1D2;ABCA1;PNPLA3;THADA;ORMDL3;TLCD1;MLXIPL;RCN3;ORMDL1;ABCD1;TM6SF2;FITM2;POLD1;ANGPTL3
prerank,snRNA 3'-end processing (GO:0034472),0.2949980529197688,0.673813086393585,0.8635204081632653,0.9633632635356099,1.0,7/19,32.29%,INTS14;EXOSC4;TOE1;INTS7;INTS6;EXOSC2;EXOSC3
prerank,determination of left/right symmetry (GO:0007368),0.267201261567501,0.6732069949620709,0.8927738927738927,0.9635974381427453,1.0,11/36,28.53%,ODAD2;CCDC39;SMO;NPHP3;DNAAF4;CITED2;LEFTY1;PKD1L1;BBS7;ENKUR;STIL
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.32579920894298064,0.6723825365826536,0.8709677419354839,0.9640193403782692,1.0,2/12,12.00%,PRKCA;CNEP1R1
prerank,regulation of dopamine secretion (GO:0014059),0.27821609828815097,0.6709920838426405,0.8807106598984772,0.9649699838233753,1.0,2/25,6.91%,SYT8;CHRNB2
prerank,microtubule depolymerization (GO:0007019),0.29924801399522816,0.670109224474949,0.8763440860215054,0.9654507255932252,1.0,4/17,20.56%,STMND1;CKAP5;KIF24;STMN2
prerank,regulation of nuclear division (GO:0051783),0.2939378375826889,0.6694955092861069,0.8852459016393442,0.9656689212504898,1.0,8/20,29.55%,RCC1;DAPK3;KIF20B;CUL9;CDK13;CCDC8;CUL7;PRMT5
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.31564697183560786,0.6692378994417336,0.8614540466392319,0.965563136440115,1.0,2/13,12.70%,PABPC1;AGO2
prerank,meiosis I (GO:0007127),0.28115478988576104,0.6682068420514314,0.8794416243654822,0.966183558158318,1.0,3/23,18.60%,FOXJ3;HSF2BP;BRDT
prerank,histone H2A monoubiquitination (GO:0035518),0.2937806728568704,0.6675309374232767,0.8819628647214854,0.9664544247680664,1.0,4/17,18.26%,RNF2;RING1;PCGF2;RYBP
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.3047017978437945,0.6673963402565836,0.8594594594594595,0.9662343875567266,1.0,3/15,13.52%,SAT2;SMOX;SRM
prerank,response to exogenous dsRNA (GO:0043330),0.29599907997207736,0.6669740802888294,0.866576819407008,0.9662900573828684,1.0,6/18,26.35%,MAVS;IRAK3;COLEC12;MUL1;SLC3A2;CGAS
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.2834805309022061,0.6667026031368996,0.896551724137931,0.9662008802605664,1.0,1/21,1.12%,FGF13
prerank,regulation of histone acetylation (GO:0035065),0.2628258056931345,0.6666108307029803,0.902291917973462,0.9659379885825624,1.0,9/33,22.60%,TADA2A;RPS6KA4;SETD5;ARRB1;FLCN;THAP7;NOC2L;CAMK1;KMT2A
prerank,regulation of gastrulation (GO:0010470),0.3173049586934098,0.6665161175100164,0.88,0.9656766988206836,1.0,2/14,6.18%,PHLDB1;POGLUT1
prerank,receptor recycling (GO:0001881),0.3301359613595734,0.6651941857378012,0.8686868686868687,0.9665682221312945,1.0,4/10,24.65%,RAB11B;PHETA2;ARFGEF2;LMTK2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.22078332981962226,-0.6646878607320267,0.9109311740890689,0.9884646427390612,1.0,6/21,18.53%,KDR;LGALS9;IGF1;HTR2B;MT3;MAPK3
prerank,positive regulation of translational initiation (GO:0045948),0.28748973264249555,0.6645007219318086,0.8734015345268542,0.9668655027259503,1.0,6/18,28.60%,CDC123;KHDRBS1;UHMK1;RPS6KB1;YTHDF1;LARP1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.17889794621391603,-0.6643998134375514,1.0,0.9872657124024155,1.0,12/55,20.98%,IGFBP2;TFRC;VCAM1;SLC7A1;CD274;SYK;IGF1;PYCARD;RPS3;CD276;AGER;CCR2
prerank,sensory perception of pain (GO:0019233),0.28402446651585656,0.6642867646816987,0.8740740740740741,0.9667105427236294,1.0,2/21,6.91%,PROK2;CHRNB2
prerank,regulation of adaptive immune response (GO:0002819),0.29151349351977146,0.66403196964989,0.8711819389110226,0.9665995016950788,1.0,4/18,19.92%,TRIM27;RIPK3;ADCY7;EIF2AK4
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.26736136246666936,0.6635583621633401,0.8851851851851852,0.9666767809931334,1.0,11/28,31.48%,ITCH;IRAK1;TAB2;UBC;RPS27A;OTULIN;CYLD;RIPK2;UBE2V1;IRGM;UBE2N
prerank,amide biosynthetic process (GO:0043604),0.25153684265209003,0.6635397105660029,0.9107142857142857,0.9663483526953064,1.0,4/47,8.39%,PCSK5;SMPD4;DMD;NANP
prerank,cellular response to interferon-beta (GO:0035458),-0.2478653861345647,-0.6633439519474784,0.8885135135135135,0.9866968344763725,1.0,3/14,13.59%,STAT1;AIM2;NDUFA13
prerank,mitochondrial fission (GO:0000266),-0.2403800048764969,-0.6627648761997946,0.8893129770992366,0.9857159887026373,1.0,5/16,17.26%,DNM3;DNM1L;MFF;OPA1;MTFR2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.25394997687681087,0.6627573071921624,0.9100467289719626,0.9667178868881792,1.0,8/42,18.35%,VCP;FAAP20;WRN;UBE2L6;UBC;RPS27A;REV1;USP10
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.32490113614964566,0.6625559318371128,0.877521613832853,0.9665544335565458,1.0,11/11,67.53%,PKD2L1;RTP4;LPO;RTP2;PKD1L3;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3
prerank,positive regulation of histone methylation (GO:0031062),0.28033507102548977,0.662428783127728,0.8699494949494949,0.9663385475674989,1.0,5/24,12.23%,PHF1;SMAD4;OGT;CHTOP;WDR5
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.2748867002579866,-0.6623256933243317,0.8580060422960725,0.9846299348426544,1.0,4/10,17.08%,PRKCQ;ZBTB7B;LGALS9;CD55
prerank,synaptic vesicle cycle (GO:0099504),-0.19878078541053967,-0.6620136956907477,0.9402173913043478,0.9834243500750197,1.0,10/30,21.40%,RIMS1;PIP5K1C;SYNDIG1;SYT10;SNCA;SNAP25;SLC32A1;SYT7;SLC18A2;CPLX2
prerank,neuron maturation (GO:0042551),0.29071409310624796,0.6619647981016329,0.8631578947368421,0.9664129620859117,1.0,4/18,14.85%,LGI4;B4GALT5;PICK1;FARP2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.3250830031166079,0.6611811334040757,0.8558951965065502,0.966758690565439,1.0,3/11,24.88%,TIMM9;TOMM70;TIMM22
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3231842102580812,0.6609964660147283,0.8627167630057804,0.9665757252236619,1.0,1/11,2.13%,MUC1
prerank,regulation of interleukin-10 production (GO:0032653),-0.18529460558049626,-0.6607884452073696,0.9669421487603306,0.9829750686508045,1.0,13/44,20.77%,TNFRSF21;CD274;SYK;LGALS9;CD34;PRKCZ;TYROBP;NOD2;CD47;PYCARD;DLL1;ISG15;AGER
prerank,histone monoubiquitination (GO:0010390),-0.20643521160836867,-0.6605762696185354,0.9134615384615384,0.9817267454321793,1.0,6/24,16.69%,BCOR;SKP1;RNF40;UBE2E1;LEO1;CTR9
prerank,regulation of lipid catabolic process (GO:0050994),-0.2265156494999009,-0.6602430282922105,0.9134199134199135,0.9805335534532781,1.0,6/19,23.25%,ADRA2A;PRKAA1;BSCL2;TYSND1;ALK;APOC1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.3138434597896369,0.6600709619013354,0.8680057388809183,0.9670338477562482,1.0,6/12,34.59%,MAVS;COLEC12;MUL1;CGAS;IFIH1;DHX9
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.27082089211271826,0.6599692239818972,0.8880503144654088,0.9667840248816084,1.0,6/26,22.33%,IRAK3;LRRC14;APPL2;APPL1;GPS2;BIRC3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.2051738832426208,-0.6596042940715051,0.927536231884058,0.9796215821580345,1.0,12/23,36.53%,HPGD;GSTM1;ALOX12;ELOVL6;ASAH2;ALOX5;CYP2E1;GSTM4;CYP1A1;ACOT7;LTC4S;GSTP1
prerank,carnitine metabolic process (GO:0009437),0.3125822863884348,0.659568398855698,0.8672199170124482,0.9667835422577079,1.0,3/12,18.44%,CPT1C;CRAT;SHMT1
prerank,primary alcohol metabolic process (GO:0034308),0.2767713194368552,0.6594322780181845,0.8979848866498741,0.9665568513228991,1.0,5/25,18.75%,CYP1B1;DHRS9;ALDH3A2;GDPD3;DHRS3
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.3322636805539319,0.6574475167600806,0.8701854493580599,0.9679353777513724,1.0,2/10,16.78%,KCNE5;SUMO1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2256101055775508,0.6573828995939739,0.9744114636642784,0.9676493793442175,1.0,17/152,15.22%,GNAS;DRD1;FSHR;ADGRL2;RAMP2;ADCY2;ADCY8;ADCY9;IAPP;RAMP1;VIP;GLP1R;MC4R;ABCA1;GPR12;GNAO1;GNA11
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.2753318799778301,0.6562392362319852,0.8998716302952503,0.9682906541678353,1.0,4/25,15.60%,LRPAP1;DLG4;ITGAV;WDR54
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.1802969461043319,-0.6539796168980334,0.9794520547945206,0.9826907576511571,1.0,4/44,6.28%,CYP7B1;PRKAG2;CYP27A1;INSIG2
prerank,macrophage chemotaxis (GO:0048246),-0.2697715289982425,-0.6538927266892701,0.8775510204081632,0.9813372122162771,1.0,10/10,73.05%,EDNRB;TAFA4;CCL5;CCL3;EDN2;SAA1;CXCL17;LGALS3;CKLF;CCL2
prerank,mitochondrial transport (GO:0006839),0.2468910651307256,0.6533621536214254,0.922566371681416,0.9704828429540481,1.0,14/53,24.88%,FLVCR1;SPG7;TOMM40;TIMM9;BCAP31;TOMM70;TMEM14C;BCS1L;COX18;STARD3;ABCB10;BAD;TIMM17B;TIMM22
prerank,acetyl-CoA metabolic process (GO:0006084),0.305422432457243,0.6531935852317324,0.8863328822733424,0.9702801815134267,1.0,5/15,28.47%,ACAT1;ACACA;HMGCS2;PPCS;ACLY
prerank,cholesterol metabolic process (GO:0008203),0.24151915426564144,0.6529783812450644,0.9285714285714286,0.9701053964888794,1.0,24/68,33.67%,SOAT1;CEL;RXRA;TSKU;NSDHL;ABCA1;LSS;EBP;IL4;STARD3;APOF;HMGCR;ANGPTL3;SOAT2;ACAT2;OSBPL5;ACLY;SQLE;INSIG1;OSBPL1A;GGPS1;GBA2;TM7SF2;PLPP6
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2590459045996466,0.6517869607010209,0.9155920281359906,0.9707817508159983,1.0,7/36,14.34%,TCF7L2;PDE6A;FZD5;NFATC1;AGO1;AGO2;GNAO1
prerank,B cell differentiation (GO:0030183),0.25103452918209485,0.6510109072189528,0.9184397163120568,0.9711047130161949,1.0,9/46,20.96%,HDAC9;HDAC4;SYVN1;PTPN2;CLCF1;TCF3;TPD52;GPS2;IL4
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3198210344450474,0.6491385266710687,0.8746438746438746,0.9723231036664176,1.0,3/10,24.25%,CALM3;DRD2;CBARP
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.2636831534019583,-0.6491266718555574,0.877742946708464,0.9835756146191992,1.0,10/10,73.65%,ZFP57;PCGF5;CTCFL;DNMT3L;PRMT7;KDM1B;PCGF3;MECP2;DNMT3A;IGF2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.2631143623353202,0.6478542945867257,0.9179734620024126,0.9730649214433775,1.0,12/31,25.91%,PPP3CC;MAPK8;YWHAE;YWHAQ;TFDP1;E2F1;BID;SFN;TP53;BAD;YWHAB;NMT1
prerank,organelle fission (GO:0048285),0.2696594180797167,0.6473252032725635,0.892059553349876,0.9731543975298805,1.0,10/24,31.04%,PEX11A;DNM2;MTFR1;SEC16B;MUL1;ACOT8;FIS1;PRKN;MIEF1;MTFR1L
prerank,rRNA metabolic process (GO:0016072),0.22268882222359304,0.646864475129333,0.9777553083923155,0.973177250359117,1.0,55/160,32.65%,C1D;RRP7A;ERN2;LAS1L;EMG1;WDR3;NVL;WDR55;ESF1;RRP12;NOLC1;UTP14A;DCAF13;XRN1;EXOSC4;NOC4L;MRTO4;BYSL;DIS3;BOP1;NOB1;RPL7A;MTREX;WDR12;NOP56;DDX49;FBL;SBDS;WDR36;NIFK;WDR46;WDR75;RPS9;TBL3;SENP3;UTP11;NOP58;DKC1;POP5;FCF1;NOP53;RPL41;RPL30;DEDD2;PIH1D2;EXOSC2;RPL27;RPL37A;RRP1B;NOP14;UTP3;RPL36A;EXOSC3;MPHOSPH6;UTP4
prerank,retinol metabolic process (GO:0042572),0.30350689217236904,0.6464913988526637,0.8929539295392954,0.9731370521282401,1.0,3/14,18.75%,CYP1B1;DHRS9;DHRS3
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.21639054283494116,-0.6456435896736175,0.9406392694063926,0.9847131300339047,1.0,7/20,20.41%,NT5C2;GMPS;IMPDH1;ADSS1;LHPP;PPAT;AMPD2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.1734899641453021,-0.6449333367583686,1.0,0.9837929504604392,1.0,7/53,11.67%,CALCRL;HTR2C;HTR4;OPRM1;CNR1;MC5R;CHRM3
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.315057672355183,0.6434843329817107,0.8796992481203008,0.9752246159205691,1.0,1/10,5.17%,GABRA3
prerank,cellular response to ATP (GO:0071318),-0.2416499246609744,-0.6431536234618214,0.9276595744680851,0.9836141184753745,1.0,14/14,75.86%,CIB2;P2RY1;P2RX7;P2RX3;P2RY2;PDXP;TRPV1;RYR3;P2RY4;HSP90B1;P2RX4;P2RY12;SSH1;TAF1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.26191944868834216,0.6420439183179556,0.9148418491484185,0.9760466995681153,1.0,12/26,30.27%,AKAP9;ARL2;SLAIN2;DCTN1;STMN2;CDK5RAP2;MET;KATNB1;DRG1;FES;TOGARAM1;RAC1
prerank,regulation of mitochondrial fission (GO:0090140),0.2726470961053569,0.6415300428143896,0.9219143576826196,0.9761132824131958,1.0,10/24,30.35%,MIEF2;MCU;MUL1;LRRK2;PINK1;CYRIB;RALA;FIS1;PRKN;MIEF1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.2814452180252455,0.641366857877888,0.9081225033288948,0.975888516132645,1.0,4/17,16.57%,MIS12;ZW10;HASPIN;IK
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.2671269750058881,0.6412398957573314,0.9083969465648855,0.9756387378199592,1.0,3/23,9.77%,KLRK1;RAET1E;CRTAM
prerank,positive regulation of phagocytosis (GO:0050766),0.2426806506694334,0.6411434956851797,0.9229024943310657,0.975371312400243,1.0,8/47,22.64%,GAS6;FCER1G;PLA2G5;LMAN2;APPL2;CALR;TUB;SLC11A1
prerank,cellular response to nitrogen compound (GO:1901699),0.2751586271410011,0.6381987153623895,0.9020618556701031,0.9773873273726141,1.0,12/20,36.14%,DDI2;SPIDR;AOC1;ATP2B4;DAXX;HSF1;DDX11;TIMELESS;RIOK3;BLM;EPG5;RTF2
prerank,zymogen activation (GO:0031638),0.24953869170159718,0.63800989926103,0.9255813953488372,0.9772043351522587,1.0,8/39,27.13%,PRSS12;MMP14;TBC1D10A;PGK1;PERP;CYFIP2;BAD;RIPK2
prerank,response to gamma radiation (GO:0010332),0.26777301657631847,0.6378547650252244,0.8975,0.9769841185280268,1.0,10/24,28.71%,WRN;ATM;LIG4;TLK2;TRIM13;MEN1;XRCC6;TP53;HSF1;ATR
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.233398572476823,-0.6358704719095768,0.9405204460966543,0.9871560516757701,1.0,5/14,20.98%,SYK;LGALS9;PTPN22;CD55;CCR2
prerank,bile acid metabolic process (GO:0008206),0.264493203183914,0.6353492434851445,0.9056122448979592,0.9786568576021646,1.0,7/27,24.66%,OSBPL7;AKR1C1;NPC1;OSBP;SLC27A2;HSD3B7;ACOT8
prerank,ceramide metabolic process (GO:0006672),0.23929002602212004,0.6341620751827803,0.9378596087456847,0.9792490969178426,1.0,4/49,6.18%,ACER3;PLPP3;SMPD4;PLPP1
prerank,phasic smooth muscle contraction (GO:0014821),0.30921356337759887,0.6340688534624184,0.8923959827833573,0.978982713048349,1.0,3/10,21.32%,EDN3;GDNF;DRD2
prerank,cell junction maintenance (GO:0034331),-0.23676278452101476,-0.6337831121551066,0.9133858267716536,0.987195205702116,1.0,7/14,29.21%,CLDN1;CBLN2;CSF1R;CBLN1;MYADM;PARD6A;NLGN2
prerank,presynapse organization (GO:0099172),0.311865798422456,0.6329839122577736,0.8870967741935484,0.9795172532581382,1.0,2/10,13.02%,DVL1;NLGN1
prerank,heterochromatin organization (GO:0070828),-0.23435513843421257,-0.6326155500695635,0.904,0.9865523851162673,1.0,1/14,0.70%,MECOM
prerank,regulation of phosphate metabolic process (GO:0019220),-0.22479083965845242,-0.6325015867369342,0.9044117647058824,0.9852218162838425,1.0,4/16,13.10%,SMG7;SRPX2;PGAM1;BARD1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.2854878510397534,0.6324370911403643,0.9059139784946236,0.9795970021632977,1.0,1/15,2.13%,MUC1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.26148933746226766,0.6315188333973998,0.910828025477707,0.9799376152411569,1.0,6/26,18.73%,EYA2;FGFR1;TERT;INHBA;AKT1;GDNF
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.2885231306967796,0.6314218904147954,0.9005449591280654,0.9796678807900566,1.0,2/14,14.20%,TERT;TNKS2
prerank,regulation of microtubule nucleation (GO:0010968),0.3096028656103226,0.6313252430065858,0.8819345661450925,0.9794011197469953,1.0,3/10,20.23%,CKAP5;GIT1;DCTN1
prerank,aerobic respiration (GO:0009060),-0.20879368065388698,-0.6312150356691282,0.9696969696969697,0.984580744914628,1.0,6/20,17.26%,ME3;UQCRC2;SLC25A14;UQCRB;UQCRC1;MTFR2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2899788787704958,0.6308197583695273,0.8928571428571429,0.979429990860808,1.0,3/15,18.74%,CHEK2;HUS1;ATF2
prerank,positive regulation of viral genome replication (GO:0045070),0.2549244805524467,0.6303828829037496,0.9339045287637698,0.9794077047470169,1.0,4/29,14.24%,PABPC1;TMEM39A;PKN2;SRPK1
prerank,nuclear membrane disassembly (GO:0051081),0.2954516577711388,0.6295796162578604,0.8990825688073395,0.9796754575053287,1.0,3/14,20.23%,PRKCA;CNEP1R1;DCTN1
prerank,positive regulation of defense response (GO:0031349),0.22259193108123487,0.6293468541089269,0.9682203389830508,0.9795084878641553,1.0,4/89,5.42%,PDCD4;IL33;ABCC1;LRSAM1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.21531239299154004,0.6286830114341547,0.9887869520897044,0.9796669014295285,1.0,44/158,28.01%,CARD16;MAVS;BRD4;TRIM27;S100B;RHOA;SHARPIN;ROR1;LTBR;CHUK;ALPK1;IRAK1;TAB2;TNFRSF10B;MID2;F2R;CASP1;AKAP13;ZDHHC13;MAP3K3;TRAF3IP2;TRIM13;HMOX1;TRIM6;IKBKE;CC2D1A;NUP62;MUL1;MIER1;TRIM8;BIRC3;MAP3K14;TBK1;PINK1;TRADD;TFG;RIPK1;TMEM106A;NDFIP1;RIPK2;NEK6;CANT1;UBE2V1;GPR89A
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2640274411086665,0.6285742781406557,0.9247448979591837,0.9794024357355552,1.0,4/25,8.20%,CNNM2;TMC8;SELENON;TRPM7
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.30489294831123853,0.627851131815082,0.9085631349782293,0.9795718883126457,1.0,6/11,33.13%,SMARCA4;NOP53;PWP1;DDX11;NCL;SIRT7
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2538325221795069,0.6270262053262186,0.9287469287469288,0.9798547388733039,1.0,15/32,34.34%,PRKCD;CYFIP1;NOLC1;FOXO3;EIF2A;ATXN2;ROCK1;RBM3;EIF4E;PUM3;METAP1;TMED10;PCIF1;TCOF1;SAMD8
prerank,T cell receptor signaling pathway (GO:0050852),0.21431604318363484,0.6262792171963366,0.9846938775510204,0.9800704169498257,1.0,39/138,27.29%,PSMD7;CD3E;PSMA8;PRAM1;BTNL9;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;PIK3CB;CUL1;KHDRBS1;PSMA6;VTCN1;WNK1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;RC3H2;DENND1B;TRAT1;PSMA3;PSMB1;PSMD4;PSMA5;STOML2;PSMA7;NFKBID;CSK;PSMC1;NCK1;MOG;WAS;RIPK2;PSMA1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.2385515585662758,-0.6255785281694328,0.9230769230769231,0.9868263250883226,1.0,4/12,24.06%,LAMA5;VANGL2;ACTB;ZDHHC7
prerank,phosphate ion transmembrane transport (GO:0035435),0.29621840683435724,0.6253098670852507,0.8969359331476323,0.980438234897695,1.0,5/12,30.85%,SLC25A3;SLC37A4;SLC37A3;SLC25A11;SLC20A2
prerank,myelin maintenance (GO:0043217),0.30980017630404416,0.625029419518943,0.9081632653061225,0.9803064315024393,1.0,4/10,21.99%,SOD1;CXCR4;CLU;ABCD1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.22969085354803837,-0.6249897091652585,0.9414225941422594,0.9857823302850356,1.0,6/16,20.41%,GMPS;IMPDH1;ADSS1;LHPP;PPAT;AMPD2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.176402338001642,-0.6243948476204525,0.9795918367346939,0.9848075593702571,1.0,37/38,72.69%,NDUFC2;NDUFA13;NDUFB2;NDUFAF1;NDUFB7;NDUFS1;NDUFA8;NDUFB11;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFB8;NDUFA11;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFS8;NDUFB5;NDUFB3;NDUFS3;NDUFB10;NDUFA10;NDUFAB1;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.2618780398140491,0.6239962750732508,0.9103535353535354,0.9806957509971695,1.0,3/23,11.17%,HDAC4;ACTN3;GIT1
prerank,Rac protein signal transduction (GO:0016601),0.27450657923542177,0.6235789003628328,0.9090909090909091,0.9806440005096786,1.0,3/18,14.85%,TIAM1;CYFIP1;FARP2
prerank,response to interferon-gamma (GO:0034341),0.22786693288139187,0.6231962988184304,0.9540481400437637,0.9805808541592674,1.0,13/67,22.64%,SLC26A6;CCL13;CCL15;CXCL16;GBP6;CASP1;CYP27B1;EPRS1;DAPK3;ACOD1;SYNCRIP;SHFL;SLC11A1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.2781415736230526,0.6225065183862389,0.9071895424836601,0.9807324572780393,1.0,3/18,12.28%,TBX21;TRIM27;EZR
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.2691161623571692,0.6224988510919002,0.9250317662007624,0.9803972273935819,1.0,8/21,24.66%,PPP1R8;TIPRL;YWHAE;ARPP19;CRY2;BOD1L1;FKBP1B;YWHAB
prerank,cellular amino acid catabolic process (GO:0009063),0.22063222550815476,0.6212003688772019,0.9702127659574468,0.9809734030515458,1.0,24/87,27.97%,HYKK;MTRR;DDAH1;IDO2;HMGCL;AUH;HNMT;ACAT1;CARNMT1;GCSH;GSTZ1;SHMT2;BCKDK;SHMT1;DAO;PHYKPL;KYAT1;BCAT1;GCDH;CRYM;BCKDHB;HIBCH;HOGA1;HGD
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.2921786310392271,0.6210014385651271,0.8997175141242938,0.9807760058591093,1.0,5/12,23.12%,IAPP;VBP1;CLU;LDLR;PFDN4
prerank,positive regulation of lipid storage (GO:0010884),0.26686245757142574,0.6196771551943738,0.9223057644110275,0.9813938399169412,1.0,4/21,19.24%,EHD1;CIDEA;PLIN3;IKBKE
prerank,mitotic spindle assembly (GO:0090307),0.23936215035418132,0.6195108177923901,0.957471264367816,0.9811653209609164,1.0,15/42,32.66%,MISP;SMC3;RHOA;CHEK2;STAG1;CCDC61;ARHGEF10;WRAP73;SMC1A;SPICE1;GOLGA2;TOGARAM1;KIF2A;BCCIP;PIBF1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.23784749923132067,0.6188440233901408,0.9425287356321839,0.9812915241803958,1.0,8/45,18.82%,PTPN3;GAS1;TOM1L1;BMP4;ZW10;CDKN1C;WEE2;HECA
prerank,nucleoside catabolic process (GO:0009164),0.30096555791989865,0.6186571014323268,0.9145658263305322,0.9810894540420706,1.0,3/11,20.78%,UPP2;DERA;NT5C
prerank,regulation of phagocytosis (GO:0050764),0.23004771094852422,0.6184261416346198,0.9474860335195531,0.9809120430584453,1.0,6/53,14.03%,GAS6;FCER1G;ITGAV;PLA2G5;PIP4P2;LMAN2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.28008157024655506,0.6182023947790826,0.9132231404958677,0.9807250888782846,1.0,5/15,23.75%,NLGN1;CLN3;USP46;DRD2;SYN3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.22728015032515292,-0.6171540235026906,0.9430604982206405,0.9877826354884078,1.0,5/14,19.50%,BCL2L1;OPA1;HSPA1A;XBP1;CREB3
prerank,carbohydrate derivative catabolic process (GO:1901136),0.27086985751198656,0.6165312724158416,0.9225806451612903,0.9815152417371337,1.0,7/18,28.40%,DERA;NGLY1;FBXO17;OGA;ADAMTS9;MANBA;STT3B
prerank,regulation of AMPA receptor activity (GO:2000311),0.2535138680142642,0.6164040952599124,0.9327521793275217,0.9812702514720272,1.0,5/25,17.66%,ARC;CNIH2;SHANK1;NLGN1;SHISA8
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.2505936242940615,0.6153195217640981,0.9452554744525548,0.9816768730315056,1.0,3/30,7.26%,TWIST1;CCAR2;YJU2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.23610467641481922,0.6148505732467824,0.9515011547344111,0.9816664206439638,1.0,15/44,29.94%,PABPC1;FTO;PUM1;METTL16;AGO2;CNOT8;UPF1;RBM24;ROCK1;METTL14;RIDA;TNRC6A;YTHDF1;ZFP36L1;KHSRP
prerank,positive regulation of signaling receptor activity (GO:2000273),0.24619553982981304,0.6147878037399858,0.9452380952380952,0.9813723513220297,1.0,5/36,15.81%,EPHB2;ARC;NRP1;HDAC1;HDAC6
prerank,thyroid hormone generation (GO:0006590),0.3063795791203693,0.6145698799913074,0.9163059163059163,0.9811759797593139,1.0,1/10,5.71%,CPQ
prerank,bile acid biosynthetic process (GO:0006699),-0.19880265287446072,-0.6144345510129946,0.9553571428571429,0.9878879713761751,1.0,2/24,5.32%,CYP7B1;CYP27A1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.23196318449280365,0.6137624316913453,0.958904109589041,0.9813719974081349,1.0,8/50,17.58%,CDC6;CDK5RAP3;CCNT2;CCNG2;CCNE2;CAMK2N1;CDC25A;CDKN1C
prerank,protein targeting to mitochondrion (GO:0006626),0.2310196891487699,0.6133813913834305,0.9569160997732427,0.981288680620175,1.0,8/52,16.96%,TOMM40;TIMM9;BCAP31;AIFM1;HSPD1;TOMM70;PMPCA;GRPEL1
prerank,positive regulation of histone modification (GO:0031058),0.24325959537329794,0.6130308783059485,0.9436964504283966,0.9811820194529006,1.0,8/33,24.33%,TADA2A;RPS6KA4;CHTOP;ARRB1;NIPBL;AKAP8;PAF1;SAP30BP
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.25126954735708334,0.6119824789125095,0.9312977099236641,0.9815594783831754,1.0,5/27,17.16%,DRD1;GPR20;F2R;GPR157;CALCA
prerank,steroid biosynthetic process (GO:0006694),0.22763375843160397,0.6116892333592668,0.9610678531701891,0.981431475045227,1.0,16/56,30.60%,CYP19A1;OSBPL7;FDXR;OSBP;LSS;PRLR;EBP;SC5D;SLC27A2;HSD3B7;ACOT8;HMGCR;SCP2;SQLE;INSIG1;OSBPL1A
prerank,transcription preinitiation complex assembly (GO:0070897),0.2921133378759962,0.6114752603659275,0.9240331491712708,0.9812440843946854,1.0,5/12,30.90%,BDP1;TBP;TAF1;GTF2A2;TAF1B
prerank,tryptophan metabolic process (GO:0006568),0.2920706586764156,0.6111730886421659,0.9090909090909091,0.9810929085106767,1.0,2/11,20.64%,IDO2;KYAT1
prerank,B cell activation (GO:0042113),0.22417652657790815,0.6098693173746407,0.9758507135016465,0.9816248198475865,1.0,12/68,21.22%,EPHB2;HDAC9;HDAC4;CHRNB2;PTPN2;HSPD1;CLCF1;TCF3;TPD52;GPS2;IL4;BANK1
prerank,negative regulation of translational initiation (GO:0045947),0.28698574729641263,0.6095371133839512,0.9276595744680851,0.9815127684624444,1.0,5/13,28.60%,AGO2;RBM4;EIF2AK4;TPR;LARP1
prerank,regulation of mitotic nuclear division (GO:0007088),0.229372211479993,0.6090040247786616,0.9608062709966405,0.9815092821656959,1.0,16/55,26.36%,LRP5;TOM1L1;EDN3;BMP4;RCC1;LCMT1;PHIP;DAPK3;KIF20B;NUP62;CUL9;CDK5RAP2;CDK13;CCDC8;CUL7;IGF2
prerank,entry into host (GO:0044409),0.2791686136584942,0.6080360271520128,0.9185082872928176,0.9817906524161358,1.0,6/13,30.23%,CBL;ITGAV;CXCR4;MET;GRB2;CTNNB1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.23656942200585357,-0.606557534794004,0.9204152249134948,0.9909908615916138,1.0,2/11,12.24%,AHR;CEACAM1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.2599150708003633,0.6059345814840006,0.9375,0.9827723973967765,1.0,2/20,7.52%,DRD1;ADCY9
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.27985724510931703,0.6055777833861375,0.9110473457675753,0.9826573615720773,1.0,7/13,38.99%,LSM2;SRSF10;USP4;DDX20;SART3;CD2BP2;PRPF31
prerank,detection of visible light (GO:0009584),-0.21660340630808847,-0.6052606277549293,0.9672131147540983,0.9902949855182975,1.0,2/16,12.16%,ABCA4;RP1
prerank,apoptotic nuclear changes (GO:0030262),0.2520199750132416,0.6040365758575166,0.91625,0.9832791755277488,1.0,5/24,18.11%,ERN2;HMGB1;CDK5RAP3;ACIN1;DFFB
prerank,positive regulation of isotype switching (GO:0045830),0.2735136399306589,0.6007692624369422,0.9092140921409214,0.9849510154255673,1.0,7/15,29.08%,KMT5C;CLCF1;MAD2L2;IL4;SHLD3;SHLD1;HMCES
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.27208837155456717,0.5964836696839944,0.9317269076305221,0.9871767299325566,1.0,6/15,34.02%,ANXA1;NR3C1;HNRNPU;ZFP36L1;SSTR2;FAM107A
prerank,response to muramyl dipeptide (GO:0032495),-0.22758783165972973,-0.5957167790591493,0.9568345323741008,0.9937447599728493,1.0,4/12,16.36%,ARHGEF2;VIM;NOD2;PTPN22
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.2736046581725471,0.5956166187147832,0.9291784702549575,0.9873449473556299,1.0,6/13,35.20%,HSPA5;UFL1;NCK1;ATF6B;WFS1;DNAJB9
prerank,covalent chromatin modification (GO:0016569),0.27395183985119287,0.5948174173421141,0.9204389574759945,0.9874986695327937,1.0,3/14,17.34%,SETD5;HDAC1;UFL1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2403835132581211,0.5945982537864822,0.9571603427172583,0.9872836779012347,1.0,9/30,28.40%,UGGT2;FUT8;UGGT1;STT3A;DPM3;LMAN1;MAGT1;MGAT5;STT3B
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.28537194155387097,0.5943267375055428,0.9171348314606742,0.9871054425939778,1.0,2/11,14.29%,SCARA3;COLEC12
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.2530620326610998,0.594200682647374,0.9329032258064516,0.9868349843653584,1.0,2/22,5.71%,AHNAK;DMD
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.18513012502139015,-0.5923350987274313,0.9623655913978495,0.9940467967451151,1.0,6/26,15.93%,CDK6;TMEM178A;MAFB;CEACAM1;HOXA7;C1QC
prerank,purine nucleotide catabolic process (GO:0006195),0.27485915700854585,0.5904876586909441,0.9309878213802436,0.9886930531771193,1.0,1/13,4.54%,XDH
prerank,alpha-amino acid metabolic process (GO:1901605),0.22732478806118586,0.5891315660490629,0.9647326507394767,0.9891023879162513,1.0,13/45,25.29%,NOX4;MTRR;DDAH1;SRR;MTHFD1;GNMT;MTHFR;RIMKLB;KYAT1;PYCR1;DPEP1;RIMKLA;SLC25A12
prerank,plasma membrane repair (GO:0001778),0.2734161808737376,0.5881027076952479,0.9280677009873061,0.9893276246634969,1.0,1/13,2.82%,AHNAK2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.2104998810915899,-0.5876637039775119,0.9558232931726908,0.9949584503097579,1.0,2/16,7.50%,PDK1;ADIPOR1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.2901814889264067,0.5871003230704301,0.9331352154531947,0.9895506576767099,1.0,3/10,28.37%,RARA;IL4;SPHK2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.23600103074226975,0.5867524762997421,0.9656398104265402,0.9894082039191651,1.0,14/33,34.21%,GCLC;DDAH1;CAD;RIMKLB;GCLM;KYAT1;PYCR1;RIMKLA;FPGS;NIT2;DGLUCY;ART4;ALDH18A1;GLUD1
prerank,microtubule-based transport (GO:0099111),0.280980528175209,0.5861186931893028,0.9388888888888889,0.9894132965310568,1.0,4/12,21.82%,ROPN1L;DNAAF4;DYNC1I2;SPAG17
prerank,cellular response to inorganic substance (GO:0071241),0.24983784957427604,0.5849157910901783,0.9427480916030534,0.989720688585759,1.0,9/21,31.68%,DDI2;SPIDR;AOC1;CDK2;DPEP1;DDX11;TIMELESS;MTR;BLM
prerank,stem cell development (GO:0048864),0.2693191845875237,0.5847359232750999,0.9209809264305178,0.9894715639812285,1.0,8/16,34.91%,NOLC1;KLHL12;SOX8;TAPT1;PTPRC;SNAI2;TCOF1;PEF1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.25047886656826,0.583783216591029,0.9534282018111255,0.9892976331796589,1.0,6/20,27.10%,AUH;ACAT1;BCKDK;BCAT1;BCKDHB;HIBCH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.25047886656826,0.583783216591029,0.9534282018111255,0.9892976331796589,1.0,6/20,27.10%,AUH;ACAT1;BCKDK;BCAT1;BCKDHB;HIBCH
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.2493737291861089,0.5829602763556043,0.94148244473342,0.9894158782338345,1.0,7/21,24.51%,SIRT5;COA8;SIRT2;HDAC6;AATF;ABCD1;PINK1
prerank,peptidyl-asparagine modification (GO:0018196),0.23426448960507207,0.5823391667656462,0.9658536585365853,0.9894117611315245,1.0,9/31,28.40%,UGGT2;FUT8;UGGT1;STT3A;DPM3;LMAN1;MAGT1;MGAT5;STT3B
prerank,endochondral bone morphogenesis (GO:0060350),0.28366317350803444,0.5820476530180775,0.9138418079096046,0.9892288843230672,1.0,3/11,20.60%,BMP4;TMEM119;FGFR3
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.2628832824645753,0.5820112931256076,0.9426666666666667,0.9889065751528864,1.0,5/17,27.40%,KCNE5;SUMO1;RNF207;VAMP2;KCNRG
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.2580785739094942,0.581172343468829,0.9445178335535006,0.9890139036695587,1.0,6/16,37.07%,SOX9;APPL2;NCOR1;WDTC1;ACADL;ERLIN1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.23551882636552118,0.5807608949922862,0.9586374695863747,0.9889058431361653,1.0,3/29,9.77%,KLRK1;RAET1E;CRTAM
prerank,canonical glycolysis (GO:0061621),-0.18066338626843065,-0.5801137399990577,0.9840425531914894,0.9956191683500487,1.0,4/24,11.13%,HK2;PGAM1;GPI;ALDOC
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.18066338626843065,-0.5801137399990577,0.9840425531914894,0.9956191683500487,1.0,4/24,11.13%,HK2;PGAM1;GPI;ALDOC
prerank,linoleic acid metabolic process (GO:0043651),0.2547919802532957,0.5796699709337588,0.9419354838709677,0.9891535331752623,1.0,5/17,27.15%,ELOVL5;FADS1;ABCD1;ALOXE3;ELOVL1
prerank,glycosphingolipid metabolic process (GO:0006687),0.2226225454771451,0.5794039708665047,0.972318339100346,0.988959159267876,1.0,8/42,19.41%,ST6GALNAC5;SMPD4;ARSA;GALC;HEXA;GLB1;SUMF2;ASAH1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.24303462672399748,0.579291052672626,0.9448621553884712,0.9886748700886058,1.0,2/25,4.16%,CSNK2A2;CSNK2A1
prerank,primary miRNA processing (GO:0031053),0.28685582054596725,0.5792436853086746,0.9229671897289586,0.9883629203989648,1.0,2/10,11.68%,HNRNPA2B1;DGCR8
prerank,phosphate ion transport (GO:0006817),0.25757111067568067,0.5779693437391167,0.9423328964613368,0.9887041795661474,1.0,5/16,30.85%,SLC25A3;SLC37A4;SLC37A3;SLC25A11;SLC20A2
prerank,regulation of steroid metabolic process (GO:0019218),0.24268040352887058,0.5774819376312079,0.9532828282828283,0.9886056107776803,1.0,5/23,19.41%,LAMTOR1;DGKQ;RORA;STUB1;ASAH1
prerank,negative regulation of histone methylation (GO:0031061),0.28942027887192323,0.577437821323246,0.9309859154929577,0.9882892526632423,1.0,2/10,12.23%,PHF1;WDR5
prerank,protein import into mitochondrial matrix (GO:0030150),0.25626552944742204,0.5759820457134366,0.9442231075697212,0.9886770013502907,1.0,6/18,32.50%,TOMM40;TOMM70;GRPEL1;TIMM17B;GRPEL2;TIMM21
prerank,sphingolipid metabolic process (GO:0006665),0.20214263295502002,0.5748184862408601,0.9884575026232949,0.9889322334575252,1.0,8/108,6.70%,ACER3;PLPP3;PDXDC1;KDSR;SMPD4;ELOVL5;PLPP1;ARSA
prerank,insulin secretion (GO:0030073),0.25080412944552016,0.5711482759244165,0.9562334217506632,0.9904042800295128,1.0,3/19,13.44%,ANXA1;RAB11FIP5;RAB11B
prerank,regulation of protein localization to centrosome (GO:1904779),-0.23035615031521367,-0.571004720854717,0.958904109589041,0.9980331945299957,1.0,3/10,16.21%,APC;CEP72;NSFL1C
prerank,negative regulation of T cell activation (GO:0050868),0.22482200102757918,0.5689433122013077,0.9629629629629629,0.9910999709498075,1.0,4/35,13.12%,SPN;GLMN;VTCN1;CD80
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.2591434096574794,0.5687430327934051,0.9465954606141522,0.9908581692510108,1.0,3/15,20.80%,ABL1;SMAD7;MAD2L2
prerank,negative regulation of hormone secretion (GO:0046888),0.2840097476898201,0.5681857492600928,0.9450867052023122,0.9907787444368451,1.0,3/10,31.73%,RAB11FIP5;LIF;RAB11FIP3
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.22413897181634587,-0.5671762017990335,0.940959409594096,0.9981285633493187,1.0,6/12,28.37%,WDR18;METTL4;WRNIP1;GMNN;TIPIN;TICRR
prerank,erythrocyte development (GO:0048821),-0.23286467486818982,-0.5669678361599659,0.9545454545454546,0.996810124757939,1.0,10/10,76.73%,SH2B3;NCKAP1L;ALAS2;ALAS1;GATA1;DMTN;LYAR;MED1;ZBTB7A;ABCB10
prerank,plasma membrane tubulation (GO:0097320),0.2667751151577593,0.5658076969448534,0.9372496662216289,0.9915589093113838,1.0,3/13,20.57%,EHD2;SNX9;CHMP4A
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.2658430543707539,0.5656867109636297,0.9363762102351314,0.9912725269250197,1.0,1/13,4.20%,STAT3
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.24041114568651295,0.5654961068695904,0.9531051964512041,0.9910218608685882,1.0,8/22,33.49%,KAT2A;LAG3;RUNX1;CBFB;SOCS1;BCL6;CD46;FANCA
prerank,positive regulation of cell aging (GO:0090343),0.2705459914815621,0.5648453835392869,0.9521857923497268,0.9909796890585241,1.0,4/11,26.35%,LMNA;HMGA1;ARG2;CGAS
prerank,regulation of response to interferon-gamma (GO:0060330),0.25860723065616664,0.5642040863512587,0.9337748344370861,0.9909311224688437,1.0,5/14,26.03%,PTPN2;SUMO1;JAK1;SOCS1;IFNGR2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.2346521142692874,0.5639111683674587,0.9717444717444718,0.9907369285017625,1.0,7/25,29.33%,FOXK1;ADPGK;PGK1;ENO2;PFKP;PFKL;GAPDHS
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.2764375143095078,0.5621384090889854,0.9370314842578711,0.9912324066410985,1.0,4/10,31.06%,IRAK3;TLE5;MAP2K5;PTPRC
prerank,establishment of melanosome localization (GO:0032401),0.2431355651662758,0.5603741717421489,0.9604221635883905,0.9916535860217724,1.0,7/19,31.14%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.24192875102564237,0.5603180381172548,0.9683377308707124,0.9913432049477554,1.0,5/20,25.90%,ADA;RPGRIP1L;GPRASP1;YWHAB;MET
prerank,cellular response to gamma radiation (GO:0071480),0.24973463323066886,0.5589004524598706,0.950863213811421,0.9916172484845005,1.0,8/17,31.80%,WRN;ATM;TLK2;XRCC6;TP53;HSF1;ATR;YAP1
prerank,ganglion development (GO:0061548),-0.22037657677272704,-0.5586914118269737,0.9825174825174825,0.9985928979194624,1.0,2/11,15.74%,NRP2;UNC5C
prerank,cholesterol biosynthetic process (GO:0006695),0.22550127952311796,0.5584408607953244,0.9645808736717828,0.9914933274233961,1.0,12/31,33.67%,NSDHL;LSS;EBP;SC5D;HMGCR;ACAT2;ACLY;SQLE;INSIG1;GGPS1;TM7SF2;PLPP6
prerank,intracellular sterol transport (GO:0032366),0.26484890590523896,0.5578307575029903,0.9459084604715673,0.9914234538708302,1.0,3/13,13.70%,NPC1;OSBP;ABCA1
prerank,glycerol metabolic process (GO:0006071),-0.220816032191101,-0.5576591316479952,0.9715189873417721,0.9975670299750423,1.0,5/10,29.43%,GK;GK5;TPI1;GOT1;COQ3
prerank,regulation of viral genome replication (GO:0045069),0.20476794811855623,0.5572046203845215,0.9900881057268722,0.9913650909960819,1.0,19/56,33.00%,PABPC1;TMEM39A;MAVS;PKN2;ILF3;SRPK1;N4BP1;TRIM6;SHFL;STAU1;BANF1;PPID;HACD3;DDB1;LARP1;PPIH;TNIP1;IFIH1;PARP10
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.2273887337404003,0.5569091235166286,0.9712140175219024,0.9911594792259729,1.0,5/28,20.47%,OSBPL7;CDK5RAP3;AXIN1;PSMC5;CLU
prerank,positive regulation of chromatin organization (GO:1905269),-0.21506591337099812,-0.556060963803552,0.9739413680781759,0.9967781501117924,1.0,12/12,78.52%,TAL1;TERF2IP;SIN3A;TERF1;ACD;TINF2;ATRX;TERF2;UBE2N;DAXX;H3-3A;MIER1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.27073981198432384,0.5556748078568899,0.9503448275862069,0.991330020820013,1.0,2/10,18.69%,MIA3;AKT1
prerank,inorganic ion transmembrane transport (GO:0098660),0.2687778050614593,0.5551406027315348,0.9415121255349501,0.9912131426579055,1.0,2/12,15.51%,TRPM4;PKD2L1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.22173287283176665,0.555000857663438,0.9776470588235294,0.9909279921739867,1.0,9/35,24.17%,CALM2;PPP6R1;TIPRL;PPP6R3;CALM3;PPP6R2;CRY2;BOD1L1;FKBP1B
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.25945872397167347,0.5549206273506664,0.9548022598870056,0.9906265415037251,1.0,1/14,6.37%,PUM1
prerank,regulation of osteoclast differentiation (GO:0045670),0.21946778306157247,0.5540496999614951,0.9721886336154776,0.9906429270510021,1.0,1/33,1.84%,UBASH3B
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.264138127260251,0.5531399976602096,0.9516778523489933,0.9906794832315312,1.0,8/13,38.88%,IL6;MGAT5;HES1;PTPRC;IL7R;JAK3;CRLF2;JAK2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.23770448772889263,0.5525989314051639,0.9612903225806452,0.9905727730473785,1.0,3/22,12.91%,UBASH3A;EZR;PTPN2
prerank,maturation of LSU-rRNA (GO:0000470),0.23046005865901198,0.551389260729407,0.9783653846153846,0.9906980677783488,1.0,11/26,33.51%,LAS1L;EIF6;BOP1;RPL7A;WDR12;NIFK;RRP15;MAK16;RPF2;RSL1D1;DDX18
prerank,cellular biogenic amine metabolic process (GO:0006576),0.2589781027972271,0.5470043120038323,0.9542857142857143,0.9920601723474156,1.0,3/12,22.12%,HNMT;SRM;SLC22A3
prerank,determination of bilateral symmetry (GO:0009855),0.22970708431001705,0.546815290915902,0.96375,0.9917979150975758,1.0,7/24,28.53%,ODAD2;NPHP3;DNAAF4;CITED2;LEFTY1;BBS7;STIL
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.23927581234539602,0.5450927508738892,0.9564032697547684,0.9921231397012436,1.0,10/19,37.41%,AEN;HIPK2;TP53;RPS27L;CDIP1;MSH2;SNW1;DYRK2;PHLDA3;BCL3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.20009050986367355,0.5420688388438702,0.9890829694323144,0.992919106494436,1.0,7/63,15.25%,EPHB2;CD3E;CHRNB2;ANXA1;CD80;CLCF1;IL6
prerank,positive regulation of B cell activation (GO:0050871),0.20490552478610383,0.5401377238433176,0.9909706546275395,0.9932766201060129,1.0,7/50,15.25%,EPHB2;MMP14;CHRNB2;KMT5C;CD27;CLCF1;IL6
prerank,negative regulation of DNA binding (GO:0043392),0.22173148988676658,0.538529434877788,0.9739130434782609,0.9935248698997484,1.0,7/28,20.80%,HEY1;SMO;SUMO1;MDFI;E2F1;NFKBIA;MAD2L2
prerank,superoxide anion generation (GO:0042554),0.2553586276524096,0.5385105327534283,0.9568245125348189,0.9931971691903452,1.0,1/13,5.99%,NOX4
prerank,mitochondrial genome maintenance (GO:0000002),0.2555103390412195,0.5383071645995439,0.9451659451659452,0.9929256723912079,1.0,3/11,16.21%,LONP1;MEF2A;PARP1
prerank,alpha-amino acid catabolic process (GO:1901606),0.2207730145179779,0.5383067348558271,0.9685230024213075,0.9925920264546866,1.0,6/29,20.64%,MTRR;IDO2;ACAT1;GSTZ1;DAO;KYAT1
prerank,negative regulation of phagocytosis (GO:0050765),0.23558420881922418,0.5381415631705626,0.9555256064690026,0.9923158906473574,1.0,4/17,24.37%,HMGB1;PIP4P2;APPL1;SNX3
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.2484535998074492,0.5369460556620262,0.9623655913978495,0.992370143795039,1.0,7/15,30.39%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5;NOP10
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.22866855752175755,0.5369227204526645,0.9657794676806084,0.9920443860086838,1.0,5/23,24.88%,TIMM9;TOMM70;COX18;BAD;TIMM22
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.1909034772019269,0.5368298519584659,0.9904862579281184,0.9917526484205141,1.0,39/87,38.76%,ECSIT;COA8;AIFM1;ACAD9;NDUFS7;SURF1;BCS1L;TTC19;FASTKD3;COX18;NDUFAF4;UQCC3;SDHAF1;NDUFB6;DMAC2;NDUFA1;SDHAF2;COA5;SDHAF4;NDUFA7;NDUFB9;NDUFV2;COX16;NDUFA6;TIMM21;NDUFAF5;NDUFV3;SDHAF3;NDUFA9;UQCC1;NDUFAB1;UQCRFS1;NUBPL;COX14;NDUFA10;COX20;NDUFB10;NDUFS3;NDUFB3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.22650421650647592,0.5368289969304513,0.9785082174462706,0.991419956565139,1.0,9/24,30.49%,MAVS;TOMM70;TRAF3IP2;TRIM6;EIF2AK4;IL4;CGAS;HSP90AA1;LILRB1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.20396760625274657,-0.5367399157103342,0.9849056603773585,1.0,1.0,13/13,79.63%,ADHFE1;D2HGDH;GOT1;AADAT;GPT2;GOT2;OGDH;TAT;DLST;IDH1;IDH2;L2HGDH;PHYH
prerank,tyrosine metabolic process (GO:0006570),-0.21390639497878386,-0.5339996872630804,0.9746376811594203,1.0,1.0,4/11,25.70%,FAH;THAP4;TYR;IL4I1
prerank,melanosome localization (GO:0032400),0.22946094137868145,0.533632892500657,0.9724047306176085,0.9921674017141262,1.0,7/21,31.14%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,positive regulation of T cell activation (GO:0050870),0.1951701895541769,0.5332280983889258,0.9966777408637874,0.9919695289141224,1.0,6/62,15.25%,ZMIZ1;CD3E;ANXA1;HSPD1;CD80;IL6
prerank,sensory perception of smell (GO:0007608),-0.2132948339715021,-0.5315635020647862,0.9719298245614035,1.0,1.0,11/11,78.69%,SYT10;SLC24A4;ADCY3;BEST2;OMP;BBS4;OBP2B;GFY;MKKS;UBR3;DRD2
prerank,negative regulation of cell division (GO:0051782),0.2587790895673449,0.5311114455293788,0.9626556016597511,0.9923219112868145,1.0,4/11,31.68%,ZFYVE19;E2F8;CHMP4C;BLM
prerank,sensory perception of taste (GO:0050909),0.2633738085492079,0.530443123322859,0.9533527696793003,0.9922243510857259,1.0,1/10,15.51%,PKD2L1
prerank,T cell homeostasis (GO:0043029),0.2598887159654976,0.5302070072724421,0.9517045454545454,0.9919658713472173,1.0,5/10,33.57%,RIPK3;AKT1;PPP2R3C;JAK3;ZC3H8
prerank,modulation by host of viral genome replication (GO:0044827),-0.19925921275660746,-0.5274223124061634,0.9777777777777777,0.9997937716547789,1.0,13/13,80.10%,ZC3H12A;IFI27;NUCKS1;FMR1;FBXL2;CCL8;CCNK;YTHDC2;PPIB;VAPA;PRKN;TBC1D20;EIF2AK4
prerank,positive regulation of JUN kinase activity (GO:0043507),0.22571704396750245,0.526675321137213,0.9693251533742331,0.9927676393780291,1.0,6/23,27.36%,MAP3K5;MAP3K10;DUSP19;TAOK3;DVL2;MAP3K11
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2158556843543607,0.525235529753315,0.9845422116527943,0.9928806367035385,1.0,4/27,16.48%,ETNK1;ETNPPL;CHKB;PLA2G15
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.24541832873999864,0.523589187119277,0.9766803840877915,0.9930449416930702,1.0,4/13,28.28%,HEY1;MAD2L2;TAF1;PER2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.22397786599993103,0.5224591750704513,0.9808429118773946,0.9930697142717327,1.0,8/21,32.06%,UBE2C;CDC20;MAD2L2;RAB1A;GOLGA2;BTRC;UBE2S;GORASP1
prerank,inner mitochondrial membrane organization (GO:0007007),0.19951328003292584,0.5222888803940751,0.9921700223713646,0.9927900443177845,1.0,17/47,36.53%,SPG7;TIMM9;MICOS10;LETM1;ATP5MC3;TOMM70;UQCC3;AFG3L2;TIMM22;ATP5MC2;DNAJC11;MTX3;ATP5PD;ATP5MF;TIMM8B;ATP5F1E;ATP5F1C
prerank,negative regulation by host of viral transcription (GO:0043922),0.2444444444444444,0.5222846034291104,0.9549295774647887,0.9924578964274138,1.0,12/12,75.57%,HDAC1;TARDBP;TFAP4;INPP5K;REST;PSMC3;CCL3;CCL4;JUN;CCL5;POU2F3;HMGA2
prerank,peptide biosynthetic process (GO:0043043),0.17977478443113398,0.5212559590155214,0.9989743589743589,0.9924351912075321,1.0,12/153,12.88%,PCSK5;RRBP1;RPSA;DMD;ABCF1;HARS2;GSPT1;MRPS18B;MRPS14;AGO2;EIF4G1;MRPL35
prerank,regulation of activated T cell proliferation (GO:0046006),0.20665034274535155,0.5202640557104388,0.9876390605686032,0.9923975116547682,1.0,3/30,10.45%,HMGB1;CRTAM;RIPK3
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.2393292234795705,0.5192853440660382,0.9620786516853933,0.9923425418604344,1.0,5/14,31.06%,TNFRSF1B;IL4;LDLR;NR1D1;PTPRC
prerank,positive regulation of behavior (GO:0048520),0.2556777031354967,0.5175200669568853,0.9598278335724534,0.9925212889805688,1.0,2/10,13.02%,AGRP;NLGN1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.207278025356478,0.5163666928896743,0.9840490797546012,0.9924842839592382,1.0,5/33,18.30%,UBASH3A;EZR;PTPN2;KCNN4;TRAT1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.256598739936934,0.5155889471432854,0.9662921348314607,0.992362143850456,1.0,3/11,21.92%,SREBF1;CNEP1R1;LDLR
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.19075791985320756,0.5118282561147552,0.9966666666666667,0.9927327776458454,1.0,25/56,40.56%,ECSIT;ACAD9;NDUFS7;BCS1L;NDUFAF4;NDUFB6;DMAC2;NDUFA1;NDUFA7;NDUFB9;NDUFV2;NDUFA6;TIMM21;NDUFAF5;NDUFV3;NDUFA9;NDUFAB1;NUBPL;NDUFA10;NDUFB10;NDUFS3;NDUFB3;NDUFB5;TMEM126A;NDUFS8
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.19075791985320756,0.5118282561147552,0.9966666666666667,0.9927327776458454,1.0,25/56,40.56%,ECSIT;ACAD9;NDUFS7;BCS1L;NDUFAF4;NDUFB6;DMAC2;NDUFA1;NDUFA7;NDUFB9;NDUFV2;NDUFA6;TIMM21;NDUFAF5;NDUFV3;NDUFA9;NDUFAB1;NUBPL;NDUFA10;NDUFB10;NDUFS3;NDUFB3;NDUFB5;TMEM126A;NDUFS8
prerank,microtubule anchoring (GO:0034453),0.2433340811417204,0.5106362730866212,0.9721059972105998,0.9927037271962745,1.0,5/12,31.50%,PCM1;CAMSAP3;PEX14;GCC2;BCCIP
prerank,cristae formation (GO:0042407),0.2114843045688673,0.5102491509509598,0.9806996381182147,0.9924753690551473,1.0,11/27,36.53%,SPG7;LETM1;ATP5MC3;UQCC3;AFG3L2;ATP5MC2;DNAJC11;ATP5PD;ATP5MF;ATP5F1E;ATP5F1C
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.20643986944514187,-0.5053408029578047,0.9859154929577465,1.0,1.0,10/10,79.38%,THAP4;IL4I1;QDPR;KYNU;PCBD1;IYD;PAH;ATP7A;ASRGL1;KYAT1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.21620783872655736,0.5025830519509297,0.9894039735099338,0.9940604348186708,1.0,4/19,24.48%,HYKK;PHYKPL;GCDH;CRYM
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.23683781103379836,0.49364809428193845,0.9704579025110783,0.9957510131339393,1.0,2/11,18.50%,ARRB1;SAG
prerank,secondary alcohol biosynthetic process (GO:1902653),0.19833189362015954,0.48721352137000423,0.9940334128878282,0.9967654216661532,1.0,11/30,33.67%,NSDHL;LSS;EBP;HMGCR;ACAT2;ACLY;SQLE;INSIG1;GGPS1;TM7SF2;PLPP6
prerank,regulation of microglial cell activation (GO:1903978),-0.1734021847705336,-0.4835854427474834,0.9961089494163424,1.0,1.0,5/15,25.05%,SPHK1;CX3CL1;SYT11;TREM2;GRN
prerank,B cell activation involved in immune response (GO:0002312),0.2260203091076739,0.4830715489674591,0.9794520547945206,0.9972227775384348,1.0,6/13,38.41%,LIG4;MSH2;GPR183;EXOSC3;RNF8;RNF168
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.2333193712942358,0.4829418043553535,0.9789915966386554,0.9969077271660084,1.0,3/11,26.25%,IL4;HDAC2;TMEM106A
prerank,negative regulation by host of viral process (GO:0044793),-0.1992216921918152,-0.4789377596314756,0.9895470383275261,1.0,1.0,10/10,80.10%,ZC3H12A;CRP;CCL8;PTX3;CCNK;LTF;PSMC3;VAPA;PRKN;EIF2AK4
prerank,carbohydrate catabolic process (GO:0016052),0.1874047254070413,0.4763590815791874,0.9964622641509434,0.9977851347288722,1.0,11/38,30.22%,MAN2C1;DERA;PGK1;ENO2;MAN2B1;ENO4;PFKFB1;MANBA;PFKL;GAPDHS;LDHA
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.21292183311280616,0.4754021996899142,0.9869451697127938,0.9976199169415049,1.0,5/16,31.95%,RIPK3;CYRIB;LILRB1;PTPRC;STX7
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.22907656442665916,0.47489911758466286,0.9796215429403202,0.9973749590095784,1.0,3/11,21.58%,NCBP1;NCBP2;PAF1
prerank,spermatid development (GO:0007286),-0.1364140528407063,-0.4729289051130345,1.0,1.0,1.0,6/32,22.73%,JAM2;NECTIN2;CEP57;TDRD5;ACRBP;SYCP3
prerank,mesenchymal cell development (GO:0014031),0.21118669815924118,0.47020051840780863,0.9825503355704698,0.9978267149615512,1.0,8/18,34.91%,HEYL;NOLC1;KLHL12;SOX8;TAPT1;SNAI2;TCOF1;PEF1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.16329510632055338,-0.4696311608180315,1.0,1.0,1.0,3/16,13.53%,ATP5ME;ATP5MC1;ATP5F1B
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.16244375312945752,-0.4692672859770137,1.0,1.0,1.0,3/17,13.53%,ATP5ME;ATP5MC1;ATP5F1B
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.22435208182832805,0.46562867003614267,0.986822840409956,0.9981947314996286,1.0,1/10,9.77%,CRTAM
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.15630494850540064,-0.46282650454784635,0.9956140350877193,1.0,1.0,18/18,84.39%,HIP1R;BOK;HSPA1A;TMEM14A;BAX;ZNF205;CHCHD10;TMEM102;GSK3B;FZD9;ACAA2;GSK3A;BAK1;MPV17L;SLC25A5;MUL1;BID;SLC35F6
prerank,positive regulation of interferon-beta production (GO:0032728),0.18456185916172071,0.4611148485912287,0.9951749095295537,0.9985343687029243,1.0,11/33,32.37%,MAVS;TOMM70;IRF3;TBK1;PTPN11;RIPK2;RNF135;HSP90AA1;RIOK3;POLR3F;IFIH1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.20600970775175365,0.4607026761798821,0.9858429858429858,0.9982613070231903,1.0,7/18,30.39%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5;NOP10
prerank,DNA catabolic process (GO:0006308),-0.18115623626890964,-0.4590313517259914,0.993127147766323,0.9998257420258898,1.0,11/11,81.90%,XRN2;DNASE1L1;SETMAR;ISG20;DNASE1;DNASE1L3;MUS81;REXO4;DNASE1L2;FBH1;DFFB
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.18964769961152786,0.45773576896738327,0.9873577749683944,0.9983334280361353,1.0,4/24,16.89%,LIG4;UBC;RPS27A;POLB
prerank,positive regulation of lymphocyte activation (GO:0051251),0.18719153979465541,0.4573873321744309,0.9962917181705809,0.9980450729006127,1.0,6/28,26.97%,PRKDC;HSPD1;IL6;XRCC6;CYRIB;CCL2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.2128542907318035,0.4470853716292221,0.9861111111111112,0.9989631168261613,1.0,7/12,38.79%,YTHDC1;CDYL;HNRNPU;RBM15;RLIM;SMCHD1;PCGF3
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.216733617875973,0.4428013685837446,0.9897360703812317,0.9987499357917449,1.0,10/10,78.34%,WNK1;MAP2K5;KLF4;ADIPOQ;IL1RN;IL10;APOA1;MYADM;MBP;MAPK7
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.216733617875973,0.4428013685837446,0.9897360703812317,0.9987499357917449,1.0,10/10,78.34%,WNK1;MAP2K5;KLF4;ADIPOQ;IL1RN;IL10;APOA1;MYADM;MBP;MAPK7
prerank,regulation of B cell activation (GO:0050864),0.18490391850658183,0.4424461486605095,0.9949811794228356,0.9984588528420917,1.0,4/25,21.22%,IKZF3;IL6;IL4;BANK1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.19633928305280457,0.4421419487217557,0.9906040268456375,0.9981600399027712,1.0,2/16,14.36%,ERCC4;MSH4
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.16568307383224512,-0.44200787841732303,1.0,0.9996352056754132,1.0,14/14,83.45%,NECTIN2;IKBKG;RPS3;CARD11;CD226;TESPA1;LCK;BCL10;RAB29;CD81;RELA;PRKD2;TRAT1;KCNN4
prerank,regulation of neutrophil migration (GO:1902622),0.22036534197154845,0.44176341123513074,0.9899425287356322,0.9978690151706323,1.0,3/10,30.27%,MPP1;BST1;RAC1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.1939100063081946,0.4412942943870714,0.9933774834437086,0.9975874204175105,1.0,7/18,33.73%,TCTA;IL4;GPR137B;LILRB3;LILRB1;FSTL3;FBN1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.20145905694396282,0.4357903489575106,0.9920424403183024,0.9978099350143931,1.0,4/15,24.81%,SREBF1;CNEP1R1;LDLR;FITM2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.21666601976251304,0.4333587427396617,0.9943899018232819,0.9976923988042515,1.0,4/10,36.53%,ATP5MC3;ATP5MC2;ATP5PD;ATP5F1C
prerank,positive regulation of immune response (GO:0050778),-0.11060450726142912,-0.4262365096391018,1.0,0.9989664733358422,1.0,22/64,33.15%,GBP5;CD74;RSAD2;LGALS9;SIRT1;NOD2;PYCARD;XBP1;ITGAM;POLR3B;POLR3D;HRG;GRN;FADD;NMI;CCL5;TLR8;IL15;CD226;MYB;IL12RB1;POLR3C
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.1936643532262065,0.4209646977057218,0.9960264900662251,0.9983672369759742,1.0,7/14,39.14%,BOP1;WDR12;NIFK;RPF2;DDX18;RPL7L1;PES1
prerank,sterol biosynthetic process (GO:0016126),0.16769748801442044,0.41814345022049526,0.9988304093567252,0.998236086130522,1.0,12/33,33.67%,NSDHL;LSS;EBP;SC5D;HMGCR;ACAT2;ACLY;SQLE;INSIG1;GGPS1;TM7SF2;PLPP6
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.1756385690119092,0.40983581131923147,1.0,0.998435366466609,1.0,2/22,12.92%,FZD5;HSPD1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.16012759892072836,0.38913834027287536,0.9988038277511961,0.9990543057281964,1.0,1/29,5.15%,HORMAD1
prerank,negative regulation of synaptic transmission (GO:0050805),0.15615296499609435,0.372309300557034,0.9987684729064039,0.9992535132274296,1.0,7/23,31.58%,ARF1;PICK1;DRD2;LRRK2;PRRT1;ATAD1;MTMR2
